Citrus Sinensis ID: 015360
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 408 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.411 | 0.355 | 0.887 | 9e-92 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.416 | 0.389 | 0.759 | 2e-77 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.911 | 0.753 | 0.407 | 3e-77 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.808 | 0.681 | 0.392 | 1e-71 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.458 | 0.400 | 0.598 | 4e-62 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.453 | 0.261 | 0.453 | 1e-43 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.477 | 0.271 | 0.450 | 1e-42 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.431 | 0.230 | 0.455 | 4e-42 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.443 | 0.265 | 0.459 | 5e-42 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.460 | 0.264 | 0.438 | 2e-41 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 337 bits (864), Expect = 9e-92, Method: Compositional matrix adjust.
Identities = 157/177 (88%), Positives = 170/177 (96%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRD+KSSNILLDRQWNA+VSDFGLAKLL SE SYVTTRVMGTFGYVA
Sbjct: 265 LAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVA 324
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGMLNEKSD+YSFGILIMEIITGRNPVDYSRPQGE NLVDWLK+MVG+R+SEEVV
Sbjct: 325 PEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVV 384
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 364
DPK+P+ P+SKALKRVLLVALRCVDPDA KRPKMGH+IHMLEA+DLL+RDERR R+
Sbjct: 385 DPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRD 441
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (740), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 136/179 (75%), Positives = 154/179 (86%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRDVKSSNILLD++WNA+VSDFGLAKLL SE SYVTTRVMGTFGYV+
Sbjct: 258 LAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVS 317
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYA TGMLNE SDVYSFG+L+MEIITGR+PVDYSRP GE+NLVDW K MV SR+ EEV+
Sbjct: 318 PEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVI 377
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPS 366
DPK+ P +ALKR LLV LRC+D D++KRPKMG +IHMLEA+D FR E R +E S
Sbjct: 378 DPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFRPEHRSNQERS 436
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (739), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 203/498 (40%), Positives = 263/498 (52%), Gaps = 126/498 (25%)
Query: 9 VNTELSKRTSIFGLR---LWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQ 65
+N E+SK+ S FGL+ LWV + +++G IV+ L +LSL +T RRK ++
Sbjct: 7 LNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKS----RRSSSKFP 62
Query: 66 ILNTPPISKEIQ-EIVHHPAPVPE---IQVD---IGK--IEH--RVVFSDR--------- 105
P +SK+I+ + P PE I+++ GK + H R SD
Sbjct: 63 FNQIPHVSKDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCSSV 122
Query: 106 --------ASSGESRGTGSACETASFGSGSVG-------PEVSHLGWGRWYTLRELEAAT 150
+ SGE G GSA +G G V PE+SHLGWG W+TLR+LE AT
Sbjct: 123 NHHERACSSHSGEEGGFGSAGR--QYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELAT 180
Query: 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNN------------------------ 186
+ NV+GEGGYG+VYRG L +GT+VAVK LLNN
Sbjct: 181 NRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 240
Query: 187 -RLAYLHEGLEPKVVHRDVKSSNILL----------DRQWNAR----------------- 218
L Y EG+ +V+ V S N+ + W AR
Sbjct: 241 RLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEA 300
Query: 219 ------------------------VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 254
+SDFGLAKLL S S++TTRVMGTFGYVAPEYA TG
Sbjct: 301 IEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 360
Query: 255 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314
+LNEKSD+YSFG+L++E ITGR+PVDY RP EVNLV+WLK MVG+R++EEVVDP+L
Sbjct: 361 LLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPR 420
Query: 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENR 374
P+ ALKR LLV+LRCVDP+A KRP+M V MLE+D+ F ERR R S + G E
Sbjct: 421 PSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKR--SKTAGME-- 476
Query: 375 DFARKVGDKQLGEGASDT 392
+ D+ LG S+T
Sbjct: 477 --IVETKDESLGPSGSET 492
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (690), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 177/451 (39%), Positives = 232/451 (51%), Gaps = 121/451 (26%)
Query: 9 VNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILN 68
+N LS+ + GL LW +I I+L ++ V+ L +SL LT RRK S+ N
Sbjct: 5 LNDTLSRNYN--GLELWEIIVIVLSAIFVVVL-AISLWLTFRRK---------TSRSSSN 52
Query: 69 TPPISKEIQEIVHHPAPVPEIQVD-----------------IGKIEHRVVFSDRASSGES 111
P+S++I V P + EI+VD G E + +G+S
Sbjct: 53 LIPVSRQIPPSV--PEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDS 110
Query: 112 RGTGSACETASFGSGSVG--------------PEVSHLGWGRWYTLRELEAATSGLCEEN 157
+GS SV PE SHLGWG W+TLR+L+ AT+ +N
Sbjct: 111 SRSGSFNHLEKKDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDN 170
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNN-------------------------RLAYLH 192
+IG+GGYG+VYRG L +GT VAVK LLNN L Y
Sbjct: 171 IIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCM 230
Query: 193 EGLEPKVVHRDVKSSNILL----DRQ------WNARV----------------------- 219
EG + +V+ V + N+ D Q W ARV
Sbjct: 231 EGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVH 290
Query: 220 ------------------SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSD 261
SDFGLAKLL +++S++TTRVMGTFGYVAPEYA +G+LNEKSD
Sbjct: 291 RDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSD 350
Query: 262 VYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALK 321
VYSFG++++E ITGR PVDY+RP EV+LV+WLK MV R+SEEVVDP L P++ ALK
Sbjct: 351 VYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALK 410
Query: 322 RVLLVALRCVDPDATKRPKMGHVIHMLEADD 352
R LL ALRCVDP + KRP+M V MLE+++
Sbjct: 411 RTLLTALRCVDPMSEKRPRMSQVARMLESEE 441
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 112/187 (59%), Positives = 148/187 (79%)
Query: 166 IVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225
++++G L+ ++ V LAYLHE +EPKVVHRD+KSSNIL+D ++A++SDFGLA
Sbjct: 243 MIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLA 302
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285
KLL ++ +YV+TRVMGTFGYVAPEYA +G+LNEKSDVYS+G++++E ITGR PVDY+RP+
Sbjct: 303 KLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPK 362
Query: 286 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345
EV++V+WLK MV ++ EEVVD +L P + LKR LL ALRCVDPDA KRPKM V
Sbjct: 363 EEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVA 422
Query: 346 HMLEADD 352
MLE+D+
Sbjct: 423 RMLESDE 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 87/192 (45%), Positives = 129/192 (67%), Gaps = 7/192 (3%)
Query: 169 RGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228
+ +L T+V + LAYLHE P+++HRD+KSSNILL+ ++ARVSDFGLA+L
Sbjct: 466 KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLA 525
Query: 229 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288
+++TTRV+GTFGY+APEYA +G L EKSDV+SFG++++E+ITGR PVD S+P G+
Sbjct: 526 LDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDE 585
Query: 289 NLVDWLKTMVG----SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344
+LV+W + ++ + + + + DPKL + R++ A CV ATKRP+MG +
Sbjct: 586 SLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQI 645
Query: 345 IHMLE---ADDL 353
+ E A+DL
Sbjct: 646 VRAFESLAAEDL 657
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 92/204 (45%), Positives = 131/204 (64%), Gaps = 9/204 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE PK++HRD+KSSNILLD ++ A+V+DFGLA+L + +S+++TRVMGTFGY+A
Sbjct: 479 LAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGYLA 538
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW----LKTMVGSRKS 303
PEYA +G L ++SDV+SFG++++E+ITGR PVD S+P GE +LV+W L +
Sbjct: 539 PEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDI 598
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL--FRDERRI 361
EVVDP+L + +++ A CV A KRP+M V+ L+ D L + ++
Sbjct: 599 SEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDDLSDLTNGVKV 658
Query: 362 GRE---PSNSYGEENRDFARKVGD 382
G+ S Y E R F R D
Sbjct: 659 GQSRVYDSGQYSNEIRIFRRASED 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 82/180 (45%), Positives = 121/180 (67%), Gaps = 4/180 (2%)
Query: 175 GTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234
T+V + LAYLHE P+++HRD+KSSNILL+ ++A VSDFGLAKL ++
Sbjct: 526 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTH 585
Query: 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294
+TTRVMGTFGY+APEYA +G L EKSDV+SFG++++E+ITGR PVD S+P G+ +LV+W
Sbjct: 586 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA 645
Query: 295 KTMVGSRKSEE----VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
+ ++ + E + DPKL + + R++ A C+ ATKRP+M ++ ++
Sbjct: 646 RPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDS 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 86/187 (45%), Positives = 128/187 (68%), Gaps = 6/187 (3%)
Query: 169 RGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228
R +++ T+V V +AYLHE P+++HRD+KSSNILLD + A V+DFGLAK+
Sbjct: 429 RPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIA 488
Query: 229 --CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 286
++V+TRVMGTFGY+APEYA +G L+EK+DVYS+G++++E+ITGR PVD S+P G
Sbjct: 489 QELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLG 548
Query: 287 EVNLVDWLKTMVG----SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342
+ +LV+W + ++G + + +E+VDP+L K + R++ A CV A KRPKM
Sbjct: 549 DESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMS 608
Query: 343 HVIHMLE 349
V+ L+
Sbjct: 609 QVVRALD 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 85/194 (43%), Positives = 129/194 (66%), Gaps = 6/194 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE PK++HRD+KS+NILLD ++ A+V+DFGLAKL S +++V+TRVMGTFGY+A
Sbjct: 462 LAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLA 521
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW----LKTMVGSRKS 303
PEYA +G L ++SDV+SFG++++E+ITGR PVD +P GE +LV+W L + +
Sbjct: 522 PEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDF 581
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL--FRDERRI 361
E+VD +L K + R++ A CV KRP+M V+ L+++ + + ++
Sbjct: 582 SELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKV 641
Query: 362 GREPSNSYGEENRD 375
G+ + G+ N D
Sbjct: 642 GQSSAYDSGQYNND 655
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 408 | ||||||
| 359489654 | 492 | PREDICTED: probable serine/threonine-pro | 0.977 | 0.810 | 0.594 | 1e-140 | |
| 356568429 | 489 | PREDICTED: probable serine/threonine-pro | 0.965 | 0.805 | 0.538 | 1e-124 | |
| 356531961 | 493 | PREDICTED: probable serine/threonine-pro | 0.965 | 0.799 | 0.532 | 1e-121 | |
| 449432126 | 492 | PREDICTED: probable serine/threonine-pro | 1.0 | 0.829 | 0.542 | 1e-113 | |
| 449480227 | 494 | PREDICTED: LOW QUALITY PROTEIN: probable | 1.0 | 0.825 | 0.538 | 1e-111 | |
| 255541684 | 492 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.539 | 0.447 | 0.866 | 1e-108 | |
| 224130370 | 485 | predicted protein [Populus trichocarpa] | 0.539 | 0.453 | 0.848 | 1e-105 | |
| 297814211 | 481 | predicted protein [Arabidopsis lyrata su | 0.502 | 0.426 | 0.774 | 1e-91 | |
| 240255713 | 479 | protein kinase family protein [Arabidops | 0.502 | 0.427 | 0.774 | 5e-91 | |
| 388500924 | 477 | unknown [Medicago truncatula] | 0.531 | 0.454 | 0.744 | 7e-91 |
| >gi|359489654|ref|XP_003633957.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] gi|297745343|emb|CBI40423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 298/501 (59%), Positives = 336/501 (67%), Gaps = 102/501 (20%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+N+ELSK TSIFGLRLWVVIGI +G++IV+ LFLLSLC+TSRR++ +
Sbjct: 1 MSVYDAAFLNSELSKPTSIFGLRLWVVIGIFVGAVIVIILFLLSLCITSRRRRPPSSSKL 60
Query: 61 QQSKQILNTPPISKEIQEIVHHPAP--------VPEIQVDIGKIEHRVVFSDRASS---G 109
+ TP +SKEIQEIVH AP EIQ+DIGK EHRVVFSDR SS G
Sbjct: 61 GAGE---FTPVVSKEIQEIVHEAAPDHRPVLPPASEIQIDIGKSEHRVVFSDRLSSQASG 117
Query: 110 ESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYR 169
ESR T S ETAS G G PEVSHLGWGRWYTLRELEAAT+GL +ENVIGEGGYGIVYR
Sbjct: 118 ESRAT-SVTETASLGGGP--PEVSHLGWGRWYTLRELEAATNGLADENVIGEGGYGIVYR 174
Query: 170 GILSDGTKVAVKNLLNNR-------------------------LAYLHEGLEPKVVHRDV 204
G+L+D T+VAVKNLLNNR L Y EG +V+ V
Sbjct: 175 GVLADNTRVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAYRMLVYEYV 234
Query: 205 KSSNILLDR------------QWNARVSDF-----GLAKL-------------------- 227
+ N LD+ W+ R++ GLA L
Sbjct: 235 DNGN--LDQWLHGDVGEVSPLTWDIRINIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 292
Query: 228 ----------------LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME 271
LCSE SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME
Sbjct: 293 DRQWNSKVSDFGLAKLLCSEISYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME 352
Query: 272 IITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCV 331
II+GRNPVDYS+ GEVNLVDWLKTMVG+RKSEEVVDPKLP+MP+SKALKRVLLVALRCV
Sbjct: 353 IISGRNPVDYSQAPGEVNLVDWLKTMVGNRKSEEVVDPKLPEMPSSKALKRVLLVALRCV 412
Query: 332 DPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEG 388
DPDATKRPKMGHVIHMLEADDLLFRDERRIGRE S+S Y +EN RK+ +KQL EG
Sbjct: 413 DPDATKRPKMGHVIHMLEADDLLFRDERRIGRESSHSHHDYQQENH-ANRKIDNKQLDEG 471
Query: 389 ASDTSE-GDGSRNNHRPTMRR 408
A D+SE D R+ + T R
Sbjct: 472 ACDSSECADSGRSQYPQTKWR 492
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568429|ref|XP_003552413.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1160), Expect = e-124, Method: Compositional matrix adjust.
Identities = 265/492 (53%), Positives = 302/492 (61%), Gaps = 98/492 (19%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS++D AF+NT+LSK TSIFGLRLWVVIGIL+G IV LFLLSLCL SRR +
Sbjct: 1 MSIFDGAFMNTQLSKHTSIFGLRLWVVIGILIGVFIVFTLFLLSLCLVSRRNRRR--SGA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPAP------VPEIQVDIGK-IEHRVVFS-DRASSGESR 112
++ +K+I IVH P P PEI V++GK EHRVV DR SS ES+
Sbjct: 59 GTGYKVAGGADAAKDIHTIVHLPGPHMLRPPAPEIHVEMGKKTEHRVVVQCDRVSSEESK 118
Query: 113 GT-GSACETASFGSGSVGP--------EVSHLGWGRWYTLRELEAATSGLCEENVIGEGG 163
T GS CET S EVSHLGWGRWYTLRELE AT GL ENV+GEGG
Sbjct: 119 VTVGSGCETTSSFGSGSVGGPGPGLGPEVSHLGWGRWYTLRELEDATGGLSPENVVGEGG 178
Query: 164 YGIVYRGILSDGTKVAVKNLLNNR-------------------------LAYLHEGLEPK 198
YGIVY G+L+DGTK+AVKNLLNN+ L Y EG
Sbjct: 179 YGIVYHGVLNDGTKIAVKNLLNNKGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEGAYRM 238
Query: 199 VVHRDVKSSNI----------LLDRQWNARVSDF-----GLAKL---------------- 227
+V+ V + N+ + WN R++ GLA L
Sbjct: 239 LVYEYVDNGNLEQWLHGDVGAVSPLTWNIRMNIILGTARGLAYLHEGLEPKVVHRDVKSS 298
Query: 228 --------------------LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGI 267
LCSE SYVTTRVMGTFGYVAPEYACTGML EKSD+YSFGI
Sbjct: 299 NILIDRQWNSKVSDFGLAKLLCSENSYVTTRVMGTFGYVAPEYACTGMLTEKSDIYSFGI 358
Query: 268 LIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVA 327
LIMEIITGR+PVDYSRPQGEVNL++WLKTMVG+RKSEEVVDPKLP+MP+SKALKR LL+A
Sbjct: 359 LIMEIITGRSPVDYSRPQGEVNLIEWLKTMVGNRKSEEVVDPKLPEMPSSKALKRALLIA 418
Query: 328 LRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQLGE 387
LRCVDPDATKRPKMGHVIHMLEADDLLF E+R E S SY E RD DK+
Sbjct: 419 LRCVDPDATKRPKMGHVIHMLEADDLLFHTEQRTEGESSRSYQSEQRDSNL---DKRRDG 475
Query: 388 GASDTSEGDGSR 399
GA+D SE +R
Sbjct: 476 GANDKSEDASTR 487
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531961|ref|XP_003534544.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-121, Method: Compositional matrix adjust.
Identities = 264/496 (53%), Positives = 302/496 (60%), Gaps = 102/496 (20%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS++D AF+NT+LSK TSIFGLRLWVVIGIL+G IV LFLLSLCL SRR + +
Sbjct: 1 MSIFDGAFMNTQLSKHTSIFGLRLWVVIGILIGVFIVFTLFLLSLCLVSRRNRRRSVAVP 60
Query: 61 QQSKQILNTPPISKEIQEIVHHPAP------VPEIQVDIGK-IEHRVVFS-DRASSGESR 112
++ +K+I IVH P P PEI V++GK EHRVV D SS ES+
Sbjct: 61 --GYKVTGDADAAKDIHTIVHLPGPHMLRPVAPEIHVEMGKKTEHRVVVQCDGVSSEESK 118
Query: 113 GT-GSACETASFGSGSVG------------PEVSHLGWGRWYTLRELEAATSGLCEENVI 159
T GS CET S PEVSHLGWGRWYTLRELE AT GL ENV+
Sbjct: 119 VTVGSGCETTSSFGSGSVGGLGLGSGPGLGPEVSHLGWGRWYTLRELEDATGGLSPENVV 178
Query: 160 GEGGYGIVYRGILSDGTKVAVKNLLNNR-------------------------LAYLHEG 194
GEGGYGIVY G+L+DGTK+AVKNLLNN+ L Y EG
Sbjct: 179 GEGGYGIVYHGVLNDGTKIAVKNLLNNKGQAEKEFKIEVEAIGRVRHKNLVRLLGYCVEG 238
Query: 195 LEPKVVHRDVKSSNI----------LLDRQWNARVSDF-----GLAKL------------ 227
+V+ V + N+ + WN R++ GLA L
Sbjct: 239 AYRMLVYEYVDNGNLEQWLHGDVGAVSPLTWNIRMNIILGTARGLAYLHEGLEPKVVHRD 298
Query: 228 ------------------------LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263
LCSE SYVTTRVMGTFGYVAPEYACTGML EKSD+Y
Sbjct: 299 VKSSNILIDRQWNSKVSDFGLAKLLCSENSYVTTRVMGTFGYVAPEYACTGMLTEKSDIY 358
Query: 264 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRV 323
SFGILIMEIITGR+PVDYSRPQGEVNL++WLKTMVG+RKSEEVVDPKLP+MP SKALKR
Sbjct: 359 SFGILIMEIITGRSPVDYSRPQGEVNLIEWLKTMVGNRKSEEVVDPKLPEMPFSKALKRA 418
Query: 324 LLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDK 383
LL+ALRCVDPDATKRPKMGHVIHMLEADDLLF E+R E S SY E++D DK
Sbjct: 419 LLIALRCVDPDATKRPKMGHVIHMLEADDLLFHTEQRTEGESSRSYQSEHKDSNL---DK 475
Query: 384 QLGEGASDTSEGDGSR 399
+ G G D SE +R
Sbjct: 476 RTGGGVIDKSEDASTR 491
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432126|ref|XP_004133851.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1061), Expect = e-113, Method: Compositional matrix adjust.
Identities = 267/492 (54%), Positives = 309/492 (62%), Gaps = 84/492 (17%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSR-RKKHNHLQQ 59
MS+YDAAFVNTELSK TSIFGLRLWVVIGI +G+LIVLALFLLSLCLTSR R +H +
Sbjct: 1 MSVYDAAFVNTELSKPTSIFGLRLWVVIGIFVGALIVLALFLLSLCLTSRKRNRHKNQIG 60
Query: 60 QQQSKQILNTPPISKEIQEIVHHPAPV------PEIQVDIGKI-------------EHRV 100
+S + P +SKEIQEIVHH P PEI V+IGK+ E R
Sbjct: 61 FPKSTTPHSPPAVSKEIQEIVHHAVPDHHHHVQPEIHVEIGKLEHRVVFSDRPSSGESRG 120
Query: 101 VFSDRASSGESR---------------------GTGSACETASFGSGSVG-PEVSHLGWG 138
S+ AS G T CE G G G + LG G
Sbjct: 121 TVSETASFGSGTVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYLGILGDG 180
Query: 139 RWYTLREL-----EAATSGLCEENVIG---------------EGGYGIVYRGILSDGT-- 176
++ L +A E IG EG Y ++ +++G
Sbjct: 181 TRIAIKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYEYVNNGNLD 240
Query: 177 ---------------KVAVKNLLNNR--LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219
++ V +L LAYLHEGLEPKVVHRDVKSSNILLDRQWNA+V
Sbjct: 241 QWLHGDVGDVSPLTWEIRVNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAKV 300
Query: 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279
SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII+GR+PV
Sbjct: 301 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIISGRSPV 360
Query: 280 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
DYSRPQGEVNLVDWLK MVG RKSEEVVDPKL + P SK LKRVLLVALRCVDPDATKRP
Sbjct: 361 DYSRPQGEVNLVDWLKAMVGDRKSEEVVDPKLREKPPSKGLKRVLLVALRCVDPDATKRP 420
Query: 340 KMGHVIHMLEADDLLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEGASDTSEGD 396
KMGHVIHMLEAD+LL DE R+G++ ++S + ENR +R+V +++ +S+ SEGD
Sbjct: 421 KMGHVIHMLEADNLLSHDEHRVGKDSTHSIEGHQHENRAVSRRVNNQKDEGASSNISEGD 480
Query: 397 GSRNNHRPTMRR 408
N H + R
Sbjct: 481 SDGNIHHQSRWR 492
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449480227|ref|XP_004155835.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1049), Expect = e-111, Method: Compositional matrix adjust.
Identities = 266/494 (53%), Positives = 310/494 (62%), Gaps = 86/494 (17%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSR-RKKHNHLQQ 59
MS+YDAAFVNTELSK TSIFGLRLWVVIGI +G+LIVLALFLLSLCLTSR R +H +
Sbjct: 1 MSVYDAAFVNTELSKPTSIFGLRLWVVIGIFVGALIVLALFLLSLCLTSRKRNRHKNQIG 60
Query: 60 QQQSKQILNTPPISKEIQEIVHHPAPV------PEIQVDIGKI-------------EHRV 100
+S + P +SKEIQEIVHH P PEI V+IGK+ E R
Sbjct: 61 FPKSTTPHSPPAVSKEIQEIVHHAVPDHHHHVQPEIHVEIGKLEHRVXFSDRPSSGESRG 120
Query: 101 VFSDRASSGESR---------------------GTGSACETASFGSGSVG-PEVSHLGWG 138
S+ AS G T CE G G G + LG G
Sbjct: 121 TVSETASFGSGTVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYLGILGDG 180
Query: 139 RWYTLREL-----EAATSGLCEENVIG---------------EGGYGIVYRGILSDGT-- 176
++ L +A E IG EG Y ++ +++G
Sbjct: 181 TRIAIKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYEYVNNGNLD 240
Query: 177 ---------------KVAVKNLLNNR--LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219
++ V +L LAYLHEGLEPKVVHRDVKSSNILLDRQWNA+V
Sbjct: 241 QWLHGDVGDVSPLTWEIRVNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAKV 300
Query: 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279
SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII+GR+PV
Sbjct: 301 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIISGRSPV 360
Query: 280 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
DYSRPQGEVNLVDWLK MVG RKSEEVVDPKL + P SK LKRVLLVALRCVDPDATKRP
Sbjct: 361 DYSRPQGEVNLVDWLKAMVGDRKSEEVVDPKLREKPPSKGLKRVLLVALRCVDPDATKRP 420
Query: 340 KMGHVIHMLEADD--LLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEGASDTSE 394
KMGHVIHMLEAD+ L+ +E R+G++ ++S + ENR +R+V +++ +S+ SE
Sbjct: 421 KMGHVIHMLEADNCYLMMYEEHRVGKDSTHSIEGHQHENRAVSRRVNNQKDEGASSNISE 480
Query: 395 GDGSRNNHRPTMRR 408
GD N H P+ R
Sbjct: 481 GDSDGNIHHPSRWR 494
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541684|ref|XP_002511906.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223549086|gb|EEF50575.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1019), Expect = e-108, Method: Compositional matrix adjust.
Identities = 194/224 (86%), Positives = 207/224 (92%), Gaps = 4/224 (1%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRDVKSSNILLDRQWN +VSDFGLAKLLCSERSYVTTRVMGTFGYVA
Sbjct: 270 LAYLHEGLEPKVVHRDVKSSNILLDRQWNPKVSDFGLAKLLCSERSYVTTRVMGTFGYVA 329
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGMLNEKSD+YSFGILIME+I+GR+PVDYSRPQGEVNLVDWLKTMVG+RKSEEVV
Sbjct: 330 PEYACTGMLNEKSDIYSFGILIMELISGRSPVDYSRPQGEVNLVDWLKTMVGNRKSEEVV 389
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DPKLP+MPASKALKRVLLVALRCVDPDAT+RPKMGHVIHMLEADDLLFRDERRIGRE SN
Sbjct: 390 DPKLPEMPASKALKRVLLVALRCVDPDATRRPKMGHVIHMLEADDLLFRDERRIGRESSN 449
Query: 368 S---YGEENRDFARKVGDKQLGEGASDTSEGDGSRNNHRPTMRR 408
S Y +EN A K+GD+Q GEG SDTSEGD SRN H+ + R
Sbjct: 450 SRHEYEQENPAVA-KLGDRQFGEGTSDTSEGDSSRNLHQQSRWR 492
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130370|ref|XP_002320820.1| predicted protein [Populus trichocarpa] gi|222861593|gb|EEE99135.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 386 bits (992), Expect = e-105, Method: Compositional matrix adjust.
Identities = 190/224 (84%), Positives = 205/224 (91%), Gaps = 4/224 (1%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH+GLEPKVVHRDVKSSNILLDRQWN++VSDFGLAKLL SERSYVTTRVMGTFGYVA
Sbjct: 263 LAYLHDGLEPKVVHRDVKSSNILLDRQWNSKVSDFGLAKLLHSERSYVTTRVMGTFGYVA 322
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGMLNEKSDVYSFGILIMEII+GR+PVDYSRPQGEVNLV+WLKTMVG+RKSEEVV
Sbjct: 323 PEYACTGMLNEKSDVYSFGILIMEIISGRSPVDYSRPQGEVNLVEWLKTMVGNRKSEEVV 382
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DPKLP+MPASKALKR LLVAL+CVDPDATKRPKMGHVIHMLEADDLLFRDERR+GREPS+
Sbjct: 383 DPKLPEMPASKALKRALLVALKCVDPDATKRPKMGHVIHMLEADDLLFRDERRVGREPSH 442
Query: 368 S---YGEENRDFARKVGDKQLGEGASDTSEGDGSRNNHRPTMRR 408
S Y +EN A K DKQ GEG SDTSEG+ R +H+PT R
Sbjct: 443 SQHDYEQENHA-AMKFIDKQSGEGTSDTSEGESGRKHHQPTRWR 485
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814211|ref|XP_002874989.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297320826|gb|EFH51248.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 342 bits (878), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 165/213 (77%), Positives = 186/213 (87%), Gaps = 8/213 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRD+KSSNILLDRQWNA+VSDFGLAKLL SE SYVTTRVMGTFGYVA
Sbjct: 275 LAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLFSESSYVTTRVMGTFGYVA 334
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGML EKSD+YSFGILIMEIITGRNPVDYSRPQGEVNLV+WLKTMVG+R+SEEVV
Sbjct: 335 PEYACTGMLTEKSDIYSFGILIMEIITGRNPVDYSRPQGEVNLVEWLKTMVGNRRSEEVV 394
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DPK+P+ P SKALKRVLLVALRCVDPDA KRPKMGH+IHMLEA+DL +RDERR RE +
Sbjct: 395 DPKIPEPPTSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLFYRDERRATREHA- 453
Query: 368 SYGEENRDFARKVGDKQLGEGASDTSEGDGSRN 400
+RD+ + ++ A++TSE D S++
Sbjct: 454 -----SRDYNQP--QTEVSAAAAETSESDSSKD 479
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240255713|ref|NP_192042.5| protein kinase family protein [Arabidopsis thaliana] gi|332656610|gb|AEE82010.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 340 bits (873), Expect = 5e-91, Method: Compositional matrix adjust.
Identities = 165/213 (77%), Positives = 184/213 (86%), Gaps = 8/213 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRD+KSSNILLDRQWNA+VSDFGLAKLL SE SYVTTRVMGTFGYVA
Sbjct: 273 LAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLFSESSYVTTRVMGTFGYVA 332
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGML EKSD+YSFGILIMEIITGRNPVDYSRPQGEVNLV+WLKTMVG+R+SEEVV
Sbjct: 333 PEYACTGMLTEKSDIYSFGILIMEIITGRNPVDYSRPQGEVNLVEWLKTMVGNRRSEEVV 392
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DPK+P+ P SKALKRVLLVALRCVDPDA KRPKMGH+IHMLEA+DL +RDERR RE
Sbjct: 393 DPKIPEPPTSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLFYRDERRATRE--- 449
Query: 368 SYGEENRDFARKVGDKQLGEGASDTSEGDGSRN 400
+RDF + ++ ++TSE D S++
Sbjct: 450 ---HASRDFNQP--RTEISPAVAETSESDSSKD 477
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388500924|gb|AFK38528.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 340 bits (872), Expect = 7e-91, Method: Compositional matrix adjust.
Identities = 169/227 (74%), Positives = 195/227 (85%), Gaps = 10/227 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRDVKSSNIL+DRQWN++VSDFGLAKLL S+ SYVTTRVMGTFGYVA
Sbjct: 255 LAYLHEGLEPKVVHRDVKSSNILIDRQWNSKVSDFGLAKLLHSDHSYVTTRVMGTFGYVA 314
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGML E+SDVYSFGILIME+ITGR+PVDYSRPQGEVNLV+WLK MVGSR++EEVV
Sbjct: 315 PEYACTGMLTERSDVYSFGILIMELITGRSPVDYSRPQGEVNLVEWLKNMVGSRRAEEVV 374
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DPK+ + P+SKALKR LLVALRCVDPD+ KRPKMGHVIHMLEADDLLFR++RRI E S+
Sbjct: 375 DPKISEKPSSKALKRSLLVALRCVDPDSLKRPKMGHVIHMLEADDLLFREDRRIVGESSH 434
Query: 368 SYGEENRDFARK-----VGDKQLGEGASDTSEGD-GSRNNHRPTMRR 408
S NRD+ R+ +G ++G +D SE D SR++H+PT R
Sbjct: 435 S----NRDYQREHKGSSLGKNRIGGEITDQSEDDSSSRSHHQPTKLR 477
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 408 | ||||||
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.490 | 0.423 | 0.798 | 4.2e-145 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.438 | 0.409 | 0.759 | 3.8e-93 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.487 | 0.402 | 0.629 | 3.7e-90 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.517 | 0.452 | 0.605 | 9.8e-90 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.458 | 0.380 | 0.656 | 4.7e-88 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.504 | 0.402 | 0.605 | 8.1e-87 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.443 | 0.373 | 0.631 | 4.6e-80 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.514 | 0.449 | 0.561 | 1.7e-78 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.517 | 0.428 | 0.649 | 1.1e-69 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.546 | 0.327 | 0.413 | 2e-54 |
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 4.2e-145, Sum P(2) = 4.2e-145
Identities = 162/203 (79%), Positives = 179/203 (88%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRD+KSSNILLDRQWNA+VSDFGLAKLL SE SYVTTRVMGTFGYVA
Sbjct: 265 LAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVA 324
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYACTGMLNEKSD+YSFGILIMEIITGRNPVDYSRPQGE NLVDWLK+MVG+R+SEEVV
Sbjct: 325 PEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVV 384
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DPK+P+ P+SKALKRVLLVALRCVDPDA KRPKMGH+IHMLEA+DLL+RDERR R+ +
Sbjct: 385 DPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRDHGS 444
Query: 368 SYGEENRDFARKVGDKQLGEGAS 390
E ++ A + GE S
Sbjct: 445 ---RERQETAVVAAGSESGESGS 464
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 715 (256.8 bits), Expect = 3.8e-93, Sum P(2) = 3.8e-93
Identities = 136/179 (75%), Positives = 154/179 (86%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHEGLEPKVVHRDVKSSNILLD++WNA+VSDFGLAKLL SE SYVTTRVMGTFGYV+
Sbjct: 258 LAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVS 317
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYA TGMLNE SDVYSFG+L+MEIITGR+PVDYSRP GE+NLVDW K MV SR+ EEV+
Sbjct: 318 PEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVI 377
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPS 366
DPK+ P +ALKR LLV LRC+D D++KRPKMG +IHMLEA+D FR E R +E S
Sbjct: 378 DPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFRPEHRSNQERS 436
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 3.7e-90, Sum P(3) = 3.7e-90
Identities = 129/205 (62%), Positives = 160/205 (78%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE +EPKVVHRD+K+SNIL+D ++NA++SDFGLAKLL S S++TTRVMGTFGYVA
Sbjct: 294 LAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVA 353
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYA TG+LNEKSD+YSFG+L++E ITGR+PVDY RP EVNLV+WLK MVG+R++EEVV
Sbjct: 354 PEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 413
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
DP+L P+ ALKR LLV+LRCVDP+A KRP+M V MLE+D+ F ERR R S
Sbjct: 414 DPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKR--SK 471
Query: 368 SYGEENRDFARKVGDKQLGEGASDT 392
+ G E + D+ LG S+T
Sbjct: 472 TAGME----IVETKDESLGPSGSET 492
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 9.8e-90, Sum P(3) = 9.8e-90
Identities = 129/213 (60%), Positives = 169/213 (79%)
Query: 168 YRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227
+ G L+ ++ V + LAYLHE +EPKVVHRD+KSSNIL+D ++NA++SDFGLAKL
Sbjct: 248 HHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKL 307
Query: 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 287
L +S+VTTRVMGTFGYVAPEYA TG+LNEKSDVYSFG+L++E ITGR+PVDY+RP E
Sbjct: 308 LGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANE 367
Query: 288 VNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347
VNLV+WLK MVGS++ EEV+DP + PA++ALKRVLL ALRC+DPD+ KRPKM V+ M
Sbjct: 368 VNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRM 427
Query: 348 LEADDL-LFRDERRIGR-EPSNSYGEENRDFAR 378
LE+++ + R+ERR+ R + NS + +R +R
Sbjct: 428 LESEEYPVPREERRVRRTQEENSDTDRSRPVSR 460
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 4.7e-88, Sum P(3) = 4.7e-88
Identities = 124/189 (65%), Positives = 155/189 (82%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE +EPKVVHRD+KSSNIL++ ++NA+VSDFGLAKLL + +S+VTTRVMGTFGYVA
Sbjct: 290 LAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 349
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYA +G+LNEKSDVYSFG++++E ITGR+PVDY RP EVNLVDWLK MVG+R+SEEVV
Sbjct: 350 PEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGTRRSEEVV 409
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL-LFRDERRIGREPS 366
DP + P +++LKR LL ALRCVDPD+ KRPKM V+ MLE+++ + R++RR R
Sbjct: 410 DPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRSRTRE 469
Query: 367 NSYGEENRD 375
S E N D
Sbjct: 470 GSM-EINSD 477
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 665 (239.2 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
Identities = 132/218 (60%), Positives = 170/218 (77%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE +EPKVVHRD+K+SNIL+D +NA++SDFGLAKLL S S++TTRVMGTFGYVA
Sbjct: 301 LAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVA 360
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYA TG+LNEKSD+YSFG+L++E ITGR+PVDY RP EVNLV+WLK MVG+R++EEVV
Sbjct: 361 PEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWLKMMVGTRRAEEVV 420
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
D ++ PA++ALKR LLVALRCVDP+A KRPKM V+ MLE+D+ FR+ERR
Sbjct: 421 DSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDEHPFREERR------- 473
Query: 368 SYGEENRDFARKVGDKQLGEGASDTSEGDG-SRNNHRP 404
++R + ++ + E ++DTS+G G S N +P
Sbjct: 474 --NRKSRTASMEIVETT--EESADTSKGPGHSENTTKP 507
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 4.6e-80, Sum P(2) = 4.6e-80
Identities = 115/182 (63%), Positives = 150/182 (82%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE +EPKVVHRD+KSSNIL+D ++N+++SDFGLAKLL +++S++TTRVMGTFGYVA
Sbjct: 277 LAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVA 336
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PEYA +G+LNEKSDVYSFG++++E ITGR PVDY+RP EV+LV+WLK MV R+SEEVV
Sbjct: 337 PEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVV 396
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL-LFRDERRIGREPS 366
DP L P++ ALKR LL ALRCVDP + KRP+M V MLE+++ + R++RR R +
Sbjct: 397 DPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPIAREDRRRRRSQN 456
Query: 367 NS 368
+
Sbjct: 457 GT 458
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.7e-78, Sum P(2) = 1.7e-78
Identities = 119/212 (56%), Positives = 160/212 (75%)
Query: 166 IVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225
++++G L+ ++ V LAYLHE +EPKVVHRD+KSSNIL+D ++A++SDFGLA
Sbjct: 243 MIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLA 302
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285
KLL ++ +YV+TRVMGTFGYVAPEYA +G+LNEKSDVYS+G++++E ITGR PVDY+RP+
Sbjct: 303 KLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPK 362
Query: 286 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345
EV++V+WLK MV ++ EEVVD +L P + LKR LL ALRCVDPDA KRPKM V
Sbjct: 363 EEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVA 422
Query: 346 HMLEADD--LLFRDERRIGREPSNSYGEENRD 375
MLE+D+ ++ R+ERR R + E+ D
Sbjct: 423 RMLESDEYPVMPREERRRRRNQNAETHRESTD 454
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 706 (253.6 bits), Expect = 1.1e-69, P = 1.1e-69
Identities = 139/214 (64%), Positives = 173/214 (80%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKS 206
E +G E+ + G GG G ++ L+ ++ + L YLHEGLEPKVVHRD+KS
Sbjct: 236 EYVDNGNLEQWIHG-GGLG--FKSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKS 292
Query: 207 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 266
SNILLD+QWN++VSDFGLAKLL SE SYVTTRVMGTFGYVAPEYA TGMLNE+SDVYSFG
Sbjct: 293 SNILLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFG 352
Query: 267 ILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLV 326
+L+MEII+GR+PVDYSR GEVNLV+WLK +V +R +E V+DP++ P+ ++LKR LLV
Sbjct: 353 VLVMEIISGRSPVDYSRAPGEVNLVEWLKRLVTNRDAEGVLDPRMVDKPSLRSLKRTLLV 412
Query: 327 ALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 360
ALRCVDP+A KRPKMGH+IHMLEA+DL+ +D+RR
Sbjct: 413 ALRCVDPNAQKRPKMGHIIHMLEAEDLVSKDDRR 446
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 2.0e-54, Sum P(2) = 2.0e-54
Identities = 96/232 (41%), Positives = 145/232 (62%)
Query: 169 RGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228
R +++ T+V V +AYLHE P+++HRD+KSSNILLD + A V+DFGLAK+
Sbjct: 429 RPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIA 488
Query: 229 --CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 286
++V+TRVMGTFGY+APEYA +G L+EK+DVYS+G++++E+ITGR PVD S+P G
Sbjct: 489 QELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLG 548
Query: 287 EVNLVDWLKTMVG----SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342
+ +LV+W + ++G + + +E+VDP+L K + R++ A CV A KRPKM
Sbjct: 549 DESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMS 608
Query: 343 HVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQ-LGEGASDTS 393
V+ L D L + G P S ++R + ++ Q + G+ D S
Sbjct: 609 QVVRAL--DTLEEATDITNGMRPGQSQVFDSRQQSAQIRMFQRMAFGSQDYS 658
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00026917001 | SubName- Full=Chromosome chr15 scaffold_40, whole genome shotgun sequence; (487 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 408 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-22 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.004 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.004 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +VHRD+K NILLD + +++DFGLA+ L TT V GT Y+A
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMA 164
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + D++S G+++ E++TG+ P G+ L++ K + +
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIG-----KPKP 214
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P+ S K ++ + + D KR
Sbjct: 215 PFPPPEWDISPEAKDLI---RKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 56/177 (31%), Positives = 80/177 (45%), Gaps = 19/177 (10%)
Query: 166 IVYRGILSDGT-KVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224
+ G LS+ K +L L YLH ++HRD+K NILLD +++DFGL
Sbjct: 89 LSRGGPLSEDEAKKIALQILR-GLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGL 144
Query: 225 AKLLCSERSYVTTRVMGTFGYVAPE-YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 283
AK L S +TT V GT Y+APE K DV+S G+++ E++TG+ P
Sbjct: 145 AKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----- 198
Query: 284 PQGEVNL-VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
GE L L + E +K L +C++ D +KRP
Sbjct: 199 FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL------IKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 38/87 (43%), Positives = 56/87 (64%), Gaps = 6/87 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L YLH ++HRD+K NILLD +++DFGL+KLL S++S + T V GT Y+
Sbjct: 105 LEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYM 160
Query: 247 APE-YACTGMLNEKSDVYSFGILIMEI 272
APE G +EKSD++S G+++ E+
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-20
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YL +HRD+ + N L+ ++SDFGL++ L + Y ++A
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSE 304
PE G KSDV+SFG+L+ EI T G P G N ++++LK G R
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKK--GYRL-- 223
Query: 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
PK P P + + L+C D RP ++ +L
Sbjct: 224 ----PKPPNCP-----PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 4e-20
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YL +HRD+ + N L+ ++SDFGL++ L + Y ++A
Sbjct: 115 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSE 304
PE G KSDV+SFG+L+ EI T G P G N ++++LK G R
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEYLKN--GYRL-- 222
Query: 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
P+ P P + + L+C D RP ++ +L
Sbjct: 223 ----PQPPNCP-----PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 31/170 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYV 246
LAYLH +VHRD+K +NIL+D +++DFG AK L E T V GT ++
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE +D++S G ++E+ TG+ P E+ +GS
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIGSSGE--- 221
Query: 307 VDPKLPKMPA--SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 354
P++P S+ K L +C+ D KRP AD+LL
Sbjct: 222 ----PPEIPEHLSEEAKDFL---RKCLRRDPKKRPT---------ADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 45/172 (26%), Positives = 65/172 (37%), Gaps = 37/172 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVM 240
+ YL K VHRD+ + N L+ ++SDFGL++ + + Y R M
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVG 299
APE G+ KSDV+SFG+L+ EI T G P Y +
Sbjct: 175 ------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YP-------------GLSN 213
Query: 300 SRKSEEVVDPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
E + P L ++ L C D RP ++ LE
Sbjct: 214 EEVLEYLRKGYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 50/152 (32%), Positives = 83/152 (54%), Gaps = 20/152 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LA+LH K++HRD+KS N+ LD N ++ D G+AKLL ++ T ++GT Y++
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLS 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE NEKSDV++ G+++ E TG++P D + L+ LK + G V
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI--LKIIRG-------V 217
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P + + S+ L +++ +C+ D +RP
Sbjct: 218 FPPVSQ-MYSQQLAQLI---DQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--- 244
+ YL VHRD+ + N L+ ++SDFGL++ + + Y G
Sbjct: 115 MEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIK 169
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
++APE G KSDV+SFG+L+ EI T G P Y E +++ L+ G R
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNE-EVLELLED--GYR-- 222
Query: 304 EEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
LP+ L ++ L+C D RP ++ L
Sbjct: 223 -------LPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 15/106 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +++RD+K NILLD + +++DFGLAK L SE S T GT Y+A
Sbjct: 106 LEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLA 161
Query: 248 PEYACTGMLNEK-----SDVYSFGILIMEIITGRNPVDYSRPQGEV 288
PE +L K D +S G+L+ E++TG+ P Y+ + E+
Sbjct: 162 PE-----VLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 31/158 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH ++HRD+K++NILL ++ DFGL+ L ++ ++GT ++A
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMA 165
Query: 248 PEYACTGMLN-----EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302
PE ++N K+D++S GI +E+ G+ P P +K +
Sbjct: 166 PE-----VINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---------MKALFKIAT 211
Query: 303 SEEVVDPKLP-KMPASKALKRVLLVALRCVDPDATKRP 339
+ P L S K L +C+ + KRP
Sbjct: 212 NGP---PGLRNPEKWSDEFKDFL---KKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH K++HRD+K NI L ++ DFG++K+L S T V GT Y++
Sbjct: 116 LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171
Query: 248 PEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE C N KSD++S G ++ E+ T ++P + L LK + G
Sbjct: 172 PE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LA--LKILKGQY----- 220
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P +P S L+ ++ + D +RP
Sbjct: 221 --PPIPSQY-SSELRNLV---SSLLQKDPEERP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 21/182 (11%)
Query: 167 VYRGILSDGTKVAVKNLLN------NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 220
+Y+ + G ++ K L L+YLH K++HRD+K SNILL R+ ++
Sbjct: 91 IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLC 147
Query: 221 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV- 279
DFG++ L + S T GT Y+APE + SDV+S G+ ++E+ R P
Sbjct: 148 DFGVSGELVN--SLAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 280 -DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338
+ P G + L+ ++ M + E+ D + S+ K + +C++ D T+R
Sbjct: 205 PEGEPPLGPIELLSYIVNM----PNPELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRR 257
Query: 339 PK 340
P
Sbjct: 258 PT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 20/152 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE V+HRD+K++NIL + +++DFG+A L + V+GT ++A
Sbjct: 112 LAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMA 167
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + SD++S G ++E++TG NP P ++N + L +V
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTG-NP-----PYYDLNPMAALFRIVQDD------ 215
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P LP+ S LK L ++C D RP
Sbjct: 216 HPPLPEG-ISPELKDFL---MQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLHE K++HRDVK SNIL++ + ++ DFG++ L + S T V GT Y+A
Sbjct: 113 LTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFV-GTSSYMA 167
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + KSD++S G+ ++E+ TGR P + + L+ +V +E
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-PENDPPDGIFELLQYIV----NEP-- 220
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPK----MGH 343
P+LP S V L C+ D +RP + H
Sbjct: 221 PPRLPSGKFSPDF--QDFVNL-CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH ++HRD+K NILLD Q + ++DF +A + + + T+ GT GY+A
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS-GTPGYMA 167
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 283
PE C + D +S G+ E + G+ P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 22/157 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH L V+HRDVK SN+L++R ++ DFG++ L S T G Y+A
Sbjct: 116 LEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMA 171
Query: 248 PEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
PE + + KSDV+S GI ++E+ TGR P D W KT K
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SW-KTPFQQLK- 218
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340
+VV+ P++PA K +C+ + +RP
Sbjct: 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 6e-16
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 23/156 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----ERSYVTTRVMGTF 243
L YLH ++HRD+K SN+L++ + +++DFG++K+L + ++V GT
Sbjct: 112 LDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTV 164
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
Y++PE + +D++S G+ ++E G+ P + P G+ + + ++ +
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFP--FL-PPGQPSFFELMQAICDGPP- 220
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P LP S + + C+ D KRP
Sbjct: 221 -----PSLPAEEFSPEFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 78.2 bits (191), Expect = 7e-16
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 18/184 (9%)
Query: 168 YRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAK 226
+G LS+ + + + + L YLH ++HRD+K NILLDR ++ DFGLAK
Sbjct: 94 RKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK 150
Query: 227 LLCSERS-----YVTTRVMGTFGYVAPEYA---CTGMLNEKSDVYSFGILIMEIITGRNP 278
LL S + + +GT GY+APE + SD++S GI + E++TG P
Sbjct: 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
Query: 279 VD-YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK 337
+ + + + + + SKA +L + + D
Sbjct: 211 FEGEKNSSATSQTLKIILELPTPSLASPL--SPSNPELISKAASDLL---KKLLAKDPKN 265
Query: 338 RPKM 341
R
Sbjct: 266 RLSS 269
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 34/171 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GY 245
+AYL +HRD+ + NIL+ +++DFGLA+L+ E T R F +
Sbjct: 116 MAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKW 170
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
APE A G KSDV+SFGIL+ EI+T GR P Y G N
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP--YP---GMTN--------------R 211
Query: 305 EVVDP-----KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
EV++ ++P+ P L+ L+C D D +RP ++ LE
Sbjct: 212 EVLEQVERGYRMPRPPNCPEELYDLM--LQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 23/156 (14%)
Query: 188 LAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
L H +P V+HRD+K +NI LD N ++ DFGLAK+L + S+ T V GT Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYY 176
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
++PE +EKSD++S G LI E+ P +R Q ++ +
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLA--------------SK 221
Query: 306 VVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 339
+ + K ++P S L V+ ++ D KRP
Sbjct: 222 IKEGKFRRIPYRYSSELNEVI---KSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 58/178 (32%), Positives = 84/178 (47%), Gaps = 28/178 (15%)
Query: 177 KVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236
K+AV + L YL E L K++HRDVK SNILLDR N ++ DFG++ L S
Sbjct: 111 KIAVATV--KALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAK 164
Query: 237 TRVMGTFGYVAPEYACTGMLNE---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 293
TR G Y+APE + +SDV+S GI + E+ TG+ P ++ D
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----KWNSVFDQ 219
Query: 294 LKTMVGSRKSEEVVDPKLPKMPASKALKR----VLLVALRCVDPDATKRPKMGHVIHM 347
L +VV P + S+ + V + L C+ D +KRPK ++
Sbjct: 220 LT---------QVVKGDPPILSNSEEREFSPSFVNFINL-CLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 58/168 (34%), Positives = 86/168 (51%), Gaps = 29/168 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L Y+H+ V+HRD+K++NIL+ N ++ DFG+A LL S +T V GT ++A
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMA 169
Query: 248 PEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE G + K+D++S GI I E+ TG P YS VD + M+ KS+
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPP--YSD-------VDAFRAMMLIPKSKP- 219
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 354
P+L SK L+ VA C+D + +R L A++LL
Sbjct: 220 --PRLEDNGYSKLLRE--FVAA-CLDEEPKER---------LSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH V+HRD+KS NILL + + +++DFG A L E+S + V GT ++A
Sbjct: 129 LEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMA 184
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE K D++S GI+ +E+ G P + P L+ + +
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-P---------LRALF------LI 228
Query: 307 VDPKLPKMPASKALKRVLLVAL-RCVDPDATKRP 339
+P + + L +C+ D KRP
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 16/98 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH ++HRD+K SNIL++ +++DFGLA+ S T + T Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 248 PE-------YACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE Y + D++S G ++ E+ G+
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 22/162 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
++Y+H+ ++HRD+K+ NI L + ++ DFG++K+L SE S T V+GT Y++
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMS 169
Query: 248 PEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE C G+ N KSD+++ G ++ E++T + D + P +NLV +K + G+
Sbjct: 170 PEL-CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLV--VKIVQGNYTPV-- 221
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
S L ++ + D KRP V+
Sbjct: 222 ------VSVYSSELISLV---HSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 52/169 (30%), Positives = 68/169 (40%), Gaps = 32/169 (18%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF-- 243
+ YL E VHRD+ + N+L+ A+VSDFGLAK + G
Sbjct: 113 EGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPV 163
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSR 301
+ APE + KSDV+SFGIL+ EI + GR P Y R P +V
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV-----------VP 210
Query: 302 KSEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
E K +M A V V C + D KRP + L
Sbjct: 211 HVE-----KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YL+ +++HRD+K SNIL++ + ++ DFG++ L + S T V GT Y++
Sbjct: 116 LTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--SIADTFV-GTSTYMS 170
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR-----PQGEVNLVDWLKTMVGSRK 302
PE G KSDV+S GI I+E+ G+ P +S + ++D L
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-------- 222
Query: 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
+++V P++P+S + + C+ D T+RP
Sbjct: 223 -QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH+ E ++VHRD+ +NI+L ++DFGLAK S +T+ V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTS-VVGTILYSC 181
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE EK+DV++FG ++ ++ T P YS N++ L T ++V
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYS-----TNMLS-LAT--------KIV 226
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
+ +P + V V C+ PDA RP + V M+
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 32/115 (27%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM------- 240
L YLH ++HRD+K NILLD+ + +++DFG AK+L S + +
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 241 ------------GTFGYVAPEYACTGMLNEK-----SDVYSFGILIMEIITGRNP 278
GT YV+PE +LNEK SD+++ G +I +++TG+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 35/83 (42%), Positives = 50/83 (60%), Gaps = 1/83 (1%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 255
E +V+HRD+KS NI L + ++ DFG A+LL S +Y T V GT YV PE
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 256 LNEKSDVYSFGILIMEIITGRNP 278
N KSD++S G ++ E+ T ++P
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLHE +HRD+K++NILL + + +++DFG++ L S S T V GT ++A
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMA 166
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE +EK+D++S GI +E+ G P
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 41/113 (36%), Positives = 64/113 (56%), Gaps = 10/113 (8%)
Query: 173 SDGTKVAVKNLLNNRLAYLHEGL----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228
+G K+ + L++ A + EG+ +HRD++++NIL+ +++DFGLA+L+
Sbjct: 94 PEGIKLTINKLID-MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152
Query: 229 CSERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
E + T R F + APE G KSDV+SFGIL+ EI+T GR P
Sbjct: 153 --EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 23/156 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L YLH+ ++VHRD+K N+L++ ++SDFG +K L T GT Y+
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYM 176
Query: 247 APEYACTGM--LNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKS 303
APE G +D++S G I+E+ TG+ P ++ PQ + V K
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI------- 229
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P++P+ +++A + LRC +PD KR
Sbjct: 230 ----HPEIPESLSAEAKNFI----LRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-----LLCSERSYVTTRVMGT 242
L YLH ++HRD+K +NIL+D + ++SDFG++K L ++ + + G+
Sbjct: 119 LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 243 FGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
++APE K+D++S G L++E++TG++P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 35/87 (40%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+AYL E +HRD+ + NIL+ +V+DFGLA+L+ E Y+++ + + A
Sbjct: 117 MAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTA 172
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT 274
PE A G + KSDV+SFGIL+ E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 42/187 (22%)
Query: 169 RGILSDGTKVAV-KNLLNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226
RG L + V K +L L YLH G +HRD+K+ NILL + +++DFG++
Sbjct: 96 RGGLDEAIIATVLKEVLKG-LEYLHSNGQ----IHRDIKAGNILLGEDGSVKIADFGVSA 150
Query: 227 LL-----CSERSYVTTRVMGTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIIT 274
L + + T +GT ++APE Y + K+D++SFGI +E+ T
Sbjct: 151 SLADGGDRTRKVRKT--FVGTPCWMAPEVMEQVHGY------DFKADIWSFGITAIELAT 202
Query: 275 GRNPVDYSR-PQGEVNLVDWLKTMVGSRKS-EEVVDPKLPKMPASKALKRVLLVALRCVD 332
G P YS+ P +V + T+ S E D K SK+ ++ +++L C+
Sbjct: 203 GAAP--YSKYPPMKV----LMLTLQNDPPSLETGADYK----KYSKSFRK--MISL-CLQ 249
Query: 333 PDATKRP 339
D +KRP
Sbjct: 250 KDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---T 242
+ YL + +HRD+ + NIL++ + ++SDFGLAK+L ++ Y + G
Sbjct: 120 KGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 243 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 274
F Y APE T + SDV+SFG+ + E+ T
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 24/160 (15%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
+ +AYLH +VHRD+K SN+L++ N +++DFG++++L + V GT Y
Sbjct: 179 SGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 246 VAPEYACTGMLNE------KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 299
++PE T LN D++S G+ I+E GR P R QG DW M
Sbjct: 235 MSPERINTD-LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QG-----DWASLMCA 287
Query: 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
S P AS+ + + C+ + KR
Sbjct: 288 ICMS----QPPEAPATASREFRHFI---SCCLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243
L + L ++H +++HRD+K +N+ + ++ D GL + S+ + + V GT
Sbjct: 115 LCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
Y++PE N KSD++S G L+ E+ ++P ++NL K K
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCK------KI 220
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344
E+ P LP S+ L+ LV+ RC++PD KRP + +V
Sbjct: 221 EKCDYPPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH K +HRD+K+ NILL+ + A+++DFG++ L + T V+GT ++A
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMA 167
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE N K+D++S GI +E+ G+ P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 10/109 (9%)
Query: 176 TKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235
+V LL LAYLH +VHRD+K +NI LD ++ DFG A L + + +
Sbjct: 101 IRVYTLQLLEG-LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
Query: 236 TTRV---MGTFGYVAPEYACTGMLNEK---SDVYSFGILIMEIITGRNP 278
V GT Y+APE G +D++S G +++E+ TG+ P
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH P VV ++ I++D + + L LLC++ T+ + YVA
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVA 846
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN--LVDWLKTMVGSRKSEE 305
PE T + EKSD+Y FG++++E++TG++P D + V+ +V+W + +
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDM 903
Query: 306 VVDPKLPKMPAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
+DP + + + V+ +AL C D T RP V+ LE+
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 20/149 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ ++V+RD+K N+LLD N R+SD GLA L + R GT GY+A
Sbjct: 108 LEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGYMA 162
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + + D ++ G + E+I GR+P R + E + LK V
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRT---LEMAV- 215
Query: 308 DPKLPK--MPASKALKRVLLVALRCVDPD 334
+ P P +K L LL DP+
Sbjct: 216 --EYPDKFSPEAKDLCEALL----QKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 36/82 (43%), Positives = 52/82 (63%), Gaps = 5/82 (6%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLN 257
+HRD++S+NIL+ +++DFGLA+L+ E + T R F + APE A G
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 258 EKSDVYSFGILIMEIIT-GRNP 278
KSDV+SFGIL+ E++T GR P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYV 246
YLH +++RD+K N+LLD ++ DFG AK L ++++ GT YV
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYV 159
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
APE + D +S GIL+ E++TGR P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
L YL E + V+HRDVK SNILLD N ++ DFG++ L ++ TR G Y
Sbjct: 125 KALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAY 180
Query: 246 VAPEY----ACTGMLNEKSDVYSFGILIMEIITGRNP 278
+APE + ++DV+S GI ++E+ TG+ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
+V+HRD+K +N+ + ++ D GL + S+ + + V GT Y++PE N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 184
Query: 258 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317
KSD++S G L+ E+ ++P Y D + +K E+ P LP S
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF-YG---------DKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 318 KALKRVLLVALRCVDPDATKRPKMGHVIHM 347
+ L+ LV++ C+ PD +RP +G+V +
Sbjct: 235 EKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 34/165 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L ++H L ++HRD+K+ NILLD+ ++ DFG++K+L S+ T V+GT Y+
Sbjct: 114 LHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM------VGS 300
+PE N+KSD+++ G ++ E+ + + + + V LK M +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIMSGTFAPISD 223
Query: 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345
R S ++ R L++++ +DP KRP++ ++
Sbjct: 224 RYSPDL---------------RQLILSMLNLDPS--KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 23/154 (14%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLN 257
+HRD++++NIL+ +++DFGLA+L+ E + T R F + APE A G
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 258 EKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316
KSDV+SFGIL+ E++T GR P G VN R+ E V+ + +MP
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPY-----PGMVN-----------REVLEQVE-RGYRMPC 224
Query: 317 SKALKRVLLVALR-CVDPDATKRPKMGHVIHMLE 349
+ L ++ C D +RP ++ LE
Sbjct: 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 4/113 (3%)
Query: 166 IVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225
+V + +G AV L +LH +V+HRD+KS NILL + +++DFG
Sbjct: 106 VVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+ E+S +T V GT ++APE K D++S GI+ +E++ G P
Sbjct: 163 AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 37/82 (45%), Positives = 51/82 (62%), Gaps = 5/82 (6%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLN 257
VHRD++++NIL+ +V+DFGLA+L+ E + T R F + APE A G
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 258 EKSDVYSFGILIMEIIT-GRNP 278
KSDV+SFGIL+ E+ T GR P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 22/160 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLHE ++HRD+K+ N+ L R +V D G+A++L ++ +T ++GT Y++
Sbjct: 115 LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMS 170
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE N KSDV++ G + E+ T ++ N D + ++V ++
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHA---------FNAKD-MNSLV-----YRII 215
Query: 308 DPKLPKMPASKALKRV-LLVALRCVDPDATKRPKMGHVIH 346
+ KLP MP + + L+ + P+ KRP + ++
Sbjct: 216 EGKLPPMPKDYSPELGELIATMLSKRPE--KRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 18/102 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-------TTRVM 240
L YLH ++HRD+K NIL+D + +++DFGL+K+ R R++
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 241 GTFGYVAPEYACTGMLNE----KSDVYSFGILIMEIITGRNP 278
GT Y+APE +L + D +S G ++ E + G P
Sbjct: 163 GTPDYIAPEV----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
+V+HRD+K +N+ + ++ D GL + S ++ ++GT Y++PE N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 258 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317
KSD++S G L+ E+ ++P Y ++NL K K E+ P LP S
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCK------KIEQCDYPPLPSDHYS 234
Query: 318 KALKRVLLVALRCVDPDATKRPKMGHVIHM 347
+ L++++ + C++PD KRP + +V +
Sbjct: 235 EELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 45/142 (31%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH K +HRD+K++N+LL Q + +++DFG+A L + T V GT ++A
Sbjct: 114 LDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK--TMVG--SRKS 303
PE + K+D++S GI +E+ G P P + L+ T+ G S+
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPF 229
Query: 304 EEVVDPKLPKMPASKALKRVLL 325
+E +D L K P+ + + LL
Sbjct: 230 KEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 166 IVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225
+V + +G AV L +LH +V+HRD+KS NILL + +++DFG
Sbjct: 107 VVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285
+ E+S + ++GT ++APE K D++S GI+ +E+I G P P
Sbjct: 164 AQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 286 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338
+ L + + + E+ +P+ A+ R L RC+D D KR
Sbjct: 223 RALYL-------IATNGTPELQNPE-----KLSAIFRDFLN--RCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GY 245
+AYL +HRD+ + N+L+ +V+DFGLA+++ E Y R F +
Sbjct: 116 MAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIY-EAREGAKFPIKW 170
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
APE A + KSDV+SFGIL+ EI+T GR P
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 41/112 (36%), Positives = 66/112 (58%), Gaps = 10/112 (8%)
Query: 174 DGTKVAVKNLLNNRLAYLHEGL----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229
+G+K + L++ A + EG+ + +HRD++++NIL+ +++DFGLA+++
Sbjct: 95 EGSKQPLPKLIDFS-AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI- 152
Query: 230 SERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
E + T R F + APE G KSDV+SFGIL+MEI+T GR P
Sbjct: 153 -EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMGTFGYV 246
+ YL E K+VHRD+ + N+L+ ++SDFGL++ + E SYV ++ ++
Sbjct: 140 MQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM 196
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
A E + +SDV+SFG+L+ EI+T G NP P+ L + LKT + E
Sbjct: 197 AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFNLLKTGYRMERPEN 253
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
S+ + ++ L C + KRP + LE
Sbjct: 254 ----------CSEEMYNLM---LTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH KV+HRD+K+ NILL + +++DFG++ S T + GT ++A
Sbjct: 116 LNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMA 171
Query: 248 PEY-ACTGM----LNEKSDVYSFGILIMEIITGRNP 278
PE AC + K+D++S GI ++E+ P
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 30/105 (28%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---------YVTTR 238
L Y+H G V+HRD+K SNILL+ +++DFGLA+ L YV TR
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 239 VMGTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIITGR 276
Y APE Y G+ D++S G ++ E++ G+
Sbjct: 177 -----WYRAPEILLGSTRYT-KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 15/95 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +V+RD+K N+LLD +++DFG AK + R+Y GT Y+A
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLA 166
Query: 248 PEYACTGMLNE---KS-DVYSFGILIMEIITGRNP 278
PE +L++ K+ D ++ GILI E++ G P
Sbjct: 167 PEI----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 15/95 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
LAY H +++HRD+K NIL++R +++DFGLA+ R+Y T V+ T Y
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYR 165
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
APE +L K D++S G + E+ITG+
Sbjct: 166 APEI----LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ +++RD+K NILLD + + ++DFGL+K +E GT Y+A
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 248 PEYACTGML--NEKSDVYSFGILIMEIITGRNP 278
PE G ++ D +S G+L E++TG +P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 4/113 (3%)
Query: 166 IVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225
+V + +G AV L +LH +V+HRD+KS NILL + +++DFG
Sbjct: 106 VVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+ E+S +T V GT ++APE K D++S GI+ +E++ G P
Sbjct: 163 AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACT 253
VHRD+ + N+LL Q A++SDFGL+K L ++ SY R G + + APE
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 254 GMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 286
+ +SDV+S+GI + E + G+ P Y + +G
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP--YKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACT 253
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 254 GMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 286
+ KSDV+SFG+L+ E + G+ P Y +G
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 33/158 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVM-GTFG 244
L +LHE +++RD+K N+LLD + + +++DFG +C E VTT GT
Sbjct: 109 LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFG----MCKEGILGGVTTSTFCGTPD 161
Query: 245 YVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
Y+APE + + D ++ G+L+ E++ G++P + E L S
Sbjct: 162 YIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQ-------SILE 210
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
+EV P+ A LK L TK P+
Sbjct: 211 DEVRYPRWLSKEAKSILKSFL-----------TKNPEK 237
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 190 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 249
YLH +++RD+K N+LLD + + +V+DFG AK + +R++ + GT Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPE 185
Query: 250 YACTGMLNEKSDVYSFGILIMEIITGRNP 278
+ + D ++ G+L+ E I G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +V+HRD+KS N+LL + +++DFG + E+S +T V GT ++A
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 183
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE K D++S GI+ +E++ G P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 26/143 (18%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
+V+RD+K NILLD + + ++DFGL+K SE T GT Y+APE +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 259 KS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV-------DPK 310
K+ D +S GILI E++TG +P T+ G R ++ V DP
Sbjct: 186 KAVDWWSLGILIFELLTGASPF----------------TLEGERNTQSEVSRRILKCDPP 229
Query: 311 LPKMPASKALKRVLLVALRCVDP 333
P + LL L DP
Sbjct: 230 FP--SFIGPEAQDLLHKLLRKDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFG 244
L++LH V+HRD+KS +ILL ++SDFG C++ S R ++GT
Sbjct: 128 LSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPY 180
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
++APE + D++S GI+++E++ G P
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 36/91 (39%), Positives = 56/91 (61%), Gaps = 7/91 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH E +V+RD+K NILLD++ + +++DFG AK L +R++ + GT Y+A
Sbjct: 114 LEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLA 166
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + N+ D ++ GILI E++ G P
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFG 244
+ YLH +VHRD+K +NIL D N ++ DFG +K L CS + + + V GT
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPY 172
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+++PE K+DV+S G ++E++T + P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS---YVTTRVMGTF 243
L+YLHE +++HRDVK +N+L+D R++DFG A L ++ + +++GT
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
++APE DV+S G +I+E+ T + P + + + L+ + + +
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340
E + P L V LRC++ RP
Sbjct: 233 PEHLSPGLRD------------VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 30/167 (17%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYACTGML 256
VHRD+ + NIL++ + ++ DFGL K+L ++ Y R G F Y APE
Sbjct: 130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKF 188
Query: 257 NEKSDVYSFGILIMEIITGRN-----PVDYSRPQGE--------VNLVDWLKTMVGSRKS 303
+ SDV+SFG+++ E+ T + P ++ R G +L++ LK R
Sbjct: 189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGR-- 244
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
LP P A + + C + D ++RP + +EA
Sbjct: 245 -------LPAPPGCPA--EIYAIMKECWNNDPSQRPSFSELALQVEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 24/101 (23%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTRVM 240
L YLH V+HRD+K SNIL++ + ++ DFGLA+ + + YV TR
Sbjct: 116 LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW- 171
Query: 241 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE +L+ D++S G + E++T +
Sbjct: 172 ----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
K++HRDVK SN+L++ + ++ DFG++ L + S T V GT Y+APE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--SIAKTYV-GTNAYMAPERISGEQYG 171
Query: 258 EKSDVYSFGILIMEIITGRNP 278
SDV+S GI ME+ GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 193 EGLE----PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 248
EG+E K+VHRD+ + NIL+ A+VSDFGLA++ +++ + AP
Sbjct: 111 EGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKL--PVKWTAP 166
Query: 249 EYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
E + KSDV+S+G+L+ E+ + GR P
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 190 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 249
+LH +V+RD+K N+LLD Q N R+SD GLA L ++ T+ GT GY+APE
Sbjct: 110 HLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPE 164
Query: 250 YACTGMLNEKSDVYSFGILIMEIITGRNP 278
+ D ++ G I E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 39/112 (34%), Positives = 64/112 (57%), Gaps = 10/112 (8%)
Query: 174 DGTKVAVKNLLNNRLAYLHEGL----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229
+G KV + L++ A + EG+ +HRD++++N+L+ +++DFGLA+++
Sbjct: 96 EGGKVLLPKLIDFS-AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI- 153
Query: 230 SERSYVTTRVMGTF--GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
E + T R F + APE G KSDV+SFGIL+ EI+T G+ P
Sbjct: 154 -EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH+ VHRD+K +NIL+D +++DFG+AK + G+ ++A
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMA 169
Query: 248 PEY-ACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE A G +D++S G ++E+ TG+ P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTGML 256
+HRD+ + N+LL ++ DFGLA+ + ++ +YV R+ ++APE +
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFNCVY 220
Query: 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315
+SDV+S+GIL+ EI + G NP P V+ + G R ++ P
Sbjct: 221 TFESDVWSYGILLWEIFSLGSNPY----PGMPVDSKFYKLIKEGYRMAQPEHAP------ 270
Query: 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ + C D D KRP ++ ++
Sbjct: 271 -----AEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 21/155 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
++YL E ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
A E + KSDV+S+G+ + E++T G +P + V+ + ++ K E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGA------KPYEGIPAVE-IPDLL--EKGE- 228
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340
+LP+ P V +V ++C DA RP
Sbjct: 229 ----RLPQPPICTI--DVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 30/81 (37%), Positives = 50/81 (61%), Gaps = 4/81 (4%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+APE G+ +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVAYD 174
Query: 259 KS-DVYSFGILIMEIITGRNP 278
S D +S G ++ +++ G +P
Sbjct: 175 SSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 31/91 (34%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ +++RD+K N+LLD+ + +++DFG+ K + +T GT Y+A
Sbjct: 109 LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE NE D +SFG+L+ E++ G++P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFGY 245
L +LH +V+RD+K NILLD + +++DFG+ K +L + T GT Y
Sbjct: 109 LQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDY 162
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+APE N D +SFG+L+ E++ G++P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLHE +HRD+K +NILL + +++DFG++ L + + + + GT ++A
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMA 169
Query: 248 PEYA---CTGMLNEKSDVYSFGILIMEIITGRNP 278
PE A G + K D+++ GI +E+ + P
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY---VTTRVMGTFG 244
LAYLH ++HRD+K+ N+L+D ++SDFG++K S+ Y + G+
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSVF 175
Query: 245 YVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNP 278
++APE + + K D++S G +++E+ GR P
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GY 245
+AYL VHRD+ + N+LL + A++SDFG+++ L + Y G + +
Sbjct: 108 MAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT 274
APE G + KSDV+S+G+ + E +
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
+ LH+ ++HRD+K N+L+D+ + +++DFGL S + +GT Y
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL-----SRNGLENKKFVGTPDY 159
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285
+APE ++ SD +S G +I E + G P P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 10/91 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H VVHRD+K SNIL++ + ++ DFGLA++ + + YV+TR Y
Sbjct: 121 LKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172
Query: 247 APEYACTGM-LNEKSDVYSFGILIMEIITGR 276
APE T + + D++S G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
K++HRD+KS NI L + ++ DFG+A++L S T +GT Y++PE N
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYN 179
Query: 258 EKSDVYSFGILIMEIIT 274
KSD+++ G ++ E+ T
Sbjct: 180 NKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 30/81 (37%), Positives = 49/81 (60%), Gaps = 4/81 (4%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+APE G +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGTAYD 174
Query: 259 KS-DVYSFGILIMEIITGRNP 278
S D +S G ++ +++ G +P
Sbjct: 175 SSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVMGTFGYVAPEYACTGMLN 257
VHRD+ + NIL++ +VSDFGL+++L E +Y T+ + APE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 258 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK-MPA 316
SDV+SFGI++ E+++ RP +++ + +K + +LP M
Sbjct: 189 SASDVWSFGIVMWEVMSFG-----ERPYWDMSNHEVMKAINDGF--------RLPAPMDC 235
Query: 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
A+ +++ L+C D +RP+ ++++L+
Sbjct: 236 PSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +H ++HRD+KS+NILL ++ DFG +K+ + S R GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE ++K+D++S G+L+ E++T + P D + ++ KT+ G
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH-----KTLAGR------ 261
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347
DP LP P+ + ++ AL DP +RP +++M
Sbjct: 262 YDP-LP--PSISPEMQEIVTALLSSDPK--RRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 24/101 (23%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-------SYVTTRVM 240
L Y+H V+HRD+K SN+LL+ + ++ DFGLA++ E YV TR
Sbjct: 119 LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR-- 173
Query: 241 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE MLN K D++S G ++ E+++ R
Sbjct: 174 ---WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT------ 253
VHRD+K N+L+DR + +++DFG A L + + + +GT Y+APE T
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 254 GMLNEKSDVYSFGILIMEIITGRNP 278
G + D +S G++ E+I GR+P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L LH+ ++V+RD+K NILLD + R+SD GLA + E + RV GT GY+A
Sbjct: 115 LEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYMA 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE D ++ G L+ E+I G++P + + + V+ L V SE+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF- 228
Query: 308 DPKLPKMPASKALKRVLLVALRCVDP 333
P +++L ++LL C DP
Sbjct: 229 ------SPDARSLCKMLL----CKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-GTFG 244
L +LH +++RD+K N++LD + + +++DFG +C E + TTR GT
Sbjct: 114 LFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFG----MCKENIFGGKTTRTFCGTPD 166
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280
Y+APE + D ++FG+L+ E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVMGTFGY 245
L YL E + K++HRDVK SNIL++ + ++ DFG++ L S+V TR Y
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SY 164
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279
++PE +SD++S G+ ++E+ GR P+
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 34/81 (41%), Positives = 47/81 (58%), Gaps = 2/81 (2%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
++V+RD+K NILLD + + R+SD GLA + E V RV GT GY+APE
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYMAPEVINNEKYT 179
Query: 258 EKSDVYSFGILIMEIITGRNP 278
D + G LI E+I G++P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSYVTT---RVMGTF 243
+ YL + +HRD+ + NILL ++ DFGL + L +E YV +V F
Sbjct: 110 MRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PF 164
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK 302
+ APE T + SDV+ FG+ + E+ T G P W G
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--------------W----AGLSG 206
Query: 303 SE--EVVDPKLPKMPASKAL-KRVLLVALRCVDPDATKRPKMGHVIHML 348
S+ + +D + ++ +A + + V L+C + RP + L
Sbjct: 207 SQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-----SERSYVTTRVMGT 242
+AYLH VVHRD+K +N++L ++ DFG A+ L S + + GT
Sbjct: 115 VAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 243 FGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
++APE KSD++S G + E+ TG+ P
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 31/92 (33%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYL E + +++HRDVK SNIL++ + ++ DFG++ L + +GT Y++
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 170
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279
PE + +SD++S G+ ++E+ GR P+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 41/98 (41%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS--DFGLAKLLCSERSYVTTRVMGTFGY 245
LAYLHE KV+HRD+K NILL + NA V DFG++ L S T + GT +
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTK--NAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYW 179
Query: 246 VAPEY-ACTGMLNE----KSDVYSFGILIMEIITGRNP 278
+APE AC + +SDV+S GI +E+ G+ P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 21/154 (13%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVMGTFGYVAPEYACTGMLN 257
VHRD+ + NIL++ +VSDFGL+++L E +Y T + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 258 EKSDVYSFGILIMEIITGRNPVDY-SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK-MP 315
SDV+S+GI++ E+++ Y RP E++ D +K + EE +LP M
Sbjct: 188 SASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAI------EE--GYRLPAPMD 233
Query: 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
AL +++ L C D +RPK ++ +L+
Sbjct: 234 CPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 174 DGTKVA--VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231
D T++A ++ +L L YLH K +HRD+K++N+LL +++DFG+A L ++
Sbjct: 99 DETQIATILREILKG-LDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TD 153
Query: 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291
+GT ++APE + K+D++S GI +E+ G P P + L+
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
Query: 292 --DWLKTMVG--SRKSEEVVDPKLPKMPASKALKRVLL 325
+ T+ G S+ +E V+ L K P+ + + LL
Sbjct: 214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 21/130 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVTTRVMGTFG 244
L Y+H V+HRD+K SN+L++ R+ DFG+A+ L S E Y T + T
Sbjct: 120 LKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 245 YVAPEYACTGMLNEKS---DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK---TMV 298
Y APE + L E + D++S G + E++ GR + + N V LK +++
Sbjct: 177 YRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQLFPGK-----NYVHQLKLILSVL 228
Query: 299 GSRKSEEVVD 308
GS SEEV++
Sbjct: 229 GS-PSEEVLN 237
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-GTFG 244
L +LH +++RD+K N++LD + + +++DFG +C E VTTR GT
Sbjct: 114 LFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFG----MCKEHMVDGVTTRTFCGTPD 166
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280
Y+APE + D +++G+L+ E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YL E + K++HRDVK SNIL++ + ++ DFG++ L + +GT Y++
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 170
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + +SD++S G+ ++E+ GR P+ + E+ L+ +SE
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSP 229
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSN 367
P+ P P S PD+ RP M + E D + + + PS
Sbjct: 230 RPRPPGRPLSS------------YGPDS--RPPMA----IFELLDYIVNEPPP--KLPSG 269
Query: 368 SYGEENRDFARKVGDKQLGEGA 389
+G E +DF K K E A
Sbjct: 270 VFGAEFQDFVNKCLIKNPAERA 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 6/95 (6%)
Query: 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGT 242
L +AY H ++HRD+K NIL+ ++ DFG A+ L S +T V T
Sbjct: 109 LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 243 FGYVAPE-YACTGMLNEKSDVYSFGILIMEIITGR 276
Y APE + DV++ G ++ E++ G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L LHE K++HRD+KS+NILL ++ D G++K+L + +GT Y+A
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMA 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + KSD++S G L+ E+ T P
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 44/142 (30%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH + +HRD+K++N+LL Q + +++DFG+A L + T V GT ++A
Sbjct: 114 LDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKS 303
PE + K+D++S GI +E+ G P P + L+ + T+ G S+
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF 229
Query: 304 EEVVDPKLPKMPASKALKRVLL 325
+E V+ L K P + + LL
Sbjct: 230 KEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ ++++RD+K N+LLD N R+SD GLA L +S T GT G++A
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMA 165
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 287
PE + D ++ G+ + E+I R P R +GE
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPF---RARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 33/81 (40%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
++V+RD+K NILLD + R+SD GLA + E + RV GT GY+APE
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYMAPEVVKNERYT 179
Query: 258 EKSDVYSFGILIMEIITGRNP 278
D + G LI E+I G++P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+AYL V+HRD+ + N L+ +VSDFG+ + + ++ +T + +
Sbjct: 113 MAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEV 288
PE + KSDV+SFG+L+ E+ + G+ P + +R EV
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH + +HRD+K+ NILL +++DFG A L+ S+V GT ++A
Sbjct: 128 LAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMA 179
Query: 248 PEYACT---GMLNEKSDVYSFGILIMEIITGRNP 278
PE G + K DV+S GI +E+ + P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 37/173 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGY 245
+AYL K VHRD+ + N ++ ++ DFG+ + + E Y + + +
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 187
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
+APE G+ KSDV+SFG+++ E+ T P Y QG N E
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP--Y---QGLSN--------------E 228
Query: 305 EVVD-------PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
EV+ LP+ K L+ + C + RP ++ L+
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKLLE----LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 18/95 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K SNI ++ ++ DFGLA+ E + YV TR Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 182
Query: 247 APEYACTGMLN-----EKSDVYSFGILIMEIITGR 276
APE MLN + D++S G ++ E++TG+
Sbjct: 183 APEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFG 244
++YLH + +VHRD+K +NIL D N ++ DFG +K L C + + + V GT
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+++PE K+DV+S G ++E++T + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH K +HRDVK +NILL + ++ DFG++ L S R T V GT ++A
Sbjct: 137 LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192
Query: 248 PEY-ACTGML----NEKSDVYSFGILIMEIITGRNPV 279
PE AC L + + DV+S GI +E+ G P+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L ++H+ K++HRD+KS NI L + A++ DFG+A+ L T +GT Y+
Sbjct: 114 LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYL 169
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280
+PE N K+D++S G ++ E+ T ++P +
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ +++RD+K NILLD Q + +++DFGL K E + VT GT Y+A
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMA 168
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + D +S G L+ +++TG P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 36/91 (39%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L LH V+RD+K NILLD + R+SD GLA + E + RV GT GY+A
Sbjct: 115 LEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMA 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE D + G LI E+I G++P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 20/99 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER---SYVTTRVMGTFG 244
L YLHE K+V+RD+K N+LLD + +++DFG LC E T+ GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG----LCKEGMGFGDRTSTFCGTPE 166
Query: 245 YVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
++APE +L E S D + G+LI E++ G +P
Sbjct: 167 FLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 21/155 (13%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMG---TFGYVAPEYACTGM 255
VHRD+ + NIL++ +VSDFGL++ L + S T T +G + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 256 LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314
SDV+S+GI++ E+++ G P Q +N ++ D +LP
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ--------------DYRLPPP 233
Query: 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
L+ L C D RPK G ++ L+
Sbjct: 234 MDCPTALHQLM--LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 32/160 (20%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG------YVAPEYACT 253
VHRD+ + NIL++ +VSDFGL++ L + TT+ G + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAPEAIAY 182
Query: 254 GMLNEKSDVYSFGILIMEIITGRNPVDY-SRPQGEVNLVDWLKT-MVGSRKSEEVVDPKL 311
SDV+SFGI++ E+++ Y RP +++ D +K G R L
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS------YGERPYWDMSNQDVIKAVEDGYR---------L 227
Query: 312 PK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
P M AL +++ L C D +RP ++ L+
Sbjct: 228 PPPMDCPSALYQLM---LDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L LH+ V++RD+K NILLD Q + + DFGL KL + T GT Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLA 161
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + D ++ G+L+ E++TG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 27/85 (31%), Positives = 51/85 (60%), Gaps = 7/85 (8%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-GTFGYVAPEYACTGM 255
+++RD+K N++LD + + +++DFG +C E + VTT+ GT Y+APE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFG----MCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 256 LNEKSDVYSFGILIMEIITGRNPVD 280
+ D ++FG+L+ E++ G+ P +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH G K+V+RD+K N++LD+ + +++DFGL K ++ + + T GT Y+A
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLA 163
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE D + G+++ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LA+ H ++HRD+K N+L++ + +++DFGLA+ S T V+ T Y A
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRA 166
Query: 248 PEYACT-GMLNEKSDVYSFGILIMEIITGR 276
PE + D++S G + E+++ R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 25/155 (16%)
Query: 177 KVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC----SER 232
K +K LLN L Y+H K++HRD+K++NIL+ + +++DFGLA+ S+
Sbjct: 122 KKVMKMLLNG-LYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 233 SYVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV-DYSRPQG 286
+ T RV+ T Y PE +L E+ D++ G ++ E+ T R+P+ + Q
Sbjct: 178 NRYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH 231
Query: 287 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALK 321
++ L+ L GS E V P + K+ K ++
Sbjct: 232 QLTLISQL---CGSITPE--VWPGVDKLELFKKME 261
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 24/148 (16%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEYACTG 254
K VHRD+ + N +LD + +V+DFGLA+ + + Y G ++A E T
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 255 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEEVVDPKL 311
KSDV+SFG+L+ E++T P P +V+ D ++ R+ E DP
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRLLQPEYCPDPLY 232
Query: 312 PKMPASKALKRVLLVALRCVDPDATKRP 339
M L C P RP
Sbjct: 233 EVM-------------LSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTG 254
E ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 255 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313
+ +SDV+S+G+ + E++T G P D P E++ + K E +LP+
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE-----RLPQ 232
Query: 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVI 345
P V ++ ++C DA RPK +I
Sbjct: 233 PPICTI--DVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 13/140 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 244
L +LHE +++RD+K N+LLD + +++D+G +C E T+ GT
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYG----MCKEGLGPGDTTSTFCGTPN 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
Y+APE D ++ G+L+ E++ GR+P D ++N D+L ++ +
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-- 219
Query: 305 EVVDPKLPKMPASKALKRVL 324
+ P+ + AS LK L
Sbjct: 220 -IRIPRFLSVKASHVLKGFL 238
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 4/86 (4%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
+V+RD+K N+LLD+ +++DFG AK++ R+Y + GT Y+APE +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT---LCGTPEYIAPEILLNVGHGK 207
Query: 259 KSDVYSFGILIMEIITGRNPVDYSRP 284
+D ++ GI I EI+ G P + P
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 244
L YLH +++RD+K NILLD Q + ++DFG LC E S T+ GT
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPE 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288
Y+APE + D + G ++ E++ G P YSR E+
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 1/80 (1%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
+++RD+K NILLD + + +++DFGL+K GT Y+APE +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 259 KSDVYSFGILIMEIITGRNP 278
+D +SFG+L+ E++TG P
Sbjct: 178 SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 20/105 (19%)
Query: 177 KVAVKNL---LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233
+K+L L + +LH ++VHRD+K NIL+ +++DFGLA++ E +
Sbjct: 106 PETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162
Query: 234 YVTTRVMGTFGYVAPE------YACTGMLNEKSDVYSFGILIMEI 272
T V+ T Y APE YA D++S G + E+
Sbjct: 163 L--TSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH ++HRDVK+ NILL ++ DFG A ++ +V GT ++A
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMA 179
Query: 248 PEYACT---GMLNEKSDVYSFGILIMEIITGRNPVD--------YSRPQGEVNLVDWLKT 296
PE G + K DV+S GI +E+ + P+ Y Q E L++
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---LQS 236
Query: 297 MVGSRKSEEVVDPKLPKMPASKALKRVLL 325
S VD L K+P + VLL
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 17/105 (16%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 259
+HRD+K N L+D + +++DFGL+K + +Y + V+G+ Y+APE +L K
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANS-VVGSPDYMAPE-----VLRGK 173
Query: 260 S-----DVYSFGILIMEIITGRNPVDYSRPQGEV--NLVDWLKTM 297
D +S G ++ E + G P S P E NL W +T+
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 38/91 (41%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 259
VHRD+ + N+L+ A+VSDFGL K S + V T APE + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 260 SDVYSFGILIMEIIT-GRNPVDYSR-PQGEV 288
SDV+SFGIL+ EI + GR P Y R P +V
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 15/142 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 244
L YLHE +++RD+K N+LLD + + +++D+G +C E T+ GT
Sbjct: 109 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPN 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWLKTMVGSRK 302
Y+APE D ++ G+L+ E++ GR+P D S + N D+L ++ +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK- 220
Query: 303 SEEVVDPKLPKMPASKALKRVL 324
++ P+ + A+ LK L
Sbjct: 221 --QIRIPRSLSVKAASVLKSFL 240
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 18/146 (12%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGTFGYVAPEYACTG 254
E ++VHR++ + NILL +++DFG+A LL ++ Y + ++A E G
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 255 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313
+SDV+S+G+ + E+++ G P RP +L++ K E + P++
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---------KGERLAQPQICT 237
Query: 314 MPASKALKRVLLVALRCVDPDATKRP 339
+ V +V ++C D RP
Sbjct: 238 ID-------VYMVMVKCWMIDENVRP 256
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 45/176 (25%), Positives = 76/176 (43%), Gaps = 30/176 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFG 244
+AYLH +HRD+ + N+LLD ++ DFGLAK + Y R G F
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP-----------QGEVNLVDW 293
Y A E + SDV+SFG+ + E++T + P QG++ +V
Sbjct: 177 Y-AVECLKENKFSYASDVWSFGVTLYELLTHCDS--KQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 294 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
++ + + + PK + V ++ C + +A RP +I +L+
Sbjct: 234 IELL---ERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 8/84 (9%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEYACTGM 255
+HRDV + N+LL A++ DFGLA+ + ++ +YV V G ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCV 290
Query: 256 LNEKSDVYSFGILIMEIIT-GRNP 278
+SDV+S+GIL+ EI + G++P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM---GTFG 244
L +LH +++RD+K N++LDR + +++DFG +C E + R GT
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG----MCKENVFGDNRASTFCGTPD 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
Y+APE D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFG 244
++YLH + +VHRD+K +NIL D N ++ DFG +K L C + + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+++PE K+D++S G ++E++T + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 14/111 (12%)
Query: 180 VKNLLNNRL---AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236
VK L+ L A+LH+ ++HRD+K+SN+LL+ + ++ DFGLA+ S T
Sbjct: 108 VKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164
Query: 237 TRVMGTFGYVAPE-YACTGMLNEKSDVYSFGILIMEIIT------GRNPVD 280
V+ T Y APE + D++S G + E++T G++ +D
Sbjct: 165 QLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTR--VMGTFG 244
L YLH V+HRD+KS +ILL ++SDFG C++ S V R ++GT
Sbjct: 130 LCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPY 182
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
++APE + D++S GI+++E++ G P
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y
Sbjct: 133 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 184
Query: 247 APEYACTGM-LNEKSDVYSFGILIMEIITGR 276
APE M N+ D++S G ++ E++TGR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +V+RD+K NILLD Q + ++DFGL K ++ S TT GT Y+A
Sbjct: 109 LGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLA 164
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288
PE + D + G ++ E++ G P Y R E+
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 244
L +LHE +++RD+K N+LLD + + +++D+G +C E T+ GT
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG----MCKEGIRPGDTTSTFCGTPN 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWL 294
Y+APE D ++ G+L+ E++ GR+P D + N D+L
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 164 YGIVYRGILSDGTKVAVKNLLN------NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 217
YG + + + ++ ++LLN ++YL E ++VHRD+ + N+L+ +
Sbjct: 92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHV 148
Query: 218 RVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-G 275
+++DFGLA+LL E Y ++A E +SDV+S+G+ + E++T G
Sbjct: 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG 208
Query: 276 RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335
P D P E+ D L+ G R LP+ P V ++ ++C D+
Sbjct: 209 AKPYD-GIPAREIP--DLLEK--GER---------LPQPPICT--IDVYMIMVKCWMIDS 252
Query: 336 TKRPKMGHVIHMLEADDLLFRDERRIGREPS 366
RP+ ++ R+ R+PS
Sbjct: 253 ECRPRFRELVDEFS----------RMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 21/62 (33%), Positives = 36/62 (58%), Gaps = 3/62 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+AY+H ++HRD+K +N+L+ +++DFGLA+L E + + + T Y A
Sbjct: 112 VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168
Query: 248 PE 249
PE
Sbjct: 169 PE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGY 245
L YLH VV+RD+K N++LD+ + +++DFGL K S GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 283
+APE D + G+++ E++ GR P Y++
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 8/93 (8%)
Query: 193 EGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAP 248
LE K +HRD+ + N L+D Q +VSDFGL++ + + Y ++ +G+ + P
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS--VGSKFPVRWSPP 170
Query: 249 EYACTGMLNEKSDVYSFGILIMEIIT-GRNPVD 280
E + KSDV++FG+L+ E+ + G+ P +
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 2/82 (2%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-- 256
+++RD+K NILLD + ++DFGL+K + GT Y+AP+ G
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 257 NEKSDVYSFGILIMEIITGRNP 278
++ D +S G+L+ E++TG +P
Sbjct: 186 DKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/141 (29%), Positives = 64/141 (45%), Gaps = 28/141 (19%)
Query: 170 GILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAK 226
G L G + + + LA H +VHRD+K NI++ + +A+V DFG+
Sbjct: 74 GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 227 LLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR---- 276
LL R TT V+GT Y APE + SD+Y++G++ +E +TG+
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190
Query: 277 ------------NPVDYSRPQ 285
+PVD S P
Sbjct: 191 GASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH ++HRD+K+ NILL +++DFG A + S+V GT ++A
Sbjct: 138 LAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMA 189
Query: 248 PEYACT---GMLNEKSDVYSFGILIMEIITGRNPV 279
PE G + K DV+S GI +E+ + P+
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 255
E ++HRDVK +N+L++ ++ DFG++ L S T + G Y+APE +G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGG 177
Query: 256 LNE------KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309
N+ +SDV+S G+ I+E+ GR P P+ N+ L +V DP
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFAQLSAIVDG-------DP 227
Query: 310 KLPKMPASKALKRVLLVALRCVDPDATKRP 339
P +P+ + VA C++ +RP
Sbjct: 228 --PTLPSGYSDDAQDFVAK-CLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ +V+RD+K NILLD + + DFGL+K ++ T GT Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLA 164
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
PE +L+EK D +S G+L+ E+ G +P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +++HRDVK +NILL + ++ DFG++ L S R T V GT ++A
Sbjct: 141 LQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 196
Query: 248 PEY-ACTGM----LNEKSDVYSFGILIMEIITGRNPV 279
PE AC + + DV+S GI +E+ G P+
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 28/83 (33%), Positives = 47/83 (56%), Gaps = 7/83 (8%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGM 255
V+HRD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 256 LNEKSDVYSFGILIMEIITGRNP 278
+ D++S GI+++E++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +++HRDVK+ NI ++ + D G A+ +++ + GT A
Sbjct: 170 LRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNA 224
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT---------GRNPVDYSRPQGEVNLVDWLKTMV 298
PE N K+D++S GI++ E++ P +Y + +L+ + T+
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK-SCHSHLLKIISTL- 282
Query: 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344
+V + P+ P S+ L R + T+ P V
Sbjct: 283 ------KVHPEEFPRDPGSR-LVRGFIEYASLERQPYTRYPCFQRV 321
|
Length = 357 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGY 245
L+YLH V+HRD+KS +ILL ++SDFG + E V R ++GT +
Sbjct: 131 LSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYW 184
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+APE + D++S GI+++E+I G P
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 14/97 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L Y+H V+HRD+K SN+LL+ + ++ DFGLA+ + ++T V+ T Y A
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV 279
PE +LN DV+S G + E++ GR P+
Sbjct: 177 PEL----LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTG 254
K +HRD+ + NILL ++ DFGLA+ + + YV R+ ++APE
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 255 MLNEKSDVYSFGILIMEIIT-GRNP 278
+ +SDV+SFG+L+ EI + G +P
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVM-GTFG 244
L +LH+ +++RD+K N+LLD + + +++DFG +C E + TT GT
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGTPD 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280
Y+APE + D ++ G+L+ E++ G P +
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 18/148 (12%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTG 254
E ++VHRD+ + N+L+ + +++DFGLA+LL E+ Y ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 255 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313
+SDV+S+G+ I E++T G P D P E+ D L+ K E +LP+
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLE------KGE-----RLPQ 232
Query: 314 MPASKALKRVLLVALRCVDPDATKRPKM 341
P V +V ++C DA RPK
Sbjct: 233 PPICTI--DVYMVMVKCWMIDADSRPKF 258
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---LLCSERSYVTTRVMGTFG 244
++YLH + +VHRD+K +NIL D N ++ DFG +K +C + + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPY 174
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+++PE K+DV+S ++E++T + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 35/113 (30%), Positives = 61/113 (53%), Gaps = 18/113 (15%)
Query: 169 RGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA--- 225
RG+ +V + +L L YLH K++HRD+K+ N+LL + +++DFG++
Sbjct: 105 RGLTEPQIQVICRQMLE-ALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160
Query: 226 -KLLCSERSYVTTRVMGTFGYVAPEYA-CTGM----LNEKSDVYSFGILIMEI 272
K L S++ GT ++APE C M + K+D++S GI ++E+
Sbjct: 161 VKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +V+RD+K NILLD Q + ++DFGL K E + T+ GT Y+A
Sbjct: 109 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTSTFCGTPEYLA 164
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288
PE + D + G ++ E++ G P YSR E+
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH E VV+RD+K N++LD+ + +++DFGL K + + + T GT Y+A
Sbjct: 108 LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLA 164
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE D + G+++ E++ GR P
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 43/123 (34%), Positives = 66/123 (53%), Gaps = 20/123 (16%)
Query: 164 YGIVYRGILS---DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 220
G++ G++ D K +K LL L Y H+ +HRD+K SNILL+ + +++
Sbjct: 103 MGLLESGLVHFSEDHIKSFMKQLLEG-LNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158
Query: 221 DFGLAKLLCSE--RSYVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEII 273
DFGLA+L SE R Y T +V+ T Y PE +L E+ DV+S G ++ E+
Sbjct: 159 DFGLARLYNSEESRPY-TNKVI-TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELF 212
Query: 274 TGR 276
T +
Sbjct: 213 TKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH ++HRD+K+ NILL +++DFG A S+V GT ++A
Sbjct: 134 LAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMA 185
Query: 248 PEYACT---GMLNEKSDVYSFGILIMEIITGRNPV 279
PE G + K DV+S GI +E+ + P+
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF---GYVAPEYACTGML 256
VHRD+ + N+LL + ++ DFGLA+ + + +YV+ TF ++APE +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLY 316
Query: 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315
SDV+S+GIL+ EI + G P P V+ + K G R ++
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKIKSGYRMAK----------- 361
Query: 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
A + V + ++C + + KRP H+ ++E+
Sbjct: 362 PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 200 VHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEY 250
+HRD+ + N L+ D ++ DFGLA+ + Y R G ++APE
Sbjct: 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLLPVRWMAPES 184
Query: 251 ACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
G +SDV+SFG+L+ EI+T G+ P
Sbjct: 185 LLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 22/116 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL-----------------LCS 230
+ Y+H V+HRD+K NILL + D+G A +C
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 286
+ +++GT Y+APE +E +D+Y+ G+++ +++T P Y R +G
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKG 236
|
Length = 932 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 27/117 (23%)
Query: 177 KVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-------- 228
K + LL + YLHE ++HRD+K++NIL+D Q +++DFGLA+
Sbjct: 118 KCYMLQLLEG-INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 229 ----CSERSYVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
R Y T ++ T Y PE +L E+ D++ G + E+ T R
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 23/161 (14%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTG 254
K +HRD+ + NILL ++ DFGLA+ + + YV + R+ ++APE
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDK 251
Query: 255 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313
+ +SDV+SFG+L+ EI + G +P Y Q LK R E
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASP--YPGVQINEEFCQRLKDGTRMRAPEN-------- 301
Query: 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 354
A+ + R++ L C D +RP ++ +L DLL
Sbjct: 302 --ATPEIYRIM---LACWQGDPKERPTFSALVEIL--GDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 244
L +LH V++RD+K NILLD + + +++DFG +C E TT GT
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG----MCKEGILNGVTTTTFCGTPD 161
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
Y+APE D ++ G+L+ E++ G+ P
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + + T GT Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE D + G+++ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 7/78 (8%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEYACTG 254
VHRD+ + N L+ ++SDFGL++ + S Y RV ++ PE G
Sbjct: 145 FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYG 201
Query: 255 MLNEKSDVYSFGILIMEI 272
+SD++SFG+++ EI
Sbjct: 202 KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K N+ ++ ++ DFGLA+ +E + YV TR Y
Sbjct: 130 LKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181
Query: 247 APEYACTGM-LNEKSDVYSFGILIMEIITGR 276
APE M N+ D++S G ++ E++TG+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 32/128 (25%), Positives = 55/128 (42%), Gaps = 29/128 (22%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAK-----------------LLCSERSYVTTR---- 238
+HRD+K NIL+D + +++DFGL K LL + V R
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 239 -------VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN-L 290
+GT Y+APE + D +S G+++ E++ G P Q N +
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242
Query: 291 VDWLKTMV 298
++W +++
Sbjct: 243 INWKESLR 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 24/76 (31%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VH+D+ + NIL+ Q + ++SD GL++ + S Y V + + ++ PE G +
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 259 KSDVYSFGILIMEIIT 274
SD++SFG+++ EI +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K SN+ ++ R+ DFGLA+ E + YV TR Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYR 182
Query: 247 APEYACTGM-LNEKSDVYSFGILIMEIITGR 276
APE M N+ D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 21/154 (13%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF---GYVAPEYACTGML 256
VHRD+ + N+L+ ++ DFGLA+ + + +Y++ TF ++APE +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFLPLKWMAPESIFNNLY 318
Query: 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315
SDV+SFGIL+ EI T G P P+ +N + G R ++ P
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTPY----PELPMNEQFYNAIKRGYRMAK----------P 364
Query: 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
A A + + +C + RP ++H++
Sbjct: 365 A-HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYVAPEYACTGMLNE 258
+HRD+ + N +L V+DFGL+K + S Y R+ ++A E +
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS 194
Query: 259 KSDVYSFGILIMEIIT-GRNP 278
KSDV++FG+ + EI T G+ P
Sbjct: 195 KSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-----ACTG 254
VHRD+K N+LLD+ + R++DFG L ++ + + +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 255 MLNEKSDVYSFGILIMEIITGRNP 278
+ D +S G+ + E++ G P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 44/172 (25%), Positives = 70/172 (40%), Gaps = 25/172 (14%)
Query: 172 LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231
LS KVA+ + + +L + VHRD+ + N L+ Q +VS L+K + +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291
Y + ++APE + KSDV+SFG+L+ E+ T QGE+
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPF- 219
Query: 292 DWLKTMVGSRKSEEVVDP----KLPKMPASKALKRVLLVALRCVDPDATKRP 339
EEV++ KL R+ + RC + RP
Sbjct: 220 -------YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 29/82 (35%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLN 257
+HRD+ + N L+ +V+DFGL++L+ + +Y T F + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTY-TAHAGAKFPIKWTAPESLAYNKFS 183
Query: 258 EKSDVYSFGILIMEIIT-GRNP 278
KSDV++FG+L+ EI T G +P
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLHE ++HRD+K SN+LL + +++DFGLA+ +T +V+ T Y A
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176
Query: 248 PEYACTGMLNEKS--DVYSFGILIMEIITGR 276
PE G + D+++ G ++ E++ +
Sbjct: 177 PEL-LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 14/153 (9%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ + +++DFG+++ L S Y + R + ++A E G
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT 210
Query: 259 KSDVYSFGILIMEIITGRNPVDYSRPQGEV---NLVDWLKTMVGSRKSEEVVDPKLPKMP 315
SDV++FG+ + E+ T YS E N ++ + + ++ + P P
Sbjct: 211 ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN-----QGRQIYLSQTPLCP 265
Query: 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
+ V + +RC D RP + H L
Sbjct: 266 SP-----VFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 9/91 (9%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG- 244
+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLPV 175
Query: 245 -YVAPEYACTGMLNEKSDVYSFGILIMEIIT 274
++A E + SDV+S+G+L+ EI++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACT 253
E + +HRD+ + N+L+ ++++DFGL++ E YV + MG ++A E
Sbjct: 137 EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGRLPVRWMAIESLNY 192
Query: 254 GMLNEKSDVYSFGILIMEIIT 274
+ KSDV+SFG+L+ EI++
Sbjct: 193 SVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K N+ ++ ++ DFGLA+ SE + YV TR Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182
Query: 247 APEYACTGM-LNEKSDVYSFGILIMEIITGR 276
APE M + D++S G ++ E++TG+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEYACTGM 255
+HRD+ + NILL ++ DFGLA+ + ++ +YV V G ++APE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCV 292
Query: 256 LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSR-KSEEVVDPKLPK 313
+SDV+S+GIL+ EI + G +P Y + +K G R S E ++
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSP--YPGMPVDSKFYKMIKE--GYRMLSPECAPSEMYD 348
Query: 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ S C D D KRP ++ ++E
Sbjct: 349 IMKS------------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-----G 254
VHRD+K NIL+D + R++DFG L + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 255 MLNEKSDVYSFGILIMEIITGRNP 278
+ D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTG 254
K +HRD+ + NILL ++ DFGLA+ + + YV R+ ++APE
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFDR 256
Query: 255 MLNEKSDVYSFGILIMEIIT-GRNP 278
+ +SDV+SFG+L+ EI + G +P
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YLH +++RD+K NILLD Q + ++DFGL K E T+ GT Y+A
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLA 164
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288
PE + D + G ++ E++ G P YSR ++
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 38/138 (27%), Positives = 61/138 (44%), Gaps = 14/138 (10%)
Query: 152 GLCEENVI---------GE-GGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVH 201
G+ EN + GE Y V + L + + L+ LAYL + VH
Sbjct: 74 GVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVH 130
Query: 202 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSD 261
RD+ + N+L+ ++ DFGL++ L E Y ++ ++APE SD
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 262 VYSFGILIMEIIT-GRNP 278
V+ FG+ + EI+ G P
Sbjct: 191 VWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA-KLLCSERSYVTTRVMGTFGYV 246
LAYLH ++HRDVK+ NI LD NA + DFG A KL + GT
Sbjct: 198 LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+PE K+D++S G+++ E+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YL +HRD+ + N L+ +VSDFGLA+ + ++ + +
Sbjct: 113 MEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVD 280
PE + KSDV+SFG+L+ E+ + G+ P +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEYACTGM 255
++HRD+K SNI++ ++ DFGLA+ C+ YV TR Y APE
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMG 198
Query: 256 LNEKSDVYSFGILIMEIITG 275
E D++S G ++ E++ G
Sbjct: 199 YKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 2/81 (2%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYVAPEYACTGMLNE 258
+HRD+ + N +L+ N V+DFGL+K + + Y R+ ++A E +
Sbjct: 134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTT 193
Query: 259 KSDVYSFGILIMEIIT-GRNP 278
KSDV+SFG+ + EI T G+ P
Sbjct: 194 KSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 3e-06
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 18/149 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L++LH+ KV+HRD+K N+LL ++ DFG++ L T +GT ++A
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 179
Query: 248 PEY-AC----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-----DWLKTM 297
PE AC + KSD++S GI +E+ G P+ P + L+ LK+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239
Query: 298 VGSRKSEEVVDPKLPK----MPASKALKR 322
S+K + ++ L K P ++ L +
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 29/187 (15%)
Query: 110 ESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELE----AATSGLCEENVIGEGGYG 165
E TG S S G ++ L LR L G+C E +GG G
Sbjct: 28 EGDNTGEQVAVKSLKPESGGNHIADL-KKEIEILRNLYHENIVKYKGICTE----DGGNG 82
Query: 166 I-VYRGILSDGT----------KVAVKNLLNNRLAYLHEGLE----PKVVHRDVKSSNIL 210
I + L G+ K+ +K L + + +G++ + VHRD+ + N+L
Sbjct: 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ-ICKGMDYLGSRQYVHRDLAARNVL 141
Query: 211 LDRQWNARVSDFGLAKLLCSERSYVTT---RVMGTFGYVAPEYACTGMLNEKSDVYSFGI 267
++ + ++ DFGL K + +++ Y T F Y APE SDV+SFG+
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGV 200
Query: 268 LIMEIIT 274
+ E++T
Sbjct: 201 TLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 15/115 (13%)
Query: 172 LSDGTKVAVKNLLN------NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225
L+ +A+ ++L + YLHE +++HRD+K+ NI ++ + + DFG A
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 226 KLLCSERSYVTTRVMGTFGYVA---PEYACTGMLNEKSDVYSFGILIMEIITGRN 277
C + G G +A PE D++S GI++ E+ T +
Sbjct: 230 ---CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGML 256
K +HRD+ + N+L+ +++DFGLA+ + Y TT ++APE +
Sbjct: 152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211
Query: 257 NEKSDVYSFGILIMEIIT 274
+SDV+SFG+L+ EI T
Sbjct: 212 THQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 27/186 (14%)
Query: 173 SDGTKVAVKNLLN--NRLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229
++G ++ VK L+ A E LE K +HRD+ + N L+ + ++SDFG+++
Sbjct: 86 TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR--- 142
Query: 230 SERSYVTTRVMGT----FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRP 284
E V G + APE G + +SDV+SFGIL+ E + G P Y+
Sbjct: 143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP--YAN- 199
Query: 285 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344
+ ++++ E ++ + V + RC + D +RP V
Sbjct: 200 -------------LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246
Query: 345 IHMLEA 350
L++
Sbjct: 247 HQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 27/83 (32%), Positives = 47/83 (56%), Gaps = 5/83 (6%)
Query: 190 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 249
Y+H+ +++HRD+K+ NI L ++ DFG+++LL TT GT Y++PE
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMSPE 175
Query: 250 YACTGMLNEKSDVYSFGILIMEI 272
+ KSD++S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYV 246
LA LH VHRD+ + N L+ + ++ DFG+++ + S Y V R M ++
Sbjct: 138 LASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
PE +SD++SFG+++ EI T G+ P
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 28/82 (34%), Positives = 47/82 (57%), Gaps = 1/82 (1%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGML 256
K++HRD+KS+NI L ++ DFG +K S V + GT Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 257 NEKSDVYSFGILIMEIITGRNP 278
++K+D++S G+++ E++T P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH ++HRD+K +N+L+ +++DFGLA+ S +T +V+ T Y A
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 248 PE--YACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + D++S G + E++ R P
Sbjct: 171 PELLFGAR-HYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 25/83 (30%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT----GM 255
+HRDVK N+LLD+ + +++DFG + E +GT Y++PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 256 LNEKSDVYSFGILIMEIITGRNP 278
+ D +S G+ + E++ G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 24/83 (28%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY----ACTGM 255
+HRDVK N+LLD+ + +++DFG + + +GT Y++PE G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 256 LNEKSDVYSFGILIMEIITGRNP 278
+ D +S G+ + E++ G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 48/208 (23%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-------RSYVTTRVM 240
L Y+H V HRD+K NIL + ++ DFGLA++ ++ YV TR
Sbjct: 116 LKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-- 170
Query: 241 GTFGYVAPEYACTGMLNEKS---DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297
Y APE C ++ + D++S G + E++TG+ P+ + V+ +D + +
Sbjct: 171 ---WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGK--NVVHQLDLITDL 223
Query: 298 VGSRKSEEV--------------VDPKLP-----KMPASKALKRVLLVALRCVDPDATKR 338
+G+ E + + K P K P + L LL L DP R
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK--DR 281
Query: 339 PKMGHVIHMLEADDLLFRDERRIGREPS 366
P + D F+ ++ REPS
Sbjct: 282 PTAEEALA-----DPYFKGLAKVEREPS 304
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 46/161 (28%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGL----------------------------------A 225
+HRD+K N+LLD + + ++SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285
+ R + +GT Y+APE N+ D +S G+++ E++ G P PQ
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 286 GEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 325
+++W +T+V P++P S+ K ++L
Sbjct: 243 ETYRKVMNWKETLVFP-----------PEVPISEKAKDLIL 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-----G 254
VHRD+K N+LLD + R++DFG + + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 255 MLNEKSDVYSFGILIMEIITGRNP 278
+ D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 7e-06
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 30/109 (27%)
Query: 188 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER---SYVTTRVMGTF 243
LA++H+ G HRD+K N+L+ +++DFGLA+ + S YV+TR
Sbjct: 112 LAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR----- 162
Query: 244 GYVAPEYACTGML------NEKSDVYSFGILIMEIIT------GRNPVD 280
Y APE +L + D+++ G ++ E+ T G + +D
Sbjct: 163 WYRAPE-----ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARV---SDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYA 251
E +HRD+ + N LL + RV +DFG+A+ + Y R M ++ PE
Sbjct: 134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193
Query: 252 CTGMLNEKSDVYSFGILIMEIIT-GRNP 278
G+ K+DV+SFG+L+ EI + G P
Sbjct: 194 LDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 10/82 (12%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPEYACTGM 255
++HRD+K SNI++ ++ DFGLA+ + YV TR Y APE GM
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE-VILGM 192
Query: 256 -LNEKSDVYSFGILIMEIITGR 276
E D++S G ++ E+I G
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGT 242
L LA+ H +V+HRD+K N+L++ + +++DFGLA+ R+Y T + T
Sbjct: 109 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 163
Query: 243 FGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGR 276
Y APE + D++S G + E++T R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 195 LEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPE 249
LE K +HRD+ + N L+ ++SDFG+++ E + T G + APE
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 250 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309
G +SDV+S+GIL+ E + G+ ++++ E ++
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL----------GDTPYPGM-----SNQQTRERIES 210
Query: 310 KLPKMPASKAL-KRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
+MPA + + + + L+C D RP + + L+
Sbjct: 211 GY-RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 46/161 (28%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGL----------------------------------A 225
+HRD+K N+LLD + + ++SDFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285
+ R + +GT Y+APE N+ D +S G+++ E++ G P PQ
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 286 GEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 325
+++W +T++ P++P S+ K ++L
Sbjct: 243 ETYKKVMNWKETLIFP-----------PEVPISEKAKDLIL 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGML 256
K +HRD+ + N+L+ +++DFGLA+ + + Y TT ++APE +
Sbjct: 157 KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
Query: 257 NEKSDVYSFGILIMEIIT-GRNP 278
+SDV+SFG+L+ EI T G +P
Sbjct: 217 THQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 15/99 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTTRVMGTF 243
LAYLH + +HRD+K +NILL + +++DFG+A + +S++ GT
Sbjct: 119 LAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTP 170
Query: 244 GYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPV 279
++APE A G N+ D+++ GI +E+ + P+
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 29/83 (34%), Positives = 47/83 (56%), Gaps = 2/83 (2%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGML 256
K +HRD+ + N+L+ +++DFGLA+ + Y TT ++APE +
Sbjct: 160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 257 NEKSDVYSFGILIMEIIT-GRNP 278
+SDV+SFG+L+ EI T G +P
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 24/80 (30%), Positives = 42/80 (52%), Gaps = 1/80 (1%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 259
+HRD+ + N L+ +VSDFG+ + + + ++ + PE + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 260 SDVYSFGILIMEIIT-GRNP 278
SDV+SFG+L+ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGML 256
K +HRD+ + N+L+ +++DFGLA+ + + Y TT ++APE +
Sbjct: 154 KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213
Query: 257 NEKSDVYSFGILIMEIIT-GRNP 278
+SDV+SFG+L+ EI T G +P
Sbjct: 214 THQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LA+LH KV+HRD+K N+LL ++ DFG++ L T +GT ++A
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 189
Query: 248 PEY-ACT----GMLNEKSDVYSFGILIMEIITGRNPV 279
PE AC + +SD++S GI +E+ G P+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 17/96 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYV 246
+AY H +V+HRD+K N+L+DR+ +++DFGLA+ R+Y T V+ T Y
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYR 166
Query: 247 APE------YACTGMLNEKSDVYSFGILIMEIITGR 276
APE T + D++S G + E++ R
Sbjct: 167 APEILLGSRQYSTPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 24/84 (28%), Positives = 43/84 (51%), Gaps = 4/84 (4%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT----G 254
++HRDVK N+LLD+ + +++DFG + +GT Y++PE + G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 255 MLNEKSDVYSFGILIMEIITGRNP 278
+ D +S G+ + E++ G P
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 49/158 (31%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---------RSYVTTR 238
L Y+H V+HRD+K N+L++ ++ DFGLA+ SE YV TR
Sbjct: 118 LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATR 173
Query: 239 VMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV----DYSRPQGEVN 289
Y APE ML+ +S DV+S G ++ E++ GR PV DY ++N
Sbjct: 174 -----WYRAPEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD---QLN 220
Query: 290 LVDWLKTM----------VGSRKSEEVVD--PKLPKMP 315
+ L+ + +GS K++ + P +PK P
Sbjct: 221 QI--LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKP 256
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 14/95 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
+AY H +V+HRD+K N+L+DR+ NA +++DFGLA+ T V+ T Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYR 170
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
APE +L + D++S G + E++ +
Sbjct: 171 APEI----LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 10/89 (11%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLN 257
+ HRD+K NIL+ +++DFG + + S+ Y T + T Y APE T G
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYYG 177
Query: 258 EKSDVYSFGILIMEIIT------GRNPVD 280
K D+++ G + EI++ G N +D
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELD 206
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 15/94 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAK-LLCSER--SYVTTRVMGTF 243
LAY+H + HRD+K N+L+D ++ DFG AK LL +R SY+ +R
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235
Query: 244 GYVAPEYACTGMLNEKS--DVYSFGILIMEIITG 275
Y APE G N + D++S G +I E+I G
Sbjct: 236 -YRAPELM-LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 17/105 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL-LCS-------------ERS 233
L YLH +VHRD+K N+L+ + +++DFGL+K+ L S R
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
++ +V GT Y+APE + D ++ GI++ E + G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 7/110 (6%)
Query: 170 GILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229
G+ ++ K ++ L L +LH +VHRD+K NIL+ +++DFGLA++
Sbjct: 104 GLPAETIKDLMRQFLRG-LDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS 159
Query: 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279
+ + T V+ T Y APE D++S G + E+ R P+
Sbjct: 160 CQMAL--TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 18/113 (15%)
Query: 169 RGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA--- 225
R + +V K L L YLHE K++HRD+K+ NIL + +++DFG++
Sbjct: 98 RPLTEPQIRVVCKQTLE-ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153
Query: 226 -KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE-----KSDVYSFGILIMEI 272
+ + S++ GT ++APE + K+DV+S GI ++E+
Sbjct: 154 TRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM-L 256
+HRDVK NIL+ +Q ++ DFG A++L T V T Y APE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQY 178
Query: 257 NEKSDVYSFGILIMEIITG 275
DV++ G + E++TG
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+A+ HE +V+HRD+K N+L++++ +++DFGLA+ + + V+ T Y A
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRA 168
Query: 248 PEYACTGMLNEKS-DVYSFGILIMEIITGR 276
P+ S D++S G ++ E+ITGR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 30/154 (19%), Positives = 64/154 (41%), Gaps = 27/154 (17%)
Query: 201 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY-----VAPEYACTGM 255
++++ S + L+ + ++ GL K+L S + M F Y + EY
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLNDIFSEY----- 199
Query: 256 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315
K D+YS G+++ EI TG+ P + + + ++ ++ + + P
Sbjct: 200 -TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD-------LIINKNNSLKLPLDCPLE- 250
Query: 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+K ++ C D+ KRP + +++ L
Sbjct: 251 ----IKCIV---EACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +VVHRD+K NIL+ +++DFGLA++ + T V+ T Y A
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRA 177
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279
PE D++S G + E+ R P+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ ++ DFG+++ + S Y V M ++ PE
Sbjct: 145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 204
Query: 259 KSDVYSFGILIMEIIT-GRNP 278
+SDV+SFG+++ EI T G+ P
Sbjct: 205 ESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 25/81 (30%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--YVAPEYACT 253
+ + +HRD+ + NIL+ + A+++DFGL++ + YV + MG ++A E
Sbjct: 142 QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLPVRWMAIESLNY 197
Query: 254 GMLNEKSDVYSFGILIMEIIT 274
+ SDV+S+G+L+ EI++
Sbjct: 198 SVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 18/154 (11%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG-TFGYVAPEYACTGMLN 257
+HRD+ + N +L+ V+DFGL+K + S Y ++A E +
Sbjct: 134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT 193
Query: 258 EKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316
SDV++FG+ + EI+T G+ P Y+ G N + + G+R K P
Sbjct: 194 THSDVWAFGVTMWEIMTRGQTP--YA---GVENSEIYNYLIKGNRL----------KQPP 238
Query: 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
L+ V + +C P+ RP H+ LE
Sbjct: 239 -DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 39/130 (30%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 171 ILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-C 229
+ SD KV + +L L YLH ++HRD+K N+L++ ++ DFGLA++
Sbjct: 100 LSSDHVKVFLYQILRG-LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155
Query: 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKS--DVYSFGILIMEIITGRNPVDYSRPQGE 287
E ++T V+ + Y APE G + S D++S G + E++ R P +
Sbjct: 156 DESKHMTQEVVTQY-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
Query: 288 VNLV-DWLKT 296
++L+ D L T
Sbjct: 214 LDLITDLLGT 223
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 22/80 (27%), Positives = 47/80 (58%), Gaps = 7/80 (8%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEYACTG 254
VVH+D+ + N+L+ + N ++SD GL + + + Y ++MG +++PE G
Sbjct: 145 VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYG 201
Query: 255 MLNEKSDVYSFGILIMEIIT 274
+ SD++S+G+++ E+ +
Sbjct: 202 KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGML 256
+ +HRD+ + N+L+ +++DFGLA+ + Y T+ ++APE +
Sbjct: 154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213
Query: 257 NEKSDVYSFGILIMEIIT 274
+SDV+SFGIL+ EI T
Sbjct: 214 THQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 2/78 (2%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE E
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 259 KSDVYSFGILIMEIITGR 276
D++S G ++ E+I G
Sbjct: 205 NVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 259 KSDVYSFGILIMEII------TGRNPVD 280
D++S G ++ E++ GR+ +D
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 11/85 (12%)
Query: 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE----RSYVTTRVMGTFGYVAPEYACTG 254
++HRD+K NIL+ + ++ DFG A+ L + YV TR Y APE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLVGD 175
Query: 255 MLNEKS-DVYSFGILIMEIITGRNP 278
++ D+++ G L+ E++TG P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG-EP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG--Y 245
+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E Y G +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 187
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT 274
++PE G+ SDV+SFG+++ EI T
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 24/91 (26%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-----VTTRVMGTFGYVAPE--- 249
+V+HRD+K N+L+D + +++DFGLA R++ V T + T Y APE
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 250 ----YACTGMLNEKSDVYSFGILIMEIITGR 276
Y+ D++S G + E+ T +
Sbjct: 175 GSPRYST------PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 12/79 (15%)
Query: 180 VKNLLN---NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCS-- 230
VK+LL N + YLH V+HRD+K +NIL+ + R + D GLA+L +
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 231 ERSYVTTRVMGTFGYVAPE 249
+ V+ T Y APE
Sbjct: 167 KPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ ++ DFG+++ + S Y V M ++ PE
Sbjct: 142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 201
Query: 259 KSDVYSFGILIMEIIT-GRNP 278
+SDV+S G+++ EI T G+ P
Sbjct: 202 ESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 50/175 (28%)
Query: 142 TLRELEAATSGLCEENVIG------EGGY-GIVYRGILSDGTKVA----------VKNLL 184
TLREL+ + EN++G EG + +V + SD KV VK +L
Sbjct: 67 TLRELKIMNE-IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL 125
Query: 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--------CSERSY-- 234
L L+ + +HRD+ +NI ++ + +++DFGLA+ S+
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 235 ----VTTRVMGTFGYVAPE---------YACTGMLNEKSDVYSFGILIMEIITGR 276
+T++V+ T Y APE +A D++S G + E++TG+
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGAEKYHFAV--------DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ + + +++DFG+++ L S Y V R ++A E G
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211
Query: 259 KSDVYSFGILIMEIIT 274
KSDV++FG+ + EI+T
Sbjct: 212 KSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 15/99 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG----LAKLLCSERSYVTTRVMGTF 243
L YLH + +HRD+K +NILL + +++DFG + + +S++ GT
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTP 170
Query: 244 GYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPV 279
++APE A G N+ D+++ GI +E+ + P+
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 23/76 (30%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ + + +++DFG+++ L S Y + R + +++ E G
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT 211
Query: 259 KSDVYSFGILIMEIIT 274
SDV++FG+ + EI+T
Sbjct: 212 ASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ ++ DFG+++ + + Y V M ++ PE
Sbjct: 144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT 203
Query: 259 KSDVYSFGILIMEIIT-GRNP 278
+SDV+SFG+++ EI T G+ P
Sbjct: 204 ESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 11/101 (10%)
Query: 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERSYVTTRVMGT 242
L L LH+ ++H D+K N+L DR + + D+GL K++ + Y GT
Sbjct: 118 LVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGT 169
Query: 243 FGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYS 282
Y +PE G + S D ++ G+L E++TG++P
Sbjct: 170 LDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 5/105 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAY H KV+HRD+K N+L++ + +++DFGLA+ + V+ T Y
Sbjct: 117 LAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 172
Query: 248 PEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291
P+ + + + D++ G + E+ +GR S + E++L+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GY 245
+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E Y G +
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 187
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT 274
+APE G+ SD++SFG+++ EI +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 31/145 (21%), Positives = 58/145 (40%), Gaps = 47/145 (32%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGL---------------------------------AK 226
+HRD+K NIL+DR + +++DFGL A
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 227 LLCSERSYVTTR-------------VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 273
C +R R ++GT Y+APE + D +S G+++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 274 TGRNPVDYSRP-QGEVNLVDWLKTM 297
G+ P P + ++ +++W ++
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 26/114 (22%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH+ +HR++K+S+IL+ + VS GL+ L R+ +V+ F
Sbjct: 114 LNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDF---- 164
Query: 248 PEYACTGML---------------NEKSDVYSFGILIMEIITGRNP-VDYSRPQ 285
P+++ T +L N KSD+YS GI E+ TGR P D R Q
Sbjct: 165 PQFS-TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 14/54 (25%), Positives = 25/54 (46%), Gaps = 1/54 (1%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
IG+GG+G VY+ G +VA+K + + + + + K NI+
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 22/75 (29%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNE 258
VHRD+ + N L+ +++DFG+++ L + Y + R + ++A E G
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 259 KSDVYSFGILIMEII 273
SDV++FG+ + EI+
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L Y H KV+HRD+K N+L++ + +++DFGLA+ + V+ T Y
Sbjct: 117 LNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRP 172
Query: 248 PEYACTGM-LNEKSDVYSFGILIMEIITGR 276
P+ + + D++ G + E+ TGR
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 27/92 (29%), Positives = 37/92 (40%), Gaps = 9/92 (9%)
Query: 188 LAYLHEGLEP-KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
A + L + +HR KS NILL W+ + G E+S M
Sbjct: 20 WAVCLQCLGALRELHRQAKSGNILL--TWDGLLKLDGSVAFKTPEQSRPDPYFM------ 71
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
APE EK+D+YS GI + E + P
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/105 (26%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L+Y H+ K++HRD+K N+L++ + +++DFGLA+ + V+ T Y
Sbjct: 116 LSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 171
Query: 248 PEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291
P+ + + D++ G ++ E+ TGR S + E++L+
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 43/141 (30%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGL----------------------------------- 224
+HRD+K NIL+DR + +++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 225 AKLLCSERSYVT--TRVM-----GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN 277
+L ER R + GT Y+APE + D +S G+++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 278 PVDYSRPQG-EVNLVDWLKTM 297
P P ++ +++W T+
Sbjct: 243 PFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 16/94 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-------CSERSYVTTRVM 240
+AYL E K VHRD+ + N L+ +++DFGL++ + SE + R M
Sbjct: 143 MAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM 199
Query: 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 274
PE +SDV+++G+++ EI +
Sbjct: 200 ------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 25/132 (18%)
Query: 170 GILSDGTKVAVKNLLNNRLAYLHEGLE----PKVVHRDVKSSNILLDR----------QW 215
G + + V + L + LAY H + +V+HRD+K NI L Q
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 216 N-------ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC--TGMLNEKSDVYSFG 266
N A++ DFGL+K + E + +GT Y +PE T ++KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 267 ILIMEIITGRNP 278
+I E+ +G+ P
Sbjct: 231 CIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 24/97 (24%), Positives = 47/97 (48%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239
V++ + + +H + +VHRD+K N+L+ ++ DFG A+ L + T
Sbjct: 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161
Query: 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 276
+ T Y +PE + D++S G ++ E+ G+
Sbjct: 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 16/35 (45%), Positives = 24/35 (68%), Gaps = 1/35 (2%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERS 233
+HRD+K N+LLD + + ++SDFGL L S R+
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 14/26 (53%), Positives = 21/26 (80%)
Query: 200 VHRDVKSSNILLDRQWNARVSDFGLA 225
+HRD+K NIL+DR + ++SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 176 TKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235
T+ +K LL + Y+H+ K++HRD+K NI L+ + DFG A ER
Sbjct: 269 TRAIMKQLLC-AVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 274
+GT +PE E +D++S G++++++++
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 23/94 (24%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERS---YVTTRVMGTF 243
L Y+H V+HRD+K +N+ ++ ++ DFGLA+++ S Y++ ++ +
Sbjct: 127 LKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 244 GYVAPEYACT-GMLNEKSDVYSFGILIMEIITGR 276
Y +P + + D+++ G + E++TG+
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.004
Identities = 34/120 (28%), Positives = 47/120 (39%), Gaps = 33/120 (27%)
Query: 188 LAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV----------- 235
L YLH G +V+RD+K NILL + +SDF L+K E V
Sbjct: 116 LEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 236 --------------TTRVM---GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
+ R GT Y+APE D ++ GIL+ E++ G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYV 235
VK+LL L +H V+HRD+K +NIL+ + +++D G A+L S +
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 236 T--TRVMGTFGYVAPEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQ 285
V+ TF Y APE K+ D+++ G + E++T P+ + R +
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 23/107 (21%)
Query: 186 NRLAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVS-----------DFGLAKLLCSERS 233
N L Y+H +G +HR VK+S+ILL +S + +S
Sbjct: 112 NALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 234 YVTTRVMGTFGYVAPEYACTGML--NEKSDVYSFGILIMEIITGRNP 278
+ + + +++PE + NEKSD+YS GI E+ G P
Sbjct: 168 --SVKNLP---WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 408 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.98 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.93 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.92 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.91 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.91 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.91 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.87 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.84 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.83 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.81 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.75 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.68 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.56 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.55 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.55 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.51 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.46 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.33 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.31 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.29 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.21 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.09 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.04 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.99 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.89 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.87 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.86 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.48 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.6 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.93 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 96.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 96.48 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 96.4 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.06 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.42 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 95.04 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 94.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.69 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 94.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 94.45 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 93.29 | |
| PF07213 | 79 | DAP10: DAP10 membrane protein; InterPro: IPR009861 | 92.83 | |
| PF14575 | 75 | EphA2_TM: Ephrin type-A receptor 2 transmembrane d | 92.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.12 | |
| PF12191 | 129 | stn_TNFRSF12A: Tumour necrosis factor receptor stn | 91.92 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.86 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 91.68 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 91.59 | |
| PF01034 | 64 | Syndecan: Syndecan domain; InterPro: IPR001050 The | 91.43 | |
| PF01034 | 64 | Syndecan: Syndecan domain; InterPro: IPR001050 The | 91.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 91.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 91.12 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 91.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 90.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 90.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 90.81 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 90.61 | |
| PF13908 | 179 | Shisa: Wnt and FGF inhibitory regulator | 90.53 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 90.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 89.85 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 89.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 89.49 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.41 | |
| PF05568 | 189 | ASFV_J13L: African swine fever virus J13L protein; | 89.4 | |
| PF08374 | 221 | Protocadherin: Protocadherin; InterPro: IPR013585 | 89.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 89.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 89.16 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.13 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 89.03 | |
| PF15102 | 146 | TMEM154: TMEM154 protein family | 88.32 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 88.17 | |
| PF12273 | 130 | RCR: Chitin synthesis regulation, resistance to Co | 87.74 | |
| PF12877 | 684 | DUF3827: Domain of unknown function (DUF3827); Int | 87.54 | |
| PF05808 | 162 | Podoplanin: Podoplanin; InterPro: IPR008783 This f | 87.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 86.75 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 86.15 | |
| PF02009 | 299 | Rifin_STEVOR: Rifin/stevor family; InterPro: IPR00 | 85.84 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 85.82 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=325.39 Aligned_cols=214 Identities=55% Similarity=0.893 Sum_probs=188.7
Q ss_pred CcceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe---------------------------------
Q 015360 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL--------------------------------- 183 (408)
Q Consensus 137 ~~~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~--------------------------------- 183 (408)
..+.|++.||+.||++|+..++||+|+||.||+|.+.+++.||||++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34779999999999999999999999999999999999999999976
Q ss_pred ------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEec
Q 015360 184 ------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 221 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~D 221 (408)
++.||+|||+.+.++|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 34559999999888999999999999999999999999
Q ss_pred cCCceeecC-CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 222 FGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 222 fg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
||+++.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+.+|....+..
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976543 22221111 7999999999999999999999999999999999999998876656666799999999999
Q ss_pred CCcccccCCCCC-CCCcH-HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 301 RKSEEVVDPKLP-KMPAS-KALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 301 ~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+...+++|+.+. ..... +++.++..++.+|++.+|.+||+|.||+++|+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999999999987 44443 6888899999999999999999999999999653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=274.54 Aligned_cols=186 Identities=28% Similarity=0.535 Sum_probs=146.9
Q ss_pred eeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------
Q 015360 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------- 183 (408)
Q Consensus 140 ~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------- 183 (408)
.+++.||+.. +.||+|..|+|||+.++. +..+|+|.+
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3677787754 789999999999999864 788999987
Q ss_pred ---------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCC
Q 015360 184 ---------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 ---------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
+.+||.|||+. .+||||||||+|||++..|.+||||||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 34459999963 2999999999999999999999999999
Q ss_pred ceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
+..+... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+ ......+.+..
T Consensus 226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~-------- 293 (364)
T KOG0581|consen 226 SGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCA-------- 293 (364)
T ss_pred cHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHH--------
Confidence 9877544 44668899999999999999999999999999999999999999975421 11122222222
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+++...+..+...+..++..++..||++||.+|||++|++++
T Consensus 294 -Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 -IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222222222222455678899999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=265.09 Aligned_cols=195 Identities=24% Similarity=0.342 Sum_probs=148.1
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
.|....++|+|+||+|||++.++ |+.||||++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667899999999999999876 999999998
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..++.|+|++ ++|||||||+|||++.++.+||||||+|+.+.. .....
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 34558999999 999999999999999999999999999998864 33345
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHH--------HHHHhcC-CCcccc
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW--------LKTMVGS-RKSEEV 306 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~ 306 (408)
+.++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|+...+.+....+.. ...+... .....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 66789999999999987 7799999999999999999999999987665443322221 1111111 111111
Q ss_pred cCCCCC-----CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 307 VDPKLP-----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 307 ~d~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.-|... ....+....-+++++..||+.||++|++.+|++..--.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 111111 11122334468899999999999999999999875433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=275.82 Aligned_cols=150 Identities=33% Similarity=0.536 Sum_probs=116.5
Q ss_pred hhhhHHHhhhCCCCc-eeeeccccCceEeCCCC-ceEEeccCCceeecCCCcceecccccccCcccccccc--cCCCCcc
Q 015360 184 LNNRLAYLHEGLEPK-VVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC--TGMLNEK 259 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~-ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~ 259 (408)
++.||.|||+. + ||||||||+|||++.++ ++||+|||+++...... ...+...||+.|||||++. ...|+.|
T Consensus 151 iArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K 226 (362)
T KOG0192|consen 151 IARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEK 226 (362)
T ss_pred HHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCcc
Confidence 45569999998 6 99999999999999997 99999999998765432 2223367999999999999 5689999
Q ss_pred ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC
Q 015360 260 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 260 sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
+||||||+++|||+||+.||...... ..+......... +.++. .+...+..|+.+||+.||.+||
T Consensus 227 ~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~R-----p~~p~----~~~~~l~~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 227 SDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGLR-----PPIPK----ECPPHLSSLMERCWLVDPSRRP 291 (362)
T ss_pred chhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCC-----CCCCc----cCCHHHHHHHHHhCCCCCCcCC
Confidence 99999999999999999999855431 111222211111 11111 1344788899999999999999
Q ss_pred CHhHHHHHHhcCC
Q 015360 340 KMGHVIHMLEADD 352 (408)
Q Consensus 340 s~~evl~~Le~~~ 352 (408)
++.|++..|+...
T Consensus 292 ~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 292 SFLEIVSRLESIM 304 (362)
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.44 Aligned_cols=177 Identities=25% Similarity=0.439 Sum_probs=143.2
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
..|...++||+|||+.+|+++. ..|+.||+|.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4578889999999999999997 77999999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..||.|||+. +|+|||||..|+||+++.++||+|||+|..+.... .
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-E 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-c
Confidence 45569999999 99999999999999999999999999999875432 3
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
...+.+|||.|.|||++.....+..+||||+||++|.||.|++||+...-.+. ...+.. .+. .++.
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~----~~Y---~~P~- 239 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKL----NEY---SMPS- 239 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHh----cCc---cccc-
Confidence 34558899999999999999999999999999999999999999975432221 111111 111 1111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.......+||.++|+.||.+|||+++|+..=
T Consensus 240 ---~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 240 ---HLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred ---ccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 2223567888999999999999999998743
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=251.42 Aligned_cols=182 Identities=29% Similarity=0.451 Sum_probs=143.7
Q ss_pred CCccceeccCCcEEEEEEE-eCCCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~------------------------------------------------ 183 (408)
|.+.++||.|+||+|||+. +.+|..+|.|.+
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 5556899999999999998 567999999977
Q ss_pred --------------------------------hhhhHHHhhhCCCC-ceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 --------------------------------LNNRLAYLHEGLEP-KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~-~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.||..+|..... .|+||||||.||+|+.+|.+||+|||+++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 45568999983221 399999999999999999999999999998855
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... .....+|||.||+||.+....|+.|+||||+||++|||..-++||... ++....... ..+ .
T Consensus 181 ~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI-~qg--------d 244 (375)
T KOG0591|consen 181 KTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI-EQG--------D 244 (375)
T ss_pred hhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH-HcC--------C
Confidence 443 344578999999999999999999999999999999999999999754 333332222 121 2
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.++.+..-....+..|+..|+..||+.||+.-.+++.+..
T Consensus 245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2233334455678888999999999999997666666554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=268.71 Aligned_cols=191 Identities=23% Similarity=0.385 Sum_probs=151.9
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------ 183 (408)
+.-.++|.++++||+|+|.+||+|+-. .+..+|||++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445678999999999999999999954 4889999987
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
|.++|+|||.. |||||||||+|||||.++.+||+|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 45569999999 99999999999999999999999999998875
Q ss_pred CCCcc------------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHH
Q 015360 230 SERSY------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 230 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
..... ....++||..|.+||++.....++.+|+|+|||+||+|+.|++||...++.-. -+.+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---FqkI~~- 301 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---FQKIQA- 301 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---HHHHHH-
Confidence 43221 11447899999999999999999999999999999999999999975443211 111111
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCccchh
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRD 357 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~~~~~ 357 (408)
++-.++..++ +.+.+|+.+.|..||.+|+|.+||-++.-...+-|.+
T Consensus 302 ---------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 302 ---------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred ---------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 1222333333 3677888999999999999999998887666555555
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=260.47 Aligned_cols=177 Identities=27% Similarity=0.420 Sum_probs=143.4
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
..|...+.||+|.||.||||.... ++.||||.+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 345666799999999999999654 889999988
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||.. +.+|||||+.|||+..++.+||+|||++..+.......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 23459999999 99999999999999999999999999998876544433
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....++ ....++...
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCCCccc
Confidence 5688999999999999889999999999999999999999999876664332111 111122222
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+.+++..||+.||+.||++.++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2344568889999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.63 Aligned_cols=185 Identities=30% Similarity=0.453 Sum_probs=148.3
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------- 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------- 183 (408)
+.-++|.. .+.||+|-||+||.|.++....||||.+
T Consensus 203 i~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 203 IPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred ecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 45555554 3779999999999999987779999987
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+++|++||+++ ++|||||.++||||+++..+||+|||+++.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 56779999999 999999999999999999999999999996
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
..++.........-...|.|||.+..+.++.|||||||||+||||+| |+.||...... +.+..+.
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le-------- 418 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLE-------- 418 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHh--------
Confidence 65544444444455678999999999999999999999999999999 99998754432 2222211
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...+...+..+...+.+|+..||+.+|++|||++.+...|+..
T Consensus 419 --~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 419 --RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 2222223334555789999999999999999999999888763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=254.99 Aligned_cols=170 Identities=29% Similarity=0.418 Sum_probs=134.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||+||..+-++ ++.+|+|.+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 568889999999999999998654 889999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..||.|||+. +||||||||+|||||.+|.++|+|||+++.......
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~- 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD- 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence 44559999999 999999999999999999999999999986533322
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.. .+........ -+..+..
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k------~~~~p~~ 248 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGK------LPLPPGY 248 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCc------CCCCCcc
Confidence 334478999999999999999999999999999999999999999755432 2222222221 0111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
......+++.+.|+.||++|..
T Consensus 249 ----ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 249 ----LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCHHHHHHHHHHhccCHHHhcC
Confidence 1225677888999999999963
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=266.13 Aligned_cols=198 Identities=30% Similarity=0.428 Sum_probs=149.0
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------- 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------- 183 (408)
.++++++...+.+.....||+|+||+||||.|- | .||||.+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 455677777777888899999999999999985 3 4999987
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
++.|+.|||.+ +|||+|||..||||.+++.|||+|||++.
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 56679999999 99999999999999999999999999996
Q ss_pred eecCC-CcceecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC
Q 015360 227 LLCSE-RSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 227 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 302 (408)
..... .........|...|||||++.. .+|++.+||||||+|+|||+||..||........ .-+++.+.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEecccc
Confidence 54221 1111223457789999999874 5689999999999999999999999973322111 11112221
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCccc
Q 015360 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLF 355 (408)
Q Consensus 303 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~~~ 355 (408)
.. .|.. .....+.+++.+|+..||..++++||.+.+|+..|+.....+
T Consensus 610 l~--pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 610 LM--PDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cC--ccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 11 1111 112334557888899999999999999999999998754433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=257.97 Aligned_cols=181 Identities=24% Similarity=0.394 Sum_probs=140.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||.|-+|.-+ +|+.||||.+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 355777899999999999999854 5999999987
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC---CceEEeccCCce
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAK 226 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kL~Dfg~a~ 226 (408)
+..++.|||+. ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 34459999999 99999999999999755 779999999999
Q ss_pred eecCCCcceecccccccCcccccccccCCC---CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTGML---NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
... ......+.+||+.|.|||++.+..+ ..++|+||+||+||-+|+|.+||....... .+.+.+ ..+..
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI----~~G~y 399 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQI----LKGRY 399 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHH----hcCcc
Confidence 875 3344566889999999999986553 347899999999999999999997543321 122111 11111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+.+....+..++.++||.+||..||++|||+.|+|+.
T Consensus 400 ------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 ------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11122234556788999999999999999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=253.38 Aligned_cols=211 Identities=28% Similarity=0.433 Sum_probs=156.5
Q ss_pred cCCCCCCCCccccCCCcceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------
Q 015360 122 SFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------ 183 (408)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------ 183 (408)
..|+|++.+...++...+++.|. +.||+|.||+||+|.|. |+.||||++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~------------e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTv 260 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQ------------EIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTV 260 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEE------------EEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHH
Confidence 45777888888887777766554 58999999999999997 999999998
Q ss_pred --------------------------------------------------------hhhhHHHhhhC-----CCCceeee
Q 015360 184 --------------------------------------------------------LNNRLAYLHEG-----LEPKVVHR 202 (408)
Q Consensus 184 --------------------------------------------------------~~~~L~yLH~~-----~~~~ivH~ 202 (408)
++.+|++||.. .+|.|.||
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHR 340 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHR 340 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcc
Confidence 45569999964 36899999
Q ss_pred ccccCceEeCCCCceEEeccCCceeecCCCcc---eecccccccCcccccccccCC----C--CccccchhhHHHHHHHH
Q 015360 203 DVKSSNILLDRQWNARVSDFGLAKLLCSERSY---VTTRVMGTFGYVAPEYACTGM----L--NEKSDVYSFGILIMEII 273 (408)
Q Consensus 203 dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlGvvl~ell 273 (408)
|||+.|||+..++.+.|+|+|+|......... ..+..+||.+|||||++...- + -..+||||||+|+||+.
T Consensus 341 DlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 341 DLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred ccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999999999876544322 234567999999999986422 1 13689999999999997
Q ss_pred hC----------CCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC-CcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 274 TG----------RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 274 tG----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
.. ++||....+.+. .+.+ +...+-.++. .|.+++. ...+.+..+.+|+..||..||.-|-|+-
T Consensus 421 rRc~~ggi~eey~~Pyyd~Vp~DP-s~ee-MrkVVCv~~~----RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 421 RRCESGGIVEEYQLPYYDVVPSDP-SFEE-MRKVVCVQKL----RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred HHhhcCCEehhhcCCcccCCCCCC-CHHH-Hhcceeeccc----CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 52 467765433322 2221 1111111122 2333322 2456788999999999999999999999
Q ss_pred HHHHHHhcC
Q 015360 343 HVIHMLEAD 351 (408)
Q Consensus 343 evl~~Le~~ 351 (408)
-+-+.|.+.
T Consensus 495 riKKtl~~l 503 (513)
T KOG2052|consen 495 RIKKTLAKL 503 (513)
T ss_pred HHHHHHHHH
Confidence 998888764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=273.33 Aligned_cols=180 Identities=28% Similarity=0.475 Sum_probs=145.7
Q ss_pred CCCccceeccCCcEEEEEEEeCC----CcEEEEEEe--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~-------------------------------------------- 183 (408)
...++++||.|.||+||+|+|+- ...||||.+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 44567999999999999999863 468999988
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
|+.++.||-+. ++|||||..+|||++.+..+|++|||+++.+.+...
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 55669999998 999999999999999999999999999998755443
Q ss_pred ceeccc--ccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 234 YVTTRV--MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 234 ~~~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
...+.. .-..+|.|||.+...+++.++||||||+++||.++ |..||-...+++..+-+ ...
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----------------e~g 850 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----------------EQG 850 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----------------Hhc
Confidence 222222 22468999999999999999999999999999887 99998655444322111 123
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
++..++.++...|.+|++.||++|-++||++.||+..|+.
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 3334455666789999999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=239.80 Aligned_cols=191 Identities=23% Similarity=0.322 Sum_probs=143.7
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||+|.||.||+|+. ..|+.||||++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566678999999999999995 45999999988
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||.+ .|+||||||.|+|++.+|.+||+|||+++.........
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 34459999999 99999999999999999999999999999887655443
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc-------
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV------- 307 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 307 (408)
.. .+-|.+|+|||.+.+ ..|+...||||.|||+.||+-|.+-|.+..+-+. ...+-..++......+.
T Consensus 159 ~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 159 TH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccccccc
Confidence 33 368999999998876 5699999999999999999999988876543321 22222222221111111
Q ss_pred --------CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 308 --------DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 308 --------d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
.+... .....+....++|+..+|..||.+|+|+.|++++--
T Consensus 235 Y~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 235 YVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 01111 112233456789999999999999999999987543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=255.61 Aligned_cols=190 Identities=28% Similarity=0.407 Sum_probs=145.7
Q ss_pred cCCCccceeccCCcEEEEEEE-eCCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||+|+||.||||+ +.+|..||+|++
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456666899999999999999 456999999988
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||.. +|+|||||.+|||||.+|.+||+|||+|++......
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 45569999999 999999999999999999999999999998877766
Q ss_pred ceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
...+..+-|.+|+|||++.+. .|+...|+||.||||.||++|++.|+...+.+. ...+..+++......+.-..++
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhccccccCC
Confidence 656677889999999999874 699999999999999999999999987654322 2222233322211111100111
Q ss_pred -------CCCcHH--------HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 -------KMPASK--------ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 -------~~~~~~--------~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
...... .....++|+..+|..||.+|.|+.++|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011111 1245678999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=260.68 Aligned_cols=190 Identities=24% Similarity=0.360 Sum_probs=145.9
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||.|+||.||+|+- ..+..||||++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4677778999999999999994 45899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+.++|+|+|.+ |+.|||+||+|||+..+..+||+|||+|+.+.+...
T Consensus 90 E~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP- 165 (538)
T KOG0661|consen 90 EFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP- 165 (538)
T ss_pred HhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCC-
Confidence 45569999999 999999999999999889999999999998866554
Q ss_pred eecccccccCcccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc-------
Q 015360 235 VTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV------- 306 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 306 (408)
.+.++.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.+..+.+.. -.+-..++......+
T Consensus 166 -YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 166 -YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred -cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccchhHHHHH
Confidence 35678999999999875 577999999999999999999999999876543321 112222222111111
Q ss_pred --cCCCCC---CCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 307 --VDPKLP---KMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 307 --~d~~~~---~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
+.-.++ +.. .+.+..+.++|+.+||..||++|||+.|++++-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111 111 112556788999999999999999999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=249.50 Aligned_cols=129 Identities=33% Similarity=0.631 Sum_probs=112.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||.|+||+||+|+++. +..||||.+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 467777889999999999999764 899999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC------CceEEeccCCceeec
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ------WNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~------~~~kL~Dfg~a~~~~ 229 (408)
++.||++||++ +||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 45569999999 99999999999999764 458999999999886
Q ss_pred CCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 284 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~ 284 (408)
... .....+|++.|||||++....|+.|+|+||+|++||+|++|+.||+....
T Consensus 167 ~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 167 PGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred chh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 332 23457899999999999999999999999999999999999999985543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.06 Aligned_cols=201 Identities=30% Similarity=0.540 Sum_probs=156.4
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~------------------------------------ 183 (408)
+++.++. ..|...++||+|+||.||+|+. .++..||||.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 4455554 4577788999999999999997 46899999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||+|||..+.++|+||||||+||+++.++.+++. |+........
T Consensus 760 lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred EEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 4556999997667799999999999999998888775 5554332211
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....++..|+|||++.+..++.++|||||||++|||+||+.||+.... .......|............++|+.+...
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence 223578999999999999999999999999999999999999954322 23456667665554444555666665432
Q ss_pred --CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 315 --PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 315 --~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...++..++.+++.+||+.||++||||.||++.|+..
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2345667889999999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=263.05 Aligned_cols=179 Identities=30% Similarity=0.500 Sum_probs=144.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
+.....+-||.|+.|-||+|++. ++.||||++
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 34445578999999999999996 888999977
Q ss_pred ------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCc
Q 015360 184 ------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245 (408)
Q Consensus 184 ------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y 245 (408)
|+.++.|||.+ .|||||||+-||||..+..+||+|||-++.+... .....+.||..|
T Consensus 203 Lka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaW 277 (904)
T KOG4721|consen 203 LKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAW 277 (904)
T ss_pred HhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhh
Confidence 56679999999 9999999999999999999999999999876443 223457899999
Q ss_pred ccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHH
Q 015360 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 325 (408)
Q Consensus 246 ~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 325 (408)
||||++.+.+.+.|+|||||||||||||||..||..-+..... | .+-...+....+..+.+-+.-
T Consensus 278 MAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-----------GVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-----------GVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-----------eccCCcccccCcccCchHHHH
Confidence 9999999999999999999999999999999999754332110 0 011112222333445556778
Q ss_pred HHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 326 VALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 326 l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
|+.+||+..|.+||++.+++..|+-
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhh
Confidence 8899999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=256.96 Aligned_cols=180 Identities=28% Similarity=0.446 Sum_probs=143.6
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
...|.....||+|..|.||.+.- ..++.||||++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34577778999999999999984 45889999988
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..||+|||.. +|+|||||.+|||++.++.+||+|||+|..+..... ...
T Consensus 352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~ 427 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRS 427 (550)
T ss_pred cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccc
Confidence 34569999999 999999999999999999999999999998865554 344
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..+||+.|||||++....|++|.||||||++++||+-|.+||-..++-.. +. ++...... .+ ....
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------ly-LIa~ng~P-----~l--k~~~ 493 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LY-LIATNGTP-----KL--KNPE 493 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HH-HHhhcCCC-----Cc--CCcc
Confidence 57899999999999999999999999999999999999999964332211 11 11111111 11 1122
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+.+++.+||+.|+++|+++.|+|+.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 334568888899999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=249.65 Aligned_cols=183 Identities=31% Similarity=0.487 Sum_probs=138.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
.++...+.||+|+||.||++...+ |...|||..
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 345566899999999999999765 899999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCCceeecC--C
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCS--E 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~~~~~--~ 231 (408)
+.++|.|||++ +|||+||||+|||++. ++.+||+|||++..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 34459999998 9999999999999999 79999999999987653 1
Q ss_pred CcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.........||+.|||||++..+ ....++|||||||++.||+||++||... .....++......... |.
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P~ 243 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----PE 243 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----CC
Confidence 22223357799999999999854 3445999999999999999999999743 1122222222222211 22
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
++.. ......+++.+|++.||++|||+.|+|+....
T Consensus 244 ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 244 IPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2222 23367788899999999999999999986643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=244.52 Aligned_cols=195 Identities=29% Similarity=0.444 Sum_probs=140.0
Q ss_pred cceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------------- 183 (408)
.++||+|.||.||||++. ++.||||++
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG 293 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG 293 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence 358999999999999996 799999988
Q ss_pred ----------------------hhhhHHHhhhCC------CCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------LNNRLAYLHEGL------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------~~~~L~yLH~~~------~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++++|+|||+.. +++|+|||||++|||+.+++++.|+|||+|..+.......
T Consensus 294 sL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~ 373 (534)
T KOG3653|consen 294 SLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQG 373 (534)
T ss_pred cHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCc
Confidence 566799999754 6789999999999999999999999999998876443322
Q ss_pred -ecccccccCcccccccccCC-CC-----ccccchhhHHHHHHHHhCCCCCCC-CCCC----------CcchhHHHHHHH
Q 015360 236 -TTRVMGTFGYVAPEYACTGM-LN-----EKSDVYSFGILIMEIITGRNPVDY-SRPQ----------GEVNLVDWLKTM 297 (408)
Q Consensus 236 -~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltG~~Pf~~-~~~~----------~~~~~~~~~~~~ 297 (408)
....+||.+|||||++.+.. +. .+.||||+|.|||||++...-+.. ..+. ....+.+.....
T Consensus 374 d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~V 453 (534)
T KOG3653|consen 374 DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELV 453 (534)
T ss_pred chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHH
Confidence 23478999999999987642 22 368999999999999986543321 1100 011122222222
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCccc
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLF 355 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~~~ 355 (408)
+.+.....+.+..... ..+..+.+.+..||+.||+.|.|+.=|-+.+....-+.
T Consensus 454 V~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 454 VRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 2222222332222221 33456778888999999999999999988887654443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=244.74 Aligned_cols=187 Identities=27% Similarity=0.402 Sum_probs=140.7
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||.|.-++||+|.. ..++.||||++
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4677788999999999999994 45799999998
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+.+||.|||.+ |.||||||+.||||+.+|.+||+|||++..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 34569999999 9999999999999999999999999988766443321
Q ss_pred e--e-cccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 235 V--T-TRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 235 ~--~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
. . ...+||+.|||||++.. ..|+.|+||||||++..||.+|..||....+.. .+...+..... ...-.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp-~~~t~ 255 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPP-TLLTS 255 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCC-Ccccc
Confidence 1 1 45689999999999543 459999999999999999999999997554432 11111111111 00001
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+...........+.+++..||+.||.+|||++++++.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111122334578889999999999999999999764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=241.71 Aligned_cols=190 Identities=25% Similarity=0.388 Sum_probs=143.1
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
.|...+++|.|+||.||+|++.+ +..||||+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 34556899999999999999765 689999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~~ 233 (408)
+.++|.|||.. +|+||||||.|+|+|.+ +.+||||||.|+.+..+..
T Consensus 105 P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 105 PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 44569999998 99999999999999966 8999999999998865554
Q ss_pred ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc---------
Q 015360 234 YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS--------- 303 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 303 (408)
. ..+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.+..+ .+...++ +++....
T Consensus 182 n--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik-~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 182 N--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIK-VLGTPTREDIKSMNPN 256 (364)
T ss_pred c--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHH-HhCCCCHHHHhhcCcc
Confidence 4 34568899999999876 469999999999999999999999998754322 2222222 2221111
Q ss_pred -ccccCCCCCCCC-----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 304 -EEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 304 -~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
.+...|.+...+ ......+.++|+.++|+.+|.+|.++.|++.+--
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 112222222221 1223457889999999999999999999976543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=257.49 Aligned_cols=171 Identities=26% Similarity=0.401 Sum_probs=138.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
-++|...++||+|+||+|+.+.++. ++.+|||.+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 3679999999999999999999864 789999988
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+.-||+|||++ +|||||||.+|||||.+|.+||+|||+++..-...
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g- 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG- 522 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence 23349999999 99999999999999999999999999998643222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
..+.+.+||+.|||||++.+..|+..+|.|+|||+|||||.|+.||...+..+. -+ .++. .|+..+.
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---Fd---sI~~-------d~~~yP~ 589 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---FD---SIVN-------DEVRYPR 589 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHhc-------CCCCCCC
Confidence 245678999999999999999999999999999999999999999986554321 11 1111 1122222
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
-...+.+.++.++|..||++|..+
T Consensus 590 ----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 ----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----cccHHHHHHHHHHhccCcccccCC
Confidence 223467788889999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=243.39 Aligned_cols=178 Identities=26% Similarity=0.377 Sum_probs=135.7
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||+||++.. .+++.||||.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367778999999999999986 46899999975
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 33448999998 999999999999999999999999999987533222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..+........ ...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~------~~~-- 224 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ------EEY-- 224 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc------ccC--
Confidence 23356899999999999999999999999999999999999999754432111 11111111100 001
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
.......+.+|+.+||+.||.+||+ ++++++.
T Consensus 225 --~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 225 --SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112336788999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=242.23 Aligned_cols=193 Identities=20% Similarity=0.282 Sum_probs=139.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.+ +++.+|||++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888899999999999999986 4788999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 33459999998 99999999999999999999999999998764333222
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH---------HHHHHhcCCCcccc
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD---------WLKTMVGSRKSEEV 306 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 306 (408)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......+...... +.............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334568999999999998889999999999999999999999997543221110000 00000000000010
Q ss_pred cCCCCCCCC------cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 307 VDPKLPKMP------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 307 ~d~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+...... .......+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001100000 0112346889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=269.34 Aligned_cols=150 Identities=24% Similarity=0.421 Sum_probs=120.8
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec-ccccccCcccccccccCCCCccccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
|+.|++||-+. .+|||||-.+|+|+.++..|||+|||+++.+...+.+... ...-..+|||||.+..++|+.++||
T Consensus 612 IAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDV 688 (774)
T KOG1026|consen 612 IAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDV 688 (774)
T ss_pred HHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhh
Confidence 45669999998 9999999999999999999999999999987665554332 2234579999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||+|||+++ |+.||.....++.. ..+..+.+ ...+..+..++.+|+..||+.+|.+||++
T Consensus 689 Ws~GVvLWEIFsyG~QPy~glSn~EVI-------e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 689 WSFGVVLWEIFSYGKQPYYGLSNQEVI-------ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred hhhhhhhhhhhccccCcccccchHHHH-------HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999999999 99999866554322 22233322 12233444579999999999999999999
Q ss_pred hHHHHHHhcCC
Q 015360 342 GHVIHMLEADD 352 (408)
Q Consensus 342 ~evl~~Le~~~ 352 (408)
+||-..|+.+.
T Consensus 753 ~eI~~~L~~~~ 763 (774)
T KOG1026|consen 753 KEIHSRLQAWA 763 (774)
T ss_pred HHHHHHHHHHH
Confidence 99999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=251.54 Aligned_cols=176 Identities=30% Similarity=0.479 Sum_probs=142.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||||+-+ +.+.||||.+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999965 4789999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +|+|||+||.|||++.++.+|++|||+|+.+... ....
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 23449999999 9999999999999999999999999999987543 3345
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
+.+.||+.|||||.+.+..|+..+|.||+||++||+++|++||... .+...++.+. .|+... +
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~--------~d~v~~---p 220 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSIL--------KDPVKP---P 220 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHh--------cCCCCC---c
Confidence 6688999999999999999999999999999999999999999632 2222222222 122221 2
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+..++...|++||.+|.|..+++..
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2444567888889999999999999998764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=245.73 Aligned_cols=186 Identities=26% Similarity=0.355 Sum_probs=136.1
Q ss_pred CCCccceeccCCcEEEEEEEeC--CCcEEEEEEe----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS--DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~--~~~~vavK~~---------------------------------------------- 183 (408)
+|...+.||+|+||.||+|... ++..||||.+
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788899999999999999863 4678999965
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 23348999998 99999999999999999999999999997
Q ss_pred eecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc---
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS--- 303 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--- 303 (408)
..... .......+++.|+|||.+.+..++.++|||||||++|||++|++||......+ ....+.........
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDW 233 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhc
Confidence 65432 12234568999999999988899999999999999999999999997543321 11111111110000
Q ss_pred -------ccccCCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 -------EEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 -------~~~~d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+.. ..+. ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 0000 112245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=264.14 Aligned_cols=194 Identities=22% Similarity=0.271 Sum_probs=139.3
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------- 183 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------- 183 (408)
.+++...+++|.+.++||+|+||+||+|... .++.||||++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3455667789999999999999999999864 4788999975
Q ss_pred ---------------------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCC--------
Q 015360 184 ---------------------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQW-------- 215 (408)
Q Consensus 184 ---------------------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~-------- 215 (408)
++.+|+|||. . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccc
Confidence 2334899996 5 999999999999997654
Q ss_pred --------ceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 015360 216 --------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 287 (408)
Q Consensus 216 --------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~ 287 (408)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998754321 12346789999999999999999999999999999999999999975543221
Q ss_pred chhHHHHHHHhcC---------------------CCcccccCCC-----CCCCC--cHHHHHHHHHHHHhccCcCCCCCC
Q 015360 288 VNLVDWLKTMVGS---------------------RKSEEVVDPK-----LPKMP--ASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 288 ~~~~~~~~~~~~~---------------------~~~~~~~d~~-----~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
... +...... .......++. ..... .......+.+|+.+||+.||++||
T Consensus 354 ~~~---i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 354 LHL---MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHH---HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 111 1111000 0000000000 00000 001124577999999999999999
Q ss_pred CHhHHHH
Q 015360 340 KMGHVIH 346 (408)
Q Consensus 340 s~~evl~ 346 (408)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=250.48 Aligned_cols=146 Identities=26% Similarity=0.488 Sum_probs=109.5
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||
T Consensus 186 aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 262 (338)
T cd05102 186 GMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSF 262 (338)
T ss_pred HHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHH
Confidence 47899998 99999999999999999999999999998654322211 122345678999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||....... .+ .. ....+.. ...+ ......+.+|+.+||+.||++|||+.||
T Consensus 263 G~il~el~~~g~~pf~~~~~~~--~~---~~-~~~~~~~-----~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 263 GVLLWEIFSLGASPYPGVQINE--EF---CQ-RLKDGTR-----MRAP----ENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred HHHHHHHHhCCCCCCCCCCccH--HH---HH-HHhcCCC-----CCCC----CCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999997 999997543221 11 11 1111111 1111 1123367889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 328 ~~~l~~ 333 (338)
T cd05102 328 VEILGD 333 (338)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=248.57 Aligned_cols=180 Identities=25% Similarity=0.346 Sum_probs=137.5
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEeh-------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLL------------------------------------------- 184 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~~------------------------------------------- 184 (408)
..++|...++||+|+||.||.++-++ |..+|+|++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999655 9999999881
Q ss_pred --------------------------------hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC--
Q 015360 185 --------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-- 230 (408)
Q Consensus 185 --------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~-- 230 (408)
.-|++-||+. |+|||||||+|+|||..|.+||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 1237889998 999999999999999999999999999853311
Q ss_pred ---------------------CCcc----e-------------------ecccccccCcccccccccCCCCccccchhhH
Q 015360 231 ---------------------ERSY----V-------------------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 266 (408)
Q Consensus 231 ---------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 266 (408)
.... . ....+|||-|+|||++.+..|+..+|.||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 0 0124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcc-hhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC---Hh
Q 015360 267 ILIMEIITGRNPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MG 342 (408)
Q Consensus 267 vvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ 342 (408)
||+||||.|.+||....+.+.. .+..|...+. .........+..+||.+||. ||++|.. ++
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 9999999999999877765432 3333433221 11111122467889999999 9999986 44
Q ss_pred HHHH
Q 015360 343 HVIH 346 (408)
Q Consensus 343 evl~ 346 (408)
||-+
T Consensus 441 EIK~ 444 (550)
T KOG0605|consen 441 EIKK 444 (550)
T ss_pred HHhc
Confidence 4443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=239.23 Aligned_cols=198 Identities=27% Similarity=0.384 Sum_probs=144.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
...|...+.||+|+||.|+.+..+ +|..||||++
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555689999999999999964 4899999988
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..||.|+|+. +++||||||.|+|++.+..+||+|||+|+....
T Consensus 101 vYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence 34559999999 999999999999999999999999999998754
Q ss_pred C-CcceecccccccCcccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH--------HHhcC
Q 015360 231 E-RSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK--------TMVGS 300 (408)
Q Consensus 231 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 300 (408)
. .....+..+.|.+|.|||++. ...|+...||||.|||+.||++|++.|.+.+......++..+. ..+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 122235678899999999875 4679999999999999999999999998765433222221100 00110
Q ss_pred CCcccccC--CCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 301 RKSEEVVD--PKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 301 ~~~~~~~d--~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+. |..+..+.. ......++|+.+||..||.+|+|++|.++.---
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 00111110 111111111 123467889999999999999999999886543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=250.49 Aligned_cols=194 Identities=20% Similarity=0.277 Sum_probs=138.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
..+|...+.||+|+||.||++... .++.||||..
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~ 170 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLY 170 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHH
Confidence 367999999999999999999964 4889999965
Q ss_pred --------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccccccc
Q 015360 184 --------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243 (408)
Q Consensus 184 --------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~ 243 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++...............||+
T Consensus 171 ~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 247 (391)
T PHA03212 171 CYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247 (391)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCcc
Confidence 34569999998 9999999999999999999999999999754332222233457999
Q ss_pred CcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc----chhHHHHHHHhcCCCcc---------------
Q 015360 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE----VNLVDWLKTMVGSRKSE--------------- 304 (408)
Q Consensus 244 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~--------------- 304 (408)
.|+|||++.+..++.++|||||||++|||++|+.||........ ......+..........
T Consensus 248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 99999999998999999999999999999999988643221110 00111111100000000
Q ss_pred ----cccCCCCCCCC--cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 305 ----EVVDPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 305 ----~~~d~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+...... .......+.+|+.+||+.||++|||+.|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0122346888999999999999999999986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=243.41 Aligned_cols=180 Identities=29% Similarity=0.388 Sum_probs=134.6
Q ss_pred CCCccceeccCCcEEEEEEEe----CCCcEEEEEEe--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~----~~~~~vavK~~-------------------------------------------- 183 (408)
+|...+.||+|+||.||+++. .++..+|+|.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 35789999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 33449999998 999999999999999999999999999876543
Q ss_pred CCcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ......... .++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~-------~~~ 228 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK-------CDP 228 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-------CCC
Confidence 333233345689999999998765 4788999999999999999999999754332211 111111111 112
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
.++.. ....+.+++.+||+.||++|| +++++++.
T Consensus 229 ~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 22211 223577889999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=237.40 Aligned_cols=181 Identities=27% Similarity=0.483 Sum_probs=140.4
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||+|...++..||+|.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 467888999999999999999988899999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.+|+|||+. +++|+||||+||+++.++.++|+|||++............
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 33458999998 9999999999999999999999999999876443222222
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...++..|+|||.+....++.++|||||||++|+|++ |+.||...... .....+ ..... .+..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~---~~~~~-----~~~~----- 226 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL---QRGYR-----MPRM----- 226 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH---HcCCC-----CCCC-----
Confidence 3345678999999988889999999999999999998 99999643221 111111 11100 0111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+.+++.+||+.+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=240.36 Aligned_cols=150 Identities=19% Similarity=0.275 Sum_probs=110.5
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc------eecccccccCcccccccccCCCCc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNE 258 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ 258 (408)
+.+|+|||+. +|+||||||+|||++.++.++|+|||+++........ ......||+.|+|||.+.+..++.
T Consensus 136 ~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~ 212 (294)
T PHA02882 136 LTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR 212 (294)
T ss_pred HHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCc
Confidence 3458999998 9999999999999999999999999999876332111 112245899999999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCCcch---hHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCC
Q 015360 259 KSDVYSFGILIMEIITGRNPVDYSRPQGEVN---LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335 (408)
Q Consensus 259 ~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP 335 (408)
++|||||||++|||++|+.||.........- ..++..... .... .+.. ....+.+++..||+.+|
T Consensus 213 ~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~-----~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 213 RGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH-EGKI------KIKN-----ANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh-hhhh------ccCC-----CCHHHHHHHHHHHhCCC
Confidence 9999999999999999999997553222110 011111111 1000 0111 12468889999999999
Q ss_pred CCCCCHhHHHHHHh
Q 015360 336 TKRPKMGHVIHMLE 349 (408)
Q Consensus 336 ~~Rps~~evl~~Le 349 (408)
++||++.++++.|+
T Consensus 281 ~~rp~~~~l~~~~~ 294 (294)
T PHA02882 281 EEKPDYDALIKIFD 294 (294)
T ss_pred CCCCCHHHHHHhhC
Confidence 99999999998763
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=226.26 Aligned_cols=185 Identities=31% Similarity=0.490 Sum_probs=140.9
Q ss_pred ceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------
Q 015360 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------- 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------- 183 (408)
....+.||+.. ..||.|+-|.||++++.. |..+|||.+
T Consensus 87 ~~~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 87 YQADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 33456676654 569999999999999764 899999987
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
+.++|.||.++| +|+|||+||+|||+|+.|++||||||
T Consensus 160 Fi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 160 FITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred EeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence 334599999886 99999999999999999999999999
Q ss_pred CceeecCCCcceecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 224 LAKLLCSERSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 224 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
++-.+.+... .+...|.+.|||||.+.- .+|+-++||||||++|+||.||+.||...+..- .. +...+.+
T Consensus 238 IsGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~---ltkvln~ 310 (391)
T KOG0983|consen 238 ISGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV---LTKVLNE 310 (391)
T ss_pred ccceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH---HHHHHhc
Confidence 9977654433 344668899999999863 468889999999999999999999998644321 11 1111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. |.++... .....+.+++..||..|+.+||...++++.
T Consensus 311 eP------P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 EP------PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CC------CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 2222211 144578899999999999999999888763
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=231.48 Aligned_cols=189 Identities=25% Similarity=0.323 Sum_probs=141.8
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.|++|+||.||+|+.+ +++.||+|++
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 3555689999999999999964 4889999988
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+.++|+|||.. .|+|||||++|+|++..|.+||+|||+|+.+.....
T Consensus 157 e~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 157 EYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred HHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 45569999999 999999999999999999999999999998765432
Q ss_pred eecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC---cccccCC-
Q 015360 235 VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEEVVDP- 309 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~- 309 (408)
..+..+-|.+|+|||.+.+. .|++..|+||+|||+.||+++++.|......+ ..+.+...++... +..+...
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d---Ql~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID---QLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH---HHHHHHHHhCCCccccCCCccccc
Confidence 24556789999999998875 59999999999999999999999998654332 2333333332211 1111100
Q ss_pred -----CCCCCCcH---------HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 310 -----KLPKMPAS---------KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 310 -----~~~~~~~~---------~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+...+.. .....-++|+..+|..||.+|.|+.|.|+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111110 022456788999999999999999999874
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=246.28 Aligned_cols=177 Identities=28% Similarity=0.463 Sum_probs=131.1
Q ss_pred CccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------------
Q 015360 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------- 183 (408)
Q Consensus 154 ~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------- 183 (408)
...+.||+|+||.||+++.. +++.||||.+
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34578999999999999965 5899999986
Q ss_pred --------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccccccc
Q 015360 184 --------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243 (408)
Q Consensus 184 --------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~ 243 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++..+..... ......||.
T Consensus 157 ~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~ 232 (353)
T PLN00034 157 GSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTI 232 (353)
T ss_pred CcccccccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccCc
Confidence 33459999998 999999999999999999999999999987643221 123356899
Q ss_pred Cccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 244 GYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 244 ~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
.|+|||.+.. ...+.++|||||||++|||++|+.||........ ........... .+.. ...
T Consensus 233 ~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~------~~~~----~~~ 299 (353)
T PLN00034 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQ------PPEA----PAT 299 (353)
T ss_pred cccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccC------CCCC----CCc
Confidence 9999998743 2345689999999999999999999973322211 11111111000 0111 112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+|+.+||+.||++|||+.||++.
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23468889999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=242.85 Aligned_cols=170 Identities=24% Similarity=0.395 Sum_probs=130.4
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||+++.. +++.+|||.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999976
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 240 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 240 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccccee
Confidence 33459999998 999999999999999999999999999875322211 123356
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... +..++.. ..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~-------~~~~p~~----~~ 219 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-------EIRFPRT----LS 219 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcC-------CCCCCCC----CC
Confidence 899999999999999999999999999999999999999643211 111111111 1111111 22
Q ss_pred HHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 321 KRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
..+.+++.+||+.||++|| ++.++++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3577899999999999999 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=239.33 Aligned_cols=191 Identities=20% Similarity=0.336 Sum_probs=135.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.+|||.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999975 5889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 159 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-T 159 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-c
Confidence 34459999998 999999999999999999999999999875432221 1
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc--------c
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE--------V 306 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 306 (408)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .....+........... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhccc
Confidence 223457899999998865 457889999999999999999999997543211 11111111111100000 0
Q ss_pred cCCC-CC--CCCc-H------HHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 307 VDPK-LP--KMPA-S------KALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 307 ~d~~-~~--~~~~-~------~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.++. .. .... . .....+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00 0000 0 01235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=222.61 Aligned_cols=187 Identities=25% Similarity=0.343 Sum_probs=141.3
Q ss_pred hcCCCccceeccCCcEEEEEEE-eCCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~--------------------------------------------- 183 (408)
-++|.+.+.||+|||..||.++ +.++..+|+|++
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3578888999999999999998 667899999988
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++++|++||+. .+++.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 45569999997 45699999999999999999999999998865
Q ss_pred ecCCCcc--------eecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 015360 228 LCSERSY--------VTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 228 ~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
..-.-.. .......|..|+|||.+. +...+.++|||||||+||+|+.|..||+.....+.-
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-------- 250 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-------- 250 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--------
Confidence 4211100 012234789999999886 445788999999999999999999999743322210
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
-...+..+.+.........+.+.+++..||+.||.+||++.+++..++.
T Consensus 251 -----laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 251 -----LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -----EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 0011122222111122244578899999999999999999999998875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=240.53 Aligned_cols=189 Identities=21% Similarity=0.340 Sum_probs=136.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 5789999965
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~ 160 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY 160 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence 34559999998 999999999999999999999999999976533222 12
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC------------Cc
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR------------KS 303 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------~~ 303 (408)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+. ...+....... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccchhh
Confidence 23457899999998865 5688999999999999999999999975433221 11111111100 00
Q ss_pred ccccCCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~~~d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+....... ......+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111111100000 011235788999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=258.64 Aligned_cols=184 Identities=28% Similarity=0.426 Sum_probs=141.3
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------- 183 (408)
+++...++|.+.+.||+|+||+||++.. .+++.||||.+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444557899999999999999999985 45899999975
Q ss_pred ----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCce
Q 015360 184 ----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 217 (408)
Q Consensus 184 ----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 217 (408)
++.+|.|||+. +|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 22348899998 99999999999999999999
Q ss_pred EEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 015360 218 RVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 218 kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence 9999999986543221 122345689999999999999999999999999999999999999964321 122222
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.... .. ++ ++. .....+.+++.+||+.||.+||++.+++..
T Consensus 257 ~~~~-~~----~~-~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAG-RY----DP-LPP----SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcC-CC----CC-CCC----CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2111 11 11 111 122368889999999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=255.61 Aligned_cols=191 Identities=25% Similarity=0.366 Sum_probs=136.8
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
...+|...++||+|+||.||+|... +++.||||++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3467999999999999999999974 4789999975
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCcee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 227 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~ 227 (408)
++.+|+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 144 lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 23458999998 999999999999998664 699999999986
Q ss_pred ecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC----
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---- 302 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---- 302 (408)
...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|.+||........ +... ........
T Consensus 221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i-~~~~~~p~~~~~ 295 (440)
T PTZ00036 221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRI-IQVLGTPTEDQL 295 (440)
T ss_pred ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHHHH
Confidence 543222 223568999999998865 4689999999999999999999999975433211 1111 11111100
Q ss_pred ------cccccCCCCC-----CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 ------SEEVVDPKLP-----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ------~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...+.-+... ...+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000000 00011122468899999999999999999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=240.17 Aligned_cols=169 Identities=27% Similarity=0.472 Sum_probs=129.1
Q ss_pred ceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||+|...+ ++.||||.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999754 788999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 33459999998 99999999999999999999999999997643222 222345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .+.++.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-------~~~~~~~----~ 219 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILND-------RPHFPRW----I 219 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-------CCCCCCC----C
Confidence 6899999999999989999999999999999999999999743321 111111111 1111111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCHh-HHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMG-HVIH 346 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~-evl~ 346 (408)
...+.+++.+||+.||.+||++. ++++
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 23567888999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=234.11 Aligned_cols=182 Identities=29% Similarity=0.462 Sum_probs=139.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.++++..||||.+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4568888999999999999999888888999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 33458999998 999999999999999999999999999987653222111
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ......... + .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~~~-----~-----~ 225 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVL---QQVDQGYRM-----P-----C 225 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCCCC-----C-----C
Confidence 11223457999999998899999999999999999999 99999643211 111 111111000 0 0
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.......+.+++.+||+.||++||++.++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11123468889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=243.16 Aligned_cols=182 Identities=24% Similarity=0.371 Sum_probs=138.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|...+ ++.||||.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368888999999999999999764 889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 33459999998 999999999999999999999999999976533
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. ..... ...+... .
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~---~~~~~--~~~~~~~-~ 224 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLK---YWKET--LQRPVYD-D 224 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHH---hcccc--ccCCCCC-c
Confidence 2234568999999999999899999999999999999999999997543221 111111 10000 0001110 0
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
+.......+.+++.+||+.+|.+||++.|+++..
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0112234678899999999999999999998763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=239.42 Aligned_cols=192 Identities=26% Similarity=0.410 Sum_probs=150.5
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe--------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~-------------------------------------------- 183 (408)
.+.+...+.++||+|-||+|..+....+.+||||.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 345566777899999999999999987899999988
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+++||.+. ++|||||.++|||++.++++||+|||+++.+....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 45569999998 99999999999999999999999999999776655
Q ss_pred cce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 233 SYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT--GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
.+. ....+-..+|||+|.+..++++.++|||+||+++||+++ ...||....+. +.++....+........++ +
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l-~ 767 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVL-S 767 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceec-c
Confidence 543 234556789999999999999999999999999999876 67788644332 2333333443333322221 1
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+.-+...+.+++++||..|-.+||+++++...|++.
T Consensus 768 -----~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 -----RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1222334688999999999999999999999988763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=245.09 Aligned_cols=181 Identities=24% Similarity=0.344 Sum_probs=138.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... +++.||||.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999975 5899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC--
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 232 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~-- 232 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 33459999998 99999999999999999999999999997654332
Q ss_pred --------------------------cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 015360 233 --------------------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 286 (408)
Q Consensus 233 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~ 286 (408)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 11123356899999999999999999999999999999999999999754321
Q ss_pred cchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC-HhHHHHHH
Q 015360 287 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIHML 348 (408)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~L 348 (408)
........... ....+... .....+.+++.+||. ||.+||+ +.|+++..
T Consensus 237 -----~~~~~i~~~~~--~~~~p~~~-----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 237 -----ETYNKIINWKE--SLRFPPDP-----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred -----HHHHHHhccCC--cccCCCCC-----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 11111111000 00001111 023467788899997 9999999 99998854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=250.25 Aligned_cols=127 Identities=27% Similarity=0.361 Sum_probs=109.3
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|.+.++||+|+||.|-||... +++.||||++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6788899999999999999954 5999999988
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC--CceEEeccCCceeecC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~--~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.+||+. +|||+||||+||||.+. ..+||+|||.+.....
T Consensus 267 fELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 267 FELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred ehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 44559999998 99999999999999543 4699999999976533
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 285 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~ 285 (408)
.. . .+..+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..
T Consensus 344 ~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 344 RV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 22 2 466789999999999999999999999999999999999888876544
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=241.58 Aligned_cols=182 Identities=28% Similarity=0.521 Sum_probs=136.9
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-Cc----EEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GT----KVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~----~vavK~~------------------------------------------ 183 (408)
.+|...+.||+|+||.||+|++.. +. .||||.+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 458888999999999999998643 33 3899976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 34459999998 99999999999999999999999999998764332
Q ss_pred cce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+. ......... +.
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~----~~ 232 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKGERL----PQ 232 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhCCCCC----CC
Confidence 221 122234668999999999999999999999999999998 99998643211 111 111111100 00
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+. .+...+.+++.+||+.||++||++.+++..|...
T Consensus 233 -~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 233 -PP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -CC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1123578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=233.40 Aligned_cols=179 Identities=25% Similarity=0.432 Sum_probs=137.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||++.+.++..+|+|.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 357778899999999999999988889999975
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||.+.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 33458999998 99999999999999999999999999987653322222222
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. +........ ...+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~---~~~i~~~~~---~~~~~------- 224 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EV---VEMISRGFR---LYRPK------- 224 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHHHHCCCC---CCCCC-------
Confidence 335568999999988889999999999999999999 89998643321 11 111111111 01111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.....+.+++.+||+.||++||++.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=238.84 Aligned_cols=173 Identities=28% Similarity=0.362 Sum_probs=134.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +++.+|||.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 23448999998 99999999999999999999999999987653321
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ......... . ..++..
T Consensus 156 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~-~------~~~~~~ 220 (291)
T cd05612 156 --WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAG-K------LEFPRH 220 (291)
T ss_pred --ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-C------cCCCcc
Confidence 2346899999999999888999999999999999999999999643321 111111111 1 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
. ...+.+|+.+||+.||.+||+ ++|+++.
T Consensus 221 ~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 L----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1 235788999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=245.74 Aligned_cols=190 Identities=28% Similarity=0.429 Sum_probs=135.1
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||.||+|+.. ++..||||.+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3677899999999999999964 5899999975
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 33459999998 99999999999999999999999999997643221
Q ss_pred c--ceecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC-------
Q 015360 233 S--YVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR------- 301 (408)
Q Consensus 233 ~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 301 (408)
. .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPETISR 234 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHH
Confidence 1 11234568999999999865 678999999999999999999999997543211 111111100000
Q ss_pred ----Ccccc---cCCCCCCCCc---HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 ----KSEEV---VDPKLPKMPA---SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ----~~~~~---~d~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..... +....+.... ......+.+++.+||+.||++|||++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0000000000 0112357789999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=235.02 Aligned_cols=181 Identities=24% Similarity=0.383 Sum_probs=136.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
++|.+.+.||+|+||.||+|.+. .+..||+|.+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56788899999999999999864 3668999975
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +++|+||||+|||++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 34558999998 99999999999999999999999999876542222
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .. +... ..... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~---~~~~-~~~~~-----~~~ 229 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DV---IKAV-EDGFR-----LPA 229 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH---HHHH-HCCCC-----CCC
Confidence 211222335678999999999999999999999999999875 99999644321 11 1111 11110 011
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+......+.+++.+||+.+|++||++.||++.|..
T Consensus 230 ----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 230 ----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11223467889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=235.36 Aligned_cols=153 Identities=21% Similarity=0.394 Sum_probs=109.1
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|.|||+. +|+|+||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||
T Consensus 149 ~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 225 (304)
T cd05096 149 SGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225 (304)
T ss_pred HHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHH
Confidence 348999998 9999999999999999999999999999765433221 122334578899999998889999999999
Q ss_pred hHHHHHHHHh--CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 265 FGILIMEIIT--GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 265 lGvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
|||++|||++ +..||...... .....+............ ...+ ......+.+|+.+||+.||++|||+.
T Consensus 226 lG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 226 FGVTLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGRQVY--LFRP----PPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred HHHHHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhcccccc--ccCC----CCCCHHHHHHHHHHccCCchhCcCHH
Confidence 9999999987 55676543321 222222222211111100 0001 11223688999999999999999999
Q ss_pred HHHHHHhc
Q 015360 343 HVIHMLEA 350 (408)
Q Consensus 343 evl~~Le~ 350 (408)
||.+.|++
T Consensus 297 ~i~~~l~~ 304 (304)
T cd05096 297 DIHAFLTE 304 (304)
T ss_pred HHHHHHhC
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=236.24 Aligned_cols=185 Identities=19% Similarity=0.353 Sum_probs=139.2
Q ss_pred ceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------
Q 015360 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------- 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------- 183 (408)
+.++.++++ +.....||+|++|.||+|.+ +|+.||||.+
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 445666763 22236899999999999999 5899999976
Q ss_pred --------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 184 --------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 184 --------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
++.+|.|||... +++||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEE
Confidence 233489999732 7789999999999999999999
Q ss_pred eccCCceeecCCCcceecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHH
Q 015360 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.....
T Consensus 165 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i 234 (283)
T PHA02988 165 ICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLI 234 (283)
T ss_pred cccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence 9999987653322 12457889999999976 67899999999999999999999999744321 111111
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
...... +.++. .....+.+++.+||+.||++|||+.||++.|+.
T Consensus 235 ~~~~~~-----~~~~~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 235 INKNNS-----LKLPL----DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HhcCCC-----CCCCC----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111110 11111 123468889999999999999999999999975
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=246.18 Aligned_cols=190 Identities=26% Similarity=0.423 Sum_probs=137.0
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++.. .+++.||||.+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 46899999965
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 23449999998 99999999999999999999999999998654333
Q ss_pred cceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc------
Q 015360 233 SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE------ 305 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 305 (408)
........+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+...........
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhH
Confidence 3223334578999999998764 478999999999999999999999975543211 111111111000000
Q ss_pred ----cc--CCCCCC------CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 306 ----VV--DPKLPK------MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 306 ----~~--d~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+ .+..+. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000000 0001123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=242.93 Aligned_cols=178 Identities=28% Similarity=0.428 Sum_probs=138.3
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
...+|...+.||+|+||.|+.|... .+..||||.+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3467888899999999999999753 5799999953
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceee
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLL 228 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~ 228 (408)
+..|++|||+. +|+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 33349999999 99999999999999999 99999999999877
Q ss_pred cCCCcceecccccccCcccccccccCC-CC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACTGM-LN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ...... +..+ .+
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~---~~ 240 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKG---EF 240 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcC---Cc
Confidence 4 2233345678999999999999877 76 789999999999999999999986321 111111 1111 11
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.++.... ...+..|+.+||..||.+|+|+.+|+.
T Consensus 241 ---~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 ---KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111110 336788889999999999999999984
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=242.16 Aligned_cols=169 Identities=24% Similarity=0.399 Sum_probs=130.7
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|.... +..+|||.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999998764 678999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 33459999998 999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ........ ..++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~---~~~i~~~~-------~~~p~- 222 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---FQSIMEHN-------VAYPK- 222 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCC-------CCCCC-
Confidence 223456899999999999999999999999999999999999999743321 11 11111110 11111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
.....+.+++.+||+.||++|++.
T Consensus 223 ---~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 ---SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---cCCHHHHHHHHHHcccCHHhcCCC
Confidence 122367889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=240.54 Aligned_cols=183 Identities=23% Similarity=0.328 Sum_probs=139.9
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
+..++|.+.+.||+|.||.|-+|... +++.||||.+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44588999999999999999999953 5899999988
Q ss_pred ---------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceE
Q 015360 184 ---------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 218 (408)
Q Consensus 184 ---------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 218 (408)
+..+|+|||.+ +||||||||+|+||+.++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 22349999999 999999999999999999999
Q ss_pred EeccCCceeecCCC----cceecccccccCcccccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 015360 219 VSDFGLAKLLCSER----SYVTTRVMGTFGYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 290 (408)
Q Consensus 219 L~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 290 (408)
|+|||.+....... .......+||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------ 324 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------ 324 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------
Confidence 99999998663221 11123367999999999987643 34688999999999999999999964321
Q ss_pred HHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 291 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 291 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.+... +++...+......+....+.+||.++|++||++|.+..+|..+.
T Consensus 325 ~~l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 LELFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111 11222222222234455788999999999999999998887654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=241.82 Aligned_cols=169 Identities=25% Similarity=0.395 Sum_probs=130.2
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|+..+ ++.||||.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999764 678999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 33459999998 999999999999999999999999999875322111
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ ..++..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~~i~~~~-------~~~~~~ 223 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL---FQSIMEHN-------VSYPKS 223 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHcCC-------CCCCCC
Confidence 123356899999999999999999999999999999999999999743321 11 11111110 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
....+.+++.+||+.||.+|++.
T Consensus 224 ----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 224 ----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 22357789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=232.35 Aligned_cols=182 Identities=27% Similarity=0.448 Sum_probs=141.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...++||+|+||.||+|..++++.+|+|.+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 3568888999999999999999988999999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 33458999998 9999999999999999999999999999766432222222
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...++..|+|||.+....++.++||||||+++|||++ |+.||...... ..... .. .... ...+
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~---~~-~~~~-----~~~~---- 225 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN---LE-RGYR-----MPRP---- 225 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH---HH-cCCC-----CCCC----
Confidence 3345678999999988889999999999999999999 99999643321 11111 11 1100 0011
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+.+++.+||+.+|++||++++++..|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122368899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=232.24 Aligned_cols=181 Identities=30% Similarity=0.467 Sum_probs=139.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|.+.+.||+|+||.||++...++..+|+|.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG 85 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence 457778899999999999999888889999977
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 33458999998 99999999999999999999999999997754332222222
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +.......... +. ...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~------~~----~~~ 226 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVERGYR------MP----CPQ 226 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC------CC----CCC
Confidence 335568999999988889999999999999999999 89999643221 11111111100 00 111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+++.+||+.||++|||+.++.+.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=241.55 Aligned_cols=173 Identities=28% Similarity=0.396 Sum_probs=134.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+.. +++.+|||.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999975 4889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 23459999998 99999999999999999999999999998664322
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .... .++..
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~-~~~~------~~p~~ 237 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKIL-AGRL------KFPNW 237 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHh-cCCc------CCCCC
Confidence 2346899999999999989999999999999999999999999643221 1111111 1110 11111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
....+.+|+.+||+.||.+||+ +++++..
T Consensus 238 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 ----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1235778999999999999997 5666644
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=232.44 Aligned_cols=181 Identities=29% Similarity=0.452 Sum_probs=140.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
.+|.+.++||+|+||.||+|+..+...||||.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 85 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCC
Confidence 468888999999999999999877778999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||.+.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 33458999998 99999999999999999999999999997664333222222
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||...+..++.++|||||||++|||++ |..||....... . ......... .....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~---~~~~~~~~~----------~~~~~ 226 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQVERGYR----------MPCPP 226 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H---HHHHhcCCC----------CCCcc
Confidence 345678999999988889999999999999999999 888886433211 1 111111100 01112
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+++.+||+.||++||++.++++.|+.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 234468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=232.73 Aligned_cols=181 Identities=25% Similarity=0.446 Sum_probs=137.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.||+|...+ +..+++|.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 346777899999999999999754 788999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|+|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 33458999998 999999999999999999999999999977643322211
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....+..|+|||.+.+..++.++|||||||++|||++ |..||...... +...... ... .+..+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~~~-- 228 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLE-KGY-----RMERPE-- 228 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-CCC-----CCCCCC--
Confidence 22234567999999998899999999999999999998 99998643221 1111111 110 011111
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+++.+||+.||++|||+.++++.|+.
T Consensus 229 --~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 229 --GCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred --CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 123468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=235.39 Aligned_cols=145 Identities=25% Similarity=0.457 Sum_probs=110.6
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||
T Consensus 136 al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 136 GMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred HHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 48999998 999999999999999999999999999976533221 11223446788999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||...... ..... +....... . .......+.+|+.+||+.||++||++.||
T Consensus 213 G~il~el~~~g~~p~~~~~~~---~~~~~----i~~~~~~~-----~----~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQ---EVIEM----IRSRQLLP-----C----PEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHH---HHHHH----HHcCCcCC-----C----cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999998 99998754322 11111 11111111 1 12233578899999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05048 277 HTRLRS 282 (283)
T ss_pred HHHHhc
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=231.62 Aligned_cols=189 Identities=26% Similarity=0.371 Sum_probs=139.6
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
.|...++||+|+||+||+|+. .+|+.||+|++
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 344456899999999999995 45899999987
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+..||+|||++ +|+||||||+|||++.+|.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 34459999999 99999999999999999999999999998
Q ss_pred eecCCCcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC---C
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---K 302 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~ 302 (408)
...-... ..+..+.|..|+|||++.+. .|+...||||+|||+.||+++++.|....+. +....+-..++.. .
T Consensus 169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCCccC
Confidence 6542222 13446689999999999876 6999999999999999999999999866542 2222222222221 1
Q ss_pred cccc---cCCC--CCCCC-c---HHH----HHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 SEEV---VDPK--LPKMP-A---SKA----LKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ~~~~---~d~~--~~~~~-~---~~~----~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+... .+.. ++... . ... .....+++.+||+.+|.+|.|++.++.+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 1111 11111 0 010 1367899999999999999999999886
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=241.51 Aligned_cols=193 Identities=24% Similarity=0.335 Sum_probs=138.4
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... .+..+|||.+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 367888999999999999999864 4889999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 23448999998 9999999999999999999999999999754322
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc------------hhHH----HHH
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV------------NLVD----WLK 295 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~------------~~~~----~~~ 295 (408)
. ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+.. .+.
T Consensus 177 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 177 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred c--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 1 123356889999999999999999999999999999999999999754321100 0000 001
Q ss_pred HHhcCCCc------ccccCC-CCCC--CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 296 TMVGSRKS------EEVVDP-KLPK--MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 296 ~~~~~~~~------~~~~d~-~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........ .+.... ..+. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11100000 000000 0000 0001112457889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=234.37 Aligned_cols=187 Identities=24% Similarity=0.353 Sum_probs=135.3
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||+||+|... +++.||||.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777899999999999999875 4888999965
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+..+|.|||+. +++|+||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 23348999998 999999999999999999999999999976
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc---
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE--- 304 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 304 (408)
...... .....++..|+|||++.+..++.++|||||||++|+|++|++||....... .+ ..+..........
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~-~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 158 YSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QL-GKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HH-HHHHHHhCCCChhhCc
Confidence 543221 223457899999999998889999999999999999999999996443221 11 1111111100000
Q ss_pred -------cccCCCCCC---CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 305 -------EVVDPKLPK---MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 305 -------~~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.... .........+.+++.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000112345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=241.57 Aligned_cols=194 Identities=23% Similarity=0.272 Sum_probs=139.3
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||++... .++.+|||.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999854 4788999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 23458999998 999999999999999999999999999976533
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH----------------HHH
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------------DWL 294 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~----------------~~~ 294 (408)
.. ......+|..|+|||++.+..++.++|||||||++|+|++|+.||............ ..+
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred cc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 21 223356899999999999989999999999999999999999999754321110000 000
Q ss_pred HHHhcCC-Cccccc------CCCCC--CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 295 KTMVGSR-KSEEVV------DPKLP--KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 295 ~~~~~~~-~~~~~~------d~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....... ...... +...+ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0010000 000000 00000 00011123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=240.60 Aligned_cols=126 Identities=26% Similarity=0.400 Sum_probs=106.6
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~-------------------------------------------- 183 (408)
...+|...+.||+|+||.||+|.... +..||+|..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l 143 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDL 143 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcH
Confidence 44689999999999999999999754 678999963
Q ss_pred ----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccccc
Q 015360 184 ----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 241 (408)
Q Consensus 184 ----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~g 241 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++....... ......|
T Consensus 144 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~g 218 (357)
T PHA03209 144 YTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAG 218 (357)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccccc
Confidence 44569999998 99999999999999999999999999987532221 1223568
Q ss_pred ccCcccccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 015360 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 279 (408)
Q Consensus 242 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf 279 (408)
|..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 219 t~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999999999999999999999999999965544
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=233.49 Aligned_cols=182 Identities=29% Similarity=0.516 Sum_probs=141.3
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe---------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~--------------------------------------------- 183 (408)
+..+|...+.||.|+||.||+|...++..+++|.+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568888999999999999999988999999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 34458999998 9999999999999999999999999999765432221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....++..|++||.+....++.++||||||+++|+|++ |+.||...... .... ....... +..
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~~~~------~~~-- 225 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD---QITAGYR------MPC-- 225 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH---HHHhCCc------CCC--
Confidence 223345678999999988889999999999999999998 89999643321 1111 1111100 001
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 --PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=236.74 Aligned_cols=173 Identities=27% Similarity=0.417 Sum_probs=131.6
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|.+.+.||+|+||.||++... +++.||||.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999865 4889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD- 156 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-
Confidence 23448999998 999999999999999999999999999875322221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +......... +..+..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~-------~~~p~~ 223 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDE-------VRYPRF 223 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CCCCCC
Confidence 123456899999999999989999999999999999999999999743321 1111111111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~ 346 (408)
....+.+++.+||+.||.+||+ +.++++
T Consensus 224 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 ----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1235778999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=237.30 Aligned_cols=170 Identities=26% Similarity=0.414 Sum_probs=130.7
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||++... +++.+|||.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5899999977
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 240 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 240 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++....... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccccc
Confidence 34459999998 999999999999999999999999999875322211 123356
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......... +..++.. ..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~-------~~~~p~~----~~ 219 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-------DIKFPRT----LS 219 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccC-------CccCCCC----CC
Confidence 899999999999889999999999999999999999999643221 111111110 1111111 22
Q ss_pred HHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 321 KRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
..+.+++.+||+.||++|| ++.|+++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3577889999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=237.16 Aligned_cols=191 Identities=24% Similarity=0.386 Sum_probs=137.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
-++|...+.||+|+||.||+++.. ++..+|+|.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888899999999999999976 4788899875
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+.+ +|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 334589999752 69999999999999999999999999987653221
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC--Cc----------
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--KS---------- 303 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~---------- 303 (408)
.....++..|+|||++.+..++.++|||||||++|||++|+.||....... +...+....... ..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccccc
Confidence 233568999999999999899999999999999999999999996433211 111000000000 00
Q ss_pred ----------------------ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 304 ----------------------EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 304 ----------------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
..+.....+..........+.+|+.+||+.||++|||+.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000001111112334688999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=233.12 Aligned_cols=181 Identities=28% Similarity=0.498 Sum_probs=136.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCc----EEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~----~vavK~~------------------------------------------ 183 (408)
++|...++||+|+||+||+|.+. ++. .||||.+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 45777899999999999999853 344 4799976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +++|+||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 34459999998 99999999999999999999999999998764332
Q ss_pred cce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..++. ..... .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~-----~ 231 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGERL-----P 231 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCcC-----C
Confidence 211 112234678999999988889999999999999999998 89998643221 1222111 11100 0
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. .......+.+++.+||+.||++||++.++++.|+.
T Consensus 232 ~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 232 Q----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 11123467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=236.29 Aligned_cols=142 Identities=26% Similarity=0.393 Sum_probs=106.6
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
..+|+|||+. +|+||||||+|||++.++.+||+|||+++....... ......|++.|+|||++.+..++.++||||
T Consensus 110 ~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 185 (323)
T cd05584 110 SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWS 185 (323)
T ss_pred HHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecc
Confidence 3448999998 999999999999999999999999999875432222 123356899999999999888999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-----
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP----- 339 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----- 339 (408)
|||++|||++|+.||...... .......... ..++.. ....+.+++.+||+.||++||
T Consensus 186 lG~il~ell~G~~pf~~~~~~------~~~~~~~~~~-------~~~~~~----~~~~~~~li~~~l~~~p~~R~~~~~~ 248 (323)
T cd05584 186 LGALMYDMLTGAPPFTAENRK------KTIDKILKGK-------LNLPPY----LTPEARDLLKKLLKRNPSSRLGAGPG 248 (323)
T ss_pred cHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-------CCCCCC----CCHHHHHHHHHHcccCHhHcCCCCCC
Confidence 999999999999999743321 1122221111 011111 123578899999999999999
Q ss_pred CHhHHHHH
Q 015360 340 KMGHVIHM 347 (408)
Q Consensus 340 s~~evl~~ 347 (408)
++.++++.
T Consensus 249 ~~~~l~~h 256 (323)
T cd05584 249 DAAEVQSH 256 (323)
T ss_pred CHHHHhcC
Confidence 77777664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=263.59 Aligned_cols=150 Identities=27% Similarity=0.460 Sum_probs=117.0
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc-ccccCcccccccccCCCCccccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-MGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
+++++.||+++ .+|||||..+|+||+....+||+|||+|+.+.....+..... .-...|||||.+..+.++.|+||
T Consensus 811 vA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDv 887 (1025)
T KOG1095|consen 811 VAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDV 887 (1025)
T ss_pred HhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccch
Confidence 56679999999 999999999999999999999999999996654444433222 34468999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++||++| |..||...++.+.. ......++ ..++..+...+.+|+..||+.+|++||++
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~------~~~~~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVL------LDVLEGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHH------HHHHhCCc----------cCCCCCCChHHHHHHHHHccCChhhCccH
Confidence 999999999999 99999865543221 11122221 11223344468899999999999999999
Q ss_pred hHHHHHHhcCC
Q 015360 342 GHVIHMLEADD 352 (408)
Q Consensus 342 ~evl~~Le~~~ 352 (408)
..|++.+..+.
T Consensus 952 ~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 952 RTIVEQDPAIS 962 (1025)
T ss_pred HHHHhhhhhhh
Confidence 99999887643
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=229.41 Aligned_cols=181 Identities=28% Similarity=0.461 Sum_probs=139.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||++.+.++..+++|.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG 85 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence 357777899999999999999887778999975
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +++|+||||+||++++++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 33458999998 99999999999999999999999999997664332222222
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....+ ...... +.. ..
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~------~~~----~~ 226 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ---VERGYR------MPC----PQ 226 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHcCCC------CCC----Cc
Confidence 345678999999988889999999999999999999 89998643321 11111 111100 001 11
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+++.+||+.||++||++++|++.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223468889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=234.93 Aligned_cols=190 Identities=23% Similarity=0.357 Sum_probs=147.7
Q ss_pred eHHHHHHHhcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe--------------------------------
Q 015360 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL-------------------------------- 183 (408)
Q Consensus 142 ~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~-------------------------------- 183 (408)
.+.||.....+|....++-+|.||.||+|.|. +.+.|.||.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 36677777788998999999999999999654 3445566644
Q ss_pred --------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC
Q 015360 184 --------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR 213 (408)
Q Consensus 184 --------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~ 213 (408)
++.+++|||.. ++||.||..+|+++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 33459999999 9999999999999999
Q ss_pred CCceEEeccCCceeecCCCccee-cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 015360 214 QWNARVSDFGLAKLLCSERSYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLV 291 (408)
Q Consensus 214 ~~~~kL~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 291 (408)
..++||+|-.+++.+.+.+...- ........||+||.+.+..|+..+|||||||++|||+| |+.|+..-++.+.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---- 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---- 507 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH----
Confidence 99999999999987755443322 22335678999999999999999999999999999999 9999875554322
Q ss_pred HHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 292 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 292 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..++..+. +...+-.+..++..++..||..+|++||+++|++.-|.+
T Consensus 508 ---~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 ---EHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---HHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 12222221 111222344578999999999999999999999998875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=230.21 Aligned_cols=181 Identities=30% Similarity=0.481 Sum_probs=137.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.+.. ...||||.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999999753 457999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 33458999998 99999999999999999999999999998764222
Q ss_pred c-ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 S-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+ . ..... +.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~-~~~~~----~~ 229 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV---E-DGYRL----PP 229 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH---H-cCCCC----CC
Confidence 2 11222334678999999998899999999999999999998 99998543211 111111 1 11000 10
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.......+.+++.+||+.+|++||++.||++.|+.
T Consensus 230 -----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 230 -----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11123467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=235.71 Aligned_cols=168 Identities=27% Similarity=0.447 Sum_probs=128.4
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||++... ++..||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 4789999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 33449999998 99999999999999999999999999987532211 122345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .+.++.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~---~~~~~~~-------~~~~~~~----~ 219 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL---FESIRVD-------TPHYPRW----I 219 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhC-------CCCCCCC----C
Confidence 6899999999999999999999999999999999999999643321 11 1111110 1111111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCHh-HHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMG-HVI 345 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~-evl 345 (408)
...+.+++.+||+.||++||++. +++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23577889999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=224.32 Aligned_cols=163 Identities=29% Similarity=0.432 Sum_probs=130.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|+||.|...+.+ +|..+|+|.+
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4667799999999999999965 4889999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..||+|||.. .|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---- 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence 33459999999 9999999999999999999999999999987443
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
+.+.+||+.|+|||++....++.++|.|||||++|||+.|.+||....+.. .. ..++ ++. -.++...
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY---~KI~-~~~------v~fP~~f 264 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IY---EKIL-EGK------VKFPSYF 264 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HH---HHHH-hCc------ccCCccc
Confidence 345789999999999999999999999999999999999999998665421 11 1111 111 1122222
Q ss_pred cHHHHHHHHHHHHhccCcCCCCC
Q 015360 316 ASKALKRVLLVALRCVDPDATKR 338 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~R 338 (408)
. ..+.+|+...|+.|-.+|
T Consensus 265 s----~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 S----SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred C----HHHHHHHHHHHhhhhHhh
Confidence 2 256778889999999999
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=241.97 Aligned_cols=187 Identities=21% Similarity=0.304 Sum_probs=140.0
Q ss_pred HHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------
Q 015360 146 LEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 146 l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------- 183 (408)
+....++|...+.||+|+||.||+++.. ++..+|||.+
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3345578999999999999999999975 4889999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 33459999998 999999999999999999999999999987643
Q ss_pred CCcceecccccccCcccccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............ +
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~--~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS--L 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc--C
Confidence 332223345689999999998653 3788999999999999999999999754321 111222111110 0
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCC--CCCHhHHHHHH
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHML 348 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 348 (408)
.++. .......+.+++.+||+.+|.+ |+++.|+++.-
T Consensus 267 ---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 267 ---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0111 1112236778889999999988 99999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=240.61 Aligned_cols=177 Identities=25% Similarity=0.453 Sum_probs=136.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
..|.+.+.||.||...||+....+.+.+|+|++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 457778999999999999999988899999977
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 234 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~- 234 (408)
+..++.++|+. +|||.||||.|+|+- .|.+||+|||+|..+......
T Consensus 441 ~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 441 CGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred cccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence 22347889988 999999999999986 468999999999887655433
Q ss_pred eecccccccCcccccccccCC-----------CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 235 VTTRVMGTFGYVAPEYACTGM-----------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
.....+||+.||+||.+.... .+.++||||||||||+|+.|++||.. +...... +
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~aK------l 582 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIAK------L 582 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHHH------H
Confidence 345678999999999875432 56789999999999999999999962 2211111 1
Q ss_pred ccccCCCC----CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 304 EEVVDPKL----PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 304 ~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
..+.+|.- +..+.. .++++++..||+.||.+|||+.|||+.-
T Consensus 583 ~aI~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HhhcCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 23334422 111111 1388999999999999999999998843
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=228.44 Aligned_cols=184 Identities=26% Similarity=0.464 Sum_probs=141.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||.||+|+.. +++.+|||.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999964 5899999964
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 33458999998 999999999999999999999999999887643
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+..... .. .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~-~~--------~ 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIE-QC--------D 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHh-cC--------C
Confidence 222 12234578899999999888899999999999999999999999853321 1112222111 11 1
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+..........+.+++.+||+.+|++||++.||++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11111223335688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=233.98 Aligned_cols=94 Identities=29% Similarity=0.462 Sum_probs=77.7
Q ss_pred hhHHHhhhCCCCceeeeccccCceEe----CCCCceEEeccCCceeecCCCcc--eecccccccCccccccccc-CCCCc
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACT-GMLNE 258 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ 258 (408)
.+|.|||+. +|+||||||+|||+ +.++.+||+|||+++........ ......+|+.|+|||++.+ ..++.
T Consensus 119 ~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 195 (317)
T cd07868 119 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK 195 (317)
T ss_pred HHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCc
Confidence 458999998 99999999999999 45678999999999876433211 1234568999999999876 45889
Q ss_pred cccchhhHHHHHHHHhCCCCCCCC
Q 015360 259 KSDVYSFGILIMEIITGRNPVDYS 282 (408)
Q Consensus 259 ~sDvwSlGvvl~elltG~~Pf~~~ 282 (408)
++||||+||++|||++|++||...
T Consensus 196 ~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 196 AIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred hhhHHHHHHHHHHHHhCCCCccCC
Confidence 999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=232.32 Aligned_cols=147 Identities=26% Similarity=0.493 Sum_probs=110.1
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccch
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
+.+|.|||+. +++|+||||+|||++.++.+||+|||+++....... .......++..|++||.+.+..++.++|||
T Consensus 119 ~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 195 (279)
T cd05111 119 AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVW 195 (279)
T ss_pred HHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHH
Confidence 3459999998 999999999999999999999999999986543222 122234467789999999988999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 264 SFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 264 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
||||++|||++ |+.||...... ...+. ...+.. ...+. . ....+.+++.+||..||++|||+.
T Consensus 196 slG~il~el~t~g~~p~~~~~~~---~~~~~----~~~~~~--~~~~~---~----~~~~~~~li~~c~~~~p~~Rps~~ 259 (279)
T cd05111 196 SYGVTVWEMMSYGAEPYAGMRPH---EVPDL----LEKGER--LAQPQ---I----CTIDVYMVMVKCWMIDENVRPTFK 259 (279)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCc--CCCCC---C----CCHHHHHHHHHHcCCCcccCcCHH
Confidence 99999999998 99999654321 11111 111111 11111 1 123567788999999999999999
Q ss_pred HHHHHHhc
Q 015360 343 HVIHMLEA 350 (408)
Q Consensus 343 evl~~Le~ 350 (408)
|+++.|+.
T Consensus 260 el~~~l~~ 267 (279)
T cd05111 260 ELANEFTR 267 (279)
T ss_pred HHHHHHHH
Confidence 99998876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=235.79 Aligned_cols=170 Identities=25% Similarity=0.393 Sum_probs=130.2
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||.||++... +|..||+|.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 5899999976
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 240 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 240 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++........ ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccccc
Confidence 34459999998 999999999999999999999999999875322211 122356
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. .......... ..++.. ..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~-------~~~p~~----~~ 219 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE-------IRFPRT----LS 219 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC-------CCCCCC----CC
Confidence 899999999999999999999999999999999999999643321 1111111110 111111 22
Q ss_pred HHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 321 KRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
..+.+++.+||+.||.+|| ++.++++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3677899999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=235.09 Aligned_cols=144 Identities=26% Similarity=0.348 Sum_probs=106.0
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
..+|.|||+. +|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||
T Consensus 103 ~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 178 (312)
T cd05585 103 LCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178 (312)
T ss_pred HHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccCCcccCCHHHHcCCCCCCccceec
Confidence 3459999998 999999999999999999999999999875422221 223456899999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
|||++|||++|+.||..... ........... ..++. .....+.+++.+||+.||.+||++..+
T Consensus 179 lGvil~el~tg~~pf~~~~~------~~~~~~~~~~~-------~~~~~----~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 179 LGVLLYEMLTGLPPFYDENV------NEMYRKILQEP-------LRFPD----GFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred hhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC-------CCCCC----cCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 99999999999999964321 12222222110 11111 122357788999999999999865444
Q ss_pred HHHHh
Q 015360 345 IHMLE 349 (408)
Q Consensus 345 l~~Le 349 (408)
.+.|.
T Consensus 242 ~e~l~ 246 (312)
T cd05585 242 QEIKN 246 (312)
T ss_pred HHHHc
Confidence 44443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=230.58 Aligned_cols=146 Identities=25% Similarity=0.397 Sum_probs=109.3
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|+|||+. +|+|+||||+|||++.++.+||+|||++.......... .....+++.|++||.+.+..++.++||||
T Consensus 123 ~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 199 (272)
T cd05075 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWS 199 (272)
T ss_pred HHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHH
Confidence 448999998 99999999999999999999999999998764332211 12223567899999999889999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|||++ |+.||...... .... . ...+.... .. ......+.+++.+||+.||++|||+.+
T Consensus 200 lG~il~el~~~g~~p~~~~~~~---~~~~---~-~~~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ 263 (272)
T cd05075 200 FGVTMWEIATRGQTPYPGVENS---EIYD---Y-LRQGNRLK-----QP----PDCLDGLYSLMSSCWLLNPKDRPSFET 263 (272)
T ss_pred HHHHHHHHHcCCCCCCCCCCHH---HHHH---H-HHcCCCCC-----CC----CCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9999999999 88998643221 1111 1 11111100 01 112335789999999999999999999
Q ss_pred HHHHHhc
Q 015360 344 VIHMLEA 350 (408)
Q Consensus 344 vl~~Le~ 350 (408)
|++.|+.
T Consensus 264 l~~~l~~ 270 (272)
T cd05075 264 LRCELEK 270 (272)
T ss_pred HHHHHHh
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=240.14 Aligned_cols=193 Identities=25% Similarity=0.294 Sum_probs=138.4
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... .++.||||.+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999864 4788999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 23458999998 9999999999999999999999999999765332
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH------------H----HHH
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV------------D----WLK 295 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~------------~----~~~ 295 (408)
. ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+........ . .+.
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 180 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred C--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 1 223356899999999999999999999999999999999999999754322110000 0 000
Q ss_pred HHhcCCCc-ccc----cCCCC--C--CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 296 TMVGSRKS-EEV----VDPKL--P--KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 296 ~~~~~~~~-~~~----~d~~~--~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........ ... ..+.. + ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000 00000 0 00011122467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=229.82 Aligned_cols=179 Identities=26% Similarity=0.430 Sum_probs=136.9
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
+|...+.||+|+||.||+|.+.++..+|||.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 46777899999999999999887778999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||.++.............
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 34459999998 999999999999999999999999999876543322222223
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
.++..|++||.+.+..++.++|||||||++|+|++ |+.||...... .... .... .... .... .
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~-~~~~-----~~~~----~ 225 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVSQ-GLRL-----YRPH----L 225 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHhc-CCCC-----CCCC----C
Confidence 35678999999988889999999999999999999 99998643321 1111 1111 1100 0011 1
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
....+.+++.+||+.||.+||++.+|++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1346888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=234.62 Aligned_cols=164 Identities=26% Similarity=0.456 Sum_probs=126.6
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||++... +++.||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 4789999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|+|||+. +++||||||+|||++.++.+||+|||++........ .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccccc
Confidence 33449999998 999999999999999999999999999875422221 22335
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... . ..+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~----~---~~~~~----~ 219 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDE----V---VYPTW----L 219 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC----C---CCCCC----C
Confidence 6899999999999889999999999999999999999999743321 1122221111 0 11111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCH
Q 015360 320 LKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
...+.+++.+||+.||++||++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 2357789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=234.50 Aligned_cols=146 Identities=21% Similarity=0.409 Sum_probs=109.0
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|+|||+. +++||||||.||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||
T Consensus 135 ~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05091 135 AGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211 (283)
T ss_pred HHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence 348999998 9999999999999999999999999998765332221 122234567899999998888999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|||++ |..||..... .++..... ..... .. .......+.+++.+||+.+|++||++.+
T Consensus 212 lG~~l~el~~~g~~p~~~~~~------~~~~~~i~-~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~ 275 (283)
T cd05091 212 YGVVLWEVFSYGLQPYCGYSN------QDVIEMIR-NRQVL-----PC----PDDCPAWVYTLMLECWNEFPSRRPRFKD 275 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCH------HHHHHHHH-cCCcC-----CC----CCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 9999999998 8888864322 12222211 11111 01 1122345788999999999999999999
Q ss_pred HHHHHhc
Q 015360 344 VIHMLEA 350 (408)
Q Consensus 344 vl~~Le~ 350 (408)
|+..|+.
T Consensus 276 i~~~l~~ 282 (283)
T cd05091 276 IHSRLRT 282 (283)
T ss_pred HHHHhhC
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=237.97 Aligned_cols=180 Identities=23% Similarity=0.344 Sum_probs=136.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... +++.+|||.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999965 5889999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 33458999998 999999999999999999999999999987654433
Q ss_pred ceecccccccCcccccccc------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 234 YVTTRVMGTFGYVAPEYAC------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..............+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~- 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF- 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC-
Confidence 3333456899999999986 456788999999999999999999999643321 111222111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+ . .......+.+|+..||+ ||.+|||+.++++.
T Consensus 231 -~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 -P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1 1 01122357788889998 99999999998763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=229.33 Aligned_cols=178 Identities=25% Similarity=0.421 Sum_probs=135.8
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
+|.+.+.||+|+||.||++.+.++..+|||.+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46677899999999999999887778999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||+++.............
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 33458999998 999999999999999999999999999876543222212222
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
.++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ... ... .. .....+. .
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~-~~-----~~~~~~~----~ 225 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---SVS-AG-----YRLYRPK----L 225 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---HHH-cC-----CcCCCCC----C
Confidence 23457999999998899999999999999999999 899996443221 111 111 11 0011111 1
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
....+.+++.+||+.+|++|||+.|+++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 233688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=240.14 Aligned_cols=188 Identities=21% Similarity=0.319 Sum_probs=138.3
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------- 183 (408)
.++....++|...+.||+|+||.||++.... ++.+|+|.+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3445556889999999999999999999754 788999975
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 33459999998 9999999999999999999999999999876
Q ss_pred cCCCcceecccccccCcccccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~ 266 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSL 266 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCccc
Confidence 43333233446799999999998754 3788999999999999999999999744321 1112221111100
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCC--CCCHhHHHHH
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHM 347 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~ 347 (408)
.++. .......+.+++.+||+.++.+ |+++.|+++.
T Consensus 267 -----~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 -----NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111 1112335667788888755543 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.28 Aligned_cols=181 Identities=24% Similarity=0.360 Sum_probs=146.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCC-cEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDG-TKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~-~~vavK~~--------------------------------------------- 183 (408)
..++.+.++|.+|||+.||.++...+ ..+|+|++
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35677789999999999999998876 99999998
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+++|+++||.. .++|||||||-+||||+.++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 34569999984 7889999999999999999999999999886
Q ss_pred eecCCCc-ce-------ecccccccCccccccc---ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 015360 227 LLCSERS-YV-------TTRVMGTFGYVAPEYA---CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295 (408)
Q Consensus 227 ~~~~~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 295 (408)
....... .. .....-|+.|++||.+ .+...++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 5422221 10 0112368999999976 467899999999999999999999999974321
Q ss_pred HHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..+++..+...+.+.....|.+||..||+.||++||++-+|+..+..
T Consensus 264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 23444444444456677789999999999999999999999988865
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=235.45 Aligned_cols=189 Identities=26% Similarity=0.387 Sum_probs=137.1
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
...++|...+.||+|+||.||++... ++..||||.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999864 5789999976
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 33459999998 9999999999999999999999999999865
Q ss_pred cCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC-----
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK----- 302 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 302 (408)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+........
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence 432 223568999999999876 568899999999999999999999996533211 1111110000000
Q ss_pred ------cccccCCCCCCCCcH-------HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 ------SEEVVDPKLPKMPAS-------KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ------~~~~~d~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..... ..++..+.. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000000 012246789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=239.55 Aligned_cols=180 Identities=24% Similarity=0.364 Sum_probs=133.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+++.. +++.||||.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 4889999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 33449999998 9999999999999999999999999998754321100
Q ss_pred -------------------------------------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCC
Q 015360 235 -------------------------------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN 277 (408)
Q Consensus 235 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~ 277 (408)
......||+.|+|||++....++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112458999999999999899999999999999999999999
Q ss_pred CCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC---HhHHHHH
Q 015360 278 PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MGHVIHM 347 (408)
Q Consensus 278 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 347 (408)
||...... ..............+ +. .......+.+++.+|+. +|.+|++ +.|+++.
T Consensus 238 Pf~~~~~~------~~~~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQ------ETYRKIINWKETLQF--PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHH------HHHHHHHcCCCccCC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99744321 111111111110000 10 00112356678888886 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=237.88 Aligned_cols=170 Identities=26% Similarity=0.400 Sum_probs=130.2
Q ss_pred ceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||+|+... ++.+|||.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999754 789999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccccc
Confidence 33459999998 999999999999999999999999999875432222 22335
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ...+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~-------~~~p~~----~ 219 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDD-------VLYPVW----L 219 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-------CCCCCC----C
Confidence 6899999999999989999999999999999999999999744321 1112211111 011111 1
Q ss_pred HHHHHHHHHhccCcCCCCCC-------CHhHHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRP-------KMGHVIHM 347 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rp-------s~~evl~~ 347 (408)
...+.+++.+||+.||++|| ++.++++.
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 23577889999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=227.73 Aligned_cols=181 Identities=27% Similarity=0.455 Sum_probs=136.4
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
+|...++||+|+||.||+|.. .+++.+|||..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999985 45889999976
Q ss_pred ----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccccc
Q 015360 184 ----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 241 (408)
Q Consensus 184 ----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~g 241 (408)
++.+|.|||+. +|+|+||||+|||++.++.++|+|||++....... .....+
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 155 (279)
T cd06619 82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVG 155 (279)
T ss_pred CCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCCC
Confidence 33448999998 99999999999999999999999999997653321 223568
Q ss_pred ccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 242 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
+..|+|||.+.+..++.++|||||||++|+|++|+.||......... ............. .+.+. .....
T Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---~~~~~ 226 (279)
T cd06619 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP---VGQFS 226 (279)
T ss_pred ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC---CCcCC
Confidence 89999999999888999999999999999999999999643322111 1111111111110 11111 11122
Q ss_pred HHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 321 KRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..+.+++.+||+.||++||+++|+++.
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 357889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=235.73 Aligned_cols=171 Identities=27% Similarity=0.422 Sum_probs=127.8
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||.||++... +++.+|+|.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 4788999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccc
Confidence 33459999998 999999999999999999999999999875322211 12335
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc--chhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE--VNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....++......... .++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~~--- 227 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPRS--- 227 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCCC---
Confidence 689999999999999999999999999999999999999964322111 1122222222211111 11111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
....+.+++.+||+.||++||++
T Consensus 228 -~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 228 -LSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCHHHHHHHHHHhcCCHHHcCCC
Confidence 12357789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=241.27 Aligned_cols=195 Identities=24% Similarity=0.270 Sum_probs=139.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC---CcEEEEEEe-------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD---GTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~---~~~vavK~~------------------------------------------- 183 (408)
...|...+.||+|+||.||++...+ +..|+||.+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCC
Confidence 3579999999999999999997542 578999976
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eeccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 239 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~ 239 (408)
+..+|.|||+. +|+||||||+|||++.++.++|+|||++......... .....
T Consensus 171 ~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~ 247 (392)
T PHA03207 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247 (392)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccc
Confidence 34569999998 9999999999999999999999999999765433221 22345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc---------------
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE--------------- 304 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 304 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 248 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (392)
T PHA03207 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQ 327 (392)
T ss_pred ccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHh
Confidence 68999999999999999999999999999999999999997654332211111111111110000
Q ss_pred --cccCCCCCCCC---cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 --EVVDPKLPKMP---ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 --~~~d~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+...... .......+.+++.+||..||++|||+.|++..
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 328 YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00112356788999999999999999999885
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=238.81 Aligned_cols=171 Identities=27% Similarity=0.368 Sum_probs=130.0
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||+||+|+.. +++.||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 5899999986
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccccc
Confidence 33459999998 999999999999999999999999999875322221 22345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..+... .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-------~~~~~~----~ 219 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP-------LRLKPN----I 219 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC-------CCCCCC----C
Confidence 689999999999999999999999999999999999999974321 11112211110 011111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...+.+++.+||+.||.+||++.+.+..+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEI 248 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCHHHH
Confidence 23578899999999999999986444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=233.80 Aligned_cols=169 Identities=26% Similarity=0.444 Sum_probs=128.8
Q ss_pred ceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||+||+|...+ ++.||||.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 788999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeee
Confidence 33448999998 999999999999999999999999999875322211 12335
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ..... .+..+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~---~i~~~-------~~~~~~~----~ 219 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQ---SIRMD-------NPCYPRW----L 219 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhC-------CCCCCcc----C
Confidence 6899999999999989999999999999999999999999753321 1111 11110 1111111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCHh-HHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMG-HVIH 346 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~-evl~ 346 (408)
...+.+++.+||+.||++||++. ++++
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 23577889999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=234.13 Aligned_cols=172 Identities=26% Similarity=0.418 Sum_probs=129.9
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||.||++... +++.+|||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 4788999987
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceecc
Confidence 33459999998 999999999999999999999999999875322221 12345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||............+++......... .++.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~----~ 226 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRF----L 226 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCC----C
Confidence 6899999999999999999999999999999999999999754433322333333332222111 11111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCHh
Q 015360 320 LKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
...+.+++.+||+.||.+|+++.
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCCC
Confidence 23567888999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=242.15 Aligned_cols=146 Identities=26% Similarity=0.458 Sum_probs=107.9
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+||||||+|||++.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 226 ~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl 302 (375)
T cd05104 226 GMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 302 (375)
T ss_pred HHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence 46889988 99999999999999999999999999998664332211 112334567999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||....... .....+ ..... +..+.. ...++.+|+.+||+.||++|||+.||
T Consensus 303 G~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 303 GILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEGYR-----MLSPEC----APSEMYDIMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred HHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhCcc-----CCCCCC----CCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999999998 888986432211 111111 11110 001111 12367889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 368 l~~l~~ 373 (375)
T cd05104 368 VQLIEQ 373 (375)
T ss_pred HHHHHh
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=227.72 Aligned_cols=147 Identities=29% Similarity=0.430 Sum_probs=109.9
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee--cccccccCcccccccccCCCCccccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
..+|+|||+. +++|+||||.||+++.++.+||+|||++........... ....++..|+|||.+....++.++||
T Consensus 105 ~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 181 (257)
T cd05116 105 SMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV 181 (257)
T ss_pred HHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHH
Confidence 3448999998 999999999999999999999999999987644332211 12234578999999988889999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++|||++ |+.||...... .. ... ...... +..+. .....+.+++.+||+.||++||++
T Consensus 182 ~slG~~l~el~t~g~~p~~~~~~~---~~---~~~-i~~~~~-----~~~~~----~~~~~l~~li~~~~~~~p~~Rp~~ 245 (257)
T cd05116 182 WSFGVLMWEAFSYGQKPYKGMKGN---EV---TQM-IESGER-----MECPQ----RCPPEMYDLMKLCWTYGVDERPGF 245 (257)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH---HH---HHH-HHCCCC-----CCCCC----CCCHHHHHHHHHHhccCchhCcCH
Confidence 999999999998 99999643221 11 111 111111 11111 122467889999999999999999
Q ss_pred hHHHHHHhc
Q 015360 342 GHVIHMLEA 350 (408)
Q Consensus 342 ~evl~~Le~ 350 (408)
.+|.+.|+.
T Consensus 246 ~~i~~~l~~ 254 (257)
T cd05116 246 AVVELRLRN 254 (257)
T ss_pred HHHHHHHhc
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=242.41 Aligned_cols=179 Identities=23% Similarity=0.330 Sum_probs=130.2
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+++.. +++.+|||.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999964 4889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC----
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---- 231 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~---- 231 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 23448999998 9999999999999999999999999997432100
Q ss_pred --------------------------------------CcceecccccccCcccccccccCCCCccccchhhHHHHHHHH
Q 015360 232 --------------------------------------RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 273 (408)
Q Consensus 232 --------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 273 (408)
.........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000011246899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC---CHhHHHHH
Q 015360 274 TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP---KMGHVIHM 347 (408)
Q Consensus 274 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s~~evl~~ 347 (408)
+|+.||....... ............ ..+. .......+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~~~~------~~~~i~~~~~~~--~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAE------TQLKVINWETTL--HIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHH------HHHHHhccCccc--cCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999997543221 111111111000 0011 1112234566777765 5999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=225.84 Aligned_cols=174 Identities=29% Similarity=0.415 Sum_probs=132.4
Q ss_pred ceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------------- 183 (408)
++||+|+||.||+|...++..+|+|.+
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 379999999999999988999999975
Q ss_pred ---------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccc
Q 015360 184 ---------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 242 (408)
Q Consensus 184 ---------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt 242 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 23348999998 999999999999999999999999999876433222112222345
Q ss_pred cCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHH
Q 015360 243 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALK 321 (408)
Q Consensus 243 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 321 (408)
..|+|||++.+..++.++||||||+++|++++ |..||...... .. ... ...... ... ......
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~---~~~-~~~~~~-----~~~----~~~~~~ 221 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QA---REQ-VEKGYR-----MSC----PQKCPD 221 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HH---HHH-HHcCCC-----CCC----CCCCCH
Confidence 67999999998889999999999999999998 99999643221 11 111 111110 011 111234
Q ss_pred HHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 322 RVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 322 ~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
.+.+++.+||+.+|++||++.|+++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 6888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=239.60 Aligned_cols=173 Identities=25% Similarity=0.354 Sum_probs=133.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCC--CcEEEEEEe---------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD--GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~--~~~vavK~~--------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.+.+ +..||||.+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998654 358999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 33448999998 99999999999999999999999999998654321
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. ........ ... .++.
T Consensus 186 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~-~~~------~~p~ 249 (340)
T PTZ00426 186 ---YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILE-GII------YFPK 249 (340)
T ss_pred ---ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhc-CCC------CCCC
Confidence 2356899999999999888999999999999999999999999743321 11111111 110 1111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
.. ...+.+++.+||+.||++|+ +++|+++.
T Consensus 250 ~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 FL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 22467888999999999995 78888765
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=224.23 Aligned_cols=184 Identities=28% Similarity=0.514 Sum_probs=142.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.+++|.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999986 6899999965
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 23348999998 999999999999999999999999999876543
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....+...... .. .
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~--------~ 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KC--------D 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cC--------C
Confidence 2221 223457889999999988889999999999999999999999986432 12222221111 11 0
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....+.......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111123334678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=238.54 Aligned_cols=191 Identities=23% Similarity=0.321 Sum_probs=141.2
Q ss_pred eHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------
Q 015360 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------- 183 (408)
Q Consensus 142 ~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------- 183 (408)
.+.++....++|...+.||+|+||.||++... +++.+|+|.+
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35566777789999999999999999999976 4788999975
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 33448999998 99999999999999999999999999998
Q ss_pred eecCCCcceecccccccCcccccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 302 (408)
..............||+.|+|||++... .++.++|||||||++|||++|+.||..... ............
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~ 264 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKN 264 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 7654333333446799999999998754 378899999999999999999999974332 111222221111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCC--CCCHhHHHHHH
Q 015360 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHML 348 (408)
Q Consensus 303 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 348 (408)
...+.+ .......+.+++.+||..++.+ |+++.|+++..
T Consensus 265 ~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 SLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 1112335677888999844433 77899988865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=234.50 Aligned_cols=165 Identities=27% Similarity=0.390 Sum_probs=126.6
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||+++.. +++.+|||.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 4789999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccccc
Confidence 33459999998 999999999999999999999999999875322221 22345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+. .......... . ..++. ..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~-~------~~~~~----~~ 219 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHK-P------LQLPG----GK 219 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcC-C------CCCCC----CC
Confidence 689999999999988899999999999999999999999964321 1111111111 0 01111 12
Q ss_pred HHHHHHHHHhccCcCCCCCCCHh
Q 015360 320 LKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
...+.+++.+||+.||.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 23578899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=230.57 Aligned_cols=194 Identities=25% Similarity=0.357 Sum_probs=136.1
Q ss_pred CccceeccCCcEEEEEEEe-----CCCcEEEEEEe---------------------------------------------
Q 015360 154 CEENVIGEGGYGIVYRGIL-----SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 154 ~~~~~lg~G~~g~Vy~g~~-----~~~~~vavK~~--------------------------------------------- 183 (408)
...+.||+|+||+||++.+ .++..||+|.+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988763 35778999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||||+|||++.++.++|+|||++.........
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 33448999998 9999999999999999999999999998865432221
Q ss_pred e--ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 235 V--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 235 ~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. .....++..|+|||.+....++.++||||||+++|||++|..||......- ....................+....
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcCCC
Confidence 1 112235567999999988889999999999999999999999986432210 0000000000000000111111111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
..........+.+++.+||+.||++|||+++|++.|+..
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111112234788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=227.49 Aligned_cols=145 Identities=26% Similarity=0.456 Sum_probs=109.2
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee-cccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+||++++++.+||+|||+++.......... .....+..|+|||.+.+..++.++|||||
T Consensus 125 aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred HHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 48999998 999999999999999999999999999987643332211 11234578999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||...... ...++ ...... +..+ ......+.+++.+||+.||++|||+.||
T Consensus 202 G~il~el~~~g~~p~~~~~~~---~~~~~---~~~~~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~ 265 (273)
T cd05035 202 GVTMWEIATRGQTPYPGVENH---EIYDY---LRHGNR------LKQP----EDCLDELYDLMYSCWRADPKDRPTFTKL 265 (273)
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHHH---HHcCCC------CCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999 88998643321 11111 111111 1111 1223468899999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 266 ~~~l~~ 271 (273)
T cd05035 266 REVLEN 271 (273)
T ss_pred HHHHHh
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=233.68 Aligned_cols=176 Identities=26% Similarity=0.405 Sum_probs=131.2
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
++||+|+||.||++... ++..||||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999975 4789999977
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+. +++||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccccc
Confidence 33459999998 999999999999999999999999999875322111 22345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC--cchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG--EVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....++.......... .++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~--- 227 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRS--- 227 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCC---
Confidence 68999999999999999999999999999999999999997433221 11222233222222111 11111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCC------HhHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPK------MGHVIH 346 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps------~~evl~ 346 (408)
....+.+++.+||+.||.+||+ +.++++
T Consensus 228 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 -LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1235788999999999999998 556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=236.36 Aligned_cols=170 Identities=24% Similarity=0.385 Sum_probs=130.2
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||.||++... ++..+|||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999976
Q ss_pred -----------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 -----------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 -----------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+ . +|+||||||+|||++.++.+||+|||++......... ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cccc
Confidence 3445999997 6 9999999999999999999999999998754322221 2235
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... . ..++.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~-~------~~~p~~----~ 219 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-E------IRFPRT----L 219 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcC-C------CCCCCC----C
Confidence 6899999999999999999999999999999999999999643321 111111111 0 111111 1
Q ss_pred HHHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
...+.+++.+||+.||++|+ ++.++++.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23577889999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=238.11 Aligned_cols=173 Identities=27% Similarity=0.364 Sum_probs=131.1
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||+||+++.. +++.+|+|.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999975 4678999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccccc
Confidence 33449999998 999999999999999999999999999875432221 22345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ .. .... ..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~-~~------~~~~----~~ 219 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK-PL------QLKP----NI 219 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhC-Cc------CCCC----CC
Confidence 6899999999999999999999999999999999999999643321 111111111 00 0111 11
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
...+.+++.+||+.||.+||++.+.+..+..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 2357788899999999999998865555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=240.31 Aligned_cols=145 Identities=31% Similarity=0.499 Sum_probs=111.8
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCCceeecCCCcceecccccccCcccccccccCC--CCccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM--LNEKS 260 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~s 260 (408)
|.++|.|||+. .|||||||-+|||++ -.|.+||+|||-++.+..-+. .+..+.||..|||||++..+. |+.++
T Consensus 684 ILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFTGTLQYMAPEvIDqG~RGYG~aA 759 (1226)
T KOG4279|consen 684 ILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDQGPRGYGKAA 759 (1226)
T ss_pred HHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cccccccchhhhChHhhccCCcCCCchh
Confidence 56679999999 999999999999995 679999999999987644333 445678999999999998654 88899
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 261 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 261 DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
|||||||++.||.||++||....... ..+..-+.. ...+..+.+...+...++++|+.+||.+||+
T Consensus 760 DIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGmy------KvHP~iPeelsaeak~FilrcFepd~~~R~s 825 (1226)
T KOG4279|consen 760 DIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGMY------KVHPPIPEELSAEAKNFILRCFEPDPCDRPS 825 (1226)
T ss_pred hhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcce------ecCCCCcHHHHHHHHHHHHHHcCCCcccCcc
Confidence 99999999999999999996332211 111111111 1112234455667888999999999999999
Q ss_pred HhHHHH
Q 015360 341 MGHVIH 346 (408)
Q Consensus 341 ~~evl~ 346 (408)
+.++++
T Consensus 826 A~~LL~ 831 (1226)
T KOG4279|consen 826 AKDLLQ 831 (1226)
T ss_pred HHHhcc
Confidence 999886
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=230.15 Aligned_cols=144 Identities=23% Similarity=0.417 Sum_probs=108.4
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus 134 ~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05049 134 GMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210 (280)
T ss_pred HHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence 37899998 9999999999999999999999999998765332211 1223345678999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||...... .....+. .+.... . .......+.+++.+||+.||++||++.||
T Consensus 211 G~il~e~~~~g~~p~~~~~~~---~~~~~~~----~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 211 GVVLWEIFTYGKQPWYGLSNE---EVIECIT----QGRLLQ-----R----PRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999998 99998643322 1222111 111110 0 11123468889999999999999999999
Q ss_pred HHHHh
Q 015360 345 IHMLE 349 (408)
Q Consensus 345 l~~Le 349 (408)
++.|+
T Consensus 275 l~~l~ 279 (280)
T cd05049 275 HERLQ 279 (280)
T ss_pred HHHhh
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=241.69 Aligned_cols=194 Identities=21% Similarity=0.307 Sum_probs=136.0
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
.+|.+.+.||+|+||.||++...+ ++.||||..
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~ 248 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYT 248 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHH
Confidence 468999999999999999999764 788999953
Q ss_pred --------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccc
Q 015360 184 --------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGT 242 (408)
Q Consensus 184 --------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt 242 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++........ ......||
T Consensus 249 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT 325 (461)
T PHA03211 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325 (461)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCC
Confidence 34559999998 9999999999999999999999999999865432221 12235689
Q ss_pred cCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC-CCCcchhHHHHHHHhcCCCc--cccc------------
Q 015360 243 FGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR-PQGEVNLVDWLKTMVGSRKS--EEVV------------ 307 (408)
Q Consensus 243 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~------------ 307 (408)
..|+|||++.+..++.++|||||||++|||++|..|+.... ..........+...+..... ..+.
T Consensus 326 ~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~ 405 (461)
T PHA03211 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYR 405 (461)
T ss_pred cCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHH
Confidence 99999999999999999999999999999999886643221 11111111111111111000 0000
Q ss_pred -------CCCCCCCCcH---HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 308 -------DPKLPKMPAS---KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 308 -------d~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+........ .....+.+|+.+||+.||.+|||+.|+|+.
T Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 406 HRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 112357789999999999999999999874
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=227.04 Aligned_cols=182 Identities=32% Similarity=0.511 Sum_probs=139.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|.+.+.||+|+||.||++..+++..++||.+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678888999999999999999888889999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 33458999998 999999999999999999999999999877643222112
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....+..|+|||.+.+..++.++||||||+++|++++ |+.||...... ... ........ ...+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~~~~~~~------~~~~--- 226 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVL---EQVERGYR------MPRP--- 226 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCCC------CCCC---
Confidence 22234568999999998889999999999999999999 99998643211 111 11111100 0000
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+.+++.+||+.||++||+++++++.|+.
T Consensus 227 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1113368889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=237.84 Aligned_cols=146 Identities=25% Similarity=0.461 Sum_probs=109.5
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +|+||||||+|||++.++.++|+|||++..+....... .....++..|+|||++.+..++.++|||||
T Consensus 185 aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~Sl 261 (337)
T cd05054 185 GMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSF 261 (337)
T ss_pred HHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHH
Confidence 37899988 99999999999999999999999999998754332221 222345678999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||......+ .+. ......... .. .......+.+++.+||+.+|++||++.||
T Consensus 262 Gv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~~-----~~----~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 262 GVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTRM-----RA----PEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred HHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCCC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999998 999996533221 111 111111100 01 11123468899999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
+++|+.
T Consensus 327 l~~l~~ 332 (337)
T cd05054 327 VEILGD 332 (337)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=240.85 Aligned_cols=146 Identities=26% Similarity=0.470 Sum_probs=108.2
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +|+||||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||
T Consensus 224 aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 300 (374)
T cd05106 224 GMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 300 (374)
T ss_pred HHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHH
Confidence 37899988 9999999999999999999999999999765433221 1122334568999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |+.||....... ... ....... .+..+.. ....+.+++.+||+.||++|||+.+|
T Consensus 301 Gvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~-----~~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 301 GILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY-----QMSRPDF----APPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred HHHHHHHHhCCCCCCccccccH--HHH----HHHHccc-----CccCCCC----CCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999997 999997543221 111 1111110 0111111 12368889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 366 ~~~l~~ 371 (374)
T cd05106 366 SQLIQR 371 (374)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=230.80 Aligned_cols=183 Identities=23% Similarity=0.424 Sum_probs=140.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-----CcEEEEEEe-----------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-----~~~vavK~~----------------------------------------- 183 (408)
.++|...++||+|+||.||+|...+ +..|++|.+
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999876 688999866
Q ss_pred -----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEecc
Q 015360 184 -----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 222 (408)
Q Consensus 184 -----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Df 222 (408)
+..+|+|||+. +++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 23348999998 9999999999999999999999999
Q ss_pred CCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 223 GLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 223 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
|+++.+...... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||....+. .+..++. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---DG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH---cC
Confidence 999865433221 1122345678999999988889999999999999999999 99999643321 1221111 11
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... .. .......+.+++.+||+.||++|||+.||++.|+..
T Consensus 236 ~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 236 YRL------AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCC------CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 110 00 011223678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=237.85 Aligned_cols=181 Identities=21% Similarity=0.343 Sum_probs=130.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||+||+|+.. +++.+|||.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 4789999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc--
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-- 233 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 233 (408)
+..+|+|||.. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 23348999998 999999999999999999999999999753211000
Q ss_pred --------------------------------------------ceecccccccCcccccccccCCCCccccchhhHHHH
Q 015360 234 --------------------------------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILI 269 (408)
Q Consensus 234 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 269 (408)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHh--ccCcCCCCCCCHhHHHHH
Q 015360 270 MEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR--CVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 270 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rps~~evl~~ 347 (408)
|||++|+.||........ ........... ..+.. ......+.+|+.+ |+..+|..||++.|++..
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~~~~~~-----~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTET------QLKVINWENTL-----HIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHH------HHHHHcccccc-----CCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999975432211 11111110000 11110 0112245566666 566777779999999875
Q ss_pred H
Q 015360 348 L 348 (408)
Q Consensus 348 L 348 (408)
-
T Consensus 306 p 306 (381)
T cd05626 306 P 306 (381)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=231.23 Aligned_cols=183 Identities=24% Similarity=0.478 Sum_probs=137.2
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe---------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~--------------------------------------- 183 (408)
.+++|...+.||+|+||.||+|.+. .+..+|||.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677899999999999999999853 2467999865
Q ss_pred --------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 184 --------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 184 --------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
++.+|.|||+. +++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 22348999998 9999999999999999999999
Q ss_pred eccCCceeecCCCccee-cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHH
Q 015360 220 SDFGLAKLLCSERSYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
+|||++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 99999876533222111 12235678999999998889999999999999999999 78888643221 111111
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. ...... .+ ......+.+++.+||+.||++|||+.|+++.|++
T Consensus 235 ~-~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 M-EGGLLD-----KP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H-cCCcCC-----CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 111110 11 1123468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=243.13 Aligned_cols=174 Identities=26% Similarity=0.408 Sum_probs=137.6
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|..++.||+|+-|.|-.|+.. .|+.+|||.+
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 455679999999999999964 5999999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..++.|+|.. +|+||||||+|+|||..+++||+|||+|.+-..+. .-
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lL 168 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LL 168 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc--cc
Confidence 34459999998 99999999999999999999999999998653332 23
Q ss_pred cccccccCcccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.+.+|++.|.|||++.+.+|. .++||||+|||||.||||+.||++.+ +...+ ..+..+..+ ++
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LL-lKV~~G~f~------MP--- 232 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLL-LKVQRGVFE------MP--- 232 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHH-HHHHcCccc------CC---
Confidence 457899999999999999985 68999999999999999999998322 22222 222222211 11
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.....+..+|+.+||..||++|.|++||+++.
T Consensus 233 -s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 233 -SNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -CcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 12233678889999999999999999998854
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=235.05 Aligned_cols=189 Identities=23% Similarity=0.378 Sum_probs=135.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+.. ++..+|||.+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999865 4788999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 161 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-Y 161 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-c
Confidence 34459999998 9999999999999999999999999998764332221 2
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC------------c
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------------S 303 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------~ 303 (408)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+.... +........ .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchhhh
Confidence 23457889999998865 4688999999999999999999999975543221111 111110000 0
Q ss_pred ccccCCCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EEVVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 0112235778999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=225.61 Aligned_cols=183 Identities=28% Similarity=0.479 Sum_probs=140.0
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++.. .++..++||.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999995 46899999965
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 23448999998 999999999999999999999999999876543
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ....+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~------~~~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE------QCDYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh------cCCCCC
Confidence 2221 2234588899999999888899999999999999999999999863321 1111111111 111111
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. ........+.+++.+||+.||++|||+.+|++.+++
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1 112234468889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=225.27 Aligned_cols=181 Identities=28% Similarity=0.484 Sum_probs=139.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||++.+.++..+++|.+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKG 85 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCC
Confidence 568888999999999999999888888999966
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||.+.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred cHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 34459999998 99999999999999999999999999987654332222222
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||.+....++.++|+|||||++|++++ |+.||...... ....+. ...... + ...
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~-----~~~ 226 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRM----P-----RPE 226 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCC----C-----Ccc
Confidence 335678999999988889999999999999999999 99999643221 111111 111000 0 011
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+++.+||+.||++||++.++++.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=230.23 Aligned_cols=181 Identities=26% Similarity=0.432 Sum_probs=135.9
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------ 183 (408)
+.+++.|...+.||+|+||.||+|... +++.+|||.+
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 346677888899999999999999875 4788999986
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCc
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a 225 (408)
++.+|+|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 33448999998 9999999999999999999999999998
Q ss_pred eeecCCCcceecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 226 KLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .... ...
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~--~~~ 230 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL--IPR 230 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH--Hhc
Confidence 76533221 223356889999999986 3457889999999999999999999996432211 1111 001
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.... ... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~~~-----~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAP-----RLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC-----CCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 111 1112236788999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=234.91 Aligned_cols=170 Identities=25% Similarity=0.419 Sum_probs=130.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++... ++..||||.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999865 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 33449999998 999999999999999999999999999875422221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ ...+..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~~i~~~~-------~~~p~~ 223 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---EL---FQSIMEHN-------VSYPKS 223 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCC-------CCCCcc
Confidence 123356899999999999889999999999999999999999999754321 11 11111111 011111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
....+.+++.+||+.||.+|++..
T Consensus 224 ----~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 224 ----LSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ----CCHHHHHHHHHHcccCHhhCCCCC
Confidence 123577889999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=225.92 Aligned_cols=179 Identities=28% Similarity=0.426 Sum_probs=135.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... ++..+++|.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999864 5889999965
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 23348999998 99999999999999999999999999987653322
Q ss_pred ccee--cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SYVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ......... .+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~-----~~~ 227 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT-----NPQ 227 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH-HHHHhccCC-----CCC
Confidence 1111 2345778999999999988999999999999999999999998643211 11 111111110 011
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
++ ......+.+++.+||+.+|++|||+.|+++.
T Consensus 228 ~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LP----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 1223367889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=228.36 Aligned_cols=178 Identities=27% Similarity=0.367 Sum_probs=135.1
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...++||+|+||+||++... +++.||||.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677899999999999999964 5889999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 23348999998 999999999999999999999999999986533222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+........ .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc----------c
Confidence 1234688999999999988899999999999999999999999975432211 111111111100 0
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
.........+.+|+.+||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11112234678899999999999999 77787664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=234.53 Aligned_cols=170 Identities=25% Similarity=0.406 Sum_probs=129.9
Q ss_pred ceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||+||++.... ++.+|||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 789999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccce
Confidence 33448999998 999999999999999999999999999875322221 12334
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .......... ...+. ..
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~-------~~~~~----~~ 219 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDE-------VRYPR----WL 219 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC-------CCCCC----cC
Confidence 6899999999999999999999999999999999999999643311 1111111111 11111 12
Q ss_pred HHHHHHHHHhccCcCCCCCCCH-----hHHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKM-----GHVIHM 347 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 347 (408)
...+.+|+.+||+.||++||++ .++++.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2367889999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=232.80 Aligned_cols=128 Identities=30% Similarity=0.503 Sum_probs=108.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... ++..+|+|.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999976 4788888865
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+.+ +++|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 334589999741 79999999999999999999999999987553221
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYS 282 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~ 282 (408)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346889999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=231.16 Aligned_cols=189 Identities=24% Similarity=0.365 Sum_probs=136.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-----CCcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-----~~~~vavK~~------------------------------------------ 183 (408)
++|.+.+.||+|+||.||++.+. ++..|+||.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777899999999999999853 4788999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 34459999998 999999999999999999999999999987643
Q ss_pred CCcce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC------c---chhHHHHHHHhc
Q 015360 231 ERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG------E---VNLVDWLKTMVG 299 (408)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~------~---~~~~~~~~~~~~ 299 (408)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..++......- . ......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 32211 111223456999999988889999999999999999999877654221100 0 000001111111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.. ............+.+|+.+||+.+|++|||+.||++.|+..
T Consensus 241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11 00011112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=225.14 Aligned_cols=176 Identities=34% Similarity=0.434 Sum_probs=136.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +..+++|..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46778899999999999999875 888999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.+|+|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~ 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC----C
Confidence 33458999998 99999999999999999999999999987643322 1
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
....+..|+|||++.+..++.++|||||||++|+|++ |+.||.... ..+....... ... +...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~-~~~-----~~~~---- 221 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEK-GYK-----MDAP---- 221 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhc-CCC-----CCCC----
Confidence 2234568999999988889999999999999999998 999986332 1111211111 100 1111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+.+++.+||+.||++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=230.05 Aligned_cols=145 Identities=26% Similarity=0.483 Sum_probs=108.3
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +++|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus 136 al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 136 GMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred HHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 37899998 9999999999999999999999999999765433221 1222345678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||...... .... ........ ..+. .....+.+++.+||+.||++||++.+|
T Consensus 213 G~il~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~-----~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i 276 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQ---EVIE----MVRKRQLL-----PCSE----DCPPRMYSLMTECWQEGPSRRPRFKDI 276 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcCCcC-----CCCC----CCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 999999998 99998643221 1111 11111111 0111 122367889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|..
T Consensus 277 ~~~l~~ 282 (283)
T cd05090 277 HTRLRS 282 (283)
T ss_pred HHHhhc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=229.02 Aligned_cols=182 Identities=27% Similarity=0.498 Sum_probs=135.5
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC------CcEEEEEEe---------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~------~~~vavK~~--------------------------------------- 183 (408)
.+++|...+.||+|+||.||+|.+.+ +..|++|..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678888999999999999999864 567888865
Q ss_pred -----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC---ceEE
Q 015360 184 -----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARV 219 (408)
Q Consensus 184 -----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL 219 (408)
++.+|+|||+. +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 23448999998 999999999999998654 5899
Q ss_pred eccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHH
Q 015360 220 SDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... ... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~---~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVM---EFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HHH
Confidence 9999998763222111 112223567999999998899999999999999999997 99999743322 111 111
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
...... ..+ ......+.+++.+||+.||++||++.+|++.|+
T Consensus 235 ~~~~~~------~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL------DPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC------CCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111 111 112246788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=231.93 Aligned_cols=182 Identities=21% Similarity=0.320 Sum_probs=132.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+++.. ++..+|||.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 4788999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 23348999998 999999999999999999999999999987654433
Q ss_pred ceecccccccCccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 234 YVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~---- 227 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERF---- 227 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcc----
Confidence 33334568999999999875 4678899999999999999999999964332 11112221111000
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCC--CCCHhHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHM 347 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~ 347 (408)
.++.. .......+.+++.+||..++.+ |++++++++.
T Consensus 228 -~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01110 1112345777888888865544 4678887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=237.74 Aligned_cols=129 Identities=29% Similarity=0.428 Sum_probs=108.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... +++.+|||.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888899999999999999865 4889999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~- 233 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 23449999998 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 015360 234 ---------------------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280 (408)
Q Consensus 234 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~ 280 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123468999999999999999999999999999999999999997
Q ss_pred CC
Q 015360 281 YS 282 (408)
Q Consensus 281 ~~ 282 (408)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 44
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=236.53 Aligned_cols=174 Identities=28% Similarity=0.369 Sum_probs=131.8
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||+||+++.. +|+.+|||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5889999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccccc
Confidence 33459999998 999999999999999999999999999875322211 22345
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..+... .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~-------~~~~~~----~ 219 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP-------LVLRPG----A 219 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC-------ccCCCC----C
Confidence 6899999999999999999999999999999999999999743321 1111111110 011111 1
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...+.+++.+||+.||.+||++.+.++.+...
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 23577889999999999999997655555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=224.64 Aligned_cols=180 Identities=28% Similarity=0.501 Sum_probs=137.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
.+|...+.||+|+||.||++.+.++..+|||.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 357778899999999999999877889999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 23448999998 99999999999999999999999999987654332221222
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ........... ....+..
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~---~~~~~~~------ 225 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAGF---RLYKPRL------ 225 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCCC---CCCCCCC------
Confidence 334578999999988889999999999999999998 9999864321 11111111110 1111111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
....+.+|+.+||+.+|++|||+.|+++.|.
T Consensus 226 -~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=225.19 Aligned_cols=174 Identities=28% Similarity=0.397 Sum_probs=129.8
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||.||+|+.. +++.+|+|..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999975 5889999964
Q ss_pred ----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee-cccc
Q 015360 184 ----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVM 240 (408)
Q Consensus 184 ----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~ 240 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 33458999998 999999999999999999999999999875432211111 1112
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.+..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ......... .. .....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~~~~-----~~----~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQGVR-----LP----CPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCCC-----CC----CcccC
Confidence 2456999999998889999999999999999998 88888643221 11 111111100 01 11122
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
...+.+++.+||+.||++|||+.+|++.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=228.75 Aligned_cols=95 Identities=28% Similarity=0.447 Sum_probs=77.7
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEe----CCCCceEEeccCCceeecCCCcc--eecccccccCccccccccc-CCCC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACT-GMLN 257 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~ 257 (408)
+.+|.|||+. +|+||||||+|||+ +.++.+||+|||+++........ ......+|+.|+|||.+.+ ..++
T Consensus 118 ~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 194 (317)
T cd07867 118 LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194 (317)
T ss_pred HHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccC
Confidence 3458999998 99999999999999 45678999999999876433221 1233567899999999876 4578
Q ss_pred ccccchhhHHHHHHHHhCCCCCCCC
Q 015360 258 EKSDVYSFGILIMEIITGRNPVDYS 282 (408)
Q Consensus 258 ~~sDvwSlGvvl~elltG~~Pf~~~ 282 (408)
.++|||||||++|||+||++||...
T Consensus 195 ~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 195 KAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=227.21 Aligned_cols=183 Identities=22% Similarity=0.334 Sum_probs=130.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+++.. +++.+|||.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999975 4889999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 23448999998 999999999999999999999999999876544333
Q ss_pred ceecccccccCccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 234 YVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.............+ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF-P 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC-C
Confidence 22333468999999999863 4578899999999999999999999964321 1112222211111111 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCc--CCCCCCCHhHHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDP--DATKRPKMGHVIHML 348 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rps~~evl~~L 348 (408)
+.. . .....+.+++.+||.. ++..|+++.++++.-
T Consensus 231 ~~~-~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 231 PDV-T----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred Ccc-C----CCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 110 0 1223456666676654 444488998888763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=228.61 Aligned_cols=147 Identities=23% Similarity=0.416 Sum_probs=109.5
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|+|||+. +++||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||
T Consensus 131 ~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 207 (288)
T cd05093 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207 (288)
T ss_pred HHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHH
Confidence 348999998 9999999999999999999999999999765332221 122233567899999999888999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|+|++ |..||...... .. ..... ..... ..... ....+.+++.+||+.||.+|||+.|
T Consensus 208 lG~il~~l~t~g~~p~~~~~~~---~~---~~~i~-~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 208 LGVVLWEIFTYGKQPWYQLSNN---EV---IECIT-QGRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHH---HH---HHHHH-cCCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999998 89998643321 11 11111 11111 01111 1235889999999999999999999
Q ss_pred HHHHHhcC
Q 015360 344 VIHMLEAD 351 (408)
Q Consensus 344 vl~~Le~~ 351 (408)
|++.|+..
T Consensus 272 v~~~l~~~ 279 (288)
T cd05093 272 IHSLLQNL 279 (288)
T ss_pred HHHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=225.25 Aligned_cols=180 Identities=29% Similarity=0.492 Sum_probs=134.6
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||+||++.... ++.+|+|.+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999765 568999987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 44559999999 99999999999999999999999999997642 2222334
Q ss_pred ccccccCcccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...++..|+|||++. +..++.++||||+|+++|+|++|..||...... +............ ...... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~----~~~~~~---~~ 226 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRP----LPSSSQ---QS 226 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTH----HHHHTT---SH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccccc----cccccc---cc
Confidence 456889999999998 788999999999999999999999999754111 1111111111000 000000 00
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000157889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=227.50 Aligned_cols=187 Identities=28% Similarity=0.435 Sum_probs=142.3
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------ 183 (408)
.++.++..+...|...+.||+|+||.||+|... +++.+|+|.+
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 467888888899999999999999999999974 4788999976
Q ss_pred --------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 184 --------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 184 --------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 33448999998 9999999999999999999999
Q ss_pred eccCCceeecCCCcceecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 015360 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~ 294 (408)
+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|..||....+....
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------ 235 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------ 235 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------
Confidence 99999875532211 122355888999999875 345788999999999999999999999643321111
Q ss_pred HHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 295 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 295 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.... .. ..+... .......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~-~~-----~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 FLIP-RN-----PPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhHh-hC-----CCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 00 001111 1122346888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=229.49 Aligned_cols=146 Identities=24% Similarity=0.402 Sum_probs=108.6
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+|+||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 144 al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 144 GMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred HHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 48999998 99999999999999999999999999998654332211 122234568999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||...... +..... ..... +.. .......+.+|+.+||+.||++|||+.|+
T Consensus 221 G~il~el~~~g~~p~~~~~~~------~~~~~~-~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ei 284 (293)
T cd05053 221 GVLLWEIFTLGGSPYPGIPVE------ELFKLL-KEGYR-----MEK----PQNCTQELYHLMRDCWHEVPSQRPTFKQL 284 (293)
T ss_pred hhHHHHHhcCCCCCCCCCCHH------HHHHHH-HcCCc-----CCC----CCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 999999998 99998643221 111111 11110 011 11223468889999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
++.|+..
T Consensus 285 l~~l~~~ 291 (293)
T cd05053 285 VEDLDRM 291 (293)
T ss_pred HHHHHHh
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-30 Score=222.11 Aligned_cols=178 Identities=22% Similarity=0.354 Sum_probs=134.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|.|+.||++... .|+.+|+|.+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 45666679999999999998753 4777777755
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceeecCCC
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+.++|.|+|.+ +|||||+||.|+||. ..--+||+|||++..+. .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 55669999999 999999999999994 33458999999999886 3
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
........|||.|||||++...+|+..+|||+.||+||-|+.|.+||...+.. .+.+.+ .. +. -..+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I---~~-g~------yd~~ 232 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQI---KA-GA------YDYP 232 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH---hc-cc------cCCC
Confidence 33345578999999999999999999999999999999999999999753321 111111 11 11 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
........+...+|+.+||..||.+|.|+.|.|.
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1112222335678888999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=225.62 Aligned_cols=144 Identities=26% Similarity=0.339 Sum_probs=105.8
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|.|||+. +|+|+||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++|||||
T Consensus 108 ~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 183 (280)
T cd05608 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFAL 183 (280)
T ss_pred HHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHH
Confidence 348999998 999999999999999999999999999976543322 1233568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-----C
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-----K 340 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s 340 (408)
||++|||++|+.||........ .......... ... .........+.+++.+||+.||++|| +
T Consensus 184 G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~---------~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 250 (280)
T cd05608 184 GVTLYEMIAARGPFRARGEKVE--NKELKQRILN---------DSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGN 250 (280)
T ss_pred HHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc---------cCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 9999999999999975432211 1111111110 000 01112234678889999999999999 5
Q ss_pred HhHHHH
Q 015360 341 MGHVIH 346 (408)
Q Consensus 341 ~~evl~ 346 (408)
++++++
T Consensus 251 ~~~~l~ 256 (280)
T cd05608 251 CDGLRT 256 (280)
T ss_pred HHHHhc
Confidence 566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=212.11 Aligned_cols=174 Identities=24% Similarity=0.346 Sum_probs=139.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|..++.||+|-||.||.|+.+. +-.||+|++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 347888999999999999999754 778999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.||.|+|.. +++||||||+|+|++..+..||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 55679999998 99999999999999999999999999987653
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.......+||.-|.+||...+..++...|+|++|++.||++.|.+||......+ ....+.. .++.+|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k-------~~~~~p--- 242 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRK-------VDLKFP--- 242 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHH-------ccccCC---
Confidence 223345789999999999999999999999999999999999999997544221 1111111 111122
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .......++|.+|+..+|.+|.+..|+++.
T Consensus 243 ~----~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 S----TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred c----ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 122357789999999999999999999864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=225.91 Aligned_cols=172 Identities=28% Similarity=0.370 Sum_probs=129.3
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||+||++... +++.+|||.+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999975 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 23448999998 999999999999999999999999999876533222
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ ...+........ ....
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~------~~~~-- 225 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE------EVYS-- 225 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc------cccC--
Confidence 1234689999999999988999999999999999999999999974432111 111111111100 0111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
......+.+|+.+||+.||++||++.
T Consensus 226 --~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 226 --AKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --ccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11223577899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=222.30 Aligned_cols=148 Identities=24% Similarity=0.448 Sum_probs=110.7
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec--ccccccCcccccccccCCCCccccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--RVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
+.+|+|||.. +++|+||||+|||++.++.+||+|||+++........... ...++..|+|||.+.+..++.++||
T Consensus 105 ~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 181 (257)
T cd05060 105 AMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181 (257)
T ss_pred HHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchH
Confidence 4458999998 9999999999999999999999999999876443322211 1223467999999998899999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++|+|++ |..||..... ..+..++. ..... .. .......+.+++.+||+.||++||++
T Consensus 182 ~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~---~~~~~------~~----~~~~~~~l~~li~~cl~~~p~~Rp~~ 245 (257)
T cd05060 182 WSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE---SGERL------PR----PEECPQEIYSIMLSCWKYRPEDRPTF 245 (257)
T ss_pred HHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH---cCCcC------CC----CCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 999999999998 9999964332 12222221 11110 01 11122467889999999999999999
Q ss_pred hHHHHHHhcC
Q 015360 342 GHVIHMLEAD 351 (408)
Q Consensus 342 ~evl~~Le~~ 351 (408)
.+|++.|+..
T Consensus 246 ~~l~~~l~~~ 255 (257)
T cd05060 246 SELESTFRRD 255 (257)
T ss_pred HHHHHHHHhc
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=234.14 Aligned_cols=138 Identities=25% Similarity=0.334 Sum_probs=100.0
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccC-CCCccccch
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVY 263 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvw 263 (408)
+.+|+|||+. +|+||||||+|||++.++.+||+|||++........ ......||..|+|||.+.+. .++.++|||
T Consensus 106 l~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 181 (330)
T cd05586 106 VLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181 (330)
T ss_pred HHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCccCCccccCHHHHcCCCCCCCcccee
Confidence 3449999998 999999999999999999999999999875422221 12345689999999998754 478999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 264 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 264 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
||||++|+|++|+.||..... ......... .. ..++.. .....+.+++.+||+.||.+||++.
T Consensus 182 slGvil~elltG~~Pf~~~~~------~~~~~~i~~-~~------~~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 182 SLGVLVFEMCCGWSPFYAEDT------QQMYRNIAF-GK------VRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ccccEEEEeccCCCCCCCCCH------HHHHHHHHc-CC------CCCCCc---cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 999999999999999964322 111111111 11 111111 1123567888999999999999544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=228.37 Aligned_cols=175 Identities=32% Similarity=0.554 Sum_probs=129.5
Q ss_pred ccceeccCCcEEEEEEEeC-----CCcEEEEEEe----------------------------------------------
Q 015360 155 EENVIGEGGYGIVYRGILS-----DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 155 ~~~~lg~G~~g~Vy~g~~~-----~~~~vavK~~---------------------------------------------- 183 (408)
..+.||.|.||.||+|.+. .+..|+||.+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 2678999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +++|+||+++|||++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 45569999998 9999999999999999999999999999876322221
Q ss_pred -eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 235 -VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 235 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
..........|+|||.+....++.++||||||+++|||++ |+.||..... .+..... ...... ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~~~-----~~- 226 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQRL-----PI- 226 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTEET-----TS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccc-----ee-
Confidence 2223446778999999999889999999999999999999 7888754321 1122222 111111 11
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.......+.+++.+||+.||++|||+.+|++.|
T Consensus 227 ---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223688899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=226.51 Aligned_cols=178 Identities=26% Similarity=0.383 Sum_probs=134.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||+||++... +++.+|||.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999965 4789999975
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 23448999998 999999999999999999999999999876533222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||........... ........ . .....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~--~----~~~~~ 226 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV--Q----EEYSE 226 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhh--h----hhcCc
Confidence 1224688999999999998999999999999999999999999975432211111 11111000 0 01111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
.....+.+|+.+||+.||++||| +.|++++
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 ----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 12235788999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=237.51 Aligned_cols=178 Identities=22% Similarity=0.353 Sum_probs=127.7
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...++||+|+||+||+|... +++.+|||.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999964 4789999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC---
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER--- 232 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~--- 232 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 23348999998 99999999999999999999999999975321000
Q ss_pred -------------------------------------------cceecccccccCcccccccccCCCCccccchhhHHHH
Q 015360 233 -------------------------------------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILI 269 (408)
Q Consensus 233 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 269 (408)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC---HhHHHH
Q 015360 270 MEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MGHVIH 346 (408)
Q Consensus 270 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~ 346 (408)
|||++|+.||....+.. ............ ..+ ........+.+++.+|+ .||.+|++ +.|+++
T Consensus 239 ~elltG~~Pf~~~~~~~------~~~~i~~~~~~~-----~~p--~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLE------TQMKVINWQTSL-----HIP--PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHH------HHHHHHccCCCc-----CCC--CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999997543211 111111111000 011 01111234556666665 59999998 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=235.77 Aligned_cols=149 Identities=23% Similarity=0.403 Sum_probs=121.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccch
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
++.+|.|||+. .+|||||..+|||+.....+||+|||+++.+.....+......-...|||||.+....++.++|||
T Consensus 500 i~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVW 576 (974)
T KOG4257|consen 500 ICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVW 576 (974)
T ss_pred HHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHH
Confidence 45569999999 999999999999999999999999999999987776665555567789999999999999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 264 SFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 264 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
-|||++||++. |..||..-.+.+....+ ...-+...++.+...+..|+.+||.+||.+||.+.
T Consensus 577 MFgVCmWEIl~lGvkPfqgvkNsDVI~~i----------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrft 640 (974)
T KOG4257|consen 577 MFGVCMWEILSLGVKPFQGVKNSDVIGHI----------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFT 640 (974)
T ss_pred HHHHHHHHHHHhcCCccccccccceEEEe----------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHH
Confidence 99999999988 99999866554432111 11111222334445788999999999999999999
Q ss_pred HHHHHHhcC
Q 015360 343 HVIHMLEAD 351 (408)
Q Consensus 343 evl~~Le~~ 351 (408)
|+...|...
T Consensus 641 ei~~~lsdv 649 (974)
T KOG4257|consen 641 EIKAILSDV 649 (974)
T ss_pred HHHHHHHHH
Confidence 999988763
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=224.40 Aligned_cols=149 Identities=24% Similarity=0.293 Sum_probs=109.7
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|+|||+. +++|+||||+||+++.++.++|+|||++........ .....++..|+|||++.+..++.++|||||
T Consensus 106 ~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 180 (277)
T cd05607 106 CGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180 (277)
T ss_pred HHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccCCCCCccCHHHHccCCCCCchhHHHH
Confidence 348999998 999999999999999999999999999876643222 233468899999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
||++|||++|+.||....... ............. .. .. .......+.+|+.+||+.||++||++.|++
T Consensus 181 Gv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~-----~~--~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 181 GCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE-----VK--FE---HQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc-----cc--cc---cccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 999999999999996433211 1111111111100 00 00 011223578899999999999999998887
Q ss_pred HHHhcC
Q 015360 346 HMLEAD 351 (408)
Q Consensus 346 ~~Le~~ 351 (408)
+.+...
T Consensus 249 ~~~~~h 254 (277)
T cd05607 249 DDPRKH 254 (277)
T ss_pred hhhhcC
Confidence 665544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=223.58 Aligned_cols=182 Identities=27% Similarity=0.392 Sum_probs=134.7
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+. .+++.+|||.+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999996 45888999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +|+|+||||+||+++.++.++|+|||++........ ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 33458999998 999999999999999999999999999986643221 122
Q ss_pred ccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 238 RVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
...++..|+|||.+. ...++.++|||||||++|||++|+.||....+..... .. ... ....+....
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~-~~~---~~~~~~~~~- 233 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-SKS---NFQPPKLKD- 233 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee-ecC---CCCCCCCcc-
Confidence 345788999999874 3457789999999999999999999985433221100 00 000 001111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.......+.+++.+||+.||++|||++++++.|
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 -KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112234688899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=244.44 Aligned_cols=158 Identities=20% Similarity=0.319 Sum_probs=108.2
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
..+|.|||+. +|+||||||+|||++.++.+||+|||++..+............||..|+|||++.+..++.++||||
T Consensus 277 ~~aL~yLH~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 353 (501)
T PHA03210 277 LCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353 (501)
T ss_pred HHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHH
Confidence 4569999998 9999999999999999999999999999876544333334467999999999999999999999999
Q ss_pred hHHHHHHHHhCCCC-CCCCCCCCcchhHHHHHHHhcCCCcccccCC-----------CCCC--CCcH------HHHHHHH
Q 015360 265 FGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----------KLPK--MPAS------KALKRVL 324 (408)
Q Consensus 265 lGvvl~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-----------~~~~--~~~~------~~~~~l~ 324 (408)
|||++|||++|..+ +..........+...+... .. ...++.++ .+.. .... .....+.
T Consensus 354 lGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (501)
T PHA03210 354 CGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL-SV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFE 431 (501)
T ss_pred HHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc-cc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHH
Confidence 99999999998754 4322211111111111110 00 00000000 0000 0000 0112466
Q ss_pred HHHHhccCcCCCCCCCHhHHHHH
Q 015360 325 LVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 325 ~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+++.+||+.||++|||+.|++++
T Consensus 432 ~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 432 YPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhccCcccCcCHHHHhhC
Confidence 77889999999999999999874
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=222.97 Aligned_cols=182 Identities=30% Similarity=0.529 Sum_probs=136.6
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-C---cEEEEEEe------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-G---TKVAVKNL------------------------------------------ 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~---~~vavK~~------------------------------------------ 183 (408)
+++|...+.||+|+||.||+|.+.. + ..++||..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999999753 3 37899876
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 23448999998 9999999999999999999999999998765432
Q ss_pred Cccee--cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 232 RSYVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 232 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
..... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .............
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~~~----- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGFRL----- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCCCC-----
Confidence 22111 11223457999999988889999999999999999998 9999864322 1122222111100
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+. .......+.+++.+||+.+|++||++.+|++.|++
T Consensus 230 ~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 PA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11 11223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=226.97 Aligned_cols=144 Identities=23% Similarity=0.333 Sum_probs=106.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhH
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 266 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 266 (408)
+|+|||+. +++|+||||+|||++.++.+||+|||++...... ........+..|+|||.+.+..++.++||||||
T Consensus 131 al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 205 (297)
T cd05089 131 GMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205 (297)
T ss_pred HHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHH
Confidence 48999998 9999999999999999999999999998643211 111112234579999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 267 ILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 267 vvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
|++|||++ |..||...... +....... .. .+..+ ......+.+|+.+||+.||.+||++.+++
T Consensus 206 ~il~el~t~g~~pf~~~~~~------~~~~~~~~-~~-----~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 269 (297)
T cd05089 206 VLLWEIVSLGGTPYCGMTCA------ELYEKLPQ-GY-----RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQIS 269 (297)
T ss_pred HHHHHHHcCCCCCCCCCCHH------HHHHHHhc-CC-----CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999997 99999643321 11111111 10 01111 11223678899999999999999999999
Q ss_pred HHHhcC
Q 015360 346 HMLEAD 351 (408)
Q Consensus 346 ~~Le~~ 351 (408)
+.|+..
T Consensus 270 ~~l~~~ 275 (297)
T cd05089 270 VQLSRM 275 (297)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=231.48 Aligned_cols=139 Identities=25% Similarity=0.395 Sum_probs=104.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccch
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++........ ......|++.|+|||.+.+..++.++|||
T Consensus 107 i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 182 (318)
T cd05582 107 LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWW 182 (318)
T ss_pred HHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceecccCChhhcCHHHHcCCCCCCcccee
Confidence 34459999998 999999999999999999999999999876533221 22335689999999999988899999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 264 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 264 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||||++|||++|+.||...... .......... ..++.. ....+.+++.+||+.||++||++.+
T Consensus 183 slG~il~el~tg~~p~~~~~~~------~~~~~i~~~~-------~~~p~~----~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 183 SFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAK-------LGMPQF----LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ccceEeeeeccCCCCCCCCCHH------HHHHHHHcCC-------CCCCCC----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9999999999999999743321 1111111110 011111 1235778899999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=244.47 Aligned_cols=190 Identities=23% Similarity=0.314 Sum_probs=130.7
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-----CcEEEEEEe----------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-----~~~vavK~~---------------------------------------- 183 (408)
..++|...+.||+|+||.||+|++.+ +..||||++
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 56889999999999999999999754 588999963
Q ss_pred ------------------------------------------------------hhhhHHHhhhCCCCceeeeccccCce
Q 015360 184 ------------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNI 209 (408)
Q Consensus 184 ------------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Ni 209 (408)
+..+|+|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 12358899998 999999999999
Q ss_pred EeCC-CCceEEeccCCceeecCCCcceecccccccCcccccccccC----------------------CCCccccchhhH
Q 015360 210 LLDR-QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG----------------------MLNEKSDVYSFG 266 (408)
Q Consensus 210 ll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvwSlG 266 (408)
|++. ++.+||+|||+++.+............+++.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 57899999999987654444444556789999999965322 234567999999
Q ss_pred HHHHHHHhCCCCCCCCCC-------CCcchhHHHHHHHhcCCCcccccCCCCCCCC--cHHHHHHHHHHHHhccCcCCCC
Q 015360 267 ILIMEIITGRNPVDYSRP-------QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP--ASKALKRVLLVALRCVDPDATK 337 (408)
Q Consensus 267 vvl~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~ 337 (408)
|+||||+++..+++.... .....+..|...... . ..+...... .........+|+.+||+.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-R-----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-c-----cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999997766432100 000011111111000 0 000000000 0001123558999999999999
Q ss_pred CCCHhHHHHH
Q 015360 338 RPKMGHVIHM 347 (408)
Q Consensus 338 Rps~~evl~~ 347 (408)
|||+.|++++
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999885
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=217.77 Aligned_cols=176 Identities=30% Similarity=0.513 Sum_probs=136.3
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+++.. ++..+++|.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 5889999975
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 33458999998 9999999999999999999999999998876443222
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....++..|+|||++.+..++.++|+|||||++|+|++|+.||...... .. ..... .... +.+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~-~~~~-----~~~~-- 222 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---AL---ILKII-RGVF-----PPVS-- 222 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-cCCC-----CCCc--
Confidence 22345788999999999988999999999999999999999999644311 11 11111 1111 1111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 --QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1223468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=224.98 Aligned_cols=182 Identities=24% Similarity=0.493 Sum_probs=137.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC------CcEEEEEEe----------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~------~~~vavK~~---------------------------------------- 183 (408)
.++|...+.||+|+||.||+|...+ +..+|||..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998743 367999976
Q ss_pred -------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEe
Q 015360 184 -------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 220 (408)
Q Consensus 184 -------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~ 220 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 22348999998 99999999999999999999999
Q ss_pred ccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHh
Q 015360 221 DFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 221 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ...... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~---~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFV---I 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHH---h
Confidence 99998765433221 1222346778999999988889999999999999999998 99998643321 111111 1
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..... ..+.. ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 -~~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DGGHL-----DLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cCCCC-----CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 11111 13468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=228.98 Aligned_cols=189 Identities=23% Similarity=0.333 Sum_probs=134.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||+|... ++..||+|.+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46778899999999999999875 4788999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++......... .
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 161 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y 161 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-c
Confidence 34459999998 9999999999999999999999999998754322211 1
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC------------CCc
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS------------RKS 303 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------~~~ 303 (408)
....+++.|+|||.+.+ ..++.++|||||||++|||++|++||...+..+ ....+...... ...
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccccc
Confidence 22346889999998865 457889999999999999999999997543221 11111111100 000
Q ss_pred ccccCCCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EEVVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+...... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000001110000 0112335778999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=220.19 Aligned_cols=174 Identities=27% Similarity=0.421 Sum_probs=132.0
Q ss_pred ceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------------- 183 (408)
++||+|+||.||++...+++.|++|..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999975
Q ss_pred ---------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee-ccccc
Q 015360 184 ---------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMG 241 (408)
Q Consensus 184 ---------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~g 241 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 23448999998 999999999999999999999999999876542221111 11223
Q ss_pred ccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 242 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
+..|+|||.+.+..++.++|+|||||++|||++ |..||....... ....+ .... ....+....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~----~~~~---------~~~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI----ESGY---------RMPAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH----hcCC---------CCCCCccCC
Confidence 567999999988889999999999999999999 888886443211 11111 1100 000111223
Q ss_pred HHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 321 KRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
..+.+++.+||+.+|++|||+.||++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 46888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=227.18 Aligned_cols=185 Identities=25% Similarity=0.483 Sum_probs=138.4
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCC------CcEEEEEEe--------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNL-------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~------~~~vavK~~-------------------------------------- 183 (408)
..+++|.+.+.||+|+||.||+|..++ +..||||.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345778889999999999999997542 457999965
Q ss_pred ---------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceE
Q 015360 184 ---------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 218 (408)
Q Consensus 184 ---------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 218 (408)
++.+|.|||+. +++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 22348999998 999999999999999999999
Q ss_pred EeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 015360 219 VSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 219 L~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 99999987653322211 112234678999999998899999999999999999999 78888643221 11111
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....... ..+. .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ~~~~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYL------DQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCC------CCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111110 0111 1124688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=233.41 Aligned_cols=148 Identities=26% Similarity=0.410 Sum_probs=114.8
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
+++++.|||++ .+|||||-.+|||+..-..+||.|||+++......... .....-.+.|||-|.+....|+.++||
T Consensus 807 IAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDV 883 (1177)
T KOG1025|consen 807 IAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDV 883 (1177)
T ss_pred HHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhh
Confidence 56679999998 99999999999999999999999999999876544332 222334568999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++||++| |..|++.....+..++. ..+ .+...++.+...+..++.+||..|+..||++
T Consensus 884 WsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~g---------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 884 WSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKG---------ERLSQPPICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred hhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hcc---------ccCCCCCCccHHHHHHHHHHhccCcccCccH
Confidence 999999999999 99998755443322221 111 1111222334467888999999999999999
Q ss_pred hHHHHHHhc
Q 015360 342 GHVIHMLEA 350 (408)
Q Consensus 342 ~evl~~Le~ 350 (408)
+++...+.+
T Consensus 948 kel~~~fs~ 956 (1177)
T KOG1025|consen 948 KELAEEFSR 956 (1177)
T ss_pred HHHHHHHHH
Confidence 999888765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=230.41 Aligned_cols=182 Identities=22% Similarity=0.330 Sum_probs=131.4
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||+||++..+. +..+|+|.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999764 678999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 23348999998 999999999999999999999999999876543333
Q ss_pred ceecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 234 YVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~--- 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ--- 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc---
Confidence 3333456899999999986 34678899999999999999999999974321 122222221111000
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCC--CCCCHhHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDAT--KRPKMGHVIHM 347 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~Rps~~evl~~ 347 (408)
++.. .......+.+|+.+|+..++. .|+++.|+++.
T Consensus 229 --~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --FPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1110 111233566777787755444 47899888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=226.32 Aligned_cols=146 Identities=25% Similarity=0.442 Sum_probs=110.3
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus 135 al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 135 GMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred HHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 48999998 9999999999999999999999999999765432211 1223446788999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |+.||...... ...+ . ........ .. ......+.+++.+||+.||++|||+.+|
T Consensus 212 G~il~el~t~g~~p~~~~~~~---~~~~---~-~~~~~~~~-----~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSNT---EVIE---C-ITQGRVLE-----RP----RVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHH---H-HhCCCCCC-----CC----ccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999999 99998643321 1111 1 11111111 01 1123468899999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
+++|+..
T Consensus 276 ~~~l~~~ 282 (291)
T cd05094 276 YKILHAL 282 (291)
T ss_pred HHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=221.42 Aligned_cols=148 Identities=26% Similarity=0.423 Sum_probs=109.4
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee--cccccccCcccccccccCCCCcccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPEYACTGMLNEKSD 261 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sD 261 (408)
++.+|.|||+. +++|+||||+|||++.++.+||+|||++........... ....++..|+|||.+.+..++.++|
T Consensus 104 i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 180 (257)
T cd05115 104 VSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180 (257)
T ss_pred HHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhh
Confidence 34458999998 999999999999999999999999999976543322211 1122356899999998888999999
Q ss_pred chhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 262 VYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 262 vwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
||||||++||+++ |..||...... +... ....+.. +..+ ......+.+++.+||+.||++||+
T Consensus 181 i~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~~-----~~~~----~~~~~~l~~li~~c~~~~~~~Rp~ 244 (257)
T cd05115 181 VWSYGITMWEAFSYGQKPYKKMKGP------EVMS-FIEQGKR-----LDCP----AECPPEMYALMKDCWIYKWEDRPN 244 (257)
T ss_pred HHHHHHHHHHHhcCCCCCcCcCCHH------HHHH-HHHCCCC-----CCCC----CCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999999999996 99999644321 1111 1111111 0111 112346778999999999999999
Q ss_pred HhHHHHHHhc
Q 015360 341 MGHVIHMLEA 350 (408)
Q Consensus 341 ~~evl~~Le~ 350 (408)
+.+|.+.|+.
T Consensus 245 ~~~i~~~l~~ 254 (257)
T cd05115 245 FAKVEERMRT 254 (257)
T ss_pred HHHHHHHHhh
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=223.15 Aligned_cols=143 Identities=33% Similarity=0.520 Sum_probs=108.3
Q ss_pred hHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+ . +++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.+..++.++|||||
T Consensus 125 ~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 199 (269)
T cd08528 125 ALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAF 199 (269)
T ss_pred HHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHH
Confidence 4899995 4 89999999999999999999999999998754433 2234568889999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
|+++|+|++|+.||..... ........ ..... + .........+.+++.+||+.||++||++.||.
T Consensus 200 G~ll~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 200 GCILYQMCTLQPPFYSTNM------LSLATKIV-EAVYE----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred HHHHHHHHhCCCcccccCH------HHHHHHHh-hccCC----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence 9999999999999863321 11111111 11111 1 01111224678899999999999999999999
Q ss_pred HHHh
Q 015360 346 HMLE 349 (408)
Q Consensus 346 ~~Le 349 (408)
.+++
T Consensus 265 ~~~~ 268 (269)
T cd08528 265 AMIS 268 (269)
T ss_pred HHhc
Confidence 9886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=221.60 Aligned_cols=181 Identities=27% Similarity=0.483 Sum_probs=137.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCCC----cEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDG----TKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~----~~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.+.+. ..++||..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 4577789999999999999997542 46888875
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 34459999998 999999999999999999999999999987644432
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.......++..|+|||.+....++.++||||||+++||+++ |..||...... .....+ ...... ..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~---~~~~~~------~~~ 230 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI---ENGERL------PMP 230 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH---HcCCcC------CCC
Confidence 22222334568999999988889999999999999999996 99999644322 111111 111110 011
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+.+++.+||..+|++|||+.++++.|+.
T Consensus 231 ----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 231 ----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1123368889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=228.03 Aligned_cols=182 Identities=27% Similarity=0.457 Sum_probs=136.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe-----------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~----------------------------------------- 183 (408)
++|...+.||+|+||.||++... .+..+|||.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888899999999999999742 2457899865
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|+|||+. +++|+||||+|||++.++.++|+|||++...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 23348999998 9999999999999999999999999999765
Q ss_pred cCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 229 CSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 229 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+. ........
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~--- 262 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEGYR--- 262 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcCCc---
Confidence 433221 1222345678999999998889999999999999999998 999986433211 111 11111100
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+..+. .....+.+++.+||+.+|++|||+.||++.|+.
T Consensus 263 --~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 --MAQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --CCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00011 112368889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=225.53 Aligned_cols=178 Identities=29% Similarity=0.477 Sum_probs=135.9
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.||+|.. .+++.++||.+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677788999999999999985 35889999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|+|||+. +|+|+||||+||+++.++.++|+|||++......... ...
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~ 175 (296)
T cd06654 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 175 (296)
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCc
Confidence 34559999998 9999999999999999999999999998765332221 122
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. .......... +.+ .....
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~------~~~--~~~~~ 241 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT------PEL--QNPEK 241 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC------CCC--CCccc
Confidence 457889999999988889999999999999999999999996443211 1111111110 001 01112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 2345788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=225.10 Aligned_cols=145 Identities=23% Similarity=0.419 Sum_probs=107.4
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+|||+++++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||
T Consensus 134 al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 134 GMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred HHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 48999998 99999999999999999999999999987653322111 122335678999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |.+||....... . .......... ..+. .....+.+++.+||+.||++||++.||
T Consensus 211 G~il~el~~~g~~p~~~~~~~~---~---~~~~~~~~~~------~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 211 GVVLWEIFTYGKQPWYQLSNTE---A---IECITQGREL------ERPR----TCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred HHHHHHHHcCCCCCCccCCHHH---H---HHHHHcCccC------CCCC----CCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999999998 899986432211 1 1111111110 0111 122357889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 275 ~~~l~~ 280 (280)
T cd05092 275 HSRLQA 280 (280)
T ss_pred HHHHhC
Confidence 998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=221.53 Aligned_cols=148 Identities=28% Similarity=0.451 Sum_probs=107.5
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce---ecccccccCcccccccccCCCCcccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTGMLNEKSD 261 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sD 261 (408)
+.+|.|||+. +++|+||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|
T Consensus 108 ~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 184 (262)
T cd05058 108 AKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSD 184 (262)
T ss_pred HHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHH
Confidence 3448999998 99999999999999999999999999987653322111 11234567899999998888999999
Q ss_pred chhhHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 262 VYSFGILIMEIITG-RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 262 vwSlGvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
||||||++|||++| .+||..... .+.......... +..+. .....+.+++.+||+.+|++||+
T Consensus 185 i~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~------~~~~~----~~~~~~~~li~~cl~~~p~~Rp~ 248 (262)
T cd05058 185 VWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRR------LLQPE----YCPDPLYEVMLSCWHPKPEMRPT 248 (262)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCC------CCCCC----cCCHHHHHHHHHHcCCChhhCCC
Confidence 99999999999995 556653221 111221111110 00011 11236788999999999999999
Q ss_pred HhHHHHHHhcC
Q 015360 341 MGHVIHMLEAD 351 (408)
Q Consensus 341 ~~evl~~Le~~ 351 (408)
+.||++.|+..
T Consensus 249 ~~~il~~l~~~ 259 (262)
T cd05058 249 FSELVSRIEQI 259 (262)
T ss_pred HHHHHHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=221.34 Aligned_cols=176 Identities=31% Similarity=0.490 Sum_probs=135.4
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. ++..+|+|..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 3477789999999999999986 5788999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 157 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS 157 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence 34458999998 99999999999999999999999999987543211 112
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..+..|+|||.+.+..++.++|+|||||++|||++ |+.||...... ...... ...... .....
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~~~~---------~~~~~ 221 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKECV-EKGYRM---------EPPEG 221 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHHH-hCCCCC---------CCCCc
Confidence 34567999999988889999999999999999998 99998644321 111111 111100 01112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
....+.+++.+||+.+|++||++++|++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=219.91 Aligned_cols=176 Identities=34% Similarity=0.461 Sum_probs=136.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||.|+||.||+|... ++.||||..
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 46777899999999999999985 889999987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 33458999998 999999999999999999999999999976532221
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
....+..|+|||.+....++.++||||||+++|+|++ |..||...... .+.. ....... ...+
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~~---- 221 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----HVEKGYR-----MEAP---- 221 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCC-----CCCc----
Confidence 2234567999999988889999999999999999998 99998643211 1111 1111110 0111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
......+.+++.+||+.+|++|||+.|++++|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1123468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=225.32 Aligned_cols=146 Identities=30% Similarity=0.505 Sum_probs=109.3
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +++|+||||+|||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 139 ~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 139 GMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred HHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 47999988 99999999999999999999999999987653332221 122335678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
|+++|||++ |..||....+. .+.. ...... ....+ ......+.+++.+||+.||++||++.|+
T Consensus 216 G~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~-----~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 216 GVLLWEIVTLGGNPYPGIAPE---RLFN----LLKTGY-----RMERP----ENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HHHHHHHHhcCCCCCCCCCHH---HHHH----HHhCCC-----CCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999999999 99998643321 1111 111111 01111 1123468889999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
++.|+..
T Consensus 280 ~~~l~~~ 286 (290)
T cd05045 280 SKELEKM 286 (290)
T ss_pred HHHHHHH
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=226.84 Aligned_cols=148 Identities=24% Similarity=0.398 Sum_probs=110.0
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|.|||+. +++|+||||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||
T Consensus 148 ~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 224 (304)
T cd05101 148 RGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224 (304)
T ss_pred HHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHH
Confidence 348899998 99999999999999999999999999998764332221 12233567899999998888999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||+++|+|++ |..||.... ..+...... ..... .. .......+.+++.+||+.+|++|||+.|
T Consensus 225 lG~~l~el~~~g~~p~~~~~------~~~~~~~~~-~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e 288 (304)
T cd05101 225 FGVLMWEIFTLGGSPYPGIP------VEELFKLLK-EGHRM-----DK----PANCTNELYMMMRDCWHAIPSHRPTFKQ 288 (304)
T ss_pred HHHHHHHHHcCCCCCcccCC------HHHHHHHHH-cCCcC-----CC----CCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 9999999998 788885432 112222211 11110 00 1122346888999999999999999999
Q ss_pred HHHHHhcCC
Q 015360 344 VIHMLEADD 352 (408)
Q Consensus 344 vl~~Le~~~ 352 (408)
|++.|+.+.
T Consensus 289 ~l~~l~~~~ 297 (304)
T cd05101 289 LVEDLDRIL 297 (304)
T ss_pred HHHHHHHHH
Confidence 999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=240.79 Aligned_cols=175 Identities=23% Similarity=0.354 Sum_probs=134.1
Q ss_pred CCccceeccCCcEEEEEEEeCC--CcEEEEEEe-----------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD--GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~--~~~vavK~~----------------------------------------------- 183 (408)
|...+.||+|+||.||++.... ++.|++|..
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 7778899999999999998543 577888865
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~- 233 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 23448999998 999999999999999999999999999987643322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+....... . ++ .+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~-~----~~-~~- 292 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK-Y----DP-FP- 292 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C----CC-CC-
Confidence 123345689999999999999999999999999999999999999964321 11122211111 1 01 11
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......+.+++.+||+.||++||++.+++.
T Consensus 293 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 ---CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112236788999999999999999999975
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=214.17 Aligned_cols=186 Identities=26% Similarity=0.356 Sum_probs=143.0
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------ 183 (408)
+.-.++|...++||.|..++|-++..+. |...|+|++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3445678888999999999999988654 778888877
Q ss_pred ---------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCC
Q 015360 184 ---------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 ---------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
+.++++|||.. +||||||||+|||++++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 34459999999 999999999999999999999999999
Q ss_pred ceeecCCCcceecccccccCcccccccccC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
+..+..+.. ....+||++|+|||.+... .|+...|+|++||++|.|+.|.+||-... . -.+..++
T Consensus 170 a~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Q--mlMLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----Q--MLMLRMI 240 (411)
T ss_pred eeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----H--HHHHHHH
Confidence 988754433 3457899999999988643 47788999999999999999999996321 1 1122233
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.+++.+ +- .....+......+|+.+||+.||.+|.|++|+|+.--.
T Consensus 241 meGkyq-F~-----speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 241 MEGKYQ-FR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred Hhcccc-cC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 333221 11 22223344567889999999999999999999875543
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=221.74 Aligned_cols=151 Identities=25% Similarity=0.439 Sum_probs=108.4
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus 142 al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 142 GMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred HHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 48999998 9999999999999999999999999998765433221 1223446778999999988889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 266 GILIMEIIT--GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 266 Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||++|||++ +..||..... .................... + ........+.+++.+||+.||++|||+.|
T Consensus 219 G~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 289 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTD---QQVIENAGHFFRDDGRQIYL-P-----RPPNCPKDIYELMLECWRRDEEDRPTFRE 289 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcCh---HHHHHHHHhccccccccccC-C-----CccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence 999999998 6677753321 11222222111111111100 0 01112246889999999999999999999
Q ss_pred HHHHHh
Q 015360 344 VIHMLE 349 (408)
Q Consensus 344 vl~~Le 349 (408)
|++.|+
T Consensus 290 l~~~L~ 295 (296)
T cd05051 290 IHLFLQ 295 (296)
T ss_pred HHHHhc
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=234.34 Aligned_cols=173 Identities=27% Similarity=0.411 Sum_probs=135.9
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
-|...+.||.|+||-||-+.. .+.+.||||++
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355667899999999999984 46889999988
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
...+|+|||+. +.||||||.-||||++.|.|||+|||.+....+.+
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--- 180 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--- 180 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence 23459999999 99999999999999999999999999997765433
Q ss_pred ecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 236 TTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.++|||.|||||++. .+.|+-++||||||++..||...++|+-..+ ....+..+.. --.|.+.
T Consensus 181 --sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQ------NesPtLq 246 (948)
T KOG0577|consen 181 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQ------NESPTLQ 246 (948)
T ss_pred --cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHh------cCCCCCC
Confidence 378999999999875 4679999999999999999999999964322 1111111111 0112332
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..+....+..++..||+.-|.+|||.++++..
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34555677888889999999999999998764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=215.93 Aligned_cols=176 Identities=32% Similarity=0.456 Sum_probs=133.0
Q ss_pred ceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------------- 183 (408)
..||.|.||+|+|-.++. |+..|||++
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~Sl 149 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISL 149 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhH
Confidence 579999999999998764 899999998
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
..+||.||.+.+ .|||||+||+|||++..|.+||||||++-.+.. +...+
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiAkT 225 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIAKT 225 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HHHhh
Confidence 123499998764 899999999999999999999999999866532 22234
Q ss_pred ccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 238 RVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.-.|...|||||.+.. ..|+-++||||||++|||+.||+.|+...+ +..+.+...+......-..+..
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~~~~~----- 295 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILLFDKE----- 295 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeecCccc-----
Confidence 4568899999999864 348889999999999999999999997443 2333343333222111111111
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.......+..++.-||-.|-..||...++++
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1123446888999999999999999988865
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=225.52 Aligned_cols=189 Identities=29% Similarity=0.413 Sum_probs=142.5
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------ 183 (408)
+++.++..++++|...+.||+|+||.||++... +++.+|+|.+
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 667788888999999999999999999999974 5788999976
Q ss_pred ---------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceE
Q 015360 184 ---------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 218 (408)
Q Consensus 184 ---------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 218 (408)
+..+|+|||+. +++|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 22348999998 999999999999999999999
Q ss_pred EeccCCceeecCCCcceecccccccCcccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHH
Q 015360 219 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 293 (408)
Q Consensus 219 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 293 (408)
|+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||....... .
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~---- 241 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--T---- 241 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--H----
Confidence 999999876543221 12234578899999987643 36789999999999999999999996432211 1
Q ss_pred HHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 294 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 294 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+.... ......+.+ .......+.+++.+||+.||++||++.|+++.
T Consensus 242 ~~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKIP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 111111111 11223468889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-28 Score=228.94 Aligned_cols=180 Identities=29% Similarity=0.409 Sum_probs=136.9
Q ss_pred HHHHHh-cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------
Q 015360 145 ELEAAT-SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t-~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------- 183 (408)
|++-.| +.|...++||+|+||.||-++..+ |..+|.|++
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 444444 678999999999999999998654 777777765
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCc
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a 225 (408)
+.-+|++||.. +||+|||||+|||||+.|++.|+|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence 33459999999 9999999999999999999999999999
Q ss_pred eeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc
Q 015360 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305 (408)
Q Consensus 226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (408)
..+...... ...+||.+|||||++.+..|+...|.|+|||++|||+.|+.||........... +.....+
T Consensus 335 vei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~~----- 404 (591)
T KOG0986|consen 335 VEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTLE----- 404 (591)
T ss_pred EecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHhc-----
Confidence 988655443 334799999999999999999999999999999999999999975543322211 1111111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 306 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
|+ ..++....++..+|+...|+.||++|....
T Consensus 405 --~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 --DP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --ch---hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11 112223334566677788999999998654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=221.75 Aligned_cols=192 Identities=27% Similarity=0.407 Sum_probs=144.1
Q ss_pred ceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------
Q 015360 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------- 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------- 183 (408)
+.+.++.+..++++|...+.||+|+||.||++... +++.+|+|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred ceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 34667888889999999999999999999999864 4788999875
Q ss_pred -----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc
Q 015360 184 -----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN 216 (408)
Q Consensus 184 -----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~ 216 (408)
+..+|.|||+. +++|+||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 23348999998 9999999999999999999
Q ss_pred eEEeccCCceeecCCCcceecccccccCccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 015360 217 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291 (408)
Q Consensus 217 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 291 (408)
+||+|||++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 99999999887643222 2223468899999998753 457889999999999999999999986433211
Q ss_pred HHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 292 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 292 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
. ..... ........++. .....+.+++.+||+.||++|||+.||++.+
T Consensus 237 ~-~~~~~-~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 A-LFKIP-RNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred H-Hhhcc-ccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 11100 00001111111 1123578899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=240.37 Aligned_cols=191 Identities=29% Similarity=0.412 Sum_probs=140.5
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEEeCCC-----cEEEEEEe----------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDG-----TKVAVKNL---------------------------------- 183 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~-----~~vavK~~---------------------------------- 183 (408)
...++...++....++||+|.||+||+|++... ..||||..
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 334444556666679999999999999997642 22899976
Q ss_pred ------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEec
Q 015360 184 ------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 221 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~D 221 (408)
.+.||+|||++ +++||||-.+|+|++.++.+||+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence 23449999999 999999999999999999999999
Q ss_pred cCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 222 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 222 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
||+++....... ......-...|+|||.+..+.|+.++|||||||++||+++ |..||...... ....++ ...
T Consensus 306 FGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~ 378 (474)
T KOG0194|consen 306 FGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKN 378 (474)
T ss_pred cccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---Hhc
Confidence 999875431110 0111124578999999999999999999999999999999 88898754332 111111 111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
+. +...+......+..++.+||..||++||+|.++.+.|+...
T Consensus 379 ~~---------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 379 GY---------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred Cc---------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 11 11111123345677788999999999999999999998744
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=235.03 Aligned_cols=181 Identities=23% Similarity=0.327 Sum_probs=130.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... +++.||||.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999864 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~- 233 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 23348999998 999999999999999999999999999863211000
Q ss_pred -----------c----------------------------------eecccccccCcccccccccCCCCccccchhhHHH
Q 015360 234 -----------Y----------------------------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGIL 268 (408)
Q Consensus 234 -----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 268 (408)
. ......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012458999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC---CCHhHHH
Q 015360 269 IMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR---PKMGHVI 345 (408)
Q Consensus 269 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~evl 345 (408)
+|||++|+.||....... ............. ++.. ......+.+++.+||+ +|.+| +++.|++
T Consensus 238 l~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~-----~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 238 MFECLIGWPPFCSENSHE------TYRKIINWRETLY-----FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhcCCCCCCCCCHHH------HHHHHHccCCccC-----CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999996443211 1111111110000 1110 0112357788889997 67765 5998888
Q ss_pred HHH
Q 015360 346 HML 348 (408)
Q Consensus 346 ~~L 348 (408)
...
T Consensus 304 ~hp 306 (377)
T cd05629 304 SHP 306 (377)
T ss_pred cCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=223.63 Aligned_cols=178 Identities=28% Similarity=0.477 Sum_probs=136.7
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.||++.. .+++.||||.+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788889999999999999996 46899999977
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++......... ...
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 174 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCc
Confidence 33458999998 9999999999999999999999999998765433221 223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+..... ...... .+.. .....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~~~--~~~~~ 240 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPEL--QNPER 240 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CCCC--CCccc
Confidence 457889999999998889999999999999999999999996543221110 000000 0000 01112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+++.+||+.||++||++.+|++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=222.38 Aligned_cols=151 Identities=23% Similarity=0.419 Sum_probs=107.1
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+||+++.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 141 al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 141 GMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred HHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 48999998 99999999999999999999999999987653322211 122335678999999988889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 266 GILIMEIIT--GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 266 Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||++|+|++ |..||...... .................... ... .....+.+|+.+||+.||++|||+++
T Consensus 218 G~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 218 GVTLWEMFTLCKEQPYSLLSDE---QVIENTGEFFRNQGRQIYLS--QTP----LCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHHHHHcCCCCCCcccChH---HHHHHHHHhhhhccccccCC--CCC----CCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 999999998 55677543221 11111111111111000000 000 11236889999999999999999999
Q ss_pred HHHHHh
Q 015360 344 VIHMLE 349 (408)
Q Consensus 344 vl~~Le 349 (408)
|++.|+
T Consensus 289 i~~~l~ 294 (295)
T cd05097 289 IHHFLR 294 (295)
T ss_pred HHHHHh
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=223.80 Aligned_cols=190 Identities=24% Similarity=0.387 Sum_probs=137.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.|+||.+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999976 4789999965
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|.|||+. +++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 34459999998 99999999999999999999999999988765443222
Q ss_pred ecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC------------CC
Q 015360 236 TTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS------------RK 302 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------~~ 302 (408)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ ........... ..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3345678899999999887 78999999999999999999999997443211 11111111100 00
Q ss_pred cc--cccCCCCC----CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 303 SE--EVVDPKLP----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 303 ~~--~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. ...+.... ..........+.+++.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 0001112456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=219.37 Aligned_cols=185 Identities=30% Similarity=0.507 Sum_probs=137.0
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------- 183 (408)
|++.+++++.....||+|+||.||+|... ++..|++|.+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45677888888899999999999999965 4778999975
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCCcee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKL 227 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~~ 227 (408)
+..+|.|||+. +|+|+||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 33458999998 9999999999999976 67899999999876
Q ss_pred ecCCCcceecccccccCcccccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (408)
...... ......++..|+|||.+.... ++.++||||||+++|+|++|+.||....... ...+......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~------ 228 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK------ 228 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc------
Confidence 533222 122345788999999986543 7889999999999999999999986432211 1111100000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 306 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..+.++ ......+.+++.+||+.+|++|||+.|++..
T Consensus 229 -~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -IHPEIP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -cCCCCC----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011111 1223467888999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=223.12 Aligned_cols=152 Identities=22% Similarity=0.389 Sum_probs=107.7
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+|||++.++.++|+|||++..+....... .....++..|++||...++.++.++|||||
T Consensus 142 al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 142 GMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred HHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 48899998 99999999999999999999999999987653322211 122334578999999888889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 266 GILIMEIIT--GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 266 Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||++|||++ |..||....... ................. .+.. ..+...+.+++.+||+.||++||++.|
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 219 GVTLWEILTLCKEQPYSQLSDEQ---VIENTGEFFRDQGRQVY-LPKP-----ALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred HHHHHHHHHhCCCCCccccChHH---HHHHHHHHHhhcccccc-CCCC-----CCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999999998 677876433221 11111111111110000 1111 112246889999999999999999999
Q ss_pred HHHHHhc
Q 015360 344 VIHMLEA 350 (408)
Q Consensus 344 vl~~Le~ 350 (408)
|++.|+.
T Consensus 290 i~~~l~~ 296 (296)
T cd05095 290 IHATLLE 296 (296)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=226.12 Aligned_cols=182 Identities=30% Similarity=0.509 Sum_probs=135.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCc----EEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~----~vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||.||+|.+. ++. .+|+|.+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45667789999999999999864 343 4788865
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcc
Confidence 33458999998 99999999999999999999999999998654322
Q ss_pred cc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....++ ...... +
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~- 231 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLL----EKGERL----P- 231 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCCCCC----C-
Confidence 21 1122335678999999988889999999999999999998 89998643211 111111 111100 0
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... .....+.+++.+||..||++||++.++++.|+..
T Consensus 232 ~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 QPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001 1123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=222.99 Aligned_cols=188 Identities=24% Similarity=0.335 Sum_probs=132.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|+.. +++.||||.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 5889999975
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 33459999998 999999999999999999999999999876532221
Q ss_pred eecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC--C----------
Q 015360 235 VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS--R---------- 301 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~---------- 301 (408)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ............ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223467899999988654 47889999999999999999999997433211 011100000000 0
Q ss_pred ---CcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 ---KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 ---~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
........... ........++.+++.+||+.||++|||+.+|+.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000012345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=234.98 Aligned_cols=130 Identities=29% Similarity=0.423 Sum_probs=109.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +++.+|||.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 4889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~- 233 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 23348999998 999999999999999999999999999875422110
Q ss_pred ---------------------------------ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 015360 234 ---------------------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280 (408)
Q Consensus 234 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~ 280 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113468999999999999999999999999999999999999997
Q ss_pred CCC
Q 015360 281 YSR 283 (408)
Q Consensus 281 ~~~ 283 (408)
...
T Consensus 238 ~~~ 240 (360)
T cd05627 238 SET 240 (360)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=221.42 Aligned_cols=146 Identities=27% Similarity=0.473 Sum_probs=109.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +|+|+||||+||+++.++.+||+|||+++........ ......++..|++||.+....++.++|||||
T Consensus 125 ~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~sl 201 (273)
T cd05074 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201 (273)
T ss_pred HHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHH
Confidence 48999998 9999999999999999999999999998865432211 1122335578999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |++||...... ....+. ...... ... ......+.+++.+||+.+|++||++.|+
T Consensus 202 G~il~el~~~g~~p~~~~~~~---~~~~~~---~~~~~~------~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~ 265 (273)
T cd05074 202 GVTMWEIMTRGQTPYAGVENS---EIYNYL---IKGNRL------KQP----PDCLEDVYELMCQCWSPEPKCRPSFQHL 265 (273)
T ss_pred HHHHHHHhhCCCCCCCCCCHH---HHHHHH---HcCCcC------CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999 88988643221 111111 111110 011 1123478899999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
++.|+..
T Consensus 266 ~~~l~~~ 272 (273)
T cd05074 266 RDQLELI 272 (273)
T ss_pred HHHHHhh
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-28 Score=232.41 Aligned_cols=177 Identities=27% Similarity=0.391 Sum_probs=141.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.+|+|+||.++..+.+ ++..+++|.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56777889999999998877754 4778999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..++.|||++ .|+|||||+.|||++.+..+||.|||+++.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 33449999988 99999999999999999999999999999987655
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.. .....||+.||+||.+.+.+|+.|+|||||||++|||++-+++|...+.. .++ ..... ....|
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li---~ki~~-----~~~~P--- 225 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELI---LKINR-----GLYSP--- 225 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHH---HHHhh-----ccCCC---
Confidence 32 34578999999999999999999999999999999999999999755432 122 11111 11111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+.....++..++..||..+|+.||++.++|.+
T Consensus 226 --lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 --LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122334468888999999999999999999876
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=217.17 Aligned_cols=176 Identities=26% Similarity=0.439 Sum_probs=136.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+++.. +++.++||.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999965 3688999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 23348999998 999999999999999999999999999987643222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. ......... ... +..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~-~~~-----~~~-- 222 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIE-GKL-----PPM-- 222 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-cCC-----CCC--
Confidence 22334578899999999999999999999999999999999999864321 111111111 111 011
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+++.+||+.||++||++.++++.
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=218.83 Aligned_cols=176 Identities=26% Similarity=0.373 Sum_probs=135.4
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+++.. ++..+++|.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999965 5888999975
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 33458999998 999999999999999999999999999876643222 1
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||..... ........ ...... ++
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~~--- 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-QGSYKP-----LP--- 221 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-cCCCCC-----CC---
Confidence 2335688899999999988899999999999999999999999964321 11111111 111110 11
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+++.+||+.||++||++.||+..
T Consensus 222 -~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 -SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=217.36 Aligned_cols=178 Identities=30% Similarity=0.480 Sum_probs=137.2
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|...+ +..+++|.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 578888999999999999999875 789999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence 33459999998 999999999999999999999999999887643321 1223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .. ..... .+.+. ....
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~-----~~~~~--~~~~ 224 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKP-----PPTLS--DPEK 224 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCC-----CCCCC--chhh
Confidence 45788999999999889999999999999999999999999754322110 00 00000 00110 1112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+++.+||+.||++|||+.||++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=226.37 Aligned_cols=193 Identities=22% Similarity=0.319 Sum_probs=144.6
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~-------------------------------------------- 183 (408)
.++.|.+...||+|.||.|.++.... +..||||++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 37889999999999999999998654 688999977
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC----------------
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---------------- 213 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---------------- 213 (408)
+.++++|||+. +++|.||||+|||+.+
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 44559999999 9999999999999832
Q ss_pred ----CCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 015360 214 ----QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 289 (408)
Q Consensus 214 ----~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 289 (408)
+..++|+|||.|....... ...+.|..|.|||++.+..++.++||||+||||+|+.||...|+..++.+...
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 2347999999998754433 34678999999999999999999999999999999999999998877554332
Q ss_pred hHHHHHHHh--------------cCCCc-----------ccccCCCCC----CCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 290 LVDWLKTMV--------------GSRKS-----------EEVVDPKLP----KMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 290 ~~~~~~~~~--------------~~~~~-----------~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
+.+.+..-. ..+.+ ..+.++..+ ......+..++++|+.+||..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 222211100 00000 001111000 1123345667999999999999999999
Q ss_pred HhHHHHHH
Q 015360 341 MGHVIHML 348 (408)
Q Consensus 341 ~~evl~~L 348 (408)
+.|+++.-
T Consensus 400 l~EAL~Hp 407 (415)
T KOG0671|consen 400 LREALSHP 407 (415)
T ss_pred HHHHhcCH
Confidence 99998743
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-29 Score=224.12 Aligned_cols=175 Identities=28% Similarity=0.407 Sum_probs=142.6
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|.+.++||+|+||.|||+.+++ |+.+|||.+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 5566799999999999999765 999999987
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 240 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 240 (408)
...+|+|||.. .-+|||||.-||||+.+|.+||+|||++-.+++.... .....
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNTVI 190 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNTVI 190 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCccc
Confidence 12359999998 8999999999999999999999999999776543332 34578
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC-CCC--CCcH
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK-LPK--MPAS 317 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-~~~--~~~~ 317 (408)
||+.|||||++..-.|+.++||||||++..||..|++||..-.+.... ++-|. .++ ..+.
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----------------FMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----------------FMIPTKPPPTFKKPE 253 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----------------EeccCCCCCCCCChH
Confidence 999999999999999999999999999999999999999765543221 11111 111 2244
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
....++-+++..||-..|++|-|+.++++.-
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 5677899999999999999999999987753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=246.59 Aligned_cols=144 Identities=29% Similarity=0.411 Sum_probs=102.5
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec-----------------CCCcceecccccccCccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-----------------SERSYVTTRVMGTFGYVA 247 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~-----------------~~~~~~~~~~~gt~~y~a 247 (408)
.+||.|+|+. +||||||||.||+|+.++.|||+|||++.... .......+..+||..|+|
T Consensus 707 lEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 3449999999 99999999999999999999999999998621 011112355789999999
Q ss_pred ccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHH
Q 015360 248 PEYACTG---MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 324 (408)
Q Consensus 248 PE~~~~~---~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 324 (408)
||++.+. +|+.|+|+||||+||+||+. ||... +.-...+.. ++.+.+... ..+.......-.
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~-LR~g~iP~~------~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTN-LRKGSIPEP------ADFFDPEHPEEA 848 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHh-cccCCCCCC------cccccccchHHH
Confidence 9999764 49999999999999999985 45421 111111211 122222211 111222233456
Q ss_pred HHHHhccCcCCCCCCCHhHHHH
Q 015360 325 LVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 325 ~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+|.++++.||++|||+.|+|.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 7888999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=230.66 Aligned_cols=192 Identities=27% Similarity=0.422 Sum_probs=136.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
+++|...+.||+|+||.||+|... +++.||||.+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467889999999999999999854 5889999975
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 23458999998 99999999999999999999999999987654322
Q ss_pred cc--eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc---cc
Q 015360 233 SY--VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE---EV 306 (408)
Q Consensus 233 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 306 (408)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... ....+.......... .+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHh
Confidence 11 1123467889999998754 568899999999999999999999996433211 111111111100000 00
Q ss_pred cC----------CCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 307 VD----------PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 307 ~d----------~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+ +...... .......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000 01123468899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=246.47 Aligned_cols=183 Identities=24% Similarity=0.378 Sum_probs=136.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||.||+|... .++.||||++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999965 4889999976
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 12348899998 99999999999999999999999999
Q ss_pred CceeecCCCc-----------------ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 015360 224 LAKLLCSERS-----------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 286 (408)
Q Consensus 224 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~ 286 (408)
++........ .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123468999999999999999999999999999999999999996532211
Q ss_pred cchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-CHhHHHHHHhc
Q 015360 287 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEA 350 (408)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~Le~ 350 (408)
. . . .. ...++.. ..+.......+.+++.+||+.||++|| +++++++.|+.
T Consensus 239 i---~-~-~~--------~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I---S-Y-RD--------VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h---h-h-hh--------hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 0 0 00 0000100 000112234577899999999999996 56777777765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=223.09 Aligned_cols=181 Identities=34% Similarity=0.491 Sum_probs=132.7
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++... +++.+|||.+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445578999999999999965 4789999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 22348899863 289999999999999999999999999987553322
Q ss_pred cceecccccccCcccccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTG---MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
. .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.... .....+....... .+
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------~~ 229 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------PP 229 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------CC
Confidence 1 1233578899999998766 68899999999999999999999996432 1111121111110 11
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+...........+.+|+.+||+.||++|||+++|+..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112234468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=218.45 Aligned_cols=179 Identities=25% Similarity=0.380 Sum_probs=132.9
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||+|.... +..+++|.+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 457778899999999999999754 788999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 33458999998 99999999999999999999999999987543221 112
Q ss_pred cccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 237 TRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
....++..|+|||++. ...++.++|||||||++|||++|..||...... ........... +..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~------~~~ 235 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP------PTL 235 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCCC------ccC
Confidence 2345788999999884 345678999999999999999999998643321 11111111110 111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ........+.+++.+||+.||++||++.++++.
T Consensus 236 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 S--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 011223357889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=220.47 Aligned_cols=178 Identities=33% Similarity=0.517 Sum_probs=132.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||.||+++.. +|..||||++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 4899999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 33448999974 289999999999999999999999999987653221
Q ss_pred cceecccccccCccccccccc----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 233 SYVTTRVMGTFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... . +........ ..
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~~------~~ 225 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVEE------PS 225 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHhc------CC
Confidence 1 122457889999998864 44688999999999999999999998632211 1 111111110 01
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+.++ .......+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1112346888999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=216.12 Aligned_cols=178 Identities=29% Similarity=0.486 Sum_probs=134.2
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
+|...+.||+|+||+||+|...+++.+|||.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36677899999999999999888999999965
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC-
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER- 232 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~- 232 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 23348999998 99999999999999999999999999987542211
Q ss_pred ----cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 233 ----SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 233 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+... ... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~-~~~~~~~----~~ 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMF-YIGAHRG----LM 227 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHH-HhhhccC----CC
Confidence 111223457889999999998889999999999999999999999996432211 111 1110000 01
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+.++. .....+.+++.+||+.+|++||++.|+++
T Consensus 228 ~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 12335788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=217.54 Aligned_cols=177 Identities=30% Similarity=0.456 Sum_probs=136.2
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|+||.||+|... +++.+++|.+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777789999999999999975 4889999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (274)
T cd06609 82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNT 157 (274)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cccc
Confidence 33458999998 999999999999999999999999999987654322 2233
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||....+.. ..... .... .+.+... .
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~-~~~~-----~~~~~~~---~ 222 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLI-PKNN-----PPSLEGN---K 222 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHh-hhcC-----CCCCccc---c
Confidence 457889999999998889999999999999999999999996443211 11111 1111 1111111 0
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+++.+||..||++|||++++++.
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 22357889999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=219.81 Aligned_cols=180 Identities=31% Similarity=0.514 Sum_probs=133.7
Q ss_pred CCCccceeccCCcEEEEEEEeCC-C---cEEEEEEe--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-G---TKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~---~~vavK~~-------------------------------------------- 183 (408)
.|...+.||+|+||.||+|.+.. + ..||||.+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46677899999999999999754 2 36999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 23458999998 999999999999999999999999999876543222
Q ss_pred ce--eccc--ccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 234 YV--TTRV--MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 234 ~~--~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.. .... ..+..|+|||.+.+..++.++|||||||++|||++ |..||...... ....++. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~---~~~~~----- 230 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE---QDYRL----- 230 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH---cCCcC-----
Confidence 11 1111 12357999999998899999999999999999987 99998643321 1222221 11000
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+. ..+....+.+++.+||+.+|++||++.+|+..|+.
T Consensus 231 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 PP-----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 11223357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=218.84 Aligned_cols=188 Identities=25% Similarity=0.409 Sum_probs=136.8
Q ss_pred cCCCccceeccCCcEEEEEEEe-----CCCcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-----~~~~~vavK~~------------------------------------------ 183 (408)
..|...+.||+|+||.||++.+ .++..||+|.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467778999999999999985 24788999976
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
++.+|+|||+. +++|+||||+||+++.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 33448999998 99999999999999999999999999998664
Q ss_pred CCCcc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC---------CCcchhHHHHHHHh
Q 015360 230 SERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP---------QGEVNLVDWLKTMV 298 (408)
Q Consensus 230 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~---------~~~~~~~~~~~~~~ 298 (408)
..... ......++..|+|||.+.+..++.++|||||||++|||++++.|...... ............ .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-L 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-H
Confidence 33221 11234466789999999888899999999999999999998766432110 001111111111 1
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....... ........+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111000 0111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=224.90 Aligned_cols=143 Identities=22% Similarity=0.351 Sum_probs=105.2
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhH
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 266 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 266 (408)
+|+|||+. +++||||||+|||++.++.+||+|||++....... .......+..|+|||.+.+..++.++||||||
T Consensus 136 al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 210 (303)
T cd05088 136 GMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 210 (303)
T ss_pred HHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhh
Confidence 37999998 99999999999999999999999999986421111 11112235679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 267 ILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 267 vvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
|++|||+| |..||...... +...... ... ....+. .....+.+|+.+||+.+|++||++.+++
T Consensus 211 ~il~ellt~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il 274 (303)
T cd05088 211 VLLWEIVSLGGTPYCGMTCA------ELYEKLP-QGY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQIL 274 (303)
T ss_pred hHHHHHHhcCCCCcccCChH------HHHHHHh-cCC-----cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999998 99999643321 1111111 110 000111 1223578899999999999999999999
Q ss_pred HHHhc
Q 015360 346 HMLEA 350 (408)
Q Consensus 346 ~~Le~ 350 (408)
+.|+.
T Consensus 275 ~~l~~ 279 (303)
T cd05088 275 VSLNR 279 (303)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=226.51 Aligned_cols=147 Identities=26% Similarity=0.440 Sum_probs=108.3
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +++|+||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 146 aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 146 GMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred HHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 48999998 99999999999999999999999999997654322211 111224467999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||...... .... ........ ..+ ......+.+++.+||+.||++|||+.|+
T Consensus 223 G~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~-----~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 223 GILMWEIFTLGGSPYPGIPVE---ELFK----LLREGHRM-----DKP----SNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-----CCC----CCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999999999 88888643221 1111 11111110 111 1122367789999999999999999999
Q ss_pred HHHHhcCC
Q 015360 345 IHMLEADD 352 (408)
Q Consensus 345 l~~Le~~~ 352 (408)
++.|+...
T Consensus 287 l~~l~~~~ 294 (314)
T cd05099 287 VEALDKVL 294 (314)
T ss_pred HHHHHHHH
Confidence 99998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=220.61 Aligned_cols=189 Identities=24% Similarity=0.377 Sum_probs=135.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.+|+|++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36778899999999999999976 4889999965
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 33459999998 999999999999999999999999999987644322 1
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC-----------CC-
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS-----------RK- 302 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----------~~- 302 (408)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ... +...... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYL-IRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCChHHhhhcccccc
Confidence 223457789999999875 5578899999999999999999999975443211 111 1111000 00
Q ss_pred cccccCCCCCCCCc-----HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 303 SEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 303 ~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......+....... ......+.+++.+||+.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000111100000 112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=224.99 Aligned_cols=146 Identities=25% Similarity=0.415 Sum_probs=107.7
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+||+++.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 152 aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 152 GMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred HHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 48899988 99999999999999999999999999987653322111 111224568999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||..... .+.... ....... .. .......+.+++.+||+.+|++|||+.+|
T Consensus 229 G~~l~el~~~g~~p~~~~~~------~~~~~~-~~~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 229 GVLLWEIFTLGGSPYPGVPV------EELFKL-LKEGHRM-----DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred HHHHHHHHcCCCCCCCcCCH------HHHHHH-HHcCCCC-----CC----CCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999998 8888854321 111111 1111110 11 11223467889999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
++.|+..
T Consensus 293 l~~l~~~ 299 (307)
T cd05098 293 VEDLDRI 299 (307)
T ss_pred HHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=232.83 Aligned_cols=188 Identities=24% Similarity=0.417 Sum_probs=150.5
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------- 183 (408)
++++....+.....+||-|-||.||.|.|+. .-.||||.+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 4555555666777899999999999999975 567999977
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
|..+++||..+ ++|||||..+|+|+.++..+|++|||+++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 34458999988 99999999999999999999999999999997
Q ss_pred CCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
...............|.|||.+....++.|+|||+|||+|||+.| |..||...+..... .++.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-------~LLE--------- 480 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------GLLE--------- 480 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-------HHHh---------
Confidence 766554444556788999999999999999999999999999998 88898754432211 1221
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..++...+..+...+.+|+..||+.+|.+||++.|+.+.+|.
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 122222233444578999999999999999999999998876
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=220.57 Aligned_cols=175 Identities=29% Similarity=0.480 Sum_probs=133.6
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|... ++..||||.+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445578999999999999865 4788999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06642 86 GGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcc
Confidence 33458999998 999999999999999999999999999876543221 12234
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.++..|+|||.+.+..++.++|||||||++|||++|+.||....+... .. ..... ..+.+ ....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~-----~~~~~----~~~~ 225 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-LIPKN-----SPPTL----EGQY 225 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-hhhcC-----CCCCC----Cccc
Confidence 578899999999988899999999999999999999999864332110 10 01000 01111 1123
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...+.+++.+||+.+|++||++.+|++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3467889999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=218.31 Aligned_cols=139 Identities=24% Similarity=0.393 Sum_probs=101.8
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCc-------eEEeccCCceeecCCCcceecccccccCcccccccc-cCC
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN-------ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-TGM 255 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~-------~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~ 255 (408)
++.+|+|||+. +|+|+||||+|||++.++. ++++|||++...... ....++..|+|||.+. +..
T Consensus 114 i~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 185 (262)
T cd05077 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKN 185 (262)
T ss_pred HHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCC
Confidence 44559999998 9999999999999976654 899999998654322 2245778899999886 466
Q ss_pred CCccccchhhHHHHHHHH-hCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcC
Q 015360 256 LNEKSDVYSFGILIMEII-TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPD 334 (408)
Q Consensus 256 ~~~~sDvwSlGvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~d 334 (408)
++.++|||||||++|||+ +|..||........ ....... . . ... .....+.+|+.+||+.|
T Consensus 186 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~~~~-~-~-----~~~----~~~~~~~~li~~cl~~d 247 (262)
T cd05077 186 LSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFYEGQ-C-M-----LVT----PSCKELADLMTHCMNYD 247 (262)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHHhcC-c-c-----CCC----CChHHHHHHHHHHcCCC
Confidence 889999999999999998 58888764322110 1111100 0 0 000 11235788999999999
Q ss_pred CCCCCCHhHHHHHH
Q 015360 335 ATKRPKMGHVIHML 348 (408)
Q Consensus 335 P~~Rps~~evl~~L 348 (408)
|++||++.+|++.|
T Consensus 248 p~~Rp~~~~il~~~ 261 (262)
T cd05077 248 PNQRPFFRAIMRDI 261 (262)
T ss_pred hhhCcCHHHHHHhc
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=219.76 Aligned_cols=178 Identities=28% Similarity=0.457 Sum_probs=135.9
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||.|+||.||+|.. .+++.|+||.+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999985 46889999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++......... ...
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 174 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCC
Confidence 33458999998 9999999999999999999999999998765433221 223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||....+.. ......... ..... ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~-~~~~~-------~~~~ 240 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG-TPELQ-------NPEK 240 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-CcccC-------Cccc
Confidence 457889999999998889999999999999999999999996543211 111111110 00000 1111
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+++.+||..||++||++.++++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2235778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=217.21 Aligned_cols=177 Identities=26% Similarity=0.419 Sum_probs=131.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.||++... .+..+++|.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888899999999999999864 4889999965
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 23348999988 999999999999999999999999999876532
Q ss_pred CCc--ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 231 ERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 231 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~-----~~ 227 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP-----TN 227 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-----CC
Confidence 111 1112245788999999999888999999999999999999999999643211 1111111111 11
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+.++. .....+.+++ +||..+|++||+++||+.
T Consensus 228 ~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQLPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 22211 1122345555 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=215.55 Aligned_cols=150 Identities=23% Similarity=0.370 Sum_probs=104.5
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccC-------CC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTG-------ML 256 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-------~~ 256 (408)
+.+|+|||+. +++|+||||+||+++.++.+||+|||++.......... .....++..|+|||++... .+
T Consensus 110 ~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 186 (269)
T cd05087 110 ALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ 186 (269)
T ss_pred HHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCC
Confidence 3448999998 99999999999999999999999999987543322211 1223467889999988542 35
Q ss_pred CccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCC
Q 015360 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335 (408)
Q Consensus 257 ~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP 335 (408)
+.++||||||+++|||++ |+.||....... .... .. ........++.+... ....+.+++.+|| .+|
T Consensus 187 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~-~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P 254 (269)
T cd05087 187 TKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TV-REQQLKLPKPRLKLP----LSDRWYEVMQFCW-LQP 254 (269)
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hh-hcccCCCCCCccCCC----CChHHHHHHHHHh-cCc
Confidence 789999999999999997 999996543221 1111 11 111112222222211 1224677888998 689
Q ss_pred CCCCCHhHHHHHHh
Q 015360 336 TKRPKMGHVIHMLE 349 (408)
Q Consensus 336 ~~Rps~~evl~~Le 349 (408)
++|||++||+..|+
T Consensus 255 ~~Rpt~~~l~~~l~ 268 (269)
T cd05087 255 EQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=219.12 Aligned_cols=189 Identities=21% Similarity=0.326 Sum_probs=132.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+++.. +|..+++|.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999975 5889999975
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+.++|.|||+. +++|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~ 156 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-Y 156 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-c
Confidence 34459999998 9999999999999999999999999998765332211 1
Q ss_pred cccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC------cccccC-
Q 015360 237 TRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------SEEVVD- 308 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~d- 308 (408)
....++..|+|||.+.+. .++.++|||||||++|+|++|..|+....... .....+........ .....+
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 224568899999988764 47899999999999999999998864322111 11111111110000 000000
Q ss_pred ---CCCCCC-----CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 ---PKLPKM-----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ---~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+..... ........+.+++.+||+.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 00112346778999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=225.24 Aligned_cols=193 Identities=24% Similarity=0.299 Sum_probs=138.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||.||++... +++.+|||.+
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467888999999999999999964 5889999975
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|+|||.. +++|+||||+||+++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 22348999998 9999999999999999999999999999865432
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc------------hhHHH----HH
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV------------NLVDW----LK 295 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~------------~~~~~----~~ 295 (408)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+... ..
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 21 22345788999999999999999999999999999999999999754321100 00000 00
Q ss_pred HHhcCCC------cccccC----CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 296 TMVGSRK------SEEVVD----PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 296 ~~~~~~~------~~~~~d----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....... ...... +.............+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000 000001111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=227.50 Aligned_cols=146 Identities=25% Similarity=0.463 Sum_probs=107.3
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +|+|+||||+|||++.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 191 al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 267 (343)
T cd05103 191 GMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 267 (343)
T ss_pred HHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHH
Confidence 37899988 99999999999999999999999999987653322211 122335678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
|+++|+|++ |..||....... ... ......... ..+.. ....+.+++.+||+.||++|||+.||
T Consensus 268 G~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~-----~~~~~----~~~~~~~~~~~cl~~~p~~Rps~~ei 332 (343)
T cd05103 268 GVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRM-----RAPDY----TTPEMYQTMLDCWHGEPSQRPTFSEL 332 (343)
T ss_pred HHHHHHHHHCCCCCCCCccccH--HHH----HHHhccCCC-----CCCCC----CCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999997 999986432211 111 111111110 11111 12357889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 333 l~~l~~ 338 (343)
T cd05103 333 VEHLGN 338 (343)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=217.92 Aligned_cols=176 Identities=28% Similarity=0.451 Sum_probs=136.4
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||.||+|... ++..+|||.+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4556678999999999999975 4889999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cccc
Confidence 33458999998 999999999999999999999999999976643322 1223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..++..|+|||.+.+..++.++|+|||||++|||++|+.||....+... ... . ...........
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~---------~~~~~~~~~~~ 224 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFL-I---------PKNNPPTLTGE 224 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhh-h---------hcCCCCCCchh
Confidence 4578899999999888899999999999999999999999864432211 000 0 00111112233
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 45578899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=218.30 Aligned_cols=181 Identities=29% Similarity=0.472 Sum_probs=135.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
.+|...+.||+|+||.||+|... .+..+|+|.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999864 2347899875
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +++|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 23458999998 99999999999999999999999999998764432
Q ss_pred cceec--ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 233 SYVTT--RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 233 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
..... ...++..|++||.+.+..++.++|+|||||++||+++ |..||...... .....+ ...... +
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~---~~~~~~-----~ 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAI---EEGYRL-----P 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHH---hCCCcC-----C
Confidence 22111 1223567999999998889999999999999999887 99998644322 111111 111000 1
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. .......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 230 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 230 A-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred C-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 1 11123367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=220.96 Aligned_cols=145 Identities=22% Similarity=0.375 Sum_probs=107.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+||+++.++.++|+|||++.......... ......+..|+|||.+.+..++.++|||||
T Consensus 142 aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 37899998 99999999999999999999999999987653322111 112234567999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||..... .+...... ..... ..+ ......+.+++.+||+.||++|||+.|+
T Consensus 219 G~il~el~~~~~~p~~~~~~------~~~~~~~~-~~~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAH------EEVIYYVR-DGNVL-----SCP----DNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCH------HHHHHHHh-cCCCC-----CCC----CCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 999999998 8888853321 12222111 11111 011 1123468889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 283 ~~~l~~ 288 (288)
T cd05050 283 NRILQR 288 (288)
T ss_pred HHHhhC
Confidence 999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=215.40 Aligned_cols=181 Identities=30% Similarity=0.451 Sum_probs=136.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||.|+||+||+|... ++..++||.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999964 5788999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 23448999998 999999999999999999999999999876544322
Q ss_pred c---eecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 234 Y---VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 234 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
. ......++..|++||.+... .++.++|+|||||++|+|++|+.||....... .+.. ..... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcCC------CC
Confidence 2 12334578899999998776 78899999999999999999999996443221 1111 11110 11
Q ss_pred CCCCCC-cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 310 KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 310 ~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+.... .......+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1123456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=217.22 Aligned_cols=177 Identities=24% Similarity=0.380 Sum_probs=130.1
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|.... +..+++|.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4455789999999999999764 677888875
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 34459999998 999999999999999999999999999876532221 1223
Q ss_pred cccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 239 VMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 239 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
..++..|+|||++. +..++.++|||||||++|||++|++||...... ............ ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~-~~~~----- 230 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPP-TLAQ----- 230 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCCC-CCCC-----
Confidence 45889999999874 345778999999999999999999998643321 111111111110 0000
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+......+.+++.+||+.||++||++.++++.
T Consensus 231 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 --PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122367889999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=229.45 Aligned_cols=188 Identities=26% Similarity=0.408 Sum_probs=134.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|+.. +++.+|||.+
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999964 5899999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 22348999998 9999999999999999999999999998754321
Q ss_pred CcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc-----------
Q 015360 232 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG----------- 299 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 299 (408)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhc
Confidence 123457888999999876 468899999999999999999999997543211 1110100000
Q ss_pred CCCcccccC--CCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 300 SRKSEEVVD--PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 300 ~~~~~~~~d--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......... +..+... .......+.+++.+||+.||++||++.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000000 00122357899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=225.25 Aligned_cols=180 Identities=24% Similarity=0.338 Sum_probs=142.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
...|.+.+.||.|.||.||+++.+. |+.+|+|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3457777899999999999999776 999999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC----CCceEEeccCCceeec
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~----~~~~kL~Dfg~a~~~~ 229 (408)
+..++.|||+. +++||||||+|+|+.. ++.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 33458999998 9999999999999953 3479999999999876
Q ss_pred CCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .. .....
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i-~~~~~------ 255 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AI-LRGDF------ 255 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HH-HcCCC------
Confidence 5 334556889999999999999999999999999999999999999997654332211 11 11111
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+...+.......+.+++..|+..||.+|+|+.++++.
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22223333344567888999999999999999999984
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-28 Score=250.87 Aligned_cols=184 Identities=30% Similarity=0.473 Sum_probs=140.3
Q ss_pred HHHHhcCCCccceeccCCcEEEEEEE-eCCCcEEEEEEe-----------------------------------------
Q 015360 146 LEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 146 l~~~t~~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~----------------------------------------- 183 (408)
|...+-++....+||.|.||.||-|. +++|...|+|-+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34456677788999999999999998 456888999865
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..++.|||+. +||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 45569999999 999999999999999999999999999988755
Q ss_pred CCcce---ecccccccCcccccccccCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH-HHhcCCCc
Q 015360 231 ERSYV---TTRVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-TMVGSRKS 303 (408)
Q Consensus 231 ~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~ 303 (408)
..... -....||+.|||||++.+.+ ...++||||+|||++||+||+.||...+.. |.. ..+..+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC
Confidence 43211 13467999999999997644 456899999999999999999999744321 111 11111111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
|.++ .....+-.+++.+||+.||.+|+++.|+++.=
T Consensus 1460 -----Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 -----PQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -----CCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2222 22444667888899999999999999887643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=230.35 Aligned_cols=146 Identities=25% Similarity=0.447 Sum_probs=108.8
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+|+||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 249 aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 249 GMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred HHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 47899988 9999999999999999999999999999865433221 1222346678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||....... .+. ........ +.. .......+.+++.+||+.||++||++.+|
T Consensus 326 Gvil~ellt~g~~P~~~~~~~~--~~~----~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 326 GILLWEIFSLGGTPYPGMIVDS--TFY----NKIKSGYR-----MAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred HHHHHHHHHCCCCCCcccchhH--HHH----HHHhcCCC-----CCC----CccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 999999997 999986432211 111 11111100 001 11223468889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
.++|+.
T Consensus 391 ~~~l~~ 396 (400)
T cd05105 391 SDIVES 396 (400)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=218.05 Aligned_cols=188 Identities=26% Similarity=0.386 Sum_probs=137.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-----CCcEEEEEEe-------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-----~~~~vavK~~------------------------------------------- 183 (408)
.|...+.||+|+||.||++++. .+..+|||.+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566689999999999999964 2678999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 33459999998 999999999999999999999999999987653
Q ss_pred CCcce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc--------hhHHHHHHHhcC
Q 015360 231 ERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--------NLVDWLKTMVGS 300 (408)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~--------~~~~~~~~~~~~ 300 (408)
..... .....++..|++||.+.+..++.++||||||+++|||++|+.|+......... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 22211 11223456799999998888999999999999999999999998543221100 001111111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.. ...........+.+++.+||+.+|++|||+.||+++|+..
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 0001111224688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=214.73 Aligned_cols=177 Identities=30% Similarity=0.518 Sum_probs=134.1
Q ss_pred CCccceeccCCcEEEEEEEeCC-----CcEEEEEEe--------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-----GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-----~~~vavK~~-------------------------------------------- 183 (408)
|.+.+.||.|+||.||+++..+ +..+|+|.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456899999999999999864 378999977
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 23348999998 99999999999999999999999999998765443
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......... .... ..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~~-----~~ 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKK-GYRL-----PK 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhc-CCCC-----CC
Confidence 322222336789999999988889999999999999999998 7888864221 111111111 1110 01
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
+. .....+.+++.+||+.||++|||+.|+++.|
T Consensus 226 ~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 1234688899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=214.72 Aligned_cols=145 Identities=27% Similarity=0.430 Sum_probs=109.7
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|.|||+. +++|+||||+||+++.++.+||+|||.+........ .......++..|+|||.+....++.++||||
T Consensus 116 ~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (262)
T cd00192 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWS 192 (262)
T ss_pred HHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHH
Confidence 448999998 999999999999999999999999999987654331 1122345678999999998888999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|+|++ |..||...... ... ..... ... ... .......+.+++.+||+.||.+|||+.|
T Consensus 193 lG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~-~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (262)
T cd00192 193 FGVLLWEIFTLGATPYPGLSNE---EVL---EYLRK-GYR-----LPK----PEYCPDELYELMLSCWQLDPEDRPTFSE 256 (262)
T ss_pred HHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHc-CCC-----CCC----CccCChHHHHHHHHHccCCcccCcCHHH
Confidence 9999999999 69999754221 111 11111 100 011 1112346889999999999999999999
Q ss_pred HHHHHh
Q 015360 344 VIHMLE 349 (408)
Q Consensus 344 vl~~Le 349 (408)
+++.|+
T Consensus 257 l~~~l~ 262 (262)
T cd00192 257 LVERLE 262 (262)
T ss_pred HHHhhC
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=220.18 Aligned_cols=190 Identities=24% Similarity=0.410 Sum_probs=134.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... ++..+++|.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888899999999999999965 4778888875
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+.+ +++|+||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~ 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---c
Confidence 334589999731 89999999999999999999999999987553221 2
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc------------
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------------ 304 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------------ 304 (408)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+... ...+...........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCC
Confidence 23467899999999988889999999999999999999999986433211 111110000000000
Q ss_pred ------------cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 305 ------------EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 305 ------------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.......+..+.......+.+++.+||+.||++|||+.||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000111233578999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=219.62 Aligned_cols=185 Identities=30% Similarity=0.447 Sum_probs=137.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... +++.+|+|.+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666789999999999999965 4888999865
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+.+ +++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 233489999632 89999999999999999999999999986542211 1
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC-----cchhHHHHHHHhcCCCcccccCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG-----EVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ......+........ .+.+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 233 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRL 233 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCC
Confidence 23468899999999988889999999999999999999999997544321 111222222222111 0111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
........+.+|+.+||+.||++|||+.|++++..
T Consensus 234 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 ---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11123346888999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=219.57 Aligned_cols=189 Identities=25% Similarity=0.413 Sum_probs=134.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.+|+|.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778899999999999999986 4889999975
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence 33448999998 999999999999999999999999999876543332 2
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc-----------CCC-
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG-----------SRK- 302 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~~- 302 (408)
.....++..|+|||.+.+ ..++.++||||||+++|||++|++||....... ....+..... ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchH
Confidence 233457889999998865 447789999999999999999999986433211 0000000000 000
Q ss_pred cccccCCCCCCCC-----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 303 SEEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 303 ~~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......+...... .......+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000001100000 0112346889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=218.20 Aligned_cols=181 Identities=27% Similarity=0.385 Sum_probs=132.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... ++..+|+|.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45667789999999999999864 4889999975
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++........ ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-ccc
Confidence 33458999998 999999999999999999999999999876543221 123
Q ss_pred ccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 238 RVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
...|+..|+|||.+. ...++.++|||||||++|+|++|..||....+... ........ ...+.....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~----~~~~~~~~~ 234 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSN----FQPPKLKDK 234 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccC----CCCCccccc
Confidence 356889999999874 45588899999999999999999999864332111 11111110 000111100
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+++.+||+.||++||++++|++.
T Consensus 235 --~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 --MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0112357789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=218.47 Aligned_cols=192 Identities=22% Similarity=0.313 Sum_probs=134.5
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
++++|...+.||+|+||.||+|... ++..++||.+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578888999999999999999864 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||.. +++|+||||+||+++.++.++|+|||+++........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 33448999998 9999999999999999999999999998754322211
Q ss_pred eecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC-------------
Q 015360 235 VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS------------- 300 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------- 300 (408)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||....... ............
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1223468899999998753 57889999999999999999999997443211 111111110000
Q ss_pred CCcccccCCCCCCCC-----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 301 RKSEEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
...........+... .......+.+++.+|++.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0001235778899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=216.60 Aligned_cols=177 Identities=27% Similarity=0.487 Sum_probs=131.1
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++... ++..+|+|.+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677789999999999999976 5899999965
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 22348899963 289999999999999999999999999987653221
Q ss_pred eecccccccCcccccccccCC------CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 235 VTTRVMGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||....... ....+..... .. .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-~~-----~ 227 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVD-GD-----P 227 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhh-cC-----C
Confidence 12245778999999986543 4789999999999999999999996432211 1111111111 00 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+.+ .......+.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 1123446788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=217.10 Aligned_cols=180 Identities=32% Similarity=0.504 Sum_probs=133.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|...+ ++.+|||.+
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999999875 899999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+. .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 95 ~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 95 LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred ccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 23448999963 18999999999999999999999999998765332221
Q ss_pred ecccccccCcccccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+.......... +..
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~------~~~ 239 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP------PSL 239 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC------CCC
Confidence 2234678999999987554 788999999999999999999999642211 111111111110 011
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
... ......+.+++.+||+.||++||++.++++.
T Consensus 240 ~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100 0123468889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=233.15 Aligned_cols=173 Identities=27% Similarity=0.463 Sum_probs=137.1
Q ss_pred cceeccCCcEEEEEEEeCC--C--cEEEEEEe------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILSD--G--TKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~~--~--~~vavK~~------------------------------------------------ 183 (408)
.++||+|+||.|++|.|+. | -.||||++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 3789999999999999864 3 36899987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-e
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-T 236 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~ 236 (408)
++.++.||..+ ++|||||..+|+||.....+||+|||+.+-+....... .
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 55669999999 99999999999999988899999999999876554332 1
Q ss_pred -cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 237 -TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 237 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....-.+.|+|||.+...+++.++|||+|||++|||+| |..||........ ++ .+|..-...
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI------L~----------~iD~~erLp 335 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI------LK----------NIDAGERLP 335 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH------HH----------hccccccCC
Confidence 12234578999999999999999999999999999999 8889975543211 11 112222223
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+..+.+++.+++..||..+|++|||+..|.+.
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 344566789999999999999999999999743
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=214.35 Aligned_cols=181 Identities=29% Similarity=0.415 Sum_probs=136.2
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... ++..+++|.+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888899999999999999975 4778999975
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||+|+||+++.++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 34459999998 999999999999999999999999999876543211 1
Q ss_pred ecccccccCcccccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTG---MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||....+... ...... . ....+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~-~---~~~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISK-S---NFPPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-c---cCCCccc-
Confidence 2234578899999998776 788999999999999999999999964332211 001100 0 0000111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.........+.+++.+||+.||.+|||+.+|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=219.74 Aligned_cols=174 Identities=26% Similarity=0.411 Sum_probs=133.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||+|... +++.|++|.+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999975 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-- 169 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-- 169 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC--
Confidence 23448999998 99999999999999999999999999987653322
Q ss_pred eecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 235 VTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
...++..|+|||.+. ...++.++||||||+++|||++|+.||...... .......... .+.
T Consensus 170 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~------~~~- 233 (307)
T cd06607 170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND------SPT- 233 (307)
T ss_pred ---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCC------CCC-
Confidence 245778999999874 456888999999999999999999998643211 1111111100 011
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.........+.+++.+||+.||++||++.+|+..
T Consensus 234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1112234468899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=222.05 Aligned_cols=191 Identities=27% Similarity=0.360 Sum_probs=136.2
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||+|.+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888899999999999999975 4899999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 23448999998 99999999999999999999999999998764332
Q ss_pred cceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc--------
Q 015360 233 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS-------- 303 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 303 (408)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|++||....... ....+.........
T Consensus 163 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 163 KP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhhc
Confidence 11 122345778999998865 457899999999999999999999997543221 11111111110000
Q ss_pred ----ccccCCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 ----EEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ----~~~~d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..+..+....... ......+.+++.+||+.||++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000 0123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=217.90 Aligned_cols=144 Identities=22% Similarity=0.352 Sum_probs=105.6
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhH
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 266 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 266 (408)
+|+|||+. +++|+||||+||+++.++.+||+|||++...... ........+..|+|||++....++.++||||||
T Consensus 124 al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 198 (270)
T cd05047 124 GMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198 (270)
T ss_pred HHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHH
Confidence 48999998 9999999999999999999999999998532211 111112235679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 267 ILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 267 vvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
|++|||++ |..||...... +........... ..+ ......+.+++.+||+.||.+|||+.+++
T Consensus 199 ~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (270)
T cd05047 199 VLLWEIVSLGGTPYCGMTCA------ELYEKLPQGYRL------EKP----LNCDDEVYDLMRQCWREKPYERPSFAQIL 262 (270)
T ss_pred HHHHHHHcCCCCCccccCHH------HHHHHHhCCCCC------CCC----CcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 99999997 99999643211 111111111000 011 11223678999999999999999999999
Q ss_pred HHHhcC
Q 015360 346 HMLEAD 351 (408)
Q Consensus 346 ~~Le~~ 351 (408)
+.|+.+
T Consensus 263 ~~l~~~ 268 (270)
T cd05047 263 VSLNRM 268 (270)
T ss_pred HHHHHh
Confidence 999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=222.56 Aligned_cols=178 Identities=25% Similarity=0.331 Sum_probs=133.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++...+ +..+|||.+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999999764 899999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||.. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 23448999998 99999999999999999999999999987543211
Q ss_pred cc----------------------------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 015360 233 SY----------------------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 284 (408)
Q Consensus 233 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~ 284 (408)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01124578899999999988899999999999999999999999964432
Q ss_pred CCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC----HhHHHH
Q 015360 285 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK----MGHVIH 346 (408)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~evl~ 346 (408)
.. ......... ..... .......+.+++.+||+.||++||| ++|++.
T Consensus 238 ~~------~~~~~~~~~-------~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE------TFSNILKKE-------VTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH------HHHHHhcCC-------ccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 111111110 00111 1113346889999999999999999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=214.07 Aligned_cols=175 Identities=27% Similarity=0.506 Sum_probs=132.6
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|... +++.+|+|.+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 667789999999999999864 4788999854
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 23348999998 999999999999999999999999999887643
Q ss_pred CCcc-----eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc
Q 015360 231 ERSY-----VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305 (408)
Q Consensus 231 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (408)
.... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... . .+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~-~~~~~~~------ 226 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----Q-AIFKIGE------ 226 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----H-HHHHHhc------
Confidence 2111 111235788999999998888999999999999999999999999743211 1 1111110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 306 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
...+..+. .....+.+++.+||+.||++||++.||++
T Consensus 227 ~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111211 22346788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=215.89 Aligned_cols=147 Identities=25% Similarity=0.439 Sum_probs=109.5
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc--eecccccccCcccccccccCCCCccccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
..+|+|||+. +++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||
T Consensus 107 ~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di 183 (257)
T cd05040 107 ANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDV 183 (257)
T ss_pred HHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhh
Confidence 3458999998 9999999999999999999999999999876442221 1122446788999999998899999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++|||++ |+.||...... +.......... .. .. .......+.+++.+||+.+|++||++
T Consensus 184 ~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~--~~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~ 248 (257)
T cd05040 184 WMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGE--RL---ER----PEACPQDIYNVMLQCWAHNPADRPTF 248 (257)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCC--cC---CC----CccCCHHHHHHHHHHCCCCcccCCCH
Confidence 999999999999 99998643221 11111111110 00 00 11123468889999999999999999
Q ss_pred hHHHHHHh
Q 015360 342 GHVIHMLE 349 (408)
Q Consensus 342 ~evl~~Le 349 (408)
.+|++.|.
T Consensus 249 ~~~~~~l~ 256 (257)
T cd05040 249 AALREFLP 256 (257)
T ss_pred HHHHHHhc
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=215.18 Aligned_cols=180 Identities=30% Similarity=0.479 Sum_probs=136.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++... +++.+++|.+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999986 4889999976
Q ss_pred ---------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ---------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+ . +++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 2345899998 7 9999999999999999999999999998755322211
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.+........ +.+ +
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------~~~---~ 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP------PRL---P 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC------CCC---C
Confidence 1557889999999998899999999999999999999999996543211 122222222221110 111 1
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+++.+||..||++|||+.|++..
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11133468889999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=216.39 Aligned_cols=190 Identities=24% Similarity=0.374 Sum_probs=132.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999975 5789999975
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||+++........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 160 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-Y 160 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-c
Confidence 34459999998 9999999999999999999999999998654221111 1
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc------------
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS------------ 303 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------ 303 (408)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .....+.........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 22346788999998865 457889999999999999999999996443110 111111111000000
Q ss_pred ccccCCCCCCCC------cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EEVVDPKLPKMP------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~~~d~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+...... .......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000 0001145678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=212.09 Aligned_cols=179 Identities=28% Similarity=0.413 Sum_probs=136.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|+||.||++... +++.+++|.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677789999999999999864 5788999976
Q ss_pred ---------------------------------hhhhHHHhhhCC--CCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 ---------------------------------LNNRLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~--~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||..+ ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 334489999221 239999999999999999999999999999876
Q ss_pred cCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+.. .......
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~----- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKF----- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCC-----
Confidence 543321 2234688999999999988899999999999999999999999975431 11111 1111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+.+ .......+.+++.+||+.+|++||++.+|+++
T Consensus 228 ~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 11223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=213.96 Aligned_cols=150 Identities=25% Similarity=0.370 Sum_probs=103.0
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCccccccccc-------CCC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACT-------GML 256 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-------~~~ 256 (408)
+.+|+|||+. +|+||||||+|||++.++.+||+|||++.......... .....++..|+|||++.. ..+
T Consensus 110 ~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 186 (269)
T cd05042 110 ASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186 (269)
T ss_pred HHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccccccccc
Confidence 3448999998 99999999999999999999999999986543322111 122335678999998743 356
Q ss_pred CccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCC
Q 015360 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335 (408)
Q Consensus 257 ~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP 335 (408)
+.++|||||||++|||++ |..||....+.. ......... ...+..+.+.. .....+.+++..|| .||
T Consensus 187 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~-~dp 254 (269)
T cd05042 187 TKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKLPKPQLDL----KYSDRWYEVMQFCW-LDP 254 (269)
T ss_pred chhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccCCCCcccc----cCCHHHHHHHHHHh-cCc
Confidence 789999999999999999 788886432211 111111111 11222222221 12235666777888 599
Q ss_pred CCCCCHhHHHHHHh
Q 015360 336 TKRPKMGHVIHMLE 349 (408)
Q Consensus 336 ~~Rps~~evl~~Le 349 (408)
++|||++||++.|.
T Consensus 255 ~~Rpt~~~v~~~l~ 268 (269)
T cd05042 255 ETRPTAEEVHELLT 268 (269)
T ss_pred ccccCHHHHHHHhc
Confidence 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=216.82 Aligned_cols=182 Identities=28% Similarity=0.479 Sum_probs=135.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-Cc----EEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GT----KVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~----~vavK~~------------------------------------------ 183 (408)
.+|...+.||+|+||.||+|.+.+ +. .+|+|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 356677899999999999999653 32 5888865
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 34459999998 99999999999999999999999999998764332
Q ss_pred ccee-cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.... ....++..|+|||.+....++.++|+||||+++||+++ |+.||...... +...... .... ..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~-~~~~--~~--- 231 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLE-KGER--LP--- 231 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHh-CCCC--CC---
Confidence 2111 11223568999999988889999999999999999999 99999654321 1111111 1110 00
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+. .....+.+++.+||..||++||++.++++.|+..
T Consensus 232 ~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 QPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011 1123577889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=217.11 Aligned_cols=145 Identities=24% Similarity=0.466 Sum_probs=107.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCC-----ceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccc
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQW-----NARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKS 260 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~-----~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~s 260 (408)
+|.|||+. +++|+||||+||+++.+. .++|+|||++.......... .....++..|+|||.+.+..++.++
T Consensus 118 ~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 194 (269)
T cd05044 118 GCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQS 194 (269)
T ss_pred HHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccch
Confidence 47899988 999999999999998877 89999999987653322111 1223456789999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC
Q 015360 261 DVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 261 DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
|||||||++|||++ |+.||...... ... ......... .........+.+++.+||+.+|.+||
T Consensus 195 Dv~slG~il~ellt~g~~p~~~~~~~---~~~---~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 195 DVWSFGVLMWEILTLGQQPYPALNNQ---EVL---QHVTAGGRL----------QKPENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred hHHHHHHHHHHHHHcCCCCCcccCHH---HHH---HHHhcCCcc----------CCcccchHHHHHHHHHHcCCCcccCC
Confidence 99999999999998 99998643221 111 111111000 01112234678999999999999999
Q ss_pred CHhHHHHHHhc
Q 015360 340 KMGHVIHMLEA 350 (408)
Q Consensus 340 s~~evl~~Le~ 350 (408)
++++|++.|++
T Consensus 259 ~~~~i~~~l~~ 269 (269)
T cd05044 259 TFDRIQEILQN 269 (269)
T ss_pred CHHHHHHHHhC
Confidence 99999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=218.84 Aligned_cols=173 Identities=27% Similarity=0.429 Sum_probs=130.7
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
..||+|+||.||++... ++..+|||.+
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 57999999999999864 4889999976
Q ss_pred -------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccC
Q 015360 184 -------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 244 (408)
Q Consensus 184 -------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~ 244 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++........ ......++..
T Consensus 108 ~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~ 183 (292)
T cd06658 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPY 183 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCcc
Confidence 33459999998 999999999999999999999999999875533222 1223457899
Q ss_pred cccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHH
Q 015360 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 324 (408)
Q Consensus 245 y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 324 (408)
|+|||.+.+..++.++||||||+++|||++|+.||....... . +.... ....+..... ......+.
T Consensus 184 y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~~~~------~~~~~~~~~~--~~~~~~~~ 249 (292)
T cd06658 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MRRIR------DNLPPRVKDS--HKVSSVLR 249 (292)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHH------hcCCCccccc--cccCHHHH
Confidence 999999988889999999999999999999999996433211 1 11110 0011111110 11223577
Q ss_pred HHHHhccCcCCCCCCCHhHHHHH
Q 015360 325 LVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 325 ~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+++.+||+.||.+|||+.|+++.
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 88889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=231.20 Aligned_cols=147 Identities=27% Similarity=0.414 Sum_probs=111.2
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccc-----cCCCCc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNE 258 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ 258 (408)
++++|.|||+. +|||||||..|||++-+|.++|+|||++....... .....+.||++|||||++. ..+|++
T Consensus 139 ~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDy 214 (1187)
T KOG0579|consen 139 VLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSFIGTPYWMAPEVVMCETFKDQPYDY 214 (1187)
T ss_pred HHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hhhccccCCcccccchheeeccccCCCchh
Confidence 35569999999 99999999999999999999999999986543221 2234578999999999864 467999
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC
Q 015360 259 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338 (408)
Q Consensus 259 ~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 338 (408)
++||||||++|.||..+.+|....++. ..+..+.... .|.+ ..+......+.+++.+||..||..|
T Consensus 215 kaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSe------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~R 280 (1187)
T KOG0579|consen 215 KADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNR 280 (1187)
T ss_pred hhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcC------CCcc--cCcchhhhHHHHHHHHHHhcCCccC
Confidence 999999999999999999997643322 2222111111 1111 1234455678899999999999999
Q ss_pred CCHhHHHHHH
Q 015360 339 PKMGHVIHML 348 (408)
Q Consensus 339 ps~~evl~~L 348 (408)
|++.++++.-
T Consensus 281 p~aaqll~Hp 290 (1187)
T KOG0579|consen 281 PPAAQLLKHP 290 (1187)
T ss_pred CCHHHHhhCc
Confidence 9999998753
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=213.60 Aligned_cols=178 Identities=25% Similarity=0.383 Sum_probs=132.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... ++..|+||.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888899999999999999975 4889999965
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 22348999998 999999999999999999999999999876432
Q ss_pred CCcc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 231 ERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 231 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .. ........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~-----~~ 227 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQP-----TN 227 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCC-----CC
Confidence 1111 112345788999999998888999999999999999999999999643211 11 11111110 01
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+.. +......+.+++.+||. +|++||+++||++.
T Consensus 228 ~~~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCC----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 22233457778888884 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=217.91 Aligned_cols=191 Identities=24% Similarity=0.325 Sum_probs=134.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|+.. +++.++||.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999965 4788999965
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+.++|+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 22348999998 99999999999999999999999999997
Q ss_pred eecCCCcc----------eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 015360 227 LLCSERSY----------VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295 (408)
Q Consensus 227 ~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 295 (408)
........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||........ ...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~~~ 240 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHLIF 240 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 65332211 1122356788999998765 4578999999999999999999999975433211 11111
Q ss_pred HHhcCCC---------ccc----ccCCCCCCCC---cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 296 TMVGSRK---------SEE----VVDPKLPKMP---ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 296 ~~~~~~~---------~~~----~~d~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....... ... ......+... .......+.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111000 000 0000110000 0112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=216.60 Aligned_cols=174 Identities=29% Similarity=0.443 Sum_probs=131.7
Q ss_pred cceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------------- 183 (408)
...||+|+||.||++... +++.++||.+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999864 5889999986
Q ss_pred --------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccccccc
Q 015360 184 --------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243 (408)
Q Consensus 184 --------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~ 243 (408)
+..+|+|||+. +++|+||||+||+++.++.+||+|||++........ ......++.
T Consensus 106 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~ 181 (297)
T cd06659 106 TDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTP 181 (297)
T ss_pred HHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCc
Confidence 34459999998 999999999999999999999999999875433221 122356889
Q ss_pred CcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHH
Q 015360 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRV 323 (408)
Q Consensus 244 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 323 (408)
.|+|||.+.+..++.++|||||||++|||++|+.||...... .. +..... ... +.... .......+
T Consensus 182 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~---~~~~~~-~~~-----~~~~~--~~~~~~~l 247 (297)
T cd06659 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QA---MKRLRD-SPP-----PKLKN--AHKISPVL 247 (297)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHhc-cCC-----CCccc--cCCCCHHH
Confidence 999999998888999999999999999999999999643321 11 111111 100 00000 01112357
Q ss_pred HHHHHhccCcCCCCCCCHhHHHHH
Q 015360 324 LLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 324 ~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+++.+||+.+|++||++.++++.
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhC
Confidence 788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=211.59 Aligned_cols=169 Identities=27% Similarity=0.382 Sum_probs=132.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|.||.|..++-+ .+..+|||++
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 67888999999999999999854 4889999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
|..+|.|||+. +||+||||.+|.|||.+|.+||+|||+++.-.... .
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-~ 323 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-D 323 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc-c
Confidence 33459999999 99999999999999999999999999998643222 2
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....+||+.|+|||++....|+...|.|.+||++|||++|+.||...+...-..++ . ..|-+++..
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---l----------~ed~kFPr~ 390 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---L----------MEDLKFPRT 390 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---H----------hhhccCCcc
Confidence 345688999999999999999999999999999999999999999754433211111 1 011222222
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
..+ +...|+...|..||.+|..
T Consensus 391 ls~----eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 391 LSP----EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred CCH----HHHHHHHHHhhcChHhhcC
Confidence 222 4556677889999999973
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=215.97 Aligned_cols=144 Identities=26% Similarity=0.411 Sum_probs=105.6
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCccccccccc-CCCCccccch
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVY 263 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvw 263 (408)
+.+|+|||+. +++|+||||+|||++.++.++|+|||++....... .....++..|+|||.+.. ..++.++|||
T Consensus 107 ~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 180 (279)
T cd05633 107 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWF 180 (279)
T ss_pred HHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhH
Confidence 3458999998 99999999999999999999999999987543222 122458899999998864 5688999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC----
Q 015360 264 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP---- 339 (408)
Q Consensus 264 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---- 339 (408)
||||++|+|++|..||.......... +...... ....++ ......+.+++.+||+.||.+||
T Consensus 181 slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~ 246 (279)
T cd05633 181 SLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNVELP----DSFSPELKSLLEGLLQRDVSKRLGCLG 246 (279)
T ss_pred HHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCcCCc----cccCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 99999999999999997543322111 1111100 111111 11234678889999999999999
Q ss_pred -CHhHHHHHH
Q 015360 340 -KMGHVIHML 348 (408)
Q Consensus 340 -s~~evl~~L 348 (408)
+++|++++.
T Consensus 247 ~~~~~~~~h~ 256 (279)
T cd05633 247 RGAQEVKEHV 256 (279)
T ss_pred CCHHHHHhCc
Confidence 588887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=211.60 Aligned_cols=179 Identities=30% Similarity=0.483 Sum_probs=133.9
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|... ++..++||.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3667789999999999999965 5889999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 34459999998 999999999999999999999999999877644332211
Q ss_pred c---ccccccCcccccccccCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 237 T---RVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 237 ~---~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
. ...++..|++||.+.... ++.++||||||+++|++++|+.||...... . ....... .. ..+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~---~~~~~~~-~~-----~~~~ 226 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F---QIMFHVG-AG-----HKPP 226 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H---HHHHHHh-cC-----CCCC
Confidence 1 245788999999998766 889999999999999999999999643211 0 1111111 11 0111
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
++.. ......+.+++.+||+.||++|||+.|++.
T Consensus 227 ~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 IPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 112345778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=213.12 Aligned_cols=175 Identities=27% Similarity=0.478 Sum_probs=133.6
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|... ++..++||.+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3566789999999999999986 6899999965
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 33458999998 99999999999999999999999999987654332
Q ss_pred ceecccccccCcccccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
......++..|++||.+.... ++.++|+|||||++|+|++|+.||...... ............ +..+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-----~~~~ 224 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL-----PPIP 224 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC-----CCcC
Confidence 223355788999999987766 899999999999999999999999643311 111111110111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......+.+++.+||+.+|++||++.+++.
T Consensus 225 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 ----DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112246778899999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=224.87 Aligned_cols=190 Identities=25% Similarity=0.357 Sum_probs=136.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||+||+++.. ++..||||.+
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999964 4889999975
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 23348999998 999999999999999999999999999976543
Q ss_pred CCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC--------
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-------- 301 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 301 (408)
.. .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+... ............
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhc
Confidence 22 12233457889999998764 468899999999999999999999996543211 111111111000
Q ss_pred ---Cccccc-------CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 ---KSEEVV-------DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ---~~~~~~-------d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...... ++.... ........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 000000 011234567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=217.98 Aligned_cols=193 Identities=28% Similarity=0.366 Sum_probs=136.9
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
.+.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578889999999999999999985 4788999876
Q ss_pred -----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEecc
Q 015360 184 -----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 222 (408)
Q Consensus 184 -----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Df 222 (408)
+..+|+|||+. +|+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence 22348999998 9999999999999999999999999
Q ss_pred CCceeecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC
Q 015360 223 GLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301 (408)
Q Consensus 223 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 301 (408)
|++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||...... .....+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~ 237 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSP 237 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Confidence 9998664333222222345778999998764 45788999999999999999999999743321 1111122221111
Q ss_pred Ccc---cc--------cCCCCCC-----CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 KSE---EV--------VDPKLPK-----MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 ~~~---~~--------~d~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
... .+ .++.... .........+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 00 0000000 000012346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=215.90 Aligned_cols=146 Identities=25% Similarity=0.410 Sum_probs=107.4
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|+|||+. +++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+..++.++|||||
T Consensus 128 ~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 204 (275)
T cd05046 128 LGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF 204 (275)
T ss_pred HHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHH
Confidence 348999998 99999999999999999999999999987543322222233345678999999988888999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
|+++|+|++ |..||...... ..... . ........ ... .....+.+++.+||+.||++|||+.|+
T Consensus 205 G~~l~~l~~~~~~p~~~~~~~---~~~~~---~-~~~~~~~~----~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 205 GVLMWEVFTQGELPFYGLSDE---EVLNR---L-QAGKLELP----VPE----GCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred HHHHHHHHhCCCCCccccchH---HHHHH---H-HcCCcCCC----CCC----CCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999999 88888533221 11111 1 11111100 011 122368889999999999999999999
Q ss_pred HHHHh
Q 015360 345 IHMLE 349 (408)
Q Consensus 345 l~~Le 349 (408)
++.|.
T Consensus 270 l~~l~ 274 (275)
T cd05046 270 VSALG 274 (275)
T ss_pred HHHhc
Confidence 99885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=223.05 Aligned_cols=147 Identities=24% Similarity=0.405 Sum_probs=109.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +++|+||||+|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 146 al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 146 GMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred HHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 47899998 99999999999999999999999999997654322211 112234567999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||..... .+......... .. .. .......+.+++.+||+.+|++|||+.|+
T Consensus 223 G~il~el~~~g~~p~~~~~~------~~~~~~~~~~~-~~-----~~----~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 223 GVLLWEIFTLGGSPYPGIPV------EELFKLLKEGH-RM-----DK----PANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred HHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-CC-----CC----CCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999998 8888864321 12222211111 00 01 11123368889999999999999999999
Q ss_pred HHHHhcCC
Q 015360 345 IHMLEADD 352 (408)
Q Consensus 345 l~~Le~~~ 352 (408)
++.|+...
T Consensus 287 l~~l~~~~ 294 (334)
T cd05100 287 VEDLDRVL 294 (334)
T ss_pred HHHHHHHh
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=213.32 Aligned_cols=140 Identities=29% Similarity=0.476 Sum_probs=104.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCC-------ceEEeccCCceeecCCCcceecccccccCcccccccccC--
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-- 254 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 254 (408)
++.+|+|||+. +|+|+||||+||+++.++ .+||+|||++..... .....++..|+|||++...
T Consensus 110 i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~ 181 (259)
T cd05037 110 LASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQA 181 (259)
T ss_pred HHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCC
Confidence 34459999998 999999999999998877 799999999876543 1123466789999998876
Q ss_pred CCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCc
Q 015360 255 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 333 (408)
Q Consensus 255 ~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 333 (408)
.++.++|||||||++|||++ |..||........ ..+.. ... ..+ .+. ...+.+++.+||+.
T Consensus 182 ~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~----~~~-------~~~-~~~---~~~~~~li~~~l~~ 243 (259)
T cd05037 182 SLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ----DQH-------RLP-MPD---CAELANLINQCWTY 243 (259)
T ss_pred CcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh----cCC-------CCC-CCC---chHHHHHHHHHhcc
Confidence 78999999999999999999 5777764432111 11110 000 000 001 14688999999999
Q ss_pred CCCCCCCHhHHHHHHh
Q 015360 334 DATKRPKMGHVIHMLE 349 (408)
Q Consensus 334 dP~~Rps~~evl~~Le 349 (408)
+|.+|||+.+|++.|+
T Consensus 244 ~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 244 DPTKRPSFRAILRDLN 259 (259)
T ss_pred ChhhCCCHHHHHHhcC
Confidence 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=211.17 Aligned_cols=181 Identities=26% Similarity=0.477 Sum_probs=139.4
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|++|.||+++..+ +..++||.+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999875 899999975
Q ss_pred ---------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ---------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+ . +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 3345999999 8 9999999999999999999999999999876433322
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....++..|+|||.+....++.++|+||||+++|+|++|+.||........... ......... +.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~~------~~~~~~- 226 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGPP------PSLPAE- 226 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhcCCC------CCCCcc-
Confidence 2234578899999999988899999999999999999999999975543121122 222221110 111111
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+.+++.+||+.+|++||++.|+++.
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 023468889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=229.07 Aligned_cols=146 Identities=24% Similarity=0.430 Sum_probs=107.8
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|+|||+. +++|+||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 251 aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 327 (401)
T cd05107 251 GMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327 (401)
T ss_pred HHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHH
Confidence 36789987 9999999999999999999999999999765332211 1122346788999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |..||......+ ........+.. +..+ ......+.+|+.+||+.+|++||+++||
T Consensus 328 Gvil~e~l~~g~~P~~~~~~~~------~~~~~~~~~~~-----~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 328 GILLWEIFTLGGTPYPELPMNE------QFYNAIKRGYR-----MAKP----AHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred HHHHHHHHHcCCCCCCCCCchH------HHHHHHHcCCC-----CCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999998 889986432211 11111111110 0111 1123468889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 393 l~~L~~ 398 (401)
T cd05107 393 VHLVGD 398 (401)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=211.46 Aligned_cols=150 Identities=18% Similarity=0.300 Sum_probs=103.8
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCccccccccc-------CCC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACT-------GML 256 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~ 256 (408)
+.+|+|||+. +++|+||||+|||++.++.++|+|||++........ .......++..|+|||++.. ..+
T Consensus 109 ~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 185 (268)
T cd05086 109 AAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQ 185 (268)
T ss_pred HHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCC
Confidence 3458999998 999999999999999999999999998764322111 11223457889999998743 235
Q ss_pred CccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCC
Q 015360 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335 (408)
Q Consensus 257 ~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP 335 (408)
+.++|||||||++|||++ |..||...... +........ ......++.+..... ..+.+++..|| .+|
T Consensus 186 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P 253 (268)
T cd05086 186 TKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFKPQLELPYS----ERWYEVLQFCW-LSP 253 (268)
T ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCCCccCCCCc----HHHHHHHHHHh-hCc
Confidence 779999999999999997 56777533221 111111111 112233333332222 35667888899 679
Q ss_pred CCCCCHhHHHHHHh
Q 015360 336 TKRPKMGHVIHMLE 349 (408)
Q Consensus 336 ~~Rps~~evl~~Le 349 (408)
++||+++||++.|.
T Consensus 254 ~~Rp~~~~i~~~l~ 267 (268)
T cd05086 254 EKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-27 Score=216.86 Aligned_cols=175 Identities=24% Similarity=0.414 Sum_probs=138.8
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
..|.+.+.||+|.||.|-++.. ..|+.||||.+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577778999999999999985 56999999977
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
|..++.|+|.+ +++|||||.+|||||.|+++||+|||++.+......
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf- 208 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF- 208 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH-
Confidence 34458999999 999999999999999999999999999987644332
Q ss_pred eecccccccCcccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
...++|++.|.+||++.+.+|. +..|.|||||+||.|+.|..||+..+. ...++++... ....|.-+.
T Consensus 209 -LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvrQIs~G----aYrEP~~PS 277 (668)
T KOG0611|consen 209 -LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVRQISRG----AYREPETPS 277 (668)
T ss_pred -HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHHHhhcc----cccCCCCCc
Confidence 3458899999999999998885 789999999999999999999986542 2223322211 122222221
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...-||.+||-.||++|.|+.+|....
T Consensus 278 --------dA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 278 --------DASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------hHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 345678899999999999999997653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=213.56 Aligned_cols=188 Identities=24% Similarity=0.336 Sum_probs=131.6
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|+.. +++.++||.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 5889999966
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 23458999998 9999999999999999999999999998765332211
Q ss_pred ecccccccCcccccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC-------------
Q 015360 236 TTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR------------- 301 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------- 301 (408)
.....++..|+|||.+.+.. ++.++|||||||++|||+||+.||....... .............
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 12234678899999887644 5889999999999999999999996433211 1111111000000
Q ss_pred --CcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 --KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 --~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.........+.. ........+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 00011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=213.68 Aligned_cols=190 Identities=24% Similarity=0.365 Sum_probs=135.4
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|... +++.++||.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999974 5889999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 33458999998 999999999999999999999999999887644332222
Q ss_pred cccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC------------c
Q 015360 237 TRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------------S 303 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------~ 303 (408)
....++..|+|||.+.+. .++.++|||||||++|||++|.+||...... .....+........ .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcchh
Confidence 334588899999988654 4688999999999999999998888643321 11111111111000 0
Q ss_pred ccccCCCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 EEVVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+...... ..+....+.+++.+||+.||++|||+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 01123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=242.53 Aligned_cols=182 Identities=26% Similarity=0.397 Sum_probs=133.4
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------ 183 (408)
....++|.+.+.||+|+||+||++.... +..+|+|.+
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445689999999999999999999754 667888865
Q ss_pred --------------------------------------hhhhHHHhhhCCC----CceeeeccccCceEeCC--------
Q 015360 184 --------------------------------------LNNRLAYLHEGLE----PKVVHRDVKSSNILLDR-------- 213 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~----~~ivH~dlk~~Nill~~-------- 213 (408)
++.+|.|||.... .+|||+||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 3345999998521 36999999999999954
Q ss_pred ---------CCceEEeccCCceeecCCCcceecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 015360 214 ---------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYS 282 (408)
Q Consensus 214 ---------~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~ 282 (408)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999976533221 233568999999999854 45889999999999999999999999643
Q ss_pred CCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 283 RPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. ....+..+. .. +.++. ......+.+|+..||+.+|.+||++.|++.
T Consensus 247 ~~-----~~qli~~lk-~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLISELK-RG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHHHHHh-cC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 122222111 11 11111 111236788999999999999999999984
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=214.90 Aligned_cols=181 Identities=32% Similarity=0.470 Sum_probs=135.6
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
.++++|...+.||+|+||.||+|... +++.+++|.+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45788999999999999999999975 4778999875
Q ss_pred ---------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCC
Q 015360 184 ---------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 ---------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 23348999998 999999999999999999999999999
Q ss_pred ceeecCCCcceecccccccCccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 299 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 299 (408)
+........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... .......
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPR 232 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhc
Confidence 876533222 1233457889999998753 346789999999999999999999996332111 1111111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
... +.+ .........+.+++.+||..||++|||+.|+++
T Consensus 233 -~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 -NPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 111 111223456888999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=215.00 Aligned_cols=179 Identities=27% Similarity=0.436 Sum_probs=136.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... ++..+++|.+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56778899999999999999854 5788999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++......... ...
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~ 174 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-ccc
Confidence 33458999998 9999999999999999999999999988765433221 223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..+++.|++||.+....++.++|||||||++|++++|+.||.......... ..... +.........
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~--------~~~~~~~~~~ 240 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN--------GTPELQNPEK 240 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcC--------CCCCCCCccc
Confidence 457889999999988889999999999999999999999997543221110 00000 0000111112
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+++.+||+.+|++||++.+++.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23457789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=218.17 Aligned_cols=191 Identities=24% Similarity=0.335 Sum_probs=134.1
Q ss_pred CCCccceeccCCcEEEEEEEeCC---CcEEEEEEeh--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD---GTKVAVKNLL-------------------------------------------- 184 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~---~~~vavK~~~-------------------------------------------- 184 (408)
.|...+.||+|+||.||+|.... +..+|||.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999754 7899999762
Q ss_pred -------------------------------------hhhHHHhhhCCCCceeeeccccCceEeCC----CCceEEeccC
Q 015360 185 -------------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDFG 223 (408)
Q Consensus 185 -------------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~----~~~~kL~Dfg 223 (408)
..+|.|||+. +++|+||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 2338999998 9999999999999998 8999999999
Q ss_pred CceeecCCCc--ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-------hhHHH
Q 015360 224 LAKLLCSERS--YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-------NLVDW 293 (408)
Q Consensus 224 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~-------~~~~~ 293 (408)
++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543322 11233457889999998766 45789999999999999999999999755433200 01111
Q ss_pred HHHHhcCC------------Cccc----ccCCCCCCCCcH-------HHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 294 LKTMVGSR------------KSEE----VVDPKLPKMPAS-------KALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 294 ~~~~~~~~------------~~~~----~~d~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+ ..+... .... ............ .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 F-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred H-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 111000 0000 000001100000 12246889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-27 Score=225.78 Aligned_cols=199 Identities=26% Similarity=0.376 Sum_probs=144.1
Q ss_pred ceeeHHHHHHHhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------
Q 015360 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------- 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------- 183 (408)
+.....++...+++|...+.||+|+||.||++.. .+++.||||++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4566788888999999999999999999999985 46889999976
Q ss_pred --------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 184 --------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 184 --------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
+..+|+|||+. +++|+||||+||+++.++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 23448999998 9999999999999999999999
Q ss_pred eccCCceeecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh
Q 015360 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +.. +....
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~ 234 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKL-ILRLV 234 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHh
Confidence 999998764322 123457889999998866 5688899999999999999999999964332110 100 00000
Q ss_pred cC-----------CCcccccC--CCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 299 GS-----------RKSEEVVD--PKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 299 ~~-----------~~~~~~~d--~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. ........ +..+.... ......+.+++.+||+.||.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00000000 00000000 0113357899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=222.50 Aligned_cols=191 Identities=27% Similarity=0.423 Sum_probs=137.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... ++..|++|++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999965 4889999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 33459999998 99999999999999999999999999997654322
Q ss_pred cc---eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC-------
Q 015360 233 SY---VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR------- 301 (408)
Q Consensus 233 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 301 (408)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhhh
Confidence 11 1123468889999998765 458899999999999999999999996543211 111111111100
Q ss_pred ----CcccccC--CCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 ----KSEEVVD--PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ----~~~~~~d--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+ +...... .......+.+++.+||+.||++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 0000000 01124568899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=218.32 Aligned_cols=190 Identities=24% Similarity=0.331 Sum_probs=134.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +++.+|||.+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999975 5889999976
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 33448999998 999999999999999999999999999976
Q ss_pred ecCCCcc---eecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 228 LCSERSY---VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 228 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ...+.........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~~~~~~~ 245 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQLCGSITP 245 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCh
Confidence 5332211 11234567889999988654 478899999999999999999999975443211 1111111110000
Q ss_pred ---ccc-----cC-CCCCCCC---------cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 ---EEV-----VD-PKLPKMP---------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ---~~~-----~d-~~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
... .+ ...+... .......+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00 0000000 0001235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=213.53 Aligned_cols=176 Identities=31% Similarity=0.482 Sum_probs=133.4
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||.||+|.. .++..++||.+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999996 45889999975
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K 157 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence 23448999998 999999999999999999999999999987644332 2
Q ss_pred ecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....++..|+|||.+.++ .++.++|+|||||++|+|++|+.||....... .... .... ..+.+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~~-----~~~~~~~~ 225 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPKS-----KPPRLEDN 225 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cccC-----CCCCCCcc
Confidence 2334688899999988654 46889999999999999999999996433211 1110 0000 11111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+.+++.+||+.||++||++.|++.
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 ---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 12346888999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=216.96 Aligned_cols=189 Identities=26% Similarity=0.336 Sum_probs=134.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.++||.+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999986 4788999876
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 33459999998 999999999999999999999999999987644321
Q ss_pred ceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC------------
Q 015360 234 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS------------ 300 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 300 (408)
. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ...+......
T Consensus 162 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 162 P-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHhhcc
Confidence 1 1234567899999988754 468899999999999999999999975432211 1111110000
Q ss_pred -----CCcccccCCCCCCCCcHH-HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 301 -----RKSEEVVDPKLPKMPASK-ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 301 -----~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..........+....... ....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000011111111 2345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=216.51 Aligned_cols=189 Identities=23% Similarity=0.304 Sum_probs=132.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999975 5889999965
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCC
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGL 224 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~ 224 (408)
++.+|.|||+. +++|+||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 23448999998 9999999999999998 88999999999
Q ss_pred ceeecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
+......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .+.... ........
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~ 233 (295)
T cd07837 158 GRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPTE 233 (295)
T ss_pred ceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCCh
Confidence 8765322111 122346788999998865 457899999999999999999999997533211 111111 11100000
Q ss_pred cc---c---c----CCCCCCC----CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EE---V---V----DPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~---~---~----d~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. . . -+..... ........+.+++.+||+.||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 0 0000000 00112346788999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=214.89 Aligned_cols=183 Identities=23% Similarity=0.371 Sum_probs=135.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++.... ++.|+||.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468888999999999999999754 678999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC--
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 232 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~-- 232 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 23458999998 99999999999999999999999999886421100
Q ss_pred ------------cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 233 ------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 233 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
........++..|+|||.+....++.++|+|||||++|||++|..||...... +........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~~ 231 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVISD 231 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc
Confidence 00111235678899999998888999999999999999999999999643221 111111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. ...+.... .....+.+++.+||+.||++||++.++++.|+.
T Consensus 232 ~----~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 D----IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c----cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 11111111 122357889999999999999998888887776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=213.55 Aligned_cols=180 Identities=27% Similarity=0.398 Sum_probs=134.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|.+.+.||+|+||.||++... ++..+++|..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888889999999999999975 5889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 33458999998 999999999999999999999999998865432221 1
Q ss_pred ecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 236 TTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.....++..|++||.+. ...++.++|||||||++|+|++|+.||...... ..+....... . +.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSE-P-----PT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCC-C-----CC
Confidence 22345888999999875 345678999999999999999999999643321 1111111110 0 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+. ........+.+++.+||+.||.+||++.++++.
T Consensus 228 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 LD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 10 011122357789999999999999999999774
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=210.92 Aligned_cols=177 Identities=27% Similarity=0.428 Sum_probs=135.7
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...++||+|+||.||.++.. ++..+++|.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4777899999999988888854 4888999965
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 23458999998 999999999999999999999999999987644332
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......++..|+|||.+.+..++.++||||||+++|+|++|..||...... +...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCCCCCC--------
Confidence 223356889999999998888899999999999999999999999643221 1121111 1111110
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.......+.+++.+||+.||++||++.++++.+
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=214.10 Aligned_cols=187 Identities=26% Similarity=0.332 Sum_probs=134.9
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|++|.||++... +++.+++|.+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999975 5888999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 34459999998 99999999999999999999999999987764433 1122
Q ss_pred ccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC---CcccccC-----
Q 015360 238 RVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---KSEEVVD----- 308 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d----- 308 (408)
...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ ............ ......+
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhhh
Confidence 34577899999998776 78899999999999999999999996543211 111111110000 0000000
Q ss_pred ----CCCCCC----CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 ----PKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ----~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+..... ........+.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 11223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=215.62 Aligned_cols=140 Identities=26% Similarity=0.455 Sum_probs=101.6
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCC-------ceEEeccCCceeecCCCcceecccccccCccccccccc-CC
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GM 255 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~ 255 (408)
++.+|+|||+. +|+||||||+|||++..+ .+|++|||++...... ....++..|+|||.+.+ ..
T Consensus 126 i~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 126 LASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNS 197 (274)
T ss_pred HHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCC
Confidence 34559999998 999999999999997543 3799999987543221 12346788999998865 56
Q ss_pred CCccccchhhHHHHHHHH-hCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcC
Q 015360 256 LNEKSDVYSFGILIMEII-TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPD 334 (408)
Q Consensus 256 ~~~~sDvwSlGvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~d 334 (408)
++.++|||||||++|||+ +|+.||........ ..... .. ...+.. ....+.+++.+||+.+
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~-------~~~~~~----~~~~~~~li~~cl~~~ 259 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---ERFYE----KK-------HRLPEP----SCKELATLISQCLTYE 259 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---HHHHH----hc-------cCCCCC----CChHHHHHHHHHcccC
Confidence 889999999999999995 69999875433211 11111 00 011111 1135788999999999
Q ss_pred CCCCCCHhHHHHHHh
Q 015360 335 ATKRPKMGHVIHMLE 349 (408)
Q Consensus 335 P~~Rps~~evl~~Le 349 (408)
|++|||+.+|++.|.
T Consensus 260 p~~Rps~~~il~~L~ 274 (274)
T cd05076 260 PTQRPSFRTILRDLT 274 (274)
T ss_pred hhhCcCHHHHHHhhC
Confidence 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=210.43 Aligned_cols=176 Identities=23% Similarity=0.414 Sum_probs=135.3
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.+|++... +++.++||.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777899999999999999864 5789999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 23348999998 999999999999999999999999999976543221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .+......... . +..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~-~-----~~~--- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGS-Y-----PPV--- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCC-C-----CCC---
Confidence 12234578899999999888899999999999999999999999864321 12222221111 0 011
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+++.+||+.+|++||++.+|++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11223368889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=210.73 Aligned_cols=186 Identities=28% Similarity=0.407 Sum_probs=137.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||.|++|.||++... +++.+|+|.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999975 4788999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 23348999998 999999999999999999999999999865432
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+........ ......+.
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~- 231 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVNM-PNPELKDE- 231 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHhcC-CchhhccC-
Confidence 211 234577899999999988999999999999999999999999975532111 111222111111 11111100
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .........+.+++.+||+.||++|||+.||++.
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0001224568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=212.01 Aligned_cols=187 Identities=26% Similarity=0.352 Sum_probs=135.2
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|+... ++.+|||.+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5567899999999999999865 889999976
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 23348999998 9999999999999999999999999998776
Q ss_pred cCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc----
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE---- 304 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 304 (408)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|++||......+ .+..............
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCC
Confidence 43322 122346789999999998889999999999999999999999987543221 1111111110000000
Q ss_pred -----cccCCCCCCC---CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 305 -----EVVDPKLPKM---PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 305 -----~~~d~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.......... ........+.+++.+||+.||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 01123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=211.95 Aligned_cols=182 Identities=26% Similarity=0.431 Sum_probs=132.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|... +++.+|||.+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999854 5889999964
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 23348999998 9999999999999999999999999998764
Q ss_pred cCCCcc-eecccccccCcccccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc
Q 015360 229 CSERSY-VTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305 (408)
Q Consensus 229 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (408)
...... ......++..|+|||.+.... ++.++|+||||+++|++++|..||...... .......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-cCC
Confidence 322111 122345788999999987654 789999999999999999999998532211 1111111111 111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 306 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...... .......+.+++.+||+.||++||++++|++.
T Consensus 232 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 11223468889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=217.29 Aligned_cols=174 Identities=26% Similarity=0.416 Sum_probs=131.9
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+++.. ++..+|||.+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566789999999999999964 5889999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 23448999998 9999999999999999999999999988654322
Q ss_pred cccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 237 TRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ........... ..
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~---------~~ 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES---------PT 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC---------CC
Confidence 2245788999999874 456889999999999999999999998643211 11111111110 01
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
.........+.+++.+||+.+|.+||++.+|++.+.
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 111122345788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=219.82 Aligned_cols=190 Identities=25% Similarity=0.351 Sum_probs=136.9
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|+||.||+|+..+ ++.++||.+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 46778899999999999999754 889999965
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +++|+||||.|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 33448999998 99999999999999999999999999998765432
Q ss_pred c--ceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC-------
Q 015360 233 S--YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------- 302 (408)
Q Consensus 233 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 302 (408)
. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ....+........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhHhhhc
Confidence 1 112334578899999999887 78999999999999999999999997544221 1111111110000
Q ss_pred ----cccccC---CCCCC---CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 ----SEEVVD---PKLPK---MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ----~~~~~d---~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+. ..... .........+.+++.+||+.||++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 00000 0001123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=213.48 Aligned_cols=188 Identities=28% Similarity=0.396 Sum_probs=133.4
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|...+ ++.++||.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4566899999999999999764 788999977
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|+|||+. +++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 23348999998 99999999999999999999999999998765443222
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc---cc-----
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE---EV----- 306 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~----- 306 (408)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+.......... ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccccchh
Confidence 233456788999997764 45789999999999999999999999754421 1111111111100000 00
Q ss_pred ---cCCCCC------CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 307 ---VDPKLP------KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 307 ---~d~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+... ..........+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0000001456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=216.10 Aligned_cols=140 Identities=25% Similarity=0.395 Sum_probs=101.5
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCc--------eEEeccCCceeecCCCcceecccccccCccccccccc-C
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-G 254 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~--------~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 254 (408)
++.+|+|||+. +|+|+||||+||+++.++. ++++|||++...... ....++..|+|||++.+ .
T Consensus 109 i~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 180 (258)
T cd05078 109 LAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQ 180 (258)
T ss_pred HHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCC
Confidence 34559999998 9999999999999977654 689999988654321 22457789999999976 4
Q ss_pred CCCccccchhhHHHHHHHHhCC-CCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCc
Q 015360 255 MLNEKSDVYSFGILIMEIITGR-NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 333 (408)
Q Consensus 255 ~~~~~sDvwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 333 (408)
.++.++|||||||++|||++|. .||....... ... ..... ..++.. ....+.+++.+||+.
T Consensus 181 ~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~-~~~~~-------~~~~~~----~~~~~~~li~~~l~~ 242 (258)
T cd05078 181 NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQ-FYEDR-------HQLPAP----KWTELANLINQCMDY 242 (258)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHH-HHHcc-------ccCCCC----CcHHHHHHHHHHhcc
Confidence 5789999999999999999985 5654322211 111 11110 111111 123578899999999
Q ss_pred CCCCCCCHhHHHHHHh
Q 015360 334 DATKRPKMGHVIHMLE 349 (408)
Q Consensus 334 dP~~Rps~~evl~~Le 349 (408)
||++|||++++++.|+
T Consensus 243 ~p~~Rps~~~il~~l~ 258 (258)
T cd05078 243 EPDFRPSFRAIIRDLN 258 (258)
T ss_pred ChhhCCCHHHHHHhcC
Confidence 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=213.35 Aligned_cols=186 Identities=23% Similarity=0.297 Sum_probs=132.9
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|... ++..+|||.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456688999999999999964 5889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|+|||+. +++|+||+|+||+++. +.+||+|||++.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 33448999998 9999999999999999 99999999999766433221
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC-----------CCc
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS-----------RKS 303 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----------~~~ 303 (408)
....++..|+|||.+.. ..++.++|||||||++|||++|..||...+.. ....+....... ...
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccccc
Confidence 23457889999997654 55788999999999999999999999754322 111222111110 000
Q ss_pred ccccCCCCCCC----CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 EEVVDPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~~~~d~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+..... ........+.+++.+||+.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 01100100000 001234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=208.85 Aligned_cols=180 Identities=27% Similarity=0.486 Sum_probs=134.2
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++.. .+++.+|+|.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 45889999866
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 23348999998 999999999999998765 5999999998766433
Q ss_pred Cc---ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 232 RS---YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 232 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.. .......++..|+|||.+.+..++.++||||+|+++|+|++|..||......... .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~-----~~ 229 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASAT-----TA 229 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccC-----CC
Confidence 11 1112345788999999998888999999999999999999999999644332211 1111111000 00
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+. .+......+.+++.+||+.||++||++.|+++
T Consensus 230 ~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 PS----IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CC----CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11 11223346888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=207.98 Aligned_cols=175 Identities=25% Similarity=0.438 Sum_probs=132.9
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++... +++.++||.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 5888999975
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 23448999998 99999999999999754 4689999999987643322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ........ ..... +.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~~~-----~~- 222 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTFAP-----IS- 222 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCCCC-----CC-
Confidence 12345788999999999888999999999999999999999998643321 11111111 11111 11
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+++.+||+.||++|||+.|+++.
T Consensus 223 ---~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 ---DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123367889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=216.58 Aligned_cols=187 Identities=21% Similarity=0.275 Sum_probs=127.0
Q ss_pred cceeccC--CcEEEEEEEeC-CCcEEEEEEe-------------------------------------------------
Q 015360 156 ENVIGEG--GYGIVYRGILS-DGTKVAVKNL------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G--~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------- 183 (408)
.++||+| +|++||++... +|+.||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 78999999864 5899999977
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc--
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-- 234 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-- 234 (408)
++.+|+|||+. +|+|+||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 33459999998 9999999999999999999999999865443211110
Q ss_pred ----eecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc---------
Q 015360 235 ----VTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG--------- 299 (408)
Q Consensus 235 ----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 299 (408)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccccchh
Confidence 0112346678999999875 458899999999999999999999996432211 00000000000
Q ss_pred -----CCCcccccCCC-----------------CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 300 -----SRKSEEVVDPK-----------------LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 300 -----~~~~~~~~d~~-----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.. ............+.+|+.+||+.||++|||++||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000000 0000111223468899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=210.78 Aligned_cols=176 Identities=30% Similarity=0.459 Sum_probs=132.6
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|++|.||++... +++.++||.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5889999965
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 240 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 240 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 176 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLV 176 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccccc
Confidence 23458999998 999999999999999999999999998865433222 122345
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
++..|+|||.+.+..++.++|||||||++|+|++|+.||....+ .......... . .+..... ....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~-----~~~~~~~--~~~~ 242 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-L-----PPKLKNL--HKVS 242 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-C-----CCCCccc--ccCC
Confidence 88999999999888899999999999999999999999864322 1111111111 0 0111110 1122
Q ss_pred HHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 321 KRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+.+++.+||+.||++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 36888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=204.69 Aligned_cols=175 Identities=29% Similarity=0.495 Sum_probs=134.8
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||++... ++..+++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999986 5888999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||.. +++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 33458999998 999999999999999999999999999987654332 233
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..++..|++||.+....++.++||||||+++|+|++|+.||...... ........ ........+ ..
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~~-------~~ 222 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGLRNP-------EK 222 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCcCcc-------cc
Confidence 55788999999998888999999999999999999999998643321 11111111 111111110 11
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1246888999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=218.41 Aligned_cols=172 Identities=23% Similarity=0.412 Sum_probs=136.2
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|..++.||+|.|+.|-.+++- .|..||||.+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 444478999999999988732 5999999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEe-CCCCceEEeccCCceeecCCCcce
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill-~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
|..++.|+|+. -+|||||||+||.+ ..-|-+||.|||++..+.....
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-- 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-- 174 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence 34459999998 89999999999876 5668899999999987654332
Q ss_pred ecccccccCcccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.+..+|+..|.|||++.+..|+ ++.||||||||||.|++|++||+..++.+... .++|=. -.
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCK--Yt 237 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCK--YT 237 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhccc--cc
Confidence 3457899999999999999887 57899999999999999999998665544321 122211 12
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+.-...++.+||..||..||.+|.+.+||..
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 23345567888999999999999999999865
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=222.21 Aligned_cols=192 Identities=26% Similarity=0.367 Sum_probs=136.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.++||++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456788889999999999999975 4788999965
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 86 LVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 23348999998 999999999999999999999999999986643322
Q ss_pred c----eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc---------
Q 015360 234 Y----VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG--------- 299 (408)
Q Consensus 234 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 299 (408)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHH
Confidence 1 2233568889999998754 4578899999999999999999999965432211 110000000
Q ss_pred ------CCCcccccCCCCC--CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 300 ------SRKSEEVVDPKLP--KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 300 ------~~~~~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
............. ..........+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 00001123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=212.09 Aligned_cols=176 Identities=27% Similarity=0.467 Sum_probs=134.1
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
-|...+.||+|+||.||+|... ++..+|||..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3566789999999999999864 5789999975
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.++.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhcc
Confidence 33448999998 999999999999999999999999999876543221 1223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ...... ..... +.+. ..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-----~~~~----~~ 224 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLI-PKNNP-----PTLE----GN 224 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHH-hcCCC-----CCCC----cc
Confidence 45788999999998888899999999999999999999998643211 111111 11110 1111 11
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 23457789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=213.65 Aligned_cols=189 Identities=24% Similarity=0.374 Sum_probs=132.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|... +++.++||.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 5889999965
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +++|+||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 34459999998 9999999999999985 56799999999976533211
Q ss_pred ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc---------
Q 015360 234 YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS--------- 303 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 303 (408)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+. +.. ..........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVTSL 234 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhccccccc
Confidence 1122456789999998865 4578899999999999999999999975432211 110 1010000000
Q ss_pred ccc--cCCCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EEV--VDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~~--~d~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
... .-+...... .......+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000000 0112245788999999999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=212.56 Aligned_cols=187 Identities=26% Similarity=0.354 Sum_probs=131.1
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||.|++|.||+|... +|..|+||++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456689999999999999864 6899999965
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~ 156 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y 156 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence 33448999998 9999999999999999999999999998765322211 1
Q ss_pred cccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC--------------
Q 015360 237 TRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-------------- 301 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------- 301 (408)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .+...........
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 223467899999987654 57889999999999999999999997543211 1111111000000
Q ss_pred -CcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 -KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 -~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
........... .........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 001112246788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=212.80 Aligned_cols=172 Identities=27% Similarity=0.391 Sum_probs=133.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +++.+|||.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999975 4889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 33459999998 9999999999999999999999999998876433
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ ... ..++..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~------~~~~~~ 220 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL-EGK------VRFPSF 220 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cCC------ccCCcc
Confidence 2234578999999999888889999999999999999999999964331 11111111 111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~ 346 (408)
....+.+++.+||+.||.+|+ +++|+++
T Consensus 221 ----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 ----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 123677899999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=211.66 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=135.9
Q ss_pred CCCccceeccCCcEEEEEEEe----CCCcEEEEEEe--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~----~~~~~vavK~~-------------------------------------------- 183 (408)
+|...+.||+|+||.||+++. .++..+|||.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467778999999999999884 35688999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++++|.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 23348999998 999999999999999999999999999876543
Q ss_pred CCcceecccccccCcccccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
..........++..|++||.+.+.. .+.++||||||+++|+|++|..||....... ............ .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-------~ 228 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-------K 228 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-------C
Confidence 3322223345788999999987655 7889999999999999999999996432221 111111211111 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+..+.. ....+.+++.+||+.||++|||+.++.+.|+.
T Consensus 229 ~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 PPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111111 22357788999999999999999988887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=207.02 Aligned_cols=183 Identities=22% Similarity=0.302 Sum_probs=137.1
Q ss_pred HHHHHHHhcCCCcccee--ccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------
Q 015360 143 LRELEAATSGLCEENVI--GEGGYGIVYRGILS-DGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~l--g~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------ 183 (408)
..++....++|.+.+.+ |+|+||.||++... ++..+++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 44555556677777776 99999999999964 4778888875
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCS 230 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +++|+||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 34559999998 999999999999999888 999999999876543
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. ...++..|+|||++.+..++.++||||||+++|+|++|+.||...... ......+.... .. . ..
T Consensus 163 ~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~---~---~~ 228 (267)
T PHA03390 163 PS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QK---K---LP 228 (267)
T ss_pred Cc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cc---c---CC
Confidence 22 235788999999999888999999999999999999999999743322 11222222111 00 0 00
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCC-HhHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIH 346 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~ 346 (408)
. .......+.+++.+||+.||.+||+ ++|+++
T Consensus 229 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 F----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred c----ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 1122346788999999999999996 588874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=206.48 Aligned_cols=175 Identities=26% Similarity=0.380 Sum_probs=134.4
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|+||.||++... ++..+|+|.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 4889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 33448999998 99999999999999999999999999987654332 1
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..+....... .. +..+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~----~~~~--- 222 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--AD----VLYP--- 222 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--cc----ccCc---
Confidence 233457889999999988889999999999999999999999997554321 1112211111 00 1111
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCH--hHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKM--GHVI 345 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~--~evl 345 (408)
......+.+++.+||+.||.+||++ +|++
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 -ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122468889999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=209.98 Aligned_cols=173 Identities=25% Similarity=0.374 Sum_probs=129.8
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
+.||+|+||.||+|... +++.+|||.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 4889999976
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 23348999998 999999999999999999999999999875432 2234
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.++..|++||.+.+..++.++||||||+++|+|++|..||...... ........ .... .........
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~------~~~~~~~~~ 220 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILS-RRIN------WPEEVKEFC 220 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-cccC------CCCcccccC
Confidence 5788999999998888899999999999999999999999643221 11111111 1100 000011112
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
...+.+++.+||+.||++||++.++.+.|..
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 3468899999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=220.28 Aligned_cols=188 Identities=23% Similarity=0.347 Sum_probs=132.4
Q ss_pred CCCccceeccCCcEEEEEEEeCC---CcEEEEEEe---------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD---GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~---~~~vavK~~--------------------------------------------- 183 (408)
+|...+.||+|+||.||++.... +..+|||.+
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999753 678999975
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 23448999998 999999999999999999999999999986543
Q ss_pred CCcc---eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC------
Q 015360 231 ERSY---VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS------ 300 (408)
Q Consensus 231 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------ 300 (408)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||....... ....+......
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 2211 1123468899999998765 468899999999999999999999997543211 11100000000
Q ss_pred -----CCcc-------cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 301 -----RKSE-------EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 301 -----~~~~-------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.... ......+.. ........+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000000 00011346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=212.30 Aligned_cols=189 Identities=23% Similarity=0.288 Sum_probs=134.3
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+|... +++.|+||.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999975 5889999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++++|.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 33448999998 999999999999999999999999999987644322
Q ss_pred ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC---------Cc
Q 015360 234 YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---------KS 303 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 303 (408)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||....... ............ ..
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 158 K-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred c-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccc
Confidence 1 122346788999998854 457889999999999999999988876443221 111111110000 00
Q ss_pred ccccCCCCCCCC-----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 EEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
............ .......+.+++.+||+.||++|||+.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 11224568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=209.71 Aligned_cols=142 Identities=26% Similarity=0.417 Sum_probs=105.2
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccC-CCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS 264 (408)
.+|.|||+. +++|+||||+||+++.++.++|+|||++........ ....|+..|+|||.+.++ .++.++||||
T Consensus 108 ~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 181 (278)
T cd05606 108 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFS 181 (278)
T ss_pred HHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cCcCCCcCCcCcHHhcCCCCCCcccchHh
Confidence 348999998 999999999999999999999999999875532221 234688999999998754 6889999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-----
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP----- 339 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----- 339 (408)
|||++|+|++|+.||........... ..... ...+.++.. ....+.+++.+||..||.+||
T Consensus 182 ~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~~~~~~~----~s~~~~~li~~~l~~~p~~R~~~~~~ 247 (278)
T cd05606 182 LGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGR 247 (278)
T ss_pred HHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccCCCCCCc----CCHHHHHHHHHHhhcCHHhccCCCCC
Confidence 99999999999999975433221111 11000 011112211 134678889999999999999
Q ss_pred CHhHHHHH
Q 015360 340 KMGHVIHM 347 (408)
Q Consensus 340 s~~evl~~ 347 (408)
++.++++.
T Consensus 248 ~~~~ll~~ 255 (278)
T cd05606 248 GAQEVKEH 255 (278)
T ss_pred CHHHHHhC
Confidence 89898863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=210.38 Aligned_cols=179 Identities=26% Similarity=0.390 Sum_probs=131.5
Q ss_pred CCCccceeccCCcEEEEEEEe----CCCcEEEEEEe--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~----~~~~~vavK~~-------------------------------------------- 183 (408)
+|...+.||+|+||.||++.. .+|..+|+|.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 36889999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 33448999998 999999999999999999999999999976543
Q ss_pred CCcceecccccccCcccccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
..........++..|+|||.+... .++.++||||||+++|+|++|+.||....... .............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~------- 228 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE------- 228 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC-------
Confidence 332222335588899999998753 46789999999999999999999996433221 1122222111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~ 346 (408)
+..+ ......+.+++.+||+.||++|| ++.+++.
T Consensus 229 ~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 PPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111 11223678899999999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=207.56 Aligned_cols=190 Identities=24% Similarity=0.318 Sum_probs=132.6
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|.+.+.||+|+||+||+|+..+ +..++||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567899999999999999864 788999975
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 23348999998 999999999999999999999999999986643222 2
Q ss_pred cccccccCcccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH----------HHHHHHhcCCCccc
Q 015360 237 TRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTMVGSRKSEE 305 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~~~~ 305 (408)
....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+..... .|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2345788999999875 455789999999999999999999999654322110000 01110000000000
Q ss_pred ccCCCCCC---CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 306 VVDPKLPK---MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 306 ~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........ .........+.+++.+||+.||++|||++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 0000113468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=225.49 Aligned_cols=184 Identities=31% Similarity=0.515 Sum_probs=138.5
Q ss_pred CCCccceeccCCcE-EEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYG-IVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g-~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
-|...+++|.|+.| .||+|.+ +|+.||||++
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS 588 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh
Confidence 35555789999998 5999999 5999999988
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---C--CceEEeccCCceeecCCC
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---Q--WNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~--~~~kL~Dfg~a~~~~~~~ 232 (408)
+..||++||+. +||||||||.||||+. + ..++|+|||+++.+....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 33459999997 9999999999999965 2 568999999999987655
Q ss_pred cce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 233 SYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITG-RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 233 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
... .....||.+|+|||.+....-+.++||||+||++|+.++| .+||......+. .++........
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~--- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH--- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee---
Confidence 443 2356799999999999998888899999999999999995 899975432211 11111110000
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCccchhhh
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 359 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~~~~~~~ 359 (408)
+. +..++ ...+||.+|++.||..||++.+|+.+ ..+|..+.
T Consensus 735 -L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H----PlFW~~ek 775 (903)
T KOG1027|consen 735 -LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH----PLFWDSEK 775 (903)
T ss_pred -ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC----CccCChHH
Confidence 10 11111 57789999999999999999999874 44555544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=209.82 Aligned_cols=179 Identities=25% Similarity=0.318 Sum_probs=136.4
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||.|.-|+||.+.+++ +...|+|.+
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35555889999999999999975 489999988
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC---
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--- 230 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~--- 230 (408)
+.-||+|||.. |||+|||||+||||.++|.+.|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 22349999999 999999999999999999999999998743210
Q ss_pred ------------------------------C-C---------------------cceecccccccCcccccccccCCCCc
Q 015360 231 ------------------------------E-R---------------------SYVTTRVMGTFGYVAPEYACTGMLNE 258 (408)
Q Consensus 231 ------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 258 (408)
. . ......++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 00112356899999999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC
Q 015360 259 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338 (408)
Q Consensus 259 ~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 338 (408)
++|.|+|||++||||.|..||......+. +.+ .+.. +..++.. ......+.+||.+.|.+||.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~N----Iv~~-------~l~Fp~~--~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRN----IVGQ-------PLKFPEE--PEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHH----HhcC-------CCcCCCC--CcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999987654432 211 1111 1122222 2344568899999999999999
Q ss_pred CC----HhHHHHHH
Q 015360 339 PK----MGHVIHML 348 (408)
Q Consensus 339 ps----~~evl~~L 348 (408)
.. +.||-+.-
T Consensus 380 lg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHP 393 (459)
T ss_pred hccccchHHhhcCc
Confidence 98 77775543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=216.83 Aligned_cols=196 Identities=24% Similarity=0.353 Sum_probs=138.2
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------- 183 (408)
++...+++|...+.||.|+||.||++... ++..+|||++
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34457789999999999999999999854 6889999965
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 23448999998 999999999999999999999999999875432
Q ss_pred CCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh---------HHHHHHHhcC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL---------VDWLKTMVGS 300 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~---------~~~~~~~~~~ 300 (408)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... .++.......
T Consensus 161 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 161 QM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred Cc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 11 22456788999998765 5688999999999999999999999975432111000 0000000000
Q ss_pred CCcccccCCCCCC-CCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 301 RKSEEVVDPKLPK-MPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 301 ~~~~~~~d~~~~~-~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+....... .+.. .....+.+++.+||+.+|++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 0001 123468899999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=221.28 Aligned_cols=172 Identities=27% Similarity=0.333 Sum_probs=135.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
++.|.....+|.|+|+.|-++... .++..+||++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 567777888999999999988854 4677888876
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEe-CCCCceEEeccCCceeecCCCcceeccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..++.|||++ ++|||||||+|||+ +..+.++|+|||.++..... ....
T Consensus 401 ~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp 473 (612)
T KOG0603|consen 401 GELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTP 473 (612)
T ss_pred cHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hccc
Confidence 33459999998 99999999999999 58899999999999876544 2223
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
+-|..|.|||++....|++++|+||||++||+||+|+.||...... .+ +...+.... . ....
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~--------~----s~~v 535 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPK--------F----SECV 535 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCc--------c----cccc
Confidence 4678999999999999999999999999999999999999765443 11 111111111 1 1223
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+|+.+||+.||.+||+|.++..
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 346778888999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=214.17 Aligned_cols=174 Identities=28% Similarity=0.413 Sum_probs=130.8
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||.||+|+.. ++..++||.+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3555678999999999999965 4788999875
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 23348999998 9999999999999999999999999998765432
Q ss_pred ecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 236 TTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||...... .......... . +..
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~~- 234 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-S-----PAL- 234 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcC-C-----CCc-
Confidence 2245788999999874 356788999999999999999999998543211 1111111110 0 111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
........+.+++.+||+.+|++||++.++++..
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1112234578899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=204.75 Aligned_cols=176 Identities=23% Similarity=0.416 Sum_probs=133.7
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++..+. +..+++|.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47778999999999999999764 788999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||||+||+++.++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 23448999998 999999999999998875 469999999876643322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ...+........ . .+ ...
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~----~~-~~~ 224 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY-F----AP-ISP 224 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc-C----CC-CCC
Confidence 1223458889999999988889999999999999999999999986432 122222222111 1 11 111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+.+++.+||+.+|++|||+.||++.
T Consensus 225 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 ----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112367888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=211.08 Aligned_cols=183 Identities=30% Similarity=0.434 Sum_probs=137.9
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
..+++|...+.||+|+||.||+|... ++..+++|.+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45677888899999999999999986 5888999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 33448999998 999999999999999999999999998865533221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......++..|++||.+.+..++.++|||||||++|+|++|+.||....+.. ....... .......+
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~------ 238 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITT-KGIPPLKN------ 238 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCCCCcc------
Confidence 1123457789999999988889999999999999999999999986432211 1111111 11111000
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.......+.+++.+||+.+|.+||++.++++..
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 111234678899999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=204.49 Aligned_cols=174 Identities=28% Similarity=0.353 Sum_probs=135.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||++... +++.++||.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999854 5788999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 23348999998 9999999999999999999999999999776443
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.. .+.. ........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~-------- 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKYP-------- 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCCC--------
Confidence 122245788999999999888999999999999999999999999644321 1111 11111111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ........+.+++.+||+.+|++||++.|+++.
T Consensus 220 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 P-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred C-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 111334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=210.13 Aligned_cols=187 Identities=25% Similarity=0.414 Sum_probs=132.9
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|++|.||+|+.. ++..+|||.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 4889999975
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 33448999998 999999999999999999999999999875532211 1
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC---------Cccc
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---------KSEE 305 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 305 (408)
.....++..|++||.+.+ ..++.++|||||||++|+|++|+.||......+. ...+....... ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcCch
Confidence 122346789999998865 4578899999999999999999999975443211 11111000000 0000
Q ss_pred ccCCCCCCCC-------cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 306 VVDPKLPKMP-------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 306 ~~d~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. ...+... .......+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000000 0112346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=209.60 Aligned_cols=170 Identities=24% Similarity=0.360 Sum_probs=132.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
.+|.+..+||+|+||.|..+.-+. .+.+|||++
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999998653 567888876
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++-+|-|||++ +|++||||.+||+||.+|.+||+|||+++.---. .
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~ 504 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-G 504 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC-C
Confidence 34458999999 9999999999999999999999999999753222 2
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
..+...+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..+..+ +-+.+. +.. .
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI~------------ehn--v 567 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAIM------------EHN--V 567 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH------------Hcc--C
Confidence 23456889999999999999999999999999999999999999998655332 111111 111 1
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
.++.....+...++...|...|.+|...
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 2223334466777888899999999743
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=211.96 Aligned_cols=172 Identities=28% Similarity=0.428 Sum_probs=129.0
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||+||+|+.. ++..++||.+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555578999999999999964 4889999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||+|+||+++.++.+||+|||++..... .
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 23448999998 999999999999999999999999998864322 1
Q ss_pred cccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 237 TRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
....++..|+|||++. ...++.++|||||||++|+|++|..||....... ......... . +...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~-----~~~~- 241 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND-S-----PTLQ- 241 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-C-----CCCC-
Confidence 2345788999999974 4568889999999999999999999986433211 111111111 0 1111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 --~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112357789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=202.27 Aligned_cols=161 Identities=24% Similarity=0.327 Sum_probs=111.5
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCC----CceEEeccCCceeecCCCcc--eecccccccCcccccccccC-CC
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACTG-ML 256 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~----~~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~ 256 (408)
+.+++.|||++ =|+||||||.|||+..+ |.+||+|||+++.+...-.. ....++-|..|+|||.+.+. .|
T Consensus 141 il~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hY 217 (438)
T KOG0666|consen 141 ILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHY 217 (438)
T ss_pred HHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccc
Confidence 44559999999 99999999999999766 89999999999987544322 23456789999999999875 58
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCCc------chhHHHHHHHhcCCCcccccCCCCCCCCcH-------------
Q 015360 257 NEKSDVYSFGILIMEIITGRNPVDYSRPQGE------VNLVDWLKTMVGSRKSEEVVDPKLPKMPAS------------- 317 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~------------- 317 (408)
+.+.|||++|||+.||+|-++.|......-. .+..+.+...++......+ |.+...+.-
T Consensus 218 T~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~W--p~lkk~Pe~q~~ls~f~~~~~~ 295 (438)
T KOG0666|consen 218 TKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDW--PDLKKMPEYQTLLSDFRRHYYD 295 (438)
T ss_pred cchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccc--hhhhhCcchHHHHHHhHHhhcC
Confidence 9999999999999999999888865432111 1112222222222211111 111111000
Q ss_pred -----H-------HHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 318 -----K-------ALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 318 -----~-------~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
. -....++|+.++|+.||-+|.|+++.++..-
T Consensus 296 n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 296 NVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred cchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 0 0012568899999999999999999987543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=206.41 Aligned_cols=177 Identities=24% Similarity=0.357 Sum_probs=132.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.||+|... ++..+++|.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999964 4889999964
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 23348999998 999999999999999999999999999976532
Q ss_pred CC--cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 231 ER--SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 231 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.. ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... . .+....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~-~~~~~~~~~-----~~ 227 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----A-AIFKIATQP-----TK 227 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----H-HHHHHHcCC-----CC
Confidence 11 11112345788999999998888999999999999999999999999643211 1 111111110 01
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+.+ +......+.+++.+||+ +|..||++.+++.
T Consensus 228 ~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 PML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 12233467888899999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=200.93 Aligned_cols=178 Identities=29% Similarity=0.450 Sum_probs=136.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|++|.||+|... ++..++||..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999986 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 23448999998 9999999999999999999999999999876544321
Q ss_pred -eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 235 -VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 235 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
......++..|++||.+....++.++||||||+++|+|++|..||..... .............. +.+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~-- 225 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP-----PEI-- 225 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC-----cCC--
Confidence 12334578899999999888899999999999999999999999975441 11111111110000 111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.......+.+++.+||+.||++||++.++++
T Consensus 226 --~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 --PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112346888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=207.80 Aligned_cols=172 Identities=28% Similarity=0.458 Sum_probs=129.9
Q ss_pred ceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------------- 183 (408)
.+||+|+||.||++... ++..+|||.+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 5889999975
Q ss_pred -------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccC
Q 015360 184 -------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 244 (408)
Q Consensus 184 -------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~ 244 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||++........ ......++..
T Consensus 106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~ 181 (292)
T cd06657 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPY 181 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCcc
Confidence 33448999998 999999999999999999999999999876543221 1223457889
Q ss_pred cccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHH
Q 015360 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 324 (408)
Q Consensus 245 y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 324 (408)
|++||.+.+..++.++|+||||+++|+|++|..||...... .....+.. . ..+.+... ......+.
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~----~-----~~~~~~~~--~~~~~~l~ 247 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----N-----LPPKLKNL--HKVSPSLK 247 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----h-----CCcccCCc--ccCCHHHH
Confidence 99999998888999999999999999999999998643221 11111111 0 00111000 11123577
Q ss_pred HHHHhccCcCCCCCCCHhHHHH
Q 015360 325 LVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 325 ~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+++.+||+.||.+||++.+++.
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhc
Confidence 8899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=202.92 Aligned_cols=176 Identities=27% Similarity=0.455 Sum_probs=136.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||.|+||.||++... ++..+++|.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999975 4889999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 23348899998 99999999999999999999999999997764433
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.......+++.|+|||.+....++.++|+||+|+++|+|++|+.||..... ......... ... +.++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~-----~~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK-GQY-----PPIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc-CCC-----CCCC
Confidence 222334678899999999888899999999999999999999999864331 111111111 111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .....+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 122367889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=203.98 Aligned_cols=144 Identities=26% Similarity=0.375 Sum_probs=106.8
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
..+|.|||+. +++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+....++.++|+||
T Consensus 103 ~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s 177 (262)
T cd05572 103 VLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177 (262)
T ss_pred HHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhh
Confidence 3458999998 99999999999999999999999999998764432 122345788999999998888999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC----
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---- 340 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---- 340 (408)
||+++|+|++|..||...... ............. ....+. .....+.+++.+||+.||++||+
T Consensus 178 lG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~~ 244 (262)
T cd05572 178 LGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG-----KLEFPN----YIDKAAKDLIKQLLRRNPEERLGNLKG 244 (262)
T ss_pred hHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC-----CCCCCc----ccCHHHHHHHHHHccCChhhCcCCccc
Confidence 999999999999999754421 1112222111000 011111 11346889999999999999999
Q ss_pred -HhHHHH
Q 015360 341 -MGHVIH 346 (408)
Q Consensus 341 -~~evl~ 346 (408)
++|+++
T Consensus 245 ~~~~l~~ 251 (262)
T cd05572 245 GIKDIKK 251 (262)
T ss_pred CHHHHhc
Confidence 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=205.03 Aligned_cols=187 Identities=26% Similarity=0.369 Sum_probs=132.8
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|+..+ ++.+++|.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4456789999999999999764 899999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 23448999998 999999999999999999999999999876543322 122
Q ss_pred ccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC---------c--cc
Q 015360 238 RVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---------S--EE 305 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~--~~ 305 (408)
...++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+........ . ..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccccccc
Confidence 23456789999998766 78899999999999999999999996543211 1111111110000 0 00
Q ss_pred ccCCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 306 VVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 306 ~~d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..-+....... ......+.+++.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 011346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=206.74 Aligned_cols=176 Identities=26% Similarity=0.390 Sum_probs=134.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.. +++.++||..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999975 5899999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 23348999998 999999999999999999999999999876543321
Q ss_pred -------------------ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 015360 234 -------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294 (408)
Q Consensus 234 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~ 294 (408)
.......++..|++||.+....++.++||||||++++++++|+.||...... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~---~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT---F 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH---H
Confidence 1122345788999999998888999999999999999999999999744311 11 1
Q ss_pred HHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH----hHHHH
Q 015360 295 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM----GHVIH 346 (408)
Q Consensus 295 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~evl~ 346 (408)
..... . ...++. .....+.+++.+||+.||.+||++ +++++
T Consensus 232 ~~~~~-~------~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILK-L------EYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHh-c------CCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 001111 113467889999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=212.04 Aligned_cols=189 Identities=26% Similarity=0.379 Sum_probs=135.6
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|... +++.+|||.+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578889999999999999999975 4788999975
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 23348999998 99999999999999999999999999987653
Q ss_pred CCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC------
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------ 302 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------ 302 (408)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+........
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHhh
Confidence 32 223457889999998865 467889999999999999999999997543221 1111111100000
Q ss_pred -----cccccCC--CC-CCCC---cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 -----SEEVVDP--KL-PKMP---ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 -----~~~~~d~--~~-~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...++.. .. .... .......+.+++.+||+.||++|||+.||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 00 0000 00123468899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=231.07 Aligned_cols=198 Identities=22% Similarity=0.303 Sum_probs=149.0
Q ss_pred eHHHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-------------------------------------
Q 015360 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------- 183 (408)
Q Consensus 142 ~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------- 183 (408)
.+.+|+...++|.+.++||+|+||.|...+.+. ++.+|.|++
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 366788888999999999999999999999754 788999987
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCc
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a 225 (408)
+.-||.-||+. |+|||||||+|||||..|.+||+|||.|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 12237778877 9999999999999999999999999999
Q ss_pred eeecCCCcceecccccccCcccccccc----c-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 226 KLLCSERSYVTTRVMGTFGYVAPEYAC----T-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
..+...........+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||.... ++.-...++..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~h 296 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNH 296 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhch
Confidence 888777777777789999999999986 2 568999999999999999999999997432 22222222221
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC---HhHHHHHHhcCCccch
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MGHVIHMLEADDLLFR 356 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~Le~~~~~~~ 356 (408)
.....+. ...+......+||.+.+ -+|+.|.. ++++-.+.-....-|.
T Consensus 297 k~~l~FP-------~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 297 KESLSFP-------DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred hhhcCCC-------cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChh
Confidence 1111111 11223345556665544 47888888 8888776655555553
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=216.27 Aligned_cols=191 Identities=21% Similarity=0.308 Sum_probs=130.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||.|+||.||+|... ++..|+||.+
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999999999999974 4788999865
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCC
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGL 224 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~ 224 (408)
+..+|.|||+. +++|+||||+||+++ .++.+||+|||+
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCccc
Confidence 23348999998 999999999999997 456789999999
Q ss_pred ceeecCCCcc--eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC-
Q 015360 225 AKLLCSERSY--VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS- 300 (408)
Q Consensus 225 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 300 (408)
+......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+.... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 239 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILESVPVVR 239 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCC
Confidence 8765322111 1122347889999998654 56788999999999999999999999644321110 0000000000
Q ss_pred --------CCc-cccc-CCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 301 --------RKS-EEVV-DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 301 --------~~~-~~~~-d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
... .... .......+. ......+.+++.+||+.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000 000000000 012246788999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=204.83 Aligned_cols=174 Identities=27% Similarity=0.456 Sum_probs=130.5
Q ss_pred eccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------------------------
Q 015360 159 IGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------------------ 183 (408)
Q Consensus 159 lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------------------ 183 (408)
||.|+||.||++...+ ++.+++|.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 899999976
Q ss_pred ---------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-------ce
Q 015360 184 ---------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YV 235 (408)
Q Consensus 184 ---------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-------~~ 235 (408)
+..+|+|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 33448999998 999999999999999999999999999875433211 11
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....++..|++||.+....++.++||||||+++|++++|+.||...... ........ .... .+...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~------~~~~~ 224 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKIE------WPEDV 224 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCcC------CCccc
Confidence 22345778999999998888999999999999999999999999643321 11111111 1110 00000
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 225 --~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 --EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 013467889999999999999999777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=200.16 Aligned_cols=175 Identities=30% Similarity=0.535 Sum_probs=134.0
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...+.||+|+||.||+++.. +++.++||.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677789999999999999865 4788999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 23448999998 9999999999999999999999999999876543332 2
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
....++..|+|||...+..++.++|||+||+++|+|++|+.||..... ..... ... .... +.++.
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~-~~~~-----~~~~~--- 221 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF-RIV-QDDH-----PPLPE--- 221 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-HHh-ccCC-----CCCCC---
Confidence 234578899999999888889999999999999999999999864331 11111 111 1110 11111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.....+.+++.+||+.+|++|||+.+++.
T Consensus 222 -~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 -GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12336788999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=204.86 Aligned_cols=145 Identities=29% Similarity=0.357 Sum_probs=103.4
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|.|||+. +++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||||
T Consensus 106 ~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 180 (277)
T cd05577 106 CGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180 (277)
T ss_pred HHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccccCCCCcCCHHHhcCCCCCchhhhHHH
Confidence 348999998 999999999999999999999999999876533211 223457789999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH-H
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH-V 344 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e-v 344 (408)
||++|+|++|+.||.......... .+..... .. ....+ ......+.+++.+||+.||.+||+..| .
T Consensus 181 G~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~----~~--~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 247 (277)
T cd05577 181 GCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTL----EM--AVEYP----DKFSPEAKDLCEALLQKDPEKRLGCRGGS 247 (277)
T ss_pred HHHHHHHhhCCCCCCCCcccccHH---HHHhccc----cc--cccCC----ccCCHHHHHHHHHHccCChhHccCCCccc
Confidence 999999999999996544321111 1111000 00 00111 112336788999999999999995544 3
Q ss_pred HHHH
Q 015360 345 IHML 348 (408)
Q Consensus 345 l~~L 348 (408)
...|
T Consensus 248 ~~~l 251 (277)
T cd05577 248 ADEV 251 (277)
T ss_pred HHHH
Confidence 3333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=220.02 Aligned_cols=144 Identities=27% Similarity=0.462 Sum_probs=109.7
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
|.++|.|||++ .|+|+|||||-+||+|+.+ |.|||+|+|+|....... ...+.|||.|||||... ..|+..+||
T Consensus 152 ILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDV 226 (632)
T KOG0584|consen 152 ILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDV 226 (632)
T ss_pred HHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhh
Confidence 66779999995 8899999999999999755 889999999998764332 23378999999999886 789999999
Q ss_pred hhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 263 YSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 263 wSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
||||++++||+|+..||.-.. +..+..+......+ ..-+. .-.-.++.++|.+||.. ..+|||+.
T Consensus 227 YaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiK-P~sl~--------kV~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 227 YAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIK-PAALS--------KVKDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred hhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCC-HHHhh--------ccCCHHHHHHHHHHhcC-chhccCHH
Confidence 999999999999999996433 22222222222211 11111 11112578899999999 99999999
Q ss_pred HHHHH
Q 015360 343 HVIHM 347 (408)
Q Consensus 343 evl~~ 347 (408)
|+|+.
T Consensus 292 eLL~d 296 (632)
T KOG0584|consen 292 ELLKD 296 (632)
T ss_pred HHhhC
Confidence 99874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=210.65 Aligned_cols=158 Identities=23% Similarity=0.323 Sum_probs=103.8
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce------ecccccccCcccccccccC--CC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV------TTRVMGTFGYVAPEYACTG--ML 256 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~ 256 (408)
..+|+|||+. +++||||||+|||++.++.++++||+.+.......... .....++..|+|||++.+. .+
T Consensus 111 ~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (328)
T cd08226 111 LRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY 187 (328)
T ss_pred HHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCC
Confidence 4459999998 99999999999999999999999997654321111100 0112245679999998763 47
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH--------------------------------HhcCCCcc
Q 015360 257 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT--------------------------------MVGSRKSE 304 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~ 304 (408)
+.++|||||||++|+|++|+.||....... ........ ........
T Consensus 188 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (328)
T cd08226 188 NVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQ 265 (328)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccc
Confidence 889999999999999999999997543211 00000000 00000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...+..+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 266 TMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111111111223345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=210.02 Aligned_cols=191 Identities=26% Similarity=0.382 Sum_probs=135.0
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------ 183 (408)
....++|...+.||+|+||.||++... ++..||||.+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999854 5889999975
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+..+|+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 22348999998 999999999999999999999999999876
Q ss_pred ecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH----------H
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK----------T 296 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~----------~ 296 (408)
..... ....+++.|++||.+.+ ..++.++|+|||||++|++++|+.||........ +..... .
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHH
Confidence 53221 22457889999998875 4588899999999999999999999974432110 000000 0
Q ss_pred HhcCCCcccccC--CCCCC----CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 297 MVGSRKSEEVVD--PKLPK----MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 297 ~~~~~~~~~~~d--~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+.......... +.... .........+.+++.+||+.||++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00000 000112235788999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=225.94 Aligned_cols=148 Identities=28% Similarity=0.487 Sum_probs=113.0
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceeccccc--ccCcccccccccCCCCccccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG--TFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv 262 (408)
+.+++||++. ++|||||-.+|||+..+..+||+|||+++.......+......+ ...|||||.+....|+.++||
T Consensus 428 a~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV 504 (609)
T KOG0200|consen 428 ANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV 504 (609)
T ss_pred HHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchh
Confidence 3458888888 89999999999999999999999999999765555544332222 346999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
||||++||||+| |..||...... .++.+ .+..+... ..+..+..++.+++..||+.+|++||++
T Consensus 505 WSfGI~L~EifsLG~~PYp~~~~~--~~l~~----~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F 569 (609)
T KOG0200|consen 505 WSFGILLWEIFTLGGTPYPGIPPT--EELLE----FLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTF 569 (609)
T ss_pred hHHHHHHHHHhhCCCCCCCCCCcH--HHHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 999999999999 88998742211 12222 22222211 1122234478899999999999999999
Q ss_pred hHHHHHHhc
Q 015360 342 GHVIHMLEA 350 (408)
Q Consensus 342 ~evl~~Le~ 350 (408)
.|+.+.++.
T Consensus 570 ~~~~~~~~~ 578 (609)
T KOG0200|consen 570 SECVEFFEK 578 (609)
T ss_pred HHHHHHHHH
Confidence 999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=217.99 Aligned_cols=190 Identities=26% Similarity=0.357 Sum_probs=135.9
Q ss_pred cceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------------- 183 (408)
.+.||+|+||.||+|+.+ .|+.||||.+
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 368999999999999954 5999999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC--CCC--ceEEeccCCceee
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD--RQW--NARVSDFGLAKLL 228 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~--~~~--~~kL~Dfg~a~~~ 228 (408)
+..||.|||++ +|+||||||.||++- .++ ..||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 34459999999 999999999999983 323 4799999999988
Q ss_pred cCCCcceecccccccCcccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
.++. .....+||..|++||... ...|+..+|.|||||++|+++||..||.............|..............
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 6554 445688999999999998 4889999999999999999999999996544332212222222111111100000
Q ss_pred CC----------CC--CCCCcHHHHHHHHHHHHhccCcCCCCCC--CHhHHHHHHhc
Q 015360 308 DP----------KL--PKMPASKALKRVLLVALRCVDPDATKRP--KMGHVIHMLEA 350 (408)
Q Consensus 308 d~----------~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rp--s~~evl~~Le~ 350 (408)
.+ .+ +.........++-.++..+|..||++|. ...+....+..
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 00 11 1222334455677777788999999999 66666655544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-26 Score=215.53 Aligned_cols=171 Identities=27% Similarity=0.453 Sum_probs=138.6
Q ss_pred cceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------------- 183 (408)
.++||.|-||+||-|+.+ +|+.||||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 479999999999999965 5999999987
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC---CceEEeccCCceeecCCCccee
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
|..+|.|||.+ +|+|+||||+||||... -++||||||+|+.+.... ..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 34459999999 99999999999999644 469999999999985432 23
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...+||+.|+|||++.+..|...-|+||.|||+|--++|..||.... ++.+.++. .. -..+..+.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQN-------Aa---FMyPp~PW 788 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQN-------AA---FMYPPNPW 788 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhc-------cc---cccCCCch
Confidence 45789999999999999999999999999999999999999996332 22222221 11 12344555
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+.....++||...|+..-.+|.|.+..+.
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 666778899999999999999999988765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=197.19 Aligned_cols=194 Identities=22% Similarity=0.389 Sum_probs=143.9
Q ss_pred CCccceeccCCcEEEEEEEe-CCCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~------------------------------------------------ 183 (408)
....+.||-|.||.||..+. ++|+.||+|++
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44558999999999999885 46999999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+.++|.|||+. +|+||||||.|.|++.|..+||+|||+++.......
T Consensus 135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 45669999999 999999999999999999999999999998766665
Q ss_pred ceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc--------
Q 015360 234 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE-------- 304 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 304 (408)
...+..+-|..|.|||++.+. .|+...||||.|||+.|++..+..|+...+....+++. .+++....+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt---dLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII---DLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH---HHhCCCcHHHHHHHhhh
Confidence 555666678999999999874 58999999999999999999999998766544333222 221111100
Q ss_pred ---ccc-----CCCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 305 ---EVV-----DPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 305 ---~~~-----d~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
-++ .|.+...+ ....-.+.+.+.+.++..||++|.+..+.+..+....
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 000 11111100 1111234556777899999999999999988775543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=209.07 Aligned_cols=154 Identities=20% Similarity=0.282 Sum_probs=104.5
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC-------------cceecccccccCccccccccc
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-------------SYVTTRVMGTFGYVAPEYACT 253 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~ 253 (408)
+|.|||+. +++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+
T Consensus 131 aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 131 GLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred HHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 38999998 99999999999999999999999999987654110 011112346788999999876
Q ss_pred C-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc-----------cCCCCCCCC---cHH
Q 015360 254 G-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV-----------VDPKLPKMP---ASK 318 (408)
Q Consensus 254 ~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~d~~~~~~~---~~~ 318 (408)
. .++.++|||||||++|||++|+.||......+ ....+...........+ .....+... ...
T Consensus 208 ~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (335)
T PTZ00024 208 AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN 284 (335)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcC
Confidence 4 46889999999999999999999997544321 11112111111100000 000000000 011
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+++.+||+.||++|||++|++.
T Consensus 285 ~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 285 ASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2346789999999999999999999987
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=197.15 Aligned_cols=184 Identities=22% Similarity=0.297 Sum_probs=138.8
Q ss_pred HhcCCCcc-ceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 149 ATSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~-~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
.|++|.+. ++||-|-.|.|..+..+ .+++.|+|.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 34555443 68999999999988864 4777888866
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceeec
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~~ 229 (408)
|..++.|||+. +|.||||||+|+|.. .|..+||+|||+|+...
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 45569999999 999999999999995 45679999999998764
Q ss_pred CCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
... .....+.|+.|.|||++...+|+...|+||+||++|-|++|.+||....... +.--++..+..+. -
T Consensus 216 ~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq------y 284 (400)
T KOG0604|consen 216 EPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ------Y 284 (400)
T ss_pred CCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC------c
Confidence 322 2334568999999999999999999999999999999999999997543321 1111222221111 1
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.++........+...++|..+|..+|.+|.|+.|++.
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2333334456677888999999999999999999976
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=202.26 Aligned_cols=159 Identities=21% Similarity=0.298 Sum_probs=106.6
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc------ceecccccccCccccccccc--CCC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------YVTTRVMGTFGYVAPEYACT--GML 256 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~ 256 (408)
..+|.|||+. +|+|+||||+||+++.++.+||+|||.+........ .......++..|+|||.+.. ..+
T Consensus 111 ~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (314)
T cd08216 111 LNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY 187 (314)
T ss_pred HHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCC
Confidence 4459999998 999999999999999999999999998875532211 11123446778999999865 357
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh----cCC-------Ccc----cccCCCC----CCCCcH
Q 015360 257 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV----GSR-------KSE----EVVDPKL----PKMPAS 317 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~----~~~-------~~~----~~~d~~~----~~~~~~ 317 (408)
+.++|||||||++|||++|+.||....... ...+...... ... ... ...++.. ......
T Consensus 188 ~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (314)
T cd08216 188 NEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265 (314)
T ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhh
Confidence 889999999999999999999997533211 1111110000 000 000 0001100 011112
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.....+.+++.+||+.||++|||++|+++.-
T Consensus 266 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 266 TFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred HHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 2335678899999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-26 Score=200.26 Aligned_cols=162 Identities=24% Similarity=0.333 Sum_probs=111.0
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce---ecccccccCccccccccc-CCCCcccc
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACT-GMLNEKSD 261 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sD 261 (408)
++|.|+|.. .|+|||+|+.|+|++.++.+||+|||+++.+....... .+..+-|..|++||.+.+ ..|+++.|
T Consensus 135 ~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iD 211 (376)
T KOG0669|consen 135 NGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPID 211 (376)
T ss_pred HHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcch
Confidence 449999999 99999999999999999999999999997653322211 233456899999999876 46899999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc--------c-CCCCCCCC---cHHHH------HHH
Q 015360 262 VYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV--------V-DPKLPKMP---ASKAL------KRV 323 (408)
Q Consensus 262 vwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-d~~~~~~~---~~~~~------~~l 323 (408)
||..|||+.||+|+.+-++.........++..+-.......+..+ + -+.++... ..+.+ ...
T Consensus 212 iWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a 291 (376)
T KOG0669|consen 212 IWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEA 291 (376)
T ss_pred hHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhH
Confidence 999999999999999988766544333332221111111111100 0 00010000 01111 256
Q ss_pred HHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 324 LLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 324 ~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
++|+..++..||.+|+++++++..--.
T Consensus 292 ~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 292 LDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred HHHHHHHhccCcccCcchHhhhchhhh
Confidence 788889999999999999999875543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=180.98 Aligned_cols=192 Identities=20% Similarity=0.277 Sum_probs=136.5
Q ss_pred CCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~----------------------------------------------- 183 (408)
+|...++||+|.||+||+|+..+ ++.||+|++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34556799999999999999554 889999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+.++|.|+|++ +++||||||.|.|++.+|.+||+|||+++..+-.... .
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc-y 158 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-Y 158 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-e
Confidence 34458999998 9999999999999999999999999999876443322 2
Q ss_pred cccccccCcccccccccCC-CCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCc---ccccCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKS---EEVVDPKL 311 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~~~ 311 (408)
...+-|..|.+|.++.+.+ |+...|+||.||++.|+.. |++.|+..+..+....+-|+.....+..+ ..+.|-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 3345689999999988755 8899999999999999987 77778765543322222222222222222 22222222
Q ss_pred CCCCcH-----HHH----HHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPAS-----KAL----KRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~-----~~~----~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+.++. ... ..-.+++++.|.-+|.+|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111 111 233578888889999999999988764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=209.78 Aligned_cols=136 Identities=29% Similarity=0.388 Sum_probs=108.9
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.++++|||.+ +||+|||||+|++|+.+|-+||.|||+|+.+.... .+.+++||+.|.|||++.+...+..+|.||
T Consensus 530 ~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWa 604 (732)
T KOG0614|consen 530 LEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWA 604 (732)
T ss_pred HHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHH
Confidence 3459999999 99999999999999999999999999999886543 346689999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
||+++|||++|.+||...++....+++-.-. ..+- .+....+...+|+.+.+..+|.+|..
T Consensus 605 LGIli~ELL~G~pPFs~~dpmktYn~ILkGi--------d~i~-------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 605 LGILIYELLTGSPPFSGVDPMKTYNLILKGI--------DKIE-------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHHHcCCCCCCCCchHHHHHHHHhhh--------hhhh-------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 9999999999999998877665444331111 1111 11222335677888888999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=196.67 Aligned_cols=140 Identities=23% Similarity=0.425 Sum_probs=104.3
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|.|||+. +++|+||+|+||+++. +.++|+|||++........ ......++..|+|||.+.+..++.++|+|||
T Consensus 117 ~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 191 (260)
T cd08222 117 LGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSL 191 (260)
T ss_pred HHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence 458999998 9999999999999975 5699999999876543222 2223457889999999988888999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
|+++|+|++|..||.... .......... .. .+.. .......+.+++.+||+.||++||++.|++
T Consensus 192 G~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 192 GCILYEMCCLAHAFEGQN------FLSVVLRIVE-GP-----TPSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred HHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CC-----CCCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 999999999999985322 1111111111 10 1111 122334688899999999999999999998
Q ss_pred H
Q 015360 346 H 346 (408)
Q Consensus 346 ~ 346 (408)
+
T Consensus 256 ~ 256 (260)
T cd08222 256 R 256 (260)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=216.47 Aligned_cols=189 Identities=28% Similarity=0.406 Sum_probs=151.4
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~------------------------------------ 183 (408)
..++.+-..++.|.+.++||.|.+|.||+++. ++++.+|||++
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 44566667788999999999999999999984 46899999987
Q ss_pred -------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEe
Q 015360 184 -------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 220 (408)
Q Consensus 184 -------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~ 220 (408)
+..+|.+||.. .++|||||-.|||++.++.+||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 23458999998 99999999999999999999999
Q ss_pred ccCCceeecCCCcceecccccccCcccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 015360 221 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295 (408)
Q Consensus 221 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 295 (408)
|||++..++..... ....+||+.|||||++... .|+..+|+||||++..||--|.+|+.+..+....
T Consensus 166 DFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------- 237 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------- 237 (953)
T ss_pred eeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------
Confidence 99999887654433 3447899999999998643 4778999999999999999999998755443211
Q ss_pred HHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .....|......+.....++.++|..||..|-++||++.++++.
T Consensus 238 --F-----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 --F-----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --c-----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0 11112333333456778899999999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=209.96 Aligned_cols=148 Identities=23% Similarity=0.317 Sum_probs=96.2
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCC-----------
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM----------- 255 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------- 255 (408)
+|.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|||.+....
T Consensus 321 aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~ 397 (507)
T PLN03224 321 GLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMA 397 (507)
T ss_pred HHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhh
Confidence 37788988 9999999999999999999999999999765433222222233578999999875322
Q ss_pred ---------C--CccccchhhHHHHHHHHhCCC-CCCCCCCCC------cchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 256 ---------L--NEKSDVYSFGILIMEIITGRN-PVDYSRPQG------EVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 256 ---------~--~~~sDvwSlGvvl~elltG~~-Pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
+ ..+.||||+||++|+|++|.. ||....... ......|.. ...... + + ....
T Consensus 398 ~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~~----~--~--~~~d 467 (507)
T PLN03224 398 ALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQKY----D--F--SLLD 467 (507)
T ss_pred hhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccCC----C--c--cccc
Confidence 1 124799999999999999875 664321110 011111111 111100 0 0 0111
Q ss_pred HHHHHHHHHHHhccCcCC---CCCCCHhHHHHH
Q 015360 318 KALKRVLLVALRCVDPDA---TKRPKMGHVIHM 347 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP---~~Rps~~evl~~ 347 (408)
.......+|+.++|..+| .+|+|++|++++
T Consensus 468 ~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 468 RNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 123457788889998765 689999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=184.55 Aligned_cols=133 Identities=35% Similarity=0.523 Sum_probs=106.5
Q ss_pred HHHHhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------
Q 015360 146 LEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 146 l~~~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------- 183 (408)
++...+.......||+|+||.|-+-++ .+|+..|+|++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444445555567899999998766654 35999999988
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+..+|.|||++. .++|||+||+|||++.+|++|+||||++-.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 234599999874 899999999999999999999999999987
Q ss_pred ecCCCcceecccccccCccccccccc----CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPVDYS 282 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltG~~Pf~~~ 282 (408)
+.+.-. .+-..|...|||||.+.. ..|+-++||||||+++.||.+++.||+..
T Consensus 199 L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 199 LVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 643322 222457789999998753 36889999999999999999999999744
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=193.10 Aligned_cols=138 Identities=30% Similarity=0.416 Sum_probs=103.3
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
+.+|.|||+. +++|+||+|+||+++.++.++|+|||++....... .......++..|++||...+...+.++|+||
T Consensus 103 ~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~s 178 (250)
T cd05123 103 VLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWS 178 (250)
T ss_pred HHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHH
Confidence 3458999998 99999999999999999999999999987754332 1223355788999999998888899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||+++|++++|+.||..... ......... . ...++.. ....+.+++.+||..||++||++.+
T Consensus 179 lG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~------~~~~~~~----~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 179 LGVLLYEMLTGKPPFYAEDR------KEIYEKILK-D------PLRFPEF----LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-C------CCCCCCC----CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 99999999999999964332 111111111 0 0111111 1236788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=218.04 Aligned_cols=95 Identities=20% Similarity=0.249 Sum_probs=67.9
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 319 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 319 (408)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..++...+.... ..+... ...
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~------~~~~~~il~~~~----~~p~~~----~~~ 606 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETP------QQVFQNILNRDI----PWPEGE----EKL 606 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC----CCCccc----ccC
Confidence 458899999999998999999999999999999999999964321 122222221110 001111 112
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...+.+++.+||..||++||++.|+++.-
T Consensus 607 ~~~~~~~l~~lL~~dP~~R~ta~e~l~h~ 635 (669)
T cd05610 607 SVNAQNAIEILLTMDPTKRAGLKELKQHP 635 (669)
T ss_pred CHHHHHHHHHHcccChhHCcCHHHHHhCH
Confidence 23577788899999999999999998853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=190.89 Aligned_cols=176 Identities=26% Similarity=0.376 Sum_probs=135.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+|+.|..+.+.. .+.+|+|.+
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 568888999999999999998754 788999977
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+.-+|.|||+. +|++||||.+|+|+|..|.+||+|||+++.--...
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g- 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG- 405 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence 22349999999 99999999999999999999999999998643222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC-CCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP-QGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
..+...+||+.|.|||++.+..|....|.|+|||+++||+.|+.||+.-.. ..+.+..+++-+.+.+..+.. |
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---p--- 479 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---P--- 479 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---c---
Confidence 234568899999999999999999999999999999999999999975432 223344455555544433221 1
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
.... .+...++...|+.||.+|..
T Consensus 480 rsls----vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 RSLS----VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ceee----hhhHHHHHHhhcCCcHHhcC
Confidence 1111 13445666788999999864
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=205.09 Aligned_cols=178 Identities=22% Similarity=0.315 Sum_probs=138.4
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------- 183 (408)
.-...|.+...||+|.|+.|..++... +..||||.+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 445678888999999999999999643 899999977
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+++|||++ .|+|||||++||||+.+.++||+|||++..+....
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence 33459999999 99999999999999999999999999998876332
Q ss_pred cceecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.....+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||+...-.+-. +..+-..+
T Consensus 210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~gk~ 272 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLRGKY 272 (596)
T ss_pred --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chheeeee
Confidence 2345789999999999998776 47999999999999999999999855432211 01111111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+-.+. ...++-+++.++|-.+|.+|++++++.+.
T Consensus 273 rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccce--eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111 01145567789999999999999998653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=189.60 Aligned_cols=130 Identities=22% Similarity=0.259 Sum_probs=97.8
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
..+|.|||+. +++|+||||+||+++.++.++|+|||.+....... ....++..|+|||.+....++.++||||
T Consensus 95 ~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dvws 167 (237)
T cd05576 95 VVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISEETEACDWWS 167 (237)
T ss_pred HHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCcccCCCCCCchhhHHH
Confidence 4458999998 99999999999999999999999999876543321 1234567899999998888999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
+|+++|||++|+.|+....... .......++.. ....+.+++.+||+.||++||++.
T Consensus 168 lG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 168 LGAILFELLTGKTLVECHPSGI-----------------NTHTTLNIPEW----VSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHCcchhhcCchhc-----------------ccccccCCccc----CCHHHHHHHHHHccCCHHHhcCCC
Confidence 9999999999998875321100 00000011111 223578899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-24 Score=201.45 Aligned_cols=194 Identities=23% Similarity=0.240 Sum_probs=137.8
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEeh------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLL------------------------------------------ 184 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~~------------------------------------------ 184 (408)
..-..|......|+|-|++|.+|.... |+.||||++-
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 345678888899999999999999543 8899999981
Q ss_pred -------------------------------------hhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCce
Q 015360 185 -------------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAK 226 (408)
Q Consensus 185 -------------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~ 226 (408)
.-+|..|... +|+|.||||+|||+++. ..+||||||.|.
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 1126666665 99999999999999865 568999999997
Q ss_pred eecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH-----HHhcCC
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-----TMVGSR 301 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----~~~~~~ 301 (408)
....+.. +.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|++........+...++ .++..+
T Consensus 586 ~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 586 FASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 7644332 23445678999999999999999999999999999999999998765432211111110 001000
Q ss_pred Cc-cc--------------------------ccCC------CCC-----CCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 302 KS-EE--------------------------VVDP------KLP-----KMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 302 ~~-~~--------------------------~~d~------~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
.. .. .+.| .+. .......+..+.+|+..||..||++|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 00 00 0111 000 0112234567889999999999999999999
Q ss_pred HHHH
Q 015360 344 VIHM 347 (408)
Q Consensus 344 vl~~ 347 (408)
.|+.
T Consensus 743 AL~H 746 (752)
T KOG0670|consen 743 ALKH 746 (752)
T ss_pred HhcC
Confidence 8864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-24 Score=198.22 Aligned_cols=181 Identities=27% Similarity=0.479 Sum_probs=130.3
Q ss_pred CCccceeccCCcEEEEEEE-eCCCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~------------------------------------------------ 183 (408)
|-...+||+|||.+||++. +.+.+.||||+-
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 4445789999999999998 556889999975
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~ 228 (408)
+..+|.||.+. .++|||-||||.||||- ..|.+||+|||+++.+
T Consensus 545 TVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 34569999985 78999999999999994 4478999999999988
Q ss_pred cCCCcc------eecccccccCcccccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh
Q 015360 229 CSERSY------VTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 229 ~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
...... .+....||.+|++||++.-+ +.+.|+||||.|||+|+++.|+.||.....+.. ++
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---------IL 694 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---------IL 694 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---------HH
Confidence 654332 23456799999999988644 478899999999999999999999975432211 11
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
.+..+.....-.++.. +....+...+|.+||++.-++|....++.
T Consensus 695 qeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111111111111 11223566788899999999998855543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=176.44 Aligned_cols=149 Identities=23% Similarity=0.184 Sum_probs=107.7
Q ss_pred cEEEEEEehhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCC
Q 015360 176 TKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 255 (408)
Q Consensus 176 ~~vavK~~~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 255 (408)
+...+-..++.+|.|||+. + ||+|||++.++.+|+ ||++....... ..|++.|+|||++.+..
T Consensus 18 ~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE~~~~~~ 80 (176)
T smart00750 18 EIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPEVIQGQS 80 (176)
T ss_pred HHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------CCCcccccChHHhcCCC
Confidence 3334445688899999998 4 999999999999999 99988764322 25789999999999999
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHH--HHHHHHHhccCc
Q 015360 256 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALK--RVLLVALRCVDP 333 (408)
Q Consensus 256 ~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~--~l~~l~~~cl~~ 333 (408)
++.++|||||||++|||++|+.||....... ..+........ . .++... ........ .+.+++.+||+.
T Consensus 81 ~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-~------~~~~~~-~~~~~~~~~~~~~~~i~~cl~~ 151 (176)
T smart00750 81 YTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMP-A------DDPRDR-SNLESVSAARSFADFMRVCASR 151 (176)
T ss_pred CcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhc-c------CCcccc-ccHHHHHhhhhHHHHHHHHHhc
Confidence 9999999999999999999999996432211 11111111110 0 000000 11112222 589999999999
Q ss_pred CCCCCCCHhHHHHHHhc
Q 015360 334 DATKRPKMGHVIHMLEA 350 (408)
Q Consensus 334 dP~~Rps~~evl~~Le~ 350 (408)
||.+||++.|+++.+..
T Consensus 152 ~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 152 LPQRREAANHYLAHCRA 168 (176)
T ss_pred ccccccCHHHHHHHHHH
Confidence 99999999999998865
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=182.23 Aligned_cols=191 Identities=21% Similarity=0.338 Sum_probs=135.0
Q ss_pred eHHHHHHHhcCCCccceeccCCcEEEEEEE-eCCCcEEEEEEe-------------------------------------
Q 015360 142 TLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL------------------------------------- 183 (408)
Q Consensus 142 ~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~------------------------------------- 183 (408)
++.|+-+.|+ ++||+|+|+.|--++ +.+|..+|||++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3677777777 789999999998887 567999999987
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC---ceEEeccCC
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGL 224 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL~Dfg~ 224 (408)
++.+|.|||.+ +|.||||||+|||..... -+||+||.+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 45669999999 999999999999996543 489999987
Q ss_pred ceeecCCCcc------eecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc----ch
Q 015360 225 AKLLCSERSY------VTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE----VN 289 (408)
Q Consensus 225 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~----~~ 289 (408)
..-+...... .....+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||...-..+- -.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 7543222111 123456888999999763 34588999999999999999999999976532110 01
Q ss_pred hH----HHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 290 LV----DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 290 ~~----~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. +.+-..+.++.. ++.|. .......+..+++...|-.|+.+|.++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkY-eFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY-EFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCC-cCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 111112222221 12221 12223445667778888999999999998877
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=178.72 Aligned_cols=143 Identities=29% Similarity=0.452 Sum_probs=106.6
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+....++.++|||+|
T Consensus 98 ~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~sl 172 (244)
T smart00220 98 SALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSL 172 (244)
T ss_pred HHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHH
Confidence 448999998 99999999999999999999999999998765432 2233557889999999988888999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
|+++|+|++|..||...... ....+. ........ ..........+.+++.+||..+|++||++.+++
T Consensus 173 G~~l~~l~~~~~p~~~~~~~--~~~~~~----~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 173 GVILYELLTGKPPFPGDDQL--LELFKK----IGKPKPPF-------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred HHHHHHHHhCCCCCCCCCcH--HHHHHH----HhccCCCC-------ccccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 99999999999998643211 111111 11111100 000000224688899999999999999999998
Q ss_pred H
Q 015360 346 H 346 (408)
Q Consensus 346 ~ 346 (408)
+
T Consensus 240 ~ 240 (244)
T smart00220 240 Q 240 (244)
T ss_pred h
Confidence 6
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-22 Score=176.70 Aligned_cols=183 Identities=23% Similarity=0.400 Sum_probs=130.0
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
+.|.+.+.||+|.||.+..+.++. .+.+++|.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 578899999999999999999865 677888866
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEe-C-CCCceEEeccCCceeecCCCcce
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL-D-RQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill-~-~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|.|+|++ ++||||||.+|||+ + +..++||||||..+..+....
T Consensus 104 aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-- 178 (378)
T KOG1345|consen 104 APRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-- 178 (378)
T ss_pred CccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh--
Confidence 55669999999 99999999999999 3 335799999999876533221
Q ss_pred ecccccccCcccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 236 TTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
....+..|.+||..... ...+.+|||.||+++|.++||++||+.. ......+.+|.+-..+ ..... |.
T Consensus 179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~r--k~~~~--P~ 251 (378)
T KOG1345|consen 179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKR--KNPAL--PK 251 (378)
T ss_pred --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcc--cCccC--ch
Confidence 12345678999976432 2467899999999999999999999833 2333345555443221 11111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
.-.... ..++++..+-|..+|++|-...++-++..
T Consensus 252 ~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 252 KFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 111122 24566777899999999976666666544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-22 Score=212.77 Aligned_cols=149 Identities=17% Similarity=0.239 Sum_probs=102.2
Q ss_pred EEEEEehhhhHHHhhhCCCCceeeeccccCceEeCC-------------------CCceEEeccCCceeecCCC------
Q 015360 178 VAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDR-------------------QWNARVSDFGLAKLLCSER------ 232 (408)
Q Consensus 178 vavK~~~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-------------------~~~~kL~Dfg~a~~~~~~~------ 232 (408)
..+-.+++.+|.|||+. +|+||||||+||||+. ++.+|++|||+++......
T Consensus 83 ~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~ 159 (793)
T PLN00181 83 FHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEK 159 (793)
T ss_pred HHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhh
Confidence 34445689999999998 9999999999999954 3456666777665321100
Q ss_pred ---------cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 233 ---------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 233 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
........||+.|||||++.+..++.++|||||||+||||++|.+|+.... ..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~---- 227 (793)
T PLN00181 160 LEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRH---- 227 (793)
T ss_pred hhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHH----
Confidence 000112357889999999999999999999999999999999988864211 11111100
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.. .........++.+||+.||.+||++.||++.
T Consensus 228 -~~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 228 -RVLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred -hhcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 0111111 1112245678889999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-22 Score=192.99 Aligned_cols=99 Identities=27% Similarity=0.495 Sum_probs=81.9
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec--C-------CCcc----------------------
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC--S-------ERSY---------------------- 234 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~--~-------~~~~---------------------- 234 (408)
.++++.|.. |+|||||||+|||||.+|.+||+|||+|.-+. . +...
T Consensus 740 cAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~ 816 (1034)
T KOG0608|consen 740 CAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLE 816 (1034)
T ss_pred HHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHH
Confidence 348999988 99999999999999999999999999995431 0 0000
Q ss_pred ----------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 015360 235 ----------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 287 (408)
Q Consensus 235 ----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~ 287 (408)
.....+||+.|+|||++....|+..+|.||.|||||||+.|++||....+.+.
T Consensus 817 ~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 817 RRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 00124699999999999999999999999999999999999999987766544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=182.72 Aligned_cols=107 Identities=16% Similarity=0.236 Sum_probs=74.0
Q ss_pred cccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC---cchhHHHHHHHhcC---------CCcccccC
Q 015360 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG---EVNLVDWLKTMVGS---------RKSEEVVD 308 (408)
Q Consensus 241 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~---------~~~~~~~d 308 (408)
.|..|+|||++.+..|++.+||||++|++|||+||...|+.....+ +.+-+..+..+++. ....++++
T Consensus 413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFn 492 (590)
T KOG1290|consen 413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFN 492 (590)
T ss_pred hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhc
Confidence 4667999999999999999999999999999999999987543221 11222222222211 11122222
Q ss_pred CC--------CCC-----------CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 PK--------LPK-----------MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ~~--------~~~-----------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+ +.. ....++..++.+++.-||+.+|++|||+.++++.
T Consensus 493 r~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 493 RRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred cccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 11 111 2345677889999999999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-21 Score=168.54 Aligned_cols=191 Identities=23% Similarity=0.362 Sum_probs=135.6
Q ss_pred hcCCCccceeccCCcEEEEEEE-eCCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~--------------------------------------------- 183 (408)
.++|.+.+++|+|-|++||.|. ..+.+++.||.+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4577788999999999999998 456899999987
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCCcceecc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|+|+. ||+|||+||.|+++|.. ..++|+|+|+|.+........ -
T Consensus 117 v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn--V 191 (338)
T KOG0668|consen 117 VNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--V 191 (338)
T ss_pred hccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceee--e
Confidence 45569999999 99999999999999854 569999999998876554432 2
Q ss_pred cccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC-------CcccccCCC
Q 015360 239 VMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-------KSEEVVDPK 310 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~d~~ 310 (408)
.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-...... .+++..++ .++.. +..-.+||.
T Consensus 192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIak-VLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAK-VLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHH-HhChHHHHHHHHHHccCCChh
Confidence 345678889998875 458889999999999999999999985432211 12222111 11100 000011111
Q ss_pred CCC----------------CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPK----------------MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~----------------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+.. ....-...+.++|+.+.|..|-.+|+|++|.+..
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 110 0000112467889999999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=173.97 Aligned_cols=161 Identities=22% Similarity=0.249 Sum_probs=114.7
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchh
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
..++.|||+. +|+||||||+||++..++.+||.|||+++..... ...+.++.|..|.|||++.+..+.+.+||||
T Consensus 128 ~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwS 202 (369)
T KOG0665|consen 128 LCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWS 202 (369)
T ss_pred HHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhh
Confidence 3458999999 9999999999999999999999999999864332 4566788999999999999988999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchh----------------HHHHHHHhcCCC------c-ccccCCCCCCCC--cHHH
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNL----------------VDWLKTMVGSRK------S-EEVVDPKLPKMP--ASKA 319 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~----------------~~~~~~~~~~~~------~-~~~~d~~~~~~~--~~~~ 319 (408)
+||++.||++|+..|.+.+.-+.... ...+..+..... . .-+.|..++... ....
T Consensus 203 vGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~ 282 (369)
T KOG0665|consen 203 VGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLD 282 (369)
T ss_pred hhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccc
Confidence 99999999999998875432111110 011111111110 0 111122221111 1123
Q ss_pred HHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 320 LKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 320 ~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+++.+||-.||++|.+++++|..---
T Consensus 283 ~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 283 CSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred hHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 4456788889999999999999999986543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=176.98 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=134.2
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe---------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~--------------------------------------- 183 (408)
....+.|...++||+|+|++||++++.. ...||+|.+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3345678888999999999999999643 678999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCC--
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSE-- 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~-- 231 (408)
+..+|.++|.+ |||||||||.|+|.+.. +.-.|.|||++......
T Consensus 112 ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 34558999998 99999999999999754 56789999999721000
Q ss_pred -------------------------------Ccc----------eecccccccCccccccccc-CCCCccccchhhHHHH
Q 015360 232 -------------------------------RSY----------VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILI 269 (408)
Q Consensus 232 -------------------------------~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl 269 (408)
... ......||++|.|||++.. ...+++.||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 000 0112459999999998864 5578899999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhHHHHH---------HHhcCCC--ccc---------------ccC-CCCCC--------C
Q 015360 270 MEIITGRNPVDYSRPQGEVNLVDWLK---------TMVGSRK--SEE---------------VVD-PKLPK--------M 314 (408)
Q Consensus 270 ~elltG~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~--~~~---------------~~d-~~~~~--------~ 314 (408)
+-+++++.||-.....- ..+.+.+. .....+. +.+ -++ ..+.. .
T Consensus 269 Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred ehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999985433221 11111100 0000111 000 000 00000 0
Q ss_pred CcHHH-HHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 315 PASKA-LKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 315 ~~~~~-~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
...+. ...+++|+.+|++.||.+|.|+++.|+.--
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 01111 226789999999999999999999987543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=158.36 Aligned_cols=110 Identities=35% Similarity=0.647 Sum_probs=93.3
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCCceeecCCCcceecccccccCcccccccccC-CCCccccch
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVY 263 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvw 263 (408)
.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+... .++.+.|+|
T Consensus 103 ~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~ 178 (215)
T cd00180 103 EGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178 (215)
T ss_pred HHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhH
Confidence 348999998 9999999999999998 89999999999986644321 12224467889999999877 788999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 264 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 264 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
++|+++++| ..+.+++..|++.||++||++.+
T Consensus 179 ~lg~~~~~l------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 179 SLGVILYEL------------------------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHHHH------------------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 999999999 36788999999999999999999
Q ss_pred HHHH
Q 015360 344 VIHM 347 (408)
Q Consensus 344 vl~~ 347 (408)
+++.
T Consensus 211 l~~~ 214 (215)
T cd00180 211 ILEH 214 (215)
T ss_pred HhhC
Confidence 9864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-19 Score=171.94 Aligned_cols=124 Identities=30% Similarity=0.474 Sum_probs=105.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.|+.+.++. ...|.||.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 457888999999999999999875 456777766
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCc
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 225 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a 225 (408)
+..++++||+. +|||||||-+|+.++.+|-+||+|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 22238899998 9999999999999999999999999999
Q ss_pred eeecCCCcceecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCC
Q 015360 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVD 280 (408)
Q Consensus 226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~ 280 (408)
.....+.- ..++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 718 a~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 87654332 34779999999999998887 456899999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-19 Score=173.78 Aligned_cols=182 Identities=25% Similarity=0.372 Sum_probs=132.8
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEeh-------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLL------------------------------------------- 184 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~~------------------------------------------- 184 (408)
..++|.....+|.|+||.|||++.. .+...|||.+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4467888899999999999999954 48889999872
Q ss_pred -----------------------------hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 185 -----------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 185 -----------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
..+|.|||.. +-+|||||-.|||+++.+.+|++|||.+..++..- ..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 2238999998 99999999999999999999999999987654221 12
Q ss_pred ecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 236 TTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.....||+.|||||+.. .+.|...+|||++|+...|+-.-++|.....+... +. +....... .|.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~------l~-LmTkS~~q---pp~lk 238 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA------LF-LMTKSGFQ---PPTLK 238 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH------HH-HhhccCCC---CCccc
Confidence 34477999999999764 56789999999999999999887777533222211 11 11111110 11111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. .......+-++++.||..+|.+||+++.+++
T Consensus 239 D--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 D--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 1123345778888999999999999987765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=152.81 Aligned_cols=126 Identities=35% Similarity=0.512 Sum_probs=105.0
Q ss_pred CCccceeccCCcEEEEEEEeCC-CcEEEEEEeh-----------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLL----------------------------------------------- 184 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~~----------------------------------------------- 184 (408)
|...+.||+|++|.||++...+ +..++||...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566899999999999999876 7899999762
Q ss_pred ---------------------------hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 185 ---------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 185 ---------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
..+|.|||+. +++|+||++.||+++.++.++|+|||++............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 2238899988 9999999999999999999999999999876543211223
Q ss_pred ccccccCccccccc-ccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 015360 238 RVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITGRNPVDY 281 (408)
Q Consensus 238 ~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltG~~Pf~~ 281 (408)
...++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34577889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=154.06 Aligned_cols=123 Identities=21% Similarity=0.314 Sum_probs=81.9
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCccccccccc--------CCCCcc
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--------GMLNEK 259 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 259 (408)
+++||.. +++|+||+|+|++++.+|.++|+||+.....+. .... ...+..|.+||.... ..++.+
T Consensus 158 vA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~ 230 (288)
T PF14531_consen 158 VANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFA 230 (288)
T ss_dssp HHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred HHHHhhc---ceEecccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeec
Confidence 7899999 999999999999999999999999987765332 1111 234578999997643 247889
Q ss_pred ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC
Q 015360 260 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338 (408)
Q Consensus 260 sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 338 (408)
.|.|+||+++|.|++|..||....+...... .+. .+. +..+.+..||..+|+.||++|
T Consensus 231 ~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 231 TDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999999985543322111 111 112 444568889999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.5e-17 Score=168.23 Aligned_cols=179 Identities=23% Similarity=0.233 Sum_probs=125.3
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
++...+.||.+.|=.|.+|+.++|. |+||.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 889987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee--cCCCcce
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYV 235 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~--~~~~~~~ 235 (408)
+..+|.-+|.. +|+|||||.+|||++.-+.+.|+||...+.. ..++...
T Consensus 103 vkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 103 VKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 23347778877 9999999999999999999999999766432 2221111
Q ss_pred ----ecccccccCcccccccccC----------C-CCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhc
Q 015360 236 ----TTRVMGTFGYVAPEYACTG----------M-LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVG 299 (408)
Q Consensus 236 ----~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 299 (408)
-.+......|.|||.+... . .+++.||||+||++.||++ |++||.. .+.......
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~aYr~~ 250 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLAYRSG 250 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHhHhcc
Confidence 1112234579999977531 1 5678999999999999998 7999852 222211111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+-..+.. ..+..|+..|++.||.+|.++++.|+.-.+
T Consensus 251 ~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 251 NADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred CccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11000000001111 146788899999999999999999987544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.1e-17 Score=141.12 Aligned_cols=150 Identities=26% Similarity=0.346 Sum_probs=117.1
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEE-eCCCcEEEEEEeh-------------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLL------------------------------------- 184 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~~------------------------------------- 184 (408)
+.++.. ..+|...+.||.|+||.+|.|. ..+|..||||.-.
T Consensus 8 ~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 8 LEELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hhhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 444433 3568889999999999999998 5679999999762
Q ss_pred ----------------------------------hhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCCcee
Q 015360 185 ----------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKL 227 (408)
Q Consensus 185 ----------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~a~~ 227 (408)
...++|+|.. +++||||||+|+|..- ...+.|+|||+++.
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 2238999999 9999999999999853 35689999999987
Q ss_pred ecCCCcce------ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 015360 228 LCSERSYV------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 228 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
..+..... .....||..|.+-....+...+...|+-|+|.+|..+.-|..||+...........+.+.+
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 64433221 2346799999998888788888899999999999999999999997766544444444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.1e-17 Score=166.52 Aligned_cols=178 Identities=24% Similarity=0.345 Sum_probs=130.0
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-----------------------------------hhhhHHHhhhC
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-----------------------------------LNNRLAYLHEG 194 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~-----------------------------------~~~~L~yLH~~ 194 (408)
.+|...+.|..|+||-||..++++ .+..|+|.- ..-+++|||..
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~Eylh~y 162 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAVEYLHSY 162 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHhHhhccC
Confidence 578888999999999999997653 455555321 12348999999
Q ss_pred CCCceeeeccccCceEeCCCCceEEeccCCceeecCC--------------CcceecccccccCcccccccccCCCCccc
Q 015360 195 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--------------RSYVTTRVMGTFGYVAPEYACTGMLNEKS 260 (408)
Q Consensus 195 ~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 260 (408)
+|+|||+||+|.++..-|.+|+.|||+.+..... ........+||+.|.|||++....|+..+
T Consensus 163 ---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpv 239 (1205)
T KOG0606|consen 163 ---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPV 239 (1205)
T ss_pred ---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCc
Confidence 9999999999999999999999999998753211 11123456899999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC-cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC
Q 015360 261 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK-SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 261 DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
|.|++|+|+||.+.|+.||....+.+-. ..++.... +.+- |..+ ..+..+++.+.|+.+|..|-
T Consensus 240 dwwamGiIlyeFLVgcvpffGdtpeelf------g~visd~i~wpE~-dea~--------p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 240 DWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISDDIEWPEE-DEAL--------PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhhhcccccc-CcCC--------CHHHHHHHHHHHHhChHhhc
Confidence 9999999999999999999866544211 11111110 1111 2222 22567788899999999997
Q ss_pred CHhHHHH
Q 015360 340 KMGHVIH 346 (408)
Q Consensus 340 s~~evl~ 346 (408)
-....++
T Consensus 305 gt~ga~e 311 (1205)
T KOG0606|consen 305 GTGGALE 311 (1205)
T ss_pred ccchhhh
Confidence 5444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=146.73 Aligned_cols=184 Identities=20% Similarity=0.220 Sum_probs=129.3
Q ss_pred CCCccceeccCCcEEEEEEEeCCC--cEEEEEEe----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDG--TKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~--~~vavK~~---------------------------------------------- 183 (408)
+|...+.||+|+||.||.+..... ..+|+|..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999996543 46777755
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-----CceEEeccCCce
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-----WNARVSDFGLAK 226 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-----~~~kL~Dfg~a~ 226 (408)
+..+|++||+. +++||||||.|+++... ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 12238999999 99999999999999754 468999999998
Q ss_pred --eecCCCc-----ce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHH
Q 015360 227 --LLCSERS-----YV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 227 --~~~~~~~-----~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
....... .. .....||..|.++....+...+.+.|+||++.++.|++.|..||........... +...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~~~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FEKD 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HHHH
Confidence 3211111 10 1234599999999999999999999999999999999999999965543322111 1111
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
... ..... . ....+. .+.++...+-..+...+|....+...|+.
T Consensus 253 ~~~----~~~~~-~-~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 253 PRK----LLTDR-F-GDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred hhh----hcccc-c-cCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 111 00110 1 111222 34444445556889999999999888765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.9e-16 Score=140.70 Aligned_cols=132 Identities=25% Similarity=0.411 Sum_probs=110.4
Q ss_pred CCCccceeccCCcEEEEEEE-eCCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~-~~~~~~vavK~~----------------------------------------------- 183 (408)
+|...++||+|+||+++.|+ +-+++.||||..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGP 108 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGP 108 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCc
Confidence 57888999999999999998 446999999965
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-----CCceEEeccCCceeecCCCcc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-----~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+...++|+|++ .+|.|||||+|+||.. ...+.++|||+|+...+....
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 12238999999 9999999999999953 245889999999887554332
Q ss_pred e------ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 015360 235 V------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 286 (408)
Q Consensus 235 ~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~ 286 (408)
. .....||..||+-....+...+...|.=|||-+++++|-|..||+......
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 2 234569999999999999999999999999999999999999998765443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-16 Score=163.33 Aligned_cols=152 Identities=25% Similarity=0.332 Sum_probs=112.0
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc---ceecccccccCcccccccccCCCCc-c
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPEYACTGMLNE-K 259 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~ 259 (408)
+..++.|||.. +|.|||||++|+++..++.+||+|||.+....-... .......|+..|+|||++.+..|++ .
T Consensus 429 L~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~ 505 (601)
T KOG0590|consen 429 LLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRA 505 (601)
T ss_pred HHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcch
Confidence 67789999999 999999999999999999999999998876533222 3345678999999999999999886 5
Q ss_pred ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC
Q 015360 260 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 260 sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
.||||.|+++..|++|+.||......+... .......... ...-+.........+...++.++|+.||.+|.
T Consensus 506 vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ 577 (601)
T KOG0590|consen 506 VDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRN---IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI 577 (601)
T ss_pred hhhhhccceEEEEecCCCccccccccccch-----hhhccccccc---cccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence 899999999999999999997655443221 0000000000 00000111123344567788899999999999
Q ss_pred CHhHHHH
Q 015360 340 KMGHVIH 346 (408)
Q Consensus 340 s~~evl~ 346 (408)
|+++|++
T Consensus 578 ti~~i~~ 584 (601)
T KOG0590|consen 578 TIEQILN 584 (601)
T ss_pred cHHHHhh
Confidence 9999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-15 Score=145.04 Aligned_cols=102 Identities=25% Similarity=0.330 Sum_probs=81.5
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC--CCcEEEEEEe-------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~--~~~~vavK~~------------------------------------------- 183 (408)
..++|...+.||+|+||+||+|.+. +++.+|||+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L 95 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL 95 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence 3467888899999999999999875 4788899973
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeecc-ccCceEeCCCCceEEeccCCceeecCCCcce---
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDV-KSSNILLDRQWNARVSDFGLAKLLCSERSYV--- 235 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dl-k~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~--- 235 (408)
+..+|.|||+. +|+|||| ||+|||++.++.+||+|||+++.........
T Consensus 96 VmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~ 172 (365)
T PRK09188 96 VRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIA 172 (365)
T ss_pred EEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhh
Confidence 12338999998 9999999 9999999989999999999998764432111
Q ss_pred ----ecccccccCccccccccc
Q 015360 236 ----TTRVMGTFGYVAPEYACT 253 (408)
Q Consensus 236 ----~~~~~gt~~y~aPE~~~~ 253 (408)
-....+++.|++||.+..
T Consensus 173 ~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 173 AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhccCccCCcccCCh
Confidence 124567888999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=152.91 Aligned_cols=181 Identities=22% Similarity=0.265 Sum_probs=129.5
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------- 183 (408)
+++.--..|.+.+.||+|+||+||+|...+|+.||+|..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 444455678899999999999999999999999999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-------CCCceEEeccCCc
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-------RQWNARVSDFGLA 225 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-------~~~~~kL~Dfg~a 225 (408)
++..++.||.. +|||+||||+|+||. .+..++|+|||.+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 23338999998 999999999999993 2345899999998
Q ss_pred eeecCC-CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 226 KLLCSE-RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 226 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
..+.-- ....-....+|-.+-++|...+.++++..|.|.|+-+++-||.|+.-- .. .+. .
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~~-~g~-~ 909 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------VK-NGS-S 909 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------hc-CCc-c
Confidence 755322 112334456788999999999999999999999999999999997421 00 111 1
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..++..++.....+....++. .+|+.|-..=|...++...|++
T Consensus 910 ~~~~~~~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 910 WMVKTNFPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred eeccccchhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHH
Confidence 111222333333333444444 4455665566777777777766
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.1e-14 Score=132.48 Aligned_cols=153 Identities=28% Similarity=0.412 Sum_probs=106.2
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCCCcc-----eecccccccCccccccccc---CCCC
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERSY-----VTTRVMGTFGYVAPEYACT---GMLN 257 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~ 257 (408)
++.|+|.. +++|||+||+||+++... .++++|||.+......... ......++..|++||.+.+ ..+.
T Consensus 113 ~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~ 189 (384)
T COG0515 113 ALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYAS 189 (384)
T ss_pred HHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCC
Confidence 37799998 899999999999999888 7999999999865443321 2355679999999999987 5788
Q ss_pred ccccchhhHHHHHHHHhCCCCCCCCCCC-CcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCC
Q 015360 258 EKSDVYSFGILIMEIITGRNPVDYSRPQ-GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 336 (408)
Q Consensus 258 ~~sDvwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 336 (408)
...|+|++|++++++++|..||...... ........+.. .... .................+.+++..|+..+|.
T Consensus 190 ~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (384)
T COG0515 190 SSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPK 264 (384)
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCCc-ccccccCccccchhhHHHHHHHHHHHhcCch
Confidence 8999999999999999999997644321 01111111111 1100 0000000000012234577888899999999
Q ss_pred CCCCHhHHHHH
Q 015360 337 KRPKMGHVIHM 347 (408)
Q Consensus 337 ~Rps~~evl~~ 347 (408)
.|.++.+....
T Consensus 265 ~r~~~~~~~~~ 275 (384)
T COG0515 265 NRLSSSSDLSH 275 (384)
T ss_pred hcCCHHHHhhc
Confidence 99999887764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-15 Score=132.66 Aligned_cols=144 Identities=22% Similarity=0.309 Sum_probs=101.9
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEe--ccCCceeecCCCcceecccccccCcccccccccCCCC---c
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS--DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN---E 258 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~ 258 (408)
++++++|||+. .+-|.--.|.+..+++|++.+++|+ |--++. +.....-.+.||+||.+...+-+ .
T Consensus 298 iargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~r 368 (448)
T KOG0195|consen 298 IARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIR 368 (448)
T ss_pred HHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchh
Confidence 45669999985 5556666789999999999888774 432222 12223346899999999876543 4
Q ss_pred cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC
Q 015360 259 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338 (408)
Q Consensus 259 ~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 338 (408)
.+|+|||.+++||+.|...||....+.+.--.+ ..+-+...+ ++.....+.+|+.-|++.||.+|
T Consensus 369 aadmwsfaillwel~trevpfadlspmecgmki-----------aleglrv~i----ppgis~hm~klm~icmnedpgkr 433 (448)
T KOG0195|consen 369 AADMWSFAILLWELNTREVPFADLSPMECGMKI-----------ALEGLRVHI----PPGISRHMNKLMNICMNEDPGKR 433 (448)
T ss_pred hhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------hhccccccC----CCCccHHHHHHHHHHhcCCCCcC
Confidence 789999999999999999999866654321000 011111222 22334468889999999999999
Q ss_pred CCHhHHHHHHhcC
Q 015360 339 PKMGHVIHMLEAD 351 (408)
Q Consensus 339 ps~~evl~~Le~~ 351 (408)
|.++.|+-.||..
T Consensus 434 pkfdmivpilekm 446 (448)
T KOG0195|consen 434 PKFDMIVPILEKM 446 (448)
T ss_pred CCcceehhhHHHh
Confidence 9999999998863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-15 Score=149.61 Aligned_cols=124 Identities=27% Similarity=0.346 Sum_probs=95.9
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhH
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 266 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 266 (408)
+++++|+. +++|+|+|++||+++.+|.+++.|||+++....... .+||..|||||++. .....+|.||||
T Consensus 109 ald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~g 178 (612)
T KOG0603|consen 109 ALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFG 178 (612)
T ss_pred HHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cccchhhhhhHhhh--ccCCcccchhhh
Confidence 38899988 999999999999999999999999999987543332 27899999999998 456789999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 267 ILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 267 vvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
++.+||+||..||.. +.+..+. ......+.+......+++..++..+|.+|--.
T Consensus 179 vl~felltg~~pf~~----------~~~~~Il-----------~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 179 VLAFELLTGTLPFGG----------DTMKRIL-----------KAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhHHHHhhCCCCCch----------HHHHHHh-----------hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 999999999999974 1111111 11122233344456677778899999999866
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-14 Score=141.15 Aligned_cols=158 Identities=28% Similarity=0.489 Sum_probs=110.2
Q ss_pred hhhhHHHhhhCCCCce-eeeccccCceEeCCCCceEEeccCCceeecCC-CcceecccccccCcccccccccCC------
Q 015360 184 LNNRLAYLHEGLEPKV-VHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTGM------ 255 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~i-vH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~------ 255 (408)
+..+|+|||.. +| .|+.|++.|+++|..+.+||+|||+....... .........-...|.|||.+....
T Consensus 57 i~~Gl~ylh~s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~ 133 (484)
T KOG1023|consen 57 ISKGLAYLHNS---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLES 133 (484)
T ss_pred HHHHHHHHhcC---cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccc
Confidence 66789999987 44 99999999999999999999999998776421 001111122346799999987632
Q ss_pred -CCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCc
Q 015360 256 -LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 333 (408)
Q Consensus 256 -~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 333 (408)
.+.+.||||||++++|+++.+.||+........ .++..+.. .....+.|.+.... +....+..++.+||..
T Consensus 134 ~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e 206 (484)
T KOG1023|consen 134 ALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEE 206 (484)
T ss_pred cccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhccc
Confidence 466799999999999999999999864433322 22222221 11111222221111 2333688899999999
Q ss_pred CCCCCCCHhHHHHHHhcC
Q 015360 334 DATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 334 dP~~Rps~~evl~~Le~~ 351 (408)
+|++||++++|-..++..
T Consensus 207 ~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 207 IPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ChhhCccHHHHHhhhhhh
Confidence 999999999998888764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.9e-14 Score=132.49 Aligned_cols=147 Identities=29% Similarity=0.330 Sum_probs=96.7
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEe--CCCC--ceEEeccCCceeecCCCc---ce--ecccccccCcccccccccCC
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILL--DRQW--NARVSDFGLAKLLCSERS---YV--TTRVMGTFGYVAPEYACTGM 255 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill--~~~~--~~kL~Dfg~a~~~~~~~~---~~--~~~~~gt~~y~aPE~~~~~~ 255 (408)
.+++.|||.+ +|.|||+|++|||+ |++. .+.|+|||++---....- +. .-..-|....||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 3448899998 99999999999998 4443 468899998753222111 11 11234777899999876432
Q ss_pred ------CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHh
Q 015360 256 ------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR 329 (408)
Q Consensus 256 ------~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 329 (408)
.-.|+|.|+.|.+.||+++...||.... ++.+ .....++---|.++...+ ..+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L--------~~r~Yqe~qLPalp~~vp----p~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLL--------DTRTYQESQLPALPSRVP----PVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccc---hhee--------chhhhhhhhCCCCcccCC----hHHHHHHHH
Confidence 1248999999999999999999997521 1111 111112222233333222 357788889
Q ss_pred ccCcCCCCCCCHhHHHHHHh
Q 015360 330 CVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 330 cl~~dP~~Rps~~evl~~Le 349 (408)
.|+.||.+|++..=....|.
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999999766555554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-14 Score=140.98 Aligned_cols=128 Identities=23% Similarity=0.394 Sum_probs=90.7
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCceeecCCC-----cceecccccccCcccccccccCCCCccccchhhHHHHHHH
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-----SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEI 272 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 272 (408)
+.+|+|+||.||++..+..+||.|||+........ ....+...||..||+||.+.+..|+.++||||||++|+|+
T Consensus 376 ~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL 455 (516)
T KOG1033|consen 376 GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAEL 455 (516)
T ss_pred cchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHH
Confidence 88999999999999999999999999987765443 2234567899999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 273 IT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 273 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
+. -...|+. ... ..++-|..+++....+.. .-..|+++++...|.+||++.++
T Consensus 456 ~~~f~T~~er------------~~t------~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 456 LIQFSTQFER------------IAT------LTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHhccHHHH------------HHh------hhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 97 2322210 000 111222222211111111 23457789999999999955443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-12 Score=118.30 Aligned_cols=113 Identities=13% Similarity=0.102 Sum_probs=85.6
Q ss_pred HHHHH--HHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEeh------------------------------------
Q 015360 143 LRELE--AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLL------------------------------------ 184 (408)
Q Consensus 143 ~~~l~--~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~~------------------------------------ 184 (408)
+.+|. ...++|...++||.|+||.||.... ++..++||.+.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 44543 3468999999999999999999665 57789999871
Q ss_pred ---------------------------------------------hhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 185 ---------------------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 185 ---------------------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
..+|..||.. +++|+|+||.||+++.++ ++|
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence 1227889988 999999999999999888 999
Q ss_pred eccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHH
Q 015360 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 273 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 273 (408)
+|||........... ..++....+..++|+|+||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999987654221110 01233445667899999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-12 Score=112.28 Aligned_cols=38 Identities=26% Similarity=0.268 Sum_probs=34.7
Q ss_pred HHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 188 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 188 L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+.+||. . +|+|+||||+|||++ ++.++|+|||++....
T Consensus 130 l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 130 MRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 789998 7 999999999999998 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.1e-12 Score=111.83 Aligned_cols=37 Identities=19% Similarity=0.280 Sum_probs=32.6
Q ss_pred HHHh-hhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 188 LAYL-HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 188 L~yL-H~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
|.|| |+. +|+||||||+|||++ ++.++|+|||++...
T Consensus 130 L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 130 MRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 7888 677 999999999999998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.3e-12 Score=110.38 Aligned_cols=94 Identities=20% Similarity=0.136 Sum_probs=68.4
Q ss_pred hhhHHHhhhCCCCceeeecc-ccCceEeCCCCceEEeccCCceeecCCCcc----e--------ecccccccCccccccc
Q 015360 185 NNRLAYLHEGLEPKVVHRDV-KSSNILLDRQWNARVSDFGLAKLLCSERSY----V--------TTRVMGTFGYVAPEYA 251 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dl-k~~Nill~~~~~~kL~Dfg~a~~~~~~~~~----~--------~~~~~gt~~y~aPE~~ 251 (408)
..+|.++|.. +|+|||| ||.|||++.++.++|+|||++......... . ......++.|+.|+..
T Consensus 101 ~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~ 177 (218)
T PRK12274 101 RRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVER 177 (218)
T ss_pred HHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHH
Confidence 4458999999 9999999 799999999999999999999855432210 0 0112246777777654
Q ss_pred ccC-CCC-ccccchhhHHHHHHHHhCCCCCCC
Q 015360 252 CTG-MLN-EKSDVYSFGILIMEIITGRNPVDY 281 (408)
Q Consensus 252 ~~~-~~~-~~sDvwSlGvvl~elltG~~Pf~~ 281 (408)
.-. ..+ ...+.++.|+-+|.++|+..++-.
T Consensus 178 ~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 178 RVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 322 233 456788899999999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.2e-11 Score=106.80 Aligned_cols=84 Identities=24% Similarity=0.211 Sum_probs=69.0
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe---------------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~--------------------------------------- 183 (408)
+.++...-..|...+.||+|+||.||++...+|+.||||++
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 34555554557888999999999999999988999999952
Q ss_pred -----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc
Q 015360 184 -----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN 216 (408)
Q Consensus 184 -----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~ 216 (408)
+..++.++|+. +++|+||||.||+++.++.
T Consensus 87 l~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 87 LKALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred HHHHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCc
Confidence 11226788887 9999999999999999999
Q ss_pred eEEeccCCceeec
Q 015360 217 ARVSDFGLAKLLC 229 (408)
Q Consensus 217 ~kL~Dfg~a~~~~ 229 (408)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-10 Score=105.79 Aligned_cols=37 Identities=24% Similarity=0.286 Sum_probs=33.6
Q ss_pred HHHhhhCCCCc-eeeeccccCceEeCCCCceEEeccCCceee
Q 015360 188 LAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 188 L~yLH~~~~~~-ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
|.+||.. + ++|+||||+||+++ ++.++|+|||.+...
T Consensus 161 l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 161 MRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred HHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 7889988 8 99999999999999 788999999998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.5e-10 Score=98.92 Aligned_cols=37 Identities=27% Similarity=0.314 Sum_probs=32.5
Q ss_pred HHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 188 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 188 L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
+.++|. . +|+|+||||+||+++ ++.++|+|||.+...
T Consensus 127 l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 127 MRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred HHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 566776 5 999999999999999 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-10 Score=119.73 Aligned_cols=149 Identities=26% Similarity=0.419 Sum_probs=108.1
Q ss_pred EehhhhHHHhh-hCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecC--CCcceeccccc-ccCcccccccccC-C
Q 015360 182 NLLNNRLAYLH-EGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCS--ERSYVTTRVMG-TFGYVAPEYACTG-M 255 (408)
Q Consensus 182 ~~~~~~L~yLH-~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~ 255 (408)
..+..++.|+| .. ++.|+|+||+|.+++.++ ..+++|||++..... +.........| ++.|+|||...+. .
T Consensus 130 ~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 130 PQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred hhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence 34667899999 77 999999999999999999 999999999987655 23333444567 9999999999874 4
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCC
Q 015360 256 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335 (408)
Q Consensus 256 ~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP 335 (408)
..+..|+||.|+++.-+++|..|+........ .+..|.... . .....+.........+++.+++..+|
T Consensus 207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---G--------RFTQLPWNSISDQAHDLLHKILKENP 274 (601)
T ss_pred cCCCcccccccccccccccCCCCccccccccc-cceeecccc---c--------ccccCccccCChhhhhcccccccCCc
Confidence 56789999999999999999999976554432 112221110 0 00111112222356777889999999
Q ss_pred CCCCCHhHHH
Q 015360 336 TKRPKMGHVI 345 (408)
Q Consensus 336 ~~Rps~~evl 345 (408)
..|.+.+++-
T Consensus 275 ~~r~s~~~~~ 284 (601)
T KOG0590|consen 275 SNRLSIEELK 284 (601)
T ss_pred hhcccccccc
Confidence 9999977764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.4e-09 Score=95.23 Aligned_cols=36 Identities=33% Similarity=0.612 Sum_probs=32.9
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
|.+||.. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 108 l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 108 VGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7889988 999999999999999 78899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.4e-09 Score=93.64 Aligned_cols=36 Identities=36% Similarity=0.595 Sum_probs=33.2
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 103 l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 103 VGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 7889998 999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-09 Score=109.98 Aligned_cols=37 Identities=38% Similarity=0.588 Sum_probs=33.7
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+|.|||+. +++||||||+|||+ .++.++|+|||+++.
T Consensus 440 ~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 440 IVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 38999998 99999999999999 577899999999865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-08 Score=100.43 Aligned_cols=39 Identities=23% Similarity=0.340 Sum_probs=33.5
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|.. +++|+|++|.||+++.++.++|+|||++..+.
T Consensus 270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 3445555 99999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-08 Score=101.67 Aligned_cols=140 Identities=24% Similarity=0.366 Sum_probs=95.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCCcc----eecccccccCcccccccccCCCCcccc
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSY----VTTRVMGTFGYVAPEYACTGMLNEKSD 261 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sD 261 (408)
+|.++|.. .++|.|+||.||++..+ ...+++|||+...+...... ......+...|++||... +.++...|
T Consensus 234 al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~d 309 (524)
T KOG0601|consen 234 ALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASD 309 (524)
T ss_pred cccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhh
Confidence 46777777 99999999999999888 88999999999887654321 112235778899999874 46788999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 262 VYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 262 vwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
+|++|.++.+..++..+........ |.. .... .++..+...-..++...+..+++.+|..|++.
T Consensus 310 i~sl~ev~l~~~l~~~~~~~g~~~~------W~~--~r~~--------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 310 IFSLGEVILEAILGSHLPSVGKNSS------WSQ--LRQG--------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred hcchhhhhHhhHhhcccccCCCCCC------ccc--cccc--------cCchhhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence 9999999999999876654321111 110 0000 01111111111234447788999999999998
Q ss_pred hHHHH
Q 015360 342 GHVIH 346 (408)
Q Consensus 342 ~evl~ 346 (408)
+.+..
T Consensus 374 q~~~~ 378 (524)
T KOG0601|consen 374 QILTA 378 (524)
T ss_pred HHHhc
Confidence 77654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.3e-08 Score=88.59 Aligned_cols=35 Identities=29% Similarity=0.311 Sum_probs=29.2
Q ss_pred HHHhhhCCCCceeeeccccCceEeCC----CCceEEeccCCc
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDFGLA 225 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~----~~~~kL~Dfg~a 225 (408)
++|||+. +|+||||||+|||++. +..++|+||+.+
T Consensus 118 ~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 118 KRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3899999 9999999999999963 347999995433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.1e-08 Score=102.93 Aligned_cols=158 Identities=18% Similarity=0.254 Sum_probs=105.1
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec--------ccccccCcccccccccCCCC
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--------RVMGTFGYVAPEYACTGMLN 257 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~ 257 (408)
+||.|+|.. .++||++|.|++|.++.++..||+.|+++........+... -..-...|.|||++.+...+
T Consensus 110 dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~ 187 (700)
T KOG2137|consen 110 DGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT 187 (700)
T ss_pred chhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence 899999976 59999999999999999999999999988765442221111 11234679999999998889
Q ss_pred ccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCC
Q 015360 258 EKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 336 (408)
Q Consensus 258 ~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 336 (408)
.++|+||+||++|-+.. |+.-+............. . .+..-..........++.+-+.+++..++.
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---~----------~~~~~~~~~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---N----------LLNAGAFGYSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---c----------ccccccccccccCcHHHHHHHHHHhcCCcc
Confidence 99999999999999984 555444322111111000 0 000000011122233567777789999999
Q ss_pred CCCCHhHHHHHHhcCCccchhh
Q 015360 337 KRPKMGHVIHMLEADDLLFRDE 358 (408)
Q Consensus 337 ~Rps~~evl~~Le~~~~~~~~~ 358 (408)
.||++.++....-..+..++--
T Consensus 255 ~rp~~~~l~~~~ff~D~~~~aL 276 (700)
T KOG2137|consen 255 VRPTLDLLLSIPFFSDPGLKAL 276 (700)
T ss_pred cCcchhhhhcccccCCchhhhh
Confidence 9998888876555544444333
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.7e-08 Score=88.29 Aligned_cols=40 Identities=33% Similarity=0.476 Sum_probs=36.0
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
..+|.+||+. +|+|+||||.|||++.++.++|+|||.+..
T Consensus 152 ~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 152 GQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3448999998 999999999999999888999999998865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.1e-08 Score=88.40 Aligned_cols=144 Identities=18% Similarity=0.274 Sum_probs=89.7
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec---CCCcceecccccccCcccccccccCCCCccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC---SERSYVTTRVMGTFGYVAPEYACTGMLNEKS 260 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 260 (408)
+..+|.|||+ +.++|+|+++..+.|++..++-+|+.---...... ...........+-++|.+||.-.....+..+
T Consensus 185 Ilsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~ 263 (458)
T KOG1266|consen 185 ILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGAS 263 (458)
T ss_pred HHhhhhhhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccch
Confidence 5678999998 58999999999999999999888874311110000 0000011122356889999987777778899
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 261 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 261 DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
|||+||+..+||..+..--......... ...+... +...-++ .-..++..|++..|+.||+
T Consensus 264 dIy~fgmcAlemailEiq~tnseS~~~~--ee~ia~~-----i~~len~------------lqr~~i~kcl~~eP~~rp~ 324 (458)
T KOG1266|consen 264 DIYKFGMCALEMAILEIQSTNSESKVEV--EENIANV-----IIGLENG------------LQRGSITKCLEGEPNGRPD 324 (458)
T ss_pred hhhhhhHHHHHHHHheeccCCCcceeeh--hhhhhhh-----eeeccCc------------cccCcCcccccCCCCCCcc
Confidence 9999999999998876532111111000 0000000 0000011 1124566999999999999
Q ss_pred HhHHHHH
Q 015360 341 MGHVIHM 347 (408)
Q Consensus 341 ~~evl~~ 347 (408)
|.+++-.
T Consensus 325 ar~llfH 331 (458)
T KOG1266|consen 325 ARLLLFH 331 (458)
T ss_pred hhhhhcC
Confidence 9988543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.8e-07 Score=77.23 Aligned_cols=41 Identities=29% Similarity=0.275 Sum_probs=35.4
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+|.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 98 ~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 98 LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 37888876445899999999999999888999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.1e-07 Score=93.10 Aligned_cols=35 Identities=23% Similarity=0.307 Sum_probs=30.7
Q ss_pred CCceeeeccccCceEeCCCC----ceEEeccCCceeecC
Q 015360 196 EPKVVHRDVKSSNILLDRQW----NARVSDFGLAKLLCS 230 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~----~~kL~Dfg~a~~~~~ 230 (408)
..+++|+|+||.||+++.++ .++++|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34899999999999999887 899999999987643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.2e-06 Score=79.57 Aligned_cols=162 Identities=19% Similarity=0.214 Sum_probs=100.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccc-----cCCCCc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNE 258 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ 258 (408)
++.+.+-||+. |.+-+|++++|+|++++..+.|.|-........ .......+|...|.+||... +..-+.
T Consensus 126 lA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~ 200 (637)
T COG4248 126 LASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTA 200 (637)
T ss_pred HHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeeccC--CceEecccCccccCCHHHhccccccccCCCc
Confidence 56678889998 999999999999999999999987543332211 22223356889999999764 334567
Q ss_pred cccchhhHHHHHHHHhC-CCCCCCCCCCCc-chhH--HHHHHH-hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCc
Q 015360 259 KSDVYSFGILIMEIITG-RNPVDYSRPQGE-VNLV--DWLKTM-VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 333 (408)
Q Consensus 259 ~sDvwSlGvvl~elltG-~~Pf~~~~~~~~-~~~~--~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 333 (408)
..|.|.||+++++++.| ++||..-..... .+-. +..... ........-..+.....+..-....+..|..+|+..
T Consensus 201 ~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~ 280 (637)
T COG4248 201 NHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTE 280 (637)
T ss_pred cccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcc
Confidence 89999999999999986 999965421111 0000 100000 000000111111111222222234556666788754
Q ss_pred --CCCCCCCHhHHHHHHhc
Q 015360 334 --DATKRPKMGHVIHMLEA 350 (408)
Q Consensus 334 --dP~~Rps~~evl~~Le~ 350 (408)
++.-|||++-.+..|..
T Consensus 281 ~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 281 SGVATPRPTAKAWVAALDA 299 (637)
T ss_pred cCCCCCCCCHHHHHHHHHH
Confidence 46789999988887765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.5e-07 Score=95.16 Aligned_cols=142 Identities=22% Similarity=0.312 Sum_probs=100.1
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC------C----C--------------------c
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS------E----R--------------------S 233 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~------~----~--------------------~ 233 (408)
+..+++|||.. .+.|+|++|.|+|...++..+++||+....... . . .
T Consensus 913 ~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~ 989 (1205)
T KOG0606|consen 913 RVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEA 989 (1205)
T ss_pred HHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchh
Confidence 44568999987 799999999999999999999999984322110 0 0 0
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.......+|+.|.+||...+......+|.|++|++++|.++|.+||....++... ..+. . ..+ .++.
T Consensus 990 ~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f------~ni~-~---~~~---~~p~ 1056 (1205)
T KOG0606|consen 990 RRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF------ENIL-N---RDI---PWPE 1056 (1205)
T ss_pred hccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh------hccc-c---CCC---CCCC
Confidence 0112356899999999999999999999999999999999999999866554321 1000 0 000 1111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
...+......+++...+..+|.+|..+.
T Consensus 1057 -g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1057 -GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -CccccChhhhhhhhhhhccCchhccCcc
Confidence 1122233566777788899999998876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-06 Score=86.86 Aligned_cols=179 Identities=23% Similarity=0.267 Sum_probs=117.8
Q ss_pred HHHHhcCCCccceeccCCcEEEEEEEeC--CCcEEEEEEeh---------------------------------------
Q 015360 146 LEAATSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLL--------------------------------------- 184 (408)
Q Consensus 146 l~~~t~~f~~~~~lg~G~~g~Vy~g~~~--~~~~vavK~~~--------------------------------------- 184 (408)
....+.+|.....||.|.|+.|++...+ ++..+++|.++
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445667999999999999999997754 47788888652
Q ss_pred ------------------------------------hhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCcee
Q 015360 185 ------------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKL 227 (408)
Q Consensus 185 ------------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~ 227 (408)
..++.++|+. .++|+|+||+||++..+ +..++.|||....
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 1125666665 99999999999999876 7889999998753
Q ss_pred ecCCCcceecccccccCc-ccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 228 LCSERSYVTTRVMGTFGY-VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
+.-... .....+..| .+++......+..+.|+|+||..+.+.+++...-.. ...|. .+
T Consensus 417 ~~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~----------~i 475 (524)
T KOG0601|consen 417 LAFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSL----------TI 475 (524)
T ss_pred cceecc---cccccccccccchhhccccccccccccccccccccccccCcccCcc--------cccce----------ee
Confidence 211110 001122333 356666677788999999999999999998753221 11111 11
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+..+.. ...+..+...+...++..||.+.++..+.+.
T Consensus 476 ~~~~~p~~~~~--~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDTPNLPGL--KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ecccccCCCch--HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111111111 1356667778889999999999887765543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.5e-06 Score=71.37 Aligned_cols=41 Identities=27% Similarity=0.304 Sum_probs=33.0
Q ss_pred hhhHHHhhhCC--CCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 185 NNRLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 185 ~~~L~yLH~~~--~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
.+.|+.||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 93 ~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 93 AKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 34588899872 22369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.5e-05 Score=70.49 Aligned_cols=38 Identities=21% Similarity=0.222 Sum_probs=31.8
Q ss_pred HHHh-hhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 188 LAYL-HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 188 L~yL-H~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
|..| |.. +++|+||++.||+++ ++.+.|+|||.+....
T Consensus 137 l~~l~H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 137 MKQLYKEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 5555 777 999999999999997 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.7e-05 Score=68.37 Aligned_cols=36 Identities=36% Similarity=0.610 Sum_probs=32.0
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+.-||.. +|+|+||.++||++.... +.++|||++..
T Consensus 105 vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 105 VGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 6789998 999999999999998664 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.1e-05 Score=66.56 Aligned_cols=37 Identities=35% Similarity=0.651 Sum_probs=31.1
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCC---ceEEeccCCcee
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKL 227 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL~Dfg~a~~ 227 (408)
+.-||.+ .|+|+||..+||+|..++ .+.++|||++..
T Consensus 126 igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 126 IGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 7889998 999999999999995443 358999999754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0001 Score=74.57 Aligned_cols=33 Identities=27% Similarity=0.356 Sum_probs=30.3
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+++|.|..|-||+++.++.+.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00034 Score=61.52 Aligned_cols=35 Identities=37% Similarity=0.529 Sum_probs=27.7
Q ss_pred HhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 190 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 190 yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
.+|.. +|+|+||.+.|||++++ .+.|+|||.+...
T Consensus 122 ~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 122 MLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence 35676 99999999999999887 9999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00089 Score=68.05 Aligned_cols=88 Identities=16% Similarity=0.251 Sum_probs=62.0
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccch
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
+..+|.|||+.+ +++|++|.-..|+++..|..||++|.++.....-.. .......-..|..|+.+.... -..|.|
T Consensus 113 Il~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~ 187 (690)
T KOG1243|consen 113 ILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSW 187 (690)
T ss_pred HHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhh
Confidence 678899998654 999999999999999999999999987754322111 001111122355565443222 346999
Q ss_pred hhHHHHHHHHhCC
Q 015360 264 SFGILIMEIITGR 276 (408)
Q Consensus 264 SlGvvl~elltG~ 276 (408)
-|||+++|++.|.
T Consensus 188 ~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 188 GLGCLIEELFNGS 200 (690)
T ss_pred hHHHHHHHHhCcc
Confidence 9999999999993
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00077 Score=61.74 Aligned_cols=30 Identities=30% Similarity=0.333 Sum_probs=27.3
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++||+|+.+-||+++++|.+.++||--+..
T Consensus 222 GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 222 GIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CccccCCchheEEEecCCCEEEEeCccccc
Confidence 899999999999999999999999965543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0019 Score=58.47 Aligned_cols=32 Identities=25% Similarity=0.298 Sum_probs=28.3
Q ss_pred CceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 197 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 197 ~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
.++||+||..=|||+. ++.+.++||+-+....
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 4899999999999999 7899999999886543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0014 Score=66.27 Aligned_cols=42 Identities=26% Similarity=0.381 Sum_probs=32.9
Q ss_pred HHhhhCCCCceeeeccccCceEeCC----CCceEEeccCCceeecC
Q 015360 189 AYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDFGLAKLLCS 230 (408)
Q Consensus 189 ~yLH~~~~~~ivH~dlk~~Nill~~----~~~~kL~Dfg~a~~~~~ 230 (408)
.|++.....|++|+|-.|-||++.. ++.+.+.|||+...+..
T Consensus 312 ~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 312 AYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3444444558999999999999983 67799999999876643
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0019 Score=51.93 Aligned_cols=31 Identities=23% Similarity=0.348 Sum_probs=18.4
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015360 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSRR 51 (408)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr 51 (408)
+|+..++++|++|+++.+++++++++|+.||
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR 90 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRR 90 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CccccceeehhHHHHHHHHHHHHHHHHHHHH
Confidence 5677778888888776655544444333333
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0021 Score=57.51 Aligned_cols=42 Identities=29% Similarity=0.395 Sum_probs=35.9
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCC---ceEEeccCCceee
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLL 228 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL~Dfg~a~~~ 228 (408)
+...+.-||+. +|+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 127 l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 127 LARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 45558889999 999999999999998776 7999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0025 Score=59.41 Aligned_cols=41 Identities=22% Similarity=0.317 Sum_probs=34.9
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCC-------CCceEEeccCCcee
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-------QWNARVSDFGLAKL 227 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-------~~~~kL~Dfg~a~~ 227 (408)
+...+.-||.. +|+|+|+++.|||++. +..+.|+||+.+..
T Consensus 147 la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 147 VATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 55668899999 9999999999999975 46789999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.016 Score=51.64 Aligned_cols=40 Identities=13% Similarity=0.066 Sum_probs=33.4
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCc--eEEeccCCcee
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKL 227 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~--~kL~Dfg~a~~ 227 (408)
+..+.-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 138 a~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 138 ALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 3448889998 9999999999999986666 99999976643
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.00089 Score=42.05 Aligned_cols=30 Identities=20% Similarity=0.335 Sum_probs=15.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhhcccc
Q 015360 24 LWVVIGILLGSLIVLALFLLSLCLTSRRKK 53 (408)
Q Consensus 24 ~~~~i~i~~g~~~~l~l~~~~~~~~~rr~~ 53 (408)
..+.+|+++.+++++++++++|++++||+|
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR~k 40 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRRKK 40 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEeccC
Confidence 333444444444555555566665566543
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.06 Score=33.28 Aligned_cols=10 Identities=20% Similarity=0.474 Sum_probs=4.2
Q ss_pred HHHHHHHHHH
Q 015360 28 IGILLGSLIV 37 (408)
Q Consensus 28 i~i~~g~~~~ 37 (408)
|+|++|++++
T Consensus 6 IaIIv~V~vg 15 (38)
T PF02439_consen 6 IAIIVAVVVG 15 (38)
T ss_pred hhHHHHHHHH
Confidence 3444444433
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.025 Score=50.73 Aligned_cols=39 Identities=21% Similarity=0.307 Sum_probs=32.6
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+.+.+.-||.. |++|+|++|.|++++.+ .++++||+..+
T Consensus 144 i~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 144 IVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 55667888888 99999999999999855 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.11 Score=45.99 Aligned_cols=31 Identities=23% Similarity=0.338 Sum_probs=28.6
Q ss_pred cCCCccceeccCCc-EEEEEEEeCCCcEEEEEE
Q 015360 151 SGLCEENVIGEGGY-GIVYRGILSDGTKVAVKN 182 (408)
Q Consensus 151 ~~f~~~~~lg~G~~-g~Vy~g~~~~~~~vavK~ 182 (408)
.+|...+.||.|.- |.|||..+. |..+|+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKl 68 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKL 68 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEE
Confidence 67888899999999 999999995 88999998
|
|
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.0052 Score=47.52 Aligned_cols=25 Identities=20% Similarity=0.240 Sum_probs=17.4
Q ss_pred cccCCchHHHHHHHHHHHHHHHHHH
Q 015360 17 TSIFGLRLWVVIGILLGSLIVLALF 41 (408)
Q Consensus 17 ~~~~~~~~~~~i~i~~g~~~~l~l~ 41 (408)
+..++++...|+||++|++++++++
T Consensus 58 t~~~~ls~gaiagi~vg~~~~v~~l 82 (96)
T PTZ00382 58 ANRSGLSTGAIAGISVAVVAVVGGL 82 (96)
T ss_pred cCCCCcccccEEEEEeehhhHHHHH
Confidence 3446778889999988876655333
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.085 Score=45.55 Aligned_cols=27 Identities=33% Similarity=0.485 Sum_probs=23.8
Q ss_pred cceeccCCcEEEEEEEeCCCcEEEEEEe
Q 015360 156 ENVIGEGGYGIVYRGILSDGTKVAVKNL 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~~~~~vavK~~ 183 (408)
.+.|++|.+|.||.|.+. |..+|+|..
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvr 53 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVR 53 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEe
Confidence 368999999999999997 668999987
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.065 Score=47.77 Aligned_cols=32 Identities=34% Similarity=0.510 Sum_probs=27.2
Q ss_pred CCceeeeccccCceEeCC--CCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDR--QWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~--~~~~kL~Dfg~a~~ 227 (408)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 173 ~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 173 RPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 358999999999999988 56689999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF07213 DAP10: DAP10 membrane protein; InterPro: IPR009861 This family consists of several mammalian DAP10 membrane proteins | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.19 Score=36.65 Aligned_cols=36 Identities=17% Similarity=0.349 Sum_probs=25.4
Q ss_pred cCCchHHHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 015360 19 IFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKH 54 (408)
Q Consensus 19 ~~~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr~~~ 54 (408)
=+.++..+++||++|.+++-++|+++.+++-|.+++
T Consensus 28 C~~ls~g~LaGiV~~D~vlTLLIv~~vy~car~r~r 63 (79)
T PF07213_consen 28 CYPLSPGLLAGIVAADAVLTLLIVLVVYYCARPRRR 63 (79)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 345789999999999888766666665555554433
|
In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. It has been suggested that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells []. |
| >PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A | Back alignment and domain information |
|---|
Probab=92.28 E-value=0.14 Score=37.68 Aligned_cols=25 Identities=24% Similarity=0.600 Sum_probs=13.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhc
Q 015360 26 VVIGILLGSLIVLALFLLSLCLTSR 50 (408)
Q Consensus 26 ~~i~i~~g~~~~l~l~~~~~~~~~r 50 (408)
+++++++|++++++++++++++.+|
T Consensus 2 ii~~~~~g~~~ll~~v~~~~~~~rr 26 (75)
T PF14575_consen 2 IIASIIVGVLLLLVLVIIVIVCFRR 26 (75)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCCTT
T ss_pred EEehHHHHHHHHHHhheeEEEEEee
Confidence 4555666665555555554444433
|
... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.12 E-value=0.12 Score=47.09 Aligned_cols=31 Identities=29% Similarity=0.418 Sum_probs=26.1
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
.+.++|+|+.+.||+++.+...-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4569999999999999877656799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12191 stn_TNFRSF12A: Tumour necrosis factor receptor stn_TNFRSF12A_TNFR domain; InterPro: IPR022316 The tumour necrosis factor (TNF) receptor (TNFR) superfamily comprises more than 20 type-I transmembrane proteins | Back alignment and domain information |
|---|
Probab=91.92 E-value=0.054 Score=43.18 Aligned_cols=47 Identities=23% Similarity=0.390 Sum_probs=7.1
Q ss_pred ccccccccccccccCCchH-HHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 015360 6 AAFVNTELSKRTSIFGLRL-WVVIGILLGSLIVLALFLLSLCLTSRRKKH 54 (408)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~-~~~i~i~~g~~~~l~l~~~~~~~~~rr~~~ 54 (408)
++||+ .|......+ +++ |.|.+.++++++|++++..++++++.|||+
T Consensus 61 S~~C~-~C~a~p~~p-~~l~~pi~~sal~v~lVl~llsg~lv~rrcrrr~ 108 (129)
T PF12191_consen 61 SPFCQ-GCPAAPPAP-FPLLWPILGSALSVVLVLALLSGFLVWRRCRRRE 108 (129)
T ss_dssp -CCCC-CHSS-SSS--SSSS------------------------------
T ss_pred Ccccc-CCCCCCCCC-cceehhhhhhHHHHHHHHHHHHHHHHHhhhhccc
Confidence 45666 455554444 344 444444555555555555444444444433
|
Family members are defined based on similarity in their extracellular domain - a region that contains many cysteine residues arranged in a specific repetitive pattern []. The cysteines allow formation of an extended rod-like structure, responsible for ligand binding []. Upon receptor activation, different intracellular signalling complexes are assembled for different members of the TNFR superfamily, depending on their intracellular domains and sequences []. Activation of TNFRs can therefore induce a range of disparate effects, including cell proliferation, differentiation, survival, or apoptotic cell death, depending upon the receptor involved []. TNFRs are widely distributed and play important roles in many crucial biological processes, such as lymphoid and neuronal development, innate and adaptive immunity, and maintenance of cellular homeostasis []. Drugs that manipulate their signalling have potential roles in the prevention and treatment of many diseases, such as viral infections, coronary heart disease, transplant rejection, and immune disease []. TNF receptor 12 (also known as TWEAK receptor, and fibroblast growth factor-inducible-14 (Fn14)) has been implicated in endothelial cell growth and migration []. The receptor may also play a role in cell-matrix interactions [].; PDB: 2KN0_A 2RPJ_A 2KMZ_A 2EQP_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.86 E-value=0.16 Score=48.23 Aligned_cols=41 Identities=34% Similarity=0.468 Sum_probs=31.6
Q ss_pred hhHHHhhh----CCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 186 NRLAYLHE----GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 186 ~~L~yLH~----~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
..++++.. ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 172 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 172 KELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34555532 235689999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=91.68 E-value=0.17 Score=45.40 Aligned_cols=33 Identities=33% Similarity=0.501 Sum_probs=22.4
Q ss_pred CCCceeeeccccCceEeC-CCCceEEeccCCcee
Q 015360 195 LEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKL 227 (408)
Q Consensus 195 ~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~ 227 (408)
....++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 164 ~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 164 LPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp SCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 345899999999999999 556668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=91.59 E-value=0.3 Score=30.23 Aligned_cols=30 Identities=10% Similarity=0.465 Sum_probs=17.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHhhhccc
Q 015360 23 RLWVVIGILLGSLIVLALFLLSLCLTSRRK 52 (408)
Q Consensus 23 ~~~~~i~i~~g~~~~l~l~~~~~~~~~rr~ 52 (408)
-+.+++++++|.+++++.+....|+.+|.+
T Consensus 5 ~IaIIv~V~vg~~iiii~~~~YaCcykk~~ 34 (38)
T PF02439_consen 5 TIAIIVAVVVGMAIIIICMFYYACCYKKHR 34 (38)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHcccc
Confidence 356777777776665555444444444433
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ] | Back alignment and domain information |
|---|
Probab=91.43 E-value=0.059 Score=37.65 Aligned_cols=29 Identities=28% Similarity=0.419 Sum_probs=0.5
Q ss_pred HHHHHHHHH-HHHHHHHHHHHhhhcccccc
Q 015360 27 VIGILLGSL-IVLALFLLSLCLTSRRKKHN 55 (408)
Q Consensus 27 ~i~i~~g~~-~~l~l~~~~~~~~~rr~~~~ 55 (408)
++|+|+|++ .+++++++++|+++|.||+.
T Consensus 11 laavIaG~Vvgll~ailLIlf~iyR~rkkd 40 (64)
T PF01034_consen 11 LAAVIAGGVVGLLFAILLILFLIYRMRKKD 40 (64)
T ss_dssp --------------------------S---
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 344444433 23334444445555544443
|
Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q. |
| >PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ] | Back alignment and domain information |
|---|
Probab=91.16 E-value=0.062 Score=37.54 Aligned_cols=34 Identities=18% Similarity=0.317 Sum_probs=0.9
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHhhhcccccc
Q 015360 22 LRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHN 55 (408)
Q Consensus 22 ~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr~~~~ 55 (408)
.-..+|+|+++|+++++++++++++.+++|....
T Consensus 10 vlaavIaG~Vvgll~ailLIlf~iyR~rkkdEGS 43 (64)
T PF01034_consen 10 VLAAVIAGGVVGLLFAILLILFLIYRMRKKDEGS 43 (64)
T ss_dssp ---------------------------S------
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3478899999999999999999999888886543
|
Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=91.13 E-value=0.19 Score=47.62 Aligned_cols=30 Identities=23% Similarity=0.265 Sum_probs=27.0
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
|+||+|.+-=||++++++.++++||--+..
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhhc
Confidence 899999999999999999999999965543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.12 E-value=0.18 Score=47.80 Aligned_cols=32 Identities=28% Similarity=0.296 Sum_probs=27.6
Q ss_pred CCCceeeeccccCceEeCCC----CceEEeccCCce
Q 015360 195 LEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAK 226 (408)
Q Consensus 195 ~~~~ivH~dlk~~Nill~~~----~~~kL~Dfg~a~ 226 (408)
....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 34689999999999999874 789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=91.11 E-value=0.33 Score=39.13 Aligned_cols=32 Identities=16% Similarity=0.317 Sum_probs=19.8
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHhhhcccc
Q 015360 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSRRKK 53 (408)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr~~ 53 (408)
+--.++++|+++|+++++ +++++++.++|+|.
T Consensus 64 ~~i~~Ii~gv~aGvIg~I-lli~y~irR~~Kk~ 95 (122)
T PF01102_consen 64 PAIIGIIFGVMAGVIGII-LLISYCIRRLRKKS 95 (122)
T ss_dssp TCHHHHHHHHHHHHHHHH-HHHHHHHHHHS---
T ss_pred cceeehhHHHHHHHHHHH-HHHHHHHHHHhccC
Confidence 445788888888876655 45566666666664
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=90.91 E-value=0.11 Score=53.29 Aligned_cols=84 Identities=27% Similarity=0.335 Sum_probs=65.2
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+.|+|||+. .-+|+| ||+..+ ...++.||+....+.... ......+++.|+|||+.....+....|+|++
T Consensus 347 ~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~ 416 (829)
T KOG0576|consen 347 RPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSL 416 (829)
T ss_pred ccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCC
Confidence 347888876 557888 777665 578999999887664433 2344678999999999999999999999999
Q ss_pred HHHHHHHHhCCCCC
Q 015360 266 GILIMEIITGRNPV 279 (408)
Q Consensus 266 Gvvl~elltG~~Pf 279 (408)
++-..++--|-+|-
T Consensus 417 ~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 417 AVSAIQMAPGLPPR 430 (829)
T ss_pred CcchhhcCCCCCCC
Confidence 98777777676654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.83 E-value=0.18 Score=45.75 Aligned_cols=31 Identities=23% Similarity=0.346 Sum_probs=26.8
Q ss_pred CCceeeeccccCceEeCC-CCceEEeccCCce
Q 015360 196 EPKVVHRDVKSSNILLDR-QWNARVSDFGLAK 226 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~ 226 (408)
...++|+|+.+.|||++. +..+.|+||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 357999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.81 E-value=0.15 Score=48.60 Aligned_cols=32 Identities=28% Similarity=0.371 Sum_probs=26.9
Q ss_pred CCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 195 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 195 ~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
...+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 34589999999999999876556899998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=90.61 E-value=0.19 Score=45.95 Aligned_cols=31 Identities=26% Similarity=0.251 Sum_probs=27.1
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 4579999999999999987778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13908 Shisa: Wnt and FGF inhibitory regulator | Back alignment and domain information |
|---|
Probab=90.53 E-value=0.18 Score=43.96 Aligned_cols=26 Identities=15% Similarity=0.458 Sum_probs=18.2
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHH
Q 015360 21 GLRLWVVIGILLGSLIVLALFLLSLC 46 (408)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~l~~~~~~ 46 (408)
++..+++++|++++++|+++|++++|
T Consensus 75 ~~~~~iivgvi~~Vi~Iv~~Iv~~~C 100 (179)
T PF13908_consen 75 YFITGIIVGVICGVIAIVVLIVCFCC 100 (179)
T ss_pred cceeeeeeehhhHHHHHHHhHhhhee
Confidence 45667888888887777666666664
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=90.29 E-value=0.092 Score=58.95 Aligned_cols=81 Identities=15% Similarity=0.116 Sum_probs=66.4
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCC
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN 277 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~ 277 (408)
.-+|++||+-|.++..+..+|+.++|+.+...+.... .....+++.|+.|+....-.++.++|+|..|+-+|+.-.|..
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence 4689999999999999999999999999843332222 233557788999999988889989999999999999888776
Q ss_pred CC
Q 015360 278 PV 279 (408)
Q Consensus 278 Pf 279 (408)
+|
T Consensus 1439 ~f 1440 (2724)
T KOG1826|consen 1439 YF 1440 (2724)
T ss_pred HH
Confidence 65
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=89.85 E-value=0.26 Score=44.71 Aligned_cols=29 Identities=17% Similarity=0.204 Sum_probs=25.6
Q ss_pred CceeeeccccCceEeCCCCceEEeccCCce
Q 015360 197 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 197 ~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 4678999999999999877 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=89.56 E-value=0.13 Score=41.68 Aligned_cols=35 Identities=26% Similarity=0.227 Sum_probs=29.5
Q ss_pred ceeccCCcEEEEEEEeCCCcEEEEEEehhhhHHHh
Q 015360 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYL 191 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~~~~vavK~~~~~~L~yL 191 (408)
+.||.|+.|.||+|++.+|+.||||.+-...-..+
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i 51 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQI 51 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHHHHH
Confidence 68999999999999999999999998855543333
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=89.49 E-value=2.8 Score=42.33 Aligned_cols=71 Identities=20% Similarity=0.390 Sum_probs=54.0
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|.++|+. |+.-+-|.+.+||++.+.+++|+..|+...+..+.. |.+. --.+-|.=.|
T Consensus 404 aaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------~~le---~~Qq~D~~~l 462 (655)
T KOG3741|consen 404 AALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------EPLE---SQQQNDLRDL 462 (655)
T ss_pred HHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------cchh---HHhhhhHHHH
Confidence 348999998 999999999999999998999988887665543321 0011 1235688899
Q ss_pred HHHHHHHHhCCC
Q 015360 266 GILIMEIITGRN 277 (408)
Q Consensus 266 Gvvl~elltG~~ 277 (408)
|.+++.|.||..
T Consensus 463 G~ll~aLAt~~~ 474 (655)
T KOG3741|consen 463 GLLLLALATGTE 474 (655)
T ss_pred HHHHHHHhhccc
Confidence 999999999854
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.41 E-value=0.27 Score=43.07 Aligned_cols=30 Identities=23% Similarity=0.254 Sum_probs=25.7
Q ss_pred CceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 197 PKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 197 ~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...+|+|+.|.||++++++ ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3679999999999998776 88999998753
|
|
| >PF05568 ASFV_J13L: African swine fever virus J13L protein; InterPro: IPR008385 This family consists of several African swine fever virus (ASFV) j13L proteins [, , ] | Back alignment and domain information |
|---|
Probab=89.40 E-value=0.61 Score=38.09 Aligned_cols=42 Identities=17% Similarity=0.209 Sum_probs=19.1
Q ss_pred cccccccCCchHHHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 015360 13 LSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKH 54 (408)
Q Consensus 13 ~~~~~~~~~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr~~~ 54 (408)
|.+..+...+--.-++.|+++++++++++++++.++.+|+|+
T Consensus 17 cls~~~~psffsthm~tILiaIvVliiiiivli~lcssRKkK 58 (189)
T PF05568_consen 17 CLSPVTPPSFFSTHMYTILIAIVVLIIIIIVLIYLCSSRKKK 58 (189)
T ss_pred hcCCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhHH
Confidence 334433333333334445555555544444444455555444
|
|
| >PF08374 Protocadherin: Protocadherin; InterPro: IPR013585 The structure of protocadherins is similar to that of classic cadherins (IPR002126 from INTERPRO), but they also have some unique features associated with the cytoplasmic domains | Back alignment and domain information |
|---|
Probab=89.28 E-value=0.21 Score=43.88 Aligned_cols=26 Identities=15% Similarity=0.396 Sum_probs=18.6
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHhh
Q 015360 23 RLWVVIGILLGSLIVLALFLLSLCLT 48 (408)
Q Consensus 23 ~~~~~i~i~~g~~~~l~l~~~~~~~~ 48 (408)
.+.++|||++|++.|+++|+++.+++
T Consensus 36 ~~~I~iaiVAG~~tVILVI~i~v~vR 61 (221)
T PF08374_consen 36 YVKIMIAIVAGIMTVILVIFIVVLVR 61 (221)
T ss_pred ceeeeeeeecchhhhHHHHHHHHHHH
Confidence 47788999998877766666555544
|
They are expressed in a variety of organisms and are found in high concentrations in the brain where they seem to be localised mainly at cell-cell contact sites. Their expression seems to be developmentally regulated []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=89.22 E-value=0.24 Score=46.72 Aligned_cols=42 Identities=31% Similarity=0.350 Sum_probs=31.6
Q ss_pred hhhHHHhhh----CCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 185 NNRLAYLHE----GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 185 ~~~L~yLH~----~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
...+.++.. ....+++|+|+.|.||+++.+..+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 344555543 224579999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=89.16 E-value=0.28 Score=45.18 Aligned_cols=29 Identities=24% Similarity=0.335 Sum_probs=25.4
Q ss_pred CceeeeccccCceEeCCCCceEEeccCCce
Q 015360 197 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 197 ~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
..++|+|+.|.||++++++ +.|+||..+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 4689999999999998876 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.13 E-value=0.32 Score=43.39 Aligned_cols=30 Identities=27% Similarity=0.502 Sum_probs=21.4
Q ss_pred ceeeeccccCceEe-CCCCceEEeccCCcee
Q 015360 198 KVVHRDVKSSNILL-DRQWNARVSDFGLAKL 227 (408)
Q Consensus 198 ~ivH~dlk~~Nill-~~~~~~kL~Dfg~a~~ 227 (408)
.+.|+|+.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 68999999999999 8889999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=89.03 E-value=0.055 Score=44.89 Aligned_cols=30 Identities=37% Similarity=0.628 Sum_probs=14.8
Q ss_pred HHHHHHHHHH--HHHHHHHHHHHHhhhccccc
Q 015360 25 WVVIGILLGS--LIVLALFLLSLCLTSRRKKH 54 (408)
Q Consensus 25 ~~~i~i~~g~--~~~l~l~~~~~~~~~rr~~~ 54 (408)
-++||+++|+ .++|++++++|++|.|++|.
T Consensus 49 nIVIGvVVGVGg~ill~il~lvf~~c~r~kkt 80 (154)
T PF04478_consen 49 NIVIGVVVGVGGPILLGILALVFIFCIRRKKT 80 (154)
T ss_pred cEEEEEEecccHHHHHHHHHhheeEEEecccC
Confidence 4566766654 23334444444455555443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PF15102 TMEM154: TMEM154 protein family | Back alignment and domain information |
|---|
Probab=88.32 E-value=0.19 Score=41.44 Aligned_cols=6 Identities=33% Similarity=0.573 Sum_probs=2.3
Q ss_pred HHHHHH
Q 015360 24 LWVVIG 29 (408)
Q Consensus 24 ~~~~i~ 29 (408)
+.++|+
T Consensus 59 LmIlIP 64 (146)
T PF15102_consen 59 LMILIP 64 (146)
T ss_pred EEEeHH
Confidence 333444
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=88.17 E-value=0.59 Score=51.30 Aligned_cols=135 Identities=21% Similarity=0.241 Sum_probs=82.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccC---ceEeCCCCceEEe--ccCCceeecCCCcceecccccccCcccccccccCCCCc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSS---NILLDRQWNARVS--DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 258 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~---Nill~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 258 (408)
+..+|.|+|.. ...|.-|... +-..+..+.+.++ ||+............ ....+..|.++|......+..
T Consensus 295 ~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~ 369 (1351)
T KOG1035|consen 295 LLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKK 369 (1351)
T ss_pred HhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchh
Confidence 44569999987 5555544444 3334555556666 888776553322211 122345677788776655544
Q ss_pred --cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCC
Q 015360 259 --KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 336 (408)
Q Consensus 259 --~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 336 (408)
..|+|.+|..+..+..|..+-...... ..+++ ..... .+.+...+|+..+++
T Consensus 370 ~r~~dL~~lgll~~~~~~~~~i~~~~~~~------------------~~~l~----~~~~~----~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 370 SRLTDLWCLGLLLLQLSQGEDISEKSAVP------------------VSLLD----VLSTS----ELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhHHHHHHHHHhhhhhcCcccccccch------------------hhhhc----cccch----hhhhhhhhhcchhhh
Confidence 479999999999999876543211100 01111 11111 356677799999999
Q ss_pred CCCCHhHHHHHHh
Q 015360 337 KRPKMGHVIHMLE 349 (408)
Q Consensus 337 ~Rps~~evl~~Le 349 (408)
+|+++.+++...-
T Consensus 424 ~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 424 ERLSALELLTHPF 436 (1351)
T ss_pred hccchhhhhhchh
Confidence 9999999988654
|
|
| >PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls | Back alignment and domain information |
|---|
Probab=87.74 E-value=0.45 Score=39.07 Aligned_cols=8 Identities=50% Similarity=0.725 Sum_probs=2.8
Q ss_pred HHHHHHHH
Q 015360 36 IVLALFLL 43 (408)
Q Consensus 36 ~~l~l~~~ 43 (408)
+++++|++
T Consensus 9 i~~i~l~~ 16 (130)
T PF12273_consen 9 IVAILLFL 16 (130)
T ss_pred HHHHHHHH
Confidence 33333333
|
Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 []. |
| >PF12877 DUF3827: Domain of unknown function (DUF3827); InterPro: IPR024606 The function of the proteins in this entry is not currently known, but one of the human proteins (Q9HCM3 from SWISSPROT) has been implicated in pilocytic astrocytomas [, , ] | Back alignment and domain information |
|---|
Probab=87.54 E-value=0.33 Score=49.45 Aligned_cols=33 Identities=27% Similarity=0.602 Sum_probs=24.3
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 015360 22 LRLWVVIGILLGSLIVLALFLLSLCLTSRRKKH 54 (408)
Q Consensus 22 ~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr~~~ 54 (408)
..+|+|||+++.+++|+++|+++.|.++|+.|.
T Consensus 267 ~NlWII~gVlvPv~vV~~Iiiil~~~LCRk~K~ 299 (684)
T PF12877_consen 267 NNLWIIAGVLVPVLVVLLIIIILYWKLCRKNKL 299 (684)
T ss_pred CCeEEEehHhHHHHHHHHHHHHHHHHHhccccc
Confidence 458999999887777777777776666666554
|
In the majority of cases of pilocytic astrocytomas a tandem duplication produces an in-frame fusion of the gene encoding this protein and the BRAF oncogene. The resulting fusion protein has constitutive BRAF kinase activity and is capable of transforming cells. |
| >PF05808 Podoplanin: Podoplanin; InterPro: IPR008783 This family consists of several mammalian podoplanin-like proteins which are thought to control specifically the unique shape of podocytes [] | Back alignment and domain information |
|---|
Probab=87.04 E-value=0.19 Score=42.16 Aligned_cols=35 Identities=20% Similarity=0.366 Sum_probs=0.0
Q ss_pred cccCCchHHHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015360 17 TSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRR 51 (408)
Q Consensus 17 ~~~~~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr 51 (408)
....|+....++|||+|+++.+.+|+-++++.-||
T Consensus 121 ~ek~GL~T~tLVGIIVGVLlaIG~igGIIivvvRK 155 (162)
T PF05808_consen 121 VEKDGLSTVTLVGIIVGVLLAIGFIGGIIIVVVRK 155 (162)
T ss_dssp -----------------------------------
T ss_pred cccCCcceeeeeeehhhHHHHHHHHhheeeEEeeh
Confidence 45668999999999999998887776555544444
|
; GO: 0016021 integral to membrane; PDB: 3IET_X. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=86.75 E-value=0.5 Score=44.80 Aligned_cols=30 Identities=30% Similarity=0.330 Sum_probs=25.5
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999987 568899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=86.15 E-value=0.54 Score=44.02 Aligned_cols=32 Identities=28% Similarity=0.449 Sum_probs=26.0
Q ss_pred CCceeeeccccCceEeCCCCc-eEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~-~kL~Dfg~a~~ 227 (408)
.+.++|+|+++.||+++.++. .-|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 357999999999999987454 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world | Back alignment and domain information |
|---|
Probab=85.84 E-value=0.82 Score=43.06 Aligned_cols=28 Identities=39% Similarity=0.619 Sum_probs=12.0
Q ss_pred HHHHHHHHHHH-HHHHHHHHHHhhhcccc
Q 015360 26 VVIGILLGSLI-VLALFLLSLCLTSRRKK 53 (408)
Q Consensus 26 ~~i~i~~g~~~-~l~l~~~~~~~~~rr~~ 53 (408)
.+++.++++++ ||+++++.+.+++||+|
T Consensus 257 ~I~aSiiaIliIVLIMvIIYLILRYRRKK 285 (299)
T PF02009_consen 257 AIIASIIAILIIVLIMVIIYLILRYRRKK 285 (299)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 33444444333 33333444445555533
|
Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens []. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=85.82 E-value=2.7 Score=40.81 Aligned_cols=70 Identities=21% Similarity=0.296 Sum_probs=0.0
Q ss_pred ceeccCCcEEEEEEEeCCC-cEEEEEEehhhh------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSDG-TKVAVKNLLNNR------------------------------------------------ 187 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~~-~~vavK~~~~~~------------------------------------------------ 187 (408)
+.||.|....||++...+| ..|.||.-....
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vME 80 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVME 80 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHh
Q ss_pred --------------------------------------------------------------------------------
Q 015360 188 -------------------------------------------------------------------------------- 187 (408)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (408)
T Consensus 81 dL~~~~ilR~~Li~g~~~p~~A~~iG~~La~tlf~tsd~~~~~~~kk~l~~~f~N~eLc~itEdlvft~py~~~~~n~~~ 160 (370)
T TIGR01767 81 DLSHHKIARKGLIEGENYPHLARHIGEFLAKTLFYSSDYALEPKVKKALVAQFTNPELCDITERLVFTDPYFDHDTNDFE 160 (370)
T ss_pred hCccchHHHHHHHcCCCChHHHHHHHHHHHHHHHhhcccccCHHHHHHHHHHhCCHHHHHHHHHhccccchhhhhhhcCC
Q ss_pred ----------------------HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 188 ----------------------LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 188 ----------------------L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
|.+.-......++|||+.+.||+++.+. ++++|+.++..
T Consensus 161 p~l~~~~~~l~~d~~l~~~v~~Lk~~f~~~~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 161 EELRPFVAKLRNDDSLKIEAAKLKHSFLASAETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred hhHHHHHHHHhcCHHHHHHHHHHHHhhccCcceeeeccCCcccEEEcCCC-CEEEcCccccc
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 408 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-97
Identities = 77/179 (43%), Positives = 117/179 (65%), Gaps = 2/179 (1%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ + ++VTT V GT G++A
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE--VNLVDWLKTMVGSRKSEE 305
PEY TG +EK+DV+ +G++++E+ITG+ D +R + V L+DW+K ++ +K E
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 364
+VD L + +++++ VAL C +RPKM V+ MLE D L R E E
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 322
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 29/58 (50%), Positives = 40/58 (68%), Gaps = 1/58 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR 187
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DGT VAVK L R
Sbjct: 10 PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 1e-87
Identities = 62/163 (38%), Positives = 99/163 (60%), Gaps = 4/163 (2%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL-LCSERSYVTTRVMGTFGYV 246
L YLH ++HRDVKS NILLD + +++DFG++K ++++++T V GT GY+
Sbjct: 152 LHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PEY G L EKSDVYSFG+++ E++ R+ + S P+ VNL +W + + E++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
VDP L ++L++ A++C+ + RP MG V+ LE
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 23/80 (28%), Positives = 35/80 (43%), Gaps = 7/80 (8%)
Query: 107 SSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGI 166
S S+ T S + ++ L +LE AT+ + +IG G +G
Sbjct: 2 GSKYSKATNSI-------NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGK 54
Query: 167 VYRGILSDGTKVAVKNLLNN 186
VY+G+L DG KVA+K
Sbjct: 55 VYKGVLRDGAKVALKRRTPE 74
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-72
Identities = 59/164 (35%), Positives = 97/164 (59%), Gaps = 9/164 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
+ +LHE +HRD+KS+NILLD + A++SDFGLA+ ++ +T+R++GT Y+
Sbjct: 146 INFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS-EE 305
APE G + KSD+YSFG++++EIITG VD R L+D + + K+ E+
Sbjct: 203 APEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIED 259
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+D K+ S +++ + VA +C+ KRP + V +L+
Sbjct: 260 YIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 18/51 (35%), Positives = 28/51 (54%), Gaps = 7/51 (13%)
Query: 139 RWYTLRELEAATSG------LCEENVIGEGGYGIVYRGILSDGTKVAVKNL 183
++ EL+ T+ N +GEGG+G+VY+G + + T VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 19/182 (10%)
Query: 188 LAYLHE-------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRV 239
LAYLHE G +P + HRD+KS N+LL A ++DFGLA + +S T
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 240 MGTFGYVAPEYACTGMLNE-----KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294
+GT Y+APE + + + D+Y+ G+++ E+ + D + + + +
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253
Query: 295 KTMVGSRKSEEVV-----DPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
+EVV P L + + C D DA R G V +
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
Query: 349 EA 350
Sbjct: 314 TQ 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 14/54 (25%), Positives = 19/54 (35%), Gaps = 1/54 (1%)
Query: 128 VGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVK 181
+G H G L + L V G +G V++ L VAVK
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK 53
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 35/217 (16%)
Query: 188 LAYLHE------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-------ERSY 234
LAYLH +P + HRD+ S N+L+ +SDFGL+ L E
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 235 VTTRVMGTFGYVAPEYA-------CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 287
+GT Y+APE ++ D+Y+ G++ EI + E
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 288 VNLVDWLKTMVGSRKSEE-----VVD----PKLPK--MPASKALKRVLLVALRCVDPDAT 336
+ +T VG+ + E V PK P+ S A++ + C D DA
Sbjct: 244 YQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301
Query: 337 KRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEEN 373
R + +L+ ER P+ + +
Sbjct: 302 ARLTAQXAEERMA--ELMMIWERNKSVSPTAHHHHHH 336
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 16/37 (43%), Positives = 18/37 (48%), Gaps = 1/37 (2%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVK 181
E L +IG G YG VY+G L D VAVK
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK 42
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 27/167 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+A+LH LEP + + S ++++D AR+S + S+ + M +VA
Sbjct: 124 MAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVA 176
Query: 248 PE---YACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKS 303
PE +D++SF +L+ E++T P D S + + + G R
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLR-- 229
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
P +P S + +++ C++ D KRPK ++ +LE
Sbjct: 230 -----PTIPP-GISPHVSKLM---KICMNEDPAKRPKFDMIVPILEK 267
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YLH P +VHR++KS N+L+D+++ +V DFGL++L S + GT ++A
Sbjct: 150 MNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMA 207
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE NEKSDVYSFG+++ E+ T + P + + Q V R
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGFKCKR----- 257
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
++P+ + + ++ C + KRP ++ +L
Sbjct: 258 --LEIPR-NLNPQVAAII---EGCWTNEPWKRPSFATIMDLLRP 295
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 15/60 (25%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLA 189
P +L + +++ L + IG G +G V+R G+ VAVK L+
Sbjct: 16 PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH 74
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
+ YLH ++HRD+KS+NI L ++ DFGLA S+ ++ G+ ++
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 247 APE---YACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRK 302
APE + + +SDVY+FGI++ E++TG+ P + + + +V GS
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR-----GSLS 244
Query: 303 SEEVVDPKLPKMPAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
P L K+ ++ K +KR++ C+ +RP ++ +E
Sbjct: 245 ------PDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 23/165 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
+AYLH ++HRD+K N+LL ++ DFG A + + T G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWM 170
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE +EK DV+S+GI++ E+IT R P + P + G+R
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----VHNGTR---- 222
Query: 306 VVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
P L K +P K ++ ++ RC D ++RP M ++ ++
Sbjct: 223 ---PPLIKNLP--KPIESLM---TRCWSKDPSQRPSMEEIVKIMT 259
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 9/33 (27%), Positives = 17/33 (51%), Gaps = 1/33 (3%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLN 185
+ E V+G G +G+V + VA+K + +
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES 41
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 32/176 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL----LCSERSYVTTRVMGTF 243
+ YLH ++H+D+KS N+ D ++DFGL + R G
Sbjct: 143 MGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 244 GYVAPEYACTGML---------NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294
++APE ++ SDV++ G + E+ P + + +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT- 257
Query: 295 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
G + P L ++ K + +L L C + +RP ++ MLE
Sbjct: 258 ----GMK-------PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEK 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 32/174 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDR--------QWNARVSDFGLAKLLCSERSYVTTRV 239
+ YLH+ ++HRD+KSSNIL+ + +++DFGLA+ R+ +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA 175
Query: 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 299
G + ++APE M ++ SDV+S+G+L+ E++TG P + + + G
Sbjct: 176 -GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F-------------RGIDG 219
Query: 300 SRKSEEVVDPKL-PKMPAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
+ V KL +P++ + +++ C +PD RP +++ L
Sbjct: 220 LAVAYGVAMNKLALPIPSTCPEPFAKLM---EDCWNPDPHSRPSFTNILDQLTT 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLE 196
L E +IG GG+G VYR G +VAVK ++ + + +E
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIE 51
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 33/174 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-----RQWNARVSDFGLAKLLCSERSYVTTRVMGT 242
+ Y+ P +VHRD++S NI L A+V+DFGL++ + + + ++G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGN 189
Query: 243 FGYVAPE--YACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMV- 298
F ++APE A EK+D YSF +++ I+TG P +YS + + ++ +
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIRE 244
Query: 299 -GSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
G R P +P+ P L+ V+ C D KRP +++ L
Sbjct: 245 EGLR-------PTIPEDCP--PRLRNVI---ELCWSGDPKKRPHFSYIVKELSE 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 13/37 (35%), Positives = 24/37 (64%), Gaps = 1/37 (2%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRL 188
+ E IG+GG+G+V++G + D + VA+K+L+
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 29/186 (15%)
Query: 188 LAYLHEGLE-----PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-- 240
LA+LH + P + HRD+KS NIL+ + ++D GLA + + +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 241 -GTFGYVAPE------YACTGMLNEKSDVYSFGILIMEIITGRNPV----DYSRP-QGEV 288
GT Y+APE ++ D+++FG+++ E+ DY P V
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 289 NLVDWLKTMVGSRKSEEVVDPKL-PKMPASKALKRVL--LVAL--RCVDPDATKRPKMGH 343
+ M V + P +P L L L C + + R
Sbjct: 238 PNDPSFEDMRKV-----VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
Query: 344 VIHMLE 349
+ L
Sbjct: 293 IKKTLT 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 36/203 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--------- 238
+AYLH ++HRD+ S N L+ N V+DFGLA+L+ E++
Sbjct: 121 MAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 239 ----VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294
V+G ++APE +EK DV+SFGI++ EII N P+
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR--------- 228
Query: 295 KTMVGSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 353
TM +D P P S + +RC D D KRP + H LE
Sbjct: 229 -TMDFGLNVRGFLDRYCPPNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLET--- 279
Query: 354 LFRDERRIGREPSNSYGEENRDF 376
R + +R F
Sbjct: 280 -LRMHLAGHLPLGPQLEQLDRGF 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 40/182 (21%), Positives = 67/182 (36%), Gaps = 21/182 (11%)
Query: 188 LAYLHE-----GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRV 239
L +LH +P + HRD+KS NIL+ + ++D GLA S+ +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 240 MGTFGYVAPE------YACTGMLNEKSDVYSFGILIMEIITGRNPV----DYSRPQGEVN 289
+GT Y+ PE +D+YSFG+++ E+ +Y P ++
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 290 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVAL--RCVDPDATKRPKMGHVIHM 347
D + + + P P +S R + L C + R V
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ-MGKLMTECWAHNPASRLTALRVKKT 325
Query: 348 LE 349
L
Sbjct: 326 LA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 35/189 (18%)
Query: 188 LAYLHEGLE-----PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRV 239
LA+LH + P + HRD+KS NIL+ + ++D GLA S
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 240 MGTFGYVAPEYACTGML-----------NEKSDVYSFGILIMEIITGRNPV----DYSRP 284
+GT Y+APE +L +++D+Y+ G++ EI + DY P
Sbjct: 212 VGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 285 -QGEVNL---VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340
V V+ ++ +V +K + + A + + +++ C + R
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM---RECWYANGAARLT 323
Query: 341 MGHVIHMLE 349
+ L
Sbjct: 324 ALRIKKTLS 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 13/74 (17%)
Query: 108 SGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIV 167
S + + + GSGS P + R + + IG+G +G V
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQ-----RTIARTIV-------LQESIGKGRFGEV 58
Query: 168 YRGILSDGTKVAVK 181
+RG G +VAVK
Sbjct: 59 WRGKW-RGEEVAVK 71
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ + H+ ++VHRD+K NIL+D ++ DFG+AK L T V+GT Y +
Sbjct: 124 IKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE A +E +D+YS GI++ E++ G P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L H HRDVK NIL+ A + DFG+A E+ +GT Y+A
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE ++D+Y+ ++ E +TG P
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--RVMGTFGY 245
L + H+ ++HRDVK +NI++ +V DFG+A+ + + VT V+GT Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
++PE A ++ +SDVYS G ++ E++TG P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 29/169 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L +LH P ++HRD+K NI + + ++ D GLA L S+ V+GT ++
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA-VIGTPEFM 197
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE +E DVY+FG+ ++E+ T P YS N + + + V
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YS---ECQNAAQIYRRV-----TSGV 246
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLF 355
K+ A +K ++ C+ + +R DLL
Sbjct: 247 KPASFDKV-AIPEVKEII---EGCIRQNKDERYS---------IKDLLN 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L ++H +V+HRD+K +N+ + ++ D GL + S+ + + V GT Y++
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 204
Query: 248 PEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE N KSD++S G L+ E+ ++P Y +L K
Sbjct: 205 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC--KKIEQCDY----- 255
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P LP S+ L++++ C++PD KRP
Sbjct: 256 --PPLPSDHYSEELRQLV---NMCINPDPEKRP 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-20
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 188 LAYLHE--GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
L H V+HRD+K +N+ LD + N ++ DFGLA++L + S+ T V GT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYY 182
Query: 246 VAPEYACTGML-NEKSDVYSFGILIMEIITGRNP 278
++PE M NEKSD++S G L+ E+ P
Sbjct: 183 MSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 24/152 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LA+LH +VH DVK +NI L + ++ DFGL L + G Y+A
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMA 224
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE G +DV+S G+ I+E+ W + G +
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQLRQG------YL 269
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P+ S L+ VL + ++PD R
Sbjct: 270 PPEFTA-GLSSELRSVL---VMMLEPDPKLRA 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 34/167 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV------------ 235
L+Y+H ++HRD+K NI +D N ++ DFGLAK + +
Sbjct: 129 LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 236 --TTRVMGTFGYVAPE-YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 292
T+ + GT YVA E TG NEK D+YS GI+ E+I + V+
Sbjct: 186 NLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGMERVN 236
Query: 293 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
LK + R P K K+++ +D D KRP
Sbjct: 237 ILKKL---RSVSIEFPPDFDD-NKMKVEKKII---RLLIDHDPNKRP 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L ++H+ K++HRD+KS NI L + ++ DFG+A++L S + GT Y++
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 248 PEYACTGML-NEKSDVYSFGILIMEIITGRNP 278
PE C N KSD+++ G ++ E+ T ++
Sbjct: 194 PE-ICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 22/157 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH + V+HRDVK SN+L++ ++ DFG++ L G Y+A
Sbjct: 122 LEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMA 177
Query: 248 PE----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
PE + KSD++S GI ++E+ R P Y LK +V
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQ---LKQVVEEP-- 230
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340
P+LP S + +C+ ++ +RP
Sbjct: 231 ----SPQLPADKFSAEFVD--FTS-QCLKKNSKERPT 260
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 35/165 (21%), Positives = 62/165 (37%), Gaps = 36/165 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT----------- 236
+ +LH ++HRD+K SNI +V DFGL + + T
Sbjct: 177 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296
T +GT Y++PE + K D++S G+++ E++ +
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----------------Q 276
Query: 297 MVGSRKSEEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 339
M R +V + K P + ++ + P T+RP
Sbjct: 277 MERVRIITDVRNLKFPLLFTQKYPQEHMMV---QDMLSPSPTERP 318
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 32/153 (20%), Positives = 61/153 (39%), Gaps = 28/153 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ Y+H K+++RD+K SNI L ++ DFGL L + TR GT Y++
Sbjct: 135 VDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTLRYMS 189
Query: 248 PEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE + ++ D+Y+ G+++ E++ + ++
Sbjct: 190 PE-QISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF------------TDL 231
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
D + + K K +L + + RP
Sbjct: 232 RDGIISDIF-DKKEKTLL---QKLLSKKPEDRP 260
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 5/130 (3%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YL E + K++HRDVK SNIL++ + ++ DFG++ L S + V GT Y++
Sbjct: 144 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMS 198
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + +SD++S G+ ++E+ GR P+ + + +
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 308 DPKLPKMPAS 317
P P
Sbjct: 259 TPGRPLNKFG 268
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 36/173 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L YLH+ ++VHRD+K N+L++ ++SDFG +K L T GT Y+
Sbjct: 135 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM 190
Query: 247 APE---YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM--VGSR 301
APE G + +D++S G I+E+ TG+ P + L + M VG
Sbjct: 191 APEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMFKVGMF 241
Query: 302 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 354
K P++P+ S K + L+C +PD KR A+DLL
Sbjct: 242 KVH----PEIPE-SMSAEAKAFI---LKCFEPDPDKRA---------CANDLL 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 53/160 (33%), Positives = 74/160 (46%), Gaps = 25/160 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +L E K++HRD+K SNILLDR N ++ DFG++ L S TR G Y+A
Sbjct: 138 LNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMA 193
Query: 248 PE----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
PE A + +SDV+S GI + E+ TGR P Y + + + T V
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFDQL----TQVVKGDP 247
Query: 304 EEVVDPKLPKMPA---SKALKRVLLVALRCVDPDATKRPK 340
P+L S + V C+ D +KRPK
Sbjct: 248 -----PQLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 19/154 (12%), Positives = 43/154 (27%), Gaps = 17/154 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
A L +VH N+ + + D + + Y
Sbjct: 207 AANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAP 259
Query: 248 PEYAC--TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
E+ T + + G+ I + P P + W + + ++
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK---GSWKRPSLRVPGTDS 316
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
+ +P +K ++ R ++ D +R
Sbjct: 317 LAFGSCTPLPD--FVKTLI---GRFLNFDRRRRL 345
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 38/166 (22%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM------- 240
+ +LH ++HRD+K SNI +V DFGL + + T
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 241 ----GTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295
GT Y++PE G + K D++S G+++ E++ ++ V L
Sbjct: 188 TGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERVRTLT 238
Query: 296 TMVGSRKSEEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 339
+V + K P + ++ + P +RP
Sbjct: 239 ---------DVRNLKFPPLFTQKYPCEYVMV---QDMLSPSPMERP 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 30/175 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM------- 240
L +H HRD+K +NILL + + D G C +
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 241 -GTFGYVAPE----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295
T Y APE + +++E++DV+S G ++ ++ G P D +G+ L
Sbjct: 204 RCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LA 259
Query: 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
P+ P+ S AL ++L + VDP +RP + ++ LEA
Sbjct: 260 VQNQLS------IPQSPRH--SSALWQLLNSMMT-VDPH--QRPHIPLLLSQLEA 303
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L+Y H +V+HRD+K N+LL +++DFG + S R GT Y+
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLP 175
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE M +EK D++S G+L E + G+ P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 30/162 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YL E + V+HRDVK SNILLD + ++ DFG++ L R G Y+A
Sbjct: 137 LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMA 192
Query: 248 PE-----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302
PE + ++DV+S GI ++E+ TG+ P Y + + ++
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVL----------- 239
Query: 303 SEEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPK 340
+V+ + P +P S + V C+ D KRPK
Sbjct: 240 -TKVLQEEPPLLPGHMGFSGDFQS--FVK-DCLTKDHRKRPK 277
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 8/96 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LA LH +VH ++ +I+LD++ ++ F + R A
Sbjct: 224 LASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTA 280
Query: 248 PE-----YACTGMLNEKSDVYSFGILIMEIITGRNP 278
++ D ++ G+ I I P
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 31/152 (20%), Positives = 54/152 (35%), Gaps = 33/152 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L+YLH +V+ D+K NI+L + ++ D G + S + GT G+ A
Sbjct: 195 LSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQA 245
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE +D+Y+ G + + + G +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L 284
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P + + R+L R +DPD +R
Sbjct: 285 PEDDPVLKTYDSYGRLL---RRAIDPDPRQRF 313
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 38/183 (20%), Positives = 73/183 (39%), Gaps = 42/183 (22%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY-- 245
+ YL +HRD+ + N L+ + ++SDFG+++ ++ Y + +
Sbjct: 226 MEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKW 281
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
APE G + +SDV+SFGIL+ E + G +P Y N +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASP--Y---PNLSN--------------Q 322
Query: 305 EVVD--------PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFR 356
+ + P P A+ R++ +C + +RP + L++ + +
Sbjct: 323 QTREFVEKGGRLPCPELCPD--AVFRLM---EQCWAYEPGQRPSFSTIYQELQS---IRK 374
Query: 357 DER 359
R
Sbjct: 375 RHR 377
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 7/92 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L ++H VV+RD+K +NILLD + R+SD GLA ++ + V GT GY+A
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMA 358
Query: 248 PEYACTGMLNEKS-DVYSFGILIMEIITGRNP 278
PE G+ + S D +S G ++ +++ G +P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 14/96 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ +++RD+K N+LLD N R+SD GLA L + ++ GT G++A
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
PE +L + D ++ G+ + E+I R P
Sbjct: 358 PE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L YLH ++HRD+K NILL+ + +++DFG AK+L E GT YV
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 247 APEYACTGMLNEK-----SDVYSFGILIMEIITGRNP 278
+PE +L EK SD+++ G +I +++ G P
Sbjct: 200 SPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 45/167 (26%), Positives = 68/167 (40%), Gaps = 26/167 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTR--VM 240
LA+LH +VHRD+K NIL+ + A +SDFGL K L R + R V
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 241 GTFGYVAPEY---ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297
GT G++APE C D++S G + +I+ + Q + N+
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI------- 240
Query: 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344
+D P+ + L+ + + D KRP HV
Sbjct: 241 ---LLGACSLDCLHPEKHEDVIARE--LIE-KMIAMDPQKRPSAKHV 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L Y HE KV+HRD+K N+L+ + +++DFG + S R + GT Y+
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLP 180
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE +EK D++ G+L E + G P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 42/194 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+AY+ VHRD++++NIL+ +V+DFGLA+L+ + A
Sbjct: 293 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE A G KSDV+SFGIL+ E+ T GR P Y G VN EV
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP--Y---PGMVN--------------REV 390
Query: 307 VDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 360
+D ++P P ++L ++ +C + +RP ++ LE
Sbjct: 391 LDQVERGYRMPCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE----------D 437
Query: 361 IGREPSNSYGEENR 374
Y
Sbjct: 438 YFTSTEPQYQPGEN 451
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 42/194 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+AY+ VHRD++++NIL+ +V+DFGLA+L+ + A
Sbjct: 376 MAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE A G KSDV+SFGIL+ E+ T GR P Y G VN EV
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP--Y---PGMVN--------------REV 473
Query: 307 VDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 360
+D ++P P ++L ++ +C + +RP ++ LE
Sbjct: 474 LDQVERGYRMPCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE----------D 520
Query: 361 IGREPSNSYGEENR 374
Y
Sbjct: 521 YFTSTEPQYQPGEN 534
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH K +HRD+K++N+LL +++DFG+A L + T +GT ++A
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMA 187
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + K+D++S GI +E+ G P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 40/195 (20%), Positives = 71/195 (36%), Gaps = 46/195 (23%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
YL + +HR++ + N L+ +V+DFGL++L+ T F
Sbjct: 332 EYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWT 386
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE + KSDV++FG+L+ EI T G +P Y G +
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--Y---PGIDL--------------SQ 427
Query: 306 VVDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 359
V + ++ + + + ++ C + + RP + E
Sbjct: 428 VYELLEKDYRMERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE---------- 474
Query: 360 RIGREPSNSYGEENR 374
+ +E S S E
Sbjct: 475 TMFQESSISDEVEKE 489
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 32/179 (17%), Positives = 59/179 (32%), Gaps = 61/179 (34%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDR-------------------QWNARVSDFGLAKLL 228
L Y+H +VH D+K SNI + R + ++ D G +
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 229 CSERSYVTTRVMGTFGYVAPEYACTGMLNE------KSDVYSFGILIMEIITGRNPVDYS 282
S + G ++A E +L E K+D+++ + ++
Sbjct: 185 SSPQVEE-----GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
Query: 283 RPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 339
W + G +LP++P S+ +L + PD +RP
Sbjct: 235 DQ--------WHEIRQG----------RLPRIPQVLSQEFTELL---KVMIHPDPERRP 272
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YL +++HRD+K NILLD + ++DF +A +L E T + GT Y+A
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMA 182
Query: 248 PEYACTGMLNEKS--------DVYSFGILIMEIITGRNP 278
PE M + + D +S G+ E++ GR P
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+Y+H + HRDVK SNIL+D+ ++SDFG ++ + ++ + GT+ ++
Sbjct: 164 FSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--RGTYEFMP 218
Query: 248 PEYACTGML---NEKSDVYSFGILIMEIITGRNP 278
PE + K D++S GI + + P
Sbjct: 219 PE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 23/192 (11%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYV 246
YL + VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE + + +SDV+SFG+++ E+ T S + +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CS---PSAEFLRMMGCERDVPALSR 252
Query: 306 VVDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 359
+++ +LP PA + ++ C P RP + L+ L+ R
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDM---LWSGSR 306
Query: 360 RIGREPSNSYGE 371
++ E
Sbjct: 307 GCETHAFTAHPE 318
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
YLH +V+HRD+K N+ L+ ++ DFGLA + + + GT Y+A
Sbjct: 128 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIA 183
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 280
PE + + DV+S G ++ ++ G+ P +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 20/102 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTR----VMGT 242
L YLH +++H DVK+ N+LL A + DFG A L + + + GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 243 FGYVAPE------YACTGMLNEKSDVYSFGILIMEIITGRNP 278
++APE + K D++S +++ ++ G +P
Sbjct: 220 ETHMAPEVVMGKPC------DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 15/96 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY+A
Sbjct: 299 LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYMA 353
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
PE ++ + D ++ G L+ E+I G++P
Sbjct: 354 PE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 26/99 (26%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV- 246
L Y+H VHR VK+S+IL+ +S + S V
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 247 -----APEYACTGML--NEKSDVYSFGILIMEIITGRNP 278
+PE + + KSD+YS GI E+ G P
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 19/102 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LA LH +VH ++ +I+LD++ ++ F R + G+
Sbjct: 219 LASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEP 270
Query: 248 PEYACT-----------GMLNEKSDVYSFGILIMEIITGRNP 278
PE ++ D ++ G++I I P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +V+HRD+KS NILL + +++DFG + E+S +T V GT ++A
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 184
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE K D++S GI+ +E+I G P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 34/88 (38%), Positives = 52/88 (59%), Gaps = 4/88 (4%)
Query: 195 LEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 251
LE VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 252 CTGMLNEKSDVYSFGILIMEIIT-GRNP 278
+ KSDV+SFG+L+ E + G+ P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH + +HRD+K+ NILL+ + +A+++DFG+A L + T + GT ++A
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMA 193
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE N +D++S GI +E+ G+ P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
A++ + +HRD++++NIL+ +++DFGLA+++ + Y T R F
Sbjct: 298 AFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEY-TAREGAKFPIKWT 352
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSE 304
APE G KSDV+SFGIL+MEI+T GR P Y EV + L+ G R
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV--IRALER--GYR--- 403
Query: 305 EVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+P+ + L ++ +RC +RP ++ +L+
Sbjct: 404 ------MPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLD 440
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 44/172 (25%), Positives = 59/172 (34%), Gaps = 31/172 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNAR---VSDFGLAKLLCSERSYVTTRVMGTFG 244
L YLHE +++HRD+K NI+L + D G AK L + T V GT
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQ 188
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---- 300
Y+APE D +SFG L E ITG P V W +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHGKVREKSNEH 243
Query: 301 -----------RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
+ S + P + L+R L L +R
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM-WHQ--RQRGTD 292
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 40/183 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-------M 240
+ YL + ++VHRD+ + N+L+ + +++DFGLAKLL +E M
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY-SRPQGEVNLVDWLKTMV 298
A E + +SDV+S+G+ + E++T G P Y P E+ L+
Sbjct: 187 ------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEI--SSILEK-- 234
Query: 299 GSRKSEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRD 357
G R LP+ P + + ++ +C DA RPK +I + RD
Sbjct: 235 GER---------LPQPPICTIDVYMIM---RKCWMIDADSRPKFRELIIEFSK---MARD 279
Query: 358 ERR 360
+R
Sbjct: 280 PQR 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YLH ++HRD+ SN+LL R N +++DFGLA L T + GT Y++
Sbjct: 125 MLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYIS 180
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE A +SDV+S G + ++ GR P
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
YLH +V+HRD+K N+ L+ ++ DFGLA + + + GT Y+A
Sbjct: 154 CQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIA 209
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + + DV+S G ++ ++ G+ P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH V+HRD+KS +ILL ++SDFG + + + V GT ++A
Sbjct: 154 LAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMA 209
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE + + D++S GI+++E++ G P
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 33/88 (37%), Positives = 53/88 (60%), Gaps = 4/88 (4%)
Query: 195 LEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYA 251
LE K VHR++ + N+LL + A++SDFGL+K L ++ SY T R G + APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 252 CTGMLNEKSDVYSFGILIMEIIT-GRNP 278
+ +SDV+S+G+ + E ++ G+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 21/164 (12%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
YL + +HRD+ + N+LL + ++ DFGL + L + + +
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE T + SD + FG+ + E+ T G+ P ++ +D G R
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----KEGER---- 243
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
LP+ + + V ++C RP + L
Sbjct: 244 -----LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 34/88 (38%), Positives = 54/88 (61%), Gaps = 4/88 (4%)
Query: 195 LEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 251
LE K VHRD+ + N+LL + A++SDFGL+K L ++ SY T R G + + APE
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 252 CTGMLNEKSDVYSFGILIMEIIT-GRNP 278
+ +SDV+S+G+ + E ++ G+ P
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 35/164 (21%), Positives = 68/164 (41%), Gaps = 30/164 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
+ +H+ +VH D+K +N L+ ++ DFG+A + S V +GT Y+
Sbjct: 121 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 247 APE-----------YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295
PE ++ KSDV+S G ++ + G+ P + + +++ +
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKL---- 230
Query: 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
+ + + P +P K L+ VL C+ D +R
Sbjct: 231 ----HAIIDPNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRI 266
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 50/175 (28%), Positives = 71/175 (40%), Gaps = 35/175 (20%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
YL VHRD+ + N+L+ A+VSDFGL + +T+ G
Sbjct: 303 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWT 353
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSE 304
APE + KSDV+SFGIL+ EI + GR P Y R P +V V ++ G +
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV--VPRVEK--GYK--- 404
Query: 305 EVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 358
+ A+ V+ C DA RP + LE + E
Sbjct: 405 ------MDAPDGCPPAVYDVM---KNCWHLDAATRPTFLQLREQLEH---IRTHE 447
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
+ +H+ +VH D+K +N L+ ++ DFG+A + S V +GT Y+
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 247 APE-----------YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295
PE ++ KSDV+S G ++ + G+ P +N + L
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLH 250
Query: 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
++ + + P +P K L+ VL C+ D +R
Sbjct: 251 AIIDPN-----HEIEFPDIP-EKDLQDVL---KCCLKRDPKQRI 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 49/186 (26%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-------------RQWNARVSDFGLAKLLCSERSY 234
+A+LH K++HRD+K NIL+ +SDFGL K L S +S
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 235 VTTRVM---GTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 284
T + GT G+ APE L D++S G + I++ +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 285 QGEVNLV------DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 338
E N++ D +K + E D L++ + +D D KR
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATD----------------LIS-QMIDHDPLKR 287
Query: 339 PKMGHV 344
P V
Sbjct: 288 PTAMKV 293
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 36/170 (21%), Positives = 70/170 (41%), Gaps = 18/170 (10%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYV 246
YL + VHRD+ + N+L++ + ++ DFGL K + +++ Y T + +
Sbjct: 140 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE SDV+SFG+ + E++T + + M +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM----TVTRL 252
Query: 307 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
V+ +LP P + +++ +C + + R ++I EA
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L++LH+ KV+HRD+K N+LL ++ DFG++ L T +GT ++A
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 197
Query: 248 PE-YACTGML----NEKSDVYSFGILIMEIITGRNP 278
PE AC + KSD++S GI +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 20/102 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF-G-- 244
L YLH+ +HRDVK+ NILL + +++DFG++ L + +V TF G
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 245 -YVAPE-------YACTGMLNEKSDVYSFGILIMEIITGRNP 278
++APE Y + K+D++SFGI +E+ TG P
Sbjct: 191 CWMAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 32/178 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGY 245
YL E +VHR++ + N+LL +V+DFG+A LL + + +
Sbjct: 129 YYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKW 183
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY-SRPQGEVNLVDWLKTMVGSRKS 303
+A E G +SDV+S+G+ + E++T G P Y EV D L+ G R
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAEV--PDLLEK--GER-- 235
Query: 304 EEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 360
L + + + V+ ++C D RP + + + RD R
Sbjct: 236 -------LAQPQICTIDVYMVM---VKCWMIDENIRPTFKELANEFTR---MARDPPR 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 33/170 (19%), Positives = 71/170 (41%), Gaps = 17/170 (10%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYV 246
YL + +HRD+ + NIL++ + ++ DFGL K+L ++ + + G +
Sbjct: 128 EYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE + SDV+SFG+++ E+ T + S+ + G +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 307 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
++ +LP+ + ++ C + + +RP + ++
Sbjct: 242 IELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
+ +H+ +VH D+K +N L+ ++ DFG+A + S V +G Y+
Sbjct: 168 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 247 APE-----------YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295
PE ++ KSDV+S G ++ + G+ P + + +++ +
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKL---- 277
Query: 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
+ + + P +P K L+ VL C+ D +R
Sbjct: 278 ----HAIIDPNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRI 313
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ +H+ VHRD+K NIL+D + R++DFG L + + ++ +GT Y++
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 248 PE-----YACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE G + D +S G+ + E++ G P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYV 246
AYLH +HRD+ + N+LLD ++ DFGLAK + Y R G +
Sbjct: 148 AYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE SDV+SFG+ + E++T + E+ + G
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-----GQMTVLR 259
Query: 306 VVDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
+ + +LP+ + ++ C + +A+ RP ++I +L+
Sbjct: 260 LTELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKT 307
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 25/96 (26%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +++HRD+K+ N+L+ + + R++DFG++ + +GT ++A
Sbjct: 130 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMA 185
Query: 248 PEYACTGML-----NEKSDVYSFGILIMEIITGRNP 278
PE + + K+D++S GI ++E+ P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 27/116 (23%), Positives = 48/116 (41%), Gaps = 18/116 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243
+ +L E +VHR++K NI+ D Q +++DFG A+ L + + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTE 179
Query: 244 GYVAPEYACTGML--------NEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNL 290
Y+ P+ +L D++S G+ TG P + P+ +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 49/199 (24%), Positives = 78/199 (39%), Gaps = 27/199 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY-- 245
+ YL + VHRD+ + NIL++ +VSDFGL ++L + T G
Sbjct: 160 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
+PE SDV+S+GI++ E+++ G P Y N G R
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--Y---WEMSNQDVIKAVDEGYR--- 268
Query: 305 EVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 363
LP AL +++ L C D RPK ++ +L+ L R+ +
Sbjct: 269 ------LPPPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK---LIRNPGSLKI 316
Query: 364 EPSNSYGEENRDFARKVGD 382
S + N + D
Sbjct: 317 ITSAAARPSNLLLDQSNVD 335
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 6e-13
Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 35/184 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+AYL VHRD+ NIL+ ++ DFGL++ + E Y + +++
Sbjct: 126 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE SDV+ F + + EI++ G+ P + N ++V
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP--F---FWLEN--------------KDV 223
Query: 307 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 360
+ +LPK L ++ RC D D + RP+ ++ L +++ E+
Sbjct: 224 IGVLEKGDRLPKPDLCPPVLYTLM---TRCWDYDPSDRPRFTELVCSLSD---VYQMEKD 277
Query: 361 IGRE 364
I E
Sbjct: 278 IAME 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 6e-13
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 46/193 (23%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
A++ E +HRD++++NIL+ + +++DFGLA+L+ + Y T R F
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWT 177
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE G KSDV+SFGIL+ EI+T GR P Y G N E
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP--Y---PGMTN--------------PE 218
Query: 306 VVDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 359
V+ ++ + + L +++ C RP ++ +LE D
Sbjct: 219 VIQNLERGYRMVRPDNCPEELYQLM---RLCWKERPEDRPTFDYLRSVLE--DFF----- 268
Query: 360 RIGREPSNSYGEE 372
Y +
Sbjct: 269 ---TATEGQYQPQ 278
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 27/116 (23%), Positives = 48/116 (41%), Gaps = 18/116 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243
+ +L E +VHR++K NI+ D Q +++DFG A+ L + + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTE 179
Query: 244 GYVAPEYACTGML--------NEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNL 290
Y+ P+ +L D++S G+ TG P + P+ +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGML 256
K +HRD+ + NILL + ++ DFGLA+ + + YV ++APE +
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272
Query: 257 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315
+SDV+SFG+L+ EI + G +P Y + + LK G+R M
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRLKE--GTR------------MR 316
Query: 316 A-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
A + L C + ++RP ++ L
Sbjct: 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 34/170 (20%), Positives = 71/170 (41%), Gaps = 17/170 (10%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYV 246
YL + +HRD+ + NIL++ + ++ DFGL K+L ++ Y + G +
Sbjct: 159 EYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE + SDV+SFG+++ E+ T + S+ + G +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 307 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
++ +LP+ + ++ C + + +RP + ++
Sbjct: 273 IELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 319
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 34/158 (21%), Positives = 73/158 (46%), Gaps = 24/158 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YLH K++HRD+K SN+L+ + +++DFG++ + ++ V GT ++A
Sbjct: 150 IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMA 205
Query: 248 PEYACTGMLNE----KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
PE + + DV++ G+ + + G+ P + ++ + KS
Sbjct: 206 PE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DERIMCLHSKI----KS 254
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
+ + P P + ++ LK L+ + +P+ R +
Sbjct: 255 QALEFPDQPDI--AEDLKD-LITRMLDKNPE--SRIVV 287
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +H +HRDVK N+LLD+ + +++DFG + E +GT Y++
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 248 PE----YACTGMLNEKSDVYSFGILIMEIITGRNP 278
PE G + D +S G+ + E++ G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 43/195 (22%), Positives = 73/195 (37%), Gaps = 38/195 (19%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
YL + +HRD+ + N L+ +V+DFGL++L+ T F
Sbjct: 125 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWT 179
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSE 304
APE + KSDV++FG+L+ EI T G +P Y +V + L+ R
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQV--YELLEK--DYR--- 230
Query: 305 EVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 363
+ + + + ++ C + + RP + E + +
Sbjct: 231 ------MERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE----------TMFQ 271
Query: 364 EPSNSYGEENRDFAR 378
E S S E R
Sbjct: 272 ESSISDEVEKELGKR 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 11/94 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYLH ++HRDVK+ NILL ++ DFG A ++ S+V GT ++A
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 218
Query: 248 PEYACT---GMLNEKSDVYSFGILIMEIITGRNP 278
PE G + K DV+S GI +E+ + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 32/180 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FG 244
+ YL + ++VHRD+ + N+L+ + +++DFGLAKLL +E G
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIK 184
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY-SRPQGEVNLVDWLKTMVGSRK 302
++A E + +SDV+S+G+ + E++T G P Y P E+ L+ G R
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEI--SSILEK--GER- 237
Query: 303 SEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRI 361
LP+ P + + ++ ++C DA RPK +I + RD +R
Sbjct: 238 --------LPQPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSK---MARDPQRY 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 37/190 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY-- 245
+ YL + VHRD+ + N+L+D +VSDFGL+++L + T G
Sbjct: 164 MRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
APE + SDV+SFG+++ E++ G P Y N
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--Y---WNMTN--------------R 261
Query: 305 EVVDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 358
+V+ +LP AL +++ L C D +RP+ ++ +L+A L R
Sbjct: 262 DVISSVEEGYRLPAPMGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVLDA---LIRSP 315
Query: 359 RRIGREPSNS 368
+ + S
Sbjct: 316 ESLRATATVS 325
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 39/179 (21%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--V 246
YL + +HRD+ + N L++ Q +VSDFGL++ + T+ V F
Sbjct: 134 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWS 188
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
PE + KSD+++FG+L+ EI + G+ P Y + N E
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--Y---ERFTN--------------SE 229
Query: 306 VVDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 358
+ +L + AS+ + ++ C A +RP ++ + + +E
Sbjct: 230 TAEHIAQGLRLYRPHLASEKVYTIM---YSCWHEKADERPTFKILLSNILD---VMDEE 282
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 6/54 (11%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL 183
P + LG+G W E++ L +G G +G+V G VA+K +
Sbjct: 9 PSTAGLGYGSW----EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI 56
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 39/181 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY-- 245
+A+L + +HRD+ + N L+DR +VSDFG+ + + + V F
Sbjct: 117 MAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKW 171
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
APE + KSDV++FGIL+ E+ + G+ P Y N
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP--Y---DLYTN--------------S 212
Query: 305 EVVDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 358
EVV +L + AS + +++ C KRP ++ +E L +
Sbjct: 213 EVVLKVSQGHRLYRPHLASDTIYQIM---YSCWHELPEKRPTFQQLLSSIEP---LREKD 266
Query: 359 R 359
+
Sbjct: 267 K 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 32/193 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY-- 245
+ YL VHRD+ + NIL++ +VSDFGL+++L + T G
Sbjct: 160 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
APE SDV+SFGI++ E++T G P Y N G R
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--Y---WELSNHEVMKAINDGFR--- 268
Query: 305 EVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA--------DDLLF 355
LP A+ +++ ++C + +RPK ++ +L+ L
Sbjct: 269 ------LPTPMDCPSAIYQLM---MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319
Query: 356 RDERRIGREPSNS 368
D R R PS S
Sbjct: 320 FDPRVSIRLPSTS 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 10/98 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ +H VHRD+K NILLDR + R++DFG L ++ + + +GT Y++
Sbjct: 175 IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 248 PEYACTGMLNEKSDVY-------SFGILIMEIITGRNP 278
PE + Y + G+ E+ G+ P
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV-- 246
YL E K VHRD+ + N +LD + +V+DFGLA+ + Y + V
Sbjct: 138 EYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 247 -APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRK 302
A E T KSDV+SFG+L+ E++T G P Y + L +L G R
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--Y---RHIDPFDLTHFLAQ--GRR- 246
Query: 303 SEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
LP+ +L +V+ +C + D RP ++ +E
Sbjct: 247 --------LPQPEYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVEQ 284
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYL + VHRD+ + N+L+ ++ DFGL++ + Y ++ ++A
Sbjct: 504 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE SDV+ FG+ + EI+ G P + QG N +V
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP--F---QGVKN--------------NDV 601
Query: 307 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 359
+ +LP P L ++ +C D ++RP+ + L + +E+
Sbjct: 602 IGRIENGERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST---ILEEEK 654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 34/170 (20%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
+L K +HRD+ + NILL + ++ DFGLA+ + + YV + M
Sbjct: 162 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM- 217
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 300
APE + +SDV+SFG+L+ EI + G +P Y + + LK G+
Sbjct: 218 -----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRLKE--GT 268
Query: 301 RKSEEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
R + + + + + L C + ++RP ++ L
Sbjct: 269 R---------MRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGM 255
VHRD+ + N+L+ A+VSDFGL + +T+ G APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKK 190
Query: 256 LNEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313
+ KSDV+SFGIL+ EI + GR P Y R P +V V ++ G + +
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV--VPRVEK--GYK---------MDA 235
Query: 314 MP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 358
A+ V+ C DA RP + LE + E
Sbjct: 236 PDGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEH---IKTHE 275
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + T + GT Y+
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYL 172
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L + D + G+++ E++ GR P
Sbjct: 173 APE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 17/96 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
YLH +++RD+K N+L+D+Q +V+DFG AK T + GT +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALA 206
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
PE ++ K D ++ G+LI E+ G P
Sbjct: 207 PE-----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH+ +++RD+K NILLD + ++DFGL+K ++ + GT Y+A
Sbjct: 172 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 248 PEYACTGMLNEKS-------DVYSFGILIMEIITGRNP 278
P+ ++ D +S G+L+ E++TG +P
Sbjct: 229 PD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +LH +++RD+K NILLD + + +++DFGL+K GT Y+
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYM 193
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE ++N + D +SFG+L+ E++TG P
Sbjct: 194 APE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L YLH +V+RD+K NILLD Q + ++DFGL K S TT GT Y+
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYL 206
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L+++ D + G ++ E++ G P
Sbjct: 207 APE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 15/97 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L YLH VV+RD+K N++LD+ + +++DFGL K + + T + GT Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYL 316
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L + D + G+++ E++ GR P
Sbjct: 317 APE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV + M
Sbjct: 159 AFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM- 214
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
APE + +SDV+S+GI + E+ + G +P
Sbjct: 215 -----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 14/114 (12%)
Query: 166 IVYRGILS-DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224
+ + LS T+ ++ LL + LH+ +VHRD+K NILLD N +++DFG
Sbjct: 115 LTEKVTLSEKETRKIMRALLEV-ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 225 AKLLCSERSYVTTRVMGTFGYVAPE------YACTGMLNEKSDVYSFGILIMEI 272
+ L + GT Y+APE ++ D++S G+ IM
Sbjct: 171 SCQL-DPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV-IMYT 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 36/213 (16%), Positives = 74/213 (34%), Gaps = 41/213 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM------- 240
+ ++H +P ++HRD+K N+LL Q ++ DFG A + Y +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 241 ----GTFGYVAPE----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 292
T Y PE Y+ + EK D+++ G ++ + ++P +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHPFEDGAK-------- 258
Query: 293 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352
L+ + G P ++ + + +R + V+H L+
Sbjct: 259 -LRIVNGKYS-----IPPHDTQ--YTVFHSLI---RAMLQVNPEERLSIAEVVHQLQE-- 305
Query: 353 LLFRDERRI-GREPSNSYGEENRDFARKVGDKQ 384
R + + P E+N + +
Sbjct: 306 --IAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 41/180 (22%), Positives = 73/180 (40%), Gaps = 35/180 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
LAYL + VHRD+ + N+L+ ++ DFGL++ + Y ++ ++A
Sbjct: 129 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE SDV+ FG+ + EI+ G P + QG N +V
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP--F---QGVKN--------------NDV 226
Query: 307 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 360
+ +LP P L ++ +C D ++RP+ + L + +E+
Sbjct: 227 IGRIENGERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST---ILEEEKA 280
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +LH+ +++RD+K NI+L+ Q + +++DFGL K + + T GT Y+
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYM 188
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L D +S G L+ +++TG P
Sbjct: 189 APE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
YL K +HRD+ + N+L+ +++DFGLA+ + Y T + M
Sbjct: 205 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM- 260
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
APE + +SDV+SFG+L+ EI T G +P
Sbjct: 261 -----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-------MG 241
YL K +HRD+ + N+L+ +++DFGLA+ + + Y T M
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM- 226
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
APE + +SDV+SFG+L+ EI T G +P
Sbjct: 227 -----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 6e-12
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGM 255
V+HRD+ + N L+ +VSDFG+ + + T+ F +PE
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 256 LNEKSDVYSFGILIMEIIT-GRNP 278
+ KSDV+SFG+L+ E+ + G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 16/99 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YL ++HRD+K NI++ + ++ DFG A L T GT Y A
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCA 197
Query: 248 PEYACTGMLNEKS------DVYSFGILIMEIITGRNPVD 280
PE +L +++S G+ + ++ NP
Sbjct: 198 PE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
+L VHRD+ + N+L+ ++ DFGLA+ + S+ +YV + M
Sbjct: 186 EFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM- 241
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
APE G+ KSDV+S+GIL+ EI + G NP
Sbjct: 242 -----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 8e-12
Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 17/96 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH +++RD+K NILLD+ + +++DFG AK VT + GT Y+A
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIA 171
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
PE +++ K D +SFGILI E++ G P
Sbjct: 172 PE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ YLH+ +VHRD+K NILL ++ ++ DFGL+ + Y +GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTAY 213
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
Y+APE NEK DV+S G+++ ++ G P
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 37/171 (21%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-------MG 241
YL K +HRD+ + N+L+ +++DFGLA+ + + Y T M
Sbjct: 217 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM- 272
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMV 298
APE + +SDV+SFG+L+ EI T G +P Y G L LK
Sbjct: 273 -----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--Y---PGIPVEELFKLLKE-- 320
Query: 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
G R + K + ++ C ++RP ++ L+
Sbjct: 321 GHR---------MDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +LH+ +++RD+K N+LLD + + +++DFG+ K TT GT Y+
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYI 191
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L E D ++ G+L+ E++ G P
Sbjct: 192 APE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 11/92 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFG 244
+ +LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 140 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 191
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGR 276
Y APE E D++S G ++ E+I G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 14/89 (15%)
Query: 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMGTFGYVAPEY 250
+HRDV + N+LL A++ DFGLA+ + ++ +Y+ + M APE
Sbjct: 184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM------APES 237
Query: 251 ACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
+ +SDV+S+GIL+ EI + G NP
Sbjct: 238 IFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 35/94 (37%), Positives = 46/94 (48%), Gaps = 20/94 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 243
+ YLH VVHRD+K SNIL D N R+ DFG AK L +E + T T
Sbjct: 129 VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 244 GYVAPEYACTGMLNEKS-----DVYSFGIL--IM 270
+VAPE +L + D++S G+L M
Sbjct: 185 NFVAPE-----VLERQGYDAACDIWSLGVLLYTM 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
++++H+ VVHRD+K N+L D N ++ DFG A+L + + T T
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLH 174
Query: 245 YVAPEYACTGMLNEKSDVYSFGIL--IM 270
Y APE +E D++S G++ M
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTM 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +LH +V+RD+K NILLD+ + +++DFG+ K + T GT Y+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYI 185
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L + D +SFG+L+ E++ G++P
Sbjct: 186 APE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ YLH+ +VHRD+K N+LL ++ +A ++ DFGL+ + E +GT
Sbjct: 149 VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAY 203
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
Y+APE +EK DV+S G+++ ++ G P
Sbjct: 204 YIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L YLHE +++RD+K N+LLD + + +++D+G+ K TT GT Y+
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYI 177
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L + D ++ G+L+ E++ GR+P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
YL E K+VHRD+ + NIL+ ++SDFGL++ + E SYV + M
Sbjct: 164 QYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM- 219
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
A E + +SDV+SFG+L+ EI+T G NP
Sbjct: 220 -----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 17/99 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-------M 240
+ YL +HRD+ + N +L V+DFGL++ + S Y +
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 241 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
A E + SDV++FG+ + EI+T G+ P
Sbjct: 207 ------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 37/112 (33%), Positives = 63/112 (56%), Gaps = 14/112 (12%)
Query: 166 IVYRGILS--DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--S 220
I+ RG+ + D + V ++ +L+ + YLHE +VHRD+K N+L + N+++ +
Sbjct: 97 ILERGVYTEKDASLV-IQQVLS-AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT 151
Query: 221 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEI 272
DFGL+K+ + ++T GT GYVAPE ++ D +S G+ I I
Sbjct: 152 DFGLSKME--QNGIMSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGV-ITYI 199
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 19/98 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSER---SYVTTRVMGTF 243
+ LH V HRD+K N+L++ ++ DFG AK L +Y+ +R
Sbjct: 142 IGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY---- 196
Query: 244 GYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE + + D++S G + E++ G
Sbjct: 197 -YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +L +++RD+K N++LD + + +++DFG+ K + TT+ GT Y+
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYI 188
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE ++ + D ++FG+L+ E++ G+ P
Sbjct: 189 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L YLHE +++RD+K N+LLD + + +++D+G+ K TT GT Y+
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYI 220
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE +L + D ++ G+L+ E++ GR+P
Sbjct: 221 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 166 IVYRGILS-DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224
+ + LS T+ +++LL +++LH +VHRD+K NILLD R+SDFG
Sbjct: 191 LTEKVALSEKETRSIMRSLLEA-VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF 246
Query: 225 AKLLCSERSYVTTRVMGTFGYVAPE------YACTGMLNEKSDVYSFGI 267
+ L + GT GY+APE ++ D+++ G+
Sbjct: 247 SCHL-EPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV-------MG 241
YL +HRD+ + N +L V+DFGL+K + S Y R+ +
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI- 216
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
A E + KSDV++FG+ + EI T G P
Sbjct: 217 -----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 33/160 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-----------DRQWNARVSDFGLAKLL--CSERSY 234
+ +H+ +++H D+K N +L D + D G + + + +
Sbjct: 185 IEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 235 VTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPVDYSRPQGEVN 289
T + T G+ E ML+ K D + + ++ G GE
Sbjct: 242 FTAKC-ETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM-KVKNEGGECK 294
Query: 290 LVDWLKTMVGSRKSEEVVDPKL-----PKMPASKALKRVL 324
+ + E L +P+ L++ L
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 11/92 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFG 244
+ +LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 177 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 228
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGR 276
Y APE E D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 166 IVYRGILS-DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSD 221
+V L K+ +L + YLHE ++HRD+K N+LL + +++D
Sbjct: 230 VVGNKRLKEATCKLYFYQMLLA-VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 222 FGLAKLLCSERSYVTTRVMGTFGYVAPE---YACTGMLNEKSDVYSFG-IL 268
FG +K+L E S + T GT Y+APE T N D +S G IL
Sbjct: 286 FGHSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 18/100 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
+ + H V+HRD+K NIL+D + ++ DFG LL + + T GT Y
Sbjct: 162 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYS 215
Query: 247 APEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
PE + + V+S GIL+ +++ G P +
Sbjct: 216 PPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
L +L +++RD+K N++LD + + +++DFG+ K + TT+ GT Y+
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYI 509
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
APE ++ + D ++FG+L+ E++ G+ P
Sbjct: 510 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 18/102 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER--SYVTTRVMGTFGY 245
L YLH +VH+D+K N+LL ++S G+A+ L T G+ +
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAF 177
Query: 246 VAPEYACTGMLNE-------KSDVYSFGILIMEIITGRNPVD 280
PE + N K D++S G+ + I TG P +
Sbjct: 178 QPPE-----IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 13/96 (13%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV-- 246
AYL+ K VHRD+ + N ++ + ++ DFG+ + + Y G G +
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 204
Query: 247 ---APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
+PE G+ SDV+SFG+++ EI T P
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ Y+H+ K+VHRD+K N+LL + +A R+ DFGL+ E S +GT
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAY 193
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
Y+APE G +EK DV+S G+++ +++G P
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 35/172 (20%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG---- 244
YL K VHRD+ + N +LD ++ +V+DFGLA+ + + Y V G
Sbjct: 142 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLP 195
Query: 245 --YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVG 299
++A E T KSDV+SFG+L+ E++T G P Y + +L G
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PDVNTFDITVYLLQ--G 248
Query: 300 SRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
R L + L V+ L+C P A RP ++ + A
Sbjct: 249 RR---------LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 21/98 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSER---SYVTTRVMGTF 243
+ ++H + HRD+K N+L++ + ++ DFG AK L +Y+ +R
Sbjct: 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF---- 206
Query: 244 GYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE ML D++S G + E+I G+
Sbjct: 207 -YRAPEL----MLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 18/95 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YR 196
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
APE MLN D++S G ++ E++TGR
Sbjct: 197 APEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 6e-11
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--YVTTRVMGTFGY 245
+ YLH + HRD+K N+LLD + N ++SDFGLA + + GT Y
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173
Query: 246 VAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
VAPE +L + DV+S GI++ ++ G P D
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 12/99 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLL----CSERSYVTTRVMG 241
L YLH + HRD+K N L + + DFGL+K E +TT+ G
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-G 236
Query: 242 TFGYVAPE--YACTGMLNEKSDVYSFGILIMEIITGRNP 278
T +VAPE K D +S G+L+ ++ G P
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 18/95 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR Y
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YR 190
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
APE +L+ D++S G ++ E++TG+
Sbjct: 191 APEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFG 244
+ + H+ VVHR++K N+LL + A V +DFGLA + E+ GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEI 272
Y++PE + D+++ G+ I+ I
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGV-ILYI 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 39/107 (36%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 166 IVYRGILS--DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--S 220
IV +G S D VK +L +AYLHE +VHRD+K N+L +A + +
Sbjct: 139 IVEKGYYSERDAADA-VKQILEA-VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 221 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGI 267
DFGL+K++ E + V GT GY APE + D++S GI
Sbjct: 194 DFGLSKIV--EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 166 IVYRGILS-DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSD 221
+V L K+ +L + YLHE ++HRD+K N+LL Q +++D
Sbjct: 105 VVGNKRLKEATCKLYFYQMLLA-VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160
Query: 222 FGLAKLLCSERSYVTTRVMGTFGYVAPE---YACTGMLNEKSDVYSFG-IL 268
FG +K+L E S + T GT Y+APE T N D +S G IL
Sbjct: 161 FGHSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 18/95 (18%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYV 246
L Y+H ++HRD+K N+ ++ ++ DFGLA+ SE + YV TR Y
Sbjct: 141 LRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YR 192
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
APE +LN D++S G ++ E+ITG+
Sbjct: 193 APEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 20/97 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFG 244
L LHE VVHRD+ NILL + + DF LA+ ++ + YVT R
Sbjct: 147 LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW----- 198
Query: 245 YVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE ++ K D++S G ++ E+ +
Sbjct: 199 YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 8/95 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
+ + H VVHRD+K NIL+D + ++ DFG LL T GT Y
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYS 205
Query: 247 APEY-ACTGMLNEKSDVYSFGILIMEIITGRNPVD 280
PE+ + + V+S GIL+ +++ G P +
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--YVTTRVMGTFGY 245
+ YLH + HRD+K N+LLD + N ++SDFGLA + + GT Y
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173
Query: 246 VAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
VAPE +L + DV+S GI++ ++ G P D
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 19/99 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ Y+H+ +VHRD+K NILL ++ + ++ DFGL+ +++ +GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAY 188
Query: 245 YVAPE-----YACTGMLNEKSDVYSFGILIMEIITGRNP 278
Y+APE Y +EK DV+S G+++ +++G P
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 16/99 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ Y H+ ++VHRD+K+ N+LLD N +++DFG + + + G Y A
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLDAFC-GAPPYAA 181
Query: 248 PEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
PE + K DV+S G+++ +++G P D
Sbjct: 182 PE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 24/101 (23%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTRVM 240
L Y+H V+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR-- 195
Query: 241 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE MLN K D++S G ++ E+++ R
Sbjct: 196 ---WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 21/100 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSY---VTTRVMGTF 243
L Y H ++HRDVK N+++D + R+ D+GLA+ + Y V +R
Sbjct: 143 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195
Query: 244 GYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
+ PE +++ + D++S G ++ +I + P
Sbjct: 196 -FKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 7/84 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFG 244
L Y H+ ++HRDVK +LL ++ +A V FG+A L RV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 245 YVAPEYACTGMLNEKSDVYSFGIL 268
++APE + DV+ G++
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 33/171 (19%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV-- 246
+L K VHRD+ + N +LD ++ +V+DFGLA+ + ++ + + T +
Sbjct: 206 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPV 260
Query: 247 ---APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGS 300
A E T KSDV+SFG+L+ E++T G P Y + +L G
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PDVNTFDITVYLLQ--GR 313
Query: 301 RKSEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
R L + L V+ L+C P A RP ++ + A
Sbjct: 314 R---------LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 352
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 21/98 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSER---SYVTTRVMGTF 243
LAY+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 221
Query: 244 GYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE + DV+S G ++ E++ G+
Sbjct: 222 -YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 38/173 (21%), Positives = 71/173 (41%), Gaps = 39/173 (22%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
YL VVH+D+ + N+L+ + N ++SD GL + + + Y R M
Sbjct: 142 EYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM- 197
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMV 298
APE G + SD++S+G+++ E+ + G P Y G N +V+ ++
Sbjct: 198 -----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--Y---CGYSNQDVVEMIRN-- 245
Query: 299 GSRKSEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
LP + ++ + C + ++RP+ + L A
Sbjct: 246 RQV---------LPCPDDCPAWVYALM---IECWNEFPSRRPRFKDIHSRLRA 286
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 16/99 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ Y H VVHRD+K N+LLD NA+++DFGL+ ++ T+ G+ Y A
Sbjct: 124 VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 178
Query: 248 PEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
PE +++ + D++S G+++ ++ G P D
Sbjct: 179 PE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 21/98 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSER---SYVTTRVMGTF 243
LAY+H + HRD+K N+LLD ++ DFG AK+L + SY+ +R
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY---- 206
Query: 244 GYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y APE + + D++S G ++ E++ G+
Sbjct: 207 -YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ Y H K+VHRD+K N+LLD N +++DFGL+ ++ T+ G+ Y A
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 175
Query: 248 PEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
PE ++N K DV+S GI++ ++ GR P D
Sbjct: 176 PE-----VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 20/98 (20%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
YL + + +HRD+ + NIL+ + A+++DFGL++ + YV R M
Sbjct: 156 DYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM- 208
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
A E + SDV+S+G+L+ EI++ G P
Sbjct: 209 -----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 8e-10
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 166 IVYRGILS-DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SD 221
IV R S ++ +L + +AY H +VHR++K N+LL + A V +D
Sbjct: 96 IVAREFYSEADASHCIQQILES-IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 222 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG-IL 268
FGLA ++ GT GY++PE ++ D+++ G IL
Sbjct: 152 FGLAI-EVNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 24/102 (23%), Positives = 50/102 (49%), Gaps = 25/102 (24%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERS-------YVTTRV 239
L Y+H V+HRD+K +N+ ++ + ++ DFGLA+++ S + T+
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK- 188
Query: 240 MGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y +P +L+ + D+++ G + E++TG+
Sbjct: 189 ----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 9/88 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ YLH + HRDVK N+L ++ NA +++DFG AK S S T T
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPY 228
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEI 272
YVAPE ++ D++S G+ IM I
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGV-IMYI 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 10/96 (10%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAKLLCSERSYVTTRVMGTFG- 244
YL E +HRD+ + N LL RV DFG+A+ + SY
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPV 209
Query: 245 -YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
++ PE G+ K+D +SFG+L+ EI + G P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 31/108 (28%), Positives = 48/108 (44%), Gaps = 31/108 (28%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------------- 233
+ LH V+HRD+K SN+L++ + +V DFGLA+++ +
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 234 YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
+V TR Y APE ML DV+S G ++ E+ R
Sbjct: 182 FVATR-----WYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ +LH + HRDVK N+L ++ +A +++DFG AK ++ + T T
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPY 194
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEI 272
YVAPE ++ D++S G+ IM I
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGV-IMYI 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 17/98 (17%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMG 241
YL VHRD+ + N L+ ++ DFG+++ + S Y R M
Sbjct: 147 VYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM- 202
Query: 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
PE +SDV+SFG+++ EI T G+ P
Sbjct: 203 -----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 18/101 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNAR--------VSDFGLAKLLCSERSYVTTRV 239
+ +L E ++H +V + NILL R+ + + +SD G++ + + + R+
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERI 181
Query: 240 MGTFGYVAPE-YACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
PE LN +D +SFG + EI + G P
Sbjct: 182 PWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 20/93 (21%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 244
+AY H+ V HRD+K N L ++ DFGLA + T+V GT
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTPY 173
Query: 245 YVAPE-----YACTGMLNEKSDVYSFGILIMEI 272
YV+P+ Y + D +S G+ +M +
Sbjct: 174 YVSPQVLEGLY------GPECDEWSAGV-MMYV 199
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 22/116 (18%)
Query: 166 IVYRGILS-DGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSD 221
I+ R S +K + + + Y+H+ +VHRD+K NILL ++ + ++ D
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSG-ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167
Query: 222 FGLAKLLCSERSYVTTRVMGTFGYVAPE-----YACTGMLNEKSDVYSFGILIMEI 272
FGL+ + + + R+ GT Y+APE Y +EK DV+S G+ I+ I
Sbjct: 168 FGLST-CFQQNTKMKDRI-GTAYYIAPEVLRGTY------DEKCDVWSAGV-ILYI 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 30/99 (30%), Positives = 43/99 (43%), Gaps = 16/99 (16%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAKLLCSERSYVTTRVMGTFGY 245
YL E +HRD+ + N LL RV DFG+A+ + Y G
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCAM 247
Query: 246 V-----APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
+ PE G+ K+D +SFG+L+ EI + G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 10/88 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 244
LAY H VVH+D+K NIL D ++ ++ DFGLA+ L + T GT
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAA-GTAL 191
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEI 272
Y+APE + K D++S G+ +M
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGV-VMYF 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 17/95 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +VVHRD+K NIL+ +++DFGLA++ + + T+ V+ T Y A
Sbjct: 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWYRA 187
Query: 248 PE------YACTGMLNEKSDVYSFGILIMEIITGR 276
PE YA T + D++S G + E+ +
Sbjct: 188 PEVLLQSSYA-TPV-----DLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 17/95 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +VHRD+K NIL+ +++DFGLA++ + + T V+ T Y A
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TLWYRA 187
Query: 248 PE------YACTGMLNEKSDVYSFGILIMEIITGR 276
PE YA D++S G + E+ +
Sbjct: 188 PEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 16/99 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ Y H VVHRD+K N+LLD NA+++DFGL+ ++ T+ G+ Y A
Sbjct: 129 VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 183
Query: 248 PEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
PE +++ + D++S G+++ ++ G P D
Sbjct: 184 PE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV-- 246
YL VHRD+ + N L+ + ++ DFG+++ + S Y +G +
Sbjct: 172 VYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGRTMLPI 224
Query: 247 ---APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
PE +SDV+SFG+++ EI T G+ P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFG 244
+AY H +VHR++K N+LL + A V +DFGLA + ++ GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPG 195
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEI 272
Y++PE ++ D+++ G+ I+ I
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGV-ILYI 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV-- 246
AYL E K VHRD+ + N L+ +++DFGL++ + S Y +
Sbjct: 188 AYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK----ADGNDAIPI 240
Query: 247 ---APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 278
PE +SDV+++G+++ EI + G P
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
L ++HE +VH D+K NI+ + + + V DFGLA L + T +
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEF 216
Query: 246 VAPEYACTGMLNEKSDVYSFGIL 268
APE + +D+++ G+L
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVL 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 7e-09
Identities = 26/97 (26%), Positives = 45/97 (46%), Gaps = 15/97 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
L + H V+HRD+K N+L++R ++++FGLA+ R Y + V+ T Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYR 168
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 278
P+ + K D++S G + E+ P
Sbjct: 169 PPDV----LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 28/95 (29%), Positives = 56/95 (58%), Gaps = 15/95 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
LA+ HE K++HRD+K N+L++++ ++ DFGLA+ ++ ++ V+ T Y
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLWYR 175
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
AP+ ++ ++ D++S G ++ E+ITG+
Sbjct: 176 APDV----LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 8/84 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFG 244
+ YLH+ +VH D+K NILL + DFG+++ + +MGT
Sbjct: 144 VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPE 198
Query: 245 YVAPEYACTGMLNEKSDVYSFGIL 268
Y+APE + +D+++ GI+
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 15/95 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
LAY H KV+HRD+K N+L++ + +++DFGLA+ ++Y V+ T Y
Sbjct: 113 LAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYR 167
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
P+ +L D++ G + E+ TGR
Sbjct: 168 PPDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 13/94 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ + H+ +HRDVK NIL+ + ++ DFG A+LL Y V T Y +
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
PE ++ + DV++ G + E+++G
Sbjct: 171 PEL----LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 15/95 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
+A+ H+ +++HRD+K N+L++ +++DFGLA+ RSY T V+ T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYR 186
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
AP+ ++ K D++S G + E+ITG+
Sbjct: 187 APDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 19/83 (22%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
L +LH + H D++ NI+ + ++ + +FG A+ L ++ + Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEY 169
Query: 246 VAPEYACTGMLNEKSDVYSFGIL 268
APE +++ +D++S G L
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTL 192
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 18/101 (17%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQW--NARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
++Y H ++ HRD+K N LLD ++ DFG +K S + V GT Y
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAY 183
Query: 246 VAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 280
+APE +L + +DV+S G+ + ++ G P +
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 34/119 (28%), Positives = 53/119 (44%), Gaps = 42/119 (35%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------------- 233
+ YLH G ++HRD+K SNILL+ + + +V+DFGL++ + R
Sbjct: 122 IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 234 -----------YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
YV TR Y APE +L D++S G ++ EI+ G+
Sbjct: 179 NFDDDQPILTDYVATR-----WYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 9/85 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 243
+ YLH K+ H D+K NI+L D+ ++ DFGLA + + GT
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIF-GTP 182
Query: 244 GYVAPEYACTGMLNEKSDVYSFGIL 268
+VAPE L ++D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 20/83 (24%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
+ ++H+ ++H D+K NIL + ++ DFGLA+ GT +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEF 254
Query: 246 VAPEYACTGMLNEKSDVYSFGIL 268
+APE ++ +D++S G++
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVI 277
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 15/95 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
+AY H+ +V+HRD+K N+L++R+ +++DFGLA+ R Y T ++ T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYR 167
Query: 247 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
AP+ ++ K D++S G + E++ G
Sbjct: 168 APDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 20/71 (28%), Positives = 33/71 (46%), Gaps = 12/71 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLL--CSERSYVTTRVM-- 240
L +LH + HRD+K NIL + ++ DF L + + S ++T +
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 241 --GTFGYVAPE 249
G+ Y+APE
Sbjct: 181 PCGSAEYMAPE 191
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 9/85 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 243
+ YLH K+ H D+K NI+L D+ ++ DFGLA + + + GT
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTP 182
Query: 244 GYVAPEYACTGMLNEKSDVYSFGIL 268
+VAPE L ++D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA----RVSDFGLAKLLCSERSYVTTRVMGTF 243
+ YLH ++ H D+K NI+L + ++ DFG+A + + + + GT
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTP 175
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILI 269
+VAPE L ++D++S G++
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 20/100 (20%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNAR-----VSDFGLAKLLCSE-RSYVTTRVMG 241
+ + H + +HRD+K N+LL + + DFGLA+ R + T ++
Sbjct: 145 VNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII- 199
Query: 242 TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
T Y PE +L + D++S + E++
Sbjct: 200 TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
L ++HE VH D+K NI+ + + + DFGL L + V GT +
Sbjct: 268 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTT-GTAEF 322
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 278
APE A + +D++S G+L +++G +P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 19/99 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-----CSERSYVTTRVMGT 242
L Y+H K++HRD+K++N+L+ R +++DFGLA+ Y T RV+ T
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNRVV-T 191
Query: 243 FGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
Y PE +L E+ D++ G ++ E+ T
Sbjct: 192 LWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 29/122 (23%), Positives = 52/122 (42%), Gaps = 43/122 (35%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------------- 233
++HE ++HRD+K +N LL++ + +V DFGLA+ + SE+
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 234 ------------YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
+V TR Y APE +L +++ D++S G + E++
Sbjct: 199 PHNKNLKKQLTSHVVTR-----WYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 277 NP 278
Sbjct: 250 QS 251
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 9/85 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTF 243
+ YLH ++ H D+K NI+L DR ++ DFGLA + + + GT
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTP 181
Query: 244 GYVAPEYACTGMLNEKSDVYSFGIL 268
+VAPE L ++D++S G++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 1e-07
Identities = 62/442 (14%), Positives = 121/442 (27%), Gaps = 139/442 (31%)
Query: 54 HNHL-----QQQQQSKQIL--NTPPI------------------SKEIQEIVHHPAPV-- 86
H+H+ + Q Q K IL +EI I+ V
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 87 -----------PE----------IQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGS 125
E ++++ + + R S +R +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR-MYIEQRDRLYND 122
Query: 126 GSVGPE--VSHLGWGRWYTLRELEAATSGL-CEENVI--GEGGYG------IVYR----- 169
V + VS R +L A L +NV+ G G G V
Sbjct: 123 NQVFAKYNVS-----RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177
Query: 170 -----GI--LSDGTKVAVKNLLN--NRLAY----------------------LHEGLEPK 198
I L+ + + +L +L Y + L
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 199 VVHRDVKSSNILLDRQWNARVSD-FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 257
+ + ++ ++L NA+ + F L+ C + +TTR +++ L+
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLS---C--KILLTTRFKQVTDFLSAATTTHISLD 292
Query: 258 EKSDVY----SFGILIMEIITGRNPVDYSRPQGEVNLVDWLK-TMVGSRKSEEVVDPKLP 312
S +L+ P D R EV + + +++ + +
Sbjct: 293 HHSMTLTPDEVKSLLLK--YLDCRPQDLPR---EVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL-LFRDERRIGREPS----- 366
K L ++ +L ++P + M + L +F I P+
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYR--------KMFD--RLSVFPPSAHI---PTILLSL 394
Query: 367 ---NSYGEENRDFARKVGDKQL 385
+ + K+ L
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSL 416
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 19/97 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
L YLH+ ++HRD+K +N+LLD +++DFGLAK S R+Y T +V+ T Y
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYR 179
Query: 247 APE-------YACTGMLNEKSDVYSFGILIMEIITGR 276
APE Y G+ D+++ G ++ E++
Sbjct: 180 APELLFGARMYG-VGV-----DMWAVGCILAELLLRV 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 31/123 (25%), Positives = 48/123 (39%), Gaps = 29/123 (23%)
Query: 168 YRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDR------QWNARVSD 221
+RGI K K LL L Y+H ++H D+K N+L++ +++D
Sbjct: 125 HRGIPLIYVKQISKQLLLG-LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 222 FGLAKLLCSERSYVTTRVMGTFGYVAPE--------YACTGMLNEKSDVYSFGILIMEII 273
G A C + T + Y +PE D++S LI E+I
Sbjct: 182 LGNA---CWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGA--------DIWSTACLIFELI 229
Query: 274 TGR 276
TG
Sbjct: 230 TGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 22/155 (14%), Positives = 35/155 (22%), Gaps = 47/155 (30%)
Query: 188 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
H G V S + VS G L +
Sbjct: 142 ADAAHRAG----VALSIDHPSRVR--------VSIDGDVVL-------------AYPATM 176
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
N + D+ G + ++ R P L + +
Sbjct: 177 PDA-------NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGL-----APAERDTAGQP 222
Query: 307 VDPKL--PKMPASKALKRVLLVALRCVDPDATKRP 339
++P +P + VA R V D R
Sbjct: 223 IEPADIDRDIPFQ-----ISAVAARSVQGDGGIRS 252
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 20/101 (19%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCSE-RSY--VTTRVM 240
+ YLH V+HRD+K +NIL+ + R ++D G A+L S + + V+
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 241 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
TF Y APE +L + D+++ G + E++T
Sbjct: 198 -TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ + H ++HRD+K NIL+ + ++ DFG A+ L + V T Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 248 PEYACTGMLNEKS-----DVYSFGILIMEIITGR 276
PE ++ + DV++ G L+ E+ G
Sbjct: 193 PEL----LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 27/135 (20%), Positives = 50/135 (37%), Gaps = 48/135 (35%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------------- 233
+ Y+H ++HRD+K +N L+++ + +V DFGLA+ + +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 234 -----------------YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIME 271
+V TR Y APE +L +++ DV+S G + E
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTR-----WYRAPEL----ILLQENYTEAIDVWSIGCIFAE 276
Query: 272 IITGRNPVDYSRPQG 286
++
Sbjct: 277 LLNMIKENVAYHADR 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 29/158 (18%), Positives = 51/158 (32%), Gaps = 56/158 (35%)
Query: 168 YRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL---------------- 211
Y+G+ K ++ +L L YLH + +++H D+K NILL
Sbjct: 140 YQGLPLPCVKKIIQQVLQG-LDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 212 ---------------------------------DRQWNARVSDFGLAKLLCSERSYVTTR 238
+ +++D G A C + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTED 253
Query: 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 276
+ T Y + E N +D++S + E+ TG
Sbjct: 254 IQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGY 245
L LH+ +++H D+K NILL +Q + +V DFG + C E V T + F Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRF-Y 265
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGR 276
APE D++S G ++ E++TG
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 23/99 (23%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGY 245
L +L E ++H D+K NILL + ++ DFG + C + + F Y
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQSRF-Y 224
Query: 246 VAPE--------YACTGMLNEKSDVYSFGILIMEIITGR 276
+PE A D++S G +++E+ TG
Sbjct: 225 RSPEVLLGMPYDLAI--------DMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 19/52 (36%), Positives = 30/52 (57%), Gaps = 5/52 (9%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYV 235
+ L Y+HE + VH D+K+SN+LL+ + +V D+GLA C E +
Sbjct: 163 DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 13/43 (30%), Positives = 24/43 (55%), Gaps = 5/43 (11%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAK 226
+ L +LHE + VH +V + NI +D + ++V + +G A
Sbjct: 170 DALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 15/43 (34%), Positives = 27/43 (62%), Gaps = 5/43 (11%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAK 226
+ L Y+HE + VH D+K++N+LL + +V +D+GL+
Sbjct: 162 DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 6/42 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAK 226
+ YLH + HRDVK N+L ++ NA +++DFG AK
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 16/46 (34%), Positives = 23/46 (50%), Gaps = 8/46 (17%)
Query: 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS-----DFGLAK 226
+R+ Y+H +++RDVK N L+ R N DF LAK
Sbjct: 116 SRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 408 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.98 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.98 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.67 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.65 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.52 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.26 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.49 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.47 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.04 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.96 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.73 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.74 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 94.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.69 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 94.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 93.62 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 93.57 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 91.87 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 91.55 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 91.52 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 90.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 90.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 89.86 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 89.84 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 89.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 89.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 89.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 89.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 88.84 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 87.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 86.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 86.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 85.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 84.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 83.43 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 81.98 | |
| 2l9u_A | 40 | Receptor tyrosine-protein kinase ERBB-3; transmenb | 81.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 81.87 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 81.37 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=311.85 Aligned_cols=186 Identities=31% Similarity=0.488 Sum_probs=138.6
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|.+.+.||+|+||+||+|++.+ .||||.+
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEc
Confidence 4567888999999999999999853 5899986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-c
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-Y 234 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~ 234 (408)
++.||+|||+. +||||||||+||||+.++.+||+|||+|+....... .
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 45679999998 999999999999999999999999999987643222 2
Q ss_pred eecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
......||+.|||||++.+ ..|+.++|||||||++|||+||+.||...... ..+...+..+. ..|.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~----~~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGY----ASPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTC----CCCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC----CCCCc
Confidence 2345679999999999864 46899999999999999999999999754321 11111222211 11111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.. ....+...+.+|+.+||+.||++||||.||++.|+..
T Consensus 260 ~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SK-LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TT-SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cc-ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1122334688899999999999999999999998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=316.30 Aligned_cols=149 Identities=23% Similarity=0.439 Sum_probs=116.4
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccch
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
+.||+|||+. +||||||||+||||++++.+||+|||+++........ ......||+.|||||++.++.|+.++|||
T Consensus 155 a~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVw 231 (308)
T 4gt4_A 155 AAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 231 (308)
T ss_dssp HHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhh
Confidence 4569999998 9999999999999999999999999999876443322 23446789999999999999999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 264 SFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 264 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
||||++|||+| |+.||...... .+... +..+... ..+ ..+...+.+|+.+||+.||++||||.
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~---~~~~~----i~~~~~~-----~~p----~~~~~~~~~li~~C~~~dP~~RPs~~ 295 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQ---DVVEM----IRNRQVL-----PCP----DDCPAWVYALMIECWNEFPSRRPRFK 295 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHH---HHHHH----HHTTCCC-----CCC----TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC-----CCc----ccchHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999999 89999754321 22222 2222111 111 12334688999999999999999999
Q ss_pred HHHHHHhcCC
Q 015360 343 HVIHMLEADD 352 (408)
Q Consensus 343 evl~~Le~~~ 352 (408)
||++.|+.+.
T Consensus 296 ei~~~L~a~~ 305 (308)
T 4gt4_A 296 DIHSRLRAWG 305 (308)
T ss_dssp HHHHHHHTSC
T ss_pred HHHHHHHhcc
Confidence 9999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=309.34 Aligned_cols=194 Identities=26% Similarity=0.372 Sum_probs=144.6
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
+|...+.||+|+||+||+|++ +|+.||||++
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 466778999999999999999 4899999987
Q ss_pred --------------------------hhhhHHHhhhC-----CCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 --------------------------LNNRLAYLHEG-----LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~-----~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.||+|||+. +.++|+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 44569999975 34689999999999999999999999999998875543
Q ss_pred cce---ecccccccCcccccccccC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc--------hhHHHHH
Q 015360 233 SYV---TTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--------NLVDWLK 295 (408)
Q Consensus 233 ~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~--------~~~~~~~ 295 (408)
... .....||+.|||||++.+. .++.++|||||||++|||+||++||......... .....+.
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 242 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH
Confidence 322 2345799999999998754 3678999999999999999998877543321110 0111222
Q ss_pred HHhcCCCcccccCCCCCCCC-cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 296 TMVGSRKSEEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
...... ..+|.++... ..+....+.+|+.+||+.||++||||.||++.|+.
T Consensus 243 ~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 243 KVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 222111 1233333222 23566788999999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.03 Aligned_cols=182 Identities=27% Similarity=0.431 Sum_probs=136.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe-----------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~----------------------------------------- 183 (408)
++|.+.++||+|+||+||+|++. +++.||||.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999975 3789999987
Q ss_pred ----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCce
Q 015360 184 ----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 217 (408)
Q Consensus 184 ----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 217 (408)
++.||+|||+. +||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 34469999998 99999999999999999999
Q ss_pred EEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHH
Q 015360 218 RVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLK 295 (408)
Q Consensus 218 kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 295 (408)
||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~-- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDC-- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence 99999999876443322 2344679999999999999999999999999999999999 99999744321 12221
Q ss_pred HHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...... +..+. .+...+.+|+.+||+.||++||||.||+++|+..
T Consensus 273 -i~~g~~------~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 273 -ITQGRE------LERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -HHHTCC------CCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHcCCC------CCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111111 11111 1234688899999999999999999999999873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.16 Aligned_cols=183 Identities=21% Similarity=0.253 Sum_probs=141.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||+|+||+||+|+.. +|+.||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 45777889999999999999975 4899999987
Q ss_pred ---------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCCCcc----eec
Q 015360 184 ---------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERSY----VTT 237 (408)
Q Consensus 184 ---------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~~~----~~~ 237 (408)
++.||+|||+. +||||||||+||||+.++ .+||+|||+|+.+...... ...
T Consensus 138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~ 214 (336)
T 4g3f_A 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214 (336)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence 45669999999 999999999999999887 6999999999876543221 123
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..+||+.|||||++.+..|+.++|||||||++|||++|++||........ ...+ ........ .++.
T Consensus 215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i---~~~~~~~~----~~~~---- 280 (336)
T 4g3f_A 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKI---ASEPPPIR----EIPP---- 280 (336)
T ss_dssp CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHH---HHSCCGGG----GSCT----
T ss_pred ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHH---HcCCCCch----hcCc----
Confidence 35799999999999999999999999999999999999999976544322 1111 11111000 1111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+|+.+||+.||++|||+.|+++.|..
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 122367889999999999999999999998865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.41 Aligned_cols=181 Identities=24% Similarity=0.431 Sum_probs=141.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe-----------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~----------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|++. ++..||||++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999974 3788999987
Q ss_pred --------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 184 --------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 184 --------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
++.||+|||+. +|+||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 34569999998 9999999999999999999999
Q ss_pred eccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHH
Q 015360 220 SDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
+|||+++......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .+.. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~---~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE---CI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH---HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HH
Confidence 9999998764433322 233568999999999999999999999999999999999 89999754321 2222 22
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.. +.. +..+. .+...+.+|+.+||+.||++|||+.||++.|+.
T Consensus 244 ~~-~~~-----~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 244 TQ-GRV-----LQRPR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HH-TCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hc-CCC-----CCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 111 11111 123468889999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=307.28 Aligned_cols=178 Identities=29% Similarity=0.424 Sum_probs=142.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
..|...+.||+|+||+||+|+.. +|+.||||++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888999999999999999975 5899999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.||+|||+. +|+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 45569999999 999999999999999999999999999987754332 2345
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
.+||+.|||||++.+..|+.++|||||||++|||++|++||..... .+.+...... ..+.+. ....
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~------~~~~~~--~~~~ 295 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDN------LPPRLK--NLHK 295 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS------SCCCCS--CGGG
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC------CCCCCC--cccc
Confidence 7899999999999999999999999999999999999999974322 1111111111 111111 1122
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+|+.+||+.||++|||+.|+++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2346788999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.21 Aligned_cols=192 Identities=24% Similarity=0.416 Sum_probs=151.4
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeCC------CcEEEEEEe-------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNL------------------------------- 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~------~~~vavK~~------------------------------- 183 (408)
+...+++...++|.+.+.||+|+||+||+|.+.. ++.||||.+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456666777899999999999999999999653 357999987
Q ss_pred ------------------------------------------------------------hhhhHHHhhhCCCCceeeec
Q 015360 184 ------------------------------------------------------------LNNRLAYLHEGLEPKVVHRD 203 (408)
Q Consensus 184 ------------------------------------------------------------~~~~L~yLH~~~~~~ivH~d 203 (408)
++.||+|||+. +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 23469999999 999999
Q ss_pred cccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCC
Q 015360 204 VKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY 281 (408)
Q Consensus 204 lk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~ 281 (408)
|||+|||++.++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3345678999999999999999999999999999999998 9999975
Q ss_pred CCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 282 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..... .+.. .+..+.. +..+.. ...++.+|+.+||+.||++|||+.||+++|+.
T Consensus 291 ~~~~~--~~~~----~i~~g~~-----~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKIDE--EFCR----RLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCSH--HHHH----HHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHH--HHHH----HHHcCCC-----CCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 43221 1111 1111111 112221 22368889999999999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=306.49 Aligned_cols=176 Identities=23% Similarity=0.408 Sum_probs=135.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +|+.||||.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999964 5899999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 44569999999 99999999999999999999999999998764321
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+....... . +.+..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~-~-----~~~~~ 247 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGS-F-----PPVSL 247 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTC-C-----CCCCT
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-C-----CCCCc
Confidence 12234679999999999999999999999999999999999999997432 122222222211 1 11111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. ....+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 H----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp T----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 2236788999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.62 Aligned_cols=178 Identities=29% Similarity=0.420 Sum_probs=141.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||+||+|+.. +|+.||||++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 5899999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.||+|||+. +||||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 45669999999 999999999999999999999999999987754333 2345
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+....... .+.+.. ...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~------~~~~~~--~~~ 372 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL------PPRLKN--LHK 372 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC------CCCCSC--TTS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC------CCCCcc--ccc
Confidence 6899999999999999999999999999999999999999964322 11111111111 111111 111
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+|+.+||+.||++|||+.|+++
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2236788999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=295.09 Aligned_cols=174 Identities=26% Similarity=0.442 Sum_probs=131.7
Q ss_pred CccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------------
Q 015360 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------- 183 (408)
Q Consensus 154 ~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------- 183 (408)
.+.++||+|+||+||+|... ++..||||.+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34568999999999999975 4889999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.||+|||++ .++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 45569999997 12399999999999997 4789999999999754322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ...... .+.........
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~-~i~~~~~~~~~------ 251 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYR-RVTSGVKPASF------ 251 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHH-HHTTTCCCGGG------
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHH-HHHcCCCCCCC------
Confidence 2344679999999998865 699999999999999999999999964322 111111 22221111111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.......+.+|+.+||+.||++|||+.|+++
T Consensus 252 --~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111235788999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=303.65 Aligned_cols=175 Identities=25% Similarity=0.388 Sum_probs=140.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +++.||||.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999964 5899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~- 233 (408)
+..||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 44559999999 999999999999999999999999999998754322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+......... ..++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-------~~~p~ 255 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLE-------YDFPE 255 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-------CCCCT
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-------CCCCc
Confidence 234457899999999999999999999999999999999999999974321 11122222111 11222
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
.. ...+.+|+.+||+.||++|||++|++
T Consensus 256 ~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 KF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22 23578899999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.01 Aligned_cols=174 Identities=26% Similarity=0.438 Sum_probs=127.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|... +|+.||||.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 5899999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~ 167 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F 167 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence 45569999999 99999999999999999999999999998754322 2
Q ss_pred ecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|||||++.+..+ +.++||||+||++|||++|+.||.... ............ +.++..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~-------~~~p~~ 234 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGV-------YTLPKF 234 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-------CCCCTT
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC-------CCCCCC
Confidence 234679999999999998876 579999999999999999999996432 112222221111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. ...+.+|+.+||+.||++|||++|+++
T Consensus 235 ~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 L----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp S----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 235778999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=295.64 Aligned_cols=218 Identities=44% Similarity=0.774 Sum_probs=188.1
Q ss_pred CCcceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe--------------------------------
Q 015360 136 GWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL-------------------------------- 183 (408)
Q Consensus 136 ~~~~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~-------------------------------- 183 (408)
+..+.|++.++...+++|...+.||+|+||.||+|...+++.||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 334679999999999999999999999999999999888999999986
Q ss_pred ---------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceE
Q 015360 184 ---------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 218 (408)
Q Consensus 184 ---------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 218 (408)
++.+|.|||+.+.++|+|+||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 34559999998777999999999999999999999
Q ss_pred EeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCC--CCCCcchhHHHHHH
Q 015360 219 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYS--RPQGEVNLVDWLKT 296 (408)
Q Consensus 219 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~--~~~~~~~~~~~~~~ 296 (408)
|+|||++...............||+.|+|||.+.+..++.++|||||||++|+|++|+.||... .........+|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999887655554455566999999999999889999999999999999999999999632 12233456677777
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCc
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 353 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~ 353 (408)
...........+..+...........+.+++.+||+.||.+|||+.||+++|+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 777777778888888777788888999999999999999999999999999997543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=298.21 Aligned_cols=170 Identities=25% Similarity=0.359 Sum_probs=133.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. .++.||||.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999852 3688999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 45669999999 99999999999999999999999999998654332
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+. .+......... +.++
T Consensus 181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~-------~~~p 246 (304)
T 3ubd_A 181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAK-------LGMP 246 (304)
T ss_dssp C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCC
T ss_pred c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCC-------CCCC
Confidence 2 23346799999999999999999999999999999999999999974332 12222222111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
.. ....+.+|+.+||+.||++|||+
T Consensus 247 ~~----~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 247 QF----LSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSTTC
T ss_pred Cc----CCHHHHHHHHHHcccCHHHCCCC
Confidence 11 22367889999999999999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.46 Aligned_cols=209 Identities=39% Similarity=0.658 Sum_probs=178.8
Q ss_pred eeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------
Q 015360 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 140 ~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------ 183 (408)
.+.+.++..++++|...+.||+|+||.||+|.+.+++.||||.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 35666777889999999999999999999999988999999976
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 34569999998 99999999999999999999999999
Q ss_pred CceeecCCCc-ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC
Q 015360 224 LAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 224 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 302 (408)
++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....+........|.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9986543222 122335589999999999999999999999999999999999999987776666677777766666677
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 303 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....+++.+...........+.+++.+||+.||++|||+.||++.|+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 7777788777777778888999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=286.34 Aligned_cols=175 Identities=24% Similarity=0.451 Sum_probs=126.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +|+.||||.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999964 5899999987
Q ss_pred ------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEec
Q 015360 184 ------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 221 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~D 221 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 34459999999 999999999999999999999999
Q ss_pred cCCceeecCCCcc-----------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 015360 222 FGLAKLLCSERSY-----------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 290 (408)
Q Consensus 222 fg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 290 (408)
||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||... .+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876443221 1233579999999999999999999999999999999996 76421 111
Q ss_pred HHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 291 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 291 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
...+.... . ...+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~-~--------~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVR-N--------LKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-T--------TCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHh-c--------CCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 1 11111 11233345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=292.04 Aligned_cols=191 Identities=25% Similarity=0.407 Sum_probs=139.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +|+.||||++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56889999999999999999964 5999999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..||.|||+. +||||||||+|||++.++.+||+|||+++.+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 34559999999 999999999999999999999999999987643
Q ss_pred CC---cceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 231 ER---SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 231 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
.. .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+.. .....+............
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCGGGT
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCChHHh
Confidence 21 1223456899999999998775 4689999999999999999999999754322 122222222111110000
Q ss_pred -----------c--CCCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 307 -----------V--DPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 307 -----------~--d~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .+........ .....+.+|+.+||+.||++|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000000 112467889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=287.53 Aligned_cols=131 Identities=31% Similarity=0.454 Sum_probs=108.8
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-----------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~----------------------------------------- 183 (408)
..+.|.+.+.||+|+||+||+|+.+ .++.||||.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 4578999999999999999999853 4678999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCCc--
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS-- 233 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~~-- 233 (408)
+..||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 99 mE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 99 MPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp EECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred EeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 44569999999 99999999999999876 7999999999986543211
Q ss_pred -------------------------ceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCC
Q 015360 234 -------------------------YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYS 282 (408)
Q Consensus 234 -------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~ 282 (408)
......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 011235699999999999875 4899999999999999999999999643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.58 Aligned_cols=177 Identities=26% Similarity=0.412 Sum_probs=139.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.++||+|+||+||+++.. +|+.||||.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999975 4899999987
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..||+|||+. +||||||||+||||+.++.+||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 34459999999 9999999999999999999999999999876443
Q ss_pred CcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
. ....+||+.|||||++.. ..|+.++|||||||++|||++|++||..........+. ...... ...
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~~~-------~~~ 412 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM-------AVE 412 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHHHC-------CCC
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhhcCC-------CCC
Confidence 2 234679999999999964 57999999999999999999999999754433221111 111111 111
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
++... ...+.+|+.+||+.||++|++ ++||+++
T Consensus 413 ~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 LPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 22222 235788999999999999998 5777653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=262.17 Aligned_cols=205 Identities=38% Similarity=0.641 Sum_probs=162.1
Q ss_pred ceeeHHHHHHHhcCCCcc------ceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------
Q 015360 139 RWYTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------- 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~------~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------- 183 (408)
+.|++.++..++++|... +.||+|+||.||+|.. +++.||||.+
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 669999999999999988 8999999999999997 5899999976
Q ss_pred --------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC
Q 015360 184 --------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR 213 (408)
Q Consensus 184 --------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~ 213 (408)
++.+|.|||+. +|+|+||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 33459999998 9999999999999999
Q ss_pred CCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 015360 214 QWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 292 (408)
Q Consensus 214 ~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 292 (408)
++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........ +..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999876443222 2334568999999998864 588999999999999999999999976543322 122
Q ss_pred HHHHHhc-CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 293 WLKTMVG-SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 293 ~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+...... ...+...+++.+.. ........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222221 22233444444432 3455677899999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=292.37 Aligned_cols=179 Identities=22% Similarity=0.300 Sum_probs=140.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|... +|+.||||.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 67999999999999999999975 5899999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC--CceEEeccCCceeecCCCcc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~--~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~- 312 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 312 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence 44569999999 99999999999999754 7899999999998754433
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....+||+.|||||++.+..|+.++|||||||++|||++|++||...... +.+....... ..+...
T Consensus 313 -~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~-------~~~~~~ 378 (573)
T 3uto_A 313 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD-------WNMDDS 378 (573)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC-------CCCCSG
T ss_pred -eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCC-------CCCCcc
Confidence 23467999999999999999999999999999999999999999743321 1122221111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+|+.+||+.||++|||+.|++++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467889999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.89 Aligned_cols=192 Identities=25% Similarity=0.421 Sum_probs=146.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||+||+|++ +++.||||.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 46788899999999999999998 5999999987
Q ss_pred ----------------------------hhhhHHHhh--------hCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ----------------------------LNNRLAYLH--------EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ----------------------------~~~~L~yLH--------~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++.+|+||| +. +|+||||||+|||++.++.+||+|||++..
T Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp CCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred hhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 345599999 66 999999999999999999999999999987
Q ss_pred ecCCCcce---ecccccccCcccccccccC------CCCccccchhhHHHHHHHHhC----------CCCCCCCCCCCcc
Q 015360 228 LCSERSYV---TTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITG----------RNPVDYSRPQGEV 288 (408)
Q Consensus 228 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltG----------~~Pf~~~~~~~~~ 288 (408)
........ .....||+.|+|||++.+. .++.++|||||||++|||++| +.||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 65443322 2234689999999999876 455799999999999999999 7888654333221
Q ss_pred hhHHHHHHHhcCCCcccccCCCCCC-CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 289 NLVDWLKTMVGSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... ......... ..+.++. .........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 243 -~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 243 -FED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp -HHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 111111111 1111211 12234667899999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=259.58 Aligned_cols=190 Identities=21% Similarity=0.269 Sum_probs=145.6
Q ss_pred HhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 346899999999999999999996 56899999975
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeecCCCc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +|+|+||||+|||+ +.++.+||+|||++........
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 44569999999 99999999999999 7889999999999987654332
Q ss_pred c------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 234 Y------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 234 ~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..............+........... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-L 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-H
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-h
Confidence 1 12345689999999999999999999999999999999999999987654443333322221111110000 0
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
... ....+.+++.+||+.||++|||+.+|++.|+.
T Consensus 243 ~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 243 CKG--------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp TTT--------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hcc--------CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 011 12368899999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=268.76 Aligned_cols=196 Identities=28% Similarity=0.364 Sum_probs=146.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...++||+|+||+||+|++. ++.||||++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 57888899999999999999986 899999987
Q ss_pred ---------------------------hhhhHHHhhhC-------CCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ---------------------------LNNRLAYLHEG-------LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~-------~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
++.+|.|||+. +..+|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~ 182 (322)
T 3soc_A 103 FHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182 (322)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEEC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccc
Confidence 34458999975 23489999999999999999999999999998765
Q ss_pred CCCcc-eecccccccCcccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH---------HH
Q 015360 230 SERSY-VTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD---------WL 294 (408)
Q Consensus 230 ~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~---------~~ 294 (408)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........+.. .+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T 3soc_A 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262 (322)
T ss_dssp TTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred cccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhh
Confidence 43322 22335689999999998763 45678899999999999999999997654432221111 11
Q ss_pred HHHhcCCCcccccCCCCCCC-CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 295 KTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 295 ~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
........ ..+.+... ........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 263 ~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 263 QEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111 11111111 1224556789999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=260.25 Aligned_cols=191 Identities=30% Similarity=0.424 Sum_probs=148.9
Q ss_pred ceeeHHHHHHHhcC----------CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------
Q 015360 139 RWYTLRELEAATSG----------LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------ 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~----------f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------ 183 (408)
..|++++++.+++. |...+.||+|+||.||+|+.. +|+.||||.+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34889999998875 667789999999999999986 6999999986
Q ss_pred -----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc
Q 015360 184 -----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN 216 (408)
Q Consensus 184 -----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~ 216 (408)
++.+|.|||+. +|+|+||||+|||++.++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCc
Confidence 34569999998 9999999999999999999
Q ss_pred eEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 015360 217 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 217 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 180 ~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~ 252 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKR 252 (321)
T ss_dssp EEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH
T ss_pred EEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 99999999987644322 22345799999999999999999999999999999999999999964321 111111
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.... ..+.+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LRDS------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHS------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcC------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 1111111 11223467889999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=257.35 Aligned_cols=189 Identities=22% Similarity=0.279 Sum_probs=146.7
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|+. .+++.||||.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 46788999999999999999996 56899999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeecCCCcc
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +|+|+||||+|||+ +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 44569999999 99999999999999 47889999999999876543321
Q ss_pred ------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 235 ------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 235 ------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.......... ...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VLC 243 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-HHT
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-HHH
Confidence 1234568999999999999999999999999999999999999998655433333222222111100000 000
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+. ....+.+++.+||+.||++|||+.+|++.|+.
T Consensus 244 ~~--------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 244 KG--------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp TT--------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hh--------CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 11 12368889999999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=258.31 Aligned_cols=189 Identities=19% Similarity=0.241 Sum_probs=145.9
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 89 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecC
Confidence 5688899999999999999995 56899999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc-----eEEeccCCceeecCCCc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~-----~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 90 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 44569999998 9999999999999987765 99999999987654322
Q ss_pred c------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 234 Y------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 234 ~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+............
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 245 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL- 245 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-
Confidence 1 123456899999999999999999999999999999999999999865543332222222211111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+. ....+.+++.+||+.||++|||+.+|++.|+..
T Consensus 246 ~~~--------~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 246 CAG--------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp TTT--------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hhh--------CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 011 123688899999999999999999999999873
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=259.06 Aligned_cols=180 Identities=28% Similarity=0.468 Sum_probs=140.8
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||+||+|.. .+++.||||.+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35789999999999999999985 45899999986
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 174 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence 34569999999 999999999999999999999999999987654333 233
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... +.+ ....
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~------~~~--~~~~ 240 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------PEL--QNPE 240 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS------CCC--SCGG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC------CCC--CCcc
Confidence 457999999999999999999999999999999999999999643321 11111111110 001 1112
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223467889999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=255.61 Aligned_cols=183 Identities=25% Similarity=0.417 Sum_probs=145.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|...++..||||.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4678888999999999999999988889999987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..+|.|||+. +|+|+||||+||+++.++.+||+|||++............
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 34559999999 9999999999999999999999999999876554443334
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ........... ...+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~~~-- 229 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHR------LYRPHL-- 229 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC------CCCCTT--
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCC------CCCCCc--
Confidence 4556778999999998899999999999999999999 99999643321 11111111110 011111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 230 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 230 --ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp --SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred --ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 123578899999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=263.44 Aligned_cols=204 Identities=27% Similarity=0.395 Sum_probs=146.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+. +++.||||.+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 5788889999999999999988 5899999986
Q ss_pred ----------------------------hhhhHHHhhhCC------CCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------LNNRLAYLHEGL------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~------~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
++.+|.|||+.+ .++|+||||||+|||++.++.+||+|||++....
T Consensus 92 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171 (336)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecc
Confidence 345599999863 3389999999999999999999999999998764
Q ss_pred CCCc-------ceecccccccCccccccccc-------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch------
Q 015360 230 SERS-------YVTTRVMGTFGYVAPEYACT-------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN------ 289 (408)
Q Consensus 230 ~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~------ 289 (408)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 251 (336)
T 3g2f_A 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251 (336)
T ss_dssp SSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHH
T ss_pred cccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcc
Confidence 3221 11223568999999999976 356678999999999999999977764332211110
Q ss_pred -----hHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCccchh
Q 015360 290 -----LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRD 357 (408)
Q Consensus 290 -----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~~~~~ 357 (408)
.................+.... .........+.+|+.+||+.||++|||+.||++.|+.....+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 252 VGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred cCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 0011111111111111111111 11234566799999999999999999999999999985544433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=261.39 Aligned_cols=188 Identities=31% Similarity=0.510 Sum_probs=136.4
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------- 183 (408)
.++....++|...+.||+|+||+||+|+. +++.||||.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34444456788899999999999999998 5899999986
Q ss_pred -------------------------------------hhhhHHHhhhCCCCc--eeeeccccCceEeCCCCceEEeccCC
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~--ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
++.+|+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 34459999998 8 99999999999999999999999999
Q ss_pred ceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
++...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... .. ..........
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~---~~~~~~~~~~- 257 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QV---VAAVGFKCKR- 257 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HH---HHHHHHSCCC-
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhcCCC-
Confidence 97643322 1223456899999999999999999999999999999999999999743321 11 1111111110
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
..++.. ....+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 258 ----~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 258 ----LEIPRN----LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp ----CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 223688899999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=257.67 Aligned_cols=189 Identities=24% Similarity=0.350 Sum_probs=140.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+..+++.||||++
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 578888999999999999999988999999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 101 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 176 (311)
T 3niz_A 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SY 176 (311)
T ss_dssp CSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cc
Confidence 34459999999 999999999999999999999999999987643322 22
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc--------
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV-------- 307 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 307 (408)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+.............
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccchh
Confidence 33568999999999876 5689999999999999999999999976544322 22222222211110000
Q ss_pred -C---CCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 -D---PKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 -d---~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+ ........ .....++.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00000000 012246789999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-33 Score=277.61 Aligned_cols=189 Identities=28% Similarity=0.455 Sum_probs=147.8
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------- 183 (408)
+++...++|...+.||+|+||.||+|.++++..||||.+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~ 261 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT 261 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEE
Confidence 344556788899999999999999999988999999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 34569999999 99999999999999999999999999998754322
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
........++..|+|||++....++.++|||||||++|||++ |+.||...... .....+ ..... ...
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i---~~~~~------~~~ 406 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL---ERGYR------MPR 406 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH---HHTCC------CCC
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcCCC------CCC
Confidence 222223446778999999998999999999999999999999 99999743321 111111 11110 001
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
+ ......+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 407 ~----~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 407 P----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1 112346888999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=267.42 Aligned_cols=172 Identities=25% Similarity=0.334 Sum_probs=132.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||+||+|... +++.||||++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 6899999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|+|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~- 212 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA- 212 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC-
Confidence 34459999998 999999999999999999999999999987643222
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+ ... ........
T Consensus 213 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~--------~~~-~~~-~~~~~~~~-------- 272 (311)
T 3p1a_A 213 -GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG--------EGW-QQL-RQGYLPPE-------- 272 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH--------HHH-HHH-TTTCCCHH--------
T ss_pred -CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHH-HHH-hccCCCcc--------
Confidence 233568999999998875 7899999999999999999997765421 111 111 11111100
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
........+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01112346889999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=256.41 Aligned_cols=182 Identities=33% Similarity=0.523 Sum_probs=141.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... ++..||||.+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46788899999999999999975 4899999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV- 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~- 235 (408)
++.+|+|||+. +|+|+||||+|||++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 34559999999 99999999999999999999999999998764332211
Q ss_pred ------------ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc---hhHHHHHHHhcC
Q 015360 236 ------------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV---NLVDWLKTMVGS 300 (408)
Q Consensus 236 ------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~---~~~~~~~~~~~~ 300 (408)
.....||+.|+|||.+.+..++.++|||||||++|||++|..||......... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~---- 242 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR---- 242 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----
Confidence 11456899999999999999999999999999999999999998754432211 11111110
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
...+..+ ..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 243 -----~~~~~~~--------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 -----YCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -----TCCTTCC--------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----cCCCCCC--------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111111 25788999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-33 Score=257.12 Aligned_cols=182 Identities=26% Similarity=0.441 Sum_probs=143.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||+|...+++.||||.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 568888999999999999999988999999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
+..+|.|||+. +|+|+||||+||+++.++.+||+|||++.............
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 34559999999 99999999999999999999999999998654333222333
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .......... .+..+..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~~------~~~~~~~--- 231 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGF------RLYKPRL--- 231 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTC------CCCCCTT---
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcCc------cCCCCCc---
Confidence 456788999999998999999999999999999999 99999743321 1111111110 0111111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 232 -~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 232 -ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 123578899999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=259.93 Aligned_cols=187 Identities=19% Similarity=0.228 Sum_probs=143.6
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCC
Confidence 5788899999999999999995 46899999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc-----eEEeccCCceeecCCCc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~-----~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 89 PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 34569999999 9999999999999998877 99999999987644322
Q ss_pred ce------ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 234 YV------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 234 ~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........... .
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-~ 244 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV-L 244 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-H
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-H
Confidence 11 2346799999999999999999999999999999999999999986544332222222211110000000 0
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. .. ...+.+++..||+.||.+||++.+|++.|+.
T Consensus 245 ~----~~-----~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 245 C----EN-----FPEMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp T----TT-----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred h----cc-----ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 0 00 1168889999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=271.67 Aligned_cols=190 Identities=19% Similarity=0.270 Sum_probs=147.9
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|.+.++||+|+||.||+|.. .+++.||||.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 36788999999999999999996 45899999975
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeecCCCcc
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +|+||||||+|||+ +.++.+||+|||+++........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 44569999999 99999999999999 57889999999999876543321
Q ss_pred e------ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 235 V------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 235 ~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...........+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR 242 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc
Confidence 1 2246799999999999999999999999999999999999999987655433333322222111111111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
. ....+.+|+.+||+.||++||++.+|++.|+..
T Consensus 243 -~--------~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 243 -G--------YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -T--------SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -C--------CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 123688999999999999999999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=256.59 Aligned_cols=182 Identities=23% Similarity=0.392 Sum_probs=140.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.+.++..||||.+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 4578888999999999999999998889999987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.+|.|||+. +|+|+||||+||+++.++.+||+|||++............
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 34559999999 9999999999999999999999999999765433322233
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .......... ....+...
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~------~~~~~~~~- 246 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGL------RLYRPHLA- 246 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC------CCCCCTTC-
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhccc------CCCCCCcC-
Confidence 3456788999999998899999999999999999998 99999743321 1111111110 01111111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 247 ---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 247 ---SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 2367889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=264.11 Aligned_cols=147 Identities=26% Similarity=0.429 Sum_probs=112.8
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|+|||+. +|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||
T Consensus 214 ~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws 290 (370)
T 2psq_A 214 RGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290 (370)
T ss_dssp HHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHH
T ss_pred HHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHH
Confidence 358999998 9999999999999999999999999999876443222 122345678999999999999999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|||++ |+.||...... .+...+ ..... +..+. .....+.+++.+||+.||++|||+.|
T Consensus 291 lG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~e 354 (370)
T 2psq_A 291 FGVLMWEIFTLGGSPYPGIPVE---ELFKLL----KEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQ 354 (370)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCC-----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCHH---HHHHHH----hcCCC-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999 99999754322 111111 11111 11111 12336888999999999999999999
Q ss_pred HHHHHhcC
Q 015360 344 VIHMLEAD 351 (408)
Q Consensus 344 vl~~Le~~ 351 (408)
+++.|+..
T Consensus 355 ll~~L~~i 362 (370)
T 2psq_A 355 LVEDLDRI 362 (370)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=264.25 Aligned_cols=198 Identities=21% Similarity=0.283 Sum_probs=145.3
Q ss_pred ceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------
Q 015360 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------- 183 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------- 183 (408)
..|++.+.....++|...+.||+|+||+||+|+.. +++.||||.+
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 34555666666789999999999999999999974 5889999986
Q ss_pred -------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-------
Q 015360 184 -------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR------- 213 (408)
Q Consensus 184 -------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~------- 213 (408)
++.+|+|||+. +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred ceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence 34459999999 9999999999999975
Q ss_pred ------------------CCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhC
Q 015360 214 ------------------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITG 275 (408)
Q Consensus 214 ------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG 275 (408)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 7889999999998643322 335689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHHHHHHhcCCC-----------cccccCC-----CCCCCC-cHH---------------HHHHH
Q 015360 276 RNPVDYSRPQGEVNLVDWLKTMVGSRK-----------SEEVVDP-----KLPKMP-ASK---------------ALKRV 323 (408)
Q Consensus 276 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~d~-----~~~~~~-~~~---------------~~~~l 323 (408)
+.||...... .....+........ .....+. ..+... ... ....+
T Consensus 256 ~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 256 SLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp SCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred CCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999754322 11111111111000 0000000 000000 000 01457
Q ss_pred HHHHHhccCcCCCCCCCHhHHHH
Q 015360 324 LLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 324 ~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+|+.+||+.||++|||+.|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 79999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=264.11 Aligned_cols=192 Identities=22% Similarity=0.281 Sum_probs=143.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC------CcEEEEEEe----------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~------~~~vavK~~---------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.+.+ ++.||||.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999999865 478999984
Q ss_pred -----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC--CC
Q 015360 184 -----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD--RQ 214 (408)
Q Consensus 184 -----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~--~~ 214 (408)
++.+|+|||+. +|+||||||+|||++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 34459999999 999999999999998 88
Q ss_pred CceEEeccCCceeecCCCcce------ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 015360 215 WNARVSDFGLAKLLCSERSYV------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288 (408)
Q Consensus 215 ~~~kL~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~ 288 (408)
+.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-- 268 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-- 268 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--
Confidence 999999999998764332211 123459999999999999999999999999999999999999997533221
Q ss_pred hhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 289 NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
........... .....++++.+.... ....+.+++..||+.||++||++.+|++.|+.
T Consensus 269 ~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 269 KYVRDSKIRYR-ENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHHHHHH-HCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhh-hhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11111111110 111222222221111 12367889999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=267.21 Aligned_cols=184 Identities=26% Similarity=0.381 Sum_probs=141.8
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|.+. +++.||||.+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888899999999999999986 6899999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 34559999999 999999999999999999999999999986533221
Q ss_pred cee-cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 234 YVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 234 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ........ ...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~-----~~~ 336 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR----EFVEKGGR-----LPC 336 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH----HHHHTTCC-----CCC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC-----CCC
Confidence 111 11235678999999998899999999999999999998 99999754321 111 11111111 011
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+. .....+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 337 ~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 PE----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 1223678899999999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=259.96 Aligned_cols=182 Identities=29% Similarity=0.464 Sum_probs=138.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.+. .+..||||.+
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999984 3556999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 34459999999 99999999999999999999999999998764432
Q ss_pred cc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 233 SY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 233 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.......... .
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~------~ 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEGYR------L 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCC------C
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcCCC------C
Confidence 21 1223346778999999998999999999999999999999 99999643221 11111111110 1
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
..+ ......+.+|+.+||+.||++|||+.||++.|+..
T Consensus 274 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 PAP----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 11224688899999999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=264.02 Aligned_cols=180 Identities=22% Similarity=0.375 Sum_probs=133.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
+.|...+.||+|+||.||++...+++.||||.+
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 468888999999999999999988999999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 234 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~- 234 (408)
++.+|.|||+. +|+||||||+|||++ ++.+||+|||++.........
T Consensus 89 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 89 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 34559999999 999999999999997 578999999999876433222
Q ss_pred eecccccccCccccccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 235 VTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..............
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 239 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCcc
Confidence 2234579999999999865 6788999999999999999999999964321 11222222211111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...+... ...+.+|+.+||+.||.+|||+.|+++..
T Consensus 240 -----~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 240 -----IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -----CCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----cCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111111 23578899999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=251.85 Aligned_cols=195 Identities=19% Similarity=0.239 Sum_probs=147.0
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||+|+||+||+|.... ++.||||.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 457888999999999999999764 899999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEe----CCCCceEEeccCCcee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +|+|+||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 34459999999 99999999999999 7778899999999987
Q ss_pred ecCCCcceecccccccCcccccccc--------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYAC--------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 299 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 299 (408)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ....+.....
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIIT 241 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhc
Confidence 654332 23356899999999886 57789999999999999999999999975433221 1122222221
Q ss_pred CCC---ccccc-----------CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 300 SRK---SEEVV-----------DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 300 ~~~---~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
... ...+. +..............+.+++.+||+.||++|||++|+++...++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111 00000 011112234566677889999999999999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=256.14 Aligned_cols=196 Identities=27% Similarity=0.442 Sum_probs=144.7
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe--------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~-------------------------------------------- 183 (408)
...++|...+.||+|+||.||+|+.. ++.||||.+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 34568999999999999999999986 999999986
Q ss_pred ------------------------------hhhhHHHhhhCC-----CCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 ------------------------------LNNRLAYLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~-----~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+.. ..+|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 344599999752 348999999999999999999999999999776
Q ss_pred cCCCcce---ecccccccCcccccccccCCCCcc------ccchhhHHHHHHHHhC----------CCCCCCCCCCCcch
Q 015360 229 CSERSYV---TTRVMGTFGYVAPEYACTGMLNEK------SDVYSFGILIMEIITG----------RNPVDYSRPQGEVN 289 (408)
Q Consensus 229 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltG----------~~Pf~~~~~~~~~~ 289 (408)
....... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||.........
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~- 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS- 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc-
Confidence 4433221 124568999999999987766655 9999999999999999 6666543322211
Q ss_pred hHHHHHHHhcCCCcccccCCCCCCC-CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 290 LVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. ........... ..+.++.. ........+.+|+.+||+.||++|||+.||++.|+.
T Consensus 272 ~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 272 Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 1 11111111111 11222211 123567789999999999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=263.85 Aligned_cols=193 Identities=21% Similarity=0.290 Sum_probs=148.3
Q ss_pred eHHHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-------------------------------------
Q 015360 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------- 183 (408)
Q Consensus 142 ~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------- 183 (408)
.+.+++...++|...++||+|+||+||+++... ++.||||.+
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 356677778999999999999999999999764 889999986
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 34459999999 99999999999999999999999999998
Q ss_pred eecCCCcceecccccccCcccccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 302 (408)
..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ...........
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~ 290 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKN 290 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccc
Confidence 77554443444577999999999997655 789999999999999999999999743321 11111111000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCC--CCCHhHHHHHHhc
Q 015360 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHMLEA 350 (408)
Q Consensus 303 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~Le~ 350 (408)
.+.-+... .....+.+|+.+||+.+|.+ ||+++||+++--.
T Consensus 291 --~~~~p~~~-----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 291 --SLTFPDDN-----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp --HCCCCTTC-----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred --cccCCCcc-----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 00001100 11236788899999999988 9999999886533
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=260.96 Aligned_cols=176 Identities=22% Similarity=0.378 Sum_probs=138.8
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.. .+|+.||||.+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788999999999999999997 46999999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 34459999999 999999999999999999999999999976543322
Q ss_pred eecccccccCcccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ........... ..++.
T Consensus 170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-------~~~p~ 235 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGK-------YRIPF 235 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCCT
T ss_pred -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CCCCC
Confidence 3446799999999999888765 799999999999999999999974321 12222221111 11111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. ...+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 YM----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TS----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 2357789999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=261.21 Aligned_cols=182 Identities=27% Similarity=0.489 Sum_probs=137.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCc----EEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~----~vavK~~------------------------------------------ 183 (408)
++|...++||+|+||+||+|++. +++ +||+|.+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 46888899999999999999964 343 3688865
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 34559999999 99999999999999999999999999998764433
Q ss_pred cc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+. .... ..
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~----~~~~-----~~ 239 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGER-----LP 239 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTCC-----CC
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHH----cCCC-----CC
Confidence 22 2223456789999999999999999999999999999999 999997543321 211111 1110 01
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
. .......+.+++.+||+.||++|||+.||++.|+..
T Consensus 240 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 240 Q----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp C----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred C----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 111233688899999999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=257.99 Aligned_cols=183 Identities=26% Similarity=0.451 Sum_probs=138.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcE----EEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTK----VAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~----vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||+||+|.... ++. |++|.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 467888999999999999999643 443 788865
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 44569999999 99999999999999999999999999998764433
Q ss_pred cc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||....... ....+. ..... .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~-----~ 237 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLE----KGERL-----A 237 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHH----TTCBC-----C
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHH----cCCCC-----C
Confidence 22 2234557889999999999999999999999999999999 999997544321 222111 11100 0
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
.+.. ....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 238 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 QPQI----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCTT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1124678899999999999999999999998743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=255.09 Aligned_cols=189 Identities=22% Similarity=0.367 Sum_probs=137.7
Q ss_pred cCCCccceeccCCcEEEEEEEe-----CCCcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-----~~~~~vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||+||+|++ .+++.||||++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5678889999999999999985 25889999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 34459999998 999999999999999999999999999987644
Q ss_pred CCcc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC---------CCcchhHHHHHHHhc
Q 015360 231 ERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP---------QGEVNLVDWLKTMVG 299 (408)
Q Consensus 231 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~---------~~~~~~~~~~~~~~~ 299 (408)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..||..... .........+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 3221 12234467789999999999999999999999999999999999863210 000001111111111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.... ...+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 247 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 247 NNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111 011112234688899999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=250.25 Aligned_cols=180 Identities=31% Similarity=0.547 Sum_probs=138.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +++.||||.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 57888899999999999999974 6899999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCc--eeeeccccCceEeCCCCc-----eEEeccCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPK--VVHRDVKSSNILLDRQWN-----ARVSDFGL 224 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~--ivH~dlk~~Nill~~~~~-----~kL~Dfg~ 224 (408)
+..+|+|||+. + |+|+||||+|||++.++. +||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 23449999998 8 999999999999987776 99999999
Q ss_pred ceeecCCCcceecccccccCcccccccc--cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYAC--TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 302 (408)
+..... ......||+.|+|||.+. ...++.++|||||||++|+|++|+.||........ ...........
T Consensus 176 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~ 247 (287)
T 4f0f_A 176 SQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGL 247 (287)
T ss_dssp CBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHHSCC
T ss_pred cccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhccCC
Confidence 975432 223456899999999984 45678999999999999999999999975443221 11111111111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 303 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.+.++. .....+.+++.+||+.||++|||+.|+++.|+.
T Consensus 248 -----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 -----RPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----CCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111111 122468889999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=251.73 Aligned_cols=186 Identities=27% Similarity=0.403 Sum_probs=137.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... ++..||||.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 56888899999999999999964 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 34459999999 9999999999999999999999999999876444333
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ............ .... ....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~-~~~~-~~~~-- 237 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSV-PNVT-TDVR-- 237 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCC-CCHH-HHSC--
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccC-CCcc-hhcc--
Confidence 33446689999999999999999999999999999999999999974321 111111111111 0000 0001
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCC-CHhHHHHHHhcC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEAD 351 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~Le~~ 351 (408)
......+.+++.+||+.||++|| +++++.+.|+..
T Consensus 238 --~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 238 --KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 11223688899999999999999 899999999873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=255.40 Aligned_cols=190 Identities=25% Similarity=0.340 Sum_probs=139.7
Q ss_pred HhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~-------------------------------------------- 183 (408)
.+++|...+.||+|+||+||+|+. .+++.||||.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 45899999975
Q ss_pred ------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEec
Q 015360 184 ------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 221 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~D 221 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 23449999999 999999999999999999999999
Q ss_pred cCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC
Q 015360 222 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301 (408)
Q Consensus 222 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 301 (408)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~ 238 (308)
T 3g33_A 164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLP 238 (308)
T ss_dssp CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 999976543222 24467899999999999999999999999999999999999999753321 1222222222111
Q ss_pred CcccccC---------CCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 KSEEVVD---------PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 ~~~~~~d---------~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.. +...... ..+....+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1100000 0000000 0112346788999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=266.79 Aligned_cols=180 Identities=22% Similarity=0.371 Sum_probs=134.4
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
..|...+.||+|+||.||++...+++.||||.+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458888999999999999999888999999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 234 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~- 234 (408)
++.+|.|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 34459999998 999999999999996 578999999999876433221
Q ss_pred eecccccccCccccccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 235 VTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.........
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 286 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTSC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCcccc
Confidence 2334579999999999865 3688999999999999999999999964321 11222222221111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
..++... ...+.+|+.+||+.||++|||+.||++..
T Consensus 287 -----~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 287 -----IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -----CCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----CCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1111111 23578899999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=268.47 Aligned_cols=193 Identities=21% Similarity=0.296 Sum_probs=148.7
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------ 183 (408)
+.+.+++..+++|...++||+|+||+||+|+..+ ++.||||++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4577788888999999999999999999999865 788999987
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 33459999998 99999999999999999999999999
Q ss_pred CceeecCCCcceecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh
Q 015360 224 LAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 224 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...... ... ....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~---~~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETY---GKIM 294 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHH---Hhhh
Confidence 99876555444444567999999999987 567899999999999999999999999743321 111 1111
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCC--CCCHhHHHHHH
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHML 348 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 348 (408)
... ..+.-|..... ....+.+|+.+||+.+|++ ||+++|+++.-
T Consensus 295 ~~~--~~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 295 NHK--ERFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp THH--HHCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hcc--ccccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 100 00011111111 1235778889999988888 99999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=258.58 Aligned_cols=175 Identities=25% Similarity=0.387 Sum_probs=137.6
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 46899999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 89 E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-- 163 (336)
T 3h4j_B 89 EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-- 163 (336)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred ECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence 34459999999 999999999999999999999999999986543322
Q ss_pred ecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........... ... ....++..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------------i~~-~~~~~p~~ 230 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------------VNS-CVYVMPDF 230 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC------------CCS-SCCCCCTT
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH------------HHc-CCCCCccc
Confidence 233569999999999988776 6899999999999999999999975432221100 000 00111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+|+.+||+.||.+|||+.|+++.
T Consensus 231 ----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 231 ----LSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22357889999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=252.43 Aligned_cols=189 Identities=24% Similarity=0.373 Sum_probs=135.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||+||+|...+++.+|||.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468888999999999999999988999999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cc
Confidence 34459999999 999999999999999999999999999976532221 12
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc--------ccc
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE--------EVV 307 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 307 (408)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......... ...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhccccc
Confidence 33468999999999876 45899999999999999999999999753321 1111121111111000 000
Q ss_pred CCCCCC-------CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPK-------MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
++.... .........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111100 000112346788999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=262.75 Aligned_cols=178 Identities=25% Similarity=0.385 Sum_probs=135.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
.++|...++||+|+||+||+++... ++.+|||++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3578899999999999999999764 788999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 33459999999 99999999999999999999999999997532222
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc--chhHHHHHHHhcCCCcccccCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE--VNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+........ ..
T Consensus 208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~ 280 (396)
T 4dc2_A 208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IR 280 (396)
T ss_dssp -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------CC
T ss_pred -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------cC
Confidence 223446799999999999999999999999999999999999999965432211 111111221111111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
++.. ....+.+|+.+||+.||++||++
T Consensus 281 ~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111 12357889999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=257.20 Aligned_cols=180 Identities=28% Similarity=0.416 Sum_probs=139.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|... +++.||||.+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999976 6899999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ce
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~ 235 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 34559999998 999999999999999999999999999986543222 12
Q ss_pred ecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+.. .. ....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----~~---------~~~~ 229 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KK---------TYLN 229 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT----TC---------TTST
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc----cc---------ccCC
Confidence 234678999999999987765 7789999999999999999999975443211 1111111 10 0011
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+|+.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112223467889999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=251.52 Aligned_cols=183 Identities=28% Similarity=0.457 Sum_probs=144.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|...++..||||.+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCC
Confidence 4678888999999999999999988889999987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++............
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 34459999999 9999999999999999999999999999876544333333
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.......... ...+.
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~~--- 233 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYR------MVRPD--- 233 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC------CCCCT---
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHhcccC------CCCcc---
Confidence 4456789999999998889999999999999999999 99999643221 11111111100 11111
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.....+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 -~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1223688899999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=270.73 Aligned_cols=185 Identities=29% Similarity=0.445 Sum_probs=140.1
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe--------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~-------------------------------------------- 183 (408)
...++|...+.||+|+||.||+|.+.++..||||.+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 345678888999999999999999988889999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 34559999999 99999999999999999999999999998764433222
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +...... .+.. ...+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~-~~~~-----~~~~-- 403 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVE-RGYR-----MPCP-- 403 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH-TTCC-----CCCC--
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cCCC-----CCCC--
Confidence 233456789999999999999999999999999999999 99999743321 1111111 1110 0111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 404 --~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 404 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12234688899999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=257.50 Aligned_cols=177 Identities=24% Similarity=0.353 Sum_probs=139.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.. +++.||||.+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999975 5899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 34459999999 999999999999999999999999999976432222
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..++..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-------~~~p~~ 227 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-------IRFPRT 227 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCCTT
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-------CCCCCC
Confidence 23346799999999999999999999999999999999999999964321 11111111111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 348 (408)
. ...+.+|+.+||+.||++|| ++.||++.-
T Consensus 228 ~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 228 L----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp S----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred C----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1 23678899999999999999 899988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=274.42 Aligned_cols=185 Identities=24% Similarity=0.432 Sum_probs=145.8
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------- 183 (408)
...++|...+.||+|+||.||+|.+.. +..||||.+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 345678888999999999999999875 889999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 34569999999 999999999999999999999999999987654333
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+. .... ...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~-----~~~- 440 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE----KDYR-----MER- 440 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH----TTCC-----CCC-
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCC-----CCC-
Confidence 22333456788999999999999999999999999999999 99999754322 1222111 1110 111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 441 ---~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 441 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 112234688899999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=251.35 Aligned_cols=182 Identities=30% Similarity=0.523 Sum_probs=134.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... ++.+|||.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999985 899999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC--------CCceEEeccCCce
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR--------QWNARVSDFGLAK 226 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~--------~~~~kL~Dfg~a~ 226 (408)
+..+|.|||+....+|+|+||||+|||++. ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 344599999982223999999999999985 6789999999997
Q ss_pred eecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ............
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 165 EWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKLA--- 232 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCCC---
T ss_pred ccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCCC---
Confidence 6543222 2346899999999999999999999999999999999999999743211 111111111110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
...+ ......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 233 --~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 233 --LPIP----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --CCCC----cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 1122468889999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=265.81 Aligned_cols=193 Identities=26% Similarity=0.396 Sum_probs=131.8
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|... +++.||||++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 5899999976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 34459999999 99999999999999999999999999998653211
Q ss_pred --------------------cceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 015360 233 --------------------SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291 (408)
Q Consensus 233 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 291 (408)
........||+.|+|||++.+ ..++.++|||||||++|||++|++||...... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~ 240 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM---NQL 240 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 111234579999999999876 67899999999999999999999999754321 111
Q ss_pred HHHHHHhcCCCccccc---------------------CCCCCCCCc------------HHHHHHHHHHHHhccCcCCCCC
Q 015360 292 DWLKTMVGSRKSEEVV---------------------DPKLPKMPA------------SKALKRVLLVALRCVDPDATKR 338 (408)
Q Consensus 292 ~~~~~~~~~~~~~~~~---------------------d~~~~~~~~------------~~~~~~l~~l~~~cl~~dP~~R 338 (408)
..+...........+. ......... ......+.+|+.+||+.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 1111111111000000 000000000 0112367899999999999999
Q ss_pred CCHhHHHHH
Q 015360 339 PKMGHVIHM 347 (408)
Q Consensus 339 ps~~evl~~ 347 (408)
||+.|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=252.80 Aligned_cols=183 Identities=25% Similarity=0.441 Sum_probs=131.4
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~------------------------------------------ 183 (408)
.++|...+.||+|+||.||+|.... +..||||..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 3578888999999999999999743 457999985
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 34459999998 99999999999999999999999999998765443
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .....+ ..... ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i---~~~~~------~~~ 238 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---ENGER------LPM 238 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---HTTCC------CCC
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH---HcCCC------CCC
Confidence 333334456789999999998899999999999999999997 99999754322 122111 11110 011
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+. .....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 239 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 239 PP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1223678899999999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=254.97 Aligned_cols=187 Identities=25% Similarity=0.363 Sum_probs=142.1
Q ss_pred hcCCCccceeccCCcEEEEEEEe----CCCcEEEEEEe------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~----~~~~~vavK~~------------------------------------------ 183 (408)
.++|...+.||+|+||.||+++. .+++.||||.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999997 36899999975
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 34459999998 9999999999999999999999999999876
Q ss_pred cCCCcceecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~------ 281 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS------ 281 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC------
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc------
Confidence 4443333445679999999999985 3478899999999999999999999975443322 12222222111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHHHhcCC
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHMLEADD 352 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~Le~~~ 352 (408)
.+..+.. ....+.+|+.+||+.||++|| ++.|+++..-...
T Consensus 282 -~~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 -EPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp -CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -CCCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 1111111 223577899999999999999 9999988665433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=248.94 Aligned_cols=185 Identities=30% Similarity=0.506 Sum_probs=131.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. ..+|||.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 56888899999999999999864 35999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC-cce
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-SYV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 235 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 34559999999 99999999999999999999999999997653321 122
Q ss_pred ecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 236 TTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.....||+.|+|||.+. +..++.++|||||||++|+|++|+.||....... .... ............ ..
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~~~-~~- 250 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGRGSLSPDLS-KV- 250 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHHTSCCCCTT-SS-
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----HhcccccCcchh-hc-
Confidence 23456899999999986 5678889999999999999999999997543221 1111 111111111110 01
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.......+.+|+.+||+.||++|||+.|+++.|+..
T Consensus 251 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 251 ---RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 112234688899999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=265.58 Aligned_cols=192 Identities=23% Similarity=0.308 Sum_probs=146.2
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------ 183 (408)
+.+.+++...++|...++||+|+||+||+++.. +++.||||.+
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 557777778899999999999999999999985 5899999987
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 33459999998 99999999999999999999999999
Q ss_pred CceeecCCCcceecccccccCcccccccc-------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 015360 224 LAKLLCSERSYVTTRVMGTFGYVAPEYAC-------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 224 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...... .. ...
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~ 281 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ET---YGK 281 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HH---HHH
Confidence 99877554443344567999999999987 356899999999999999999999999753321 11 111
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC---CCHhHHHHHH
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR---PKMGHVIHML 348 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~evl~~L 348 (408)
..... .....+..... ....+.+|+.+||+ +|.+| |+++|++++-
T Consensus 282 i~~~~--~~~~~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 282 IVHYK--EHLSLPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHTHH--HHCCCC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHhcc--cCcCCCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 11100 00001111111 12367889999999 99998 5899987754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=265.70 Aligned_cols=179 Identities=32% Similarity=0.414 Sum_probs=141.2
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe---------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~--------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|.+. ++.||||.+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3467888899999999999999985 889999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 34569999999 99999999999999999999999999998543221
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+ . .+.. ...+.
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i---~-~~~~-----~~~p~- 409 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV---E-KGYK-----MDAPD- 409 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHH---H-TTCC-----CCCCT-
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---H-cCCC-----CCCCC-
Confidence 12356789999999999999999999999999999998 999997554332 11111 1 1110 11111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.....+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 410 ---~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 410 ---GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2234688899999999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=248.40 Aligned_cols=191 Identities=20% Similarity=0.276 Sum_probs=138.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|... +++.||||.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 4889999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence 34559999999 999999999999999999999999999987643322 2
Q ss_pred ecccccccCcccccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc------cccC
Q 015360 236 TTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------EVVD 308 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~d 308 (408)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+.......... ...+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 23456899999999998766 79999999999999999998888642221 111222222221111100 0000
Q ss_pred C---------CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 P---------KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ~---------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .............+.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000111223467889999999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=264.74 Aligned_cols=183 Identities=27% Similarity=0.438 Sum_probs=139.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe----------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~---------------------------------------- 183 (408)
.++|...+.||+|+||+||+|++. ++..||||.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888899999999999999953 3668999986
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC---ceEEe
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVS 220 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL~ 220 (408)
++.+|+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 33458999999 999999999999998544 59999
Q ss_pred ccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHh
Q 015360 221 DFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 221 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence 9999975432211 12233457889999999999999999999999999999998 99999753321 1111111
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.... ...+. .....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 301 ~~~~------~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGR------MDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCC------CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC------CCCCc----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 01111 1223578899999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=257.02 Aligned_cols=194 Identities=19% Similarity=0.308 Sum_probs=136.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... .+..+|||..
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999985 4788999975
Q ss_pred -------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC--ceE
Q 015360 184 -------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW--NAR 218 (408)
Q Consensus 184 -------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~--~~k 218 (408)
++.+|.|||+. +|+||||||+|||++.++ .+|
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 33459999999 999999999999998777 999
Q ss_pred EeccCCceeecCCCcc------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 015360 219 VSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 292 (408)
Q Consensus 219 L~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 292 (408)
|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-AVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-HHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-HHHH
Confidence 9999999876432211 11345689999999999999999999999999999999999999964322111 1111
Q ss_pred HHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCc
Q 015360 293 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 353 (408)
Q Consensus 293 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~ 353 (408)
....... .... ........ ......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 273 ~~~~~~~-~~~~-~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLD-ELPQ-SVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHH-TTTH-HHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcc-cccH-HHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111 0000 00000000 0122368889999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=261.76 Aligned_cols=177 Identities=23% Similarity=0.388 Sum_probs=134.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...++||+|+||+||+++.. +++.||||.+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999975 4899999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 33459999999 99999999999999999999999999997543222
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......... ..++
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~-------~~~p 244 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDE-------VVYP 244 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------CCCC
T ss_pred -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-------CCCC
Confidence 2234467999999999999888999999999999999999999999743321 1122222111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCH------hHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKM------GHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 347 (408)
.. ....+.+|+.+||+.||++||++ .|++++
T Consensus 245 ~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 245 TW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11 12357789999999999999998 677663
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=251.77 Aligned_cols=186 Identities=28% Similarity=0.461 Sum_probs=136.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||+||+|++. ++.||||.+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSL 86 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBH
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCH
Confidence 46778899999999999999985 889999987
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc-eEEeccCCceeecCCCcceecc
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~-~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|+|||+.+..+|+|+||||+|||++.++. +||+|||++...... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~ 162 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTN 162 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----ccc
Confidence 335699999943349999999999999988876 799999999765322 123
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... ... +.... .
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~-----~~~~~----~ 228 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTR-----PPLIK----N 228 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCC-----CCCBT----T
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCC-----CCccc----c
Confidence 458999999999999999999999999999999999999997433221 111111111 111 11111 1
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCccc
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLF 355 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~~~ 355 (408)
....+.+++.+||+.||++|||+.|+++.|+.....+
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 2236788999999999999999999999998754433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=263.95 Aligned_cols=182 Identities=27% Similarity=0.466 Sum_probs=129.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||.||+|++. ++..||||.+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999975 5778999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 34559999998 99999999999999999999999999998764432
Q ss_pred cce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 233 SYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 233 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .. ..... ... ..+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~---~~~i~-~~~----~~~ 270 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DV---IKAVD-EGY----RLP 270 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HH---HHHHH-TTE----ECC
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHH-cCC----CCC
Confidence 211 122335678999999999999999999999999999998 99999643321 11 11111 110 001
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
. .......+.+++.+||+.||++||++.||++.|+..
T Consensus 271 -~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 271 -P----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -C----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1 112234688899999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=257.35 Aligned_cols=190 Identities=25% Similarity=0.428 Sum_probs=134.2
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEEeCCCc----EEEEEEe-----------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGT----KVAVKNL----------------------------------- 183 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~----~vavK~~----------------------------------- 183 (408)
++++....++|...+.||+|+||.||+|...... .||||.+
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3344445678999999999999999999975432 7999976
Q ss_pred ---------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC
Q 015360 184 ---------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD 212 (408)
Q Consensus 184 ---------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~ 212 (408)
++.+|.|||+. +|+|+||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc
Confidence 23458999999 999999999999999
Q ss_pred CCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015360 213 RQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNL 290 (408)
Q Consensus 213 ~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 290 (408)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~ 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I 248 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H
Confidence 9999999999999876433221 1223446788999999999999999999999999999999 999997543321 1
Q ss_pred HHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 291 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 291 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
. ........ ...+ ......+.+|+.+||+.||++|||+.++++.|+..
T Consensus 249 ~---~~~~~~~~------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 Y---NYLIGGNR------LKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp H---HHHHTTCC------CCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHhcCCC------CCCC----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11111111 0111 11224688899999999999999999999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=263.19 Aligned_cols=190 Identities=23% Similarity=0.271 Sum_probs=136.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||+||+|... +++.||||++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467899999999999999999864 4889999987
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 33459999999 9999999999999999999999999999876432
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc--------
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS-------- 303 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 303 (408)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....+.........
T Consensus 218 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 218 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp C--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHTTSCH
T ss_pred c--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHcch
Confidence 2 2344679999999999999999999999999999999999999997543211 11111111111000
Q ss_pred --ccccC--CCC--------------CCCC--cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 --EEVVD--PKL--------------PKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 --~~~~d--~~~--------------~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...+. +.. +... .......+.+|+.+||+.||++|||++|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000 0000 11124568899999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=254.43 Aligned_cols=189 Identities=23% Similarity=0.364 Sum_probs=134.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|... +++.||||.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999976 5899999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 157 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 157 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cc
Confidence 34569999999 999999999999999999999999999976543222 12
Q ss_pred cccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc---ccc-----
Q 015360 237 TRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE---EVV----- 307 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----- 307 (408)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.......... ...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchhh
Confidence 33468999999999876 56899999999999999999999999754322 2222222222211110 000
Q ss_pred ----CCCCCCCC----cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 ----DPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 ----d~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+...... .......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0011246788999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=257.05 Aligned_cols=177 Identities=26% Similarity=0.411 Sum_probs=137.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++.... ++.||||.+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568888999999999999999754 789999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 34459999999 99999999999999999999999999998764332
Q ss_pred eecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||................. .. ...
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~~-------~~~ 239 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---TV-------VTY 239 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---CC-------CCC
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---cc-------cCC
Confidence 2344679999999999864 4589999999999999999999999975544332222221111 10 111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCC-HhHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIH 346 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~ 346 (408)
+.. ....+.+|+.+||+.||.+||+ +++|++
T Consensus 240 p~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 PSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCc----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111 1236888999999999999998 777665
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=255.53 Aligned_cols=182 Identities=29% Similarity=0.500 Sum_probs=133.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcE----EEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTK----VAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~----vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||.||+|... +++. |++|.+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 57888999999999999999964 3443 577754
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 34559999999 99999999999999999999999999998764332
Q ss_pred cc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+. .... ..
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----~~~~-----~~ 239 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGER-----LP 239 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTCC-----CC
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCCC-----CC
Confidence 21 1223446788999999999999999999999999999999 999997543321 211111 1110 01
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+. .....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 240 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 240 QPP----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1223578899999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=249.55 Aligned_cols=182 Identities=26% Similarity=0.444 Sum_probs=142.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||++...+++.||||.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 568888999999999999999988999999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++.............
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 34559999999 99999999999999999999999999997654322222233
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ............ ...+..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~~~------~~~~~~--- 229 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR------LYKPRL--- 229 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC------CCCCTT---
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcCCc------CCCCcc---
Confidence 456788999999998899999999999999999999 8999974321 111221111110 111111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 230 -~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 230 -ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 123678899999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=262.55 Aligned_cols=127 Identities=27% Similarity=0.357 Sum_probs=110.2
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
..+|...++||+|+||+||+|.... ++.||||.+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 3568889999999999999998654 889999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc--eEEeccCCceee
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKLL 228 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~--~kL~Dfg~a~~~ 228 (408)
++.+|+|||+. +|+||||||+|||++.++. +||+|||++...
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 34459999999 9999999999999998887 999999999764
Q ss_pred cCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 015360 229 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 283 (408)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~ 283 (408)
... .....+|+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 322 223568999999999999999999999999999999999999997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=257.65 Aligned_cols=182 Identities=24% Similarity=0.335 Sum_probs=133.1
Q ss_pred cCCCcc-ceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 151 SGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~-~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
++|... ++||+|+||+||++... +++.||||.+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 456554 68999999999999975 4889999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 34459999998 9999999999999987 788999999999875432
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHHHHHHhcCCCcccccCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.. ... .+..+.
T Consensus 218 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~-~~~~~~ 290 (400)
T 1nxk_A 218 NS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY-EFPNPE 290 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC-CCCTTT
T ss_pred Cc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc-cCCCcc
Confidence 22 23456899999999999999999999999999999999999999765433211 11111111 100 000111
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 291 -----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 -----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123467889999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=250.29 Aligned_cols=183 Identities=25% Similarity=0.466 Sum_probs=138.6
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~------------------------------------------ 183 (408)
.++|...+.||+|+||.||+|.+.+ +..||||.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4578888999999999999999653 235999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 34459999998 99999999999999999999999999998765433
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+.. ... ...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~---~~~------~~~ 235 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK---GDR------LPK 235 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH---TCC------CCC
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc---CCC------CCC
Confidence 333334457789999999998899999999999999999998 99999744322 12221111 110 011
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+.. ....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 236 ~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 PDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111 123588899999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=251.30 Aligned_cols=184 Identities=26% Similarity=0.459 Sum_probs=146.5
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~------------------------------------------- 183 (408)
...++|...+.||+|+||.||+|...+ +..||||.+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 345678889999999999999999865 788999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 34559999999 999999999999999999999999999987655444
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+. ... ....+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~---~~~------~~~~~ 234 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE---KDY------RMERP 234 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH---TTC------CCCCC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh---ccC------CCCCC
Confidence 44444567889999999999999999999999999999999 99999754322 1221111 110 01111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. .....+.+|+.+||+.||.+|||+.|+++.|+.
T Consensus 235 ~----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 235 E----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 1 122468889999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=252.26 Aligned_cols=195 Identities=26% Similarity=0.399 Sum_probs=147.7
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------- 183 (408)
....++|...+.||+|+||.||+|+. +++.||||.+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 44557899999999999999999998 4999999987
Q ss_pred -------------------------------hhhhHHHhh--------hCCCCceeeeccccCceEeCCCCceEEeccCC
Q 015360 184 -------------------------------LNNRLAYLH--------EGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 -------------------------------~~~~L~yLH--------~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
++.+|.||| +. +|+|+||||+|||++.++.+||+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 344599999 66 999999999999999999999999999
Q ss_pred ceeecCCCcc---eecccccccCcccccccccC------CCCccccchhhHHHHHHHHhC----------CCCCCCCCCC
Q 015360 225 AKLLCSERSY---VTTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITG----------RNPVDYSRPQ 285 (408)
Q Consensus 225 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltG----------~~Pf~~~~~~ 285 (408)
+......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876544332 12345689999999998765 234689999999999999999 7787654332
Q ss_pred CcchhHHHHHHHhcCCCcccccCCCCCCC-CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 286 GEVNLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.. ....+..... ... ..+.++.. ........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 274 ~~-~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 274 DP-SVEEMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp SC-CHHHHHHHHT-TSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-cHHHHHHHHH-HHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 21 1222222211 111 11222211 1235667899999999999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=255.14 Aligned_cols=130 Identities=24% Similarity=0.339 Sum_probs=110.2
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||+||+|... +++.||||.+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 3578999999999999999999965 5789999987
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC--CCCceEEeccCCcee
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~--~~~~~kL~Dfg~a~~ 227 (408)
++.+|.|||.. ..+|+||||||+|||++ .++.+||+|||++..
T Consensus 132 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 33458999952 33999999999999994 477899999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 283 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~ 283 (408)
.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6432 223568999999999999999999999999999999999999997543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=252.88 Aligned_cols=190 Identities=23% Similarity=0.397 Sum_probs=125.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356888899999999999999865 4899999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 33459999998 999999999999999999999999999987643
Q ss_pred CCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC---cccc
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEEV 306 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 306 (408)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........ ....
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGGG
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhhh
Confidence 222 1233568999999999876 46899999999999999999999999754321 11222222111110 0000
Q ss_pred -----cCCCCCCC----C--------cHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 307 -----VDPKLPKM----P--------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 307 -----~d~~~~~~----~--------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+..... . .......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 0 0011236889999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=246.13 Aligned_cols=184 Identities=24% Similarity=0.337 Sum_probs=132.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... +++.||||.+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367999999999999999999975 5889999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 33459999999 999999999999999999999999999977654333
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC-CcccccCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-KSEEVVDPKLP 312 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~ 312 (408)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... . .+....... .......+.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------S-VMGAHINQAIPRPSTVRPGIP 262 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------H-HHHHHHHSCCCCGGGTSTTCC
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------H-HHHHHhccCCCCccccCCCCC
Confidence 333345689999999999999999999999999999999999999964321 1 111111111 11111111221
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCC-CHhHHHHHHhcC
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEAD 351 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~Le~~ 351 (408)
..+.+++.+||+.||++|| +++++++.|+..
T Consensus 263 --------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 263 --------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp --------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred --------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 2678899999999999999 999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=257.31 Aligned_cols=180 Identities=21% Similarity=0.285 Sum_probs=138.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||.||++... +|+.||||.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467888999999999999999975 4899999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----ceEEeccCCce
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAK 226 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kL~Dfg~a~ 226 (408)
+..+|.|||+. +|+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 34459999999 999999999999998776 79999999998
Q ss_pred eecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........... .
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~-~--- 235 (361)
T 2yab_A 168 EIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVS-Y--- 235 (361)
T ss_dssp ECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-C---
T ss_pred EcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-C---
Confidence 7654322 2345699999999999998999999999999999999999999964321 11112111111 0
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 ---DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000001122467889999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=264.25 Aligned_cols=181 Identities=20% Similarity=0.313 Sum_probs=137.2
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||+||++... +++.+|+|.+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467889999999999999999864 5889999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 34559999999 999999999999998 4678999999999876443
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... .. ........ . ....+..
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~---~~~i~~~~-~-~~~~~~~ 237 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RL---YQQIKAGA-Y-DFPSPEW 237 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHHTC-C-CCCTTTT
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HH---HHHHHhCC-C-CCCcccc
Confidence 32 223467999999999999999999999999999999999999999643211 11 11111111 0 1111111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+|+.+||+.||++|||+.|+++.
T Consensus 238 -----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 238 -----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1122367889999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-31 Score=259.16 Aligned_cols=189 Identities=27% Similarity=0.406 Sum_probs=138.3
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...++||+|+||.||+|+.. +++.||||++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 5777899999999999999985 4899999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-CceEEeccCCceeecCCC
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.+ +.+||+|||+++......
T Consensus 135 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp CCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 33459999998 99999999999999855 568999999998764332
Q ss_pred cceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC----------C
Q 015360 233 SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS----------R 301 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------~ 301 (408)
. .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+...+. .... .
T Consensus 212 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~-~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 212 P--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK-VLGTPTREQIREMNP 286 (420)
T ss_dssp C--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCSCCHHHHHHHCS
T ss_pred C--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHHHHhhCh
Confidence 2 2335689999999998764 78999999999999999999999997543211 1111111 1111 0
Q ss_pred CcccccCCCCCCCCc-----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 302 KSEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 302 ~~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
....+..+.+..... ......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 111111111111111 11234688999999999999999999998743
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=256.44 Aligned_cols=179 Identities=25% Similarity=0.412 Sum_probs=138.7
Q ss_pred HHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------
Q 015360 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 147 ~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------ 183 (408)
....++|...+.||+|+||.||+|+.. +++.||||.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 4889999987
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 33459999999 99999999999999999999999999997643
Q ss_pred CCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ +
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~---~~~i~~~~-------~ 235 (345)
T 1xjd_A 170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL---FHSIRMDN-------P 235 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCC-------C
T ss_pred cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HH---HHHHHhCC-------C
Confidence 2221 234467999999999999999999999999999999999999999743221 11 11111111 1
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh-HHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMG-HVIH 346 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 346 (408)
.++... ...+.+|+.+||+.||++||++. ||++
T Consensus 236 ~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 121111 23678899999999999999997 6654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=249.55 Aligned_cols=180 Identities=18% Similarity=0.297 Sum_probs=139.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... ++..+|+|.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 467889999999999999999975 4789999976
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC--CCceEEeccCCceeecCCCcc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~--~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+||||||+|||++. ++.+||+|||++........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence 44569999999 9999999999999987 78999999999987654332
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ +...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~-------~~~~ 225 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYT-------FDEE 225 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC-------CCHH
T ss_pred -cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCC-------CChh
Confidence 23456899999999999888999999999999999999999999643221 112221111100 0000
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+|+.+||+.||.+|||+.|+++.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001123468889999999999999999999884
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=259.41 Aligned_cols=148 Identities=24% Similarity=0.393 Sum_probs=113.1
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|.|||+. +|+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||
T Consensus 202 ~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diws 278 (382)
T 3tt0_A 202 RGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278 (382)
T ss_dssp HHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHH
T ss_pred HHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHH
Confidence 358999998 999999999999999999999999999986643322 1223345788999999999999999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|+|++ |..||..... .+...... .... ...+. .....+.+|+.+||+.||++|||+.|
T Consensus 279 lG~il~ellt~g~~p~~~~~~------~~~~~~~~-~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~e 342 (382)
T 3tt0_A 279 FGVLLWEIFTLGGSPYPGVPV------EELFKLLK-EGHR-----MDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQ 342 (382)
T ss_dssp HHHHHHHHHTTSCCSSTTCCH------HHHHHHHH-TTCC-----CCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-cCCC-----CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999 9999964331 11122111 1111 11111 12236888999999999999999999
Q ss_pred HHHHHhcCC
Q 015360 344 VIHMLEADD 352 (408)
Q Consensus 344 vl~~Le~~~ 352 (408)
|++.|+...
T Consensus 343 ll~~L~~~~ 351 (382)
T 3tt0_A 343 LVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=258.38 Aligned_cols=189 Identities=25% Similarity=0.386 Sum_probs=139.0
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
.+|...++||+|+||+||+|+..++..+|||++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 357888999999999999999987778999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCCceeecCCC
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++ .++.+||+|||+++......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 34459999999 999999999999998 78999999999998764333
Q ss_pred cceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC---------
Q 015360 233 SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK--------- 302 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 302 (408)
. .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+...+ .......
T Consensus 197 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~-~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 197 P--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEII-KVLGTPSREQIKTMNP 271 (394)
T ss_dssp C--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCHHHHHHHCG
T ss_pred C--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCCHHHHHhhCh
Confidence 2 2345689999999998764 58999999999999999999999997543211 111111 1111100
Q ss_pred -cccccCCCCCCCCcH-----HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 -SEEVVDPKLPKMPAS-----KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 -~~~~~d~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.....-+........ .....+.+|+.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000001111111111 123468899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=273.33 Aligned_cols=182 Identities=30% Similarity=0.453 Sum_probs=141.9
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.+.++..||||.+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~g 346 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 346 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTE
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCC
Confidence 456677899999999999999988889999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 347 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 34559999999 99999999999999999999999999998654322111223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...... +...... .+.. ...+ .
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~-~~~~-----~~~~----~ 487 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVE-RGYR-----MPCP----P 487 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHH-TTCC-----CCCC----T
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cCCC-----CCCC----C
Confidence 446788999999999999999999999999999999 99999743321 1111111 1110 0111 1
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2233688899999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=253.47 Aligned_cols=177 Identities=26% Similarity=0.395 Sum_probs=133.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.. +++.||||.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999976 4889999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 33459999999 999999999999999999999999999975432221
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc--hhHHHHHHHhcCCCcccccCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--NLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+........ ..+
T Consensus 166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~ 238 (345)
T 3a8x_A 166 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRI 238 (345)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------CCC
T ss_pred -cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------CCC
Confidence 233467999999999999999999999999999999999999999653221110 11111111111111 111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
+.. ....+.+|+.+||+.||.+||++
T Consensus 239 p~~----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 PRS----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CTT----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCC----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 12357889999999999999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=259.49 Aligned_cols=181 Identities=26% Similarity=0.320 Sum_probs=140.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||.||+++... ++.+|||.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 568889999999999999999764 788999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 34459999999 99999999999999999999999999997543222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..++.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~~~ 260 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP-------LQLKP 260 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSC-------CCCCS
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcc-------cCCCC
Confidence 123446799999999999999999999999999999999999999964321 11122222111 11111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
.. ...+.+|+.+||+.||.+||++.+.++.+....
T Consensus 261 ~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 261 NI----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp SS----CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred CC----CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 11 235788999999999999999976665555544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=256.38 Aligned_cols=177 Identities=23% Similarity=0.354 Sum_probs=137.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
.++|...++||+|+||.||+++... ++.||||.+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999999864 788999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 33459999999 99999999999999999999999999997643222
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..++
T Consensus 176 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~p 241 (353)
T 2i0e_A 176 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN-------VAYP 241 (353)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCC
T ss_pred c-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC-------CCCC
Confidence 1 23346799999999999999999999999999999999999999974321 11122222111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
.. ....+.+|+.+||+.||.+||+ ++||++.
T Consensus 242 ~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 KS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TT----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 2236788999999999999996 4666554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=244.29 Aligned_cols=141 Identities=21% Similarity=0.370 Sum_probs=105.5
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCC---CCccccch
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM---LNEKSDVY 263 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvw 263 (408)
+|+|||+. +|+|+||||+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||
T Consensus 149 ~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~ 224 (298)
T 2zv2_A 149 GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224 (298)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHH
T ss_pred HHHHHHHC---CeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhH
Confidence 39999999 999999999999999999999999999987654332 223457999999999997655 47789999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 264 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 264 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
||||++|+|++|+.||.... ........... ... .+.. ......+.+|+.+||+.||++|||+.|
T Consensus 225 slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~-~~~---~~~~-----~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 225 AMGVTLYCFVFGQCPFMDER------IMCLHSKIKSQ-ALE---FPDQ-----PDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp HHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-CCC---CCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred hHHHHHHHHHHCCCCCCCcc------HHHHHHHHhcc-cCC---CCCc-----cccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 99999999999999996432 11111111111 110 0110 111236788999999999999999999
Q ss_pred HHH
Q 015360 344 VIH 346 (408)
Q Consensus 344 vl~ 346 (408)
+++
T Consensus 290 ~l~ 292 (298)
T 2zv2_A 290 IKL 292 (298)
T ss_dssp HTT
T ss_pred Hhc
Confidence 875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=257.48 Aligned_cols=176 Identities=27% Similarity=0.401 Sum_probs=136.5
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||+||+|.. .+++.||||.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588889999999999999996 46899999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 34459999999 9999999999999999999999999999765432
Q ss_pred ceecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 234 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...+........ +.
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~------~~ 272 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------PA 272 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------CC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC------CC
Confidence 2356899999999984 56789999999999999999999999964321 111222221111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.... .....+.+|+.+||+.||++|||+.++++..
T Consensus 273 ~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 LQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111 1123577889999999999999999998743
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=253.96 Aligned_cols=184 Identities=27% Similarity=0.368 Sum_probs=138.6
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... +++.||||.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 457889999999999999999975 4889999987
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC----CceEEeccCCceeecCCCcce
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~----~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+. +|+||||||+|||+..+ +.+||+|||++........ .
T Consensus 101 g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 176 (342)
T 2qr7_A 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-L 176 (342)
T ss_dssp CBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-C
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-c
Confidence 44569999999 99999999999998433 3499999999987644332 2
Q ss_pred ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||..........+ ...... .... +....
T Consensus 177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i~~-~~~~------~~~~~ 246 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGS-GKFS------LSGGY 246 (342)
T ss_dssp BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHHHH-CCCC------CCSTT
T ss_pred eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHHcc-CCcc------cCccc
Confidence 2345689999999999888899999999999999999999999975432222122 222111 1110 11111
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123367889999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=250.22 Aligned_cols=182 Identities=25% Similarity=0.356 Sum_probs=131.6
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~-------------------------------------------- 183 (408)
..+.|...+.||+|+||.||+|+... ++.||||.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 45789999999999999999999864 788999986
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCCceeecCCCcc
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +|+||||||+|||++. ++.+||+|||++.......
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 205 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-- 205 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence 44569999999 9999999999999975 7899999999998654322
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ....+.
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~--~~~~~~---- 274 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEY--YFISPW---- 274 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCC--CCCTTT----
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCC--ccCCch----
Confidence 1234568999999999999999999999999999999999999996433211 11111211111 011111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 275 -~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 -WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223367889999999999999999999873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=257.06 Aligned_cols=181 Identities=20% Similarity=0.338 Sum_probs=139.0
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|... +++.||||.+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999975 4899999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC---CceEEeccCCceeecC
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 34559999999 99999999999999765 4599999999987643
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+. ....... . .
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~---~~i~~~~-~------~ 248 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY---AQIKAGA-Y------D 248 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTC-C------C
T ss_pred Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhCC-C------C
Confidence 322 2345799999999999998999999999999999999999999964321 1111 1111111 0 0
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+..........+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111223467889999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=250.45 Aligned_cols=190 Identities=25% Similarity=0.388 Sum_probs=134.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|.... ++.||||.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578889999999999999999754 899999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY- 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence 34459999999 9999999999999999999999999999876433222
Q ss_pred ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC-----------C-C
Q 015360 236 TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS-----------R-K 302 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----------~-~ 302 (408)
.....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ...+...... . .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhcccccccccccccccc
Confidence 233568999999999876 6689999999999999999999999975432211 1111111111 0 0
Q ss_pred cccccCCCCCCCCc-----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 SEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+....... ......+.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000 1123457889999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=252.51 Aligned_cols=179 Identities=22% Similarity=0.324 Sum_probs=123.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
.+|...++||+|+||.||+|... +++.||||++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 57888899999999999999964 5899999976
Q ss_pred -------------------------------------hhhhHHHhhhCCCCc--eeeeccccCceEeCCCCceEEeccCC
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~--ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
++.+|.|||+. + |+|+||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 33459999998 7 99999999999999999999999999
Q ss_pred ceeecCCCcce-----------ecccccccCccccccc---ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 015360 225 AKLLCSERSYV-----------TTRVMGTFGYVAPEYA---CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 290 (408)
Q Consensus 225 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 290 (408)
+.......... .....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98764332211 1134589999999998 56678899999999999999999999996432211
Q ss_pred HHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 291 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 291 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.... ... ...... ....+.+|+.+||+.||++|||+.|+++.|+..
T Consensus 261 --~~~~-----~~~----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 --IVNG-----KYS----IPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ------------CC----CCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhcC-----ccc----CCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 000 000111 112477899999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=247.57 Aligned_cols=179 Identities=27% Similarity=0.390 Sum_probs=129.9
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++.. .+++.||||.+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788889999999999999996 56899999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|+|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 33459999999 999999999999999999999999999986643
Q ss_pred CCcc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc-ccc
Q 015360 231 ERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE-EVV 307 (408)
Q Consensus 231 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 307 (408)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .............. ...
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCHHHH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCcccc
Confidence 3221 22335689999999999999999999999999999999999999964332 11111111111110 000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. .....+.+++.+||+.||++||++.+++.
T Consensus 243 ~~--------~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 243 HE--------GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ST--------TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred cC--------CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00 12236788999999999999997766654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=260.71 Aligned_cols=146 Identities=25% Similarity=0.446 Sum_probs=111.6
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+|+||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||
T Consensus 205 aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 281 (359)
T 3vhe_A 205 GMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 281 (359)
T ss_dssp HHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhH
Confidence 58999998 999999999999999999999999999986543322 22334568889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |+.||....... .....+. .... ...+.. ....+.+++.+||+.||++|||+.||
T Consensus 282 G~il~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~-----~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~el 346 (359)
T 3vhe_A 282 GVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSEL 346 (359)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSH--HHHHHHH----HTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhcCCCCCCccchhH--HHHHHHH----cCCC-----CCCCCC----CCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999999998 999997544321 1111111 1110 111111 12367889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
+++|+.
T Consensus 347 l~~L~~ 352 (359)
T 3vhe_A 347 VEHLGN 352 (359)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=252.66 Aligned_cols=179 Identities=22% Similarity=0.290 Sum_probs=137.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||++... +++.||||.+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999975 4899999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----ceEEeccCCcee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAKL 227 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +|+|+||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 34459999998 999999999999998877 799999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 168 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~------ 233 (326)
T 2y0a_A 168 IDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVN------ 233 (326)
T ss_dssp CCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTC------
T ss_pred CCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcC------
Confidence 643322 23356999999999999899999999999999999999999999643211 1111111110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..............+.+|+.+||+.||++|||+.|+++.
T Consensus 234 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 -YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000001122467889999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=250.89 Aligned_cols=174 Identities=29% Similarity=0.415 Sum_probs=138.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.. +|+.||||.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999975 5899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 34459999998 9999999999999999999999999999875432
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..++..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-------~~~p~~ 225 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE-------LRFPPF 225 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC-------CCCCTT
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CCCCCC
Confidence 2335699999999999999999999999999999999999999964321 11122222111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 348 (408)
. ...+.+++.+||+.||++|| +++|+++.-
T Consensus 226 ~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 226 F----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp S----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred C----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 1 23678899999999999999 888887643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=253.37 Aligned_cols=192 Identities=18% Similarity=0.230 Sum_probs=142.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCC---------CcEEEEEEe--------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD---------GTKVAVKNL-------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~---------~~~vavK~~-------------------------------------- 183 (408)
++|...+.||+|+||.||+|.... ++.||||.+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 568888999999999999999764 789999976
Q ss_pred ----------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC--
Q 015360 184 ----------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-- 215 (408)
Q Consensus 184 ----------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-- 215 (408)
++.+|.|||+. +|+||||||+|||++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~ 198 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQS 198 (352)
T ss_dssp CCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEE
T ss_pred hhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCc
Confidence 23349999999 999999999999999988
Q ss_pred ceEEeccCCceeecCCCcc------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 015360 216 NARVSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 289 (408)
Q Consensus 216 ~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 289 (408)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~ 277 (352)
T 2jii_A 199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-ED 277 (352)
T ss_dssp EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HH
T ss_pred eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-HH
Confidence 8999999999876432211 1133468999999999999999999999999999999999999997543221 11
Q ss_pred hHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 290 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
........... ...+.+.... .......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 278 ~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 278 IMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 22222211111 1111111110 001123688899999999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=252.78 Aligned_cols=146 Identities=32% Similarity=0.517 Sum_probs=112.5
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+|+||||+|||++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||
T Consensus 162 ~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 162 GMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp HHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 48999998 99999999999999999999999999998765433322 223456788999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |+.||...... .+...+. .... +..+. .....+.+++.+||+.||++|||+.||
T Consensus 239 G~il~el~t~g~~p~~~~~~~---~~~~~~~----~~~~-----~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPE---RLFNLLK----TGHR-----MERPD----NCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGG---GHHHHHH----TTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHHHhh----cCCc-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999 99999754432 1221111 1111 11111 122368889999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
++.|+..
T Consensus 303 ~~~l~~~ 309 (314)
T 2ivs_A 303 SKDLEKM 309 (314)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.71 Aligned_cols=179 Identities=23% Similarity=0.346 Sum_probs=138.8
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...++||+|+||.||++... +++.||||.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 5889999976
Q ss_pred ------------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 ------------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||+ . +|+||||||+|||++.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 3455999998 7 99999999999999999999999999997543222
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ........ ..++
T Consensus 304 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~---~~~i~~~~-------~~~p 369 (446)
T 4ejn_A 304 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL---FELILMEE-------IRFP 369 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCC-------CCCC
T ss_pred c-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH---HHHHHhCC-------CCCC
Confidence 2 233467999999999999999999999999999999999999999643221 11 11111111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHHHh
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHMLE 349 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~Le 349 (408)
... ...+.+|+.+||+.||.+|| +++|+++.--
T Consensus 370 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 370 RTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 111 23678899999999999999 9999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=252.07 Aligned_cols=178 Identities=14% Similarity=0.176 Sum_probs=138.8
Q ss_pred HhcCCCccceeccCCcEEEEEEE------eCCCcEEEEEEe---------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGI------LSDGTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~------~~~~~~vavK~~--------------------------------------- 183 (408)
..++|...+.||+|+||+||+|. ..+++.||||.+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 45778899999999999999994 446899999987
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-----------C
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-----------Q 214 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-----------~ 214 (408)
++.+|+|||+. +|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 34569999998 9999999999999988 8
Q ss_pred CceEEeccCCceeecCC-CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHH
Q 015360 215 WNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 293 (408)
Q Consensus 215 ~~~kL~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 293 (408)
+.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 99999999999765422 2223345679999999999999999999999999999999999999986332211
Q ss_pred HHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCC-CCHhHHHHHHhc
Q 015360 294 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR-PKMGHVIHMLEA 350 (408)
Q Consensus 294 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-ps~~evl~~Le~ 350 (408)
......+...... ..+.+++..||+.+|.+| |++.++.+.|+.
T Consensus 293 -----------~~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -----------CKPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -----------EEECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -----------eeechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0011122222222 345667789999999999 578888888876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=247.65 Aligned_cols=187 Identities=26% Similarity=0.416 Sum_probs=141.2
Q ss_pred cCCCccceeccCCcEEEEEEEe-----CCCcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-----~~~~~vavK~~------------------------------------------ 183 (408)
+.|...+.||+|+||.||++++ .+++.||||.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477789999999999999994 35899999986
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|+|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 34459999999 99999999999999999999999999998765
Q ss_pred CCCcc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC--------C-CCcchhHHHHHHHh
Q 015360 230 SERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR--------P-QGEVNLVDWLKTMV 298 (408)
Q Consensus 230 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~--------~-~~~~~~~~~~~~~~ 298 (408)
..... ......+|..|+|||.+.+..++.++|||||||++|+|++|..|+.... + ............ .
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-L 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-H
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-H
Confidence 44332 2234557888999999999999999999999999999999998864221 0 111111111111 1
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..... ... .......+.+|+.+||+.||.+|||+.|+++.|+.
T Consensus 257 ~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 257 KEGKR-----LPC----PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HTTCC-----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCC-----CCC----CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11111 111 11122468899999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=245.82 Aligned_cols=175 Identities=27% Similarity=0.454 Sum_probs=134.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.... +..||||.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4678889999999999999998754 678999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 33459999998 99999999999999999999999999886543222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ...++.
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-------~~~~~~ 228 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRV-------EFTFPD 228 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT-------CCCCCT
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhC-------CCCCCC
Confidence 2335689999999999999999999999999999999999999974321 1111111111 111111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ....+.+|+.+||+.||++|||+.||++.
T Consensus 229 ~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 229 F----VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp T----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred c----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 12357789999999999999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=253.82 Aligned_cols=193 Identities=24% Similarity=0.456 Sum_probs=147.1
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe-------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL------------------------------- 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~------------------------------- 183 (408)
+...+++...++|...+.||+|+||.||+|... .+..||||.+
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455566788999999999999999999864 3678999976
Q ss_pred ----------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEe
Q 015360 184 ----------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL 211 (408)
Q Consensus 184 ----------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill 211 (408)
++.+|.|||+. +|+|+||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 23458999999 99999999999999
Q ss_pred CCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcch
Q 015360 212 DRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 289 (408)
Q Consensus 212 ~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~ 289 (408)
+.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 999999999999997654332211 223456889999999999999999999999999999999 8999864321
Q ss_pred hHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 290 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
......... .... ..+. .....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 247 -~~~~~~~~~-~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 247 -EQVLRFVME-GGLL-----DKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -HHHHHHHHT-TCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -HHHHHHHHc-CCcC-----CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 111111111 1111 1111 12236788999999999999999999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=262.91 Aligned_cols=131 Identities=17% Similarity=0.178 Sum_probs=102.3
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCccccccc----------ccCCC
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA----------CTGML 256 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~ 256 (408)
+|+|||+. +|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....+
T Consensus 223 aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~ 294 (413)
T 3dzo_A 223 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM 294 (413)
T ss_dssp HHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred HHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCC
Confidence 48999998 9999999999999999999999999998765332 233557 999999998 55568
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCC
Q 015360 257 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 336 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 336 (408)
+.++|||||||++|||++|+.||.......... .++. ..... ...+.+|+.+||+.||+
T Consensus 295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------------~~~~-~~~~~-----~~~~~~li~~~l~~dP~ 353 (413)
T 3dzo_A 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------------WIFR-SCKNI-----PQPVRALLEGFLRYPKE 353 (413)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---------------GGGS-SCCCC-----CHHHHHHHHHHTCSSGG
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---------------HHHh-hcccC-----CHHHHHHHHHHccCChh
Confidence 889999999999999999999997543222111 1111 01111 13688899999999999
Q ss_pred CCCCHhHHHH
Q 015360 337 KRPKMGHVIH 346 (408)
Q Consensus 337 ~Rps~~evl~ 346 (408)
+|||+.|+++
T Consensus 354 ~Rpt~~~~l~ 363 (413)
T 3dzo_A 354 DRLLPLQAME 363 (413)
T ss_dssp GSCCHHHHTT
T ss_pred hCcCHHHHHh
Confidence 9999988865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=254.75 Aligned_cols=191 Identities=25% Similarity=0.342 Sum_probs=139.3
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+. .+++.||||++
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688889999999999999997 46899999976
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 34459999999 999999999999999999999999999987
Q ss_pred ecCCCc---ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 228 LCSERS---YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 228 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.........
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITP 250 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCh
Confidence 642221 12234568999999998876 45899999999999999999999999754322 122222222211110
Q ss_pred c---ccc--------C-CCCCCCCcHHH------HHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 E---EVV--------D-PKLPKMPASKA------LKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~---~~~--------d-~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ... . ........... ...+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 000 0 00000011111 2347899999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=250.99 Aligned_cols=177 Identities=27% Similarity=0.414 Sum_probs=134.2
Q ss_pred cCCCccceeccCCcEEEEEEEe----CCCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~----~~~~~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||.||+++. .+++.||||.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788899999999999999997 46899999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 33459999999 999999999999999999999999999875432
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~-------~~ 239 (327)
T 3a62_A 174 DGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCK-------LN 239 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC-------CC
T ss_pred CCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-------CC
Confidence 222 22345689999999999998999999999999999999999999974321 11112221111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 348 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 348 (408)
++.. ....+.+|+.+||+.||++|| ++.|+++.-
T Consensus 240 ~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 240 LPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp CCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred CCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 1111 123678899999999999999 677877644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=253.41 Aligned_cols=190 Identities=20% Similarity=0.214 Sum_probs=141.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +++.||||.+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 67889999999999999999864 5889999976
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----------
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---------- 215 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---------- 215 (408)
++.+|.|||+.+ +|+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 117 GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 334499999853 899999999999998775
Q ss_pred ---------------------------------------ceEEeccCCceeecCCCcceecccccccCcccccccccCCC
Q 015360 216 ---------------------------------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 256 (408)
Q Consensus 216 ---------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 256 (408)
.+||+|||++...... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 7999999999876432 233568999999999999999
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH---HHHHHHhcCCC---------cccccCC--------CCC----
Q 015360 257 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV---DWLKTMVGSRK---------SEEVVDP--------KLP---- 312 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~d~--------~~~---- 312 (408)
+.++|||||||++|||++|+.||............ ..+........ ...+... ...
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 99999999999999999999999765543322111 11111111110 0000000 000
Q ss_pred -------CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 -------KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 -------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..........+.+|+.+||+.||++|||+.|+++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0123455677899999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=249.87 Aligned_cols=178 Identities=24% Similarity=0.349 Sum_probs=136.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||+||+|... +++.||||.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999975 5899999975
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc---eEEeccCCc
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLA 225 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kL~Dfg~a 225 (408)
+..+|.|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 33449999999 9999999999999976554 999999999
Q ss_pred eeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc
Q 015360 226 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305 (408)
Q Consensus 226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (408)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ..........
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~---~~~i~~~~~~-- 250 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL---FEGIIKGKYK-- 250 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH---HHHHHHTCCC--
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH---HHHHHcCCCC--
Confidence 87654322 2334569999999999999999999999999999999999999997421 111 1111111100
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 306 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
............+.+|+.+||+.||++|||+.|+++
T Consensus 251 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -----MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000112246788999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=254.02 Aligned_cols=147 Identities=28% Similarity=0.457 Sum_probs=113.0
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||
T Consensus 184 aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 184 GMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp HHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 48899998 9999999999999999999999999999876443322 2334557889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|+|++ |..||....... .+... ..... .+..+. .....+.+|+.+||+.||.+|||+.||
T Consensus 261 G~il~el~t~g~~p~~~~~~~~--~~~~~----~~~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDA--NFYKL----IQNGF-----KMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSH--HHHHH----HHTTC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHcCCCCCcccCCcHH--HHHHH----HhcCC-----CCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 999999998 999997554321 11111 11111 011111 112368889999999999999999999
Q ss_pred HHHHhcC
Q 015360 345 IHMLEAD 351 (408)
Q Consensus 345 l~~Le~~ 351 (408)
++.|+..
T Consensus 326 ~~~l~~~ 332 (344)
T 1rjb_A 326 TSFLGCQ 332 (344)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=254.30 Aligned_cols=174 Identities=26% Similarity=0.370 Sum_probs=138.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.. +++.||||.+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999975 5899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 34459999999 9999999999999999999999999999876432
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..++..
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-------~~~p~~ 260 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK-------VRFPSH 260 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCCTT
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCC-------CCCCCC
Confidence 2235689999999999999999999999999999999999999974321 11122221111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK-----MGHVIHML 348 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~L 348 (408)
....+.+++.+||+.||.+||+ ++||++.-
T Consensus 261 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 1236788999999999999998 78877643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=251.63 Aligned_cols=180 Identities=22% Similarity=0.350 Sum_probs=116.0
Q ss_pred cceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------------- 183 (408)
.+.||+|+||+||+|... +++.||||.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 378999999999999975 4899999987
Q ss_pred -------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC---ceEEeccCCceeecCCCcceeccccc
Q 015360 184 -------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLLCSERSYVTTRVMG 241 (408)
Q Consensus 184 -------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~g 241 (408)
+..+|+|||+. +|+||||||+|||++.++ .+||+|||++........ ......+
T Consensus 96 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 171 (325)
T 3kn6_A 96 RIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCF 171 (325)
T ss_dssp HHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccccCC
Confidence 34559999999 999999999999997655 799999999986543322 2233568
Q ss_pred ccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHHHHHHhcCCCcccccCCCCCCCCcHHHH
Q 015360 242 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 320 (408)
Q Consensus 242 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 320 (408)
|+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...+.... +..... .+.........
T Consensus 172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~------~~~~~~~~~~s 244 (325)
T 3kn6_A 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF------SFEGEAWKNVS 244 (325)
T ss_dssp ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC------CCCSHHHHTSC
T ss_pred CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC------CCCcccccCCC
Confidence 99999999999999999999999999999999999999755432111 11222222 211111 01111111223
Q ss_pred HHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 321 KRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 321 ~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 46889999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=255.95 Aligned_cols=181 Identities=31% Similarity=0.490 Sum_probs=129.2
Q ss_pred CCCccceeccCCcEEEEEEEeCC----CcEEEEEEe--------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~-------------------------------------------- 183 (408)
.|...+.||+|+||+||+|.+.+ +..||||.+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35667899999999999999743 236899976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 34559999999 99999999999999999999999999998654322
Q ss_pred cc---eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 233 SY---VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 233 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.. ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||....... ....+ .....
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~~~~------ 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGRR------ 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HTTCC------
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---HcCCC------
Confidence 11 1223456788999999999999999999999999999999 777886544322 22111 11110
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...+. .....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 315 ~~~p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 LLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 1123688899999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=254.96 Aligned_cols=181 Identities=22% Similarity=0.320 Sum_probs=128.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+++.. +++.||||.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 56888899999999999999976 5899999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc--eEEeccCCceeecCCCccee
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +|+||||||+|||++.++. +||+|||+++...... ..
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 174 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CC
Confidence 44569999998 9999999999999987765 9999999987432221 12
Q ss_pred cccccccCcccccccccCCCCcc-ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEK-SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+........ .++.
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~-------~~~~-- 243 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKY-------SIPD-- 243 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCC-------CCCT--
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCC-------CCCC--
Confidence 33569999999999988887665 8999999999999999999975443322 2222222221110 0100
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00112367889999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=250.19 Aligned_cols=194 Identities=24% Similarity=0.328 Sum_probs=137.7
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
...++|...+.||+|+||.||+|... +++.||||.+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 4899999976
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 33459999999 99999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.... ......+|+.|+|||.+.+. .++.++|||||||++|||++|.+||...... .....+...........+.+
T Consensus 164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSS
T ss_pred CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChhhhhh
Confidence 3322 22345689999999998754 5889999999999999999999998654321 11111111111111110000
Q ss_pred ----------CCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 309 ----------PKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 309 ----------~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...+..+. ......+.+|+.+||+.||++|||+.|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00011010 11235688999999999999999999998854
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=256.88 Aligned_cols=144 Identities=12% Similarity=0.062 Sum_probs=105.6
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCccccccccc--CCCCccccchhh
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSF 265 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSl 265 (408)
|+|||+. +|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||
T Consensus 207 L~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 207 AANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 8899998 9999999999999999999999999999865321 113457799999999987 679999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 266 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 266 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
||++|||++|+.||....+....... .......................+.+|+.+||+.||++|||+.|++
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHHHHHHHhCCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999999999999865432211000 0000000001111111112234688899999999999999999997
Q ss_pred H
Q 015360 346 H 346 (408)
Q Consensus 346 ~ 346 (408)
+
T Consensus 352 ~ 352 (371)
T 3q60_A 352 E 352 (371)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=255.43 Aligned_cols=180 Identities=20% Similarity=0.275 Sum_probs=138.6
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||.||+|... +++.+|+|.+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357889999999999999999975 5889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC--CCceEEeccCCceeecCCCc
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~--~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +|+||||||+|||++. ++.+||+|||++........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 34559999999 9999999999999974 46799999999987654332
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+......... .++..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~---~~~~~-- 273 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE---FDEDA-- 273 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC---CCSST--
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CCccc--
Confidence 2334689999999999999999999999999999999999999974321 1111111111100 01111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 274 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 --FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11123367889999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=252.10 Aligned_cols=193 Identities=25% Similarity=0.407 Sum_probs=148.9
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEe------CCCcEEEEEEe-------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL------------------------------- 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~------~~~~~vavK~~------------------------------- 183 (408)
+...++....++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44566666778999999999999999999984 34688999986
Q ss_pred ------------------------------------------------------------hhhhHHHhhhCCCCceeeec
Q 015360 184 ------------------------------------------------------------LNNRLAYLHEGLEPKVVHRD 203 (408)
Q Consensus 184 ------------------------------------------------------------~~~~L~yLH~~~~~~ivH~d 203 (408)
++.+|.|||+. +|+|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 22348999998 999999
Q ss_pred cccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCC
Q 015360 204 VKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY 281 (408)
Q Consensus 204 lk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~ 281 (408)
|||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543322 22334557889999999999999999999999999999998 9999975
Q ss_pred CCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 282 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
..... .+...+. . ... ...+.. ....+.+++.+||+.||.+|||+.||++.|+..
T Consensus 254 ~~~~~--~~~~~~~---~-~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE--EFCRRLK---E-GTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH--HHHHHHH---H-TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH--HHHHHhc---c-Ccc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 43221 1111111 1 110 111111 123678899999999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=244.81 Aligned_cols=178 Identities=33% Similarity=0.425 Sum_probs=135.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... ++.||||.+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 367888899999999999999985 899999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 34459999999 99999999999999999999999999987653322
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCC
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 315 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 315 (408)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ... .... .+..+.
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~~-~~~~-----~~~~~~-- 237 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PRV-EKGY-----KMDAPD-- 237 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH---HHH-TTTC-----CCCCCT--
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHH-hcCC-----CCCCcc--
Confidence 22357889999999999999999999999999999998 99999754321 111 111 1111 111111
Q ss_pred cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 316 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 316 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 238 --~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 238 --GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1223688899999999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=261.63 Aligned_cols=121 Identities=30% Similarity=0.452 Sum_probs=92.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||+||+|... +++.||||++
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67899999999999999999865 5899999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 34459999999 9999999999999999999999999999875422
Q ss_pred Cc--------------------------ceecccccccCccccccc-ccCCCCccccchhhHHHHHHHHh
Q 015360 232 RS--------------------------YVTTRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIIT 274 (408)
Q Consensus 232 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~ellt 274 (408)
.. .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 11 112345689999999976 46679999999999999999999
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=244.83 Aligned_cols=182 Identities=26% Similarity=0.432 Sum_probs=140.5
Q ss_pred cCCCccc-eeccCCcEEEEEEEeC---CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~-~lg~G~~g~Vy~g~~~---~~~~vavK~~------------------------------------------- 183 (408)
++|...+ .||+|+||.||+|.+. ++..||||.+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3455555 9999999999999864 5788999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 34459999999 999999999999999999999999999987654333
Q ss_pred ce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 234 YV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 234 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+ . .... +.
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i---~-~~~~-----~~ 233 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI---E-QGKR-----ME 233 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH---H-TTCC-----CC
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH---h-cCCc-----CC
Confidence 22 122346789999999988889999999999999999998 99999754321 122111 1 1111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+. .....+.+++.+||+.||++||++.|+++.|+..
T Consensus 234 ~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 234 CPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1223688899999999999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=243.67 Aligned_cols=180 Identities=20% Similarity=0.366 Sum_probs=137.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 4889999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc---eEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+|+||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 34459999999 9999999999999976654 999999999776433
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ........ . ....+..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~---~~~~~~~~-~-~~~~~~~ 231 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL---YAQIKAGA-Y-DYPSPEW 231 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHTC-C-CCCTTTT
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HH---HHHHHhcc-c-cCCchhh
Confidence 22 23356899999999999999999999999999999999999999643211 11 11111111 0 0011111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+++.+||+.||++|||+.|+++.
T Consensus 232 -----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 232 -----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1122367889999999999999999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=250.41 Aligned_cols=186 Identities=28% Similarity=0.425 Sum_probs=139.7
Q ss_pred CCccceeccCCcEEEEEEEeC-----CCcEEEEEEe--------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-----DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-----~~~~vavK~~-------------------------------------------- 183 (408)
|...+.||+|+||+||++.+. +++.||||.+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377789999999999998753 5889999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 33459999999 999999999999999999999999999987754432
Q ss_pred c--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCC---------CcchhHHHHHHHhcCCC
Q 015360 234 Y--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ---------GEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 234 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~ 302 (408)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ...... .+........
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-RLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH-HHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH-HHHHHHhccc
Confidence 2 123345788899999999989999999999999999999999998632110 000000 1111111111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 303 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...........+.+|+.+||+.||++|||+.|+++.|+..
T Consensus 269 ---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 269 ---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111112234688999999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=255.31 Aligned_cols=191 Identities=24% Similarity=0.336 Sum_probs=145.7
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe---------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL--------------------------------- 183 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~--------------------------------- 183 (408)
+..+....++|...+.||+|+||.||+|... +++.||||.+
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4455556789999999999999999999975 3488999986
Q ss_pred ----------------------------------------------------------------hhhhHHHhhhCCCCce
Q 015360 184 ----------------------------------------------------------------LNNRLAYLHEGLEPKV 199 (408)
Q Consensus 184 ----------------------------------------------------------------~~~~L~yLH~~~~~~i 199 (408)
++.+|.|||+. +|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 11248999998 99
Q ss_pred eeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCC
Q 015360 200 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRN 277 (408)
Q Consensus 200 vH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~ 277 (408)
+|+||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999976543222 11233457889999999998899999999999999999999 999
Q ss_pred CCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 278 PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 278 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
||..... .+...... ..... ..+. .....+.+++.+||+.||++|||+.+|++.|+...
T Consensus 276 p~~~~~~------~~~~~~~~-~~~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 276 PYYGMAH------EEVIYYVR-DGNIL-----ACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTTTSCH------HHHHHHHH-TTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCh------HHHHHHHh-CCCcC-----CCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 9964321 11111111 11111 1111 12236888999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=242.19 Aligned_cols=175 Identities=27% Similarity=0.467 Sum_probs=117.1
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788899999999999999997 46899999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 33459999999 999999999999999999999999999987643222
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
. .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......... .... . .+...+.
T Consensus 168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~----~---~~~~~~~ 233 (278)
T 3cok_A 168 K-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVV----L---ADYEMPS 233 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC----S---SCCCCCT
T ss_pred c-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHh----h---cccCCcc
Confidence 1 22356899999999999888999999999999999999999999754332111 0000 0 0111111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. ....+.+++.+||+.||++|||+.++++
T Consensus 234 ~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 F----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp T----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1 1236788999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=250.94 Aligned_cols=170 Identities=22% Similarity=0.418 Sum_probs=136.3
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999985 45889999965
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 34459999999 999999999999999999999999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... . ...
T Consensus 180 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~-----~~~ 240 (335)
T 3dls_A 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V-----EAA 240 (335)
T ss_dssp CCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T-----TTC
T ss_pred CCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H-----hhc
Confidence 654332 233568999999999988776 78999999999999999999999632110 0 000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ..+.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~--~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 I--HPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C--CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred c--CCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00111 12357889999999999999999999885
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=249.78 Aligned_cols=146 Identities=26% Similarity=0.460 Sum_probs=111.9
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
+|.|||+. +|+|+||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||
T Consensus 157 ~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 157 GMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp HHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 58999998 9999999999999999999999999999876543332 2233457789999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|+|++ |+.||....... .....+.. .. .+..+. .....+.+++.+||+.||.+|||+.|+
T Consensus 234 G~il~ellt~g~~p~~~~~~~~--~~~~~~~~----~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~el 298 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDS--KFYKMIKE----GF-----RMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQI 298 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSH--HHHHHHHH----TC-----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhCCCCCCCcccchh--HHHHHhcc----CC-----CCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 999999999 999997543321 11111111 10 011111 122368889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 299 l~~L~~ 304 (313)
T 1t46_A 299 VQLIEK 304 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=250.79 Aligned_cols=196 Identities=21% Similarity=0.297 Sum_probs=133.0
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------- 183 (408)
.+.....++|...+.||+|+||.||+|+.. +++.||||++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 455667789999999999999999999975 5899999976
Q ss_pred ------------------------------------------hhhhHHHhh--hCCCCceeeeccccCceEeCC-CCceE
Q 015360 184 ------------------------------------------LNNRLAYLH--EGLEPKVVHRDVKSSNILLDR-QWNAR 218 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH--~~~~~~ivH~dlk~~Nill~~-~~~~k 218 (408)
+..+|.||| +. +|+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence 233489999 76 9999999999999986 89999
Q ss_pred EeccCCceeecCCCcceecccccccCcccccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHH
Q 015360 219 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 219 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ....+...
T Consensus 173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~ 247 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRV 247 (360)
T ss_dssp ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH
T ss_pred EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHH
Confidence 999999987644332 23356899999999986644 8999999999999999999999997543221 11111111
Q ss_pred hcCC------------CcccccCCC-C-----CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 298 VGSR------------KSEEVVDPK-L-----PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 298 ~~~~------------~~~~~~d~~-~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.... ......+.. . ...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110 000000000 0 000011134578899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=252.62 Aligned_cols=199 Identities=26% Similarity=0.340 Sum_probs=141.2
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------- 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------- 183 (408)
..+.++....++|...+.||+|+||.||+|...++..||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4578899999999999999999999999999888999999965
Q ss_pred ---------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC
Q 015360 184 ---------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD 212 (408)
Q Consensus 184 ---------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~ 212 (408)
++.+|.|||+. +|+|+||||+|||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 23349999999 999999999999999
Q ss_pred CCCceEEeccCCceeecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 015360 213 RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291 (408)
Q Consensus 213 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 291 (408)
.++.+||+|||++........ .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~ 243 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQL 243 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred CCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 999999999999975433222 233568899999999876 67899999999999999999999999754321 111
Q ss_pred HHHHHHhcCCCcc-----------cccCCCC---CCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 292 DWLKTMVGSRKSE-----------EVVDPKL---PKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 292 ~~~~~~~~~~~~~-----------~~~d~~~---~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..+.......... ....... +.... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111111100 0000000 00000 1113468899999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=245.62 Aligned_cols=149 Identities=28% Similarity=0.445 Sum_probs=110.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc---ceecccccccCcccccccccCCCCccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPEYACTGMLNEKS 260 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~s 260 (408)
++.+|+|||+. +++|+||||+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++
T Consensus 133 i~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 209 (298)
T 3pls_A 133 VARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKS 209 (298)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHH
T ss_pred HHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhh
Confidence 34559999999 999999999999999999999999999976533221 112334578899999999999999999
Q ss_pred cchhhHHHHHHHHhCCCC-CCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC
Q 015360 261 DVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 261 DvwSlGvvl~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
|||||||++|+|++|..| |..... ......+. .... ...+. .....+.+++.+||+.||.+||
T Consensus 210 Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~---~~~~------~~~~~----~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 210 DVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLA---QGRR------LPQPE----YCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHH---TTCC------CCCCT----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred chhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhh---cCCC------CCCCc----cchHHHHHHHHHHccCChhhCc
Confidence 999999999999996555 432221 12222111 1110 01111 1123688899999999999999
Q ss_pred CHhHHHHHHhcC
Q 015360 340 KMGHVIHMLEAD 351 (408)
Q Consensus 340 s~~evl~~Le~~ 351 (408)
|+.++++.|+..
T Consensus 274 s~~~ll~~l~~~ 285 (298)
T 3pls_A 274 TFRVLVGEVEQI 285 (298)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=272.06 Aligned_cols=177 Identities=23% Similarity=0.358 Sum_probs=138.9
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...++||+|+||.||++... +++.||||.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999975 4788999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 34459999999 9999999999999999999999999999864322
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+......... ..+
T Consensus 496 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~-------~~~ 561 (674)
T 3pfq_A 496 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN-------VAY 561 (674)
T ss_dssp TC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSC-------CCC
T ss_pred Cc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC-------CCC
Confidence 22 23446799999999999999999999999999999999999999975322 12222222211 111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCH-----hHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKM-----GHVIH 346 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~ 346 (408)
+.. ....+.+|+.+||+.||++||++ +||++
T Consensus 562 p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 PKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred Ccc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 22367889999999999999998 56654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=248.43 Aligned_cols=190 Identities=21% Similarity=0.307 Sum_probs=137.8
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|.. .+++.||||.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 5688889999999999999986 46899999987
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCCCcceeccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
++.+|+|||+. +|+||||||+|||++.++ .+||+|||++........ ....
T Consensus 116 ~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 190 (330)
T 3nsz_A 116 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVR 190 (330)
T ss_dssp CCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSC
T ss_pred CchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccc
Confidence 34569999999 999999999999998766 899999999987644332 2335
Q ss_pred ccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC---------CC-------
Q 015360 240 MGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---------RK------- 302 (408)
Q Consensus 240 ~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~------- 302 (408)
.++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ..+.. +...... ..
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVR-IAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHH-HHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHH-HHHhcCCchhhhHHHHhccccccch
Confidence 68899999999877 678999999999999999999999995432211 01111 0000000 00
Q ss_pred -------cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 -------SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 -------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....................+.+|+.+||+.||++|||++|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000001111111233568899999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=252.95 Aligned_cols=194 Identities=20% Similarity=0.254 Sum_probs=145.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||+|+||+||+|.... ++.||||.+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 457788999999999999999764 899999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEe----CCCCceEEeccCCcee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kL~Dfg~a~~ 227 (408)
++.+|+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 34459999999 99999999999999 7778899999999987
Q ss_pred ecCCCcceecccccccCccccccccc--------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACT--------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 299 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 299 (408)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.+.....
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~ 241 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT 241 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc
Confidence 644322 233568999999999865 56788999999999999999999999754332211 122222222
Q ss_pred CCCcc---cc----------c-CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 300 SRKSE---EV----------V-DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 300 ~~~~~---~~----------~-d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
..... .. . +..............+.+++.+||+.||++||++.|+++.++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 21110 00 0 01111223355667788999999999999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=244.14 Aligned_cols=185 Identities=28% Similarity=0.458 Sum_probs=130.6
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999996 46899999976
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 33459999999 999999999999999999999999999876543
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ..... .
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~~~-----~ 257 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-QCDYP-----P 257 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHH-TTCSC-----C
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhh-cccCC-----C
Confidence 222 12335689999999999999999999999999999999999999964322 1222222221 11111 1
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
.. .......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 258 ~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 258 LP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11 1112236788999999999999999999999998743
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-31 Score=256.42 Aligned_cols=130 Identities=16% Similarity=0.175 Sum_probs=100.9
Q ss_pred HHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccC-----------CC
Q 015360 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-----------ML 256 (408)
Q Consensus 188 L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~ 256 (408)
|+|||+. +|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .+
T Consensus 219 L~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~ 290 (377)
T 3byv_A 219 LASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM 290 (377)
T ss_dssp HHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred HHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccC
Confidence 8999998 999999999999999999999999999986322 2234557 999999999887 89
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCC
Q 015360 257 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 336 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 336 (408)
+.++|||||||++|||++|+.||.......... .+.. .... . ...+.+|+.+||+.||+
T Consensus 291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------~~~~-~~~~-~----~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------------WIFR-SCKN-I----PQPVRALLEGFLRYPKE 349 (377)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCC------CCSG---------------GGGS-SCCC-C----CHHHHHHHHHHTCSSGG
T ss_pred ChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------------hhhh-hccC-C----CHHHHHHHHHHcCCCch
Confidence 999999999999999999999997543322111 1111 1111 1 23678899999999999
Q ss_pred CCCCHhHHHH
Q 015360 337 KRPKMGHVIH 346 (408)
Q Consensus 337 ~Rps~~evl~ 346 (408)
+|||+.|+++
T Consensus 350 ~Rpt~~e~l~ 359 (377)
T 3byv_A 350 DRLLPLQAME 359 (377)
T ss_dssp GCCCHHHHHT
T ss_pred hCCCHHHHhh
Confidence 9999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=250.20 Aligned_cols=187 Identities=25% Similarity=0.380 Sum_probs=133.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||.||+|... +|+.||||++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888899999999999999974 5899999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 33459999999 999999999999999999999999999987543
Q ss_pred CCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc------
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS------ 303 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------ 303 (408)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.........
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHTC
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHh
Confidence 2 233568999999999877 67999999999999999999999999754321 111111111111000
Q ss_pred ------------ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 ------------EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.......+.. ........+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 001123467889999999999999999999884
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=244.32 Aligned_cols=182 Identities=32% Similarity=0.516 Sum_probs=135.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCCC----cEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDG----TKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~----~~vavK~~------------------------------------------- 183 (408)
..|...++||+|+||+||+|.+.+. ..+|||.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 3577778999999999999996432 35899976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 34559999999 9999999999999999999999999999866433
Q ss_pred Ccc---eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 232 RSY---VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 232 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||....... ..... .....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~---~~~~~----- 250 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGRR----- 250 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHH---HTTCC-----
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH---hcCCC-----
Confidence 221 1233457789999999999999999999999999999999 566665433221 11111 11110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...+.. ....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 251 -~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 -LLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001111 123588899999999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=245.61 Aligned_cols=187 Identities=22% Similarity=0.332 Sum_probs=139.1
Q ss_pred cCCCccceeccCCcEEEEEEEe--CCCcEEEEEEe---------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL--SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~--~~~~~vavK~~--------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 5788889999999999999986 35889999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-----------------
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR----------------- 213 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~----------------- 213 (408)
++.+|+|||+. +|+||||||+|||++.
T Consensus 94 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 94 IVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 34459999999 9999999999999987
Q ss_pred --CCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 015360 214 --QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291 (408)
Q Consensus 214 --~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 291 (408)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~ 243 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HL 243 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HH
T ss_pred ccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HH
Confidence 668999999999864332 223568999999999999999999999999999999999999997543221 11
Q ss_pred HHHHHHhcCCCc--------cccc-C--CCCC-------------------CCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 292 DWLKTMVGSRKS--------EEVV-D--PKLP-------------------KMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 292 ~~~~~~~~~~~~--------~~~~-d--~~~~-------------------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
..+......... .... . .... ..........+.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111111111000 0000 0 0000 01122345678899999999999999999
Q ss_pred hHHHHH
Q 015360 342 GHVIHM 347 (408)
Q Consensus 342 ~evl~~ 347 (408)
.|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=264.56 Aligned_cols=180 Identities=25% Similarity=0.365 Sum_probs=140.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...++||+|+||.||+++.. +|+.||||.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 5899999987
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 34459999999 9999999999999999999999999999876443
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .. ...+
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~-~~------~~~~ 408 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVK-EV------PEEY 408 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHH-HC------CCCC
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhh-cc------cccC
Confidence 32 233579999999999999899999999999999999999999997654322211 1111111 11 0111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
+.. ....+.+|+.+||+.||.+|| ++.||+++
T Consensus 409 p~~----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 SER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred Ccc----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111 123678899999999999999 67888764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=250.64 Aligned_cols=193 Identities=25% Similarity=0.400 Sum_probs=140.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888999999999999999865 5888999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 34459999999 99999999999999999999999999998764332
Q ss_pred cce--ecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc---
Q 015360 233 SYV--TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV--- 306 (408)
Q Consensus 233 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 306 (408)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+............
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHHTC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHh
Confidence 211 234578999999998654 558999999999999999999999997544322 22222111111100000
Q ss_pred --------c--CCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 307 --------V--DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 307 --------~--d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
. .+....... ......+.+|+.+||+.||++|||+.|+++.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 000000000 11124678999999999999999999998743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=248.08 Aligned_cols=188 Identities=27% Similarity=0.427 Sum_probs=136.9
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe-------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~------------------------------------- 183 (408)
++....++|...+.||+|+||.||+|.+.. +..||||.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334455778888999999999999998643 458999976
Q ss_pred ------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC
Q 015360 184 ------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW 215 (408)
Q Consensus 184 ------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~ 215 (408)
++.+|.|||+. +|+|+||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 23459999998 999999999999999999
Q ss_pred ceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHH
Q 015360 216 NARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDW 293 (408)
Q Consensus 216 ~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 293 (408)
.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH
Confidence 9999999999866433221 1223456789999999999999999999999999999999 89998754322 11111
Q ss_pred HHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 294 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 294 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...... +.. .......+.+++.+||+.||++|||+.++++.|+..
T Consensus 262 ---~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 262 ---LLHGHR------LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp ---HHTTCC------CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHcCCC------CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 111 112224688899999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-31 Score=247.04 Aligned_cols=184 Identities=30% Similarity=0.425 Sum_probs=140.7
Q ss_pred HhcCCCccc-eeccCCcEEEEEEEeC---CCcEEEEEEe-----------------------------------------
Q 015360 149 ATSGLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~-~lg~G~~g~Vy~g~~~---~~~~vavK~~----------------------------------------- 183 (408)
..++|...+ .||+|+||.||+|.+. .+..||||.+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 345677777 9999999999999653 3678999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 34459999999 9999999999999999999999999999876544
Q ss_pred Cccee--cccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 232 RSYVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 232 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
..... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .......
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~----- 238 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGER----- 238 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCC-----
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC-----
Confidence 33221 22345688999999998889999999999999999999 99999753321 1111 1111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+..+. .....+.+++.+||+.||++|||+.+|++.|+..
T Consensus 239 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 MGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 1223688899999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-31 Score=250.40 Aligned_cols=188 Identities=26% Similarity=0.389 Sum_probs=142.8
Q ss_pred cCCCccceeccCCcEEEEEEEe-----CCCcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-----~~~~~vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||.||++.+ .+++.||||.+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999995 35889999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|+|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 34459999998 999999999999999999999999999987654
Q ss_pred CCcc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCC---------CcchhHHHHHHHhc
Q 015360 231 ERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ---------GEVNLVDWLKTMVG 299 (408)
Q Consensus 231 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~ 299 (408)
.... ......+|..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....... +.....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH-HHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH-HHHHhh
Confidence 3322 123345788899999999989999999999999999999999998532210 0001111 111111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... ...........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 259 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 259 EGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred ccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111122234688899999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-31 Score=253.12 Aligned_cols=190 Identities=26% Similarity=0.416 Sum_probs=134.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.... ++.||||.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 468888999999999999999764 899999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++........ .
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-c
Confidence 34459999999 999999999999999999999999999976543322 2
Q ss_pred ecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc------------CCC
Q 015360 236 TTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG------------SRK 302 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------~~~ 302 (408)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ....+..... ...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhhhHhhhccc
Confidence 2335689999999999775 78999999999999999999999997543221 1111111100 000
Q ss_pred cccccCCCCCCCCc-----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 SEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+..... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01111111111111 1123568899999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=242.19 Aligned_cols=176 Identities=23% Similarity=0.331 Sum_probs=136.2
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+.+ ++.+|||.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999985 899999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCc--eeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~--ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. + ++|+||||+||+++.++.++|+|||+......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 34459999997 7 99999999999999999999998887654221
Q ss_pred CCcceecccccccCcccccccccCCCCc---cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNE---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
....+|+.|+|||.+.+..++. ++|||||||++|||++|+.||..... ............
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~----- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGL----- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCC-----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCC-----
Confidence 2345889999999998765554 79999999999999999999964321 111111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+.++.. ....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 229 ~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 RPTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111111 223688899999999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=270.19 Aligned_cols=175 Identities=27% Similarity=0.448 Sum_probs=132.8
Q ss_pred eeccCCcEEEEEEEeC---CCcEEEEEEe---------------------------------------------------
Q 015360 158 VIGEGGYGIVYRGILS---DGTKVAVKNL--------------------------------------------------- 183 (408)
Q Consensus 158 ~lg~G~~g~Vy~g~~~---~~~~vavK~~--------------------------------------------------- 183 (408)
.||+|+||.||+|.+. ++..||||.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999874 4667999987
Q ss_pred ----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee--ccc
Q 015360 184 ----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRV 239 (408)
Q Consensus 184 ----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~ 239 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++.......... ...
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 34569999999 999999999999999999999999999987643322211 223
Q ss_pred ccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
.+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+ ..+.. ...+ ..
T Consensus 500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i----~~~~~-----~~~p----~~ 563 (613)
T 2ozo_A 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQGKR-----MECP----PE 563 (613)
T ss_dssp --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHH----HTTCC-----CCCC----TT
T ss_pred CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCC-----CCCC----Cc
Confidence 35689999999999999999999999999999998 99999754432 122211 11111 1111 12
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
....+.+|+.+||+.||++||++.+|++.|+..
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 234688899999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=249.50 Aligned_cols=148 Identities=26% Similarity=0.419 Sum_probs=112.5
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYS 264 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 264 (408)
.+|.|||+. +|+|+||||+|||++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||
T Consensus 168 ~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 244 (334)
T 2pvf_A 168 RGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244 (334)
T ss_dssp HHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHH
Confidence 348999998 99999999999999999999999999998765433221 22345678899999999888999999999
Q ss_pred hHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhH
Q 015360 265 FGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343 (408)
Q Consensus 265 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 343 (408)
|||++|||++ |+.||...... .+. ....... . +..+. .....+.+++.+||+.||.+|||+.|
T Consensus 245 lG~il~ellt~g~~p~~~~~~~---~~~---~~~~~~~-~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 245 FGVLMWEIFTLGGSPYPGIPVE---ELF---KLLKEGH-R-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHH---HHH---HHHHHTC-C-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhCCCCCcCcCCHH---HHH---HHHhcCC-C-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999 99999643211 111 1111111 0 11111 12236888999999999999999999
Q ss_pred HHHHHhcCC
Q 015360 344 VIHMLEADD 352 (408)
Q Consensus 344 vl~~Le~~~ 352 (408)
+++.|+...
T Consensus 309 ll~~L~~l~ 317 (334)
T 2pvf_A 309 LVEDLDRIL 317 (334)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=248.60 Aligned_cols=182 Identities=29% Similarity=0.503 Sum_probs=132.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-----CcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-----~~~vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||.||+|.+.. +..||||.+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667999999999999998753 235999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 34459999999 9999999999999999999999999999876433
Q ss_pred Ccc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 232 RSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 232 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~~------ 268 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFR------ 268 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCCCc------
Confidence 221 1122345778999999999999999999999999999999 9999964322 111111111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
..... .....+.+++.+||+.||++||++.||++.|+..
T Consensus 269 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 LPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 1223678899999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=245.40 Aligned_cols=187 Identities=23% Similarity=0.324 Sum_probs=137.5
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++.. .+++.||||.+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999997 56899999976
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 34459999999 9999999999999999999999999998764
Q ss_pred cCCCcc--------eecccccccCcccccccccCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHH
Q 015360 229 CSERSY--------VTTRVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297 (408)
Q Consensus 229 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 297 (408)
...... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||........ .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~-- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQ-- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhh--
Confidence 321110 012234789999999987554 68899999999999999999999953211111 1111111
Q ss_pred hcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCCc
Q 015360 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 353 (408)
Q Consensus 298 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~~ 353 (408)
.. . ..+. .......+.+++.+||+.||.+|||+.||++.|+....
T Consensus 262 --~~-~---~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 --NQ-L---SIPQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --CC------CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --cc-C---CCCc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 10 0 0011 11122368889999999999999999999999998543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=252.64 Aligned_cols=192 Identities=20% Similarity=0.266 Sum_probs=136.3
Q ss_pred cCCCccceeccC--CcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 151 SGLCEENVIGEG--GYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G--~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
++|...+.||+| +||.||+|+.. +++.||||.+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 468888999999 99999999986 5899999987
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 34459999999 9999999999999999999999999988654322
Q ss_pred Cc------ceecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc----
Q 015360 232 RS------YVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG---- 299 (408)
Q Consensus 232 ~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---- 299 (408)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcccc
Confidence 11 11123468899999999987 57899999999999999999999999754432211 100000000
Q ss_pred CC------------------Cccccc---CC-----CC-CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 300 SR------------------KSEEVV---DP-----KL-PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 300 ~~------------------~~~~~~---d~-----~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. ...... .+ .. ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000000 00 00 000111223468889999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=239.77 Aligned_cols=180 Identities=28% Similarity=0.417 Sum_probs=138.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56888999999999999999975 5899999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ce
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~ 235 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 34459999998 999999999999999999999999999986543221 11
Q ss_pred ecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ .+..+. ..... ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~---------~~ 229 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---------LN 229 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCTT---------ST
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcccc---------cC
Confidence 234568999999999987665 7789999999999999999999975443211 111111 11100 00
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 111223367889999999999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=249.49 Aligned_cols=190 Identities=24% Similarity=0.271 Sum_probs=131.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 67889999999999999999864 5889999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 33459999999 99999999999999999999999999998654321
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH----------------
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT---------------- 296 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~---------------- 296 (408)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 182 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHHTTSCHH
T ss_pred --ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhhH
Confidence 2234568999999999999999999999999999999999999997543211 1000000
Q ss_pred ---HhcCCCc------ccccC-CCCCCCC--cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 297 ---MVGSRKS------EEVVD-PKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 297 ---~~~~~~~------~~~~d-~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
....... ..... ...+... .......+.+|+.+||+.||++|||++|+++.-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000 00000 0000000 112356788999999999999999999998843
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=252.81 Aligned_cols=194 Identities=22% Similarity=0.329 Sum_probs=124.5
Q ss_pred CCCc-cceeccCCcEEEEEEEeC---CCcEEEEEEe--------------------------------------------
Q 015360 152 GLCE-ENVIGEGGYGIVYRGILS---DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 152 ~f~~-~~~lg~G~~g~Vy~g~~~---~~~~vavK~~-------------------------------------------- 183 (408)
.|.. .++||+|+||+||+|... ++..||||.+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 3544 458999999999999976 4789999976
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEe----CCCCceEEeccC
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFG 223 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kL~Dfg 223 (408)
++.+|.|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 101 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 101 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp CCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred CCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 34459999999 99999999999999 677899999999
Q ss_pred CceeecCCCc--ceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCC------cchhHHHH
Q 015360 224 LAKLLCSERS--YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQG------EVNLVDWL 294 (408)
Q Consensus 224 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~------~~~~~~~~ 294 (408)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .......+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 9987643221 122346789999999999874 58999999999999999999999997543211 01111112
Q ss_pred HHHhcCCCcccccC----------------CCCCCCCcHH--------HHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 295 KTMVGSRKSEEVVD----------------PKLPKMPASK--------ALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 295 ~~~~~~~~~~~~~d----------------~~~~~~~~~~--------~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...+.......+.+ .......... ....+.+|+.+||+.||.+|||+.|+++.-
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 11111111000000 0000000000 023578899999999999999999998843
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=244.98 Aligned_cols=179 Identities=29% Similarity=0.449 Sum_probs=127.5
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||+||++.. .+++.||||.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999997 46899999977
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. .+|+|+||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 34459999984 28999999999999999999999999999766433
Q ss_pred CcceecccccccCccccccc----ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 232 RSYVTTRVMGTFGYVAPEYA----CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
.. .....||+.|+|||.+ .+..++.++|||||||++|+|++|+.||..... ... .+........
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~-~~~~~~~~~~----- 231 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQ-QLKQVVEEPS----- 231 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHH-HHHHHHHSCC-----
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHH-HHHHHhccCC-----
Confidence 22 2234689999999996 556789999999999999999999999964321 111 1111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
+... .......+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -PQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 1112236788999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=258.72 Aligned_cols=174 Identities=27% Similarity=0.439 Sum_probs=137.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|+.. +|+.||||.+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999975 6899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 34459999998 999999999999999999999999999987644322
Q ss_pred eecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ......... .. ..+.
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~-~~------~~p~ 237 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDG-IF------YTPQ 237 (476)
T ss_dssp -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTT-CC------CCCT
T ss_pred -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcC-Cc------CCCc
Confidence 234569999999999988765 68999999999999999999999743321 112222111 10 1111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. ...+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 238 YL----NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cC----CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11 235788999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=250.40 Aligned_cols=190 Identities=22% Similarity=0.281 Sum_probs=131.4
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||+||+|... +++.||||.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 467999999999999999999854 5889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEe-----CCCCceEEeccCCceeecC
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill-----~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 113 e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 113 EYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp ECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 34559999999 99999999999999 4455699999999976543
Q ss_pred CCcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccc----
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE---- 305 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---- 305 (408)
... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...........
T Consensus 190 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 190 PIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSTTG
T ss_pred ccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchhhhhhh
Confidence 222 22335679999999999874 4899999999999999999999999753321 11111111111100000
Q ss_pred -----c--cCCCCCCCCcHH-----HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 306 -----V--VDPKLPKMPASK-----ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 306 -----~--~d~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. ..+......... ....+.+|+.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 000111111111 2246789999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=251.91 Aligned_cols=152 Identities=19% Similarity=0.267 Sum_probs=106.9
Q ss_pred hHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCCceeecCCCcceecccccccCcccccccccC-CCCccccchh
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYS 264 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS 264 (408)
+|.|||+. +|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||
T Consensus 153 aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 153 AVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 48999998 999999999999997 688999999999987644332 2335689999999998765 4899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC----------cccccCCCCCCCC-----cHHHHHHHHHHHHh
Q 015360 265 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK----------SEEVVDPKLPKMP-----ASKALKRVLLVALR 329 (408)
Q Consensus 265 lGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~d~~~~~~~-----~~~~~~~l~~l~~~ 329 (408)
|||++|||++|+.||...... .....+........ .....-+...... .......+.+|+.+
T Consensus 228 lG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 999999999999999754321 11111111111110 0111111111110 11123458899999
Q ss_pred ccCcCCCCCCCHhHHHH
Q 015360 330 CVDPDATKRPKMGHVIH 346 (408)
Q Consensus 330 cl~~dP~~Rps~~evl~ 346 (408)
||+.||++|||+.|+++
T Consensus 305 ~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HCCSSGGGSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=245.19 Aligned_cols=185 Identities=25% Similarity=0.417 Sum_probs=139.9
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------- 183 (408)
.......++|...+.||+|+||.||+|... +|+.||||.+
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344455678999999999999999999985 6999999975
Q ss_pred ------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEec
Q 015360 184 ------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 221 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~D 221 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence 23349999998 999999999999999999999999
Q ss_pred cCCceeecCCCcceecccccccCccccccccc------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 015360 222 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACT------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295 (408)
Q Consensus 222 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 295 (408)
||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ... ..
T Consensus 244 fG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~---~~ 315 (365)
T 2y7j_A 244 FGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM---LR 315 (365)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HH
T ss_pred cCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH---HH
Confidence 999987654322 234568999999999863 3588899999999999999999999964321 111 11
Q ss_pred HHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
...... .. ...+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 316 ~i~~~~-~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQ-YQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTC-CC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCC-CC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111110 00 000000 011235888999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=252.84 Aligned_cols=126 Identities=30% Similarity=0.467 Sum_probs=103.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 57888999999999999999965 4788999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 34459999999 9999999999999999999999999999876433
Q ss_pred Ccc---------------------eecccccccCccccccc-ccCCCCccccchhhHHHHHHHHhCCCCC
Q 015360 232 RSY---------------------VTTRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITGRNPV 279 (408)
Q Consensus 232 ~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltG~~Pf 279 (408)
... ......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 211 12456789999999986 5567999999999999999999865544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=241.13 Aligned_cols=179 Identities=21% Similarity=0.285 Sum_probs=138.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||++... +++.||||.+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 56888999999999999999975 5889999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----ceEEeccCCcee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAKL 227 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +|+|+||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 34459999999 999999999999998887 799999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... .+..........
T Consensus 169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~----- 235 (321)
T 2a2a_A 169 IEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSY----- 235 (321)
T ss_dssp CCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC-----
T ss_pred cCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc-----
Confidence 654322 2335689999999999999999999999999999999999999964321 111111111100
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.............+.+|+.+||+.||++|||+.|+++.
T Consensus 236 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 --DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000001112367889999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=247.22 Aligned_cols=175 Identities=19% Similarity=0.304 Sum_probs=129.5
Q ss_pred ccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------------
Q 015360 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------------- 183 (408)
Q Consensus 155 ~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------------- 183 (408)
..++||+|+||.||+|... +++.||||.+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999964 5899999986
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEe--CCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill--~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.+|.|||+. +|+||||||+|||+ +.++.+||+|||++........ ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 34559999999 99999999999999 5678899999999987644332 223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+......... +.......
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~-------~~~~~~~~ 314 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD-------LEDEEFQD 314 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC-------SCSGGGTT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC-------CChhhhcc
Confidence 46899999999999889999999999999999999999999743321 112222211100 00000111
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+.+|+.+||+.||.+|||+.|+++.
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22468889999999999999999999883
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=245.14 Aligned_cols=140 Identities=23% Similarity=0.397 Sum_probs=105.1
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-----------ceecccccccCcccccccccCC
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-----------YVTTRVMGTFGYVAPEYACTGM 255 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~ 255 (408)
+|+|||+. +|+||||||+|||++.++.+||+|||++........ .......||+.|+|||.+.+..
T Consensus 176 aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 252 (332)
T 3qd2_B 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252 (332)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC
T ss_pred HHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC
Confidence 48999998 999999999999999999999999999987654321 1123356899999999999999
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCC
Q 015360 256 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA 335 (408)
Q Consensus 256 ~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP 335 (408)
++.++|||||||++|||++|..|+. .......... .. .. ..........+.+|+.+||+.||
T Consensus 253 ~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~-~~--------~~-~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 253 YSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVR-NL--------KF-PLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp CCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHH-TT--------CC-CHHHHHHCHHHHHHHHHHHCSSG
T ss_pred CcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhh-cc--------CC-CcccccCChhHHHHHHHHccCCC
Confidence 9999999999999999999877642 1111111111 11 11 11122334567889999999999
Q ss_pred CCCCCHhHHHHH
Q 015360 336 TKRPKMGHVIHM 347 (408)
Q Consensus 336 ~~Rps~~evl~~ 347 (408)
++|||+.|+++.
T Consensus 315 ~~Rps~~~~l~~ 326 (332)
T 3qd2_B 315 TERPEATDIIEN 326 (332)
T ss_dssp GGSCCHHHHHHS
T ss_pred CcCCCHHHHhhc
Confidence 999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=248.00 Aligned_cols=183 Identities=22% Similarity=0.315 Sum_probs=135.7
Q ss_pred HHHhcCCCcc-ceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------
Q 015360 147 EAATSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 147 ~~~t~~f~~~-~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------- 183 (408)
+...+.|... +.||+|+||.||+|... +++.||||.+
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3444556665 88999999999999976 4899999976
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCC
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 224 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~ 224 (408)
+..+|+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 34459999999 9999999999999987 78999999999
Q ss_pred ceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .. ........
T Consensus 181 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~--- 249 (327)
T 3lm5_A 181 SRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ET---YLNISQVN--- 249 (327)
T ss_dssp CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHTC---
T ss_pred ccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HH---HHHHHhcc---
Confidence 987643322 23356899999999999999999999999999999999999999643321 11 11111100
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..............+.+|+.+||+.||++|||++|+++.
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 ----VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 001111111223467889999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=250.24 Aligned_cols=185 Identities=28% Similarity=0.444 Sum_probs=141.6
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC------CcEEEEEEe---------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~------~~~vavK~~--------------------------------------- 183 (408)
..++|...+.||+|+||.||+|.... ...||||.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34678889999999999999999643 247999976
Q ss_pred -------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC
Q 015360 184 -------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ 214 (408)
Q Consensus 184 -------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~ 214 (408)
++.+|.|||+. +|+|+||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 22358999998 99999999999999999
Q ss_pred CceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 015360 215 WNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVD 292 (408)
Q Consensus 215 ~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~ 292 (408)
+.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence 99999999999865433322 2233456789999999999999999999999999999999 999997543321 1111
Q ss_pred HHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 293 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 293 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+.. .. ....+.. ....+.+++.+||+.||.+|||+.||++.|+..
T Consensus 279 ~~~~----~~-----~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LVKD----GY-----QMAQPAF----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHH----TC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc----CC-----CCCCCCC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111 10 0111111 123678899999999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=246.34 Aligned_cols=189 Identities=22% Similarity=0.363 Sum_probs=141.5
Q ss_pred cCCCccceeccCCcEEEEEEEe-----CCCcEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-----~~~~~vavK~~------------------------------------------ 183 (408)
++|...+.||+|+||.||++.+ .+++.||||.+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4677889999999999999984 35889999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 34459999998 999999999999999999999999999987654
Q ss_pred CCcce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC---------CCCcchhHHHHHHHhc
Q 015360 231 ERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR---------PQGEVNLVDWLKTMVG 299 (408)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~---------~~~~~~~~~~~~~~~~ 299 (408)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..||.... ..........+...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 43321 223446778999999998889999999999999999999999875321 0000001111111111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.... ... .......+.+++.+||+.||++|||+.||++.|+..
T Consensus 278 ~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 278 NNGR-----LPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp TTCC-----CCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC-----CCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 011 112234688899999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=259.39 Aligned_cols=174 Identities=26% Similarity=0.385 Sum_probs=136.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||.||+++.. +|+.||||.+
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999985 5899999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 33459999999 999999999999999999999999999987644
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ ..
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-------~~ 411 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-------VT 411 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC-------CC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc-------cC
Confidence 332 22335799999999999999999999999999999999999999976543221 111222221111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
++.. ....+.+|+.+||+.||++||++
T Consensus 412 ~p~~----~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 YPDK----FSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCcc----cCHHHHHHHHHhccCCHhHCCCC
Confidence 1111 22367889999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=245.29 Aligned_cols=186 Identities=23% Similarity=0.319 Sum_probs=137.9
Q ss_pred cCCCccceeccCCcEEEEEEEeCC--CcEEEEEEe---------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD--GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~--~~~vavK~~--------------------------------------------- 183 (408)
++|...+.||+|+||+||+|.... ++.||||.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 578889999999999999999643 368999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEe-------------------
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL------------------- 211 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill------------------- 211 (408)
++.+|.|||+. +|+||||||+|||+
T Consensus 99 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 99 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccc
Confidence 34459999998 99999999999999
Q ss_pred CCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 015360 212 DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 291 (408)
Q Consensus 212 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 291 (408)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~ 248 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR---EHL 248 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred cCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 567889999999998643322 3356899999999999999999999999999999999999999754322 111
Q ss_pred HHHHHHhcCCCc--------cc-ccCC--CC-------------------CCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 292 DWLKTMVGSRKS--------EE-VVDP--KL-------------------PKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 292 ~~~~~~~~~~~~--------~~-~~d~--~~-------------------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
..+......... .. .... .. ...........+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 112111111000 00 0000 00 001122334578899999999999999999
Q ss_pred hHHHH
Q 015360 342 GHVIH 346 (408)
Q Consensus 342 ~evl~ 346 (408)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=254.11 Aligned_cols=183 Identities=25% Similarity=0.374 Sum_probs=132.1
Q ss_pred HHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------
Q 015360 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 148 ~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------- 183 (408)
...++|...+.||+|+||+||+|... +++.||||.+
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 44688999999999999999999875 4789999975
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC---CceEEeccCC
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGL 224 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kL~Dfg~ 224 (408)
++.+|+|||+. +|+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 33459999999 99999999999999654 4599999999
Q ss_pred ceeecCCCcceecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 301 (408)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+...+. ..
T Consensus 289 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~----~~ 360 (419)
T 3i6u_A 289 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT----SG 360 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH----TT
T ss_pred ceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh----cC
Confidence 98764322 2234668999999999853 568889999999999999999999997543322 1221111 11
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
... ............+.+|+.+||+.||++|||+.|+++.
T Consensus 361 ~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 100 0000001123468899999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=252.08 Aligned_cols=189 Identities=26% Similarity=0.419 Sum_probs=126.6
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +|+.||||++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367889999999999999999854 5899999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 33459999998 999999999999999999999999999976533
Q ss_pred CCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc-----
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE----- 304 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (408)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+..........
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHTTC
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHh
Confidence 2 233568999999999876 67899999999999999999999999754321 1112122211111000
Q ss_pred ------cccC--CCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 305 ------EVVD--PKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 305 ------~~~d--~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
.++. +..+..... .....+.+|+.+||+.||++|||+.|+++.-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0000 000110000 1124678899999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=246.92 Aligned_cols=188 Identities=27% Similarity=0.405 Sum_probs=135.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999865 5899999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 33459999999 9999999999999999999999999999765332
Q ss_pred CcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC--
Q 015360 232 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD-- 308 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 308 (408)
.....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+........ .+...
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~~ 269 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPG-TEFVQKL 269 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC-HHHHTTC
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCc-HHHHHHh
Confidence 233568999999999877 67899999999999999999999999753321 11111111111000 00000
Q ss_pred ------------CCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 309 ------------PKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 309 ------------~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
+....... ......+.+|+.+||+.||++|||+.|+++.-
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000000 11234688999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=246.03 Aligned_cols=186 Identities=22% Similarity=0.371 Sum_probs=135.0
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------- 183 (408)
..+....++|...+.||+|+||.||++...+++.||||.+
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3333445678889999999999999999988999999986
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
+..+|.|||+. +|+|+||||+|||+++ +.+||+|||++...
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 34459999999 9999999999999964 78999999999876
Q ss_pred cCCCcc-eecccccccCccccccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 015360 229 CSERSY-VTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 296 (408)
Q Consensus 229 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 296 (408)
...... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~ 251 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA 251 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHH
Confidence 433221 1234568999999999875 4688899999999999999999999964321 1112222
Q ss_pred HhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 297 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 297 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....... ..++... ...+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNHE-----IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTSC-----CCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcccc-----cCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2221111 1111111 2367889999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=242.91 Aligned_cols=190 Identities=26% Similarity=0.345 Sum_probs=140.2
Q ss_pred HhcCCCccceeccCCcEEEEEEEe--CCCcEEEEEEe-------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGIL--SDGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~--~~~~~vavK~~------------------------------------------- 183 (408)
+.++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 45889999976
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
++.+|.|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 33449999999 99999999999999999999999999
Q ss_pred CceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 224 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 224 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
++....... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+.........
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 166 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCG
T ss_pred ccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCc
Confidence 997654322 223356899999999999999999999999999999999999999754321 111222211111100
Q ss_pred ccc----------cCCCCC---CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 304 EEV----------VDPKLP---KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 304 ~~~----------~d~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+ ...... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000000 0001112346788999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-31 Score=245.71 Aligned_cols=183 Identities=25% Similarity=0.407 Sum_probs=133.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCC--Cc--EEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD--GT--KVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~--~~--~vavK~~------------------------------------------- 183 (408)
++|...+.||+|+||+||+|.+.. ++ .||||.+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 568888999999999999998642 33 6899975
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 33459999999 9999999999999999999999999999876443
Q ss_pred Ccce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 232 RSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 232 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..............
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~---- 244 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL---- 244 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC----
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC----
Confidence 3221 223457788999999998889999999999999999999 9999974432 11222222111110
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... ......+.+++.+||+.||++|||+.++++.|+..
T Consensus 245 -~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 245 -PRP----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC----cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 011 11224688899999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=243.64 Aligned_cols=191 Identities=20% Similarity=0.268 Sum_probs=136.0
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+. .+++.||||.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5788899999999999999996 45899999975
Q ss_pred -----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC------CCCc
Q 015360 184 -----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD------RQWN 216 (408)
Q Consensus 184 -----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~------~~~~ 216 (408)
++.+|+|||+.+ +|+||||||+|||++ ..+.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 99 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcce
Confidence 233489999842 899999999999994 4457
Q ss_pred eEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc---hhHHH
Q 015360 217 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV---NLVDW 293 (408)
Q Consensus 217 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~---~~~~~ 293 (408)
+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .....
T Consensus 177 ~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 177 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 999999999876432 22346899999999999999999999999999999999999999754422111 11111
Q ss_pred HHHHhcCCC-------------------cccccCCCC---------CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 294 LKTMVGSRK-------------------SEEVVDPKL---------PKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 294 ~~~~~~~~~-------------------~~~~~d~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
+........ ...+..... ...........+.+|+.+||+.||++|||+.||+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 111111100 000000000 0112345567889999999999999999999998
Q ss_pred HH
Q 015360 346 HM 347 (408)
Q Consensus 346 ~~ 347 (408)
+.
T Consensus 333 ~h 334 (373)
T 1q8y_A 333 NH 334 (373)
T ss_dssp TC
T ss_pred hC
Confidence 73
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=268.96 Aligned_cols=175 Identities=30% Similarity=0.454 Sum_probs=132.5
Q ss_pred ceeccCCcEEEEEEEeC---CCcEEEEEEe--------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILS---DGTKVAVKNL-------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~---~~~~vavK~~-------------------------------------------------- 183 (408)
+.||+|+||.||+|.+. .+..||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999763 3678999987
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc--eecc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTR 238 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~ 238 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 34459999999 9999999999999999999999999999876433221 1223
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ... ..+..... ...+.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~-----~~~p~---- 595 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGER-----MGCPA---- 595 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCC-----CCCCT----
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC-----CCCCC----
Confidence 446788999999999999999999999999999998 99999754321 111 11111111 11111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 123468889999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=237.65 Aligned_cols=176 Identities=26% Similarity=0.385 Sum_probs=129.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||++... ++..+|||.+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999974 4889999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeec
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|+|||+. +|+|+||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 34459999999 99999999999999 456789999999997654
Q ss_pred CCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
.... .....+|+.|+|||.+. ..++.++|||||||++|+|++|+.||...... ...............
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~--- 246 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV--- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC---
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc---
Confidence 3222 23456899999999885 56889999999999999999999999743211 111111111100000
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.... ....+.+|+.+||+.||++|||+.||++
T Consensus 247 ~~~~-----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ECRP-----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC-----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 1235778999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=241.78 Aligned_cols=145 Identities=23% Similarity=0.312 Sum_probs=104.7
Q ss_pred hHHHhhhCCCCceeeeccccCceEeCCCC--ceEEeccCCceeecCCCc---ceecccccccCccccccccc--CCCCcc
Q 015360 187 RLAYLHEGLEPKVVHRDVKSSNILLDRQW--NARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPEYACT--GMLNEK 259 (408)
Q Consensus 187 ~L~yLH~~~~~~ivH~dlk~~Nill~~~~--~~kL~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 259 (408)
+|+|||+. +|+|+||||+|||++.++ .+||+|||++........ .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 58999999 999999999999998766 899999999987543221 12234568999999999875 678899
Q ss_pred ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC
Q 015360 260 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339 (408)
Q Consensus 260 sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 339 (408)
+|||||||++|||++|+.||...... +........... ............+.+|+.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999643321 112222211110 00111111234688899999999999999
Q ss_pred CHhHHHHH
Q 015360 340 KMGHVIHM 347 (408)
Q Consensus 340 s~~evl~~ 347 (408)
|+.|+++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=240.21 Aligned_cols=178 Identities=27% Similarity=0.453 Sum_probs=139.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||.||+|... +++.||||.+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888899999999999999864 5889999986
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.+|.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 177 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 177 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBC
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccC
Confidence 34559999999 999999999999999999999999999987644322 223
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
...+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ....... . .+.+....
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~~-~-----~~~~~~~~-- 243 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KV---LFLIPKN-N-----PPTLEGNY-- 243 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH---HHHHHHS-C-----CCCCCSSC--
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HH---HHHhhcC-C-----CCCCcccc--
Confidence 456899999999999999999999999999999999999999643211 11 1111111 1 11111111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHH
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHML 348 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 348 (408)
...+.+|+.+||+.||++|||+.|+++..
T Consensus 244 --~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 244 --SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp --CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 23578899999999999999999998744
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=246.41 Aligned_cols=183 Identities=23% Similarity=0.308 Sum_probs=116.7
Q ss_pred hcCCCcc-ceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 150 TSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~-~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
.++|... ++||+|+||+||+|... +++.||||.+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 3567774 57999999999999976 5899999986
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCCceeecC
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~a~~~~~ 230 (408)
+..+|.|||+. +|+|+||||+|||++. ++.+||+|||++.....
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 34569999999 9999999999999976 45599999999986543
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ......... ...
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~------~~~ 251 (336)
T 3fhr_A 184 NA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLG------QYG 251 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------C
T ss_pred cc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcc------ccc
Confidence 22 223567999999999988889999999999999999999999996543321100 000000000 001
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+..........+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111223467889999999999999999999983
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=246.35 Aligned_cols=192 Identities=25% Similarity=0.384 Sum_probs=137.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999975 5889999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 34459999999 99999999999999999999999999998764322
Q ss_pred cc---------eecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC
Q 015360 233 SY---------VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302 (408)
Q Consensus 233 ~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 302 (408)
.. ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...... .....+........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGIIGTPH 243 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCc
Confidence 11 1123468999999998764 67899999999999999999999999754321 11111111111110
Q ss_pred cccc------------c--CCCCCCCCc----HHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 SEEV------------V--DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ~~~~------------~--d~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.... . .+....... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0 000000000 1123467889999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=245.43 Aligned_cols=188 Identities=27% Similarity=0.432 Sum_probs=135.8
Q ss_pred eeHHHHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------
Q 015360 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------ 183 (408)
+++.++....++|...+.||+|+||.||+|... +++.||||.+
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 455566667889999999999999999999974 5899999986
Q ss_pred --------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEE
Q 015360 184 --------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219 (408)
Q Consensus 184 --------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL 219 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 33459999999 9999999999999999999999
Q ss_pred eccCCceeecCCCcceecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 015360 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 294 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~ 294 (408)
+|||++........ ......+++.|+|||++. ...++.++|||||||++|+|++|+.||...... ...
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~ 243 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 243 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH
Confidence 99999876543221 123356899999999987 566889999999999999999999999643211 111
Q ss_pred HHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 295 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 295 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...... .. +.... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~-~~-----~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FLIPRN-PA-----PRLKS---KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHS-CC-----CCCSC---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhcC-cc-----ccCCc---cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111 11 11111 1112367889999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=238.86 Aligned_cols=174 Identities=26% Similarity=0.400 Sum_probs=137.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 4778999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 33459999998 99999999999999999999999999987654322
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... +..++..
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~-------~~~~~~~ 234 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNV-------DLKFPPF 234 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTT-------CCCCCTT
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcc-------ccCCCCc
Confidence 2335689999999999999999999999999999999999999964321 1111111111 1111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ...+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 235 L----SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp S----CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred C----CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1 2357889999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=237.80 Aligned_cols=176 Identities=23% Similarity=0.449 Sum_probs=140.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
.+|...+.||+|+||.||+|... +++.||||.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 56888899999999999999986 6899999976
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 167 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFG 167 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcch
Confidence 23449999998 99999999999999999999999999
Q ss_pred CceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 224 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 224 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.. ......... ..
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~~~~~-~~-- 234 (284)
T 2a19_B 168 LVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFFTDLR-DG-- 234 (284)
T ss_dssp TCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHHHHHH-TT--
T ss_pred hheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHHHHhh-cc--
Confidence 9987644322 2335689999999999998999999999999999999999988741 111111111 11
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
.+....+ ..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 235 ------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 ------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111112 25778899999999999999999999998743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=235.05 Aligned_cols=174 Identities=26% Similarity=0.437 Sum_probs=131.8
Q ss_pred CCccceeccCCcEEEEEEEeC-CCcEEEEEEe------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------ 183 (408)
|...+.||+|+||.||+|... ++..||+|.+
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 556678999999999999975 4778999976
Q ss_pred ------------------------------hhhhHHHhhhCCCCc--eeeeccccCceEeC-CCCceEEeccCCceeecC
Q 015360 184 ------------------------------LNNRLAYLHEGLEPK--VVHRDVKSSNILLD-RQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~--ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~~~~ 230 (408)
++.+|.|||+. + |+|+||||+|||++ .++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 34459999998 7 99999999999997 788999999999965433
Q ss_pred CCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. .....||+.|+|||.+. ..++.++|||||||++|+|++|+.||..... ......... ........+
T Consensus 185 ~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~-~~~~~~~~~-- 252 (290)
T 1t4h_A 185 SF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVT-SGVKPASFD-- 252 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHT-TTCCCGGGG--
T ss_pred cc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHh-ccCCccccC--
Confidence 22 23356899999999886 4589999999999999999999999964322 112222211 111111111
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112368889999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=238.50 Aligned_cols=180 Identities=27% Similarity=0.407 Sum_probs=134.5
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~-------------------------------------------- 183 (408)
..+.|...+.||+|+||.||+|.... ++.||||.+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 34678999999999999999999764 899999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 182 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR 182 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence 34559999998 999999999999999999999999999987643322 22
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... .+.+ ...
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------~~~~--~~~ 248 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNP------PPTF--RKP 248 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC------CCCC--SSG
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCC------Cccc--CCc
Confidence 3356899999999999989999999999999999999999999643211 1111111111 0111 011
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112346888999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=233.95 Aligned_cols=178 Identities=21% Similarity=0.289 Sum_probs=135.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.... +..+|+|.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3568889999999999999999764 678999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeecCCCc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|.|||+. +|+|+||||+||++ +.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 34559999999 99999999999999 7888999999999987643332
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||...... ........... ..+.
T Consensus 165 --~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~-------~~~~ 228 (277)
T 3f3z_A 165 --MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTF-------TFPE 228 (277)
T ss_dssp --BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-------CCCH
T ss_pred --hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-------CCCc
Confidence 2335689999999998654 899999999999999999999999643221 11111111100 0000
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000012346888999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=251.94 Aligned_cols=180 Identities=27% Similarity=0.380 Sum_probs=130.7
Q ss_pred CCccceeccCCcEEEEEEEeCCCcEEEEEEe-------------------------------------------------
Q 015360 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------- 183 (408)
Q Consensus 153 f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------- 183 (408)
|...++||+|+||+||.+...+|+.||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~ 96 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQ 96 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHH
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHH
Confidence 4446889999999997666667999999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC-------------CceEEeccC
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-------------WNARVSDFG 223 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~-------------~~~kL~Dfg 223 (408)
++.+|+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 33458999998 99999999999999653 479999999
Q ss_pred CceeecCCCcc---eecccccccCccccccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 015360 224 LAKLLCSERSY---VTTRVMGTFGYVAPEYACT-------GMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVD 292 (408)
Q Consensus 224 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~ 292 (408)
++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...... ...
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~ 249 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----ESN 249 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----HHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----HHH
Confidence 99876543322 1223569999999999865 568999999999999999999 99999643221 111
Q ss_pred HHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 293 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 293 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+.. ... .+.............+.+|+.+||+.||.+|||+.||++.
T Consensus 250 i~~~---~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 250 IIRG---IFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHT---CCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhcC---CCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111 000 1111222234456678999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=239.91 Aligned_cols=180 Identities=30% Similarity=0.492 Sum_probs=122.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999985 5899999987
Q ss_pred -----------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.+|.|||+ . +++|+||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 3445999998 5 899999999999999999999999999976543222
Q ss_pred ceecccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 234 YVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.....+++.|+|||++. ...++.++|||||||++|+|++|+.||...... ............
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~------ 247 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP------ 247 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC------
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC------
Confidence 23356899999999984 456888999999999999999999999743211 111222222111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+.++.. ......+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 PLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111100 0112367889999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=247.93 Aligned_cols=189 Identities=24% Similarity=0.398 Sum_probs=135.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||++... ++..||+|.+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999976 5889999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..+|.|||+.+ +|+|+||||+|||++.++.+||+|||++...... ..
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 344599999831 7999999999999999999999999998654322 12
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC-------------C-
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-------------K- 302 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------~- 302 (408)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ........... .
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL---ELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH---HHHHC---------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccCCCCCCCcccCCCcc
Confidence 335689999999999999999999999999999999999999975332110 00000000000 0
Q ss_pred ----------------cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 ----------------SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ----------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...+................+.+|+.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000111111123368889999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=245.23 Aligned_cols=188 Identities=21% Similarity=0.283 Sum_probs=130.1
Q ss_pred cCCCc-cceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 151 SGLCE-ENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~-~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
+.|.. .++||+|+||.||+|... +++.||||.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34555 378999999999999954 5899999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc---eEEeccCCceeecCCC
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kL~Dfg~a~~~~~~~ 232 (408)
+..+|+|||+. +|+||||||+|||++.++. +||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 34559999999 9999999999999987765 9999999987653221
Q ss_pred c------ceecccccccCccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc--------hhHHH
Q 015360 233 S------YVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--------NLVDW 293 (408)
Q Consensus 233 ~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~--------~~~~~ 293 (408)
. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......... .....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1 11123458999999999875 45789999999999999999999999765432210 00011
Q ss_pred HHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 294 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 294 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+......... .++..........+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 249 LFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111110 00000000123468899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=245.32 Aligned_cols=186 Identities=25% Similarity=0.368 Sum_probs=135.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +|+.||||.+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888899999999999999975 5899999986
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 33459999999 9999999999999999999999999999765322
Q ss_pred cceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC---------
Q 015360 233 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK--------- 302 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 302 (408)
.....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+........
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHHTTCSC
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHHhh
Confidence 223568999999999876 67899999999999999999999999754321 11111111110000
Q ss_pred ---------cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 ---------SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 ---------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+.. ........+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000001100 011223468889999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=240.25 Aligned_cols=176 Identities=23% Similarity=0.374 Sum_probs=137.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++...+ ++.+|+|.+
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 467788999999999999999764 788999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 34459999999 999999999999999999999999999987643222
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .+......... ..++..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-------~~~~~~ 237 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-------YSIPKH 237 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------CCCCTT
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhcc-------CCCccc
Confidence 22335689999999999988899999999999999999999999964321 11111111111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ...+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 I----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 2357889999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=240.08 Aligned_cols=180 Identities=27% Similarity=0.383 Sum_probs=137.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +++.||||.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57888899999999999999975 5899999986
Q ss_pred ----------------------------------hhhhHHHhhhCCCCc-----eeeeccccCceEeCCCCceEEeccCC
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPK-----VVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~-----ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
++.+|.|||+. + |+|+||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 33459999998 7 99999999999999999999999999
Q ss_pred ceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+. .....
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~----~~~~~ 234 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIR----EGKFR 234 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HTCCC
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHh----hcccc
Confidence 976543322 12234689999999999998999999999999999999999999974421 11111111 11111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 305 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.++.. ....+.+++.+||+.||++|||+.||++.+..
T Consensus 235 -----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 -----RIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----cCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11111 22367889999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=234.11 Aligned_cols=178 Identities=21% Similarity=0.320 Sum_probs=134.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++... +++.||||.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999986 5899999975
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----ceEEeccCCcee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAKL 227 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kL~Dfg~a~~ 227 (408)
++.+|.|||+. +++|+||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 33459999998 999999999999998776 799999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 162 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------ 227 (283)
T 3bhy_A 162 IEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVN------ 227 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC------
T ss_pred ccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcc------
Confidence 643322 23356899999999999999999999999999999999999999643211 1111111110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..............+.+++.+||+.||++|||+.|+++
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 -YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000000112236788999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=238.11 Aligned_cols=188 Identities=23% Similarity=0.351 Sum_probs=135.4
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------- 183 (408)
.+.....++|...+.||+|+||.||+|...+ .+|||.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444445788899999999999999999853 4888876
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
++.+|.|||+. +++|+||||+|||++ ++.+||+|||++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 44569999999 999999999999998 679999999998754
Q ss_pred cCCC----cceecccccccCccccccccc---------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 015360 229 CSER----SYVTTRVMGTFGYVAPEYACT---------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295 (408)
Q Consensus 229 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 295 (408)
.... ........|++.|+|||.+.. ..++.++|||||||++|||++|+.||...... ....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~ 253 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIW 253 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 3211 111223458899999999864 35788999999999999999999999743221 1111
Q ss_pred HHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
... ............ ...+.+++.+||+.||++|||+.+|++.|+...
T Consensus 254 ~~~-~~~~~~~~~~~~--------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 254 QMG-TGMKPNLSQIGM--------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHH-TTCCCCCCCSSC--------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred Hhc-cCCCCCCCcCCC--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111 111111111111 125788999999999999999999999999743
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=243.59 Aligned_cols=176 Identities=23% Similarity=0.374 Sum_probs=138.0
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||++...+ ++.+|+|.+
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 568888999999999999999764 788999976
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 34459999999 999999999999999999999999999987643322
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .+......... ..++..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-------~~~~~~ 263 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-------YSIPKH 263 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-------CCCCTT
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCC-------CCCCcc
Confidence 22335689999999999998899999999999999999999999964321 11111111111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ...+.+|+.+||+.||++|||+.|+++.
T Consensus 264 ~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 264 I----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 2357789999999999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=238.63 Aligned_cols=175 Identities=25% Similarity=0.421 Sum_probs=132.6
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-C-------cEEEEEEe---------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-G-------TKVAVKNL--------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~-------~~vavK~~--------------------------------------- 183 (408)
++|...+.||+|+||.||+|.... + ..||+|.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568888999999999999998653 2 46999986
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc--------eEEec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------ARVSD 221 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~--------~kL~D 221 (408)
++.+|.|||+. +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 34559999999 9999999999999988876 99999
Q ss_pred cCCceeecCCCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCC-CCCCCCCCCcchhHHHHHHHhc
Q 015360 222 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRN-PVDYSRPQGEVNLVDWLKTMVG 299 (408)
Q Consensus 222 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~-Pf~~~~~~~~~~~~~~~~~~~~ 299 (408)
||++...... ....+++.|+|||.+.+ ..++.++|||||||++|||++|.. ||..... .........
T Consensus 165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~ 233 (289)
T 4fvq_A 165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQFYED 233 (289)
T ss_dssp CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHT
T ss_pred CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHHhhc
Confidence 9998654221 22457889999999987 678999999999999999999654 4432211 111111111
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... ++... ...+.+|+.+||+.||++|||+.|+++.|+..
T Consensus 234 ~~~--------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 234 RHQ--------LPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp TCC--------CCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred cCC--------CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111 11111 12477899999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-30 Score=256.87 Aligned_cols=178 Identities=22% Similarity=0.348 Sum_probs=134.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||+||++... +++.||||.+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46888999999999999999975 5899999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceeecCCC
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +|+||||||+|||++ .++.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 34459999999 999999999999995 45679999999997654332
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .+........... ..
T Consensus 179 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~-------~~ 242 (486)
T 3mwu_A 179 K--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYA-------FD 242 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC-------SC
T ss_pred c--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-------CC
Confidence 2 234569999999999875 589999999999999999999999964322 1111111111100 00
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111223467889999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=244.47 Aligned_cols=177 Identities=27% Similarity=0.424 Sum_probs=136.5
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------- 183 (408)
.+.....++|...+.||+|+||.||+|.. .+++.||||.+
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34444567899999999999999999985 45889999975
Q ss_pred ------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEe
Q 015360 184 ------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVS 220 (408)
Q Consensus 184 ------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~ 220 (408)
++.+|+|||+. +|+|+||||+|||++ .++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 33459999998 999999999999998 77899999
Q ss_pred ccCCceeecCCCcceecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhc
Q 015360 221 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 299 (408)
Q Consensus 221 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 299 (408)
|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....
T Consensus 193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~---- 257 (320)
T 3a99_A 193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIR---- 257 (320)
T ss_dssp CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH----
T ss_pred eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhhc----
Confidence 999998764322 233568999999999887665 678999999999999999999996321 1110
Q ss_pred CCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHh
Q 015360 300 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349 (408)
Q Consensus 300 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le 349 (408)
.. ....... ...+.+|+.+||+.||++|||+.||++.--
T Consensus 258 ~~-------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 258 GQ-------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CC-------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred cc-------ccccccC----CHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 00 0011111 236788999999999999999999988543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=242.92 Aligned_cols=181 Identities=33% Similarity=0.475 Sum_probs=116.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888899999999999999985 5899999987
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. .+|+|+||||+|||++.++.+||+|||++......
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 33458999984 28999999999999999999999999999765432
Q ss_pred CcceecccccccCccccccc----ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 232 RSYVTTRVMGTFGYVAPEYA----CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
.. .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... +.+.... ...
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~------~~~ 246 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVV------KGD 246 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC------CSC
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHh------cCC
Confidence 22 2234689999999998 45678999999999999999999999997432210 0000000 000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+.+...........+.+|+.+||+.||++|||+.||++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111122346888999999999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=235.89 Aligned_cols=178 Identities=23% Similarity=0.354 Sum_probs=137.2
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+++.. +++.||||.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 56888899999999999999975 5899999986
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeecCCCcc
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+|+||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 34559999999 99999999999999 778899999999987543221
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .. ........ . ....+
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~---~~~i~~~~-~-~~~~~----- 229 (304)
T 2jam_A 164 -MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KL---FEKIKEGY-Y-EFESP----- 229 (304)
T ss_dssp -THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH---HHHHHHCC-C-CCCTT-----
T ss_pred -cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHcCC-C-CCCcc-----
Confidence 22345899999999999999999999999999999999999999643211 11 11111111 0 00001
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111122468889999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=236.49 Aligned_cols=177 Identities=31% Similarity=0.550 Sum_probs=132.0
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
.|....+||+|+||.||+|.. .+++.||||.+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455567999999999999996 45889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCCceeecCCCcc
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 34559999998 9999999999999987 88999999999987643222
Q ss_pred eecccccccCcccccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...+...... ..+.++
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-------~~~~~~ 248 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFK-------VHPEIP 248 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHHC-------CCCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcccc-------cccccc
Confidence 123356899999999987644 7899999999999999999999996432111 1111111110 111222
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ES----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 2236788999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=237.76 Aligned_cols=178 Identities=24% Similarity=0.294 Sum_probs=137.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||++... +++.+|||.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999974 5889999986
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..+|.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 33459999999 99999999999999999999999999998764
Q ss_pred CCC-cceecccccccCcccccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 230 SER-SYVTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 230 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
... ........+++.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .......... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~-~---- 229 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKG-S---- 229 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHC-C----
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcC-C----
Confidence 322 22233456899999999987644 37799999999999999999999974321 1111111111 1
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..++.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 230 --~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 --YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 12367889999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=259.21 Aligned_cols=178 Identities=25% Similarity=0.397 Sum_probs=136.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...++||+|+||.||++... +++.||||.+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888899999999999999976 6899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEe---CCCCceEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 34459999999 99999999999999 56788999999999766433
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|++||...... .. .......... .
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~~~-------~ 246 (484)
T 3nyv_A 183 KK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DI---LKKVEKGKYT-------F 246 (484)
T ss_dssp CS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCCCC-------C
T ss_pred cc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHcCCCC-------C
Confidence 22 233569999999999866 6899999999999999999999999743321 11 1111111100 0
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 011112223468889999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=245.47 Aligned_cols=183 Identities=27% Similarity=0.465 Sum_probs=135.2
Q ss_pred hcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe----------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~---------------------------------------- 183 (408)
.++|...+.||+|+||.||+|++. ++..||||.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 367888999999999999999842 4678999986
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEe
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVS 220 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~ 220 (408)
++.+|.|||+. +|+|+||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 33458999999 9999999999999984 4569999
Q ss_pred ccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHh
Q 015360 221 DFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 221 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...... .. .....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~---~~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV---LEFVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH---HHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HH---HHHHh
Confidence 99998755332221 1223457889999999998999999999999999999998 99999643211 11 11111
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.... +.... .....+.+++.+||+.||.+|||+.||++.|+..
T Consensus 260 ~~~~------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGR------MDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCC------CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC------CCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111 11111 1223678899999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=235.83 Aligned_cols=171 Identities=21% Similarity=0.365 Sum_probs=131.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
+++|...+.||+|+||+||+|... +++.||||.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999986 6899999986
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC----------------
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---------------- 213 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---------------- 213 (408)
++.+|.|||+. +|+|+||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 34459999999 9999999999999984
Q ss_pred ---CCceEEeccCCceeecCCCcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 015360 214 ---QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 289 (408)
Q Consensus 214 ---~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 289 (408)
...+||+|||++....... ...+|+.|+|||.+.+. .++.++|||||||++|+|++|.+++... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------D 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------h
Confidence 4479999999998764332 23589999999999765 5678999999999999999998876421 1
Q ss_pred hHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 290 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
... ... .... +.++... ...+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~---~~~-~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 QWH---EIR-QGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH---HHH-TTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH---HHH-cCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 111 1111 1121111 2367889999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=240.56 Aligned_cols=181 Identities=25% Similarity=0.378 Sum_probs=135.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357889999999999999999975 4789999974
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc---eEEeccCCce
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAK 226 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kL~Dfg~a~ 226 (408)
++.+|.|||+. +|+|+||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 33459999998 9999999999999986654 9999999998
Q ss_pred eecCCCcceecccccccCcccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ +...+.. ...
T Consensus 166 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~~~ 237 (322)
T 2ycf_A 166 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS----GKY 237 (322)
T ss_dssp ECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH----TCC
T ss_pred eccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh----Ccc
Confidence 764322 123356899999999874 56788999999999999999999999975443321 2221111 100
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. ............+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 N------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp C------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0 0000001123468899999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=236.11 Aligned_cols=175 Identities=27% Similarity=0.458 Sum_probs=129.0
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999976 6899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 34459999999 999999999999999999999999999976543221
Q ss_pred eecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ........... ..++.
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-------~~~~~ 232 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGV-------FYIPE 232 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCCT
T ss_pred -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc-------ccCch
Confidence 223468899999999987765 6899999999999999999999964321 11111111110 01111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. ...+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 233 YL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 2357889999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=255.27 Aligned_cols=178 Identities=23% Similarity=0.387 Sum_probs=132.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||+||+|+.. ++..+|||.+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888899999999999999975 5889999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC---CceEEeccCCceeecCCC
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kL~Dfg~a~~~~~~~ 232 (408)
+..+|.|||+. +|+||||||+|||++.. +.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 34559999999 99999999999999754 559999999998764432
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. .....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... +........... ...+..
T Consensus 194 ~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~--~~~~~~- 261 (494)
T 3lij_A 194 K--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYT--FDSPEW- 261 (494)
T ss_dssp C--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC--CCSGGG-
T ss_pred c--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC--CCchhc-
Confidence 2 23456999999999886 56999999999999999999999999743321 111211111100 000111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......+.+|+.+||+.||.+|||+.|+++.
T Consensus 262 ----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 262 ----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1122367889999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=238.66 Aligned_cols=185 Identities=28% Similarity=0.435 Sum_probs=129.0
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||.||+|... +++.||||.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3468899999999999999999864 5889999965
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 23459999998 99999999999999999999999999987
Q ss_pred eecCCCc----ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC
Q 015360 227 LLCSERS----YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301 (408)
Q Consensus 227 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 301 (408)
....... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .. .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~~ 243 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQND 243 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHTSS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhccC
Confidence 6543211 11233568999999999875 568999999999999999999999997543221 11 1111111
Q ss_pred C---cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 K---SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 ~---~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. .....++...... ...+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0111111111111 236788999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=266.05 Aligned_cols=183 Identities=25% Similarity=0.451 Sum_probs=138.9
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe-----------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL----------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~----------------------------------------- 183 (408)
..++|...+.||+|+||.||+|.+.. +..||||.+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 34678888999999999999999743 467999975
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 34559999999 9999999999999999999999999999876544
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .... ....... +.
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~---~i~~~~~------~~ 612 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIENGER------LP 612 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHHTCC------CC
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHcCCC------CC
Confidence 3333334457789999999998999999999999999999997 99999743321 1111 1111111 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.+. .....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 613 ~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 613 MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 122368889999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=243.80 Aligned_cols=144 Identities=22% Similarity=0.350 Sum_probs=107.7
Q ss_pred hhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhh
Q 015360 186 NRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 265 (408)
Q Consensus 186 ~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 265 (408)
.+|.|||+. +|+|+||||+|||++.++.+||+|||++....... ......+++.|+|||.+.+..++.++|||||
T Consensus 153 ~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp HHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHH
Confidence 358999998 99999999999999999999999999987432211 1222346789999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 266 GILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 266 Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
||++|||++ |+.||..... ........ ... ....+. .....+.+|+.+||+.||++|||+.|+
T Consensus 228 G~il~ellt~g~~pf~~~~~------~~~~~~~~-~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 228 GVLLWEIVSLGGTPYCGMTC------AELYEKLP-QGY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCH------HHHHHHGG-GTC-----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHcCCCCCCCCCcH------HHHHHHhh-cCC-----CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999998 9999964331 11111111 110 011111 122368889999999999999999999
Q ss_pred HHHHhc
Q 015360 345 IHMLEA 350 (408)
Q Consensus 345 l~~Le~ 350 (408)
++.|+.
T Consensus 292 l~~L~~ 297 (327)
T 1fvr_A 292 LVSLNR 297 (327)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=237.97 Aligned_cols=180 Identities=23% Similarity=0.358 Sum_probs=134.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||.||+|.... +..+|+|.+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 3578888999999999999999864 889999976
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.+|.|||+. +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 34559999999 99999999999999999999999999875432111 11
Q ss_pred ecccccccCccccccc-----ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 236 TTRVMGTFGYVAPEYA-----CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.....|++.|+|||++ ....++.++|||||||++|+|++|+.||..... ............. .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------~ 241 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPP------T 241 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC------C
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCc------c
Confidence 2234689999999988 466788999999999999999999999974332 1111111111110 0
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 242 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 --LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01112223468889999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=246.06 Aligned_cols=181 Identities=30% Similarity=0.438 Sum_probs=128.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
..+|...++||+|+||+||.....+++.||||++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 3468888999999999855444457999999987
Q ss_pred ------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-----CCceEEeccCCceeecCCCc-
Q 015360 184 ------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 ------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-----~~~~kL~Dfg~a~~~~~~~~- 233 (408)
++.+|.|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 34569999999 9999999999999943 34588999999987643322
Q ss_pred -ceecccccccCcccccccc---cCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 234 -YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 234 -~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||...... ........... .
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~-~--- 248 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACSL-D--- 248 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCCC-T---
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCCc-c---
Confidence 1223466999999999997 4567889999999999999999 99999533211 11111111111 0
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. .........+.+|+.+||+.||++|||+.||++.
T Consensus 249 -~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 249 -CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 01 1112334457789999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=233.38 Aligned_cols=179 Identities=24% Similarity=0.331 Sum_probs=137.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 5889999975
Q ss_pred -------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 184 -------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 184 -------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
+..+|.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 22349999999 99999999999999999999999999998
Q ss_pred eecCCCcceecccccccCcccccccc------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 227 LLCSERSYVTTRVMGTFGYVAPEYAC------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 227 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
....... .....+++.|+|||++. ...++.++||||||+++|+|++|+.||..... ..........
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~ 244 (298)
T 1phk_A 173 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSG 244 (298)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT
T ss_pred hcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcC
Confidence 7643322 23356899999999885 45688899999999999999999999964321 1111111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. . .............+.+++.+||+.||++|||+.|+++
T Consensus 245 ~-~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 N-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C-c------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 0 0111111223346889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=252.43 Aligned_cols=179 Identities=25% Similarity=0.375 Sum_probs=134.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||+||+|.... ++.+|||.+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4678889999999999999999754 789999975
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC---ceEEe
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVS 220 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kL~ 220 (408)
+..+|.|||+. +|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 23349999999 999999999999998765 69999
Q ss_pred ccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcC
Q 015360 221 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 300 (408)
Q Consensus 221 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 300 (408)
|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||...... +........
T Consensus 192 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~ 262 (504)
T 3q5i_A 192 DFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIKKVEKG 262 (504)
T ss_dssp CCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC
T ss_pred ECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence 9999987644322 23456999999999986 46899999999999999999999999753321 112221111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 301 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 301 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
... ............+.+|+.+||+.||.+|||+.|+++.
T Consensus 263 ~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYY-------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCC-------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC-------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 100 0000001122468889999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=235.71 Aligned_cols=191 Identities=19% Similarity=0.334 Sum_probs=129.1
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.... ++.||||.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578888999999999999999865 899999975
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCC
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGL 224 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~ 224 (408)
++.+|+|||+. +|+|+||||+|||++ .++.+||+|||+
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 23459999999 999999999999997 567899999999
Q ss_pred ceeecCCCc--ceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC
Q 015360 225 AKLLCSERS--YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301 (408)
Q Consensus 225 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 301 (408)
+........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~ 244 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLILESIPVV 244 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHSCCC
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence 986543211 11233457899999998865 678999999999999999999999997543211 111111100000
Q ss_pred C----------cc-----cccCCCCCC-CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 K----------SE-----EVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ~----------~~-----~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .. ....+.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 00 000000000 0000123468899999999999999999999873
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=233.85 Aligned_cols=185 Identities=19% Similarity=0.316 Sum_probs=138.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|.. +++.||||.+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788999999999999999999 8999999975
Q ss_pred ---------------------------------------------------hhhhHHHhhh-CCCCceeeeccccCceEe
Q 015360 184 ---------------------------------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILL 211 (408)
Q Consensus 184 ---------------------------------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill 211 (408)
++.+|.|||+ . +++|+||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 2234899998 7 99999999999999
Q ss_pred CCCCceEEeccCCceeecCCCcceecccccccCcccccccccC-CCCc-cccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 015360 212 DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNE-KSDVYSFGILIMEIITGRNPVDYSRPQGEVN 289 (408)
Q Consensus 212 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 289 (408)
+.++.+||+|||++...... ......++..|+|||.+.+. .++. ++|||||||++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876433 23445689999999999877 6666 999999999999999999999754331
Q ss_pred hHHHHHHHhcCCCcccc------cCCCCC---CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 290 LVDWLKTMVGSRKSEEV------VDPKLP---KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 290 ~~~~~~~~~~~~~~~~~------~d~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+...... ....... ..+... ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 259 -~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 -VELFNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HHHHHHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111 1111000 000000 00001123468889999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-29 Score=234.92 Aligned_cols=174 Identities=29% Similarity=0.499 Sum_probs=132.2
Q ss_pred HHHHHhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------
Q 015360 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 145 ~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------- 183 (408)
+.+...++|...+.||+|+||.||+|... +++.||||.+
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 33445678999999999999999999863 5889999975
Q ss_pred -------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEE
Q 015360 184 -------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARV 219 (408)
Q Consensus 184 -------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL 219 (408)
+..+|.|||+. +|+|+||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 23349999999 999999999999998 8899999
Q ss_pred eccCCceeecCCCcceecccccccCcccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh
Q 015360 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 220 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
+|||++....... .....++..|+|||++.+..+. .++|||||||++|+|++|+.||.... ....
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~--- 247 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EILE--- 247 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH---
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHhh---
Confidence 9999998765432 2335689999999998876664 58999999999999999999996311 1110
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. ..+... ....+.+++.+||+.||++|||+.|+++.
T Consensus 248 -~~-------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 -AE-------LHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -TC-------CCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hc-------cCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011111 12367889999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=228.59 Aligned_cols=180 Identities=31% Similarity=0.466 Sum_probs=129.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|+.. +++.||||.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 457888999999999999999964 6899999976
Q ss_pred ----------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 184 ----------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
+..+|+|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 23349999999 99999999999999999999999999
Q ss_pred CceeecCCC-------------cceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 015360 224 LAKLLCSER-------------SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 289 (408)
Q Consensus 224 ~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 289 (408)
++....... ........+++.|+|||.+.+. .++.++|||||||++|+|++ ||... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~ 233 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----ME 233 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hh
Confidence 997653221 1112335689999999999764 68999999999999999998 44311 11
Q ss_pred hHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 290 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........... ...++..........+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11222222111 1111122222233467889999999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=226.60 Aligned_cols=178 Identities=23% Similarity=0.354 Sum_probs=134.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|...+.||+|+||.||+|... +++.||||.+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467999999999999999999975 5899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCC---CceEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +++|+||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 34459999999 99999999999999654 46999999998765432
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+............. .
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~-----~ 243 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAFD-----L 243 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC-----S
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCCC-----c
Confidence 22 223458899999998865 489999999999999999999999964321 111221111110000 0
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.........+.+++.+||+.||++|||+.|+++
T Consensus 244 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 --PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000112236788999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=246.24 Aligned_cols=168 Identities=25% Similarity=0.358 Sum_probs=132.9
Q ss_pred hcCCCccceeccCCcEEEEEEEeC--CCcEEEEEEe--------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~--~~~~vavK~~-------------------------------------------- 183 (408)
.++|.+.+.||+|+||.||+|... +++.||||.+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 5899999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
+..+|.|||+. +|+||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 34459999999 99999999999999876 8999999999876433
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
....||+.|+|||++.+.. +.++|||||||++|+|++|..||....... ..
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------------~~ 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------------LP 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------------CC
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------------cc
Confidence 3356899999999987654 889999999999999999998875321110 00
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCC-HhHHHHHHhc
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIHMLEA 350 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~Le~ 350 (408)
...........+.+|+.+||+.||++||+ ++++.+.|..
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 01111223356888999999999999995 6666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-27 Score=244.47 Aligned_cols=184 Identities=27% Similarity=0.360 Sum_probs=131.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|... +++.||||.+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999974 5899999975
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCc---eEEeccCC
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGL 224 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kL~Dfg~ 224 (408)
++.+|.|||+. +|+|+||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 23459999998 9999999999999986654 89999999
Q ss_pred ceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh------
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV------ 298 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~------ 298 (408)
+........ .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...|.....
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchh
Confidence 987643322 2345789999999999999999999999999999999999999964311 111100000
Q ss_pred --cCCCccc-c-cCC--CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHH
Q 015360 299 --GSRKSEE-V-VDP--KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344 (408)
Q Consensus 299 --~~~~~~~-~-~d~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 344 (408)
....... . ... ..+..........+.+++.+||+.||++|||+.|+
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 0 000 11112233456678999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=217.14 Aligned_cols=160 Identities=21% Similarity=0.292 Sum_probs=117.2
Q ss_pred cCCCcc-ceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 151 SGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~-~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
++|... ++||+|+||.||++... +++.||||.+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 456555 78999999999999974 5889999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~a~~~~~~ 231 (408)
++.+|.|||+. +|+|+||||+|||++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 34569999999 9999999999999987 7889999999986532
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
+..++.++|||||||++|||++|+.||......... ......+.....
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~~~ 219 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMGQY 219 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCC
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhccc
Confidence 234678999999999999999999999644321100 000001111111
Q ss_pred CCCC--cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.... .......+.+++.+||+.||++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 01123468889999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=217.06 Aligned_cols=158 Identities=12% Similarity=0.071 Sum_probs=119.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||.||+|.... ++.||||.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 468888999999999999999864 899999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
++.+|+|||+. +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 34459999999 99999999999999999999998543
Q ss_pred cccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC--C
Q 015360 237 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK--M 314 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~ 314 (408)
|++ .++.++|||||||++|||++|+.||............ .......... .
T Consensus 175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQPIEPAD 227 (286)
T ss_dssp --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSCBCCHHH
T ss_pred --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccCCCChhh
Confidence 333 3678999999999999999999999865433211000 0000000000 0
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
........+.+|+.+||+.||++| |+.|+++.|+...
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 001122468889999999999999 9999999998743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=211.57 Aligned_cols=133 Identities=14% Similarity=0.109 Sum_probs=96.0
Q ss_pred HHHhh-hCCCCceeeeccccCceEeCCCC--------------------ceEEeccCCceeecCCCcceecccccccCcc
Q 015360 188 LAYLH-EGLEPKVVHRDVKSSNILLDRQW--------------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246 (408)
Q Consensus 188 L~yLH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 246 (408)
|+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 89999 88 999999999999998876 8999999999876432 246999999
Q ss_pred cccccccCCCCccccchhhHHH-HHHHHhCCCCCCCCCCCCcchhHHHH-HHHhcCCCcccccCCCCCCCCcHHHHHHHH
Q 015360 247 APEYACTGMLNEKSDVYSFGIL-IMEIITGRNPVDYSRPQGEVNLVDWL-KTMVGSRKSEEVVDPKLPKMPASKALKRVL 324 (408)
Q Consensus 247 aPE~~~~~~~~~~sDvwSlGvv-l~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 324 (408)
|||++.+.. +.++|||||+++ .+++++|..||... ...... ......... ...............+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc----CcccchhhhhhcCHHHH
Confidence 999998766 889999998777 77888899998410 000001 111111110 11111112334667899
Q ss_pred HHHHhccCcCCCCCCCHhHHH
Q 015360 325 LVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 325 ~l~~~cl~~dP~~Rps~~evl 345 (408)
+|+.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999977 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.6e-18 Score=174.74 Aligned_cols=89 Identities=21% Similarity=0.157 Sum_probs=58.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccch
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
++.+|+|||++ +||||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+ .+..++|+|
T Consensus 348 Il~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~ 422 (569)
T 4azs_A 348 LLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWR 422 (569)
T ss_dssp HHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------
T ss_pred HHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCccccc
Confidence 55669999999 999999999999999999999999999987644332 2344679999999999865 467789999
Q ss_pred hhHHHHHHHHhCCC
Q 015360 264 SFGILIMEIITGRN 277 (408)
Q Consensus 264 SlGvvl~elltG~~ 277 (408)
++|++++++.++..
T Consensus 423 s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 423 SAPVHPFNLPQPWS 436 (569)
T ss_dssp ------CCCCTTHH
T ss_pred ccccchhhhccccc
Confidence 99999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4.5e-17 Score=165.73 Aligned_cols=120 Identities=22% Similarity=0.291 Sum_probs=92.0
Q ss_pred CccceeccCCcEEEEEEEeCCCcEEEEEEe--------------------------------------------------
Q 015360 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNL-------------------------------------------------- 183 (408)
Q Consensus 154 ~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~-------------------------------------------------- 183 (408)
...++||+|+||+||+|.+ .+..+++|..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3357899999999999976 4788999974
Q ss_pred ----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce------
Q 015360 184 ----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV------ 235 (408)
Q Consensus 184 ----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~------ 235 (408)
+..+|+|||+. +|+||||||+|||++. .+||+|||+++.........
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence 23459999999 9999999999999998 99999999999875432211
Q ss_pred ecccccccCccccccccc--CCCCccccchhhHHHHHHHHhCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPV 279 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltG~~Pf 279 (408)
.....||+.|+|||++.. ..|+...|+|+..+-.++.+.++.+|
T Consensus 493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 234679999999999986 56788899999999999988877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=135.73 Aligned_cols=92 Identities=18% Similarity=0.094 Sum_probs=76.4
Q ss_pred HHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEeh--------------------------------------
Q 015360 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLL-------------------------------------- 184 (408)
Q Consensus 143 ~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~~-------------------------------------- 184 (408)
+..+.....-|...+.||+|+||.||+|...+|+.||||.+.
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 445555556677789999999999999999779999999761
Q ss_pred -----------------------------------------hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccC
Q 015360 185 -----------------------------------------NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 223 (408)
Q Consensus 185 -----------------------------------------~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg 223 (408)
+.+|.|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 162 ~~~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 162 QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp TTSSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred cCCCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 1238999998 999999999999999 9999999999
Q ss_pred CceeecCCCcceecccccccCcccccccc
Q 015360 224 LAKLLCSERSYVTTRVMGTFGYVAPEYAC 252 (408)
Q Consensus 224 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 252 (408)
+++. +..++|||++.
T Consensus 238 ~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TCEE--------------TTSTTHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHH
Confidence 9863 24568888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=9.7e-12 Score=114.29 Aligned_cols=36 Identities=31% Similarity=0.379 Sum_probs=33.4
Q ss_pred HHHhh-hCCCCceeeeccccCceEeCCCCceEEeccCCceee
Q 015360 188 LAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228 (408)
Q Consensus 188 L~yLH-~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~ 228 (408)
|.||| +. +|+||||||.|||++. .++|+|||++...
T Consensus 183 l~~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 183 VKRLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 88999 87 9999999999999988 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.9e-11 Score=115.74 Aligned_cols=74 Identities=18% Similarity=0.135 Sum_probs=64.0
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
-|.+.+.||+|+||.||+|...+|+.||||.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48889999999999999999989999999974
Q ss_pred --------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----------
Q 015360 184 --------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW---------- 215 (408)
Q Consensus 184 --------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~---------- 215 (408)
+..+|.|||+. +||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~ 252 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITL 252 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccccccccc
Confidence 22338999998 999999999999998766
Q ss_pred ceEEeccCCceee
Q 015360 216 NARVSDFGLAKLL 228 (408)
Q Consensus 216 ~~kL~Dfg~a~~~ 228 (408)
.+.|+||+-+...
T Consensus 253 ~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 253 TPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECCCTTCEET
T ss_pred ceEEEEeCCcccC
Confidence 3889999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0002 Score=64.93 Aligned_cols=37 Identities=11% Similarity=-0.056 Sum_probs=28.9
Q ss_pred HHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe
Q 015360 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL 183 (408)
Q Consensus 146 l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~ 183 (408)
|.....+|.....++.|+++.||+.... ++.+++|..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~ 45 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMT 45 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeC
Confidence 3444567888888888889999999864 788999985
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0002 Score=44.03 Aligned_cols=34 Identities=32% Similarity=0.384 Sum_probs=24.1
Q ss_pred ccCCchHHHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015360 18 SIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRR 51 (408)
Q Consensus 18 ~~~~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr 51 (408)
..++++...++||++|+++.+++++.+.|+++||
T Consensus 4 ~~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 4 VSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp SSTTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3456788999999999887766666555555444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0001 Score=66.47 Aligned_cols=29 Identities=24% Similarity=0.284 Sum_probs=25.4
Q ss_pred eeeeccccCceEeCCCCceEEeccCCcee
Q 015360 199 VVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 199 ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++|+|++|.||+++.+..+.|+||+.+..
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00046 Score=43.72 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=16.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcccc
Q 015360 26 VVIGILLGSLIVLALFLLSLCLTSRRKK 53 (408)
Q Consensus 26 ~~i~i~~g~~~~l~l~~~~~~~~~rr~~ 53 (408)
+++|+++|++++++++++++++++||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 5566666666666555555555555544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0011 Score=41.90 Aligned_cols=30 Identities=17% Similarity=0.270 Sum_probs=16.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 015360 25 WVVIGILLGSLIVLALFLLSLCLTSRRKKH 54 (408)
Q Consensus 25 ~~~i~i~~g~~~~l~l~~~~~~~~~rr~~~ 54 (408)
.++.|+++|++++++++++++++++||+++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 355556666666655555555555555443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0027 Score=40.00 Aligned_cols=29 Identities=31% Similarity=0.406 Sum_probs=15.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhhccc
Q 015360 24 LWVVIGILLGSLIVLALFLLSLCLTSRRK 52 (408)
Q Consensus 24 ~~~~i~i~~g~~~~l~l~~~~~~~~~rr~ 52 (408)
...++++++|+++++++.++++++++||+
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehhh
Confidence 55667777775444444444444444443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00016 Score=67.24 Aligned_cols=79 Identities=22% Similarity=0.279 Sum_probs=49.8
Q ss_pred CCceeeeccccCceEeCC--CCceEEeccCCceeecCCCcceecccccccCc---ccccccc----c-CCC---------
Q 015360 196 EPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSERSYVTTRVMGTFGY---VAPEYAC----T-GML--------- 256 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~----~-~~~--------- 256 (408)
.+.++|+|+++.||+++. ...+.|+||+.+.......... ....+ ..|+... . +..
T Consensus 190 ~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~ 264 (304)
T 3sg8_A 190 YPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY 264 (304)
T ss_dssp CCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH
T ss_pred CceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH
Confidence 457999999999999987 4567899999886542211100 00011 1222111 0 011
Q ss_pred CccccchhhHHHHHHHHhCCCCC
Q 015360 257 NEKSDVYSFGILIMEIITGRNPV 279 (408)
Q Consensus 257 ~~~sDvwSlGvvl~elltG~~Pf 279 (408)
....+.|+++.++|.+.+|..+|
T Consensus 265 ~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 265 RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHcCCHHH
Confidence 12358999999999999998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.047 Score=49.86 Aligned_cols=32 Identities=31% Similarity=0.308 Sum_probs=27.7
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~ 183 (408)
.+...+.+|.|..+.||+.++.||+.+.||+.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~ 47 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKAL 47 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEe
Confidence 34556789999999999999999999999974
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=94.73 E-value=0.04 Score=32.45 Aligned_cols=30 Identities=27% Similarity=0.485 Sum_probs=23.2
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHhhhc
Q 015360 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSR 50 (408)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~l~~~~~~~~~r 50 (408)
+++...++||++|.+++.++++++++++.|
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 456788999999998888777777766654
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.52 E-value=0.03 Score=34.99 Aligned_cols=25 Identities=24% Similarity=0.428 Sum_probs=12.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhh
Q 015360 24 LWVVIGILLGSLIVLALFLLSLCLT 48 (408)
Q Consensus 24 ~~~~i~i~~g~~~~l~l~~~~~~~~ 48 (408)
..+++++++|+++++++++++++++
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~ 37 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIH 37 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEe
Confidence 4455556666555443444434333
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=93.62 E-value=0.034 Score=51.86 Aligned_cols=31 Identities=26% Similarity=0.389 Sum_probs=27.7
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4589999999999999877889999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.038 Score=52.21 Aligned_cols=31 Identities=26% Similarity=0.413 Sum_probs=26.7
Q ss_pred CceeeeccccCceEeCCCCc--eEEeccCCcee
Q 015360 197 PKVVHRDVKSSNILLDRQWN--ARVSDFGLAKL 227 (408)
Q Consensus 197 ~~ivH~dlk~~Nill~~~~~--~kL~Dfg~a~~ 227 (408)
..++|+|+++.||+++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 58999999999999987653 68999998865
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=91.87 E-value=0.083 Score=31.38 Aligned_cols=26 Identities=31% Similarity=0.520 Sum_probs=11.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015360 26 VVIGILLGSLIVLALFLLSLCLTSRR 51 (408)
Q Consensus 26 ~~i~i~~g~~~~l~l~~~~~~~~~rr 51 (408)
.+++.++|.++++++.+.+.++++||
T Consensus 9 sIaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 9 FIIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred EeHHHHHHHHHHHHHHHHhheEEeec
Confidence 34444455333333333344444444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=91.55 E-value=0.098 Score=50.63 Aligned_cols=79 Identities=9% Similarity=-0.014 Sum_probs=45.6
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccC---CCCccccchhhHHHHHHH
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG---MLNEKSDVYSFGILIMEI 272 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~el 272 (408)
...++|+|+++.|||++.++ ++|+||+.+..-.........-..-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999998776 99999998875421111000000001235555544311 111234455677777777
Q ss_pred HhC
Q 015360 273 ITG 275 (408)
Q Consensus 273 ltG 275 (408)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 664
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.52 E-value=0.25 Score=32.53 Aligned_cols=25 Identities=28% Similarity=0.723 Sum_probs=16.9
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHH
Q 015360 22 LRLWVVIGILLGSLIVLALFLLSLC 46 (408)
Q Consensus 22 ~~~~~~i~i~~g~~~~l~l~~~~~~ 46 (408)
.-+|++++.++|.+++++++.++++
T Consensus 10 vp~wiIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 10 IPIWWVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHH
Confidence 4578877777776766666665554
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.88 E-value=0.27 Score=32.25 Aligned_cols=25 Identities=32% Similarity=0.703 Sum_probs=16.7
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHH
Q 015360 22 LRLWVVIGILLGSLIVLALFLLSLC 46 (408)
Q Consensus 22 ~~~~~~i~i~~g~~~~l~l~~~~~~ 46 (408)
.-+|++++.++|.++++++++++++
T Consensus 7 vp~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 7 VPLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHH
Confidence 4478877777776766666665555
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=89.86 E-value=0.14 Score=45.94 Aligned_cols=30 Identities=23% Similarity=0.295 Sum_probs=26.1
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 589999999999999877778999998754
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=89.84 E-value=0.72 Score=28.69 Aligned_cols=26 Identities=27% Similarity=0.701 Sum_probs=17.6
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHH
Q 015360 21 GLRLWVVIGILLGSLIVLALFLLSLC 46 (408)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~l~~~~~~ 46 (408)
..-+|++++.++|.+++++++.++++
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 34578887777777776666666655
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.68 E-value=0.12 Score=47.78 Aligned_cols=44 Identities=23% Similarity=0.298 Sum_probs=32.5
Q ss_pred hhhhHHHhhhC----CCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 LNNRLAYLHEG----LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ~~~~L~yLH~~----~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+...+++++.. ....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 44456666532 245799999999999998776568999987753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=89.47 E-value=0.2 Score=46.18 Aligned_cols=33 Identities=27% Similarity=0.514 Sum_probs=27.0
Q ss_pred CCCceeeeccccCceEeCC---CCc-eEEeccCCcee
Q 015360 195 LEPKVVHRDVKSSNILLDR---QWN-ARVSDFGLAKL 227 (408)
Q Consensus 195 ~~~~ivH~dlk~~Nill~~---~~~-~kL~Dfg~a~~ 227 (408)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 188 ~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 188 YTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3558999999999999987 345 58999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=89.02 E-value=0.21 Score=46.48 Aligned_cols=33 Identities=36% Similarity=0.360 Sum_probs=28.1
Q ss_pred CCceeeeccccCceEeCCC----CceEEeccCCceee
Q 015360 196 EPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKLL 228 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~----~~~kL~Dfg~a~~~ 228 (408)
...++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4589999999999999874 67899999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=88.84 E-value=0.15 Score=47.89 Aligned_cols=32 Identities=25% Similarity=0.388 Sum_probs=26.6
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45899999999999998644578999988753
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.55 E-value=0.31 Score=35.13 Aligned_cols=8 Identities=0% Similarity=0.218 Sum_probs=3.4
Q ss_pred HHHHHHHH
Q 015360 27 VIGILLGS 34 (408)
Q Consensus 27 ~i~i~~g~ 34 (408)
+.|+++|+
T Consensus 14 v~gvi~gi 21 (79)
T 2knc_B 14 LLSVMGAI 21 (79)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 33444443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.62 E-value=0.33 Score=44.88 Aligned_cols=30 Identities=23% Similarity=0.250 Sum_probs=25.7
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45789999999999998 4 899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=86.17 E-value=1.1 Score=39.17 Aligned_cols=100 Identities=17% Similarity=0.105 Sum_probs=55.4
Q ss_pred ceeeHHHHHHHhcCCCccceeccCCcEEEEEEEeCCCcEEEEEEehhhhHHHh-hhCCCCceeeeccccCceEeCCCCce
Q 015360 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYL-HEGLEPKVVHRDVKSSNILLDRQWNA 217 (408)
Q Consensus 139 ~~~~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~~~~~L~yL-H~~~~~~ivH~dlk~~Nill~~~~~~ 217 (408)
...+|.|+....+ . -+++.+..||-.+.+..|.-+ +... + ..+=+.|..|++..+|.+
T Consensus 31 ~~vSL~eIL~~~~-----~-------------PlsEEqaWALc~Qc~~~L~~~~~~~~--~-~~~i~~~~~i~l~~dG~V 89 (229)
T 2yle_A 31 DALSLEEILRLYN-----Q-------------PINEEQAWAVCYQCCGSLRAAARRRQ--P-RHRVRSAAQIRVWRDGAV 89 (229)
T ss_dssp SEEEHHHHHHHHT-----S-------------CCCHHHHHHHHHHHHHHHHHHHHTTC--C-CCCCCSGGGEEEETTSCE
T ss_pred ccccHHHHHHHcC-----C-------------CcCHHHHHHHHHHHHHHHHhhhhccc--C-CceecCCcceEEecCCce
Confidence 4578888876543 1 233456666655555554443 1111 1 123345688899888888
Q ss_pred EEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHh
Q 015360 218 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 274 (408)
Q Consensus 218 kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 274 (408)
.+.+ ..+. .....+.+||... ...+.+.=|||||+++|..+-
T Consensus 90 ~f~~-~~s~-------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 90 TLAP-AADD-------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp EECC-C-------------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred eccc-cccc-------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 7764 1110 1123466888763 344567889999999999886
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=85.39 E-value=0.4 Score=45.29 Aligned_cols=31 Identities=23% Similarity=0.387 Sum_probs=25.3
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.|||++.+. +.|+||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 34799999999999998654 89999987753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.73 E-value=0.4 Score=44.90 Aligned_cols=32 Identities=19% Similarity=0.340 Sum_probs=27.9
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999878899999987754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=84.43 E-value=0.56 Score=44.74 Aligned_cols=31 Identities=19% Similarity=0.359 Sum_probs=26.4
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.||+++.+ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3589999999999999865 489999987764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=83.43 E-value=0.59 Score=42.68 Aligned_cols=31 Identities=19% Similarity=0.219 Sum_probs=25.9
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 457999999999999 5566789999988754
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=81.98 E-value=0.27 Score=52.34 Aligned_cols=33 Identities=36% Similarity=0.503 Sum_probs=0.0
Q ss_pred cCCchHHHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015360 19 IFGLRLWVVIGILLGSLIVLALFLLSLCLTSRR 51 (408)
Q Consensus 19 ~~~~~~~~~i~i~~g~~~~l~l~~~~~~~~~rr 51 (408)
..+++.+++++|++|++++|+++++++++++||
T Consensus 699 ~~~l~~~aii~il~~~~~ll~~~ll~~~~~~~~ 731 (880)
T 1q55_A 699 VGGFDLPIILVILGSVLALLILFLLLLLFLKRK 731 (880)
T ss_dssp ---------------------------------
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 447788889999888877776666655555444
|
| >2l9u_A Receptor tyrosine-protein kinase ERBB-3; transmenbrane dimer, membrane protein, EGFR; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.90 E-value=2.3 Score=24.76 Aligned_cols=28 Identities=11% Similarity=0.245 Sum_probs=15.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015360 24 LWVVIGILLGSLIVLALFLLSLCLTSRR 51 (408)
Q Consensus 24 ~~~~i~i~~g~~~~l~l~~~~~~~~~rr 51 (408)
+.+.+.+++|.+++..+++--|++++-|
T Consensus 6 l~malt~i~gl~vif~~lg~tflywrgr 33 (40)
T 2l9u_A 6 LTMALTVIAGLVVIFMMLGGTFLYWRGR 33 (40)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCceeEEEccc
Confidence 3445556666666555555544444433
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=81.87 E-value=0.63 Score=45.15 Aligned_cols=32 Identities=28% Similarity=0.375 Sum_probs=25.1
Q ss_pred CCceeeeccccCceEeCCC----------------------------CceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQ----------------------------WNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~----------------------------~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.|||++.+ ..+.|+||..+..
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 3479999999999999875 6788999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=81.37 E-value=0.86 Score=44.60 Aligned_cols=17 Identities=35% Similarity=0.339 Sum_probs=15.2
Q ss_pred CCceeeeccccCceEeC
Q 015360 196 EPKVVHRDVKSSNILLD 212 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~ 212 (408)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 34799999999999998
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 408 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 0.001 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-04 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-06 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-05 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-06 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-04 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-06 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 0.001 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-29 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-29 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-04 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-06 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-28 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-04 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-28 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-05 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 0.002 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 0.003 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 0.001 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 0.002 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-27 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-04 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 0.002 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-04 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-04 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 0.002 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 0.001 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-04 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-24 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-24 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-04 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-24 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-04 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-24 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 0.001 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 0.001 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-04 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 0.002 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-21 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-04 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-20 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-04 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 0.002 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-20 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-04 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-20 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-04 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 0.001 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-20 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-04 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-05 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 0.001 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-04 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-04 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 0.003 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 0.001 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-18 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 0.002 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-04 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-04 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-04 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 0.002 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-05 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-15 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-04 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-14 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-05 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 0.002 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 0.001 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 0.001 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-12 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 0.001 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 0.004 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-37
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
+ YLH ++HRD+KS+NI L ++ DFGLA + S+ ++ G+ ++
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 247 APEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
APE + +SDVY+FGI++ E++TG+ P +N D + MVG
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVG---- 223
Query: 304 EEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ P L K+ + KA+KR++ C+ +RP ++ +E
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 0.001
Identities = 16/56 (28%), Positives = 21/56 (37%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILL 211
IG G +G VY+G V + N+ L V R + NILL
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 188 LAYLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRV 239
LA+LH + +P + HRD+KS NIL+ + ++D GLA S +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 240 MGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNP----VDYSRPQGEVN 289
+GT Y+APE + +++D+Y+ G++ EI + DY P ++
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 290 LVDWLKTMVGSRKSEEVVDPKLPKMPASK-ALKRVLLVALRCVDPDATKRPKMGHVIHML 348
D + E+ + P +P S AL+ + + C + R + L
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 349 E 349
Sbjct: 293 S 293
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 12/26 (46%), Positives = 17/26 (65%), Gaps = 1/26 (3%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVK 181
+ IG+G +G V+RG G +VAVK
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK 32
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-32
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 22/164 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+A++ E +HRD++++NIL+ + +++DFGLA+L+ + A
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--NLVDWLKTMVGSRKSEE 305
PE G KSDV+SFGIL+ EI+T EV NL + + EE
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ + C RP ++ +LE
Sbjct: 239 LYQ-----------------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.8 bits (108), Expect = 4e-06
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRL 188
+G G +G V+ G + TKVAVK+L +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM 50
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-32
Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 17/172 (9%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTT 237
+ +L A + VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297
+ APE SDV+SFGI++ E++T + EV
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--------- 222
Query: 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ ++ + + ++C + +RPK ++ +L+
Sbjct: 223 ------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 5/42 (11%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGT-----KVAVKNL 183
E S + + VIG G +G VY+G+L + VA+K L
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL 44
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 18/166 (10%)
Query: 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 243
+ + +AY+ VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 244 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303
+ APE A G KSDV+SFGIL+ E+ T EV +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------LDQV 227
Query: 304 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
E P ++L ++ +C + +RP ++ LE
Sbjct: 228 ERGYRMPCPP-ECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (108), Expect = 3e-06
Identities = 13/55 (23%), Positives = 29/55 (52%), Gaps = 1/55 (1%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
E +G+G +G V+ G + T+VA+K L ++ E +V+ + ++ ++
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK-LRHEKLV 75
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-31
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 191 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVA 247
+ K VHRD+ + N +LD ++ +V+DFGLA+ + + + T ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
E T KSDV+SFG+L+ E++T P P +VN D ++ + ++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLL---QGRRLL 254
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
P+ L V L+C P A RP ++ + A
Sbjct: 255 QPEY----CPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 2e-04
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 5/60 (8%)
Query: 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNL-LNNRLAYLHEGLEPKVVHRDVKSSNIL 210
VIG G +G VY G L D AVK+L + + + L ++ +D N+L
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-31
Identities = 35/171 (20%), Positives = 70/171 (40%), Gaps = 15/171 (8%)
Query: 179 AVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238
+ + + + E V+HRD+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161
Query: 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298
+ +PE + KSDV+SFG+L+ E+ + +R E +V+ +
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI---- 215
Query: 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ P+L AS + +++ C RP ++ L
Sbjct: 216 --STGFRLYKPRL----ASTHVYQIM---NHCWKERPEDRPAFSRLLRQLA 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (106), Expect = 6e-06
Identities = 10/27 (37%), Positives = 16/27 (59%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNL 183
IG G +G+V+ G + KVA+K +
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTI 37
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 1e-30
Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 19/163 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYV 246
+AYL E K VHRD+ + N L+ +++DFGL++ + S Y ++
Sbjct: 153 MAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM 209
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE +SDV+++G+++ EI + Y EV V
Sbjct: 210 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV--------------IYYV 255
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
D + P + + C RP + +L+
Sbjct: 256 RDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.3 bits (88), Expect = 0.001
Identities = 15/47 (31%), Positives = 20/47 (42%), Gaps = 6/47 (12%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL 183
L LE + + IGEG +G V++ T VAVK L
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 51
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-29
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMGTFGYV 246
+ +L VHRD+ + N+L+ ++ DFGLA+ + S+ +YV ++
Sbjct: 177 MEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM 233
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE G+ KSDV+S+GIL+ EI + G NP +
Sbjct: 234 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF---------------YK 278
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
++ A + + ++ C D+ KRP ++ L
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 6e-29
Identities = 35/181 (19%), Positives = 69/181 (38%), Gaps = 18/181 (9%)
Query: 169 RGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 228
R +S + + +++ + YL + +HRD+ + N L+ +V+DFGL++L+
Sbjct: 109 RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165
Query: 229 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 288
+ + APE + KSDV++FG+L+ EI T +V
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
Query: 289 NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 348
E+++ ++V + C + + RP +
Sbjct: 226 ---------------YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
Query: 349 E 349
E
Sbjct: 271 E 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.6 bits (97), Expect = 1e-04
Identities = 18/67 (26%), Positives = 32/67 (47%), Gaps = 2/67 (2%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRLAYLHEGLEPKVVHRD 203
+ E + + ++ +G G YG VY G+ VAVK L + E L+ V ++
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKE 69
Query: 204 VKSSNIL 210
+K N++
Sbjct: 70 IKHPNLV 76
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 7e-29
Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 21/175 (12%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR- 238
+ +L A + + VHRD+ + NIL++ +VSDFGL++ L + S T
Sbjct: 130 LVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 239 ---VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL 294
+ APE SDV+S+GI++ E+++ G P Q +N ++
Sbjct: 190 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ- 248
Query: 295 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
D +LP P + + L C D RPK G +++ L+
Sbjct: 249 -------------DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 45.5 bits (107), Expect = 5e-06
Identities = 16/56 (28%), Positives = 21/56 (37%), Gaps = 13/56 (23%)
Query: 141 YTLRELEAATSGLCEE---------NVIGEGGYGIVYRGILSDGTK----VAVKNL 183
+T + A +E VIG G +G V G L K VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-28
Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 20/159 (12%)
Query: 189 AYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+LH P ++HRD+K NI + + ++ D GLA L R+ V+GT ++A
Sbjct: 126 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMA 181
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE +E DVY+FG+ ++E+ T P + ++ R+ V
Sbjct: 182 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----------RRVTSGV 229
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346
P A +K ++ C+ + +R + +++
Sbjct: 230 KPASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 4e-04
Identities = 10/34 (29%), Positives = 19/34 (55%), Gaps = 1/34 (2%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRL 188
+ IG G + VY+G+ ++ +VA L + +L
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 47
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 33/162 (20%), Positives = 63/162 (38%), Gaps = 18/162 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YL + +HRD+ + N L++ Q +VSDFGL++ + + + +
Sbjct: 113 MEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + KSD+++FG+L+ EI + E +E +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------------AEHIA 215
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
P A ++V + C A +RP ++ +
Sbjct: 216 QGLRLYRP-HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (104), Expect = 1e-05
Identities = 11/54 (20%), Positives = 22/54 (40%), Gaps = 1/54 (1%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+G G +G+V G VA+K ++ E +E V ++ ++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 4e-28
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 188 LAYLHEGLE--PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 245
L H + V+HRD+K +N+ LD + N ++ DFGLA++L + S+ +GT Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYY 180
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
++PE NEKSD++S G L+ E+ P + +
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---------------GK 225
Query: 306 VVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRPKMGHVI 345
+ + K ++P S L ++ R ++ RP + ++
Sbjct: 226 IREGKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (86), Expect = 0.002
Identities = 10/28 (35%), Positives = 12/28 (42%), Gaps = 1/28 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL 183
IG G YG + SDG + K L
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKEL 37
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-28
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYV 246
+ YL + ++VHRD+ + N+L+ + +++DFGLAKLL + E+ Y ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
A E + +SDV+S+G+ + E++T + P E+ S +
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSIL 226
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRI----G 362
+ P V ++ ++C DA RPK +I + RD +R G
Sbjct: 227 EKGERLPQP-PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK---MARDPQRYLVIQG 282
Query: 363 REPSNSYGEENRDFARKVGDKQLGEGASDTSE 394
E + + +F R + D++ + D E
Sbjct: 283 DERMHLPSPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 11/32 (34%), Positives = 16/32 (50%), Gaps = 5/32 (15%)
Query: 157 NVIGEGGYGIVYRGILSD-----GTKVAVKNL 183
V+G G +G VY+G+ VA+K L
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL 46
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 5/169 (2%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YL E + K++HRDVK SNIL++ + ++ DFG++ L +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMS 171
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + +SD++S G+ ++E+ GR P+ + + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFR 356
P P + + + PK+ + LE D + +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.1 bits (88), Expect = 0.001
Identities = 7/26 (26%), Positives = 13/26 (50%), Gaps = 1/26 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK 181
+ +G G G+V++ G +A K
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARK 37
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 30/159 (18%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 191 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 250
+ + + +HRD+ + NIL+ + A+++DFGL++ T ++A E
Sbjct: 140 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIES 197
Query: 251 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310
+ SDV+S+G+L+ EI++ P + + E++
Sbjct: 198 LNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY---------EKLPQGY 243
Query: 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ P V + +C +RP ++ L
Sbjct: 244 RLEKP-LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 9/31 (29%), Positives = 16/31 (51%), Gaps = 3/31 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNL 183
++VIGEG +G V + + A+K +
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 45
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-27
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 23/158 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L+Y H +V+HRD+K N+LL +++DFG + S R T + GT Y+
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 172
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE M +EK D++S G+L E + G+ P + + Q + ++ +E
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 232
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345
D + R + + ++RP + V+
Sbjct: 233 D-----------------LISRLLKHNPSQRPMLREVL 253
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (90), Expect = 6e-04
Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 11/76 (14%)
Query: 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRL---AYLHEG 194
R + L + E +G+G +G VY +A+K L +L H+
Sbjct: 1 RQWALEDFE-------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 195 LEPKVVHRDVKSSNIL 210
+ ++ NIL
Sbjct: 54 RREVEIQSHLRHPNIL 69
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-27
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 24/167 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGY 245
+ YL E VHRD+ + N+LL + A++SDFGL+K L ++ SY T R +
Sbjct: 122 MKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE + +SDV+S+G+ + E ++ P ++ + +
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVM---------AF 224
Query: 306 VVDPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350
+ K + P L ++ C RP V + A
Sbjct: 225 IEQGKRMECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (86), Expect = 0.002
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 4/44 (9%)
Query: 144 RELEAATSGLCEENV-IGEGGYGIVYRGIL---SDGTKVAVKNL 183
++L L ++ +G G +G V +G+ VA+K L
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL 44
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 6e-27
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 24/166 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGY 245
+ YL E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + +
Sbjct: 120 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE + KSDV+SFG+L+ E + EV +
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAM 222
Query: 306 VVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ + PA + + ++ C D RP V L
Sbjct: 223 LEKGERMGCPAGCPREMYDLM---NLCWTYDVENRPGFAAVELRLR 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (96), Expect = 1e-04
Identities = 11/32 (34%), Positives = 15/32 (46%), Gaps = 3/32 (9%)
Query: 155 EENVIGEGGYGIVYRGILSD---GTKVAVKNL 183
E+ +G G +G V +G VAVK L
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL 42
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 36/163 (22%), Positives = 68/163 (41%), Gaps = 18/163 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYV 246
+A+L +HRD+ + NILL ++ DFGLA+ + ++ +Y V ++
Sbjct: 158 MAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE + +SDV+S+GI + E+ + + P K ++
Sbjct: 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------------KFYKM 260
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ + A + + C D D KRP ++ ++E
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-26
Identities = 45/162 (27%), Positives = 64/162 (39%), Gaps = 22/162 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ YL VHRD+ + N+L+ A+VSDFGL K S + + A
Sbjct: 116 MEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 168
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + KSDV+SFGIL+ EI + P + L D + + E+
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV------PRVEKGY 217
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
P A+ V+ C DA RP + LE
Sbjct: 218 KMDAPD-GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLE 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 4e-04
Identities = 13/31 (41%), Positives = 17/31 (54%), Gaps = 1/31 (3%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNR 187
IG+G +G V G G KVAVK + N+
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA 42
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-26
Identities = 37/163 (22%), Positives = 68/163 (41%), Gaps = 18/163 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYV 246
+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV ++
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE + +SDV+SFG+L+ EI + P V + + + +E
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRL-----KEG 253
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ P + + L C + ++RP ++ L
Sbjct: 254 TRMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-26
Identities = 34/174 (19%), Positives = 66/174 (37%), Gaps = 22/174 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L + VHRD+ + N+L+ ++ DFGL++ + Y ++ ++A
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE SDV+ FG+ + EI+ P V D + +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVI---------GRIE 223
Query: 308 DPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 359
+ + MP L ++ +C D ++RP+ + L + +E+
Sbjct: 224 NGERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST---ILEEEK 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (86), Expect = 0.002
Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 5/60 (8%)
Query: 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRLAYLHEGLEPKV-VHRDVKSSNIL 210
IGEG +G V++GI VA+K N + E + R +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 6e-25
Identities = 39/188 (20%), Positives = 70/188 (37%), Gaps = 24/188 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYV 246
+ K VHRD+ + N ++ + ++ DFG+ + + Y + + ++
Sbjct: 143 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
+PE G+ SDV+SFG+++ EI T +V V
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--------------LRFV 248
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIG-REP 365
++ L P + + C + RP +I ++ +E G RE
Sbjct: 249 MEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK-------EEMEPGFREV 300
Query: 366 SNSYGEEN 373
S Y EEN
Sbjct: 301 SFYYSEEN 308
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 14/49 (28%), Positives = 23/49 (46%), Gaps = 6/49 (12%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL 183
Y E E A + +G+G +G+VY G+ T+VA+K +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (252), Expect = 8e-25
Identities = 42/185 (22%), Positives = 68/185 (36%), Gaps = 26/185 (14%)
Query: 160 GEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 219
V++ L + AV + LAYLH ++HRDVK+ NILL ++
Sbjct: 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKL 156
Query: 220 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGR 276
DFG A ++ +GT ++APE G + K DV+S GI +E+ +
Sbjct: 157 GDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 277 NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 336
P+ + + P L S+ + + C+
Sbjct: 212 PPLFNMNAMSAL------------YHIAQNESPALQSGHWSEYFRNFV---DSCLQKIPQ 256
Query: 337 KRPKM 341
RP
Sbjct: 257 DRPTS 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.8 bits (90), Expect = 7e-04
Identities = 9/30 (30%), Positives = 15/30 (50%), Gaps = 1/30 (3%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL 183
+ IG G +G VY + + VA+K +
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKM 48
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-24
Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 19/164 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGY 245
+ YL + +HRD+ + N+LL + ++ DFGL + L + + F +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE T + SD + FG+ + E+ T P +N L + E
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKID----KEG 231
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
P+ P + + V ++C RP + L
Sbjct: 232 ERLPRPEDCP-----QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 1e-24
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYV 246
+ YLH + HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YV
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 247 APEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE + E DV+S GI++ ++ G P D + K ++
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKK 223
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 344
K+ A +L + + + + R + +
Sbjct: 224 TYLNPWKKI--DSAPLALL---HKILVENPSARITIPDI 257
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 5e-04
Identities = 13/56 (23%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKV-VHRDVKSSNIL 210
+GEG YG V + VAVK + R E ++ ++ +++ + N++
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +V+HRD+KS NILL + +++DFG + E+S +T V GT ++A
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 184
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE K D++S GI+ +E+I G P P + L+ +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----------ATNGTP 234
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
+ + P+ S + L RC+D D KR
Sbjct: 235 ELQNPE-KLSAIFRDFL---NRCLDMDVEKRGSA 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (96), Expect = 1e-04
Identities = 14/55 (25%), Positives = 28/55 (50%), Gaps = 1/55 (1%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
IG+G G VY + ++ G +VA++ + + + +V R+ K+ NI+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 5e-24
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 23/159 (14%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L YLH+ K++HRD+K+ NIL + +++DFG++ + + GT ++A
Sbjct: 123 LNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMA 178
Query: 248 PEYACTGML-----NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 302
PE + K+DV+S GI ++E+ P P + + K
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------AK 229
Query: 303 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
SE + + S K L +C++ + R
Sbjct: 230 SEPPTLAQPSRW--SSNFKDFL---KKCLEKNVDARWTT 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (88), Expect = 0.001
Identities = 10/55 (18%), Positives = 19/55 (34%), Gaps = 1/55 (1%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+G+G +G VY+ A K + L + + + NI+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 2e-23
Identities = 36/163 (22%), Positives = 66/163 (40%), Gaps = 19/163 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 246
+ YL K +HRD+ + N+L+ +++DFGLA+ + Y T ++
Sbjct: 148 MEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 204
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
APE + +SDV+SFG+L+ EI T P E+ + +
Sbjct: 205 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--------------FKLL 250
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ P S + ++ C ++RP ++ L+
Sbjct: 251 KEGHRMDKP-SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 91.0 bits (225), Expect = 2e-21
Identities = 27/177 (15%), Positives = 57/177 (32%), Gaps = 23/177 (12%)
Query: 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAKLLCSERS----- 233
+ R+ +HE +V+RD+K N L+ R + V DFG+ K +
Sbjct: 110 MLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 234 -YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 292
+ GT Y++ + + D+ + G + M + G P + +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226
Query: 293 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 349
+ S E+ P + + + + P ++ +
Sbjct: 227 RIGEKKQSTPLREL----CAGFP--EEFYKYM---HYARNLAFDATPDYDYLQGLFS 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.6 bits (89), Expect = 0.001
Identities = 10/27 (37%), Positives = 17/27 (62%), Gaps = 1/27 (3%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK 181
IGEG +G+++ G L + +VA+K
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIK 36
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.3 bits (226), Expect = 3e-21
Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +++RD+K NILLD+ + +++DFG AK + + GT Y+A
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIA 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE T N+ D +SFGILI E++ G P S + +E
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI---------LNAELRF 220
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
P ++ +K +L R + D ++R
Sbjct: 221 PPFF-----NEDVKDLL---SRLITRDLSQRL 244
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.7 bits (92), Expect = 4e-04
Identities = 12/58 (20%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+G G +G V+ +G A+K L + RL + + +++ V I+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 4e-21
Identities = 36/164 (21%), Positives = 68/164 (41%), Gaps = 15/164 (9%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L +LH +VVHRD+K NIL+ +++DFGLA++ + + T V+ T Y A
Sbjct: 129 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRA 183
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTM 297
PE D++S G + E+ + S ++ + DW + +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
R++ + + + + + L+C+ + KR
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 14/39 (35%), Positives = 20/39 (51%), Gaps = 9/39 (23%)
Query: 152 GLCEEN-------VIGEGGYGIVYRG--ILSDGTKVAVK 181
GLC + IGEG YG V++ + + G VA+K
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK 39
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (226), Expect = 5e-21
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L ++H VV+RD+K +NILLD + R+SD GLA ++ +GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173
Query: 248 PEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
PE G+ + +D +S G ++ +++ G +P + + + + TM
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------- 224
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGH 343
+LP S L+ +L + D +R
Sbjct: 225 -AVELPD-SFSPELRSLL---EGLLQRDVNRRLGCLG 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.9 bits (95), Expect = 2e-04
Identities = 13/34 (38%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRL 188
+IG GG+G VY +D G A+K L R+
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 42
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.3 bits (221), Expect = 1e-20
Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYV 246
++ L ++HRD+K NILL+ + +++DFG AK+L E + +GT YV
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306
+PE + SD+++ G +I +++ G P + + + K +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKL------- 225
Query: 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
+ P+ + ++ + + DATKR
Sbjct: 226 -EYDFPE-KFFPKARDLV---EKLLVLDATKRL 253
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 4e-04
Identities = 9/58 (15%), Positives = 19/58 (32%), Gaps = 4/58 (6%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLA---YLHEGLEPKVVHRDVKSSNI 209
++GEG + V L+ + A+K L + + + V +
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 87.9 bits (217), Expect = 2e-20
Identities = 41/173 (23%), Positives = 74/173 (42%), Gaps = 16/173 (9%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TT 237
++ + L+ + ++HRDVK +NI++ +V DFG+A+ + + V T
Sbjct: 113 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297
V+GT Y++PE A ++ +SDVYS G ++ E++TG P P
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------ 226
Query: 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIHMLE 349
E+ + P S L V+ L+ + + R + + L
Sbjct: 227 ----VREDPIPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 37.8 bits (87), Expect = 0.002
Identities = 9/27 (33%), Positives = 12/27 (44%), Gaps = 1/27 (3%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK 181
++G GG V+ L VAVK
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVK 38
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 88.6 bits (219), Expect = 3e-20
Identities = 46/229 (20%), Positives = 74/229 (32%), Gaps = 36/229 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
L ++HE VH D+K NI+ + + + DFGL L ++S T GT +
Sbjct: 137 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEF 191
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE A + +D++S G+L +++G +P + V KS +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----------KSCD 241
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL----FRDERRI 361
S+ K + + + D R L
Sbjct: 242 WNMDDSAFSGISEDGKDFI---RKLLLADPNTRMT---------IHQALEHPWLTPGNAP 289
Query: 362 GRE---PSNSYGEENRDFARKVGDKQLGEGASDTSEGDGSRNNHRPTMR 407
GR+ PS+ Y + K S HRP
Sbjct: 290 GRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEY 338
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 41.2 bits (96), Expect = 1e-04
Identities = 8/53 (15%), Positives = 20/53 (37%), Gaps = 1/53 (1%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNI 209
+G G +G+V+R + G A K ++ + + ++ +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-20
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ L +V+RD+K NILLD+ + +++DFG+ K + T GT Y+A
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIA 171
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE N D +SFG+L+ E++ G++P + L ++
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMD---------- 218
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP 339
+P P+ K K +L ++ + KR
Sbjct: 219 NPFYPRW-LEKEAKDLL---VKLFVREPEKRL 246
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (90), Expect = 7e-04
Identities = 10/50 (20%), Positives = 22/50 (44%), Gaps = 2/50 (4%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDV 204
++G+G +G V+ A+K L + + + +E +V + V
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRV 55
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.2 bits (215), Expect = 6e-20
Identities = 32/179 (17%), Positives = 56/179 (31%), Gaps = 23/179 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYV------TTR 238
+ Y+H +HRDVK N L + + DFGLAK R++
Sbjct: 116 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298
+ GT Y + + + D+ S G ++M G P + + + +
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRD 357
S E + L C +P ++ + +L R
Sbjct: 233 MSTPIEVLCK------GYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFR--NLFHRQ 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.9 bits (87), Expect = 0.001
Identities = 10/27 (37%), Positives = 16/27 (59%), Gaps = 1/27 (3%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK 181
IG G +G +Y G ++ G +VA+K
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIK 38
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 86.7 bits (214), Expect = 7e-20
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 24/160 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ LH+ +VHRD+K NILLD N +++DFG + L V GT Y+A
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLA 177
Query: 248 PEYACTGML------NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301
PE M ++ D++S G+++ ++ G P + + + ++
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MS 229
Query: 302 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
+ + P+ S +K ++ R + KR
Sbjct: 230 GNYQFGSPEWDDY--SDTVKDLV---SRFLVVQPQKRYTA 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 40.1 bits (93), Expect = 3e-04
Identities = 11/56 (19%), Positives = 21/56 (37%), Gaps = 1/56 (1%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+ ++G G +V R I + AVK + ++ +K +IL
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 85.3 bits (210), Expect = 3e-19
Identities = 27/166 (16%), Positives = 62/166 (37%), Gaps = 12/166 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L + + +V+HRD+K N+L++R+ +++DFGLA+ T ++ +
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
+ + D++S G + E++ G ++ + + S+ V
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 308 D--------PKLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 341
+ +P LK + + + + D +R
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 42.6 bits (99), Expect = 4e-05
Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
IGEG YG+VY+ + G A+K L + + +++K SNI+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 3e-19
Identities = 33/174 (18%), Positives = 65/174 (37%), Gaps = 12/174 (6%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 239
+K+ L L L +V+HRD+K N+L++ + +++DFGLA+ T V
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 240 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------- 291
+ + + D++S G + E++T R ++ +
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 292 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 341
+ + V S + PK + SK + + + + D KR
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 12/26 (46%), Positives = 15/26 (57%), Gaps = 1/26 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK 181
IGEG YG+VY+ G VA+K
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALK 33
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 4e-19
Identities = 43/227 (18%), Positives = 91/227 (40%), Gaps = 23/227 (10%)
Query: 132 VSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYL 191
+ R T+ +++ +++G Y ++ LS+ + L Y+
Sbjct: 69 IGINDIIRAPTIEQMK---DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 192 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPE 249
H V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 250 YACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTMV 298
+ D++S G ++ E+++ R ++N + D +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 299 GSRKSEEVVDPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 341
++ + P K+P ++ AL + + + KR ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 7e-04
Identities = 14/55 (25%), Positives = 22/55 (40%), Gaps = 2/55 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRLAYLHEGLEPKVVHRDVKSSNI 209
+ IGEG YG+V + +VA+K + Y L + + NI
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 85.5 bits (211), Expect = 5e-19
Identities = 46/229 (20%), Positives = 80/229 (34%), Gaps = 35/229 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
L ++HE +VH D+K NI+ + + + V DFGLA L + + T +
Sbjct: 140 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEF 194
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE + +D+++ G+L +++G +P GE +L + +E
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQNVKRCDWEFDE 249
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL----FRD--ER 359
+ S K + + + KR D L +
Sbjct: 250 DAFSSV-----SPEAKDFI---KNLLQKEPRKRLT---------VHDALEHPWLKGDHSN 292
Query: 360 RIGREPSNSYGEENRDFARKVGDKQLGEGASDTSEGDGSRNNHRPTMRR 408
R PS+ Y + + K D + A S HRP +
Sbjct: 293 LTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQ 341
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 39.3 bits (91), Expect = 6e-04
Identities = 7/54 (12%), Positives = 19/54 (35%), Gaps = 1/54 (1%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+G G +G+V+R + + G K + + + + ++
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 1e-18
Identities = 36/188 (19%), Positives = 69/188 (36%), Gaps = 30/188 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ YLH + HRDVK N+L + +++DFG AK S S T T
Sbjct: 124 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPY 178
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
YVAPE ++ D++S G+++ ++ G P + M +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AISPGMKTRIRMG 232
Query: 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL----FRDERR 360
+ P S+ +K ++ + + T+R + + +
Sbjct: 233 QYEFPNPEWSEVSEEVKMLI---RNLLKTEPTQRMT---------ITEFMNHPWIMQSTK 280
Query: 361 IGREPSNS 368
+ + P ++
Sbjct: 281 VPQTPLHT 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (86), Expect = 0.003
Identities = 8/27 (29%), Positives = 11/27 (40%), Gaps = 1/27 (3%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK 181
V+G G G V + K A+K
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK 43
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 4e-18
Identities = 23/170 (13%), Positives = 53/170 (31%), Gaps = 19/170 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L L V+HRD+K N+L++R ++++FGLA+ + V+ +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNP----------------VDYSRPQGEVNLV 291
+ + D++S G + E+ P + + + + +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 292 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
L + + +L + + +R
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISA 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 15/56 (26%), Positives = 24/56 (42%), Gaps = 3/56 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRLAYLHEGLEPKVVHRDVKSSNI 209
IGEG YG V++ VA+K L ++ L + +++K NI
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 4e-18
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 22/167 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
++ L VV+RD+K N++LD+ + +++DFGL K S+ + GT Y+A
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE D + G+++ E++ GR P + + ++
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME------- 220
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 354
+ + P+ S K +L + D +R G +A +++
Sbjct: 221 EIRFPR-TLSPEAKSLL---AGLLKKDPKQRLGGG----PSDAKEVM 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (87), Expect = 0.002
Identities = 8/33 (24%), Positives = 15/33 (45%), Gaps = 1/33 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRL 188
++G+G +G V + G A+K L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI 43
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 8e-18
Identities = 32/166 (19%), Positives = 58/166 (34%), Gaps = 13/166 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L L + ++HRD+K +N+LLD +++DFGLAK S T +V T Y A
Sbjct: 110 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRA 168
Query: 248 PEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------DWLKTMVG 299
PE + D+++ G ++ E++ + ++ + +
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 300 SRKSEEVVDPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 341
+ V P +P L + R
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (96), Expect = 1e-04
Identities = 11/59 (18%), Positives = 25/59 (42%), Gaps = 6/59 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKV-----VHRDVKSSNI 209
+ +GEG + VY+ + VA+K + + +G+ + +++ NI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.6 bits (201), Expect = 8e-18
Identities = 27/156 (17%), Positives = 57/156 (36%), Gaps = 20/156 (12%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGY 245
L +LH + H D++ NI+ + ++ + +FG A+ L ++ Y
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEY 169
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
APE +++ +D++S G L+ +++G NP Q + + + E
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------MNAE 219
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
+ S + R + + R
Sbjct: 220 YTFDEEAFKEISIEAMDFV---DRLLVKERKSRMTA 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 9e-18
Identities = 37/200 (18%), Positives = 75/200 (37%), Gaps = 19/200 (9%)
Query: 161 EGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 220
E + +L T +K ++ L L+ K++HRD+K++N+L+ R +++
Sbjct: 100 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 159
Query: 221 DFGLAKLLCSERS---YVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGR 276
DFGLA+ ++ T + T Y PE D++ G ++ E+ T
Sbjct: 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
Query: 277 NPVDYSRPQGEVNLV---------DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVA 327
+ + Q ++ L+ + + E++ K K LK +
Sbjct: 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDP 279
Query: 328 L------RCVDPDATKRPKM 341
+ + D +R
Sbjct: 280 YALDLIDKLLVLDPAQRIDS 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (90), Expect = 6e-04
Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLL--NNRLAYLHEGLEPKVVHRDVKSSNI 209
IG+G +G V++ G KVA+K +L N + + L + + +K N+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.6 bits (193), Expect = 6e-17
Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 19/166 (11%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCSERSYV 235
L L ++ ++ H D+K NI+L + + + DFGLA + +
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 236 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 295
+ GT +VAPE L ++D++S G++ +++G +P Q + V
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---- 228
Query: 296 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
S + E D S K + R + D KR +
Sbjct: 229 ----SAVNYEFEDEYFSNT--SALAKDFI---RRLLVKDPKKRMTI 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 11/49 (22%), Positives = 21/49 (42%), Gaps = 1/49 (2%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVK 205
+G G + +V + S G + A K + R G+ + + R+V
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.4 bits (187), Expect = 5e-16
Identities = 38/153 (24%), Positives = 62/153 (40%), Gaps = 24/153 (15%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
YLH +++RD+K N+L+D+Q +V+DFG AK + + GT +A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALA 206
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307
PE + N+ D ++ G+LI E+ G P +P + K S S ++
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340
D + + D TKR
Sbjct: 267 D-----------------LLRNLLQVDLTKRFG 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.9 bits (87), Expect = 0.002
Identities = 11/56 (19%), Positives = 20/56 (35%), Gaps = 4/56 (7%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLA---YLHEGLEPKVVHRDVKSSNI 209
+G G +G V G A+K L ++ + L K + + V +
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 6e-16
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 19/169 (11%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
+ L + +++RD+K NILLD + ++DFGL+K ++ + GT Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 248 PEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 305
P+ G ++ D +S G+L+ E++TG +P + + KSE
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-----TVDGEKNSQAEISRRILKSEP 253
Query: 306 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 354
++ S K ++ R + D KR G +AD++
Sbjct: 254 PYPQEM-----SALAKDLI---QRLLMKDPKKRLGCGP----RDADEIK 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 1e-15
Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 28/164 (17%)
Query: 180 VKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTR 238
++ L + V+HRD+K NIL+D ++ DFG LL T
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTD 168
Query: 239 VMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 297
GT Y PE+ + V+S GIL+ +++ G P ++
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------- 213
Query: 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
E + + S + ++ C+ + RP
Sbjct: 214 -----EEIIRGQVFFRQRVSSECQHLI---RWCLALRPSDRPTF 249
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 8e-05
Identities = 17/49 (34%), Positives = 28/49 (57%), Gaps = 1/49 (2%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVK 205
++G GG+G VY GI +SD VA+K++ +R++ E V +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 72.4 bits (177), Expect = 9e-15
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 244
+ YLH+ +VHRD+K N+L D +SDFGL+K+ + V + GT G
Sbjct: 120 VKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPG 174
Query: 245 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304
YVAPE ++ D +S G++ ++ G P + N + ++ +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQIL--KAEY 226
Query: 305 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341
E P + S + K + ++ D KR
Sbjct: 227 EFDSPYWDDI--SDSAKDFI---RHLMEKDPEKRFTC 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 6e-04
Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 2/57 (3%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKV-VHRDVKSSNIL 210
+V+G G + V VA+K + L +E ++ V +K NI+
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 4e-14
Identities = 33/165 (20%), Positives = 61/165 (36%), Gaps = 17/165 (10%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
LAY+H + HRD+K N+LLD ++ DFG AK L + + +
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRA 190
Query: 247 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL-------KTMVG 299
DV+S G ++ E++ G+ ++ + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 300 SRKSEEVVDPKLPKMPASKALKRVL---LVAL--RCVDPDATKRP 339
+ E P++ P +K + +AL R ++ T R
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (102), Expect = 3e-05
Identities = 17/57 (29%), Positives = 28/57 (49%), Gaps = 5/57 (8%)
Query: 155 EENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+ VIG G +G+VY+ L G VA+K +L ++ E + R + NI+
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 7e-13
Identities = 39/197 (19%), Positives = 71/197 (36%), Gaps = 33/197 (16%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 247
L Y+H ++HRD+K N+ ++ ++ DFGLA+ SE T V+ +
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAP 187
Query: 248 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTM 297
+ D++S G ++ E+ITG+ S ++ + +
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 298 VGSRKSEEVVDPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKMGHVIHMLEADDL 353
K+ P+L K + L +A+ + + DA +R A +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---------AGEA 298
Query: 354 L----FRDERRIGREPS 366
L F EP
Sbjct: 299 LAHPYFESLHDTEDEPQ 315
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 10/25 (40%), Positives = 13/25 (52%), Gaps = 1/25 (4%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK 181
+G G YG V + G KVA+K
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIK 49
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 2e-12
Identities = 44/232 (18%), Positives = 82/232 (35%), Gaps = 33/232 (14%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLD 212
+++G IV L+D + + L Y+H ++HRD+K SN+ ++
Sbjct: 99 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 155
Query: 213 RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEI 272
++ DFGLA +T V + N+ D++S G ++ E+
Sbjct: 156 EDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 273 ITGRNPVDYSRPQGEVNLV----------DWLKTMVGSRKSEEVVDPKLPKMPASKALKR 322
+TGR + ++ L+ K S ++ ++PKM +
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 323 VLLVAL----RCVDPDATKRPKMGHVIHMLEADDLL----FRDERRIGREPS 366
+A+ + + D+ KR A L F EP
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRIT---------AAQALAHAYFAQYHDPDDEPV 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 10/26 (38%), Positives = 13/26 (50%), Gaps = 1/26 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK 181
+ +G G YG V G +VAVK
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVK 49
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.4 bits (158), Expect = 2e-12
Identities = 21/113 (18%), Positives = 41/113 (36%), Gaps = 2/113 (1%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTR-VMGTFGY 245
L + ++H D+K N+L++ + +A L + + T Y
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 246 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 298
+PE +D++S LI E+ITG + D + ++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.5 bits (88), Expect = 0.001
Identities = 7/34 (20%), Positives = 17/34 (50%), Gaps = 1/34 (2%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRL 188
+G G + V+ + + T VA+K + +++
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV 51
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 63.7 bits (154), Expect = 8e-12
Identities = 23/93 (24%), Positives = 44/93 (47%), Gaps = 7/93 (7%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 246
L Y H ++HRDVK N+++D + R+ D+GLA+ + Y + + +
Sbjct: 142 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFK 196
Query: 247 APEYACTGML-NEKSDVYSFGILIMEIITGRNP 278
PE + + D++S G ++ +I + P
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 38.3 bits (88), Expect = 0.001
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 3/55 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNIL 210
+G G Y V+ I +++ KV VK L + + E K++ NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR--EIKILENLRGGPNII 93
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.0 bits (152), Expect = 1e-11
Identities = 39/200 (19%), Positives = 74/200 (37%), Gaps = 27/200 (13%)
Query: 165 GIVYRGILSDGTKVAVKNLLNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224
+ + I + + LL L + ++HRD+K SNI++ ++ DFGL
Sbjct: 106 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 284
A+ + S++ T + T Y APE E D++S G ++ E++ +
Sbjct: 166 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 285 QGEVNLV---------DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVAL------- 328
+ N V +++K + + ++ PK + K L A
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283
Query: 329 ---------RCVDPDATKRP 339
+ + D KR
Sbjct: 284 ASQARDLLSKMLVIDPAKRI 303
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 9/25 (36%), Positives = 10/25 (40%), Gaps = 1/25 (4%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK 181
IG G GIV VA+K
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIK 48
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 41.3 bits (96), Expect = 6e-05
Identities = 6/25 (24%), Positives = 10/25 (40%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK 181
++GEG V+ + VK
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVK 30
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 38.6 bits (89), Expect = 6e-04
Identities = 15/86 (17%), Positives = 31/86 (36%), Gaps = 12/86 (13%)
Query: 188 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--YVTTRVMGTFGY 245
+A + +VH D+ N+L+ + + DF + + E + V Y
Sbjct: 116 VAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 246 VAPEYACTGMLNEKSDVYSFGILIME 271
+ Y + D+ S I++
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 408 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.98 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.68 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 94.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 85.73 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=304.94 Aligned_cols=183 Identities=27% Similarity=0.411 Sum_probs=145.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|.+.+.||+|+||+||+|.+++++.||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 4578888999999999999999988899999987
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.||.|||+. +|+||||||+||||+.++.+||+|||+++...........
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 45669999998 9999999999999999999999999999987655544445
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
...||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+...... .+. .+..+.
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~~~~~i~-~~~-----~~~~p~---- 233 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLE-RGY-----RMVRPD---- 233 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHH-TTC-----CCCCCT----
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH-hcC-----CCCCcc----
Confidence 56789999999999999999999999999999999996555432211 111122211 111 111111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+|+.+||+.||++||||+||++.|+.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 122367889999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=303.25 Aligned_cols=182 Identities=26% Similarity=0.436 Sum_probs=133.7
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||+||+|.+.+++.||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 468888999999999999999988999999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 55679999999 99999999999999999999999999998775544444444
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITG-RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..||+.|+|||++.+..++.++|||||||++|||+|+ ++||..... ..+...+. .... +..+..
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~---~~~~------~~~p~~--- 226 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS---TGFR------LYKPRL--- 226 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHH---HTCC------CCCCTT---
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---hcCC------CCCccc---
Confidence 6789999999999999999999999999999999995 555543221 11222221 1111 111111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...++.+|+.+||+.||++||||+||++.|+..
T Consensus 227 -~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 227 -ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 123678899999999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=297.86 Aligned_cols=181 Identities=23% Similarity=0.390 Sum_probs=147.5
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|++++++.||||.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 678999999999999999999988889999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 55679999998 99999999999999999999999999998765554444445
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .. .... ..... +..+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~---~~~i-~~~~~-----~~~p~---- 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ET---AEHI-AQGLR-----LYRPH---- 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH---HHHH-HTTCC-----CCCCT----
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HH---HHHH-HhCCC-----CCCcc----
Confidence 678999999999999999999999999999999998 89999744321 11 1112 11111 11111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+|+.+||+.||++|||++||++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122468899999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=297.50 Aligned_cols=186 Identities=29% Similarity=0.485 Sum_probs=138.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeCCCcEEEEEEe----------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~---------------------------------------------- 183 (408)
.++|...+.||+|+||+||+|+++ ..||||.+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 467888999999999999999975 35999987
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-c
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-Y 234 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~ 234 (408)
++.||+|||+. +||||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 45679999998 999999999999999999999999999987643322 2
Q ss_pred eecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... . +......+.. .+.+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~~~----~p~~ 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRGYL----SPDL 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHTSC----CCCG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcCCC----CCcc
Confidence 2345679999999999864 358899999999999999999999997543221 1 1111111111 1111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
. .........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 232 ~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 232 S-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp G-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 01111234688899999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-40 Score=307.85 Aligned_cols=185 Identities=24% Similarity=0.413 Sum_probs=146.4
Q ss_pred HhcCCCccceeccCCcEEEEEEEeCC-CcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~~-~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||+||+|++.+ ++.||||++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 45678888999999999999999864 889999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 45679999998 9999999999999999999999999999887655554
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
......|++.|+|||++.+..++.++|||||||++|||++|..||..... ... +...+..+. .+..+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~~i~~~~-----~~~~~~- 239 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKDY-----RMERPE- 239 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHHHHHTTC-----CCCCCT-
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHHHHhcCC-----CCCCCc-
Confidence 45556688999999999999999999999999999999997776543221 111 111121111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 240 ---~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 240 ---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1224688899999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-39 Score=303.03 Aligned_cols=191 Identities=29% Similarity=0.481 Sum_probs=135.7
Q ss_pred eeHHHHHHHhcCC---------CccceeccCCcEEEEEEEeCC-C---cEEEEEEe------------------------
Q 015360 141 YTLRELEAATSGL---------CEENVIGEGGYGIVYRGILSD-G---TKVAVKNL------------------------ 183 (408)
Q Consensus 141 ~~~~~l~~~t~~f---------~~~~~lg~G~~g~Vy~g~~~~-~---~~vavK~~------------------------ 183 (408)
|+++|+..++.+| ...++||+|+||+||+|.+.. + ..||||.+
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4556666665544 445899999999999999753 2 36899976
Q ss_pred --------------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC
Q 015360 184 --------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR 213 (408)
Q Consensus 184 --------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~ 213 (408)
++.||.|||+. +|+||||||+||||+.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECC
Confidence 55669999998 9999999999999999
Q ss_pred CCceEEeccCCceeecCCCcce----ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 015360 214 QWNARVSDFGLAKLLCSERSYV----TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEV 288 (408)
Q Consensus 214 ~~~~kL~Dfg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~ 288 (408)
++.+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--- 240 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--- 240 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999998764432211 122457899999999999999999999999999999998 89999744321
Q ss_pred hhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 289 NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.+.. ....... +. .+......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 241 ~~~~---~i~~~~~------~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 241 DVIN---AIEQDYR------LP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp HHHH---HHHTTCC------CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHH---HHHcCCC------CC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2222 1111111 11 111223468889999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=299.07 Aligned_cols=182 Identities=28% Similarity=0.512 Sum_probs=133.2
Q ss_pred cCCCccceeccCCcEEEEEEEeCCC-----cEEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDG-----TKVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~-----~~vavK~~------------------------------------------ 183 (408)
+.|...++||+|+||+||+|.+++. ..||||++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999998643 37999987
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 45569999998 9999999999999999999999999999876443
Q ss_pred Cc--ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 232 RS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 232 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... .+..... ..+.. +
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i-~~~~~-----~ 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAI-NDGFR-----L 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH-HTTCC-----C
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHH-hccCC-----C
Confidence 22 1223356899999999999999999999999999999999976665422211 1112211 11111 1
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..+ ......+.+|+.+||+.||++||||.||++.|+.
T Consensus 233 ~~~----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 233 PTP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp CCC----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCc----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111 1223468889999999999999999999999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=294.48 Aligned_cols=179 Identities=27% Similarity=0.388 Sum_probs=139.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +|+.||||.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999974 5899999986
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ce
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YV 235 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~ 235 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 45669999999 999999999999999999999999999987644332 22
Q ss_pred ecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .+ ........ ...
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~----~~~~~~~~---------~~~ 227 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKKT---------YLN 227 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HH----HHHHTTCT---------TST
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HH----HHHhcCCC---------CCC
Confidence 345679999999999988776 5789999999999999999999975443211 11 11111110 011
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
........+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11222346778999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=293.99 Aligned_cols=173 Identities=28% Similarity=0.459 Sum_probs=139.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +++.||||.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999975 5889999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 45569999999 99999999999999999999999999998654332
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... +.++..
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~p~~ 226 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVE-------FTFPDF 226 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------CCCCTT
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-------CCCCcc
Confidence 2345799999999999999999999999999999999999999964321 11122221111 112121
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+|+.+||+.||++|||++|+++
T Consensus 227 ----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 ----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1236778999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-38 Score=292.59 Aligned_cols=178 Identities=29% Similarity=0.479 Sum_probs=141.2
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|.. .+|+.||||.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999996 45999999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 45669999999 999999999999999999999999999987754332 2344
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+........ +.+ ..+..
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~------~~~--~~~~~ 241 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------PEL--QNPEK 241 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS------CCC--SSGGG
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC------CCC--CCccc
Confidence 67999999999999999999999999999999999999999643321 11111111111 111 11122
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2346788999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=296.08 Aligned_cols=184 Identities=28% Similarity=0.399 Sum_probs=138.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|++++++.||||.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g 96 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 96 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCC
Confidence 578889999999999999999998889999987
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 238 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 238 (408)
++.||+|||+. +|+||||||+||||+.++.+||+|||+++............
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 55669999999 99999999999999999999999999998765444444444
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 318 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 318 (408)
..||+.|+|||++....++.++|||||||++|||++|..|+...... ......+ . .+.. +..+. .
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i---~-~~~~-----~~~~~----~ 238 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV---E-RGYR-----MPCPP----E 238 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH---H-TTCC-----CCCCT----T
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH---H-hcCC-----CCCCc----c
Confidence 66899999999999999999999999999999999976665432211 1122221 1 1111 11111 2
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcCC
Q 015360 319 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 352 (408)
Q Consensus 319 ~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~~ 352 (408)
...++.+|+.+||+.||++|||+++|+++|+...
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2236888999999999999999999999998743
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-39 Score=300.84 Aligned_cols=191 Identities=24% Similarity=0.351 Sum_probs=148.9
Q ss_pred eHHHHHHHhcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe--------------------------------
Q 015360 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL-------------------------------- 183 (408)
Q Consensus 142 ~~~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~-------------------------------- 183 (408)
.|.+|+...++|.+.+.||+|+||+||+|++. +++.||||++
T Consensus 4 ~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred chhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 36778888899999999999999999999964 3578999987
Q ss_pred -----------------------------------------------------------------hhhhHHHhhhCCCCc
Q 015360 184 -----------------------------------------------------------------LNNRLAYLHEGLEPK 198 (408)
Q Consensus 184 -----------------------------------------------------------------~~~~L~yLH~~~~~~ 198 (408)
++.+|+|||+. +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence 34459999998 9
Q ss_pred eeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCC-
Q 015360 199 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR- 276 (408)
Q Consensus 199 ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~- 276 (408)
||||||||+|||++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999999999999999999999866443222 233456889999999999999999999999999999999985
Q ss_pred CCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 277 NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 277 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
+||...... +..... ..+... ..+. ....++.+|+.+||+.||++||||.||+++|+.+
T Consensus 241 ~p~~~~~~~------e~~~~v-~~~~~~-----~~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 241 QPYYGMAHE------EVIYYV-RDGNIL-----ACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp CTTTTSCHH------HHHHHH-HTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCCHH------HHHHHH-HcCCCC-----CCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 566543221 112222 222111 1111 1223688999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=299.84 Aligned_cols=147 Identities=28% Similarity=0.466 Sum_probs=114.2
Q ss_pred hhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccch
Q 015360 185 NNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 185 ~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||
T Consensus 174 ~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 3459999998 9999999999999999999999999999876544332 23445689999999999999999999999
Q ss_pred hhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 264 SFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 264 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
||||++|||+| |+.||....... .+. ..+..+. .+..+.. ....+.+|+.+||+.||++|||++
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~--~~~----~~~~~~~-----~~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDA--NFY----KLIQNGF-----KMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH--HHH----HHHHTTC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHH--HHH----HHHhcCC-----CCCCCCc----CCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999998 899997544321 111 1221111 1111111 224688899999999999999999
Q ss_pred HHHHHHh
Q 015360 343 HVIHMLE 349 (408)
Q Consensus 343 evl~~Le 349 (408)
||+++|.
T Consensus 316 ei~~~L~ 322 (325)
T d1rjba_ 316 NLTSFLG 322 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-38 Score=291.10 Aligned_cols=182 Identities=26% Similarity=0.444 Sum_probs=142.4
Q ss_pred cCCCccce-eccCCcEEEEEEEeC---CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENV-IGEGGYGIVYRGILS---DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~-lg~G~~g~Vy~g~~~---~~~~vavK~~------------------------------------------- 183 (408)
++|...++ ||+|+||+||+|.+. ++..||||.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 45666664 999999999999864 3557999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 55679999998 999999999999999999999999999998755433
Q ss_pred ce--ecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 234 YV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 234 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+... +..+.. +.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~~~~-----~~ 232 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKR-----ME 232 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCC-----CC
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC-----CC
Confidence 22 223458899999999999999999999999999999998 99999754321 22221 112211 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
.+. .....+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 233 ~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 CPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 1224678899999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=290.69 Aligned_cols=179 Identities=27% Similarity=0.385 Sum_probs=129.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +|+.||||.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999964 5899999986
Q ss_pred ----------------------------------hhhhHHHhhhCC--CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ----------------------------------LNNRLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~--~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 445699999862 12499999999999999999999999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+ ..... .....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~---~~~i~-~~~~~--- 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL---AGKIR-EGKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHH-HTCCC---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHH---HHHHH-cCCCC---
Confidence 654332 23346799999999999999999999999999999999999999964321 111 11111 11111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.++.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 233 --~~~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --RIPYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCcc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111 2236788999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=297.01 Aligned_cols=189 Identities=24% Similarity=0.391 Sum_probs=139.9
Q ss_pred HHHHHHhcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe----------------------------------
Q 015360 144 RELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL---------------------------------- 183 (408)
Q Consensus 144 ~~l~~~t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~---------------------------------- 183 (408)
.+++...++|...+.||+|+||.||+|.+. +++.||||.+
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344444578999999999999999999964 2468999987
Q ss_pred ---------------------------------------------------------hhhhHHHhhhCCCCceeeecccc
Q 015360 184 ---------------------------------------------------------LNNRLAYLHEGLEPKVVHRDVKS 206 (408)
Q Consensus 184 ---------------------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~ 206 (408)
++.||.|||+. +|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 34569999998 999999999
Q ss_pred CceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCC
Q 015360 207 SNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITG-RNPVDYSRP 284 (408)
Q Consensus 207 ~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG-~~Pf~~~~~ 284 (408)
+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443332 23446799999999999999999999999999999999996 567764332
Q ss_pred CCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 285 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.. .+.. .+..+.. +..+.. ....+.+|+.+||+.||++|||+.||+++|+.
T Consensus 243 ~~--~~~~----~~~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 243 DE--EFCR----RLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp SH--HHHH----HHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHH----HHhcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 21 1111 1111111 111111 22368889999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-38 Score=292.61 Aligned_cols=176 Identities=25% Similarity=0.391 Sum_probs=137.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +++.||||.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56899999999999999999974 5899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~- 233 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 44569999999 999999999999999999999999999987643322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+......... ..++.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~-------~~~p~ 231 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLE-------YDFPE 231 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTC-------CCCCT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCC-------CCCCc
Confidence 223446799999999999999999999999999999999999999974321 11122222111 11222
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.. ...+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 232 KF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 12 235788999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-38 Score=298.71 Aligned_cols=191 Identities=24% Similarity=0.395 Sum_probs=139.0
Q ss_pred HhcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe--------------------------------------------
Q 015360 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 149 ~t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~-------------------------------------------- 183 (408)
..++|...+.||+|+||+||+|+.. +|+.||||.+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 5899999986
Q ss_pred -----------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..||.|||+ . +|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 4556999996 5 89999999999999999999999999998654322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC------------
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR------------ 301 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------ 301 (408)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..... ... ........
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE-LMF-GCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH-HHC---------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHH-HHHhcCCcccCCcccccccc
Confidence 23467999999999999999999999999999999999999999754422110 000 00000000
Q ss_pred Cc-----------------ccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 KS-----------------EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ~~-----------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.. ........+..+......++.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 00000000011111122467889999999999999999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-37 Score=287.69 Aligned_cols=178 Identities=24% Similarity=0.380 Sum_probs=138.1
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||+||+|+.. +++.||||.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999975 5889999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 45669999999 999999999999999999999999999976533211 22
Q ss_pred cccccccCcccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 237 TRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
....||+.|+|||++. ...|+.++|||||||++|||++|+.||....... . +........ +.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~~~~~------~~~ 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIAKSEP------PTL 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHHSCC------CCC
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHHcCCC------CCC
Confidence 3467999999999984 4568899999999999999999999997543321 1 111111111 111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223346888999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=287.41 Aligned_cols=175 Identities=30% Similarity=0.450 Sum_probs=136.6
Q ss_pred ceeccCCcEEEEEEEeCC---CcEEEEEEe--------------------------------------------------
Q 015360 157 NVIGEGGYGIVYRGILSD---GTKVAVKNL-------------------------------------------------- 183 (408)
Q Consensus 157 ~~lg~G~~g~Vy~g~~~~---~~~vavK~~-------------------------------------------------- 183 (408)
+.||+|+||+||+|.+.+ ++.||||.+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 579999999999998754 467999987
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce--ecc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTR 238 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~--~~~ 238 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 45669999998 99999999999999999999999999998765443322 233
Q ss_pred cccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcH
Q 015360 239 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 317 (408)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 317 (408)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+..+.. +..+.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~-----~~~p~---- 233 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGER-----MGCPA---- 233 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCC-----CCCCT----
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHcCCC-----CCCCc----
Confidence 568999999999999999999999999999999998 89999753321 1111 1211111 11111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 318 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 318 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 122467889999999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=280.94 Aligned_cols=174 Identities=26% Similarity=0.440 Sum_probs=131.2
Q ss_pred CccceeccCCcEEEEEEEeC-CCcEEEEEEe-------------------------------------------------
Q 015360 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNL------------------------------------------------- 183 (408)
Q Consensus 154 ~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~------------------------------------------------- 183 (408)
.+.+.||+|+||+||+|+.. +++.||||.+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34468999999999999975 4789999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeC-CCCceEEeccCCceeecCCCc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.||+|||+. .++|+||||||+|||++ .++.+||+|||+++......
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~- 169 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 169 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc-
Confidence 45569999997 12399999999999996 57899999999997643322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ...... +..+......
T Consensus 170 --~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~-i~~~~~~~~~------ 234 (270)
T d1t4ha_ 170 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR-VTSGVKPASF------ 234 (270)
T ss_dssp --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH-HTTTCCCGGG------
T ss_pred --cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHH-HHcCCCCccc------
Confidence 234679999999999865 6999999999999999999999999643221 111111 1111111111
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
......++.+|+.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112235788999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=287.77 Aligned_cols=182 Identities=25% Similarity=0.444 Sum_probs=132.7
Q ss_pred hcCCCccceeccCCcEEEEEEEeCC----CcEEEEEEe------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNL------------------------------------------ 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~~----~~~vavK~~------------------------------------------ 183 (408)
.++|...+.||+|+||.||+|++.. +..||||.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 3578888999999999999999753 356889976
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 45669999999 99999999999999999999999999998765544
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
........||+.|+|||++.+..++.++|||||||++|||++ |.+||...... .+...+ .. +.. +..
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i---~~-~~~-----~~~ 230 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---EN-GER-----LPM 230 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---HT-TCC-----CCC
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHH---Hc-CCC-----CCC
Confidence 444455668999999999999999999999999999999998 89999755432 222211 11 111 111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+. .....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 231 ~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 231 PP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 122468889999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-37 Score=293.13 Aligned_cols=172 Identities=27% Similarity=0.425 Sum_probs=135.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
.|...+.||+|+||+||+|+.. +++.||||.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999964 5889999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 45669999999 9999999999999999999999999999865432
Q ss_pred ecccccccCccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 236 TTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... .+.+........ +.+.
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~------~~~~ 235 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------PALQ 235 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------CCCS
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC------CCCC
Confidence 23569999999999864 4589999999999999999999999964321 111222211111 1111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. ......+.+|+.+||+.||++|||++|+++
T Consensus 236 ~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 111236788999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=293.35 Aligned_cols=181 Identities=28% Similarity=0.505 Sum_probs=138.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCC-Cc----EEEEEEe------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD-GT----KVAVKNL------------------------------------------ 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~-~~----~vavK~~------------------------------------------ 183 (408)
.+|...++||+|+||+||+|.+.. |+ +||||.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 358889999999999999999753 43 6899876
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 55679999998 99999999999999999999999999998765433
Q ss_pred cc-eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 233 SY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
.. ......||+.|+|||++.++.++.++|||||||++|||+| |++||....... +...+.. +.. +.
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~----~~~-----~~ 233 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----GER-----LP 233 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHH----TCC-----CC
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CCC-----CC
Confidence 32 2233568999999999999999999999999999999999 888987543322 2222211 110 11
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
.+ ......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 234 ~p----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 234 QP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp CC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11 1122467889999999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=288.83 Aligned_cols=194 Identities=26% Similarity=0.388 Sum_probs=144.1
Q ss_pred CCCccceeccCCcEEEEEEEeCCCcEEEEEEe------------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNL------------------------------------------------ 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~------------------------------------------------ 183 (408)
.|...+.||+|+||.||+|++ +|+.||||.+
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 466678999999999999998 5899999987
Q ss_pred --------------------------hhhhHHHhhhC-----CCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 --------------------------LNNRLAYLHEG-----LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~-----~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.+|+|||.. +..+|+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred ccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 34559999963 13599999999999999999999999999998875543
Q ss_pred cce---ecccccccCcccccccccCC------CCccccchhhHHHHHHHHhCCCCCCCCCCCCcc--------hhHHHHH
Q 015360 233 SYV---TTRVMGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--------NLVDWLK 295 (408)
Q Consensus 233 ~~~---~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~--------~~~~~~~ 295 (408)
... .....||+.|+|||++.+.. ++.++|||||||++|||+||..||......... .......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 322 23467999999999987543 567899999999999999999887543322110 1111222
Q ss_pred HHhcCCCcccccCCCCCCCC-cHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 296 TMVGSRKSEEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 296 ~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
....... .+|.++... ..+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 243 ~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 243 KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2222111 223332222 33456778999999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-36 Score=290.23 Aligned_cols=177 Identities=27% Similarity=0.411 Sum_probs=138.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.++||+|+||.||+|+.. +|+.||||.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 5899999986
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 44559999999 9999999999999999999999999999876543
Q ss_pred CcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 310 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 310 (408)
. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ..... ..... ...
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~-~~~~~------~~~ 227 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDR-MTLTM------AVE 227 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHH-HSSSC------CCC
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH-hcccC------CCC
Confidence 2 234579999999999874 5689999999999999999999999976543321 11111 11110 111
Q ss_pred CCCCCcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 311 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 311 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
++.. ....+.+|+.+||+.||++||| ++|++++
T Consensus 228 ~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 228 LPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111 1235788999999999999999 5777653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=286.16 Aligned_cols=182 Identities=25% Similarity=0.416 Sum_probs=134.8
Q ss_pred cCCCccceeccCCcEEEEEEEeCC--C--cEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSD--G--TKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~--~--~~vavK~~------------------------------------------- 183 (408)
++|.+.+.||+|+||.||+|++.. + ..||||.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 468888999999999999998643 2 36899976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCC
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~ 231 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 55669999998 9999999999999999999999999999987544
Q ss_pred Ccc--eecccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccC
Q 015360 232 RSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 308 (408)
Q Consensus 232 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 308 (408)
... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+............
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~---- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL---- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC----
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCC----
Confidence 332 2233457889999999999999999999999999999998 8999964322 22222222222111
Q ss_pred CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 309 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 309 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
..+. .....+.+|+.+||+.||++||||.||++.|++
T Consensus 235 -~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 -PRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111 112367889999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-36 Score=283.12 Aligned_cols=180 Identities=22% Similarity=0.297 Sum_probs=129.0
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|.+.+.||+|+||+||+|+.. +++.||||.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466899999999999999999975 5899999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceeecCCC
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~~~~~ 232 (408)
++.||+|||+. +|+||||||+|||+. .++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 45669999999 999999999999994 57889999999998664332
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCC
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 312 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 312 (408)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .+.
T Consensus 165 ~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~-------~~~ 229 (307)
T d1a06a_ 165 V--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAEY-------EFD 229 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTCC-------CCC
T ss_pred e--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccCC-------CCC
Confidence 2 2346799999999999999999999999999999999999999964321 111112221111 111
Q ss_pred CCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 313 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 313 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..........+.+|+.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111223467889999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-36 Score=276.47 Aligned_cols=177 Identities=33% Similarity=0.421 Sum_probs=135.9
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|.+.+.||+|+||.||+|.++ |+.||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 45777899999999999999995 889999988
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 158 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC----c
Confidence 55669999998 99999999999999999999999999998653322 2
Q ss_pred ccccccCcccccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCc
Q 015360 238 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 316 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 316 (408)
...++..|+|||++.+..++.++|||||||++|||+| |++||...... ++..++ ..+.. +.++..
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~-----~~~~~~-- 224 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYK-----MDAPDG-- 224 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCC-----CCCCTT--
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCC-----CCCCcc--
Confidence 3457889999999999999999999999999999998 78887644322 222222 11111 112221
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 317 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 317 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
...++.+|+.+||+.||++||||.||+++|+..
T Consensus 225 --~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 225 --CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 223678899999999999999999999999863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-36 Score=289.32 Aligned_cols=179 Identities=22% Similarity=0.299 Sum_probs=140.6
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +|+.||||.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47889999999999999999974 5899999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeC--CCCceEEeccCCceeecCCCcc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~--~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 45669999999 999999999999995 467899999999987754433
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+....... ..+...
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~~~~ 247 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCD-------WNMDDS 247 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-------CCSCCG
T ss_pred -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CCCCcc
Confidence 2346799999999999999999999999999999999999999964321 12222221111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467889999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-36 Score=282.85 Aligned_cols=173 Identities=29% Similarity=0.417 Sum_probs=138.9
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +|+.||||++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999974 5899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.+|+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 44559999999 99999999999999999999999999998764332
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..++..
T Consensus 159 --~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~-------~~~p~~ 223 (316)
T d1fota_ 159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE-------LRFPPF 223 (316)
T ss_dssp --CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC-------CCCCTT
T ss_pred --ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCC-------CCCCCC
Confidence 346799999999999999999999999999999999999999974321 12222222111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 347 (408)
. ...+.+++.+||+.||.+|+ |++|++++
T Consensus 224 ~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 F----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp S----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 23577899999999999996 89998874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-35 Score=275.84 Aligned_cols=183 Identities=26% Similarity=0.357 Sum_probs=136.8
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|.. .+++.||||.+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688999999999999999996 46999999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.||+|||+. +|+||||||+|||++.++..+|+|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 45569999998 999999999999999999999999999876533
Q ss_pred CCc--ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc-cccc
Q 015360 231 ERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS-EEVV 307 (408)
Q Consensus 231 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 307 (408)
... .......||+.|+|||++.+..++.++|||||||++|||+||++||..... .+........... ....
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSAR 237 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCGGGT
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCCchh
Confidence 222 223446799999999999999999999999999999999999999974321 1222222222211 1111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCC-CHhHHHHHHhc
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEA 350 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~Le~ 350 (408)
.+. ....+.+++.+||+.||++|| |++++++.|..
T Consensus 238 ~~~--------~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 238 HEG--------LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSS--------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccC--------CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 111 123678899999999999999 89999988865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=287.23 Aligned_cols=176 Identities=24% Similarity=0.365 Sum_probs=139.8
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.++||+|+||.||+|+. .+|+.||||.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999996 46899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 44559999999 999999999999999999999999999986543322
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.. .......... ..++..
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~-------~~~p~~ 227 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE-------IRFPRT 227 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------CCCCTT
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCC-------CCCCcc
Confidence 234467999999999999999999999999999999999999999754321 1112111111 112222
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 347 (408)
. ...+.+|+.+||+.||.+||+ ++|++++
T Consensus 228 ~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 228 L----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp S----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 2 235778999999999999995 7777663
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-36 Score=289.75 Aligned_cols=172 Identities=26% Similarity=0.376 Sum_probs=138.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +|+.||||.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46889999999999999999974 5999999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||.|||+. +||||||||+|||++.++.+||+|||+++......
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 44569999999 99999999999999999999999999998764332
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
....||+.|||||++.+..++.++|||||||++|||+||+.||..... ........... +..+..
T Consensus 196 --~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~-------~~~p~~ 260 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK-------VRFPSH 260 (350)
T ss_dssp --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------CCCCTT
T ss_pred --ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCC-------CCCCcc
Confidence 335799999999999999999999999999999999999999964321 11122221111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCC-----CHhHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 346 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~ 346 (408)
....+.+|+.+||+.||.+|+ |++|+++
T Consensus 261 ----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 223678899999999999994 8899876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-36 Score=288.34 Aligned_cols=179 Identities=20% Similarity=0.272 Sum_probs=140.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|.+.+.||+|+||+||+|+.. +|+.||||.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46888999999999999999964 6999999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeC--CCCceEEeccCCceeecCCCcc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~--~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||.|||+. +|+||||||+|||++ .++.+||+|||++........
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 45669999999 999999999999997 578999999999988754432
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.+....... ..++..
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~-------~~~~~~ 250 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD-------WEFDED 250 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC-------CCCCSS
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CCCCcc
Confidence 33456899999999999999999999999999999999999999643221 1111111111 111111
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+|+.+||+.||.+|||+.|++++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222367889999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-36 Score=280.13 Aligned_cols=188 Identities=21% Similarity=0.273 Sum_probs=141.0
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+. .+|+.||||.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 4588899999999999999996 45899999976
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeC---CCCceEEeccCCceeecCCCcc-
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSY- 234 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kL~Dfg~a~~~~~~~~~- 234 (408)
++.+|+|||+. +|+||||||+|||++ .+..+||+|||+++........
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 45569999999 999999999999985 4567999999999987543321
Q ss_pred -----eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCC
Q 015360 235 -----VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 309 (408)
Q Consensus 235 -----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 309 (408)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................... ..+
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-LCK 242 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH-HTT
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH-hcc
Confidence 12345799999999999999999999999999999999999999976554332222211111100000000 011
Q ss_pred CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 310 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 310 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
. ...++.+++.+||+.||++||++.++.+.|+.
T Consensus 243 ~--------~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 243 G--------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp T--------SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred C--------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1 12368889999999999999999999988875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-36 Score=283.18 Aligned_cols=190 Identities=25% Similarity=0.318 Sum_probs=140.5
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-C-CcEEEEEEe--------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-D-GTKVAVKNL-------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~-~~~vavK~~-------------------------------------------- 183 (408)
.++|...+.||+|+||+||+|+.. + ++.||||++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 367999999999999999999963 3 667999986
Q ss_pred ---------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCC
Q 015360 184 ---------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 224 (408)
Q Consensus 184 ---------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~ 224 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 34559999999 999999999999999999999999999
Q ss_pred ceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc
Q 015360 225 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 304 (408)
Q Consensus 225 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (408)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..........
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGG
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCchh
Confidence 87653322 234467999999999999999999999999999999999999999754322 1111121111111000
Q ss_pred cc---------cCCCCCC----CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 EV---------VDPKLPK----MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 ~~---------~d~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
.+ ....... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000000 0011122457789999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-35 Score=275.37 Aligned_cols=178 Identities=22% Similarity=0.288 Sum_probs=138.5
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
+.|...+.||+|+||+||+|+.. +|+.||||.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999974 5899999976
Q ss_pred --------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC----ceEEeccCCcee
Q 015360 184 --------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAKL 227 (408)
Q Consensus 184 --------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kL~Dfg~a~~ 227 (408)
+..||+|||+. +|+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 34559999999 999999999999998766 499999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 167 ~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 167 IDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNY----- 233 (293)
T ss_dssp CTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCC-----
T ss_pred cCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHhcCC-----
Confidence 644332 2345689999999999999999999999999999999999999974322 111222111110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.+...........+.+|+.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 --EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0100001112346788999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-36 Score=281.84 Aligned_cols=150 Identities=27% Similarity=0.452 Sum_probs=112.9
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc---eecccccccCcccccccccCCCCccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY---VTTRVMGTFGYVAPEYACTGMLNEKS 260 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~s 260 (408)
++.||.|||+. +|+||||||+|||+++++.+||+|||+++........ ......||+.|+|||.+....++.++
T Consensus 139 ia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks 215 (311)
T d1r0pa_ 139 VAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 215 (311)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHH
T ss_pred HHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChh
Confidence 45569999999 9999999999999999999999999999876443222 12335689999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC
Q 015360 261 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 340 (408)
Q Consensus 261 DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 340 (408)
||||||+++|||+||..||...... .....++ .. +.. ...| .. ....+.+|+.+||+.||++|||
T Consensus 216 DI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~-g~~--~~~p---~~----~~~~l~~li~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 216 DVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQ-GRR--LLQP---EY----CPDPLYEVMLKCWHPKAEMRPS 280 (311)
T ss_dssp HHHHHHHHHHHHHTTSCCSCC--------CHHHH---HT-TCC--CCCC---TT----CCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---Hc-CCC--CCCc---cc----CcHHHHHHHHHHcCCCHhHCcC
Confidence 9999999999999988877543221 1122221 11 111 1111 11 1236888999999999999999
Q ss_pred HhHHHHHHhcC
Q 015360 341 MGHVIHMLEAD 351 (408)
Q Consensus 341 ~~evl~~Le~~ 351 (408)
|.||++.|+..
T Consensus 281 ~~ei~~~L~~i 291 (311)
T d1r0pa_ 281 FSELVSRISAI 291 (311)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-36 Score=282.97 Aligned_cols=183 Identities=23% Similarity=0.444 Sum_probs=143.3
Q ss_pred hcCCCccceeccCCcEEEEEEEeC------CCcEEEEEEe----------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNL---------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~------~~~~vavK~~---------------------------------------- 183 (408)
.++|...+.||+|+||+||+|.+. +++.||||++
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999874 2578999987
Q ss_pred -------------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEe
Q 015360 184 -------------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 220 (408)
Q Consensus 184 -------------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~ 220 (408)
++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 44569999998 99999999999999999999999
Q ss_pred ccCCceeecCCCcce-ecccccccCcccccccccCCCCccccchhhHHHHHHHHhCC-CCCCCCCCCCcchhHHHHHHHh
Q 015360 221 DFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR-NPVDYSRPQGEVNLVDWLKTMV 298 (408)
Q Consensus 221 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~ 298 (408)
|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||+||. +||.... ..+......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHHHHH
Confidence 999998764433322 23446899999999999999999999999999999999985 6775332 222222222
Q ss_pred cCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhcC
Q 015360 299 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 351 (408)
Q Consensus 299 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~~ 351 (408)
... .. ..+.. ....+.+|+.+||+.||++|||+.||+++|+..
T Consensus 250 ~~~-~~-----~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGG-LL-----DKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTC-CC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCC-CC-----CCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 211 11 11111 223688899999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-36 Score=281.95 Aligned_cols=149 Identities=25% Similarity=0.419 Sum_probs=115.0
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc-eecccccccCcccccccccCCCCccccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
++.||+|||+. +||||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||
T Consensus 144 i~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di 220 (299)
T d1fgka_ 144 VARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220 (299)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence 44569999999 9999999999999999999999999999876543332 2344568899999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++|||++ |.+||...... . +...+..+.. +..+.. ....+.+|+.+||+.||++|||+
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~---~----~~~~i~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~Rps~ 284 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVE---E----LFKLLKEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTF 284 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHH---H----HHHHHHTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhHHHHHHhccCCCCCCCCCCHH---H----HHHHHHcCCC-----CCCCcc----chHHHHHHHHHHccCCHhHCcCH
Confidence 999999999998 78888643321 1 1122222211 111111 22368889999999999999999
Q ss_pred hHHHHHHhcC
Q 015360 342 GHVIHMLEAD 351 (408)
Q Consensus 342 ~evl~~Le~~ 351 (408)
.||++.|+..
T Consensus 285 ~eil~~L~~i 294 (299)
T d1fgka_ 285 KQLVEDLDRI 294 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-36 Score=276.98 Aligned_cols=168 Identities=26% Similarity=0.427 Sum_probs=133.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.++||+|+||+||+|+.. +|+.||||.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 56888999999999999999964 6899999975
Q ss_pred -----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-CCceEEeccCCcee
Q 015360 184 -----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKL 227 (408)
Q Consensus 184 -----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kL~Dfg~a~~ 227 (408)
+..||+|||+. +|+||||||+|||++. ++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 34559999999 9999999999999985 47899999999987
Q ss_pred ecCCCcceecccccccCcccccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccc
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 306 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (408)
..... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... ...
T Consensus 161 ~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~----~~~----- 220 (273)
T d1xwsa_ 161 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EII----RGQ----- 220 (273)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH----HCC-----
T ss_pred ccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHh----hcc-----
Confidence 54322 234679999999999987665 567899999999999999999996321 111 110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 307 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 307 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..++... ..++.+|+.+||+.||++|||++|+++.
T Consensus 221 --~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 --VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111111 2367889999999999999999999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-36 Score=282.94 Aligned_cols=149 Identities=25% Similarity=0.437 Sum_probs=113.3
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc-ceecccccccCcccccccccCCCCccccc
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDV 262 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv 262 (408)
++.||+|||+. +++||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||
T Consensus 154 i~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI 230 (311)
T d1t46a_ 154 VAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (311)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence 34559999999 999999999999999999999999999987654333 23345678999999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCH
Q 015360 263 YSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 341 (408)
Q Consensus 263 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 341 (408)
|||||++|||+| |.+||....... .+...+. .+. .+..+. .....+.+|+.+||+.||++||||
T Consensus 231 wS~G~~l~ellt~g~p~~~~~~~~~--~~~~~i~----~~~-----~~~~~~----~~~~~l~~Li~~cl~~dP~~RPs~ 295 (311)
T d1t46a_ 231 WSYGIFLWELFSLGSSPYPGMPVDS--KFYKMIK----EGF-----RMLSPE----HAPAEMYDIMKTCWDADPLKRPTF 295 (311)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSH--HHHHHHH----HTC-----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cchHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh----cCC-----CCCCcc----cccHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999 555554433221 1111121 111 111111 122368889999999999999999
Q ss_pred hHHHHHHhc
Q 015360 342 GHVIHMLEA 350 (408)
Q Consensus 342 ~evl~~Le~ 350 (408)
.||+++|+.
T Consensus 296 ~~il~~L~~ 304 (311)
T d1t46a_ 296 KQIVQLIEK 304 (311)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=279.77 Aligned_cols=183 Identities=25% Similarity=0.319 Sum_probs=139.5
Q ss_pred cCCCcc-ceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 151 SGLCEE-NVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~-~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
++|.+. ++||+|+||+||+|+. .+++.||||.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 578765 4699999999999996 45899999987
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC---CCceEEeccCCceeecCC
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLLCSE 231 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kL~Dfg~a~~~~~~ 231 (408)
+..||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCC
Confidence 45569999999 9999999999999975 457999999999876543
Q ss_pred CcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCC
Q 015360 232 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 311 (408)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 311 (408)
.. .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||......... ..+..... .....+
T Consensus 168 ~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~------~~~~~~ 236 (335)
T d2ozaa1 168 NS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIR------MGQYEF 236 (335)
T ss_dssp CC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC------SCSSSC
T ss_pred Cc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHh------cCCCCC
Confidence 32 23467999999999999999999999999999999999999999755432211 11111000 001111
Q ss_pred CCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 312 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 312 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+..........+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 121222344578899999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=278.24 Aligned_cols=184 Identities=24% Similarity=0.319 Sum_probs=135.4
Q ss_pred cceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------------
Q 015360 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------------- 183 (408)
Q Consensus 156 ~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------------- 183 (408)
.++||+|+||+||+|... +|+.||||++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999964 5899999976
Q ss_pred --------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceec
Q 015360 184 --------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 237 (408)
Q Consensus 184 --------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 237 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-cc
Confidence 44559999999 9999999999999999999999999999866443322 23
Q ss_pred ccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc---------
Q 015360 238 RVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV--------- 307 (408)
Q Consensus 238 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 307 (408)
...||+.|+|||++... .++.++|||||||++|||++|++||...... +....+.............
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhccchhh
Confidence 35689999999998754 5799999999999999999999999754322 2222222222111110000
Q ss_pred -CCCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 308 -DPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 308 -d~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
....+..+.. .....+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0011111111 12346889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-36 Score=278.43 Aligned_cols=189 Identities=24% Similarity=0.371 Sum_probs=136.3
Q ss_pred cCCCccceeccCCcEEEEEEEeCCCcEEEEEEe-----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~----------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.++|+.||||.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578889999999999999999999999999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCccee
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 236 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 236 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 45569999998 999999999999999999999999999987643322 22
Q ss_pred cccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc------cc---
Q 015360 237 TRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------EV--- 306 (408)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~--- 306 (408)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.......... ..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhhhhc
Confidence 334688999999998754 5689999999999999999999999743321 1111111111110000 00
Q ss_pred ---c---CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 307 ---V---DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 307 ---~---d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. .+.............+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000001112346788999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=280.89 Aligned_cols=175 Identities=26% Similarity=0.427 Sum_probs=139.4
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +++.||||.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999975 5899999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 44559999999 999999999999999999999999999986543322
Q ss_pred ceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCC
Q 015360 234 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 313 (408)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 313 (408)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ....... .+.++.
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i~~~-------~~~~p~ 224 (320)
T d1xjda_ 159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL---FHSIRMD-------NPFYPR 224 (320)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHC-------CCCCCT
T ss_pred -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHHcC-------CCCCCc
Confidence 234467999999999999999999999999999999999999999743321 11 1111111 112222
Q ss_pred CCcHHHHHHHHHHHHhccCcCCCCCCCHh-HHHH
Q 015360 314 MPASKALKRVLLVALRCVDPDATKRPKMG-HVIH 346 (408)
Q Consensus 314 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 346 (408)
.. ...+.+|+.+||+.||++|||+. |+++
T Consensus 225 ~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 WL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22 23578899999999999999995 6754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-35 Score=276.71 Aligned_cols=191 Identities=25% Similarity=0.331 Sum_probs=138.7
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +|+.||||++
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57888899999999999999974 6999999986
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+..||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 44559999999 999999999999999999999999999977
Q ss_pred ecCCCcc---eecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCc
Q 015360 228 LCSERSY---VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 303 (408)
Q Consensus 228 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 303 (408)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.........
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITP 243 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhcCCCCh
Confidence 6432221 12235689999999998765 6899999999999999999999999743321 111222222211100
Q ss_pred c---cc---------cCCCCCCCCcHHH------HHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 304 E---EV---------VDPKLPKMPASKA------LKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 304 ~---~~---------~d~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
. .. ...........+. ...+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00 0000001111111 2356789999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=276.21 Aligned_cols=190 Identities=25% Similarity=0.339 Sum_probs=139.3
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+. .+++.||||.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999996 46899999986
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 45569999999 999999999999999999999999999987643332
Q ss_pred eecccccccCcccccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC---Cccc---cc
Q 015360 235 VTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---KSEE---VV 307 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~ 307 (408)
......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+... ....+....... .... ..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhcccccccc
Confidence 233457999999999877655 5789999999999999999999997543211 111111111110 0000 00
Q ss_pred C-----CCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 308 D-----PKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 308 d-----~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
+ +........ .....+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000000001 112467889999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-35 Score=271.11 Aligned_cols=178 Identities=24% Similarity=0.332 Sum_probs=138.2
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+. .+++.+|||++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999996 46899999985
Q ss_pred ------------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 184 ------------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 184 ------------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 34459999999 999999999999999999999999999988
Q ss_pred ecCCCcceecccccccCccccccccc------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC
Q 015360 228 LCSERSYVTTRVMGTFGYVAPEYACT------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 301 (408)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 301 (408)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 160 ~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~~ 231 (277)
T d1phka_ 160 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGN 231 (277)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC
T ss_pred ccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhCC
Confidence 754332 344679999999998853 34688999999999999999999999743321 1111111111
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 302 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 302 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
. .++.........++.+|+.+||+.||++|||++||++
T Consensus 232 -~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 -Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1111112223346888999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=278.18 Aligned_cols=147 Identities=21% Similarity=0.322 Sum_probs=109.8
Q ss_pred hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccch
Q 015360 184 LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 263 (408)
Q Consensus 184 ~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 263 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||
T Consensus 136 ia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvw 210 (309)
T d1fvra_ 136 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVW 210 (309)
T ss_dssp HHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHhhhcC---CccccccccceEEEcCCCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceee
Confidence 34569999999 999999999999999999999999999976433222 2234589999999999999999999999
Q ss_pred hhHHHHHHHHhCC-CCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHh
Q 015360 264 SFGILIMEIITGR-NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 342 (408)
Q Consensus 264 SlGvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 342 (408)
||||++|||++|. +||.... ..+...... .+. .+..+. .....+.+|+.+||+.||++||||.
T Consensus 211 SfGvil~ell~~~~~p~~~~~------~~~~~~~i~-~~~-----~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~ 274 (309)
T d1fvra_ 211 SYGVLLWEIVSLGGTPYCGMT------CAELYEKLP-QGY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFA 274 (309)
T ss_dssp HHHHHHHHHHTTSCCTTTTCC------HHHHHHHGG-GTC-----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhHHHHHHHHhcCCCCCCCCC------HHHHHHHHH-hcC-----CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHH
Confidence 9999999999975 5665332 112222211 111 111111 1234688899999999999999999
Q ss_pred HHHHHHhcC
Q 015360 343 HVIHMLEAD 351 (408)
Q Consensus 343 evl~~Le~~ 351 (408)
||++.|+..
T Consensus 275 eil~~L~~i 283 (309)
T d1fvra_ 275 QILVSLNRM 283 (309)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-34 Score=269.29 Aligned_cols=188 Identities=19% Similarity=0.255 Sum_probs=143.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+.. +|+.||||.+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~ 84 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecC
Confidence 57888999999999999999964 5899999986
Q ss_pred -------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC-----CCceEEeccCCceeecCCCc
Q 015360 184 -------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 -------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~-----~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..+|+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 34559999999 9999999999999964 56799999999987643322
Q ss_pred c------eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 234 Y------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 234 ~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+..........++.
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence 1 1234579999999999999999999999999999999999999998655443322222222111111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHHHhc
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 350 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~Le~ 350 (408)
+.+ .+++.+++..|++.+|++||+++.+.+.|++
T Consensus 242 -~~~--------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 242 -AGF--------PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp -TTS--------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -CCC--------CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111 1367888899999999999999999888775
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-34 Score=274.95 Aligned_cols=188 Identities=26% Similarity=0.394 Sum_probs=136.5
Q ss_pred CCCccceeccCCcEEEEEEEeC-CCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~----------------------------------------------- 183 (408)
+|...++||+|+||+||+|+.. +|+.||||++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 4667789999999999999975 5899999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCCC
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~ 232 (408)
++.||+|||+. +|+||||||+|||++.++ .+||+|||++.......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 45569999998 999999999999998765 89999999998764433
Q ss_pred cceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCC----------
Q 015360 233 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---------- 301 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 301 (408)
. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+.... ......
T Consensus 178 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~-~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 178 P--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEII-KVLGTPTREQIREMNP 252 (350)
T ss_dssp C--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHH-HHHCCCCHHHHHHHCC
T ss_pred c--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHH-HHhCCChHHhhhhhcc
Confidence 2 233578999999998765 568999999999999999999999997543211 111111 111000
Q ss_pred CcccccCCCCCC-----CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 302 KSEEVVDPKLPK-----MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 302 ~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
......-+.... .........+.+|+.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 0111123467889999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-34 Score=268.37 Aligned_cols=180 Identities=18% Similarity=0.294 Sum_probs=139.2
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.++|.+.+.||+|+||+||+|... +++.||||.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 367889999999999999999975 5889999987
Q ss_pred ---------------------------hhhhHHHhhhCCCCceeeeccccCceEeCC--CCceEEeccCCceeecCCCcc
Q 015360 184 ---------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 ---------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~--~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
++.||+|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 45669999998 9999999999999974 45799999999987643332
Q ss_pred eecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcccccCCCCCCC
Q 015360 235 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 314 (408)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 314 (408)
.....+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...... +.......... .++..
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~-------~~~~~ 225 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEY-------TFDEE 225 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------CCCHH
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------CCChh
Confidence 33456899999999999999999999999999999999999999754321 11222211110 00000
Q ss_pred CcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 315 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 315 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001122357889999999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-34 Score=269.38 Aligned_cols=180 Identities=26% Similarity=0.391 Sum_probs=138.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC----CCcEEEEEEe-------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNL------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~----~~~~vavK~~------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|... +|+.||||.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 4789999976
Q ss_pred ----------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeec
Q 015360 184 ----------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 229 (408)
Q Consensus 184 ----------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~ 229 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 44569999999 99999999999999999999999999998775
Q ss_pred CCCcceecccccccCcccccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCccccc
Q 015360 230 SERSYVTTRVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 307 (408)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (408)
...........|++.|++||.+.+. .++.++|||||||+||||++|+.||............ .......
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~------- 251 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS------- 251 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC-------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccC-------
Confidence 5544444556799999999998754 4678999999999999999999999766544322211 1111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCC-----HhHHHH
Q 015360 308 DPKLPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 346 (408)
Q Consensus 308 d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~ 346 (408)
.+.++. .....+.+|+.+||+.||++||| ++|+++
T Consensus 252 ~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111 12346888999999999999995 778765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-34 Score=271.23 Aligned_cols=191 Identities=25% Similarity=0.401 Sum_probs=136.0
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+. .+|+.||||++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688889999999999999986 46999999987
Q ss_pred ------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCc
Q 015360 184 ------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 233 (408)
Q Consensus 184 ------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~ 233 (408)
+..||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 44569999999 999999999999999999999999999987644322
Q ss_pred c--eecccccccCcccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc------
Q 015360 234 Y--VTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------ 304 (408)
Q Consensus 234 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 304 (408)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||........ ..............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHTCC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhhhhhhh
Confidence 2 223466899999999985 45678999999999999999999999975432111 11111111100000
Q ss_pred -------cccCCCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 -------EVVDPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 -------~~~d~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
....+........ ....++.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000111111110 112357889999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-33 Score=267.87 Aligned_cols=187 Identities=25% Similarity=0.369 Sum_probs=132.1
Q ss_pred hcCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~--------------------------------------------- 183 (408)
.+.|...+.||+|+||+||+|+.. +|+.||||++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888899999999999999964 5999999987
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 44569999999 999999999999999999999999999987643
Q ss_pred CCcceecccccccCccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCC-------
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------- 302 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 302 (408)
.. ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+... .............
T Consensus 174 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 174 EM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp SC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHTC
T ss_pred cc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCCcHHHHhhh
Confidence 32 34568999999999876 457899999999999999999999997543211 1111111000000
Q ss_pred -----------cccccCCCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 303 -----------SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 303 -----------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
........+.. ........+.+|+.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 001112357789999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.4e-33 Score=258.98 Aligned_cols=191 Identities=20% Similarity=0.281 Sum_probs=138.3
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...+.||+|+||+||+|+.. +++.||||++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999964 6889999986
Q ss_pred ----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcce
Q 015360 184 ----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 235 (408)
Q Consensus 184 ----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 235 (408)
+..+|+|||+. +|+||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 44569999999 999999999999999999999999999987644332 2
Q ss_pred ecccccccCcccccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc------cccC
Q 015360 236 TTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------EVVD 308 (408)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~d 308 (408)
.....+++.|+|||.+.... ++.++|||||||++|||++|+.||..... .......+.......... ...+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 23345778999999987665 68999999999999999999999753221 111222222221111000 0000
Q ss_pred ---------CCCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 309 ---------PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 309 ---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
..............+.+|+.+||+.||.+|||++||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001111223467889999999999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.98 E-value=6e-33 Score=263.70 Aligned_cols=189 Identities=19% Similarity=0.282 Sum_probs=138.0
Q ss_pred cCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~---------------------------------------------- 183 (408)
++|.+.+.||+|+||+||+|+. .+++.||||++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5789999999999999999997 46899999987
Q ss_pred -----------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCC-ceEEeccCCceeecCCCcceeccc
Q 015360 184 -----------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERSYVTTRV 239 (408)
Q Consensus 184 -----------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 239 (408)
+..||+|||+. +|+||||||+|||++.++ .+||+|||++........ ....
T Consensus 115 ~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~~~~ 189 (328)
T d3bqca1 115 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVR 189 (328)
T ss_dssp CSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--CCSC
T ss_pred CCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc--cccc
Confidence 45669999999 999999999999998654 699999999987654332 2345
Q ss_pred ccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHh------------cCCCccc-
Q 015360 240 MGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV------------GSRKSEE- 305 (408)
Q Consensus 240 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~- 305 (408)
.+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ....+.... .......
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 689999999998765 479999999999999999999999975432211 111011000 0000000
Q ss_pred --ccCC--------CCCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHH
Q 015360 306 --VVDP--------KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 346 (408)
Q Consensus 306 --~~d~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 346 (408)
.... ............++.+|+.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0111111222346788999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-32 Score=260.30 Aligned_cols=192 Identities=22% Similarity=0.263 Sum_probs=131.8
Q ss_pred cCCCccceeccCCcEEEEEEEeC-CCcEEEEEEe----------------------------------------------
Q 015360 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL---------------------------------------------- 183 (408)
Q Consensus 151 ~~f~~~~~lg~G~~g~Vy~g~~~-~~~~vavK~~---------------------------------------------- 183 (408)
++|...++||+|+||+||+|... +|+.||||++
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999975 5999999987
Q ss_pred -------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCC
Q 015360 184 -------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 232 (408)
Q Consensus 184 -------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~ 232 (408)
+..||.|||+. +|+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc
Confidence 34559999999 99999999999999999999999999987654322
Q ss_pred cceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH----------------HHHHH
Q 015360 233 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------------DWLKT 296 (408)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~----------------~~~~~ 296 (408)
......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+........ .....
T Consensus 174 --~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred --ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 234456899999999999999999999999999999999999999744311100000 00000
Q ss_pred HhcCCC------cccccCCC-CCC--CCcHHHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 297 MVGSRK------SEEVVDPK-LPK--MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 297 ~~~~~~------~~~~~d~~-~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
...... ........ ... .........+.+|+.+||+.||++|||++||+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000000 000 1122345678899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.9e-31 Score=256.46 Aligned_cols=189 Identities=21% Similarity=0.234 Sum_probs=135.5
Q ss_pred CCCccceeccCCcEEEEEEEe-CCCcEEEEEEe-----------------------------------------------
Q 015360 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL----------------------------------------------- 183 (408)
Q Consensus 152 ~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~----------------------------------------------- 183 (408)
.|.+.++||+|+||+||+|+. .+|+.||||++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 388889999999999999996 46999999986
Q ss_pred ----------------------------------------hhhhHHHhhh-CCCCceeeeccccCceEeCCCC------c
Q 015360 184 ----------------------------------------LNNRLAYLHE-GLEPKVVHRDVKSSNILLDRQW------N 216 (408)
Q Consensus 184 ----------------------------------------~~~~L~yLH~-~~~~~ivH~dlk~~Nill~~~~------~ 216 (408)
+..||+|||+ . +|+||||||+|||++.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 3445899997 5 999999999999997654 3
Q ss_pred eEEeccCCceeecCCCcceecccccccCcccccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHH-
Q 015360 217 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK- 295 (408)
Q Consensus 217 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~- 295 (408)
++++|||.+...... .....||+.|+|||.+....++.++||||+||++++|++|+.||............+...
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999998765332 234569999999999999999999999999999999999999997543322111111111
Q ss_pred --HHhcCC------------------CcccccCCC----------CCCCCcHHHHHHHHHHHHhccCcCCCCCCCHhHHH
Q 015360 296 --TMVGSR------------------KSEEVVDPK----------LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 345 (408)
Q Consensus 296 --~~~~~~------------------~~~~~~d~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 345 (408)
..+... .....+... ............+.+|+.+||+.||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 111100 000000000 01112345567899999999999999999999998
Q ss_pred HH
Q 015360 346 HM 347 (408)
Q Consensus 346 ~~ 347 (408)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 64
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.5e-32 Score=257.74 Aligned_cols=188 Identities=27% Similarity=0.405 Sum_probs=133.7
Q ss_pred hcCCCccceeccCCcEEEEEEEe-CCCcEEEEEEe---------------------------------------------
Q 015360 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL--------------------------------------------- 183 (408)
Q Consensus 150 t~~f~~~~~lg~G~~g~Vy~g~~-~~~~~vavK~~--------------------------------------------- 183 (408)
+++|...+.||+|+||+||+|+. .+|+.||||++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46788999999999999999995 46999999986
Q ss_pred ---------------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecC
Q 015360 184 ---------------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 230 (408)
Q Consensus 184 ---------------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~ 230 (408)
+..||+|||+. +|+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence 44559999999 999999999999999999999999999875432
Q ss_pred CCcceecccccccCcccccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHHhcCCCcc-----
Q 015360 231 ERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE----- 304 (408)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (408)
. .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.. .....+..........
T Consensus 174 ~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 174 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp G----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHTTC
T ss_pred c----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChHHhhhc
Confidence 2 2335688999999987665 4688999999999999999999999754321 1111111111100000
Q ss_pred ------ccc--CCCCCCCCcH----HHHHHHHHHHHhccCcCCCCCCCHhHHHHH
Q 015360 305 ------EVV--DPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 347 (408)
Q Consensus 305 ------~~~--d~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 347 (408)
... .+........ .....+.+|+.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 0000000000 112457889999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.68 E-value=9.5e-18 Score=145.45 Aligned_cols=102 Identities=19% Similarity=0.188 Sum_probs=77.3
Q ss_pred CccceeccCCcEEEEEEEeCCCcEEEEEEe--------------------------------------------------
Q 015360 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNL-------------------------------------------------- 183 (408)
Q Consensus 154 ~~~~~lg~G~~g~Vy~g~~~~~~~vavK~~-------------------------------------------------- 183 (408)
+..+.||+|+||+||+|+..+|+.||||.+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999888999999964
Q ss_pred -----------------------------hhhhHHHhhhCCCCceeeeccccCceEeCCCCceEEeccCCceeecCCCcc
Q 015360 184 -----------------------------LNNRLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 234 (408)
Q Consensus 184 -----------------------------~~~~L~yLH~~~~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 234 (408)
+..+|.|||+. +|+||||||+|||++++ .++|+|||++.....+...
T Consensus 83 ~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~ 158 (191)
T d1zara2 83 EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR 158 (191)
T ss_dssp ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH
T ss_pred cCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH
Confidence 33449999998 99999999999999865 5899999999765433221
Q ss_pred eecccccccCcccc------cccccCCCCccccchhhHHHH
Q 015360 235 VTTRVMGTFGYVAP------EYACTGMLNEKSDVYSFGILI 269 (408)
Q Consensus 235 ~~~~~~gt~~y~aP------E~~~~~~~~~~sDvwSlGvvl 269 (408)
.|... +.+ ...|+.++|+||+.--+
T Consensus 159 ---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 159 ---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 11111 111 35678899999975443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.85 E-value=0.04 Score=48.79 Aligned_cols=31 Identities=23% Similarity=0.253 Sum_probs=27.4
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCce
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 226 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~ 226 (408)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999988777899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=94.65 E-value=0.037 Score=47.32 Aligned_cols=30 Identities=23% Similarity=0.256 Sum_probs=25.6
Q ss_pred ceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 198 KVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 198 ~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
.++|+|+.+.||+++++..+-|+||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 479999999999999776677999987753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.63 E-value=0.071 Score=47.48 Aligned_cols=30 Identities=23% Similarity=0.221 Sum_probs=24.3
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
..++||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4579999999999999743 45899987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.36 E-value=0.063 Score=45.58 Aligned_cols=31 Identities=23% Similarity=0.223 Sum_probs=26.2
Q ss_pred CceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 197 PKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 197 ~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3589999999999998876678999987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=85.73 E-value=0.21 Score=45.58 Aligned_cols=31 Identities=19% Similarity=0.359 Sum_probs=26.4
Q ss_pred CCceeeeccccCceEeCCCCceEEeccCCcee
Q 015360 196 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 227 (408)
Q Consensus 196 ~~~ivH~dlk~~Nill~~~~~~kL~Dfg~a~~ 227 (408)
...++|+|+.+.|||++++ .++|+||..+..
T Consensus 222 ~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred CcceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 3479999999999999876 489999988765
|